0001414932-24-000016 | 10-K | XBRL Viewer | Oaktree Specialty Lending Corp

Share Data and Net Assets

12 Months Ended

Sep. 30, 2024

Stockholders' Equity Note [Abstract]

The share and per share information disclosed in Note 5 have been retroactively adjusted as necessary to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.

Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the years ended September 30, 2024, 2023 and 2022:


(Share amounts in thousands)	Year ended September 30, 2024		Year ended September 30, 2023		Year ended September 30, 2022
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations	$	57,905	$	117,331	$	29,223
Weighted average common shares outstanding — basic and diluted	80,418		72,119		60,727
Earnings (loss) per common share — basic and diluted	$	0.72	$	1.63	$	0.48

Changes in Net Assets

The following table presents the changes in net assets for the years ended September 30, 2024, 2023 and 2022:


	Common Stock
(Share amounts in thousands)	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2021	60,120	$	601	$	1,805,557	$	(493,335)	$	1,312,823
Net investment income	—	—		—		148,621		148,621
Net unrealized appreciation (depreciation)	—	—		—		(136,248)		(136,248)
Net realized gains (losses)	—	—		—		17,179		17,179
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(329)		(329)
Distributions to stockholders	—	—		—		(118,657)		(118,657)
Issuance of common stock in connection with the "at the market" offering	934	9		20,613		—		20,622
Issuance of common stock under dividend reinvestment plan	166	2		3,407		—		3,409
Repurchase of common stock under dividend reinvestment plan	(95)	(1)		(1,856)		—		(1,857)
Balance as of September 30, 2022	61,125	611		1,827,721		(582,769)		1,245,563
Net investment income	—	—		—		180,697		180,697
Net unrealized appreciation (depreciation)	—	—		—		(28,555)		(28,555)
Net realized gains (losses)	—	—		—		(33,155)		(33,155)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(1,656)		(1,656)
Distributions to stockholders	—	—		—		(185,900)		(185,900)
Issuance of common stock in connection with the OSI2 Merger	15,860	159		333,875		—		334,034
Issuance of common stock in connection with the "at the market" offering	69	1		1,299		—		1,300
Issuance of common stock under dividend reinvestment plan	297	3		5,851		—		5,854
Repurchase of common stock under dividend reinvestment plan	(126)	(2)		(2,416)		—		(2,418)
Balance as of September 30, 2023	77,225	772		2,166,330		(651,338)		1,515,764
Net investment income	—	—		—		175,052		175,052
Net unrealized appreciation (depreciation)	—	—		—		19,101		19,101
Net realized gains (losses)	—	—		—		(136,356)		(136,356)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		108		108
Distributions to stockholders	—	—		—		(184,027)		(184,027)
Issuance of common stock in connection with the "at the market" offering	4,725	47		92,460		—		92,507
Issuance of common stock under dividend reinvestment plan	390	4		7,209		—		7,213
Repurchase of common stock under dividend reinvestment plan	(95)	(1)		(1,550)		—		(1,551)
Balance as of September 30, 2024	82,245	$	822	$	2,264,449	$	(777,460)	$	1,487,811

Distributions

Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the Board of Directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment.

The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Company’s Board of Directors declares a cash distribution, then the Company’s stockholders who have not “opted out” of the Company’s DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash distribution. If the Company’s shares are trading at a premium to net asset value, the Company typically issues new shares to implement the DRIP with such shares issued at the greater of the most recently computed net asset value per share of common stock or 95% of the current market price per share of common stock on the payment date for such distribution. If the Company’s shares are trading at a discount to net asset value, the Company typically purchases shares in the open market in connection with the Company’s obligations under the DRIP.

For income tax purposes, the Company has reported its distributions for the 2023 calendar year as ordinary income. The character of such distributions was appropriately reported to the Internal Revenue Service and stockholders for the 2023 calendar year. To the extent the Company’s taxable earnings for a fiscal and taxable year fall below the amount of distributions

paid for the fiscal and taxable year, a portion of the total amount of the Company’s distributions for the fiscal and taxable year is deemed a return of capital for U.S. federal income tax purposes to the Company’s stockholders.

The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the years ended September 30, 2024, 2023 and 2022:


Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	November 8, 2023	December 15, 2023	December 29, 2023	$	0.55	$	41.7	million	87,472	(1)	$	1.7	million
Special	November 8, 2023	December 15, 2023	December 29, 2023	0.07		5.3		million	11,133	(1)	0.2		million
Quarterly	January 26, 2024	March 15, 2024	March 29, 2024	0.55		42.8		million	96,850	(1)	1.9		million
Quarterly	April 26, 2024	June 14, 2024	June 28, 2024	0.55		43.3		million	100,029	(1)	1.9		million
Quarterly	July 26, 2024	September 16, 2024	September 30, 2024	0.55		43.7		million	94,873	(2)	1.6		million
Total for the year ended September 30, 2024				$	2.27	$	176.8	million	390,357		$	7.2	million
Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	November 10, 2022	December 15, 2022	December 30, 2022	$	0.54	$	32.0	million	53,369	(1)	$	1.1	million
Special	November 10, 2022	December 15, 2022	December 30, 2022	0.42		24.8		million	41,510	(1)	0.8		million
Quarterly	January 27, 2023	March 15, 2023	March 31, 2023	0.55		41.1		million	68,412	(2)	1.3		million
Quarterly	April 28, 2023	June 15, 2023	June 30, 2023	0.55		41.3		million	57,279	(2)	1.1		million
Quarterly	July 28, 2023	September 15, 2023	September 29, 2023	0.55		40.9		million	76,766	(1)	1.5 million
Total for the year ended September 30, 2023				$	2.61	$	180.0	million	297,336		$	5.9	million
Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	October 13, 2021	December 15, 2021	December 31, 2021	$	0.465	$	27.2	million	35,990	(1)	$	0.8	million
Quarterly	January 28, 2022	March 15, 2022	March 31, 2022	0.48		28.5		million	34,804	(1)	0.8		million
Quarterly	April 29, 2022	June 15, 2022	June 30, 2022	0.495		29.4		million	43,676	(2)	0.9		million
Quarterly	July 29, 2022	September 15, 2022	September 30, 2022	0.51		30.2		million	51,181	(2)	1.0		million
Total for the year ended September 30, 2022				$	1.95	$	115.3	million	165,651		$	3.4	million

__________

(1) New shares were issued and distributed.

(2) Shares were purchased on the open market and distributed.

(3) Totals may not sum due to rounding.

Common Stock Issuances

On January 23, 2023, in connection with the OSI2 Merger, the Company issued an aggregate of 15,860,200 shares of common stock to former OSI2 stockholders. During the years ended September 30, 2024, 2023 and 2022, the Company issued 295,484, 171,645 and 70,794 shares of common stock as part of the DRIP, respectively.

The Company is party to an equity distribution agreement, dated February 7, 2022, as amended, by and among the Company, the Adviser and Oaktree Administrator and Keefe, Bruyette & Woods, Inc., Citizens JMP Securities, LLC, Jefferies LLC and Raymond James & Associates, Inc., pursuant to which the Company may offer and sell shares of its common stock from time to time having an aggregate offering price of up to $300.0 million under its current shelf registration statement. Sales of the common stock may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices.

In connection with the "at the market" offering, the Company issued and sold 4,724,506 shares of common stock during the year ended September 30, 2024 for net proceeds of $92.5 million (net of offering costs).


	Number of Shares Issued	Gross Proceeds		Placement Agent Fees		Net Proceeds (1)		Average Sales Price per Share (2)
"At the market" offering	4,724,506	$	93,685	$	937	$	92,748	$	19.83

(1) Net proceeds excludes offering costs of $0.2 million.

(2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.

In connection with the "at the market" offering, the Company issued and sold 68,752 shares of common stock during the year ended September 30, 2023 for net proceeds of $1.3 million (net of offering costs).


	Number of Shares Issued	Gross Proceeds		Placement Agent Fees		Net Proceeds (1)		Average Sales Price per Share (2)
"At the market" offering	68,752	$	1,384	$	14	$	1,370	$	20.13

(1) Net proceeds excludes offering costs of $0.1 million.

(2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-18

+ Details

Subsequent Events	12 Months Ended
Subsequent Events	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company’s management evaluated subsequent events through the date of issuance of the Consolidated Financial Statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in the Consolidated Financial Statements as of and for the fiscal year ended September 30, 2024, except as discussed below. Distribution Declaration On November 7, 2024, the Company’s Board of Directors declared a quarterly distribution of $0.55 per share, payable in cash on December 31, 2024 to stockholders of record on December 16, 2024.

Share Data and Net Assets - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands

12 Months Ended

Sep. 30, 2024

Sep. 30, 2023

Sep. 30, 2022

Earnings (loss) per common share — basic and diluted:

Net increase (decrease) in net assets resulting from operations

$ 57,905

$ 117,331

$ 29,223

Weighted average common shares outstanding - basic (in shares)

^[1]

80,418

72,119

60,727

Weighted average common shares outstanding - diluted (in shares)

^[1]

80,418

72,119

60,727

Earnings (loss) per common share - basic (in dollars per share)

^[1]

$ 0.72

$ 1.63

$ 0.48

Earnings (loss) per common share - diluted (in dollars per share)

^[1]

$ 0.72

$ 1.63

$ 0.48

[1]

As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis as necessary.

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Borrowings - Components of Interest and Other Debt Expenses (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
2025 Notes
Debt Instrument [Line Items]
Coupon interest	$ 10.5	$ 10.5	$ 10.5
Amortization of financing costs and discount	1.3	1.3	1.3
Effect of interest rate swap	0.0	0.0	0.0
Total interest expense	$ 11.8	$ 11.8	$ 11.8
Coupon interest rate (net of effect of interest rate swaps) (as a percent)	3.50%	3.50%	3.50%
2027 Notes
Debt Instrument [Line Items]
Coupon interest	$ 9.5	$ 9.5	$ 9.5
Amortization of financing costs and discount	0.9	0.9	0.9
Effect of interest rate swap	16.3	13.4	(0.4)
Total interest expense	$ 26.7	$ 23.8	$ 10.0
Coupon interest rate (net of effect of interest rate swaps) (as a percent)	7.259%	6.539%	2.585%
2029 Notes
Debt Instrument [Line Items]
Coupon interest	$ 21.3	$ 2.7
Amortization of financing costs and discount	1.3	0.2
Effect of interest rate swap	4.4	0.6
Total interest expense	$ 27.0	$ 3.5
Coupon interest rate (net of effect of interest rate swaps) (as a percent)	8.437%	8.49%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482900/835-30-50-1

+ Details

Consolidated Statements of Changes in Net Assets
shares in Thousands, $ in Thousands

12 Months Ended

Sep. 30, 2024

USD ($)

$ / shares

Sep. 30, 2023

USD ($)

$ / shares

Sep. 30, 2022

USD ($)

$ / shares

Operations:

Net investment income

$ 175,052

$ 180,697

$ 148,621

Net unrealized appreciation (depreciation)

19,101

(28,555)

(136,248)

Net realized gains (losses)

(136,356)

(33,155)

17,179

(Provision) benefit for taxes on realized and unrealized gains (losses)

108

(1,656)

(329)

Net increase (decrease) in net assets resulting from operations

57,905

117,331

29,223

Stockholder transactions:

Net increase (decrease) in net assets from stockholder transactions

(184,027)

(185,900)

(118,657)

Capital share transactions:

Issuance of common stock in connection with mergers

334,034

Issuance of common stock under dividend reinvestment plan

7,213

5,854

3,409

Repurchase of common stock under dividend reinvestment plan

(1,551)

(2,418)

(1,857)

Issuance of common stock in connection with the "at the market" offering

92,507

1,300

20,622

Net increase (decrease) in net assets from capital share transactions

98,169

338,770

22,174

Total increase (decrease) in net assets

(27,953)

270,201

(67,260)

Net assets at beginning of period

1,515,764

1,245,563

1,312,823

Net assets at end of period

$ 1,487,811

$ 1,515,764

$ 1,245,563

Net asset value per common share (in dollars per share) | $ / shares

$ 18.09

^[1]

$ 19.63

^[1]

$ 20.38

^[1]

Common shares outstanding at end of period (in shares) | shares

82,245

^[1]

77,225

^[1]

61,125

^[1]

[1]

Financial Highlights

12 Months Ended

Sep. 30, 2024

Investment Company [Abstract]

Financial Highlights


(Share amounts in thousands)	Year ended September 30, 2024	Year ended September 30, 2023(6)	Year ended September 30, 2022(6)	Year ended September 30, 2021(6)	Year ended September 30, 2020(6)
Net asset value per share at beginning of period	$19.63	$20.38	$21.84	$19.47	$19.81
Net investment income (1)	2.18	2.51	2.45	1.80	1.53
Net unrealized appreciation (depreciation) (1)(7)	0.25	(0.17)	(2.23)	2.19	(0.44)
Net realized gains (losses) (1)	(1.70)	(0.46)	0.28	0.49	(0.30)
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)	—	(0.02)	(0.01)	(0.02)	0.04
Distributions of net investment income to stockholders	(2.27)	(2.61)	(1.95)	(1.52)	(1.17)
Issuance of common stock	—	—	—	(0.57)	—
Net asset value per share at end of period	$18.09	$19.63	$20.38	$21.84	$19.47
Per share market value at beginning of period	$20.12	$18.00	$21.18	$14.52	$15.54
Per share market value at end of period	$16.31	$20.12	$18.00	$21.18	$14.52
Total return (2)	(8.47)%	27.30%	(6.71)%	57.61%	2.10%
Common shares outstanding at beginning of period	77,225	61,125	60,120	46,987	46,987
Common shares outstanding at end of period	82,245	77,225	61,125	60,120	46,987
Net assets at beginning of period	$1,515,764	$1,245,563	$1,312,823	$914,879	$930,630
Net assets at end of period	$1,487,811	$1,515,764	$1,245,563	$1,312,823	$914,879
Average net assets (3)	$1,520,016	$1,437,728	$1,308,518	$1,150,662	$871,305
Ratio of net investment income to average net assets (3)	11.52%	12.57%	11.36%	8.44%	8.26%
Ratio of total expenses to average net assets (3)	14.23%	14.19%	8.68%	9.65%	7.57%
Ratio of net expenses to average net assets (3)	13.59%	13.81%	8.45%	9.51%	8.16%
Ratio of portfolio turnover to average investments at fair value	35.96%	26.12%	26.99%	39.66%	38.99%
Weighted average outstanding debt (4)	$1,683,757	$1,659,701	$1,361,151	$964,390	$647,080
Average debt per share (1)	$20.94	$23.01	$22.41	$17.85	$13.77
Asset coverage ratio at end of period (5)	188.14%	187.74%	188.64%	201.68%	227.22%

__________


(1)			Calculated based upon weighted average shares outstanding for the period.
(2)			Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)			Calculated based upon the weighted average net assets for the period.
(4)			Calculated based upon the weighted average of principal debt outstanding for the period.
(5)			Based on outstanding senior securities of $1,663.8 million, $1,660.0 million, $1,350.0 million, $1,280.0 million and $714.8 million as of September 30, 2024, 2023, 2022, 2021 and 2020, respectively.
(6)			The share and per share information disclosed in this table has been retroactively adjusted as necessary to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(7)			For the year ended September 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger. For the year ended September 30, 2021, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OCSI Merger.

Senior Securities

Information about our senior securities (including debt securities and other indebtedness) is shown in the following table as of the fiscal years ended September 30 for the years indicated below.


Class and Year(1)	Total Amount Outstanding Exclusive of Treasury Securities (2)		Asset Coverage Per Unit(3)	Involuntary Liquidating Preference Per Unit(4)	Average Market Value Per Unit(5)
Syndicated Facility and Prior ING Facility
Fiscal 2015	$	383,495	2,389	—	N/A
Fiscal 2016	472,495		2,208	—	N/A
Fiscal 2017	226,495		2,274	—	N/A
Fiscal 2018	241,000		2,330	—	N/A
Fiscal 2019	314,825		2,949	—	N/A
Fiscal 2020	414,825		2,272	—	N/A
Fiscal 2021	495,000		2,017	—	N/A
Fiscal 2022	540,000		1,886	—	N/A
Fiscal 2023	430,000		1,877	—	N/A
Fiscal 2024	430,000		1,881	—	N/A

Citibank Facility
Fiscal 2021	$	135,000	2,017	—	N/A
Fiscal 2022	160,000		1,886	—	N/A

OSI2 Citibank Facility
Fiscal 2023	$	280,000	1,877	—	N/A
Fiscal 2024	280,000		1,881	—	N/A

Sumitomo Facility
Fiscal 2015	$	43,800	2,389	—	N/A
Fiscal 2016	43,800		2,208	—	N/A
Fiscal 2017	29,500		2,274	—	N/A

Convertible Notes
Fiscal 2015	$	115,000	2,389	—	N/A

Secured Borrowings
Fiscal 2015	$	21,787	2,389	—	N/A
Fiscal 2016	18,929		2,208	—	N/A
Fiscal 2017	13,489		2,274	—	N/A
Fiscal 2018	12,314		2,330	—	N/A

2019 Notes
Fiscal 2015	$	250,000	2,389	—	N/A
Fiscal 2016	250,000		2,208	—	N/A
Fiscal 2017	250,000		2,274	—	N/A
Fiscal 2018	228,825		2,330	—	N/A


Class and Year(1)	Total Amount Outstanding Exclusive of Treasury Securities (2)		Asset Coverage Per Unit(3)	Involuntary Liquidating Preference Per Unit(4)	Average Market Value Per Unit(5)
2024 Notes
Fiscal 2015	$	75,000	2,389	—	991.94
Fiscal 2016	75,000		2,208	—	993.70
Fiscal 2017	75,000		2,274	—	1,006.74
Fiscal 2018	75,000		2,330	—	1,010.72
Fiscal 2019	75,000		2,949	—	1,012.76

2025 Notes
Fiscal 2020	$	300,000	2,272	—	N/A
Fiscal 2021	300,000		2,017	—	N/A
Fiscal 2022	300,000		1,886	—	N/A
Fiscal 2023	300,000		1,877	—	N/A
Fiscal 2024	300,000		1,881	—	N/A

2027 Notes
Fiscal 2021	$	350,000	2,017	—	N/A
Fiscal 2022	350,000		1,886	—	N/A
Fiscal 2023	350,000		1,877	—	N/A
Fiscal 2024	350,000		1,881	—	N/A

2028 Notes
Fiscal 2015	$	86,250	2,389	—	988.06
Fiscal 2016	86,250		2,208	—	999.29
Fiscal 2017	86,250		2,274	—	1,007.51
Fiscal 2018	86,250		2,330	—	994.82
Fiscal 2019	86,250		2,949	—	993.33

2029 Notes
Fiscal 2023	$	300,000	1,877	—	N/A
Fiscal 2024	300,000		1,881	—	N/A

Total Senior Securities
Fiscal 2015	$	975,332	2,389	—
Fiscal 2016	946,474		2,208	—
Fiscal 2017	680,734		2,274	—
Fiscal 2018	643,389		2,330	—
Fiscal 2019	476,075		2,949	—
Fiscal 2020	714,825		2,272	—
Fiscal 2021	1,280,000		2,017	—
Fiscal 2022	1,350,000		1,886	—
Fiscal 2023	1,660,000		1,877	—
Fiscal 2024	1,660,000		1,881	—

______________

(1)This table excludes any SBA-guaranteed debentures outstanding during the relevant periods because the SEC has granted the Company exemptive relief that permits it to exclude such debentures from the definition of senior securities in the asset coverage ratio the Company is required to maintain under the Investment Company Act.

(2)Total amount of each class of senior securities outstanding at the end of the period, presented in thousands.

(3)The asset coverage ratio for a class of senior securities representing indebtedness is calculated as the Company's consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by total senior securities representing indebtedness. This asset coverage ratio is multiplied by $1,000 to determine the “Asset Coverage Per Unit.”

(4)The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The “-” indicates information that the Securities and Exchange Commission expressly does not require to be disclosed for certain types of senior securities.

(5)Calculated on a daily average basis.

Share Data and Net Assets - Schedule of Changes in Net Assets (Details) - USD ($) $ in Thousands		12 Months Ended
	Jan. 23, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Investment Company, Net Assets [Roll Forward]
Beginning of period (in shares)		77,225,000
Net assets at beginning of period		$ 1,515,764	$ 1,245,563	$ 1,312,823
Net investment income		175,052	180,697	148,621
Net unrealized appreciation (depreciation)		19,101	(28,555)	(136,248)
Net realized gains (losses)		(136,356)	(33,155)	17,179
(Provision) benefit for taxes on realized and unrealized gains (losses)		108	(1,656)	(329)
Distributions to stockholders		(184,027)	(185,900)	(118,657)
Issuance of common stock in connection with the "at the market" offering		92,507	1,300	20,622
Issuance of common stock in connection with the OSI2 Merger (in shares)	15,860,200
Issuance of common stock in connection with the OSI2 Merger		$ 0	$ 334,034	$ 0
Issuance of common stock under dividend reinvestment plan (in shares)		390,357,000	297,336,000	165,651
Issuance of common stock under dividend reinvestment plan		$ 7,213	$ 5,854	$ 3,409
Repurchase of common stock under dividend reinvestment plan		$ (1,551)	$ (2,418)	(1,857)
End of period (in shares)		82,245,000	77,225,000
Net assets at end of period		$ 1,487,811	$ 1,515,764	$ 1,245,563
Common Stock
Investment Company, Net Assets [Roll Forward]
Beginning of period (in shares)		77,225,000	61,125,000	60,120,000
Net assets at beginning of period		$ 772	$ 611	$ 601
Issuance of common stock in connection with the "at the market" offering (in shares)		4,725,000	69,000	934,000
Issuance of common stock in connection with the "at the market" offering		$ 47	$ 1	$ 9
Issuance of common stock in connection with the OSI2 Merger (in shares)			15,860,000
Issuance of common stock in connection with the OSI2 Merger			$ 159
Issuance of common stock under dividend reinvestment plan (in shares)		390,000	297,000	166,000
Issuance of common stock under dividend reinvestment plan		$ 4	$ 3	$ 2
Repurchase of common stock under dividend reinvestment plan (in shares)		(95,000)	(126,000)	(95,000)
Repurchase of common stock under dividend reinvestment plan		$ (1)	$ (2)	$ (1)
End of period (in shares)		82,245,000	77,225,000	61,125,000
Net assets at end of period		$ 822	$ 772	$ 611
Additional paid-in-capital
Investment Company, Net Assets [Roll Forward]
Net assets at beginning of period		2,166,330	1,827,721	1,805,557
Issuance of common stock in connection with the "at the market" offering		92,460	1,299	20,613
Issuance of common stock in connection with the OSI2 Merger			333,875
Issuance of common stock under dividend reinvestment plan		7,209	5,851	3,407
Repurchase of common stock under dividend reinvestment plan		(1,550)	(2,416)	(1,856)
Net assets at end of period		2,264,449	2,166,330	1,827,721
Accumulated Overdistributed Earnings
Investment Company, Net Assets [Roll Forward]
Net assets at beginning of period		(651,338)	(582,769)	(493,335)
Net investment income		175,052	180,697	148,621
Net unrealized appreciation (depreciation)		19,101	(28,555)	(136,248)
Net realized gains (losses)		(136,356)	(33,155)	17,179
(Provision) benefit for taxes on realized and unrealized gains (losses)		108	(1,656)	(329)
Distributions to stockholders		(184,027)	(185,900)	(118,657)
Net assets at end of period		$ (777,460)	$ (651,338)	$ (582,769)

Taxable/Distributable Income and Dividend Distributions (Tables)

12 Months Ended

Sep. 30, 2024

Income Tax Disclosure [Abstract]

Schedule of Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations

Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the years ended September 30, 2024, 2023 and 2022.


	Year ended September 30, 2024		Year ended September 30, 2023		Year ended September 30, 2022
Net increase (decrease) in net assets resulting from operations	$	57,905	$	117,331	$	29,223
Net unrealized (appreciation) depreciation	(19,101)		28,555		136,248
Book/tax difference due to organizational costs	—		—		(87)
Book/tax difference due to capital losses suspended (utilized)	137,723		34,607		(16,490)
Other book/tax differences	(24,729)		(14,691)		(6,506)
Taxable/Distributable Income (1)	$	151,798	$	165,802	$	142,388

__________

(1) The Company's taxable income for the year ended September 30, 2024 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2024. Therefore, the final taxable income may be different than the estimate.

Schedule of Components of Accumulated Overdistributed Earnings

As of September 30, 2024, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:


Undistributed ordinary income, net	$	2,986
Net realized capital losses	(642,467)
Unrealized losses, net	(137,979)
Accumulated overdistributed earnings	$	(777,460)

Derivative Instruments - Schedule of Foreign Currency Forward Contracts and Interest Rate Swap (Details) € in Thousands, £ in Thousands, $ in Thousands	Sep. 30, 2024 USD ($)	Sep. 30, 2024 EUR (€)	Sep. 30, 2024 GBP (£)	Sep. 30, 2023 USD ($)	Sep. 30, 2023 EUR (€)	Sep. 30, 2023 GBP (£)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	$ 0			$ 4,910
Derivative liabilities at fair value	16,843			47,519
Foreign currency forward contract
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	0			4,910
Derivative liabilities at fair value	3,841			0
Interest rate swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	7,227			0
Derivative liabilities at fair value	20,229			47,519
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing August 8, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	0
Derivative liabilities at fair value	1,102
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 9, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased	84,291			42,182
Notional Amount to be Sold \| €		€ 76,394			€ 38,026
Derivative assets at fair value				1,857
Derivative liabilities at fair value	1,102			0
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing August 8, 2024
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets at fair value	0
Derivative liabilities at fair value	2,739
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 9, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount to be Purchased	53,624			72,098
Notional Amount to be Sold \| £			£ 42,021			£ 56,556
Derivative assets at fair value				3,053
Derivative liabilities at fair value	2,739			0
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing February 15, 2029
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	300,000			300,000
Derivative assets at fair value	7,227			0
Derivative liabilities at fair value	0			7,000
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing January 15, 2027
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional Amount	350,000			350,000
Derivative assets at fair value	0			0
Derivative liabilities at fair value	$ 20,229			$ 40,519

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Aggregate Net Realized Gains (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Investments [Line Items]
Net realized gains (losses)	$ (136,356)	$ (33,155)	$ 17,179
Thrasio, LLC
Schedule of Investments [Line Items]
Net realized gains (losses)	(68,500)
Pluralsight, LLC
Schedule of Investments [Line Items]
Net realized gains (losses)	(35,300)
Impel Pharmaceuticals Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)	(17,200)
All Web Leads Inc
Schedule of Investments [Line Items]
Net realized gains (losses)	(13,400)
Continental Intermodal Group LP
Schedule of Investments [Line Items]
Net realized gains (losses)	(6,800)
American Tire Distributors Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)	(3,600)
P&L Development LLC
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,900)
Zephyr Bidco Limited
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,700)
Lift Brands Holdings, Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)	(1,400)
Alvotech
Schedule of Investments [Line Items]
Net realized gains (losses)	4,800
Ardonagh Midco 3 PLC
Schedule of Investments [Line Items]
Net realized gains (losses)	4,600
Foreign currency forward contracts
Schedule of Investments [Line Items]
Net realized gains (losses)	1,100	(5,800)	13,700
SIO2 Medical Products Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		(13,900)
Convergeone Holdings Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		(6,000)
Aden & Anais Merger Sub Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		(5,200)
Radiology Partners Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		(4,200)
Carvana Co.
Schedule of Investments [Line Items]
Net realized gains (losses)		(2,800)
Impel Neuropharma Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		(2,300)
ASP Unifrax Holdings Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		(2,100)
WP CPP Holdings LLC
Schedule of Investments [Line Items]
Net realized gains (losses)		(1,300)	(1,700)
Global Medical Response Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		(1,000)
Athenex Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)		6,500
Tersera Therapeutics LLC
Schedule of Investments [Line Items]
Net realized gains (losses)		5,200
CorEvitas Group Holdings LP
Schedule of Investments [Line Items]
Net realized gains (losses)		4,000
Other, net
Schedule of Investments [Line Items]
Net realized gains (losses)	$ 2,900	$ (4,300)	(700)
OmniSYS Acquisition Corporation
Schedule of Investments [Line Items]
Net realized gains (losses)			2,200
First Star Speir Aviation Limited
Schedule of Investments [Line Items]
Net realized gains (losses)			1,900
TigerConnect Inc.
Schedule of Investments [Line Items]
Net realized gains (losses)			$ 1,800

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation

12 Months Ended

Sep. 30, 2024

Investment Company [Abstract]

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation

Realized Gains or Losses

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.

During the year ended September 30, 2024, the Company recorded an aggregate net realized loss of $136.4 million, which consisted of the following:


($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Thrasio, LLC	$	(68.5)
Pluralsight, LLC	(35.3)
Impel Pharmaceuticals Inc.	(17.2)
All Web Leads Inc	(13.4)
Continental Intermodal Group LP	(6.8)
American Tire Distributors Inc.	(3.6)
P&L Development LLC	(1.9)
Zephyr Bidco Limited (1)	(1.7)
Lift Brands Holdings, Inc.	(1.4)
Alvotech	4.8
Ardonagh Midco 3 PLC (1)	4.6
Foreign currency forward contracts	1.1
Other, net	2.9
Total, net	$	(136.4)

__________

(1) This investment was denominated in foreign currency and the realized gain (loss) shown in this table includes gains (losses) due to foreign currency translation, which was offset by gains (losses) on foreign currency forward contracts.

During the year ended September 30, 2023, the Company recorded an aggregate net realized loss of $33.2 million, which consisted of the following:


($ in millions)
Portfolio Company	Net Realized Gain (Loss)
SIO2 Medical Products Inc.	$	(13.9)
Convergeone Holdings Inc.	(6.0)
Foreign currency forward contracts	(5.8)
Aden & Anais Merger Sub Inc.	(5.2)
Radiology Partners Inc.	(4.2)
Carvana Co.	(2.8)
Impel Neuropharma Inc.	(2.3)
ASP Unifrax Holdings Inc.	(2.1)
WP CPP Holdings LLC	(1.3)
Global Medical Response Inc.	(1.0)
Athenex Inc.	6.5
Tersera Therapeutics LLC	5.2
CorEvitas Group Holdings LP	4.0
Other, net	(4.3)
Total, net	$	(33.2)

During the year ended September 30, 2022, the Company recorded an aggregate net realized gain of $17.2 million, which consisted of the following:


($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	13.7
OmniSYS Acquisition Corporation	2.2
First Star Speir Aviation Limited	1.9
TigerConnect Inc.	1.8
WP CPP Holdings, LLC	(1.7)
Other, net	(0.7)
Total, net	$	17.2

Net Unrealized Appreciation or Depreciation

Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation.

During the years ended September 30, 2024, 2023 and 2022, the Company recorded net unrealized appreciation (depreciation) of $19.1 million, $(28.6) million and $(136.2) million, respectively. For the year ended September 30, 2024, this consisted of $69.8 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses), partially offset by $37.5 million of net unrealized depreciation on equity investments, $8.8 million of net unrealized depreciation of foreign currency forward contracts and $4.4 million of net unrealized depreciation on debt investments. For the year ended September 30, 2023, this consisted of $49.1 million of net unrealized depreciation on debt investments and $4.9 million of net unrealized depreciation on equity investments, partially offset by $25.4 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $0.1 million of net unrealized appreciation of foreign currency forward contracts. For the year ended September 30, 2022, this consisted of $94.1 million of net unrealized depreciation on debt investments, $35.4 million of net unrealized depreciation on equity investments and $11.7 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains), partially offset by $4.9 million of net unrealized appreciation of foreign currency forward contracts.

Portfolio Investments - Composition of Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,144,919	$ 3,044,119
Investments at fair value	3,021,279	2,892,420
Debt investments, fair value	$ 2,846,410	$ 2,719,775
% of Debt Portfolio	100.00%	100.00%
Investments in debt securities
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,723,134	$ 2,654,484
Investments at fair value	2,684,858	2,557,102
Investments in equity securities
Schedule of Investments [Line Items]
Investment owned, at cost	202,670	171,858
Investments at fair value	152,328	143,767
Debt investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	164,324	162,986
Investments at fair value	161,552	162,673
Equity investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	54,791	54,791
Investments at fair value	22,541	28,878
Floating rate debt securities, including the debt investments in the JVs
Schedule of Investments [Line Items]
Debt investments, fair value	$ 2,516,316	$ 2,345,205
% of Debt Portfolio	88.40%	86.23%
Fixed rate debt securities
Schedule of Investments [Line Items]
Debt investments, fair value	$ 330,094	$ 374,570
% of Debt Portfolio	11.60%	13.77%

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	$ 19,101	$ (28,555)	$ (136,248)
Investments in equity securities
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(37,500)	4,900	35,400
Investments in debt securities
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(4,400)	49,100	94,100
Foreign currency forward contracts
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	(8,800)	100	4,900
Exited Investments
Schedule of Investments [Line Items]
Net unrealized appreciation (depreciation)	$ 69,800	$ 25,400	$ 11,700

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column B)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 10))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column D))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B)(Footnote 10))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 42: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 43: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 44: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 45: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 12))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 46: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 13))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 47: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 48: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 49: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 50: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 51: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 52: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 53: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 54: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 55: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 56: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 57: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 58: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 59: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 60: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 61: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 62: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 63: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 64: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 19
-Subparagraph (1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19

Reference 65: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 19
-Subparagraph (3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19

+ Details

Fee Income	12 Months Ended
Fee Income	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Fee Income	Fee Income For the years ended September 30, 2024, 2023 and 2022, the Company recorded total fee income of $9.2 million, $6.5 million and $6.6 million, respectively, of which $0.3 million, $0.9 million and $0.9 million, respectively, was recurring in nature. Recurring fee income primarily consisted of servicing fees.

Share Data and Net Assets - Narrative (Details) $ in Millions				12 Months Ended
	Jan. 23, 2023 shares	Jan. 20, 2023	Feb. 07, 2022 USD ($)	Sep. 30, 2024 shares	Sep. 30, 2023 shares	Sep. 30, 2022 shares
Investment Company, Changes in Net Assets [Line Items]
Stock split, conversion ratio		0.3333
Issuance of common stock in connection with the OSI2 Merger (in shares)	15,860,200
Issuance of common stock under dividend reinvestment plan (in shares)				390,357,000	297,336,000	165,651
Aggregate offering price \| $			$ 300.0
At the Market
Investment Company, Changes in Net Assets [Line Items]
Dividend reinvestment plan, percent of current market price (as a percent)				95.00%
Number of shares issued (in shares)				4,724,506	68,752
Common Stock
Investment Company, Changes in Net Assets [Line Items]
Issuance of common stock under dividend reinvestment plan (in shares)				295,484	171,645	70,794

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Significant Accounting Policies (Policies)	12 Months Ended
Significant Accounting Policies (Policies)	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-K and Regulation S-X. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding have been retroactively adjusted as necessary to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
Use of Estimates	Use of Estimates: The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.
Consolidation	Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries. As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value.
Fair Value Measurements	Fair Value Measurements: Oaktree, as the valuation designee of the Company's Board of Directors pursuant to Rule 2a-5 under the Investment Company Act, determines the fair value of the Company's assets on at least a quarterly basis in accordance with ASC 820. ASC 820 defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: •Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. •Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. •Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: •The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; •Preliminary valuations are then reviewed and discussed with management of Oaktree; •Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; •Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; •The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and •Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of September 30, 2024 and September 30, 2023 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax liability," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable " and "payables from unsettled transactions" approximate fair value due to their short maturities.
Foreign Currency Translation	Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.
Derivative Instruments	Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and, as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses interest rate swaps to hedge some of the Company's fixed rate debt. The Company designated the interest rate swaps as the hedging instruments in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of each interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swaps is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreements are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities.
Investment Income	Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of September 30, 2024, there were nine investments on non-accrual status that in aggregate represented 4.9% and 4.0% of total debt investments at cost and fair value, respectively. As of September 30, 2023, there were four investments on non-accrual status that in aggregate represented 2.4% and 1.8% of total debt investments at cost and fair value, respectively. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost basis of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.
Cash and Cash Equivalents and Restricted Cash	Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets.
Due from Portfolio Companies	Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company (e.g., principal payments on the scheduled amortization payment date).
Receivables/Payables from Unsettled Transactions	Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.
Deferred Financing Costs	Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment.
Deferred Offering Costs	Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed.
Income Taxes	Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. For calendar year 2022, the Company incurred $0.1 million of excise tax. The Company did not incur any U.S. federal excise tax for calendar year 2023. The Company does not expect to incur a U.S. federal excise tax for calendar year 2024. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2021, 2022 and 2023. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280), which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and interim period within fiscal years beginning after December 15, 2024. The Company does not expect this guidance to materially impact its consolidated financial statements.

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Consolidated Schedule of Investments - Derivatives € in Thousands, £ in Thousands, $ in Thousands	Sep. 30, 2024 USD ($)	Sep. 30, 2024 EUR (€)	Sep. 30, 2024 GBP (£)	Sep. 30, 2023 USD ($)	Sep. 30, 2023 EUR (€)	Sep. 30, 2023 GBP (£)
Schedule of Investments [Line Items]
Derivative assets	$ 0			$ 4,910
Derivative liability	(16,843)			(47,519)
Foreign currency forward contracts
Schedule of Investments [Line Items]
Derivative assets	0			4,910
Derivative liability	(3,841)			0
Derivative assets (liability)	(3,841)
Interest rate swap
Schedule of Investments [Line Items]
Derivative assets	7,227			0
Derivative liability	(20,229)			(47,519)
Derivative assets (liability)	(13,002)
Interest Rate Swap Maturing 2027
Schedule of Investments [Line Items]
Derivative liability	$ (20,229)			$ (40,519)
Interest rate (as a percent)	2.70%	2.70%	2.70%	2.70%	2.70%	2.70%
Floating interest rate (as a percent)	1.658%	1.658%	1.658%	1.658%	1.658%	1.658%
Notional amount	$ 350,000			$ 350,000
Interest Rate Swap Maturing 2029
Schedule of Investments [Line Items]
Derivative assets	$ 7,227
Derivative liability				$ (7,000)
Interest rate (as a percent)	7.10%	7.10%	7.10%	7.10%	7.10%	7.10%
Floating interest rate (as a percent)	3.1255%	3.1255%	3.1255%	3.1255%	3.1255%	3.1255%
Notional amount	$ 300,000			$ 300,000
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing August 8, 2024
Schedule of Investments [Line Items]
Derivative assets	0
Derivative liability	(1,102)
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 9, 2023
Schedule of Investments [Line Items]
Notional Amount to be Purchased	84,291			42,182
Notional Amount to be Sold \| €		€ 76,394			€ 38,026
Derivative assets				1,857
Derivative liability	(1,102)			0
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing August 8, 2024
Schedule of Investments [Line Items]
Derivative assets	0
Derivative liability	(2,739)
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 9, 2023
Schedule of Investments [Line Items]
Notional Amount to be Purchased	53,624			72,098
Notional Amount to be Sold \| £			£ 42,021			£ 56,556
Derivative assets				3,053
Derivative liability	(2,739)			0
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing February 15, 2029
Schedule of Investments [Line Items]
Derivative assets	7,227			0
Derivative liability	0			(7,000)
Notional amount	300,000			300,000
Open Forward Foreign Currency Contract, Identifier [Axis]: Interest rate swap, Maturing January 15, 2027
Schedule of Investments [Line Items]
Derivative assets	0			0
Derivative liability	(20,229)			(40,519)
Notional amount	$ 350,000			$ 350,000

Portfolio Investments - Significant Unobservable Inputs for Level 3 Investments (Details) $ in Thousands	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 3,021,279	$ 2,892,420
Senior secured debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,574,937	2,501,385
Subordinated Debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	109,921	55,717
Debt investments in the JVs
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	161,552	162,673
Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,723,732	2,619,912
Level 3 \| Senior secured debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	2,320,310	2,292,691
Level 3 \| Senior secured debt \| Market Yield \| Market Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 2,044,221	$ 1,904,140
Level 3 \| Senior secured debt \| Market Yield \| Market Yield \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	0.057	0.090
Level 3 \| Senior secured debt \| Market Yield \| Market Yield \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	0.310	0.320
Level 3 \| Senior secured debt \| Market Yield \| Market Yield \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	0.120	0.147
Level 3 \| Senior secured debt \| Enterprise Value \| Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 52,857
Level 3 \| Senior secured debt \| Enterprise Value \| Revenue Multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	2.0
Level 3 \| Senior secured debt \| Enterprise Value \| Revenue Multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	5.5
Level 3 \| Senior secured debt \| Enterprise Value \| Revenue Multiple \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	3.7
Level 3 \| Senior secured debt \| Enterprise Value \| EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 26,927	$ 64,802
Level 3 \| Senior secured debt \| Enterprise Value \| EBITDA Multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	4.5	3.0
Level 3 \| Senior secured debt \| Enterprise Value \| EBITDA Multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	7.5	6.0
Level 3 \| Senior secured debt \| Enterprise Value \| EBITDA Multiple \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	5.7	4.6
Level 3 \| Senior secured debt \| Transaction Precedent \| Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 33,272	$ 33,816
Level 3 \| Senior secured debt \| Broker Quotations \| Broker Quoted Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	163,033	289,933
Level 3 \| Subordinated Debt \| Market Yield \| Market Yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 93,794	$ 22,881
Level 3 \| Subordinated Debt \| Market Yield \| Market Yield \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	0.050	0.100
Level 3 \| Subordinated Debt \| Market Yield \| Market Yield \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	0.450	0.220
Level 3 \| Subordinated Debt \| Market Yield \| Market Yield \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	0.101	0.112
Level 3 \| Subordinated Debt \| Broker Quotations \| Broker Quoted Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value		$ 4,170
Level 3 \| Debt investments in the JVs \| Enterprise Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 161,552	162,673
Level 3 \| Preferred & Common Equity \| Enterprise Value \| Revenue Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 80,720	$ 32,318
Level 3 \| Preferred & Common Equity \| Enterprise Value \| Revenue Multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	0.3	0.4
Level 3 \| Preferred & Common Equity \| Enterprise Value \| Revenue Multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	7.2	3.2
Level 3 \| Preferred & Common Equity \| Enterprise Value \| Revenue Multiple \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	2.0	0.5
Level 3 \| Preferred & Common Equity \| Enterprise Value \| EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 66,106	$ 103,661
Level 3 \| Preferred & Common Equity \| Enterprise Value \| EBITDA Multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	2.9	1.7
Level 3 \| Preferred & Common Equity \| Enterprise Value \| EBITDA Multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	15.0	15.1
Level 3 \| Preferred & Common Equity \| Enterprise Value \| EBITDA Multiple \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	10.2	8.8
Level 3 \| Preferred & Common Equity \| Enterprise Value \| Asset Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value	$ 1,250	$ 1,097
Level 3 \| Preferred & Common Equity \| Enterprise Value \| Asset Multiple \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	1.0	1.0
Level 3 \| Preferred & Common Equity \| Enterprise Value \| Asset Multiple \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	1.4	1.4
Level 3 \| Preferred & Common Equity \| Enterprise Value \| Asset Multiple \| Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value, measurement input	1.4	1.4
Level 3 \| Preferred & Common Equity \| Transaction Precedent \| Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments at fair value		$ 421

Taxable/Distributable Income and Dividend Distributions - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net	$ 696,000
Valuation allowance	8,700
Deferred tax assets	8,700
(Provision) benefit for taxes on realized and unrealized gains (losses)	108	$ (1,656)	$ (329)
(Provision) benefit for taxes on net investment income	0	0	3,308
Income tax expense			1,300
Deferred income tax benefit	5	$ (1,670)	$ 973
Cost of investments	3,153,000
Unrealized appreciation	674,500
Unrealized depreciation	812,500
Unrealized appreciation (depreciation)	138,000
Short-Term Capital Loss Carryforward
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net	73,000
Long-Term Capital Loss Carryforward
Investments, Owned, Federal Income Tax Note [Line Items]
Undistributed ordinary income, net	$ 623,000

Realized Gains or Losses and Net Unrealized Appreciation or Depreciation (Tables)

12 Months Ended

Sep. 30, 2024

Investment Company [Abstract]

Schedule of Aggregate Net Realized Gains

During the year ended September 30, 2024, the Company recorded an aggregate net realized loss of $136.4 million, which consisted of the following:


($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Thrasio, LLC	$	(68.5)
Pluralsight, LLC	(35.3)
Impel Pharmaceuticals Inc.	(17.2)
All Web Leads Inc	(13.4)
Continental Intermodal Group LP	(6.8)
American Tire Distributors Inc.	(3.6)
P&L Development LLC	(1.9)
Zephyr Bidco Limited (1)	(1.7)
Lift Brands Holdings, Inc.	(1.4)
Alvotech	4.8
Ardonagh Midco 3 PLC (1)	4.6
Foreign currency forward contracts	1.1
Other, net	2.9
Total, net	$	(136.4)

__________

During the year ended September 30, 2023, the Company recorded an aggregate net realized loss of $33.2 million, which consisted of the following:


($ in millions)
Portfolio Company	Net Realized Gain (Loss)
SIO2 Medical Products Inc.	$	(13.9)
Convergeone Holdings Inc.	(6.0)
Foreign currency forward contracts	(5.8)
Aden & Anais Merger Sub Inc.	(5.2)
Radiology Partners Inc.	(4.2)
Carvana Co.	(2.8)
Impel Neuropharma Inc.	(2.3)
ASP Unifrax Holdings Inc.	(2.1)
WP CPP Holdings LLC	(1.3)
Global Medical Response Inc.	(1.0)
Athenex Inc.	6.5
Tersera Therapeutics LLC	5.2
CorEvitas Group Holdings LP	4.0
Other, net	(4.3)
Total, net	$	(33.2)

During the year ended September 30, 2022, the Company recorded an aggregate net realized gain of $17.2 million, which consisted of the following:


($ in millions)
Portfolio Company	Net Realized Gain (Loss)
Foreign currency forward contracts	$	13.7
OmniSYS Acquisition Corporation	2.2
First Star Speir Aviation Limited	1.9
TigerConnect Inc.	1.8
WP CPP Holdings, LLC	(1.7)
Other, net	(0.7)
Total, net	$	17.2

Portfolio Investments - Schedule of Financial Instruments Carried at Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Schedule of Investments [Line Items]
Investments at fair value	$ 3,021,279	$ 2,892,420
Cash equivalents	34,597	83,262
Derivative assets	0	4,910
Total assets at fair value	3,055,876	2,980,592
Derivative liabilities	16,843	47,519
Total liabilities at fair value	16,843	47,519
Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	2,574,937	2,501,385
Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	271,473	218,390
Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	66,320	86,057
Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	108,549	86,588
Level 1
Schedule of Investments [Line Items]
Investments at fair value	1,422	4,317
Cash equivalents	34,597	83,262
Derivative assets		0
Total assets at fair value	36,019	87,579
Derivative liabilities	0	0
Total liabilities at fair value	0	0
Level 1 \| Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 \| Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 \| Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 1 \| Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	1,422	4,317
Level 2
Schedule of Investments [Line Items]
Investments at fair value	273,584	239,313
Cash equivalents	0	0
Derivative assets		4,910
Total assets at fair value	273,584	244,223
Derivative liabilities	16,843	47,519
Total liabilities at fair value	16,843	47,519
Level 2 \| Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	254,627	208,694
Level 2 \| Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	16,127	28,666
Level 2 \| Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	0	0
Level 2 \| Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	2,830	1,953
Level 3
Schedule of Investments [Line Items]
Investments at fair value	2,723,732	2,619,912
Cash equivalents	0	0
Derivative assets		0
Total assets at fair value	2,723,732	2,619,912
Derivative liabilities	0	0
Total liabilities at fair value	0	0
Level 3 \| Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	2,320,310	2,292,691
Level 3 \| Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	255,346	189,724
Level 3 \| Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	66,320	86,057
Level 3 \| Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	81,756	51,440
Measured at Net Asset Value
Schedule of Investments [Line Items]
Investments at fair value	22,541	28,878
Cash equivalents	0	0
Derivative assets		0
Total assets at fair value	22,541	28,878
Derivative liabilities	0	0
Total liabilities at fair value	0	0
Measured at Net Asset Value \| Senior secured debt
Schedule of Investments [Line Items]
Investments at fair value	0	0
Measured at Net Asset Value \| Subordinated debt securities, including JV debt instruments CLO Notes
Schedule of Investments [Line Items]
Investments at fair value	0	0
Measured at Net Asset Value \| Preferred equity
Schedule of Investments [Line Items]
Investments at fair value	0	0
Measured at Net Asset Value \| Equity Securities, Common And Warrants, Including JV Investments
Schedule of Investments [Line Items]
Investments at fair value	$ 22,541	$ 28,878

Insider Trading Policies and Procedures	12 Months Ended
Insider Trading Policies and Procedures	Sep. 30, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Significant Accounting Policies	12 Months Ended
Significant Accounting Policies	Sep. 30, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-K and Regulation S-X. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding have been retroactively adjusted as necessary to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. Use of Estimates: The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition. Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries. As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value. Fair Value Measurements: Oaktree, as the valuation designee of the Company's Board of Directors pursuant to Rule 2a-5 under the Investment Company Act, determines the fair value of the Company's assets on at least a quarterly basis in accordance with ASC 820. ASC 820 defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: •Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. •Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. •Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: •The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; •Preliminary valuations are then reviewed and discussed with management of Oaktree; •Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; •Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; •The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and •Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of September 30, 2024 and September 30, 2023 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax liability," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable " and "payables from unsettled transactions" approximate fair value due to their short maturities. Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company. Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and, as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses interest rate swaps to hedge some of the Company's fixed rate debt. The Company designated the interest rate swaps as the hedging instruments in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of each interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swaps is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreements are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities. Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of September 30, 2024, there were nine investments on non-accrual status that in aggregate represented 4.9% and 4.0% of total debt investments at cost and fair value, respectively. As of September 30, 2023, there were four investments on non-accrual status that in aggregate represented 2.4% and 1.8% of total debt investments at cost and fair value, respectively. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost basis of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment. Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets. As of September 30, 2024, included in restricted cash was $14.6 million that was held at Deutsche Bank Trust Company Americas in connection with the OSI2 Citibank Facility (as defined in Note 6. Borrowings). Pursuant to the terms of the OSI2 Citibank Facility, the Company was restricted in terms of access to the $14.6 million until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the OSI2 Citibank Facility. As of September 30, 2023, included in restricted cash was $9.1 million that was held at Deutsche Bank Trust Company Americas in connection with the OSI2 Citibank Facility. Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company (e.g., principal payments on the scheduled amortization payment date). Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date. Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment. Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed. Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. For calendar year 2022, the Company incurred $0.1 million of excise tax. The Company did not incur any U.S. federal excise tax for calendar year 2023. The Company does not expect to incur a U.S. federal excise tax for calendar year 2024. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2021, 2022 and 2023. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months. Recently Adopted Accounting Pronouncements In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280), which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and interim period within fiscal years beginning after December 15, 2024. The Company does not expect this guidance to materially impact its consolidated financial statements.

Portfolio Investments (Tables)

12 Months Ended

Sep. 30, 2024

Schedule of Investments [Abstract]

Schedule of Composition of Investments

The composition of the Company's investments as of September 30, 2024 and September 30, 2023 at cost and fair value was as follows:


	September 30, 2024				September 30, 2023
	Cost		Fair Value		Cost		Fair Value
Investments in debt securities	$	2,723,134	$	2,684,858	$	2,654,484	$	2,557,102
Investments in equity securities	202,670		152,328		171,858		143,767
Debt investments in the JVs	164,324		161,552		162,986		162,673
Equity investments in the JVs	54,791		22,541		54,791		28,878
Total	$	3,144,919	$	3,021,279	$	3,044,119	$	2,892,420

The following table presents the composition of the Company's debt investments as of September 30, 2024 and September 30, 2023 at floating rates and fixed rates:


	September 30, 2024				September 30, 2023
	Fair Value		% of Debt Portfolio		Fair Value		% of Debt Portfolio
Floating rate debt securities, including the debt investments in the JVs	$	2,516,316	88.40	%	$	2,345,205	86.23	%
Fixed rate debt securities	330,094		11.60		374,570		13.77
Total	$	2,846,410	100.00	%	$	2,719,775	100.00	%

The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of September 30, 2024 and September 30, 2023:


	September 30, 2024				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Application Software	$	532,200	16.85	%	$	468,483	15.39	%
Multi-Sector Holdings (1)	228,181		7.26		219,469		7.21
Health Care Services	149,904		4.77		81,560		2.68
Health Care Technology	105,932		3.37		106,915		3.51
Interactive Media & Services	95,564		3.04		19,013		0.62
Pharmaceuticals	94,639		3.01		84,948		2.79
Industrial Machinery & Supplies & Components	82,624		2.63		99,511		3.27
Data Processing & Outsourced Services	80,058		2.55		133,410		4.38
Diversified Support Services	79,799		2.54		23,435		0.77
Aerospace & Defense	72,927		2.32		51,797		1.70
Real Estate Operating Companies	72,839		2.32		83,754		2.75
Diversified Financial Services	66,597		2.12		61,725		2.03
Environmental & Facilities Services	65,229		2.07		63,064		2.07
Metal, Glass & Plastic Containers	64,769		2.06		55,530		1.82
Personal Care Products	63,425		2.02		68,146		2.24
Airport Services	63,110		2.01		55,961		1.84
Health Care Distributors	60,316		1.92		62,044		2.04
Real Estate Services	55,220		1.76		44,717		1.47
Fertilizers & Agricultural Chemicals	54,677		1.74		64,720		2.13
Internet Services & Infrastructure	53,376		1.70		60,934		2.00
Diversified Metals & Mining	50,061		1.59		49,842		1.64
Home Improvement Retail	49,891		1.59		54,236		1.78
Communications Equipment	46,764		1.49		—		—
Specialized Finance	45,156		1.44		73,035		2.40
Biotechnology	43,821		1.39		126,349		4.15
Soft Drinks & Non-alcoholic Beverages	42,898		1.36		42,628		1.40
Automotive Retail	40,964		1.30		57,596		1.89
Systems Software	39,316		1.25		23,111		0.76
Office Services & Supplies	38,891		1.24		—		—
Real Estate Development	38,237		1.22		23,965		0.79
Leisure Facilities	37,958		1.21		39,076		1.28
Other Specialty Retail	36,810		1.17		41,088		1.35
Electrical Components & Equipment	32,834		1.04		32,440		1.07
Construction & Engineering	31,602		1.00		22,102		0.73
Movies & Entertainment	30,779		0.98		12,188		0.40
Health Care Equipment	28,823		0.92		22,441		0.74
Construction Machinery & Heavy Transportation Equipment	25,901		0.82		—		—
Specialized Consumer Services	25,763		0.82		—		—
Passenger Airlines	25,039		0.80		24,920		0.82
Wireless Telecommunication Services	24,257		0.77		—		—
Home Furnishings	24,102		0.77		23,859		0.78
Gold	23,454		0.75		23,310		0.77
Broadline Retail	22,231		0.71		83,290		2.74
Hotels, Resorts & Cruise Lines	20,612		0.66		17,195		0.56
Packaged Foods & Meats	19,863		0.63		—		—
Specialty Chemicals	19,407		0.62		38,640		1.27
Oil & Gas Storage & Transportation	19,309		0.61		22,042		0.72
Insurance Brokers	19,222		0.61		52,856		1.74
Paper & Plastic Packaging Products & Materials	18,379		0.58		3,254		0.11
Apparel Retail	17,855		0.57		4,999		0.16
Food Distributors	14,639		0.47		5,897		0.19
Health Care Supplies	14,426		0.46		11,646		0.38
Advertising	11,418		0.36		25,597		0.84
Education Services	8,205		0.26		13,871		0.46
Financial Exchanges & Data	8,050		0.26		—		—
Housewares & Specialties	2,806		0.09		2,908		0.10
Integrated Telecommunication Services	2,057		0.07		18,801		0.62
Distributors	1,733		0.06		37,666		1.24
Auto Parts & Equipment	—		—		48,536		1.59
Consumer Finance	—		—		16,440		0.54
Restaurants	—		—		12,603		0.41
Air Freight & Logistics	—		—		4,925		0.16
Integrated Oil & Gas	—		—		4,894		0.16
Research & Consulting Services	—		—		4,871		0.16
Cable & Satellite	—		—		4,619		0.15
Other Specialized REITs	—		—		4,379		0.14
Leisure Products	—		—		2,055		0.07
Technology Distributors	—		—		813		0.03
	$	3,144,919	100.00	%	$	3,044,119	100.00	%


	September 30, 2024						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Application Software	$	523,007	17.34	%	35.16	%	$	455,719	15.73	%	30.03	%
Multi-Sector Holdings (1)	193,579		6.41		13.01		193,431		6.69		12.76
Health Care Services	127,935		4.23		8.60		66,683		2.31		4.40
Health Care Technology	104,795		3.47		7.04		95,404		3.30		6.29
Interactive Media & Services	96,963		3.21		6.52		19,199		0.66		1.27
Pharmaceuticals	91,804		3.04		6.17		80,455		2.78		5.31
Industrial Machinery & Supplies & Components	84,977		2.81		5.71		98,352		3.40		6.49
Diversified Support Services	80,638		2.67		5.42		23,352		0.81		1.54
Aerospace & Defense	74,327		2.46		5.00		51,862		1.79		3.42
Data Processing & Outsourced Services	73,673		2.44		4.95		125,259		4.33		8.26
Real Estate Operating Companies	71,246		2.36		4.79		82,463		2.85		5.44
Diversified Financial Services	66,324		2.20		4.46		60,003		2.07		3.96
Environmental & Facilities Services	64,119		2.12		4.31		62,413		2.16		4.12
Health Care Distributors	58,906		1.95		3.96		60,865		2.10		4.02
Personal Care Products	57,451		1.90		3.86		59,928		2.07		3.95
Airport Services	55,434		1.83		3.73		54,453		1.88		3.59
Fertilizers & Agricultural Chemicals	54,668		1.81		3.67		63,185		2.18		4.17
Real Estate Services	54,197		1.79		3.64		43,886		1.52		2.90
Internet Services & Infrastructure	53,019		1.75		3.56		60,579		2.09		4.00
Diversified Metals & Mining	50,419		1.67		3.39		49,869		1.72		3.29
Home Improvement Retail	48,775		1.61		3.28		53,168		1.84		3.51
Metal, Glass & Plastic Containers	47,191		1.56		3.17		53,459		1.85		3.53
Communications Equipment	46,858		1.55		3.15		—		—		—
Biotechnology	45,954		1.52		3.09		125,678		4.35		8.29
Specialized Finance	44,551		1.47		2.99		69,590		2.41		4.59
Soft Drinks & Non-alcoholic Beverages	42,674		1.41		2.87		42,391		1.47		2.80
Systems Software	39,813		1.32		2.68		21,968		0.76		1.45
Other Specialty Retail	39,660		1.31		2.67		41,115		1.42		2.71
Automotive Retail	39,111		1.29		2.63		55,805		1.93		3.68
Real Estate Development	38,237		1.27		2.57		23,679		0.82		1.56
Office Services & Supplies	38,149		1.26		2.56		—		—		—
Leisure Facilities	37,544		1.24		2.52		36,963		1.28		2.44
Electrical Components & Equipment	32,246		1.07		2.17		32,573		1.13		2.15
Construction & Engineering	31,063		1.03		2.09		21,903		0.76		1.45
Movies & Entertainment	30,863		1.02		2.07		11,865		0.41		0.78
Passenger Airlines	26,556		0.88		1.78		27,512		0.95		1.82
Construction Machinery & Heavy Transportation Equipment	26,486		0.88		1.78		—		—		—
Health Care Equipment	26,264		0.87		1.77		22,436		0.78		1.48
Specialized Consumer Services	25,772		0.85		1.73		—		—		—
Gold	25,054		0.83		1.68		23,328		0.81		1.54
Wireless Telecommunication Services	24,311		0.80		1.63		—		—		—
Broadline Retail	22,554		0.75		1.52		69,040		2.39		4.55
Hotels, Resorts & Cruise Lines	20,342		0.67		1.37		16,991		0.59		1.12
Packaged Foods & Meats	19,846		0.66		1.33		—		—		—
Specialty Chemicals	19,431		0.64		1.31		38,615		1.34		2.55
Insurance Brokers	19,221		0.64		1.29		53,050		1.83		3.50
Paper & Plastic Packaging Products & Materials	18,307		0.61		1.23		3,061		0.11		0.20
Apparel Retail	18,017		0.60		1.21		5,002		0.17		0.33
Oil & Gas Storage & Transportation	15,604		0.52		1.05		16,040		0.55		1.06
Food Distributors	15,484		0.51		1.04		5,166		0.18		0.34
Health Care Supplies	14,218		0.47		0.96		11,363		0.39		0.75
Advertising	11,515		0.38		0.77		11,955		0.41		0.79
Home Furnishings	9,376		0.31		0.63		19,954		0.69		1.32
Education Services	8,263		0.27		0.56		13,618		0.47		0.90
Financial Exchanges & Data	8,065		0.27		0.54		—		—		—
Housewares & Specialties	2,546		0.08		0.17		2,808		0.10		0.19
Distributors	2,220		0.07		0.15		37,311		1.29		2.46
Integrated Telecommunication Services	1,657		0.05		0.11		16,492		0.57		1.09
Auto Parts & Equipment	—		—		—		49,148		1.70		3.24
Consumer Finance	—		—		—		15,087		0.52		1.00
Restaurants	—		—		—		12,464		0.43		0.82
Research & Consulting Services	—		—		—		4,831		0.17		0.32
Integrated Oil & Gas	—		—		—		4,785		0.17		0.32
Cable & Satellite	—		—		—		4,546		0.16		0.30
Air Freight & Logistics	—		—		—		4,263		0.15		0.28
Other Specialized REITs	—		—		—		3,198		0.11		0.21
Leisure Products	—		—		—		2,063		0.07		0.14
Technology Distributors	—		—		—		776		0.03		0.05
Total	$	3,021,279	100.00	%	203.07	%	$	2,892,420	100.00	%	190.82	%

___________________

(1)This industry includes the Company's investments in the JVs and CLOs.

SLF JV I Portfolio as of September 30, 2024


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.25%		8/18/2028		$	10,495	$	10,404	$	10,553	(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.37%		12/18/2025		1,026		1,019		985		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.37%		12/18/2025		6,072		6,038		5,829		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.45%		6/30/2025		8,329		8,304		7,663		(4)
Artera Services LLC	Construction & Engineering	First Lien Term Loan	SOFR+	4.50%	9.10%		2/15/2031		7,961		7,902		7,781
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.52%		12/29/2027		4,092		4,048		3,896		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%	11.29%		12/29/2027		290		284		266		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	6.75%	11.35%		2/25/2028		2,546		2,517		2,111		(4)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%			10/25/2028		4,037		3,877		1,161		(4)(6)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	8.95%		8/19/2028		7,775		7,589		7,660
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.20%		8/19/2028		1,970		1,886		1,944
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.10%		2/15/2029		9,034		8,790		8,992
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	7.00%	7.70%	4.00%	12/24/2026		6,548		6,430		6,351		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	9.87%		6/11/2027		1,735		1,724		1,633		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	9.87%		6/11/2027		6,242		6,183		5,875		(4)
Bausch + Lomb Corporation	Health Care Supplies	First Lien Term Loan	SOFR+	3.25%	8.27%		5/10/2027		9,173		9,017		9,151
Boxer Parent Company Inc.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.01%		7/30/2031		8,000		7,983		7,994
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.16%		8/10/2027		2,348		2,325		1,751
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	12.27%		8/10/2027		1,976		1,955		1,474
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.16%		8/10/2027		1,955		1,936		1,458
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	11.50%		8/10/2027		600		594		447		(5)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	12.02%		8/10/2027		2		2		1
Cloud Software Group, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	8.60%		3/30/2029		8,153		7,621		8,129
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	9.60%		10/13/2029		7,765		7,428		7,381		(4)
Crown Subsea Communications Holding, Inc.	Alternative Carriers	First Lien Term Loan	SOFR+	4.00%	9.25%		1/30/2031		7,980		7,900		8,039
Curium Bidco S.à.r.l.	Pharmaceuticals	First Lien Term Loan	SOFR+	4.00%	8.60%		7/31/2029		8,643		8,559		8,684
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.25%	10.21%		8/2/2029		6,711		6,635		6,618
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.60%		4/26/2029		9,029		8,913		9,076
Eagle Parent Corp.	Diversified Support Services	First Lien Term Loan	SOFR+	4.25%	9.55%		4/2/2029		1,179		1,177		1,121
Engineering Research and Consulting LLC	Construction & Engineering	First Lien Term Loan	SOFR+	5.00%	10.06%		8/29/2031		4,208		4,149		4,182		(4)
Frontier Communications Holdings, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	3.50%	8.76%		7/1/2031		7,000		6,965		7,061
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.20%		4/9/2029		7,840		7,687		7,646		(4)


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Husky Injection Molding Systems Ltd.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	5.00%	10.33%		2/15/2029		$	5,089	$	5,028	$	5,071
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.21%		6/30/2026		7,256		7,205		7,247
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	10.62%		3/25/2027		8,500		8,392		7,140		(4)
KDC/ONE Development Corp Inc	Personal Care Products	First Lien Term Loan	SOFR+	4.50%	9.36%		8/15/2028		8,890		8,675		8,908
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	9.95%		10/29/2028		7,896		7,682		7,734		(4)
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	SOFR+	5.00%	9.96%		5/9/2026		29		29		28		(4)
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	SOFR+	4.75%	9.60%		7/29/2029		10,000		9,876		9,848
M2S Group Intermediate Holdings Inc	Multi-Sector Holdings	First Lien Term Loan	SOFR+	4.75%	9.85%		8/25/2031		10,000		9,652		9,625
McAfee Corp.	Systems Software	First Lien Term Loan	SOFR+	3.25%	8.45%		3/1/2029		7,890		7,656		7,872
Mitchell International, Inc.	Application Software	First Lien Term Loan	SOFR+	3.25%	8.10%		6/17/2031		8,000		7,953		7,892
Peraton Corp.	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	8.70%		2/1/2028		1,978		1,977		1,909
PetSmart LLC	Other Specialty Retail	First Lien Term Loan	SOFR+	3.75%	8.70%		2/11/2028		7,948		7,871		7,893
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	7.50%		12.62%	8/22/2029		1,544		1,544		1,544		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	4.50%	8.12%	1.50%	8/22/2029		1,030		1,030		1,030		(4)
Pluralsight, LLC	Application Software	Common Stock						514,789			1,719		1,719		(4)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.25%	9.10%		4/5/2030		8,920		8,793		8,927
SCIH Salt Holdings Inc.	Diversified Chemicals	First Lien Term Loan	SOFR+	3.50%	8.76%		3/16/2027		2,963		2,963		2,966
Shearer's Foods LLC	Packaged Foods & Meats	First Lien Term Loan	SOFR+	4.00%	8.85%		2/12/2031		6,983		6,913		6,996
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	6.50%	11.82%		6/30/2029		938		893		919
SHO Holding I Corporation	Footwear	First Lien Term Loan		6.50%	11.82%		6/30/2029		2,634		2,634		2,529
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	7.00%	12.32%		6/30/2029		1,451		1,451		1,306
SHO Holding I Corporation	Footwear	Common Stock						2,746			4,295		3,145
SM Wellness Holdings, Inc.	Health Care Services	First Lien Term Loan	SOFR+	4.50%	10.01%		4/17/2028		2,947		2,640		2,888		(4)
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	3.75%	8.00%		10/5/2027		8,601		8,563		8,628
Staples, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.75%	10.69%		9/4/2029		5,349		5,147		4,873		(4)
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	3.75%	8.35%		9/27/2030		7,960		7,841		7,757
SupplyOne, Inc.	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	4.25%	9.10%		4/19/2031		4,478		4,433		4,496
Swissport Stratosphere USA LLC	Air Freight & Logistics	First Lien Term Loan	SOFR+	4.25%	9.57%		4/4/2031		5,486		5,459		5,512
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	10.95%		12/29/2028		7,139		7,052		6,996		(4)
Trident TPI Holdings, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.00%	8.60%		9/15/2028		7,481		7,481		7,502
Total Portfolio Investments									$	330,094	$	337,882	$	329,496

_______

(1) Represents the interest rate as of September 30, 2024. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2024, the reference rates for SLF JV I's variable rate loans were the 30-day SOFR at 4.85% and the 90-day SOFR at 4.59%. Most loans include an interest floor, which generally ranges from 0% to 2%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of September 30, 2024 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and SLF JV I as of September 30, 2024.

(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

(6) This investment was on non-accrual status as of September 30, 2024.

SLF JV I Portfolio as of September 30, 2023


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.32%		8/18/2028		$	8,596	$	8,503	$	8,499
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.90%		12/18/2025		1,149		1,135		1,128		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.15%		12/18/2025		6,771		6,701		6,648		(4)
Altice France S.A.	Integrated Telecommunication Services	First Lien Term Loan	L+	4.00%	9.63%		8/14/2026		2,969		2,853		2,810
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	13.04%		6/30/2025		8,798		8,737		8,218		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.43%		6/9/2028		4,957		4,734		4,614
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.81%		10/20/2028		4,824		4,763		4,239		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.15%	9.54%		11/26/2026		7,720		7,643		7,720
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.40%		8/11/2025		1,523		1,191		1,099		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027		—		(7)		(29)		(4)(5)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.63%		12/29/2027		4,134		4,076		3,892		(4)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%	10.90%		10/25/2028		5,052		4,888		3,817		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.42%		8/19/2028		4,950		4,747		4,809
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.67%		8/19/2028		1,990		1,884		1,937
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.68%		1/20/2029		4,346		4,036		3,871
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.57%		2/15/2029		4,320		4,080		4,251
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	6.00%	11.49%		12/24/2026		6,289		6,216		6,028		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027		1,753		1,742		1,711		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027		6,306		6,247		6,155		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.55%		8/10/2027		2,354		2,322		2,281
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.55%		8/10/2027		1,983		1,954		1,921
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	11.57%		8/10/2027		600		592		581
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.55%		8/10/2027		1,960		1,935		1,899
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.39%		10/13/2029		6,343		5,983		6,285		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	SOFR+	4.50%	9.89%		7/31/2029		8,730		8,642		8,730
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.43%		8/2/2027		5,799		5,715		5,681		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	10.12%		4/26/2029		7,920		7,792		7,729		(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.57%		8/11/2028		7,369		7,295		6,190		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.67%		4/9/2029		7,920		7,731		7,517		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.90%		6/30/2026		7,331		7,249		7,340


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	11.40%		3/25/2027		$	9,000	$	8,839	$	7,080	(4)
KDC/ONE Development Corp Inc	Personal Care Products	First Lien Term Loan	SOFR+	5.00%	10.32%		8/15/2028		10,000		9,666		9,665
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	10.42%		10/29/2028		3,962		3,815		3,955
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.32%		10/14/2027		7,369		7,269		7,267
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	SOFR+	5.00%	10.65%		5/9/2026		11,249		11,106		10,912		(4)
McAfee Corp.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.18%		3/1/2029		5,940		5,654		5,812
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	SOFR+	7.00%			2/14/2025		—		(2)		(8)		(4)(5)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	7.00%	12.52%		2/14/2025		4,669		4,648		4,594		(4)
Mitchell International, Inc.	Application Software	First Lien Term Loan	SOFR+	3.75%	9.18%		10/15/2028		2,985		2,845		2,941
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026		—		(3)		(7)		(4)(5)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.99%		2/10/2026		8,319		8,164		8,147		(4)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.99%		2/10/2026		2,211		2,210		2,165		(4)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.76%	10.15%		3/31/2025		6,615		6,608		6,565
OEConnection LLC	Application Software	First Lien Term Loan	SOFR+	4.00%	9.43%		9/25/2026		10,987		10,827		10,971
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	10.42%		11/10/2027		9,825		9,492		9,698		(4)
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.65%		12/17/2027		2,416		2,298		2,390
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.74%		12/18/2028		4,503		4,435		4,098		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.45%		4/6/2027		318		301		297		(4)(5)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.45%		4/6/2027		8,116		7,850		7,773		(4)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.75%	9.99%		4/5/2030		5,000		4,860		4,969
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.23%	10.86%		4/27/2024		138		138		94
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.25%	10.88%		4/27/2024		8,113		8,111		5,531
SM Wellness Holdings, Inc.	Health Care Services	First Lien Term Loan	SOFR+	4.75%	10.38%		4/17/2028		2,977		2,580		2,799		(4)
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	4.00%	9.43%		10/5/2027		7,680		7,642		7,643
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.25%	10.67%		11/20/2028		8,843		8,713		8,717		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.92%		4/5/2029		8,801		8,442		8,794
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	4.00%	9.33%		9/19/2030		8,000		7,880		7,834
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.99%		3/30/2029		8,215		7,559		7,913
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.42%		12/29/2028		7,212		7,103		7,022		(4)
Veritas US Inc.	Application Software	First Lien Term Loan	SOFR+	5.00%	10.43%		9/1/2025		6,305		6,257		5,500
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.67%		9/21/2027		6,148		6,008		5,939		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	9.27%		4/30/2025		1,965		1,920		1,855		(4)
Total Portfolio Investments									$	332,637	$	331,808	$	322,179

_________

(1) Represents the interest rate as of September 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR and/or LIBOR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39% and the 30-day LIBOR at 5.43%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(3) Represents the current determination of fair value as of September 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.

(4) This investment was held by both the Company and SLF JV I as of September 30, 2023.

Glick JV Portfolio as of September 30, 2024


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.25%		8/18/2028	$	1,980	$	1,948	$	1,991	(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.37%		12/18/2025	3,359		3,341		3,225		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.37%		12/18/2025	513		510		493		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.45%		6/30/2025	5,897		5,880		5,426		(4)
Artera Services LLC	Construction & Engineering	First Lien Term Loan	SOFR+	4.50%	9.10%		2/15/2031	3,485		3,459		3,406
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.52%		12/29/2027	1,699		1,681		1,617		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%	11.29%		12/29/2027	120		118		110		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	6.75%	11.35%		2/25/2028	1,047		1,035		868		(4)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%			10/25/2028	1,661		1,619		477		(4)(6)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	8.95%		8/19/2028	3,149		3,073		3,102
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.20%		8/19/2028	985		943		972
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.10%		2/15/2029	2,942		2,850		2,929
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	7.00%	7.70%	4.00%	12/24/2026	3,778		3,710		3,664		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	9.87%		6/11/2027	3,328		3,298		3,133		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	9.87%		6/11/2027	792		787		745		(4)
Bausch + Lomb Corporation	Health Care Supplies	First Lien Term Loan	SOFR+	3.25%	8.27%		5/10/2027	3,718		3,657		3,710
Boxer Parent Company Inc.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.01%		7/30/2031	3,000		2,993		2,998
Cloud Software Group, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	8.60%		3/30/2029	2,621		2,456		2,613
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	9.60%		10/13/2029	2,570		2,446		2,443		(4)
Crown Subsea Communications Holding, Inc.	Alternative Carriers	First Lien Term Loan	SOFR+	4.00%	9.25%		1/30/2031	2,993		2,963		3,015
Curium Bidco S.à.r.l.	Pharmaceuticals	First Lien Term Loan	SOFR+	4.00%	8.60%		7/31/2029	2,813		2,792		2,826
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.25%	10.21%		8/2/2029	2,957		2,932		2,916
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.60%		4/26/2029	3,534		3,488		3,553
Eagle Parent Corp.	Diversified Support Services	First Lien Term Loan	SOFR+	4.25%	8.85%		4/2/2029	392		387		373
Engineering Research and Consulting LLC	Construction & Engineering	First Lien Term Loan	SOFR+	5.00%	10.06%		8/29/2031	1,025		1,011		1,019		(4)
Frontier Communications Holdings, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	3.50%	8.76%		7/1/2031	3,000		2,985		3,026


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.20%		4/9/2029	$	3,920	$	3,843	$	3,823	(4)
Husky Injection Molding Systems Ltd.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	5.00%	10.33%		2/15/2029	3,125		3,088		3,114
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.21%		6/30/2026	3,870		3,842		3,865
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	10.62%		3/25/2027	2,125		2,098		1,785		(4)
KDC US Holdings, Inc.	Personal Care Products	First Lien Term Loan	SOFR+	4.50%	9.36%		8/15/2028	3,551		3,454		3,558
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	9.95%		10/29/2028	2,987		2,899		2,926		(4)
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	SOFR+	4.75%	9.60%		7/29/2029	4,000		3,950		3,939
M2S Group Intermediate Holdings Inc	Multi-Sector Holdings	First Lien Term Loan	SOFR+	4.75%	9.85%		8/25/2031	4,000		3,861		3,850
Mitchell International, Inc.	Application Software	First Lien Term Loan	SOFR+	3.25%	8.10%		6/17/2031	3,500		3,480		3,453
Peraton Corp.	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	8.70%		2/1/2028	990		989		954
PetSmart LLC	Other Specialty Retail	First Lien Term Loan	SOFR+	3.75%	8.70%		2/11/2028	2,980		2,944		2,959
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	4.50%	8.12%	1.50%	8/22/2029	662		662		662		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	7.50%		12.62%	8/22/2029	993		993		993		(4)
Pluralsight, LLC	Application Software	Common Equity & Warrants								1,105		1,105		(4)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.25%	9.10%		4/5/2030	1,985		1,980		1,986
SCIH Salt Holdings Inc.	Diversified Chemicals	First Lien Term Loan	SOFR+	3.50%	8.76%		3/16/2027	1,480		1,481		1,483
Shearer's Foods LLC	Packaged Foods & Meats	First Lien Term Loan	SOFR+	4.00%	8.85%		2/12/2031	2,993		2,963		2,998
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	6.50%	11.82%		6/30/2029	697		664		683
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	6.50%	11.82%		6/30/2029	1,957		1,957		1,879
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	7.00%	12.32%		6/30/2029	1,078		1,078		970
SHO Holding I Corporation	Footwear	Common Equity & Warrants								3,194		2,337
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	3.75%	8.00%		10/5/2027	3,266		3,250		3,277
Staples, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.75%	10.69%		9/4/2029	1,918		1,846		1,748		(4)
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	3.75%	8.35%		9/27/2030	3,980		3,920		3,878
SupplyOne, Inc.	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	4.25%	9.10%		4/19/2031	1,493		1,478		1,499
Swissport Stratosphere USA LLC	Air Freight & Logistics	First Lien Term Loan	SOFR+	4.25%	9.57%		4/4/2031	1,995		1,985		2,004
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	10.95%		12/29/2028	8		7		7		(4)
Trident TPI Holdings, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.00%	8.60%		9/15/2028	2,494		2,494		2,502
Total Portfolio Investments								$	125,405	$	127,867	$	124,887

__________

(1) Represents the interest rate as of September 30, 2024. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for all of the floating rate loans is indexed to SOFR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2024, the reference rates for the Glick JV's variable rate loans were the 30-day SOFR at 4.85% and the 90-day SOFR at 4.59%. Most loans include an interest floor, which generally ranges from 0% to 2%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(4) This investment was held by both the Company and the Glick JV as of September 30, 2024.

(6) This investment was on non-accrual status as of September 30, 2024.

Glick JV Portfolio as of September 30, 2023


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.32%		8/18/2028	$	2,000	$	1,960	$	1,978
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.90%		12/18/2025	574		568		564		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.15%		12/18/2025	3,746		3,709		3,678		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	13.04%		6/30/2025	6,230		6,185		5,819		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.43%		6/9/2028	2,478		2,367		2,307
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.81%		10/20/2028	2,860		2,825		2,514		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.15%	9.54%		11/26/2026	2,895		2,866		2,895
Amynta Agency Borrower Inc.	Property & Casualty Insurance	First Lien Term Loan	SOFR+	5.00%	10.42%		2/28/2028	2,993		2,913		2,997
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.40%		8/11/2025	907		705		654		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.63%		12/29/2027	1,716		1,692		1,616		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027	—		(3)		(12)		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%	10.90%		10/25/2028	2,078		2,039		1,570		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.42%		8/19/2028	1,980		1,899		1,924
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.67%		8/19/2028	995		942		968
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.68%		1/20/2029	2,423		2,244		2,158
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.57%		2/15/2029	1,772		1,674		1,744
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	6.00%	11.49%		12/24/2026	3,628		3,586		3,478		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027	3,363		3,332		3,282		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027	800		795		780		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.39%		10/13/2029	2,766		2,607		2,741		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	SOFR+	4.50%	9.89%		7/31/2029	2,841		2,820		2,841
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.43%		8/2/2027	2,460		2,435		2,410		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	10.12%		4/26/2029	2,970		2,922		2,899		(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.57%		8/11/2028	3,930		3,891		3,301		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.67%		4/9/2029	3,960		3,865		3,759		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.90%		6/30/2026	3,910		3,866		3,915
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	11.40%		3/25/2027	2,250		2,210		1,770		(4)
KDC/ONE Development Corp Inc	Personal Care Products	First Lien Term Loan	SOFR+	5.00%	10.32%		8/15/2028	4,500		4,350		4,349


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.32%		10/14/2027	$	3,930	$	3,877	$	3,876
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.99%		2/10/2026	1,630		1,616		1,596		(4)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026	—		(1)		(3)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.76%	10.15%		3/31/2025	5,198		5,192		5,159
OEConnection LLC	Application Software	First Lien Term Loan	SOFR+	4.00%	9.43%		9/25/2026	3,849		3,830		3,843
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.65%		12/17/2027	683		650		676
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.74%		12/18/2028	2,842		2,799		2,586		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.45%		4/6/2027	5,182		5,029		4,964		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.45%		4/6/2027	226		216		211		(4)(5)
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.25%	10.88%		4/27/2024	6,029		6,025		4,110
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.23%	10.86%		4/27/2024	103		102		70
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	4.00%	9.43%		10/5/2027	3,292		3,275		3,276
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.25%	10.67%		11/20/2028	4,913		4,840		4,843		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.92%		4/5/2029	5,227		5,032		5,224
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	4.00%	9.33%		9/27/2030	4,000		3,939		3,916
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.99%		3/30/2029	2,641		2,439		2,544
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.42%		12/29/2028	2,993		2,948		2,914		(4)
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.67%		9/21/2027	3,843		3,756		3,712		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	9.27%		4/30/2025	983		960		927		(4)
Total Portfolio Investments								$	130,589	$	127,788	$	123,343

__________

(1) Represents the interest rate as of September 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for all of the floating rate loans is indexed to SOFR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2023, the reference rates for the Glick JV's variable rate loans were the 30-day SOFR at 5.32% and the 90-day SOFR at 5.39%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(4) This investment was held by both the Company and the Glick JV as of September 30, 2023.

Schedule of Financial Instruments Carried at Fair Value

The following table presents the financial instruments carried at fair value as of September 30, 2024 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:


	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	254,627	$	2,320,310	$	—	$	2,574,937
Investments in debt securities (subordinated, including the debt investments in the JVs, CLO Notes and Credit Linked Notes)	—		16,127		255,346		—		271,473
Investments in equity securities (preferred)	—		—		66,320		—		66,320
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	1,422		2,830		81,756		22,541		108,549
Total investments at fair value	1,422		273,584		2,723,732		22,541		3,021,279
Cash equivalents	34,597		—		—		—		34,597
Total assets at fair value	$	36,019	$	273,584	$	2,723,732	$	22,541	$	3,055,876
Derivative liabilities	$	—	$	16,843	$	—	$	—	$	16,843
Total liabilities at fair value	$	—	$	16,843	$	—	$	—	$	16,843

__________

(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.

The following table presents the financial instruments carried at fair value as of September 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:


	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	208,694	$	2,292,691	$	—	$	2,501,385
Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes)	—		28,666		189,724		—		218,390
Investments in equity securities (preferred)	—		—		86,057		—		86,057
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	4,317		1,953		51,440		28,878		86,588
Total investments at fair value	4,317		239,313		2,619,912		28,878		2,892,420
Cash equivalents	83,262		—		—		—		83,262
Derivative assets	—		4,910		—		—		4,910
Total assets at fair value	$	87,579	$	244,223	$	2,619,912	$	28,878	$	2,980,592
Derivative liabilities	$	—	$	47,519	$	—	$	—	$	47,519
Total liabilities at fair value	$	—	$	47,519	$	—	$	—	$	47,519

__________

Schedule of Roll-Forward in the Changes in Fair Value

The following table provides a roll-forward in the changes in fair value from September 30, 2023 to September 30, 2024 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors:


	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs and credit linked notes)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2023	$	2,292,691	$	189,724	$	86,057	$	51,440	$	2,619,912
Purchases	838,357		71,788		7,578		1,749		919,472
Sales and repayments	(732,739)		(5,019)		(205)		(860)		(738,823)
Transfers in (a)(c)	43,451		—		—		63,952		107,403
Transfers out (b)(c)	(97,840)		(4,657)		(1,159)		(283)		(103,939)
Capitalized PIK interest income	22,624		2,339		—		—		24,963
Accretion of OID	12,756		1,418		—		—		14,174
Net unrealized appreciation (depreciation)	43,104		(293)		11,642		(32,516)		21,937
Net realized gains (losses)	(102,094)		46		(37,593)		(1,726)		(141,367)
Fair value as of September 30, 2024	$	2,320,310	$	255,346	$	66,320	$	81,756	$	2,723,732
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of September 30, 2024 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the year ended September 30, 2024	$	(5,669)	$	(873)	$	5,704	$	(35,621)	$	(36,459)

__________

(a) There were $38.8 million of transfers into Level 3 from Level 2 for investments during the year ended September 30, 2024 as a result of a change in the number of market quotes available and/or a change in market liquidity.

(b) There were $35.0 million of transfers out of Level 3 to Level 2 for investments during the year ended September 30, 2024

as a result of a change in the number of market quotes available and/or a change in market liquidity.

Level 3 senior secured debt was exchanged for Level 3 common equity, (2) $4.7 million of Level 3 subordinated debt was exchanged for Level 3 senior secured debt, (3) $1.2 million of Level 3 preferred equity was exchanged for Level 3 common equity and (4) $0.3 million of Level 3 common stock was converted to Level 1 common stock.

The following table provides a roll-forward in the changes in fair value from September 30, 2022 to September 30, 2023 for all investments for which Oaktree determined fair value using unobservable (Level 3) factors:


	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2022	$	1,910,606	$	159,388	$	79,523	$	19,958	$	2,169,475
Purchases (a)	1,080,654		30,690		14,296		5,611		1,131,251
Sales and repayments	(650,437)		(1,396)		—		(13,894)		(665,727)
Transfers in (b)(c)	19,075		—		—		40,093		59,168
Transfers out (c)	(40,093)		—		—		—		(40,093)
Capitalized PIK interest income	15,016		628		—		—		15,644
Accretion of OID	16,322		1,449		—		—		17,771
Net unrealized appreciation (depreciation)	(37,253)		(1,035)		(7,762)		(2,921)		(48,971)
Net realized gains (losses)	(21,199)		—		—		2,593		(18,606)
Fair value as of September 30, 2023	$	2,292,691	$	189,724	$	86,057	$	51,440	$	2,619,912
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of September 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the year ended September 30, 2023	$	(48,680)	$	(1,035)	$	(7,762)	$	(6,513)	$	(63,990)

__________

(a) Includes Level 3 investments acquired in connection with the OSI2 Merger during the year ended September 30, 2023.

(b) There was one transfer into Level 3 from Level 2 for an investment during the year ended September 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity.

(c) There was one investment restructuring in which Level 3 senior secured debt was exchanged for Level 3 common equity during the year ended September 30, 2023.

Schedule of Significant Unobservable Inputs for Level 3 Investments

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2024:

Asset

Fair Value

Valuation Technique

Unobservable Input

Range

Weighted
Average (a)

Senior Secured Debt

2,044,221

Market Yield

(b)

5.7%

31.0%

12.0%

52,857

Enterprise Value

Revenue Multiple

(c)

2.0x

5.5x

3.7x

26,927

Enterprise Value

EBITDA Multiple

(c)

4.5x

7.5x

5.7x

33,272

Transaction Precedent

Transaction Price

(d)

N/A

163,033

Broker Quotations

Broker Quoted Price

(e)

N/A

Subordinated Debt

93,794

Market Yield

(b)

5.0%

45.0%

10.1%

Debt Investments in the JVs

161,552

Enterprise Value

N/A

(f)

N/A

Preferred & Common Equity

80,720

Enterprise Value

Revenue Multiple

(c)

0.3x

7.2x

2.0x

66,106

Enterprise Value

EBITDA Multiple

(c)

2.9x

15.0x

10.2x

1,250

Enterprise Value

Asset Multiple

(c)

1.0x

1.4x

Total

2,723,732

__________

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

(e)Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated.

(f)Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2023:

Asset

Fair Value

Valuation Technique

Unobservable Input

Range

Weighted
Average (a)

Senior Secured Debt

1,904,140

Market Yield

(b)

9.0%

32.0%

14.7%

64,802

Enterprise Value

EBITDA Multiple

(c)

3.0x

6.0x

4.6x

33,816

Transaction Precedent

Transaction Price

(d)

N/A

289,933

Broker quotations

Broker Quoted Price

(e)

N/A

Subordinated Debt

22,881

Market Yield

(b)

10.0%

22.0%

11.2%

4,170

Broker Quotations

Broker Quoted Price

(e)

N/A

Debt Investments in the JVs

162,673

Enterprise Value

N/A

(f)

N/A

Preferred & Common Equity

32,318

Enterprise Value

Revenue Multiple

(c)

0.4x

3.2x

0.5x

103,661

Enterprise Value

EBITDA Multiple

(c)

1.7x

15.1x

8.8x

1,097

Enterprise Value

Asset Multiple

(c)

1.0x

1.4x

421

Transaction Precedent

Transaction Price

(d)

N/A

Total

2,619,912

__________

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated.

Schedule of Fair Value Disclosure of Asset and Liability Not Measured at Fair Value

The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2024 and the level of each financial liability within the fair value hierarchy:


	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	430,000	$	430,000	$	—	$	—	$	430,000
OSI2 Citibank Facility payable	280,000		280,000		—		—		280,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	299,492		298,146		—		298,146		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	327,612		327,723		—		327,723		—
2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	301,589		312,264		—		312,264		—
Total	$	1,638,693	$	1,648,133	$	—	$	938,133	$	710,000

The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2023 and the level of each financial liability within the fair value hierarchy:


	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	430,000	$	430,000	$	—	$	—	$	430,000
OSI2 Citibank Facility payable	280,000		280,000		—		—		280,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	298,241		286,437		—		286,437		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	306,412		301,784		—		301,784		—
2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	286,078		289,980		—		289,980		—
Total	$	1,600,731	$	1,588,201	$	—	$	878,201	$	710,000

Schedule of Portfolio Composition

Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables:


	September 30, 2024				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Senior secured debt	$	2,615,066	83.14	%	$	2,594,640	85.24	%
Debt investments in the JVs	164,324		5.23	%	162,986		5.35	%
Common equity and warrants	134,452		4.28	%	72,261		2.37	%
Subordinated debt	108,068		3.44	%	59,844		1.97	%
Preferred equity	68,218		2.17	%	99,597		3.27	%
LLC equity interests of the JVs	54,791		1.74	%	54,791		1.80	%
Total	$	3,144,919	100.00	%	$	3,044,119	100.00	%


	September 30, 2024						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Senior secured debt	$	2,574,937	85.21	%	173.06	%	$	2,501,385	86.47	%	165.01	%
Debt investments in the JVs	161,552		5.35	%	10.86	%	162,673		5.62	%	10.73	%
Subordinated debt	109,921		3.64	%	7.39	%	55,717		1.93	%	3.68	%
Common equity and warrants	86,008		2.85	%	5.78	%	57,710		2.00	%	3.81	%
Preferred equity	66,320		2.20	%	4.46	%	86,057		2.98	%	5.68	%
LLC equity interests of the JVs	22,541		0.75	%	1.52	%	28,878		1.00	%	1.91	%
Total	$	3,021,279	100.00	%	203.07	%	$	2,892,420	100.00	%	190.82	%

The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets:


	September 30, 2024				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Northeast	$	1,033,467	32.86	%	$	1,012,955	33.27	%
Southeast	464,992		14.79	%	375,247		12.33	%
Midwest	397,640		12.64	%	360,506		11.84	%
International	343,033		10.91	%	418,595		13.75	%
West	320,407		10.19	%	393,390		12.92	%
Southwest	285,648		9.08	%	153,318		5.04	%
South	241,098		7.67	%	202,374		6.65	%
Northwest	58,634		1.86	%	127,734		4.20	%
Total	$	3,144,919	100.00	%	$	3,044,119	100.00	%


	September 30, 2024						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Northeast	$	965,469	31.94	%	64.89	%	$	945,422	32.69	%	62.37	%
Southeast	419,669		13.89	%	28.21	%	354,444		12.25	%	23.38	%
Midwest	390,607		12.93	%	26.25	%	350,620		12.12	%	23.13	%
International	354,662		11.74	%	23.84	%	414,079		14.32	%	27.32	%
West	314,994		10.43	%	21.17	%	384,055		13.28	%	25.34	%
Southwest	279,653		9.26	%	18.80	%	130,455		4.51	%	8.61	%
South	237,634		7.87	%	15.97	%	188,541		6.52	%	12.44	%
Northwest	58,591		1.94	%	3.94	%	124,804		4.31	%	8.23	%
Total	$	3,021,279	100.00	%	203.07	%	$	2,892,420	100.00	%	190.82	%

Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of September 30, 2024 and September 30, 2023:


	September 30, 2024	September 30, 2023
Senior secured loans (1)	$330,094	$332,637
Weighted average interest rate on senior secured loans (2)	9.56%	10.62%
Number of borrowers in SLF JV I	48	48
Largest exposure to a single borrower (1)	$10,495	$11,286
Total of five largest loan exposures to borrowers (1)	$49,413	$54,051

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of September 30, 2024 and September 30, 2023:


	September 30, 2024	September 30, 2023
Senior secured loans (1)	$125,405	$130,589
Weighted average current interest rate on senior secured loans (2)	9.65%	10.77%
Number of borrowers in the Glick JV	44	38
Largest loan exposure to a single borrower (1)	$5,898	$6,230
Total of five largest loan exposures to borrowers (1)	$22,152	$28,396

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.


(Share amounts in thousands)	Year ended September 30, 2024	Year ended September 30, 2023(6)	Year ended September 30, 2022(6)	Year ended September 30, 2021(6)	Year ended September 30, 2020(6)
Net asset value per share at beginning of period	$19.63	$20.38	$21.84	$19.47	$19.81
Net investment income (1)	2.18	2.51	2.45	1.80	1.53
Net unrealized appreciation (depreciation) (1)(7)	0.25	(0.17)	(2.23)	2.19	(0.44)
Net realized gains (losses) (1)	(1.70)	(0.46)	0.28	0.49	(0.30)
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)	—	(0.02)	(0.01)	(0.02)	0.04
Distributions of net investment income to stockholders	(2.27)	(2.61)	(1.95)	(1.52)	(1.17)
Issuance of common stock	—	—	—	(0.57)	—
Net asset value per share at end of period	$18.09	$19.63	$20.38	$21.84	$19.47
Per share market value at beginning of period	$20.12	$18.00	$21.18	$14.52	$15.54
Per share market value at end of period	$16.31	$20.12	$18.00	$21.18	$14.52
Total return (2)	(8.47)%	27.30%	(6.71)%	57.61%	2.10%
Common shares outstanding at beginning of period	77,225	61,125	60,120	46,987	46,987
Common shares outstanding at end of period	82,245	77,225	61,125	60,120	46,987
Net assets at beginning of period	$1,515,764	$1,245,563	$1,312,823	$914,879	$930,630
Net assets at end of period	$1,487,811	$1,515,764	$1,245,563	$1,312,823	$914,879
Average net assets (3)	$1,520,016	$1,437,728	$1,308,518	$1,150,662	$871,305
Ratio of net investment income to average net assets (3)	11.52%	12.57%	11.36%	8.44%	8.26%
Ratio of total expenses to average net assets (3)	14.23%	14.19%	8.68%	9.65%	7.57%
Ratio of net expenses to average net assets (3)	13.59%	13.81%	8.45%	9.51%	8.16%
Ratio of portfolio turnover to average investments at fair value	35.96%	26.12%	26.99%	39.66%	38.99%
Weighted average outstanding debt (4)	$1,683,757	$1,659,701	$1,361,151	$964,390	$647,080
Average debt per share (1)	$20.94	$23.01	$22.41	$17.85	$13.77
Asset coverage ratio at end of period (5)	188.14%	187.74%	188.64%	201.68%	227.22%

__________


(1)			Calculated based upon weighted average shares outstanding for the period.
(2)			Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)			Calculated based upon the weighted average net assets for the period.
(4)			Calculated based upon the weighted average of principal debt outstanding for the period.
(5)			Based on outstanding senior securities of $1,663.8 million, $1,660.0 million, $1,350.0 million, $1,280.0 million and $714.8 million as of September 30, 2024, 2023, 2022, 2021 and 2020, respectively.
(6)			The share and per share information disclosed in this table has been retroactively adjusted as necessary to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(7)			For the year ended September 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger. For the year ended September 30, 2021, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OCSI Merger.

Senior Securities

Information about our senior securities (including debt securities and other indebtedness) is shown in the following table as of the fiscal years ended September 30 for the years indicated below.


Class and Year(1)	Total Amount Outstanding Exclusive of Treasury Securities (2)		Asset Coverage Per Unit(3)	Involuntary Liquidating Preference Per Unit(4)	Average Market Value Per Unit(5)
Syndicated Facility and Prior ING Facility
Fiscal 2015	$	383,495	2,389	—	N/A
Fiscal 2016	472,495		2,208	—	N/A
Fiscal 2017	226,495		2,274	—	N/A
Fiscal 2018	241,000		2,330	—	N/A
Fiscal 2019	314,825		2,949	—	N/A
Fiscal 2020	414,825		2,272	—	N/A
Fiscal 2021	495,000		2,017	—	N/A
Fiscal 2022	540,000		1,886	—	N/A
Fiscal 2023	430,000		1,877	—	N/A
Fiscal 2024	430,000		1,881	—	N/A

Citibank Facility
Fiscal 2021	$	135,000	2,017	—	N/A
Fiscal 2022	160,000		1,886	—	N/A

OSI2 Citibank Facility
Fiscal 2023	$	280,000	1,877	—	N/A
Fiscal 2024	280,000		1,881	—	N/A

Sumitomo Facility
Fiscal 2015	$	43,800	2,389	—	N/A
Fiscal 2016	43,800		2,208	—	N/A
Fiscal 2017	29,500		2,274	—	N/A

Convertible Notes
Fiscal 2015	$	115,000	2,389	—	N/A

Secured Borrowings
Fiscal 2015	$	21,787	2,389	—	N/A
Fiscal 2016	18,929		2,208	—	N/A
Fiscal 2017	13,489		2,274	—	N/A
Fiscal 2018	12,314		2,330	—	N/A

2019 Notes
Fiscal 2015	$	250,000	2,389	—	N/A
Fiscal 2016	250,000		2,208	—	N/A
Fiscal 2017	250,000		2,274	—	N/A
Fiscal 2018	228,825		2,330	—	N/A


Class and Year(1)	Total Amount Outstanding Exclusive of Treasury Securities (2)		Asset Coverage Per Unit(3)	Involuntary Liquidating Preference Per Unit(4)	Average Market Value Per Unit(5)
2024 Notes
Fiscal 2015	$	75,000	2,389	—	991.94
Fiscal 2016	75,000		2,208	—	993.70
Fiscal 2017	75,000		2,274	—	1,006.74
Fiscal 2018	75,000		2,330	—	1,010.72
Fiscal 2019	75,000		2,949	—	1,012.76

2025 Notes
Fiscal 2020	$	300,000	2,272	—	N/A
Fiscal 2021	300,000		2,017	—	N/A
Fiscal 2022	300,000		1,886	—	N/A
Fiscal 2023	300,000		1,877	—	N/A
Fiscal 2024	300,000		1,881	—	N/A

2027 Notes
Fiscal 2021	$	350,000	2,017	—	N/A
Fiscal 2022	350,000		1,886	—	N/A
Fiscal 2023	350,000		1,877	—	N/A
Fiscal 2024	350,000		1,881	—	N/A

2028 Notes
Fiscal 2015	$	86,250	2,389	—	988.06
Fiscal 2016	86,250		2,208	—	999.29
Fiscal 2017	86,250		2,274	—	1,007.51
Fiscal 2018	86,250		2,330	—	994.82
Fiscal 2019	86,250		2,949	—	993.33

2029 Notes
Fiscal 2023	$	300,000	1,877	—	N/A
Fiscal 2024	300,000		1,881	—	N/A

Total Senior Securities
Fiscal 2015	$	975,332	2,389	—
Fiscal 2016	946,474		2,208	—
Fiscal 2017	680,734		2,274	—
Fiscal 2018	643,389		2,330	—
Fiscal 2019	476,075		2,949	—
Fiscal 2020	714,825		2,272	—
Fiscal 2021	1,280,000		2,017	—
Fiscal 2022	1,350,000		1,886	—
Fiscal 2023	1,660,000		1,877	—
Fiscal 2024	1,660,000		1,881	—

______________

(2)Total amount of each class of senior securities outstanding at the end of the period, presented in thousands.

(5)Calculated on a daily average basis.

Schedule of Summarized Financial Information

Below is certain summarized financial information for SLF JV I as of September 30, 2024 and September 30, 2023 and for the years ended September 30, 2024, 2023 and 2022:


	September 30, 2024		September 30, 2023
Selected Balance Sheet Information:
Investments at fair value (cost September 30, 2024: $337,882; cost September 30, 2023: $331,808)	$	329,496	$	322,179
Cash and cash equivalents	36,082		31,950
Restricted cash	6,994		2,987
Other assets	3,260		18,988
Total assets	$	375,832	$	376,104

Senior credit facility payable	$	200,000	$	149,000
Secured borrowings	11,311		38,845
SLF JV I Notes payable at fair value (proceeds September 30, 2024: $128,750; proceeds September 30, 2023: $128,750)	128,750		128,750
Other liabilities	10,007		26,630
Total liabilities	$	350,068	$	343,225
Members' equity	25,764		32,879
Total liabilities and members' equity	$	375,832	$	376,104


	Year ended September 30, 2024		Year ended September 30, 2023		Year ended September 30, 2022
Selected Statements of Operations Information:
Interest income	$	37,250	$	38,984	$	24,014
Other income	153		290		198
Total investment income	37,403		39,274		24,212
Senior credit facility and secured borrowing interest expense	15,904		19,002		7,713
SLF JV I Notes interest expense	16,292		14,544		9,146
Other expenses	315		442		253
Total expenses (1)	32,511		33,988		17,112
Net investment income	4,892		5,286		7,100
Net unrealized appreciation (depreciation)	1,245		13,416		(23,661)
Net realized gains (losses)	(7,251)		(10,962)		534
Net income (loss)	$	(1,114)	$	7,740	$	(16,027)

__________

(1) There are no management fees or incentive fees charged at SLF JV I.

Below is certain summarized financial information for the Glick JV as of September 30, 2024 and September 30, 2023 and for the years ended September 30, 2024, 2023 and 2022:


	September 30, 2024		September 30, 2023
Selected Balance Sheet Information:
Investments at fair value (cost September 30, 2024: $127,867; cost September 30, 2023: $127,788)	$	124,887	$	123,343
Cash and cash equivalents	10,907		12,119
Restricted cash	1,032		184
Other assets	8,177		5,521
Total assets	$	145,003	$	141,167

Senior credit facility payable	$	79,000	$	53,000
Glick JV Notes payable at fair value (proceeds September 30, 2024: $66,685; proceeds September 30, 2023: $66,685)	55,886		57,201
Secured borrowings	5,766		18,106
Other liabilities	4,351		12,860
Total liabilities	$	145,003	$	141,167
Members' equity	—		—
Total liabilities and members' equity	$	145,003	$	141,167


	For the year ended September 30, 2024		For the year ended September 30, 2023		For the year ended September 30, 2022
Selected Statements of Operations Information:
Interest income	$	14,111	$	14,043	$	9,703
Fee income	70		63		149
Total investment income	14,181		14,106		9,852
Senior credit facility and secured borrowing interest expense	6,228		6,560		2,747
Glick JV Notes interest expense	6,743		6,056		3,576
Other expenses	143		182		168
Total expenses (1)	13,114		12,798		6,491
Net investment income	1,067		1,308		3,361
Net unrealized appreciation (depreciation)	2,781		1,254		(3,216)
Realized gain (loss)	(3,848)		(2,562)		(145)
Net income (loss)	$	—	$	—	$	—

__________

(1) There are no management fees or incentive fees charged at the Glick JV.

- Definition

Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.

+ References + Details

Portfolio Investments - Summary of Portfolio (Details)
€ in Thousands, £ in Thousands, $ in Thousands

Sep. 30, 2024

USD ($)

borrower

Sep. 30, 2024

EUR (€)

borrower

Sep. 30, 2024

GBP (£)

borrower

Sep. 30, 2023

USD ($)

borrower

Sep. 30, 2023

EUR (€)

borrower

Sep. 30, 2023

GBP (£)

borrower

Investment Company, Nonconsolidated Subsidiary [Line Items]

Number of borrowers | borrower

144

143

Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,989

^{[1],[2],[3],[4]}

$ 1,269

^{[5],[6],[7],[8]}

Investment, interest rate (as a percent)

13.00%

^{[1],[2],[3],[9]}

13.00%

^{[1],[2],[3],[9]}

13.00%

^{[1],[2],[3],[9]}

12.50%

^{[5],[6],[8],[10],[11]}

12.50%

^{[5],[6],[8],[10],[11]}

12.50%

^{[5],[6],[8],[10],[11]}

Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 31,231

^[1],[2],[4]

$ 18,869

^[5],[7],[8]

Investment, interest rate (as a percent)

11.00%

^[1],[2],[9]

11.00%

^[1],[2],[9]

11.00%

^[1],[2],[9]

11.00%

^{[5],[8],[10],[11]}

11.00%

^{[5],[8],[10],[11]}

11.00%

^{[5],[8],[10],[11]}

Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,336

^{[1],[2],[3],[4]}

$ 4,070

^{[5],[6],[7],[8]}

Investment, interest rate (as a percent)

13.00%

^{[1],[2],[3],[9]}

13.00%

^{[1],[2],[3],[9]}

13.00%

^{[1],[2],[3],[9]}

12.00%

^{[5],[6],[8],[10],[11]}

12.00%

^{[5],[6],[8],[10],[11]}

12.00%

^{[5],[6],[8],[10],[11]}

Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 21,870

^{[1],[4],[12],[13]}

$ 21,434

^{[7],[8],[14],[15]}

Investment, interest rate (as a percent)

14.25%

^{[1],[9],[12],[13]}

14.25%

^{[1],[9],[12],[13]}

14.25%

^{[1],[9],[12],[13]}

14.25%

^{[8],[10],[11],[14],[15]}

14.25%

^{[8],[10],[11],[14],[15]}

14.25%

^{[8],[10],[11],[14],[15]}

Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,835

^{[1],[4],[12],[16]}

$ 6,021

^[7],[8],[14]

Investment, Identifier [Axis]: ACESO Holding 4 S.A.R.L., Health Care Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12],[17]}

$ 0

Investment, Identifier [Axis]: ACESO Holding 4 S.A.R.L., Health Care Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | €

^{[1],[4],[12],[17]}

€ 16,817

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

8.91%

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,079

^[1],[4],[17]

$ 3,446

^[7],[8],[10]

Investment, interest rate (as a percent)

11.37%

^[1],[9],[17]

11.37%

^[1],[9],[17]

11.37%

^[1],[9],[17]

11.90%

^{[8],[10],[11]}

11.90%

^{[8],[10],[11]}

11.90%

^{[8],[10],[11]}

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 875

^[1],[4],[17]

$ 17,901

^[7],[8],[10]

Investment, interest rate (as a percent)

12.01%

^[1],[9],[17]

12.01%

^[1],[9],[17]

12.01%

^[1],[9],[17]

12.15%

^{[8],[10],[11]}

12.15%

^{[8],[10],[11]}

12.15%

^{[8],[10],[11]}

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 16,053

^[1],[4],[17]

$ 963

^[7],[8],[10]

Investment, interest rate (as a percent)

11.37%

^[1],[9],[17]

11.37%

^[1],[9],[17]

11.37%

^[1],[9],[17]

12.13%

^{[8],[10],[11]}

12.13%

^{[8],[10],[11]}

12.13%

^{[8],[10],[11]}

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[12],[17]}

$ 6,589

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

12.25%

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[14]}

$ 6,589

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

13.04%

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10],[14]}

$ 0

Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | €

^{[7],[10],[14]}

€ 5,500

Investment, interest rate (as a percent)

^{[10],[11],[14]}

8.86%

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 17,873

Investment, interest rate (as a percent)

^{[8],[10],[11]}

13.17%

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 230

^{[1],[2],[4],[12],[17]}

$ 0

^{[5],[7],[8],[10],[14]}

Investment, interest rate (as a percent)

^{[1],[2],[9],[12],[17]}

11.29%

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,243

^{[1],[4],[12],[17]}

$ 3,276

^{[7],[8],[10],[14]}

Investment, interest rate (as a percent)

10.66%

^{[1],[9],[12],[17]}

10.66%

^{[1],[9],[12],[17]}

10.66%

^{[1],[9],[12],[17]}

11.63%

^{[8],[10],[11],[14]}

11.63%

^{[8],[10],[11],[14]}

11.63%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 12,989

^{[1],[4],[12],[13]}

$ 12,222

^{[7],[8],[14],[15]}

Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[4],[17]

$ 1,985

Investment, interest rate (as a percent)

^[9],[17]

10.25%

Investment, Identifier [Axis]: Accession Risk Management Group, Inc., Insurance Brokers, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Accession Risk Management Group, Inc., Insurance Brokers, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,482

^{[1],[2],[4],[17]}

$ 2,033

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

10.90%

^{[1],[2],[9],[17]}

10.90%

^{[1],[2],[9],[17]}

10.90%

^{[1],[2],[9],[17]}

11.55%

^{[5],[8],[10],[11]}

11.55%

^{[5],[8],[10],[11]}

11.55%

^{[5],[8],[10],[11]}

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 20,234

^[7],[8],[10]

Investment, interest rate (as a percent)

^{[8],[10],[11]}

11.55%

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 20,024

^[1],[4],[17]

$ 0

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^[1],[9],[17]

10.90%

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,084

^{[1],[2],[4],[17]}

$ 1,333

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

12.47%

^{[1],[2],[9],[17]}

12.47%

^{[1],[2],[9],[17]}

12.47%

^{[1],[2],[9],[17]}

12.72%

^{[5],[8],[10],[11]}

12.72%

^{[5],[8],[10],[11]}

12.72%

^{[5],[8],[10],[11]}

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 6,400

^[1],[4],[17]

$ 6,400

^[7],[8],[10]

Investment, interest rate (as a percent)

12.46%

^[1],[9],[17]

12.46%

^[1],[9],[17]

12.46%

^[1],[9],[17]

12.34%

^{[8],[10],[11]}

12.34%

^{[8],[10],[11]}

12.34%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 25,332

^[1],[4],[17]

$ 25,332

^[7],[8],[10]

Investment, interest rate (as a percent)

12.46%

^[1],[9],[17]

12.46%

^[1],[9],[17]

12.46%

^[1],[9],[17]

12.34%

^{[8],[10],[11]}

12.34%

^{[8],[10],[11]}

12.34%

^{[8],[10],[11]}

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 1,560

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

8.70%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[18]}

$ 23,562

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 1,819

Investment, interest rate (as a percent)

^[1],[9],[17]

6.70%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 3,637

Investment, interest rate (as a percent)

^[1],[9],[17]

7.70%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[16]

$ 3,541

Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[14]

$ 4,050

Investment, interest rate (as a percent)

^{[10],[11],[14]}

5.50%

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 10,134

^[1],[4],[17]

$ 9,057

^[7],[8],[10]

Investment, interest rate (as a percent)

8.00%

^[1],[9],[17]

8.00%

^[1],[9],[17]

8.00%

^[1],[9],[17]

5.00%

^{[8],[10],[11]}

5.00%

^{[8],[10],[11]}

5.00%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 16,143

^[1],[4],[17]

$ 17,053

^[7],[8],[10]

Investment, interest rate (as a percent)

12.45%

^[1],[9],[17]

12.45%

^[1],[9],[17]

12.45%

^[1],[9],[17]

13.04%

^{[8],[10],[11]}

13.04%

^{[8],[10],[11]}

13.04%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[14]

$ 28,464

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

8.50%

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[14]

$ 2,121

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

8.50%

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[14]

$ 27,692

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

8.50%

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[14]

$ 2,064

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

8.50%

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 17,048

Investment, interest rate (as a percent)

^{[8],[10],[11]}

14.14%

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[4],[17]

$ 2,487

Investment, interest rate (as a percent)

^[9],[17]

9.75%

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 17,048

Investment, interest rate (as a percent)

^[1],[9],[17]

13.50%

Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 19,115

Investment, interest rate (as a percent)

^[10],[11]

11.81%

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[14]}

$ 12,500

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

13.54%

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 33,390

Investment, interest rate (as a percent)

^[1],[9],[17]

10.10%

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 3,700

Investment, interest rate (as a percent)

^[10],[11]

9.40%

Investment, Identifier [Axis]: Anchorage Capital CLO 20, LTD., Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[4],[12],[17]}

$ 750

Investment, interest rate (as a percent)

^{[9],[12],[17]}

12.89%

Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 47,451

Investment, interest rate (as a percent)

^[1],[9],[17]

10.35%

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | €

^{[7],[8],[10],[14]}

€ 3,017

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

10.95%

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[14]}

$ 10,519

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

11.57%

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | £

^{[7],[8],[10],[14]}

£ 4,949

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

12.46%

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | £

^{[7],[8],[10],[14]}

£ 23,675

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

12.46%

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | £

^{[7],[8],[10],[14]}

£ 3,649

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

9.70%

Investment, Identifier [Axis]: Ares XLIV CLO, Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[4],[12],[17]}

$ 3,500

Investment, interest rate (as a percent)

^{[9],[12],[17]}

12.43%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Advertising, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 21,852

Investment, interest rate (as a percent)

12.14%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10]}

$ 21,852

Investment, interest rate (as a percent)

^{[5],[8],[10],[11]}

12.14%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 8,490

Investment, interest rate (as a percent)

^[10],[11]

10.90%

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[4],[17]

$ 7,907

Investment, interest rate (as a percent)

^[9],[17]

11.35%

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[16],[17]}

$ 12,537

Investment, Identifier [Axis]: Aurelia Netherlands Midco 2 B.V., Interactive Media & Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | €

^{[1],[4],[12],[17]}

€ 28,022

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

9.55%

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 30,724

^{[1],[4],[12],[17]}

$ 29,509

^{[7],[8],[10],[14]}

Investment, interest rate (as a percent)

7.70%

^{[1],[9],[12],[17]}

7.70%

^{[1],[9],[12],[17]}

7.70%

^{[1],[9],[12],[17]}

11.49%

^{[8],[10],[11],[14]}

11.49%

^{[8],[10],[11],[14]}

11.49%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 50,470

^[1],[4],[17]

$ 50,470

^[7],[8],[10]

Investment, interest rate (as a percent)

10.85%

^[1],[9],[17]

10.85%

^[1],[9],[17]

10.85%

^[1],[9],[17]

12.64%

^{[8],[10],[11]}

12.64%

^{[8],[10],[11]}

12.64%

^{[8],[10],[11]}

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,214

^[1],[4],[17]

$ 3,247

^[7],[8],[10]

Investment, interest rate (as a percent)

9.87%

^[1],[9],[17]

9.87%

^[1],[9],[17]

9.87%

^[1],[9],[17]

10.65%

^{[8],[10],[11]}

10.65%

^{[8],[10],[11]}

10.65%

^{[8],[10],[11]}

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,248

^[1],[4],[17]

$ 1,261

^[7],[8],[10]

Investment, interest rate (as a percent)

9.87%

^[1],[9],[17]

9.87%

^[1],[9],[17]

9.87%

^[1],[9],[17]

10.65%

^{[8],[10],[11]}

10.65%

^{[8],[10],[11]}

10.65%

^{[8],[10],[11]}

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 6,452

^[1],[4],[17]

$ 8,920

^[7],[8],[10]

Investment, interest rate (as a percent)

13.35%

^[1],[9],[17]

13.35%

^[1],[9],[17]

13.35%

^[1],[9],[17]

14.15%

^{[8],[10],[11]}

14.15%

^{[8],[10],[11]}

14.15%

^{[8],[10],[11]}

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,920

^[1],[4],[17]

$ 2,091

^[7],[8],[10]

Investment, interest rate (as a percent)

13.37%

^[1],[9],[17]

13.37%

^[1],[9],[17]

13.37%

^[1],[9],[17]

14.15%

^{[8],[10],[11]}

14.15%

^{[8],[10],[11]}

14.15%

^{[8],[10],[11]}

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 4,361

Investment, interest rate (as a percent)

^{[8],[10],[11]}

14.15%

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,835

^{[1],[2],[4],[17]}

$ 2,221

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

10.52%

^{[1],[2],[9],[17]}

10.52%

^{[1],[2],[9],[17]}

10.52%

^{[1],[2],[9],[17]}

13.00%

^{[5],[8],[10],[11]}

13.00%

^{[5],[8],[10],[11]}

13.00%

^{[5],[8],[10],[11]}

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 40,246

^[1],[4],[17]

$ 40,660

^[7],[8],[10]

Investment, interest rate (as a percent)

10.90%

^[1],[9],[17]

10.90%

^[1],[9],[17]

10.90%

^[1],[9],[17]

11.02%

^{[8],[10],[11]}

11.02%

^{[8],[10],[11]}

11.02%

^{[8],[10],[11]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[12],[17]}

$ 6,757

^[7],[8],[14]

Investment, interest rate (as a percent)

^{[1],[2],[9],[12],[17]}

8.00%

^{[8],[10],[11],[14]}

8.00%

^{[8],[10],[11],[14]}

8.00%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,930

^{[1],[4],[12],[17]}

$ 3,316

^{[5],[7],[8],[14],[15]}

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

8.00%

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,062

^{[1],[4],[12],[17]}

$ 0

^{[5],[7],[8],[14]}

Investment, interest rate (as a percent)

8.00%

^{[1],[9],[12],[17]}

8.00%

^{[1],[9],[12],[17]}

8.00%

^{[1],[9],[12],[17]}

8.00%

^{[5],[8],[10],[11],[14]}

8.00%

^{[5],[8],[10],[11],[14]}

8.00%

^{[5],[8],[10],[11],[14]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[12],[17]}

$ 0

^{[5],[7],[8],[14]}

Investment, interest rate (as a percent)

^{[5],[8],[10],[11],[14]}

8.00%

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12],[17]}

$ 0

^{[5],[7],[8],[14],[15]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[14],[15]}

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[4],[17]

$ 19,336

Investment, interest rate (as a percent)

^[9],[17]

9.85%

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 30,625

Investment, interest rate (as a percent)

^[10],[11]

12.43%

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8]

$ 5,257

Investment, interest rate (as a percent)

^{[8],[10],[11]}

9.00%

Investment, Identifier [Axis]: CBAM 2017-2, LTD., Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[4],[12],[17]}

$ 489

Investment, interest rate (as a percent)

^{[9],[12],[17]}

12.65%

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | £

^{[4],[12],[17]}

£ 14,807

Investment, interest rate (as a percent)

^{[9],[12],[17]}

10.95%

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[4],[12],[17]}

$ 14,725

Investment, interest rate (as a percent)

^{[9],[12],[17]}

10.45%

Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[18]}

$ 727

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 37

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.07%

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 3,031

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.07%

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 1,557

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.07%

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 1,024

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.07%

Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

Investment, Identifier [Axis]: Centralsquare Technologies, LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Centralsquare Technologies, LLC, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 12,830

Investment, interest rate (as a percent)

^[1],[9],[17]

8.10%

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[14]

$ 2,632

Investment, interest rate (as a percent)

^{[10],[11],[14]}

7.50%

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[14]

$ 176

Investment, interest rate (as a percent)

^{[10],[11],[14]}

7.75%

Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7]

$ 8,420

Investment, interest rate (as a percent)

^[10],[11]

7.38%

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[18]}

$ 22,084

Investment, Identifier [Axis]: CoreRx, Inc., Pharmaceuticals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 6,494

Investment, interest rate (as a percent)

^[1],[9],[17]

12.10%

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 13,157

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.82%

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 13,124

^[1],[4],[17]

$ 0

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^[1],[9],[17]

10.75%

Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 10,878

^[4],[17]

$ 14,750

^[7],[10]

Investment, interest rate (as a percent)

9.60%

^[9],[17]

9.60%

^[9],[17]

9.60%

^[9],[17]

10.39%

^[10],[11]

10.39%

^[10],[11]

10.39%

^[10],[11]

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10]}

$ 933

Investment, interest rate (as a percent)

^{[5],[8],[10],[11]}

11.47%

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 18,013

Investment, interest rate (as a percent)

^{[8],[10],[11]}

11.52%

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 20,924

Investment, interest rate (as a percent)

^[1],[9],[17]

11.35%

Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 4,950

Investment, interest rate (as a percent)

^[10],[11]

10.12%

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[14]}

$ 17,465

Investment, interest rate (as a percent)

^{[5],[8],[10],[11],[14]}

3.00%

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12]}

$ 8,456

Investment, interest rate (as a percent)

^{[1],[2],[9],[12]}

8.00%

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[12]

$ 34,316

Investment, interest rate (as a percent)

^[1],[9],[12]

3.00%

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 20,757

Investment, interest rate (as a percent)

^{[8],[10],[11]}

14.54%

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 23,660

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

655

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

647

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

1,039

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 5

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

852

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8]

$ 654

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[16]

725

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[16]

959

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[16]

952

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[16]

1,679

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 284

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^{[5],[8],[10],[11]}

12.49%

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 12,386

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.49%

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 54,454

Investment, interest rate (as a percent)

^[1],[9],[17]

10.60%

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 2,939

Investment, interest rate (as a percent)

^[1],[9],[17]

10.60%

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 4,641

Investment, interest rate (as a percent)

^[10],[11]

10.43%

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,574

^[1],[4],[17]

$ 5,574

^[7],[8],[10]

Investment, interest rate (as a percent)

9.75%

^[1],[9],[17]

9.75%

^[1],[9],[17]

9.75%

^[1],[9],[17]

10.54%

^{[8],[10],[11]}

10.54%

^{[8],[10],[11]}

10.54%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 13,928

^[1],[4],[17]

$ 14,068

^[7],[8],[10]

Investment, interest rate (as a percent)

9.74%

^[1],[9],[17]

9.74%

^[1],[9],[17]

9.74%

^[1],[9],[17]

10.54%

^{[8],[10],[11]}

10.54%

^{[8],[10],[11]}

10.54%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 2,090

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

10.42%

^{[5],[8],[10],[11]}

10.42%

^{[5],[8],[10],[11]}

10.42%

^{[5],[8],[10],[11]}

Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,974

^[1],[4],[17]

$ 8,974

^[7],[8],[10]

Investment, interest rate (as a percent)

12.25%

^[1],[9],[17]

12.25%

^[1],[9],[17]

12.25%

^[1],[9],[17]

13.04%

^{[8],[10],[11]}

13.04%

^{[8],[10],[11]}

13.04%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Engineering Research and Consulting LLC, Construction & Engineering, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 11,933

Investment, interest rate (as a percent)

^[1],[9],[17]

10.06%

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 121

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

10.35%

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 24,741

Investment, interest rate (as a percent)

^[1],[9],[17]

10.35%

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,834

^[1],[4],[12]

$ 11,065

^[7],[8],[14]

Investment, interest rate (as a percent)

9.00%

^[1],[9],[12]

9.00%

^[1],[9],[12]

9.00%

^[1],[9],[12]

3.00%

^{[8],[10],[11],[14]}

3.00%

^{[8],[10],[11],[14]}

3.00%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[12]}

$ 1,772

^[7],[8],[14]

Investment, interest rate (as a percent)

9.00%

^{[1],[2],[9],[12]}

9.00%

^{[1],[2],[9],[12]}

9.00%

^{[1],[2],[9],[12]}

3.00%

^{[8],[10],[11],[14]}

3.00%

^{[8],[10],[11],[14]}

3.00%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[12]}

$ 0

^{[5],[7],[8],[14]}

Investment, interest rate (as a percent)

9.00%

^{[1],[2],[9],[12]}

9.00%

^{[1],[2],[9],[12]}

9.00%

^{[1],[2],[9],[12]}

3.00%

^{[5],[8],[10],[11],[14]}

3.00%

^{[5],[8],[10],[11],[14]}

3.00%

^{[5],[8],[10],[11],[14]}

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 11,454

^[1],[4],[12]

$ 0

^{[5],[7],[8],[14]}

Investment, interest rate (as a percent)

9.00%

^[1],[9],[12]

9.00%

^[1],[9],[12]

9.00%

^[1],[9],[12]

3.00%

^{[5],[8],[10],[11],[14]}

3.00%

^{[5],[8],[10],[11],[14]}

3.00%

^{[5],[8],[10],[11],[14]}

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 20,014

Investment, interest rate (as a percent)

^[1],[9],[17]

10.33%

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 1,961

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

10.30%

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 14,736

Investment, interest rate (as a percent)

^{[8],[10],[11]}

11.32%

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 14,625

Investment, interest rate (as a percent)

^[1],[9],[17]

9.35%

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 3,692

Investment, interest rate (as a percent)

^[1],[9],[17]

9.35%

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 4,368

Investment, interest rate (as a percent)

^[1],[9],[17]

10.80%

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 31,074

Investment, interest rate (as a percent)

^[10],[11]

12.18%

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 48,920

^[1],[4]

$ 59,950

^[5],[7],[8]

Investment, interest rate (as a percent)

9.00%

^[1],[9]

9.00%

^[1],[9]

9.00%

^[1],[9]

9.00%

^{[5],[8],[10],[11]}

9.00%

^{[5],[8],[10],[11]}

9.00%

^{[5],[8],[10],[11]}

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 564

^{[1],[2],[4],[12],[17]}

$ 258

^{[5],[7],[8],[10],[14]}

Investment, interest rate (as a percent)

12.18%

^{[1],[2],[9],[12],[17]}

12.18%

^{[1],[2],[9],[12],[17]}

12.18%

^{[1],[2],[9],[12],[17]}

12.55%

^{[5],[8],[10],[11],[14]}

12.55%

^{[5],[8],[10],[11],[14]}

12.55%

^{[5],[8],[10],[11],[14]}

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 11,683

^{[1],[4],[12],[17]}

$ 11,742

^{[7],[8],[10],[14]}

Investment, interest rate (as a percent)

12.18%

^{[1],[9],[12],[17]}

12.18%

^{[1],[9],[12],[17]}

12.18%

^{[1],[9],[12],[17]}

12.55%

^{[8],[10],[11],[14]}

12.55%

^{[8],[10],[11],[14]}

12.55%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Finthrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 4,291

Investment, interest rate (as a percent)

^[1],[9],[17]

8.96%

Investment, Identifier [Axis]: Finthrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[16],[17]}

$ 31,074

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[14]

$ 11,918

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

11.00%

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[14]

$ 4,881

Investment, interest rate (as a percent)

^{[10],[11],[14]}

6.00%

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,536

^{[1],[2],[4],[17]}

$ 1,638

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

11.85%

^{[1],[2],[9],[17]}

11.85%

^{[1],[2],[9],[17]}

11.85%

^{[1],[2],[9],[17]}

12.64%

^{[5],[8],[10],[11]}

12.64%

^{[5],[8],[10],[11]}

12.64%

^{[5],[8],[10],[11]}

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 23,536

^[1],[4],[17]

$ 23,774

^[7],[8],[10]

Investment, interest rate (as a percent)

11.85%

^[1],[9],[17]

11.85%

^[1],[9],[17]

11.85%

^[1],[9],[17]

12.64%

^{[8],[10],[11]}

12.64%

^{[8],[10],[11]}

12.64%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 2,456

Investment, interest rate (as a percent)

^{[8],[10],[11]}

10.57%

Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | €

^{[7],[10],[14]}

€ 1,000

Investment, interest rate (as a percent)

^{[10],[11],[14]}

6.56%

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,524

^[1],[4],[17]

$ 17,444

^[7],[8],[10]

Investment, interest rate (as a percent)

12.95%

^[1],[9],[17]

12.95%

^[1],[9],[17]

12.95%

^[1],[9],[17]

13.42%

^{[8],[10],[11]}

13.42%

^{[8],[10],[11]}

13.42%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 17,268

^[1],[4],[17]

$ 0

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^[1],[9],[17]

12.95%

Investment, Identifier [Axis]: HPS Loan Management 10-2016, Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[4],[12],[17]}

$ 2,250

Investment, interest rate (as a percent)

^{[9],[12],[17]}

11.95%

Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,473

^[4],[17]

$ 14,347

^[7],[10]

Investment, interest rate (as a percent)

10.20%

^[9],[17]

10.20%

^[9],[17]

10.20%

^[9],[17]

10.67%

^[10],[11]

10.67%

^[10],[11]

10.67%

^[10],[11]

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[12],[17]}

$ 7,448

^{[7],[8],[10],[14]}

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

11.89%

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,432

^{[1],[4],[12],[17]}

$ 0

^{[5],[7],[8],[10],[14]}

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

11.25%

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,448

^{[1],[4],[12],[17]}

$ 1,432

^{[7],[8],[10],[14]}

Investment, interest rate (as a percent)

11.25%

^{[1],[9],[12],[17]}

11.25%

^{[1],[9],[12],[17]}

11.25%

^{[1],[9],[12],[17]}

12.04%

^{[8],[10],[11],[14]}

12.04%

^{[8],[10],[11],[14]}

12.04%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[14]

$ 6,808

Investment, interest rate (as a percent)

^{[10],[11],[14]}

4.46%

Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 23,975

^{[1],[4],[12],[17]}

$ 23,975

^{[7],[8],[10],[14]}

Investment, interest rate (as a percent)

13.37%

^{[1],[9],[12],[17]}

13.37%

^{[1],[9],[12],[17]}

13.37%

^{[1],[9],[12],[17]}

13.62%

^{[8],[10],[11],[14]}

13.62%

^{[8],[10],[11],[14]}

13.62%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 42,075

^[4],[17]

$ 44,550

^[7],[8],[10]

Investment, interest rate (as a percent)

10.62%

^[9],[17]

10.62%

^[9],[17]

10.62%

^[9],[17]

11.40%

^{[8],[10],[11]}

11.40%

^{[8],[10],[11]}

11.40%

^{[8],[10],[11]}

Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 36,029

^[1],[4],[17]

$ 40,587

^[7],[8],[10]

Investment, interest rate (as a percent)

11.97%

^[1],[9],[17]

11.97%

^[1],[9],[17]

11.97%

^[1],[9],[17]

11.92%

^{[8],[10],[11]}

11.92%

^{[8],[10],[11]}

11.92%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Icefall Parent, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Icefall Parent, Inc., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 10,446

Investment, interest rate (as a percent)

^[1],[9],[17]

11.35%

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 26,613

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

787

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10]}

688

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[14]}

$ 7,179

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

11.14%

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 19,559

Investment, interest rate (as a percent)

^[1],[9],[17]

10.08%

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 33,079

^[1],[4],[17]

$ 33,414

^[7],[8],[10]

Investment, interest rate (as a percent)

12.46%

^[1],[9],[17]

12.46%

^[1],[9],[17]

12.46%

^[1],[9],[17]

12.93%

^{[8],[10],[11]}

12.93%

^{[8],[10],[11]}

12.93%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 13,939

Investment, interest rate (as a percent)

^[10],[11]

12.78%

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,259

^{[1],[2],[4],[17]}

$ 272

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

12.50%

^{[1],[2],[9],[17]}

12.50%

^{[1],[2],[9],[17]}

12.50%

^{[1],[2],[9],[17]}

11.84%

^{[5],[8],[10],[11]}

11.84%

^{[5],[8],[10],[11]}

11.84%

^{[5],[8],[10],[11]}

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 926

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

12.00%

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 37,635

^[1],[4],[17]

$ 16,752

^[7],[8],[10]

Investment, interest rate (as a percent)

9.95%

^[1],[9],[17]

9.95%

^[1],[9],[17]

9.95%

^[1],[9],[17]

11.84%

^{[8],[10],[11]}

11.84%

^{[8],[10],[11]}

11.84%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 16,552

^[1],[4],[17]

$ 38,015

^[7],[8],[10]

Investment, interest rate (as a percent)

10.68%

^[1],[9],[17]

10.68%

^[1],[9],[17]

10.68%

^[1],[9],[17]

11.80%

^{[8],[10],[11]}

11.80%

^{[8],[10],[11]}

11.80%

^{[8],[10],[11]}

Investment, Identifier [Axis]: LABL, Inc., Office Services & Supplies, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[4],[17]

$ 19,351

Investment, interest rate (as a percent)

^[9],[17]

9.95%

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,014

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

10.95%

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,708

^[1],[4],[17]

$ 2,736

^[7],[8],[10]

Investment, interest rate (as a percent)

10.95%

^[1],[9],[17]

10.95%

^[1],[9],[17]

10.95%

^[1],[9],[17]

11.42%

^{[8],[10],[11]}

11.42%

^{[8],[10],[11]}

11.42%

^{[8],[10],[11]}

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 23,256

^[1],[4],[17]

$ 23,494

^[7],[8],[10]

Investment, interest rate (as a percent)

10.95%

^[1],[9],[17]

10.95%

^[1],[9],[17]

10.95%

^[1],[9],[17]

11.42%

^{[8],[10],[11]}

11.42%

^{[8],[10],[11]}

11.42%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 26,156

^{[4],[12],[17]}

$ 26,422

^{[7],[10],[14]}

Investment, interest rate (as a percent)

14.95%

^{[9],[12],[17]}

14.95%

^{[9],[12],[17]}

14.95%

^{[9],[12],[17]}

14.95%

^{[10],[11],[14]}

14.95%

^{[10],[11],[14]}

14.95%

^{[10],[11],[14]}

Investment, Identifier [Axis]: Learfield Communications, LLC, Movies & Entertainment, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[4],[17]

$ 30,856

Investment, interest rate (as a percent)

^[9],[17]

10.35%

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 26,358

Investment, interest rate (as a percent)

^[1],[9],[17]

10.13%

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 55,873

^[1],[4],[17]

$ 45,243

^[7],[8],[10]

Investment, interest rate (as a percent)

9.96%

^[1],[9],[17]

9.96%

^[1],[9],[17]

9.96%

^[1],[9],[17]

10.65%

^{[8],[10],[11]}

10.65%

^{[8],[10],[11]}

10.65%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,167

^[1],[4],[17]

$ 5,403

^[7],[8],[10]

Investment, interest rate (as a percent)

13.20%

^[1],[9],[17]

13.20%

^[1],[9],[17]

13.20%

^[1],[9],[17]

13.99%

^{[8],[10],[11]}

13.99%

^{[8],[10],[11]}

13.99%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,822

^[1],[4],[17]

$ 2,939

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

13.20%

^[1],[9],[17]

13.20%

^[1],[9],[17]

13.20%

^[1],[9],[17]

13.99%

^{[5],[8],[10],[11]}

13.99%

^{[5],[8],[10],[11]}

13.99%

^{[5],[8],[10],[11]}

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 964

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^{[5],[8],[10],[11]}

11.42%

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,604

^[1],[4],[17]

$ 20,125

^[7],[8],[10]

Investment, interest rate (as a percent)

11.40%

^[1],[9],[17]

11.40%

^[1],[9],[17]

11.40%

^[1],[9],[17]

11.52%

^{[8],[10],[11]}

11.52%

^{[8],[10],[11]}

11.52%

^{[8],[10],[11]}

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,224

^[1],[4],[17]

$ 2,631

^[7],[8],[10]

Investment, interest rate (as a percent)

11.40%

^[1],[9],[17]

11.40%

^[1],[9],[17]

11.40%

^[1],[9],[17]

11.52%

^{[8],[10],[11]}

11.52%

^{[8],[10],[11]}

11.52%

^{[8],[10],[11]}

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10]}

$ 1,466

Investment, interest rate (as a percent)

^{[5],[8],[10],[11]}

12.83%

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 40,538

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.89%

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 33,831

^[1],[4],[17]

$ 13,973

^[7],[8],[10]

Investment, interest rate (as a percent)

9.35%

^[1],[9],[17]

9.35%

^[1],[9],[17]

9.35%

^[1],[9],[17]

10.99%

^{[8],[10],[11]}

10.99%

^{[8],[10],[11]}

10.99%

^{[8],[10],[11]}

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 13,829

^[1],[4],[17]

$ 21,328

^[7],[8],[10]

Investment, interest rate (as a percent)

9.35%

^[1],[9],[17]

9.35%

^[1],[9],[17]

9.35%

^[1],[9],[17]

10.99%

^{[8],[10],[11]}

10.99%

^{[8],[10],[11]}

10.99%

^{[8],[10],[11]}

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 6,652

Investment, interest rate (as a percent)

^[1],[9],[17]

9.35%

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 792

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

9.35%

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,139

^[1],[4],[12]

$ 8,568

^[7],[8],[14]

Investment, interest rate (as a percent)

11.50%

^[1],[9],[12]

11.50%

^[1],[9],[12]

11.50%

^[1],[9],[12]

11.50%

^{[8],[10],[11],[14]}

11.50%

^{[8],[10],[11],[14]}

11.50%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,855

^[1],[4],[12]

$ 4,284

^[7],[8],[14]

Investment, interest rate (as a percent)

11.50%

^[1],[9],[12]

11.50%

^[1],[9],[12]

11.50%

^[1],[9],[12]

11.50%

^{[8],[10],[11],[14]}

11.50%

^{[8],[10],[11],[14]}

11.50%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,070

^[1],[4],[12]

$ 8,568

^[7],[8],[14]

Investment, interest rate (as a percent)

11.50%

^[1],[9],[12]

11.50%

^[1],[9],[12]

11.50%

^[1],[9],[12]

11.50%

^{[8],[10],[11],[14]}

11.50%

^{[8],[10],[11],[14]}

11.50%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,660

^[1],[4],[12]

$ 9,106

^[7],[8],[14]

Investment, interest rate (as a percent)

9.75%

^[1],[9],[12]

9.75%

^[1],[9],[12]

9.75%

^[1],[9],[12]

8.00%

^{[8],[10],[11],[14]}

8.00%

^{[8],[10],[11],[14]}

8.00%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[14]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[14]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 51,356

^[1],[4],[17]

$ 5,248

^[7],[8],[10]

Investment, interest rate (as a percent)

12.40%

^[1],[9],[17]

12.40%

^[1],[9],[17]

12.40%

^[1],[9],[17]

12.52%

^{[8],[10],[11]}

12.52%

^{[8],[10],[11]}

12.52%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,294

^[1],[4],[17]

$ 46,687

^[7],[8],[10]

Investment, interest rate (as a percent)

12.40%

^[1],[9],[17]

12.40%

^[1],[9],[17]

12.40%

^[1],[9],[17]

12.52%

^{[8],[10],[11]}

12.52%

^{[8],[10],[11]}

12.52%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12],[17]}

$ 0

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[12],[17]}

$ 7,056

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

9.85%

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12],[17]}

$ 0

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[12],[17]}

$ 1,176

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

9.85%

Investment, Identifier [Axis]: Modena Buyer LLC, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[4],[17]

$ 27,705

Investment, interest rate (as a percent)

^[9],[17]

9.10%

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 38,326

Investment, interest rate (as a percent)

^[1],[9],[17]

10.56%

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 50,077

^[1],[4],[17]

$ 54,559

^[7],[8],[10]

Investment, interest rate (as a percent)

10.58%

^[1],[9],[17]

10.58%

^[1],[9],[17]

10.58%

^[1],[9],[17]

12.51%

^{[8],[10],[11]}

12.51%

^{[8],[10],[11]}

12.51%

^{[8],[10],[11]}

Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7]

$ 10,191

Investment, interest rate (as a percent)

^[10],[11]

6.88%

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 56,701

^{[1],[4],[12],[17]}

$ 73,362

^{[7],[8],[10],[14]}

Investment, interest rate (as a percent)

11.82%

^{[1],[9],[12],[17]}

11.82%

^{[1],[9],[12],[17]}

11.82%

^{[1],[9],[12],[17]}

12.29%

^{[8],[10],[11],[14]}

12.29%

^{[8],[10],[11],[14]}

12.29%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 30,339

Investment, interest rate (as a percent)

^{[8],[10],[11]}

13.99%

Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 55,783

^[1],[4],[17]

$ 64,606

^[7],[8],[10]

Investment, interest rate (as a percent)

6.85%

^[1],[9],[17]

6.85%

^[1],[9],[17]

6.85%

^[1],[9],[17]

14.89%

^{[8],[10],[11]}

14.89%

^{[8],[10],[11]}

14.89%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 19,895

Investment, interest rate (as a percent)

^[1],[9],[17]

11.06%

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Northwoods Capital 25 Ltd, Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[4],[12],[17]}

$ 700

Investment, interest rate (as a percent)

^{[9],[12],[17]}

12.68%

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 58,349

^{[1],[2],[4],[12],[17],[19]}

$ 58,349

^{[5],[7],[8],[10],[14],[20]}

Investment, interest rate (as a percent)

9.95%

^{[1],[2],[9],[12],[17],[19]}

9.95%

^{[1],[2],[9],[12],[17],[19]}

9.95%

^{[1],[2],[9],[12],[17],[19]}

9.76%

^{[5],[8],[10],[11],[14],[20]}

9.76%

^{[5],[8],[10],[11],[14],[20]}

9.76%

^{[5],[8],[10],[11],[14],[20]}

Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 9,323

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.49%

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 12,070

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 25,712

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10]}

1,210

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 15,231

Investment, interest rate (as a percent)

^{[8],[10],[11]}

13.12%

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 15,231

Investment, interest rate (as a percent)

^[1],[9],[17]

12.75%

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 4,047

Investment, interest rate (as a percent)

^[1],[9],[17]

12.50%

Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7]

$ 4,519

Investment, interest rate (as a percent)

^[10],[11]

7.75%

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 753

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

11.35%

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 10,895

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.32%

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 10,786

Investment, interest rate (as a percent)

^[1],[9],[17]

11.35%

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 5,088

Investment, interest rate (as a percent)

^[1],[9],[17]

10.10%

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 26,176

^[1],[4],[17]

$ 38,414

^[7],[8],[10]

Investment, interest rate (as a percent)

11.90%

^[1],[9],[17]

11.90%

^[1],[9],[17]

11.90%

^[1],[9],[17]

12.01%

^{[8],[10],[11]}

12.01%

^{[8],[10],[11]}

12.01%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 9,676

Investment, interest rate (as a percent)

^[10],[11]

10.42%

Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 22,375

^[1],[4],[17]

$ 22,375

^[7],[8],[10]

Investment, interest rate (as a percent)

11.11%

^[1],[9],[17]

11.11%

^[1],[9],[17]

11.11%

^[1],[9],[17]

11.57%

^{[8],[10],[11]}

11.57%

^{[8],[10],[11]}

11.57%

^{[8],[10],[11]}

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 52,244

Investment, interest rate (as a percent)

^[1],[9],[17]

10.85%

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 36,499

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.74%

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4]

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 3,003

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^{[5],[8],[10],[11]}

13.45%

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 67,244

Investment, interest rate (as a percent)

^{[8],[10],[11]}

13.45%

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 4,965

Investment, interest rate (as a percent)

^[1],[9],[17]

8.12%

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 8,601

Investment, interest rate (as a percent)

^[1],[9],[17]

8.12%

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 12,902

Investment, Identifier [Axis]: Poseidon Midco AB, Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | €

^{[1],[4],[12],[17]}

€ 12,868

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

8.97%

Investment, Identifier [Axis]: Poseidon Midco AB, Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12],[17]}

$ 0

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[12],[17]}

$ 26,642

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

11.84%

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 24,503

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.78%

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 2,819

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.78%

Investment, Identifier [Axis]: Protein For Pets Opco, LLC, Packaged Foods & Meats, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Protein For Pets Opco, LLC, Packaged Foods & Meats, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 20,274

Investment, interest rate (as a percent)

^[1],[9],[17]

10.10%

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | £

^{[7],[8],[10],[14]}

£ 4,626

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

11.21%

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | £

^{[1],[4],[12],[17]}

£ 9,739

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

10.73%

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12],[17]}

$ 2,123

Investment, interest rate (as a percent)

^{[1],[2],[9],[12],[17]}

10.70%

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10]}

$ 0

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 32,329

Investment, interest rate (as a percent)

^{[8],[10],[11]}

11.92%

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,819

^{[1],[4],[12],[17]}

$ 36,707

^{[7],[8],[10],[14]}

Investment, interest rate (as a percent)

12.77%

^{[1],[9],[12],[17]}

12.77%

^{[1],[9],[12],[17]}

12.77%

^{[1],[9],[12],[17]}

13.90%

^{[8],[10],[11],[14]}

13.90%

^{[8],[10],[11],[14]}

13.90%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 29,223

^{[1],[4],[12],[17]}

$ 13,504

^{[7],[8],[10],[14]}

Investment, interest rate (as a percent)

12.77%

^{[1],[9],[12],[17]}

12.77%

^{[1],[9],[12],[17]}

12.77%

^{[1],[9],[12],[17]}

13.90%

^{[8],[10],[11],[14]}

13.90%

^{[8],[10],[11],[14]}

13.90%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 8,010

Investment, interest rate (as a percent)

^{[8],[10],[11]}

14.18%

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10]}

$ 0

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 17,907

^[1],[4]

15,874

^[7],[8]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

3,550

^[1],[4]

1,359

^[5],[7],[8]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4]

3,332

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4]

1,600

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 5

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[2],[4]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,406

^[1],[4],[17]

$ 4,452

^[7],[8],[10]

Investment, interest rate (as a percent)

10.01%

^[1],[9],[17]

10.01%

^[1],[9],[17]

10.01%

^[1],[9],[17]

10.38%

^{[8],[10],[11]}

10.38%

^{[8],[10],[11]}

10.38%

^{[8],[10],[11]}

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 12,034

^[1],[4],[17]

$ 12,034

^[7],[8],[10]

Investment, interest rate (as a percent)

13.51%

^[1],[9],[17]

13.51%

^[1],[9],[17]

13.51%

^[1],[9],[17]

13.63%

^{[8],[10],[11]}

13.63%

^{[8],[10],[11]}

13.63%

^{[8],[10],[11]}

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 25,527

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.40%

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[16],[17]}

$ 28,146

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[16],[17]}

932

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 22,107

^[1],[4],[17]

$ 25,558

^[7],[8],[10]

Investment, interest rate (as a percent)

14.85%

^[1],[9],[17]

14.85%

^[1],[9],[17]

14.85%

^[1],[9],[17]

15.24%

^{[8],[10],[11]}

15.24%

^{[8],[10],[11]}

15.24%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Saratoga, Diversified Financial Services, Credit Linked Note

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[12],[17],[21]}

$ 24,500

Investment, interest rate (as a percent)

^{[1],[9],[12],[17],[21]}

10.18%

Investment, Identifier [Axis]: Secure Acquisition Inc., Paper & Plastic Packaging Products & Materials, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[4],[17]

$ 14,963

Investment, interest rate (as a percent)

^[9],[17]

8.85%

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 112,656

^{[1],[2],[4],[12],[17],[19]}

$ 112,656

^{[5],[7],[8],[10],[14],[20]}

Investment, interest rate (as a percent)

12.45%

^{[1],[2],[9],[12],[17],[19]}

12.45%

^{[1],[2],[9],[12],[17],[19]}

12.45%

^{[1],[2],[9],[12],[17],[19]}

12.26%

^{[5],[8],[10],[11],[14],[20]}

12.26%

^{[5],[8],[10],[11],[14],[20]}

12.26%

^{[5],[8],[10],[11],[14],[20]}

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[14]}

$ 7,191

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

12.88%

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[14]}

$ 2,697

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

12.88%

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10],[14]}

$ 0

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10],[14]}

Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 821

Investment, interest rate (as a percent)

^{[8],[10],[11]}

13.04%

Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 47,730

Investment, interest rate (as a percent)

^[1],[9],[17]

10.60%

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 618

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^{[5],[8],[10],[11]}

10.42%

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 18,058

^[1],[4],[17]

$ 4,488

^[7],[8],[10]

Investment, interest rate (as a percent)

10.20%

^[1],[9],[17]

10.20%

^[1],[9],[17]

10.20%

^[1],[9],[17]

10.67%

^{[8],[10],[11]}

10.67%

^{[8],[10],[11]}

10.67%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[4],[17]

$ 13,780

Investment, interest rate (as a percent)

^[9],[17]

10.69%

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[4]

$ 6,835

Investment, interest rate (as a percent)

^[9]

10.75%

Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | €

^{[7],[8],[10],[14]}

€ 23,731

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

12.32%

Investment, Identifier [Axis]: SumUp Holdings Luxembourg, Diversified Financial Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12],[17]}

$ 18,846

Investment, interest rate (as a percent)

^{[1],[2],[9],[12],[17]}

10.04%

Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 49,520

Investment, interest rate (as a percent)

^{[8],[10],[11]}

13.32%

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 1,552

^{[7],[8],[10],[22]}

Investment, interest rate (as a percent)

^{[8],[10],[11],[22]}

12.44%

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10],[22]}

$ 1,099

Investment, interest rate (as a percent)

^{[5],[8],[10],[11],[22]}

12.51%

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,721

^[1],[4],[17]

$ 32,104

^{[7],[8],[10],[22]}

Investment, interest rate (as a percent)

12.58%

^[1],[9],[17]

12.58%

^[1],[9],[17]

12.58%

^[1],[9],[17]

12.51%

^{[8],[10],[11],[22]}

12.51%

^{[8],[10],[11],[22]}

12.51%

^{[8],[10],[11],[22]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

€ 3,273

^[1],[4],[17]

$ 2,749

^{[7],[8],[10],[22]}

Investment, interest rate (as a percent)

12.58%

^[1],[9],[17]

12.58%

^[1],[9],[17]

12.58%

^[1],[9],[17]

12.51%

^{[8],[10],[11],[22]}

12.51%

^{[8],[10],[11],[22]}

12.51%

^{[8],[10],[11],[22]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 31,778

Investment, interest rate (as a percent)

^[1],[9],[17]

12.58%

Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[6],[7],[8],[14]}

$ 4,984

Investment, interest rate (as a percent)

^{[6],[8],[10],[11],[14]}

11.50%

Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 50,419

^[1],[4],[12]

$ 50,419

^[7],[8],[14]

Investment, interest rate (as a percent)

13.00%

^[1],[9],[12]

13.00%

^[1],[9],[12]

13.00%

^[1],[9],[12]

13.00%

^{[8],[10],[11],[14]}

13.00%

^{[8],[10],[11],[14]}

13.00%

^{[8],[10],[11],[14]}

Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 12,843

Investment, interest rate (as a percent)

^[10],[11]

13.43%

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10],[14]}

$ 0

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[14]}

$ 28,826

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

11.42%

Investment, Identifier [Axis]: Telephone and Data Systems, Inc., Wireless Telecommunication Services, Subordinated Debt Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[12],[17]}

$ 25,031

Investment, interest rate (as a percent)

^{[1],[9],[12],[17]}

12.25%

Investment, Identifier [Axis]: Telephone and Data Systems, Inc., Wireless Telecommunication Services, Subordinated Debt Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12],[17]}

$ 0

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

1,946

^{[1],[2],[4],[16],[17]}

$ 1,861

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

^{[5],[8],[10],[11]}

15.17%

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

26,553

^{[1],[4],[16],[17]}

$ 23,423

^[7],[8],[10]

Investment, interest rate (as a percent)

^{[8],[10],[11]}

15.26%

Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 19,683

^[1],[4],[17]

$ 19,947

^[7],[8],[10]

Investment, interest rate (as a percent)

10.74%

^[1],[9],[17]

10.74%

^[1],[9],[17]

10.74%

^[1],[9],[17]

11.32%

^{[8],[10],[11]}

11.32%

^{[8],[10],[11]}

11.32%

^{[8],[10],[11]}

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[18]}

$ 19,163

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[16]

$ 5,065

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[16]

20,917

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[7],[8],[10],[18]}

4,641

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

46,832

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

6,141

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[16],[17]}

18,844

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 14,508

^[1],[4],[17]

$ 11,671

^[7],[8],[10]

Investment, interest rate (as a percent)

10.95%

^[1],[9],[17]

10.95%

^[1],[9],[17]

10.95%

^[1],[9],[17]

11.42%

^{[8],[10],[11]}

11.42%

^{[8],[10],[11]}

11.42%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Trinitas CLO VI Ltd., Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[4],[12],[17]}

$ 905

Investment, interest rate (as a percent)

^{[9],[12],[17]}

12.36%

Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,000

^{[4],[12],[17]}

$ 1,000

^{[7],[10],[14]}

Investment, interest rate (as a percent)

12.99%

^{[9],[12],[17]}

12.99%

^{[9],[12],[17]}

12.99%

^{[9],[12],[17]}

13.06%

^{[10],[11],[14]}

13.06%

^{[10],[11],[14]}

13.06%

^{[10],[11],[14]}

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 29

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

10.85%

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 26,457

Investment, interest rate (as a percent)

^[1],[9],[17]

10.86%

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 0

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 975

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

10.10%

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 15,773

Investment, interest rate (as a percent)

^[1],[9],[17]

10.35%

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

$ 24

Investment, interest rate (as a percent)

^{[1],[2],[9],[17]}

10.35%

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[14]

$ 4,500

Investment, interest rate (as a percent)

^{[10],[11],[14]}

6.50%

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[14]

$ 300

Investment, interest rate (as a percent)

^{[10],[11],[14]}

4.75%

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[12]

$ 2,512

Investment, interest rate (as a percent)

^[1],[9],[12]

11.00%

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[12]

$ 3,198

Investment, interest rate (as a percent)

^[1],[9],[12]

11.00%

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12]}

$ 0

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12]}

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 5

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[4],[12],[13]}

4,652

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 6

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[12],[13]}

Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 1,140

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.68%

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[4],[17]}

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 11,792

Investment, interest rate (as a percent)

^[10],[11]

9.27%

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 30,570

Investment, interest rate (as a percent)

^[1],[9],[17]

8.39%

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 1,449

Investment, interest rate (as a percent)

^[1],[9],[17]

8.39%

Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 5,000

Investment, interest rate (as a percent)

^{[8],[10],[11]}

12.65%

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[1],[4],[17]

$ 2,782

Investment, interest rate (as a percent)

^[1],[9],[17]

12.85%

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 1,565

Investment, interest rate (as a percent)

^{[8],[10],[11]}

21.68%

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 1,323

Investment, interest rate (as a percent)

^{[8],[10],[11]}

21.68%

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[10]

$ 8,983

Investment, interest rate (as a percent)

^[10],[11]

11.67%

Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 19,431

^[1],[4],[17]

$ 19,578

^[7],[8],[10]

Investment, interest rate (as a percent)

8.25%

^[1],[9],[17]

8.25%

^[1],[9],[17]

8.25%

^[1],[9],[17]

9.32%

^{[8],[10],[11]}

9.32%

^{[8],[10],[11]}

9.32%

^{[8],[10],[11]}

Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal | £

^{[7],[8],[10],[14]}

£ 20,000

Investment, interest rate (as a percent)

^{[8],[10],[11],[14]}

12.72%

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 678

^{[1],[2],[4],[17]}

$ 377

^{[5],[7],[8],[10]}

Investment, interest rate (as a percent)

10.67%

^{[1],[2],[9],[17]}

10.67%

^{[1],[2],[9],[17]}

10.67%

^{[1],[2],[9],[17]}

12.14%

^{[5],[8],[10],[11]}

12.14%

^{[5],[8],[10],[11]}

12.14%

^{[5],[8],[10],[11]}

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 25,491

^[1],[4],[17]

$ 24,427

^[7],[8],[10]

Investment, interest rate (as a percent)

10.67%

^[1],[9],[17]

10.67%

^[1],[9],[17]

10.67%

^[1],[9],[17]

12.63%

^{[8],[10],[11]}

12.63%

^{[8],[10],[11]}

12.63%

^{[8],[10],[11]}

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,636

^[1],[4],[17]

$ 3,636

^[7],[8],[10]

Investment, interest rate (as a percent)

11.17%

^[1],[9],[17]

11.17%

^[1],[9],[17]

11.17%

^[1],[9],[17]

12.63%

^{[8],[10],[11]}

12.63%

^{[8],[10],[11]}

12.63%

^{[8],[10],[11]}

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

^{[1],[2],[4],[17]}

$ 0

^{[5],[7],[8],[10]}

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^[7],[8],[10]

$ 5,212

Investment, interest rate (as a percent)

^{[8],[10],[11]}

11.75%

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10]}

$ 0

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[7],[8],[10]}

SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 330,094

$ 332,637

Number of borrowers | borrower

SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,026

$ 1,149

Investment, interest rate (as a percent)

11.37%

11.90%

SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 6,072

$ 6,771

Investment, interest rate (as a percent)

11.37%

12.15%

SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 290

$ 0

Investment, interest rate (as a percent)

11.29%

SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,092

$ 4,134

Investment, interest rate (as a percent)

11.52%

11.63%

SLF JV I | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 10,495

$ 8,596

Investment, interest rate (as a percent)

10.25%

10.32%

SLF JV I | Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,969

Investment, interest rate (as a percent)

9.63%

SLF JV I | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,329

$ 8,798

Investment, interest rate (as a percent)

12.45%

13.04%

SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,957

Investment, interest rate (as a percent)

9.43%

SLF JV I | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,824

Investment, interest rate (as a percent)

11.81%

SLF JV I | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,720

Investment, interest rate (as a percent)

9.54%

SLF JV I | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,523

Investment, interest rate (as a percent)

9.40%

SLF JV I | Investment, Identifier [Axis]: Artera Services LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,961

Investment, interest rate (as a percent)

9.10%

SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,052

Investment, interest rate (as a percent)

10.90%

SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,546

Investment, interest rate (as a percent)

11.35%

SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,037

Investment, interest rate (as a percent)

SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,775

$ 4,950

Investment, interest rate (as a percent)

8.95%

9.42%

SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,970

$ 1,990

Investment, interest rate (as a percent)

9.20%

9.67%

SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,346

Investment, interest rate (as a percent)

10.68%

SLF JV I | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 6,548

$ 6,289

Investment, interest rate (as a percent)

7.70%

11.49%

SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,735

$ 1,753

Investment, interest rate (as a percent)

9.87%

10.65%

SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 6,242

$ 6,306

Investment, interest rate (as a percent)

9.87%

10.65%

SLF JV I | Investment, Identifier [Axis]: Bausch + Lomb Corporation, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 9,173

Investment, interest rate (as a percent)

8.27%

SLF JV I | Investment, Identifier [Axis]: Boxer Parent Company Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,000

Investment, interest rate (as a percent)

9.01%

SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 600

Investment, interest rate (as a percent)

11.57%

SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 600

Investment, interest rate (as a percent)

11.50%

SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2

Investment, interest rate (as a percent)

12.02%

SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,348

$ 2,354

Investment, interest rate (as a percent)

11.16%

11.55%

SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,976

$ 1,983

Investment, interest rate (as a percent)

12.27%

11.55%

SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,955

$ 1,960

Investment, interest rate (as a percent)

11.16%

11.55%

SLF JV I | Investment, Identifier [Axis]: Cloud Software Group, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,153

Investment, interest rate (as a percent)

8.60%

SLF JV I | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,765

$ 6,343

Investment, interest rate (as a percent)

9.60%

10.39%

SLF JV I | Investment, Identifier [Axis]: Crown Subsea Communications Holding, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,980

Investment, interest rate (as a percent)

9.25%

SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,643

$ 8,730

Investment, interest rate (as a percent)

8.60%

9.89%

SLF JV I | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 9,029

$ 7,920

Investment, interest rate (as a percent)

9.60%

10.12%

SLF JV I | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 6,711

$ 5,799

Investment, interest rate (as a percent)

10.21%

10.43%

SLF JV I | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,179

Investment, interest rate (as a percent)

9.55%

SLF JV I | Investment, Identifier [Axis]: Engineering Research and Consulting LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,208

Investment, interest rate (as a percent)

10.06%

SLF JV I | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 49,413

$ 54,051

SLF JV I | Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,000

Investment, interest rate (as a percent)

8.76%

SLF JV I | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,369

Investment, interest rate (as a percent)

10.57%

SLF JV I | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,840

$ 7,920

Investment, interest rate (as a percent)

10.20%

10.67%

SLF JV I | Investment, Identifier [Axis]: Husky Injection Molding Systems Ltd., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,089

Investment, interest rate (as a percent)

10.33%

SLF JV I | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,500

$ 9,000

Investment, interest rate (as a percent)

10.62%

11.40%

SLF JV I | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,256

$ 7,331

Investment, interest rate (as a percent)

10.21%

10.90%

SLF JV I | Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,890

$ 10,000

Investment, interest rate (as a percent)

9.36%

10.32%

SLF JV I | Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,896

$ 3,962

Investment, interest rate (as a percent)

9.95%

10.42%

SLF JV I | Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 10,000

Investment, interest rate (as a percent)

9.60%

SLF JV I | Investment, Identifier [Axis]: Largest Exposure To A Single Borrower

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 10,495

$ 11,286

SLF JV I | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,369

Investment, interest rate (as a percent)

11.32%

SLF JV I | Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 29

$ 11,249

Investment, interest rate (as a percent)

9.96%

10.65%

SLF JV I | Investment, Identifier [Axis]: M2S Group Intermediate Holdings Inc, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 10,000

Investment, interest rate (as a percent)

9.85%

SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,319

Investment, interest rate (as a percent)

10.99%

SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,211

Investment, interest rate (as a percent)

10.99%

SLF JV I | Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,890

$ 5,940

Investment, interest rate (as a percent)

8.45%

9.18%

SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,669

Investment, interest rate (as a percent)

12.52%

SLF JV I | Investment, Identifier [Axis]: Mitchell International, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,000

$ 2,985

Investment, interest rate (as a percent)

8.10%

9.18%

SLF JV I | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 6,615

Investment, interest rate (as a percent)

10.15%

SLF JV I | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 10,987

Investment, interest rate (as a percent)

9.43%

SLF JV I | Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 9,825

Investment, interest rate (as a percent)

10.42%

SLF JV I | Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,978

Investment, interest rate (as a percent)

8.70%

SLF JV I | Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,948

Investment, interest rate (as a percent)

8.70%

SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,416

Investment, interest rate (as a percent)

9.65%

SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,503

Investment, interest rate (as a percent)

12.74%

SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 318

Investment, interest rate (as a percent)

13.45%

SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,116

Investment, interest rate (as a percent)

13.45%

SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,544

SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,030

Investment, interest rate (as a percent)

8.12%

SLF JV I | Investment, Identifier [Axis]: Renaissance Holding Corp., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,920

$ 5,000

Investment, interest rate (as a percent)

9.10%

9.99%

SLF JV I | Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,963

Investment, interest rate (as a percent)

8.76%

SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 938

$ 138

Investment, interest rate (as a percent)

11.82%

10.86%

SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,634

$ 8,113

Investment, interest rate (as a percent)

11.82%

10.88%

SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,451

Investment, interest rate (as a percent)

12.32%

SLF JV I | Investment, Identifier [Axis]: SM Wellness Holdings, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,947

$ 2,977

Investment, interest rate (as a percent)

10.01%

10.38%

SLF JV I | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,801

Investment, interest rate (as a percent)

9.92%

SLF JV I | Investment, Identifier [Axis]: Shearer's Foods LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 6,983

Investment, interest rate (as a percent)

8.85%

SLF JV I | Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,680

Investment, interest rate (as a percent)

9.43%

SLF JV I | Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,601

Investment, interest rate (as a percent)

8.00%

SLF JV I | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,843

Investment, interest rate (as a percent)

10.67%

SLF JV I | Investment, Identifier [Axis]: Staples, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,349

Investment, interest rate (as a percent)

10.69%

SLF JV I | Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,960

$ 8,000

Investment, interest rate (as a percent)

8.35%

9.33%

SLF JV I | Investment, Identifier [Axis]: SupplyOne Inc, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,478

Investment, interest rate (as a percent)

9.10%

SLF JV I | Investment, Identifier [Axis]: Swissport Stratosphere USA LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,486

Investment, interest rate (as a percent)

9.57%

SLF JV I | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8,215

Investment, interest rate (as a percent)

9.99%

SLF JV I | Investment, Identifier [Axis]: Total Portfolio Investments, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 332,637

SLF JV I | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,139

$ 7,212

Investment, interest rate (as a percent)

10.95%

11.42%

SLF JV I | Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 7,481

Investment, interest rate (as a percent)

8.60%

SLF JV I | Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 6,305

Investment, interest rate (as a percent)

10.43%

SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,965

Investment, interest rate (as a percent)

9.27%

SLF JV I | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 6,148

Investment, interest rate (as a percent)

11.67%

SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 9,034

$ 4,320

Investment, interest rate (as a percent)

8.10%

8.57%

SLF JV I | Weighted Average

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

9.56%

10.62%

Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 125,405

$ 130,589

Number of borrowers | borrower

Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,359

$ 574

Investment, interest rate (as a percent)

11.37%

11.90%

Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 513

$ 3,746

Investment, interest rate (as a percent)

11.37%

12.15%

Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 120

$ 0

Investment, interest rate (as a percent)

11.29%

Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,699

$ 1,716

Investment, interest rate (as a percent)

11.52%

11.63%

Glick JV LLC | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,980

$ 2,000

Investment, interest rate (as a percent)

10.25%

10.32%

Glick JV LLC | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,897

$ 6,230

Investment, interest rate (as a percent)

12.45%

13.04%

Glick JV LLC | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,478

Investment, interest rate (as a percent)

9.43%

Glick JV LLC | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,860

Investment, interest rate (as a percent)

11.81%

Glick JV LLC | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,895

Investment, interest rate (as a percent)

9.54%

Glick JV LLC | Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,993

Investment, interest rate (as a percent)

10.42%

Glick JV LLC | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 907

Investment, interest rate (as a percent)

9.40%

Glick JV LLC | Investment, Identifier [Axis]: Artera Services LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,485

Investment, interest rate (as a percent)

9.10%

Glick JV LLC | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,078

Investment, interest rate (as a percent)

10.90%

Glick JV LLC | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,047

Investment, interest rate (as a percent)

11.35%

Glick JV LLC | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,661

Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,149

$ 1,980

Investment, interest rate (as a percent)

8.95%

9.42%

Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 985

$ 995

Investment, interest rate (as a percent)

9.20%

9.67%

Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,423

Investment, interest rate (as a percent)

10.68%

Glick JV LLC | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,778

$ 3,628

Investment, interest rate (as a percent)

7.70%

11.49%

Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,328

$ 3,363

Investment, interest rate (as a percent)

9.87%

10.65%

Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 792

$ 800

Investment, interest rate (as a percent)

9.87%

10.65%

Glick JV LLC | Investment, Identifier [Axis]: Bausch + Lomb Corporation, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,718

Investment, interest rate (as a percent)

8.27%

Glick JV LLC | Investment, Identifier [Axis]: Boxer Parent Company Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,000

Investment, interest rate (as a percent)

9.01%

Glick JV LLC | Investment, Identifier [Axis]: Cloud Software Group, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,621

Investment, interest rate (as a percent)

8.60%

Glick JV LLC | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,570

$ 2,766

Investment, interest rate (as a percent)

9.60%

10.39%

Glick JV LLC | Investment, Identifier [Axis]: Crown Subsea Communications Holding, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,993

Investment, interest rate (as a percent)

9.25%

Glick JV LLC | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,813

$ 2,841

Investment, interest rate (as a percent)

8.60%

9.89%

Glick JV LLC | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,534

$ 2,970

Investment, interest rate (as a percent)

9.60%

10.12%

Glick JV LLC | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,957

$ 2,460

Investment, interest rate (as a percent)

10.21%

10.43%

Glick JV LLC | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 392

Investment, interest rate (as a percent)

8.85%

Glick JV LLC | Investment, Identifier [Axis]: Engineering Research and Consulting LLC., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,025

Investment, interest rate (as a percent)

10.06%

Glick JV LLC | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 22,152

$ 28,396

Glick JV LLC | Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,000

Investment, interest rate (as a percent)

8.76%

Glick JV LLC | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,930

Investment, interest rate (as a percent)

10.57%

Glick JV LLC | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,920

$ 3,960

Investment, interest rate (as a percent)

10.20%

10.67%

Glick JV LLC | Investment, Identifier [Axis]: Husky Injection Molding Systems Ltd., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,125

Investment, interest rate (as a percent)

10.33%

Glick JV LLC | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,125

$ 2,250

Investment, interest rate (as a percent)

10.62%

11.40%

Glick JV LLC | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,870

$ 3,910

Investment, interest rate (as a percent)

10.21%

10.90%

Glick JV LLC | Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,551

$ 4,500

Investment, interest rate (as a percent)

9.36%

10.32%

Glick JV LLC | Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,987

Investment, interest rate (as a percent)

9.95%

Glick JV LLC | Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,898

$ 6,230

Glick JV LLC | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,000

$ 3,930

Investment, interest rate (as a percent)

9.60%

11.32%

Glick JV LLC | Investment, Identifier [Axis]: M2S Group Intermediate Holdings Inc, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,000

Investment, interest rate (as a percent)

9.85%

Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 0

Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,630

Investment, interest rate (as a percent)

10.99%

Glick JV LLC | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,198

Investment, interest rate (as a percent)

10.15%

Glick JV LLC | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,500

$ 3,849

Investment, interest rate (as a percent)

8.10%

9.43%

Glick JV LLC | Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 990

Investment, interest rate (as a percent)

8.70%

Glick JV LLC | Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,980

Investment, interest rate (as a percent)

8.70%

Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 683

Investment, interest rate (as a percent)

9.65%

Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,842

Investment, interest rate (as a percent)

12.74%

Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 226

Investment, interest rate (as a percent)

13.45%

Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,182

Investment, interest rate (as a percent)

13.45%

Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 662

Investment, interest rate (as a percent)

8.12%

Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 993

Glick JV LLC | Investment, Identifier [Axis]: Renaissance Holding Corp, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,985

Investment, interest rate (as a percent)

9.10%

Glick JV LLC | Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,480

Investment, interest rate (as a percent)

8.76%

Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 697

$ 6,029

Investment, interest rate (as a percent)

11.82%

10.88%

Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,957

$ 103

Investment, interest rate (as a percent)

11.82%

10.86%

Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,078

Investment, interest rate (as a percent)

12.32%

Glick JV LLC | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,227

Investment, interest rate (as a percent)

9.92%

Glick JV LLC | Investment, Identifier [Axis]: Shearer's Foods LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,993

Investment, interest rate (as a percent)

8.85%

Glick JV LLC | Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,266

$ 3,292

Investment, interest rate (as a percent)

8.00%

9.43%

Glick JV LLC | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 4,913

Investment, interest rate (as a percent)

10.67%

Glick JV LLC | Investment, Identifier [Axis]: Staples, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,918

Investment, interest rate (as a percent)

10.69%

Glick JV LLC | Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,980

$ 4,000

Investment, interest rate (as a percent)

8.35%

9.33%

Glick JV LLC | Investment, Identifier [Axis]: SupplyOne Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,493

Investment, interest rate (as a percent)

9.10%

Glick JV LLC | Investment, Identifier [Axis]: Swissport Stratosphere Usa LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 1,995

Investment, interest rate (as a percent)

9.57%

Glick JV LLC | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,641

Investment, interest rate (as a percent)

9.99%

Glick JV LLC | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 8

$ 2,993

Investment, interest rate (as a percent)

10.95%

11.42%

Glick JV LLC | Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,494

Investment, interest rate (as a percent)

8.60%

Glick JV LLC | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 983

Investment, interest rate (as a percent)

9.27%

Glick JV LLC | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 3,843

Investment, interest rate (as a percent)

11.67%

Glick JV LLC | Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 2,942

$ 1,772

Investment, interest rate (as a percent)

8.10%

8.57%

Glick JV LLC | Senior Secured Loans

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 125,405

$ 130,589

Glick JV LLC | Weighted Average

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

9.65%

10.77%

[1]	As of September 30, 2024, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").
[2]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[3]	This investment represents a participation interest in the underlying securities shown.
[4]	Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[5]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[6]	This investment represents a participation interest in the underlying securities shown.
[7]	Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[8]	As of September 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by ASC 820.
[9]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[10]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[11]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[12]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2024, qualifying assets represented 74.4% of the Company's total assets and non-qualifying assets represented 25.6% of the Company's total assets.
[13]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[14]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 73.6% of the Company's total assets and non-qualifying assets represented 26.4% of the Company's total assets.
[15]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[16]	This investment was on non-accrual status as of September 30, 2024.
[17]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2024, the reference rates for the Company's variable rate loans were the 30-day SOFR at 4.85%, the 90-day SOFR at 4.59%, the 180-day SOFR at 4.25%, the PRIME at 8.00%, the SONIA at 5.50%, the 90-day EURIBOR at 3.54% and the 180-day EURIBOR at 3.11%. Most loans include an interest floor, which generally ranges from 0% to 3.00%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[18]	This investment was on non-accrual status as of September 30, 2023.
[19]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition of the Company's joint ventures.
[20]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[21]	This investment represents a credit default swap that functions, in substance, like a credit linked note and represents a credit risk transfer for a pool of reference assets owned by a bank. The Company fully funded margin up front and in return the Company receives periodic interest payments. The Company’s risk of loss is limited to the principal amount disclosed herein. The reference assets are primarily composed of investment grade corporate debt. The Company may be exposed to counterparty risk, which could make it difficult for the Company to collect on obligations, thereby resulting in potentially significant losses. In addition, the Company only has a contractual relationship with the counterparty bank, and not with the reference obligors of the reference assets. Accordingly, the Company generally may have no right to directly enforce compliance by the reference obligors with the terms of the reference assets. The Company will not directly benefit from the reference assets and will not have the benefit of the remedies that would normally be available to a holder of such reference assets. In addition, in the event of the insolvency of the counterparty bank, the Company may be treated as a general creditor of such counterparty bank, and will not have any claim with respect to the reference assets.
[22]	This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Borrowings - Components of the Carrying Value of Notes (Details) - USD ($)	Sep. 30, 2024	Sep. 30, 2023	Aug. 15, 2023	May 18, 2021	Feb. 25, 2020
Debt Instrument [Line Items]
Unamortized financing costs	$ (4,935,000)	$ (7,076,000)
Net carrying value	1,638,693,000	1,600,731,000
2025 Notes
Debt Instrument [Line Items]
Principal	300,000,000.0	300,000,000.0			$ 300,000,000
Unamortized financing costs	(300,000)	(1,100,000)
Unaccreted discount	(200,000)	(700,000)			$ (2,500,000)
Interest rate swap fair value adjustment	0	0
Net carrying value	299,500,000	298,200,000
Fair Value	298,100,000	286,400,000
2027 Notes
Debt Instrument [Line Items]
Principal	350,000,000.0	350,000,000.0		$ 350,000,000
Unamortized financing costs	(1,800,000)	(2,500,000)
Unaccreted discount	(400,000)	(600,000)		$ (1,000,000)
Interest rate swap fair value adjustment	(20,200,000)	(40,500,000)
Net carrying value	327,600,000	306,400,000
Fair Value	327,700,000	301,800,000
2029 Notes
Debt Instrument [Line Items]
Principal	300,000,000.0	300,000,000.0	$ 300,000,000
Unamortized financing costs	(2,900,000)	(3,500,000)
Unaccreted discount	(2,700,000)	(3,400,000)	$ (3,500,000)
Interest rate swap fair value adjustment	7,200,000	(7,000,000.0)
Net carrying value	301,600,000	286,100,000
Fair Value	$ 312,300,000	$ 290,000,000.0

Derivative Instruments

12 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of September 30, 2024, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts.

Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2024.


Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	84,291	€	76,394	11/7/2024	$	—	$	1,102	Derivative liability
Foreign currency forward contract	$	53,624	£	42,021	11/7/2024	—		2,739		Derivative liability
						$	—	$	3,841

Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2023.


Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	42,182	€	38,026	11/9/2023	$	1,857	$	—	Derivative asset
Foreign currency forward contract	$	72,098	£	56,556	11/9/2023	3,053		—		Derivative asset
						$	4,910	$	—

In connection with the issuance of the 2027 Notes and 2029 Notes, the Company entered into interest rate swap agreements with the Royal Bank of Canada pursuant to ISDA Master Agreements. As of September 30, 2024 and 2023, the Company paid $17.1 million and $54.3 million, respectively, to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreements, which is included in due from broker on the Consolidated Statement of Assets and Liabilities.

Certain information related to the Company’s interest rate swaps is presented below as of September 30, 2024.


Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	20,229	Derivative liability
Interest rate swap	300,000		2/15/2029	7,227		—		Derivative liability
				$	7,227	$	20,229

Certain information related to the Company’s interest rate swap is presented below as of September 30, 2023.


Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	40,519	Derivative liability
Interest rate swap	300,000		2/15/2029	—		7,000		Derivative liability
				$	—	$	47,519

Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands

Sep. 30, 2024

Sep. 30, 2023

ASSETS

Investments at fair value

$ 3,021,279

$ 2,892,420

Cash and cash equivalents

63,966

136,450

Restricted cash

14,577

9,089

Interest, dividends and fees receivable

38,804

44,570

Due from portfolio companies

12,530

6,317

Receivables from unsettled transactions

17,548

55,441

Due from broker

17,060

54,260

Deferred financing costs

11,677

12,541

Deferred offering costs

125

160

Derivative assets at fair value

4,910

Other assets

775

1,681

Total assets

3,198,341

3,217,839

Liabilities:

Accounts payable, accrued expenses and other liabilities

3,492

2,950

Base management fee and incentive fee payable

15,517

19,547

Due to affiliate

4,088

4,310

Interest payable

16,231

16,007

Payables from unsettled transactions

15,666

11,006

Derivative liabilities at fair value

16,843

47,519

Deferred tax liability

Credit facilities payable

710,000

Unsecured notes payable (net of $4,935 and $7,076 of unamortized financing costs as of September 30, 2024 and September 30, 2023, respectively)

928,693

890,731

Total liabilities

1,710,530

1,702,075

Commitments and contingencies (Note 13)

Net assets:

Common stock, $0.01 par value per share, 250,000 shares authorized; 82,245 and 77,225 shares issued and outstanding as of September 30, 2024 and September 30, 2023, respectively

822

772

Additional paid-in-capital

2,264,449

2,166,330

Accumulated overdistributed earnings

(777,460)

(651,338)

Total net assets (equivalent to $18.09 and $19.63 per common share as of September 30, 2024 and September 30, 2023, respectively) (Note 11)

1,487,811

1,515,764

Total liabilities and net assets

3,198,341

3,217,839

Control investments

ASSETS

Investments at fair value

289,404

^[1],[2]

297,091

^[3],[4]

Affiliate investments

ASSETS

Investments at fair value

35,677

23,349

Non-control/Non-affiliate investments

ASSETS

Investments at fair value

$ 2,696,198

^[5]

$ 2,571,980

^[4]

[1]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2024 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[2]	Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[3]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the Company's annual report on Form 10-K for the year ended September 30, 2023 for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[4]	Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[5]	Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

Portfolio Investments - Summarized Statement of Operations Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Investment Company, Nonconsolidated Subsidiary [Line Items]
Total investment income	$ 381,665	$ 379,286	$ 262,520
Interest expense	128,622	111,642	46,929
Total expenses	216,301	204,036	113,591
Net investment income before taxes	175,052	180,775	151,929
Net increase (decrease) in net assets resulting from operations	57,905	117,331	29,223
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	37,250	38,984	24,014
Other income/Fee income	153	290	198
Total investment income	37,403	39,274	24,212
Other expenses	315	442	253
Total expenses	32,511	33,988	17,112
Net investment income before taxes	4,892	5,286	7,100
Net unrealized appreciation (depreciation)	1,245	13,416	(23,661)
Realized gain (loss)	(7,251)	(10,962)	534
Net increase (decrease) in net assets resulting from operations	(1,114)	7,740	(16,027)
SLF JV I \| Senior Credit Facility
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	15,904	19,002	7,713
SLF JV I \| SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	16,292	14,544	9,146
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	14,111	14,043	9,703
Other income/Fee income	70	63	149
Total investment income	14,181	14,106	9,852
Other expenses	143	182	168
Total expenses	13,114	12,798	6,491
Net investment income before taxes	1,067	1,308	3,361
Net unrealized appreciation (depreciation)	2,781	1,254	(3,216)
Realized gain (loss)	(3,848)	(2,562)	(145)
Net increase (decrease) in net assets resulting from operations	0	0	0
OCSI Glick JV LLC \| Senior Credit Facility
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	6,228	6,560	2,747
OCSI Glick JV LLC \| Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest expense	$ 6,743	$ 6,056	$ 3,576

Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands

Sep. 30, 2024

Sep. 30, 2023

Investment, cost

$ 3,144,919

$ 3,044,119

Unamortized financing costs

$ 4,935

$ 7,076

Common stock, par value (in dollars per share)

$ 0.01

Common stock, shares authorized (in shares)

250,000

Common stock, shares issued (in shares)

82,245

77,225

Common stock, shares outstanding (in shares)

^[1]

82,245

77,225

Net asset value per common share (in dollars per share)

^[1]

$ 18.09

$ 19.63

Control investments

Investment, cost

$ 372,901

^[2],[3]

$ 345,245

^[4],[5]

Affiliate investments

Investment, cost

38,175

24,898

Non-control/Non-affiliate investments

Investment, cost

$ 2,733,843

^[6]

$ 2,673,976

^[5]

[1]	As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis as necessary.
[2]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2024 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[3]	Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[4]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the Company's annual report on Form 10-K for the year ended September 30, 2023 for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[5]	Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[6]	Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.

Portfolio Investments - Portfolio of Investments by Industry (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,144,919	$ 3,044,119
Investments at fair value	$ 3,021,279	$ 2,892,420
Investment owned, percent of net assets (as a percent)	203.07%	190.82%
Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	100.00%	100.00%
Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,021,279	$ 2,892,420
Investment owned, percent of net assets (as a percent)	203.07%	190.82%
Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	100.00%	100.00%
Application Software
Schedule of Investments [Line Items]
Investment owned, at cost	$ 532,200	$ 468,483
Application Software \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	16.85%	15.39%
Application Software \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 523,007	$ 455,719
Investment owned, percent of net assets (as a percent)	35.16%	30.03%
Application Software \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	17.34%	15.73%
Multi-Sector Holdings
Schedule of Investments [Line Items]
Investment owned, at cost	$ 228,181	$ 219,469
Multi-Sector Holdings \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	7.26%	7.21%
Multi-Sector Holdings \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 193,579	$ 193,431
Investment owned, percent of net assets (as a percent)	13.01%	12.76%
Multi-Sector Holdings \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	6.41%	6.69%
Health Care Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 149,904	$ 81,560
Health Care Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	4.77%	2.68%
Health Care Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 127,935	$ 66,683
Investment owned, percent of net assets (as a percent)	8.60%	4.40%
Health Care Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	4.23%	2.31%
Health Care Technology
Schedule of Investments [Line Items]
Investment owned, at cost	$ 105,932	$ 106,915
Health Care Technology \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	3.37%	3.51%
Health Care Technology \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 104,795	$ 95,404
Investment owned, percent of net assets (as a percent)	7.04%	6.29%
Health Care Technology \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	3.47%	3.30%
Interactive Media & Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 95,564	$ 19,013
Interactive Media & Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	3.04%	0.62%
Interactive Media & Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 96,963	$ 19,199
Investment owned, percent of net assets (as a percent)	6.52%	1.27%
Interactive Media & Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	3.21%	0.66%
Pharmaceuticals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 94,639	$ 84,948
Pharmaceuticals \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	3.01%	2.79%
Pharmaceuticals \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 91,804	$ 80,455
Investment owned, percent of net assets (as a percent)	6.17%	5.31%
Pharmaceuticals \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	3.04%	2.78%
Industrial Machinery & Supplies & Components
Schedule of Investments [Line Items]
Investment owned, at cost	$ 82,624	$ 99,511
Industrial Machinery & Supplies & Components \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.63%	3.27%
Industrial Machinery & Supplies & Components \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 84,977	$ 98,352
Investment owned, percent of net assets (as a percent)	5.71%	6.49%
Industrial Machinery & Supplies & Components \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.81%	3.40%
Data Processing & Outsourced Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 80,058	$ 133,410
Data Processing & Outsourced Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.55%	4.38%
Data Processing & Outsourced Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 73,673	$ 125,259
Investment owned, percent of net assets (as a percent)	4.95%	8.26%
Data Processing & Outsourced Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.44%	4.33%
Diversified Support Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 79,799	$ 23,435
Diversified Support Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.54%	0.77%
Diversified Support Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 80,638	$ 23,352
Investment owned, percent of net assets (as a percent)	5.42%	1.54%
Diversified Support Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.67%	0.81%
Aerospace & Defense
Schedule of Investments [Line Items]
Investment owned, at cost	$ 72,927	$ 51,797
Aerospace & Defense \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.32%	1.70%
Aerospace & Defense \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 74,327	$ 51,862
Investment owned, percent of net assets (as a percent)	5.00%	3.42%
Aerospace & Defense \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.46%	1.79%
Real Estate Operating Companies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 72,839	$ 83,754
Real Estate Operating Companies \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.32%	2.75%
Real Estate Operating Companies \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 71,246	$ 82,463
Investment owned, percent of net assets (as a percent)	4.79%	5.44%
Real Estate Operating Companies \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.36%	2.85%
Diversified Financial Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 66,597	$ 61,725
Diversified Financial Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.12%	2.03%
Diversified Financial Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 66,324	$ 60,003
Investment owned, percent of net assets (as a percent)	4.46%	3.96%
Diversified Financial Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.20%	2.07%
Environmental & Facilities Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 65,229	$ 63,064
Environmental & Facilities Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.07%	2.07%
Environmental & Facilities Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 64,119	$ 62,413
Investment owned, percent of net assets (as a percent)	4.31%	4.12%
Environmental & Facilities Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.12%	2.16%
Metal, Glass & Plastic Containers
Schedule of Investments [Line Items]
Investment owned, at cost	$ 64,769	$ 55,530
Metal, Glass & Plastic Containers \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.06%	1.82%
Metal, Glass & Plastic Containers \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 47,191	$ 53,459
Investment owned, percent of net assets (as a percent)	3.17%	3.53%
Metal, Glass & Plastic Containers \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.56%	1.85%
Personal Care Products
Schedule of Investments [Line Items]
Investment owned, at cost	$ 63,425	$ 68,146
Personal Care Products \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.02%	2.24%
Personal Care Products \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 57,451	$ 59,928
Investment owned, percent of net assets (as a percent)	3.86%	3.95%
Personal Care Products \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.90%	2.07%
Airport Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 63,110	$ 55,961
Airport Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.01%	1.84%
Airport Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 55,434	$ 54,453
Investment owned, percent of net assets (as a percent)	3.73%	3.59%
Airport Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.83%	1.88%
Health Care Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 60,316	$ 62,044
Health Care Distributors \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.92%	2.04%
Health Care Distributors \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 58,906	$ 60,865
Investment owned, percent of net assets (as a percent)	3.96%	4.02%
Health Care Distributors \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.95%	2.10%
Real Estate Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 55,220	$ 44,717
Real Estate Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.76%	1.47%
Real Estate Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 54,197	$ 43,886
Investment owned, percent of net assets (as a percent)	3.64%	2.90%
Real Estate Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.79%	1.52%
Fertilizers & Agricultural Chemicals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 54,677	$ 64,720
Fertilizers & Agricultural Chemicals \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.74%	2.13%
Fertilizers & Agricultural Chemicals \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 54,668	$ 63,185
Investment owned, percent of net assets (as a percent)	3.67%	4.17%
Fertilizers & Agricultural Chemicals \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.81%	2.18%
Internet Services & Infrastructure
Schedule of Investments [Line Items]
Investment owned, at cost	$ 53,376	$ 60,934
Internet Services & Infrastructure \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.70%	2.00%
Internet Services & Infrastructure \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 53,019	$ 60,579
Investment owned, percent of net assets (as a percent)	3.56%	4.00%
Internet Services & Infrastructure \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.75%	2.09%
Diversified Metals & Mining
Schedule of Investments [Line Items]
Investment owned, at cost	$ 50,061	$ 49,842
Diversified Metals & Mining \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.59%	1.64%
Diversified Metals & Mining \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 50,419	$ 49,869
Investment owned, percent of net assets (as a percent)	3.39%	3.29%
Diversified Metals & Mining \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.67%	1.72%
Home Improvement Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 49,891	$ 54,236
Home Improvement Retail \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.59%	1.78%
Home Improvement Retail \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 48,775	$ 53,168
Investment owned, percent of net assets (as a percent)	3.28%	3.51%
Home Improvement Retail \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.61%	1.84%
Communications Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 46,764	$ 0
Communications Equipment \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.49%	0.00%
Communications Equipment \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 46,858	$ 0
Investment owned, percent of net assets (as a percent)	3.15%	0.00%
Communications Equipment \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.55%	0.00%
Specialized Finance
Schedule of Investments [Line Items]
Investment owned, at cost	$ 45,156	$ 73,035
Specialized Finance \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.44%	2.40%
Specialized Finance \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 44,551	$ 69,590
Investment owned, percent of net assets (as a percent)	2.99%	4.59%
Specialized Finance \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.47%	2.41%
Biotechnology
Schedule of Investments [Line Items]
Investment owned, at cost	$ 43,821	$ 126,349
Biotechnology \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.39%	4.15%
Biotechnology \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 45,954	$ 125,678
Investment owned, percent of net assets (as a percent)	3.09%	8.29%
Biotechnology \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.52%	4.35%
Soft Drinks & Non-alcoholic Beverages
Schedule of Investments [Line Items]
Investment owned, at cost	$ 42,898	$ 42,628
Soft Drinks & Non-alcoholic Beverages \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.36%	1.40%
Soft Drinks & Non-alcoholic Beverages \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 42,674	$ 42,391
Investment owned, percent of net assets (as a percent)	2.87%	2.80%
Soft Drinks & Non-alcoholic Beverages \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.41%	1.47%
Automotive Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 40,964	$ 57,596
Automotive Retail \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.30%	1.89%
Automotive Retail \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 39,111	$ 55,805
Investment owned, percent of net assets (as a percent)	2.63%	3.68%
Automotive Retail \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.29%	1.93%
Systems Software
Schedule of Investments [Line Items]
Investment owned, at cost	$ 39,316	$ 23,111
Systems Software \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.25%	0.76%
Systems Software \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 39,813	$ 21,968
Investment owned, percent of net assets (as a percent)	2.68%	1.45%
Systems Software \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.32%	0.76%
Office Services & Supplies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 38,891	$ 0
Office Services & Supplies \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.24%	0.00%
Office Services & Supplies \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 38,149	$ 0
Investment owned, percent of net assets (as a percent)	2.56%	0.00%
Office Services & Supplies \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.26%	0.00%
Real Estate Development
Schedule of Investments [Line Items]
Investment owned, at cost	$ 38,237	$ 23,965
Real Estate Development \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.22%	0.79%
Real Estate Development \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 38,237	$ 23,679
Investment owned, percent of net assets (as a percent)	2.57%	1.56%
Real Estate Development \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.27%	0.82%
Leisure Facilities
Schedule of Investments [Line Items]
Investment owned, at cost	$ 37,958	$ 39,076
Leisure Facilities \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.21%	1.28%
Leisure Facilities \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 37,544	$ 36,963
Investment owned, percent of net assets (as a percent)	2.52%	2.44%
Leisure Facilities \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.24%	1.28%
Other Specialty Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 36,810	$ 41,088
Other Specialty Retail \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.17%	1.35%
Other Specialty Retail \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 39,660	$ 41,115
Investment owned, percent of net assets (as a percent)	2.67%	2.71%
Other Specialty Retail \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.31%	1.42%
Electrical Components & Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 32,834	$ 32,440
Electrical Components & Equipment \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.04%	1.07%
Electrical Components & Equipment \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 32,246	$ 32,573
Investment owned, percent of net assets (as a percent)	2.17%	2.15%
Electrical Components & Equipment \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.07%	1.13%
Construction & Engineering
Schedule of Investments [Line Items]
Investment owned, at cost	$ 31,602	$ 22,102
Construction & Engineering \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.00%	0.73%
Construction & Engineering \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 31,063	$ 21,903
Investment owned, percent of net assets (as a percent)	2.09%	1.45%
Construction & Engineering \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.03%	0.76%
Movies & Entertainment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 30,779	$ 12,188
Movies & Entertainment \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.98%	0.40%
Movies & Entertainment \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 30,863	$ 11,865
Investment owned, percent of net assets (as a percent)	2.07%	0.78%
Movies & Entertainment \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.02%	0.41%
Health Care Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 28,823	$ 22,441
Health Care Equipment \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.92%	0.74%
Health Care Equipment \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 26,264	$ 22,436
Investment owned, percent of net assets (as a percent)	1.77%	1.48%
Health Care Equipment \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.87%	0.78%
Construction Machinery & Heavy Transportation Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 25,901	$ 0
Construction Machinery & Heavy Transportation Equipment \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.82%	0.00%
Construction Machinery & Heavy Transportation Equipment \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 26,486	$ 0
Investment owned, percent of net assets (as a percent)	1.78%	0.00%
Construction Machinery & Heavy Transportation Equipment \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.88%	0.00%
Specialized Consumer Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 25,763	$ 0
Specialized Consumer Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.82%	0.00%
Specialized Consumer Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 25,772	$ 0
Investment owned, percent of net assets (as a percent)	1.73%	0.00%
Specialized Consumer Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.85%	0.00%
Passenger Airlines
Schedule of Investments [Line Items]
Investment owned, at cost	$ 25,039	$ 24,920
Passenger Airlines \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.80%	0.82%
Passenger Airlines \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 26,556	$ 27,512
Investment owned, percent of net assets (as a percent)	1.78%	1.82%
Passenger Airlines \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.88%	0.95%
Wireless Telecommunication Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 24,257	$ 0
Wireless Telecommunication Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.77%	0.00%
Wireless Telecommunication Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 24,311	$ 0
Investment owned, percent of net assets (as a percent)	1.63%	0.00%
Wireless Telecommunication Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.80%	0.00%
Home Furnishings
Schedule of Investments [Line Items]
Investment owned, at cost	$ 24,102	$ 23,859
Home Furnishings \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.77%	0.78%
Home Furnishings \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 9,376	$ 19,954
Investment owned, percent of net assets (as a percent)	0.63%	1.32%
Home Furnishings \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.31%	0.69%
Gold
Schedule of Investments [Line Items]
Investment owned, at cost	$ 23,454	$ 23,310
Gold \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.75%	0.77%
Gold \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 25,054	$ 23,328
Investment owned, percent of net assets (as a percent)	1.68%	1.54%
Gold \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.83%	0.81%
Broadline Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 22,231	$ 83,290
Broadline Retail \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.71%	2.74%
Broadline Retail \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 22,554	$ 69,040
Investment owned, percent of net assets (as a percent)	1.52%	4.55%
Broadline Retail \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.75%	2.39%
Hotels, Resorts & Cruise Lines
Schedule of Investments [Line Items]
Investment owned, at cost	$ 20,612	$ 17,195
Hotels, Resorts & Cruise Lines \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.66%	0.56%
Hotels, Resorts & Cruise Lines \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 20,342	$ 16,991
Investment owned, percent of net assets (as a percent)	1.37%	1.12%
Hotels, Resorts & Cruise Lines \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.67%	0.59%
Packaged Foods & Meats
Schedule of Investments [Line Items]
Investment owned, at cost	$ 19,863	$ 0
Packaged Foods & Meats \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.63%	0.00%
Packaged Foods & Meats \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 19,846	$ 0
Investment owned, percent of net assets (as a percent)	1.33%	0.00%
Packaged Foods & Meats \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.66%	0.00%
Specialty Chemicals
Schedule of Investments [Line Items]
Investment owned, at cost	$ 19,407	$ 38,640
Specialty Chemicals \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.62%	1.27%
Specialty Chemicals \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 19,431	$ 38,615
Investment owned, percent of net assets (as a percent)	1.31%	2.55%
Specialty Chemicals \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.64%	1.34%
Oil & Gas Storage & Transportation
Schedule of Investments [Line Items]
Investment owned, at cost	$ 19,309	$ 22,042
Oil & Gas Storage & Transportation \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.61%	0.72%
Oil & Gas Storage & Transportation \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 15,604	$ 16,040
Investment owned, percent of net assets (as a percent)	1.05%	1.06%
Oil & Gas Storage & Transportation \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.52%	0.55%
Air Freight & Logistics
Schedule of Investments [Line Items]
Investment owned, at cost	$ 19,222	$ 52,856
Air Freight & Logistics \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.61%	1.74%
Air Freight & Logistics \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 19,221	$ 53,050
Investment owned, percent of net assets (as a percent)	1.29%	3.50%
Air Freight & Logistics \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.64%	1.83%
Paper & Plastic Packaging Products & Materials
Schedule of Investments [Line Items]
Investment owned, at cost	$ 18,379	$ 3,254
Paper & Plastic Packaging Products & Materials \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.58%	0.11%
Paper & Plastic Packaging Products & Materials \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 18,307	$ 3,061
Investment owned, percent of net assets (as a percent)	1.23%	0.20%
Paper & Plastic Packaging Products & Materials \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.61%	0.11%
Apparel Retail
Schedule of Investments [Line Items]
Investment owned, at cost	$ 17,855	$ 4,999
Apparel Retail \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.57%	0.16%
Apparel Retail \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 18,017	$ 5,002
Investment owned, percent of net assets (as a percent)	1.21%	0.33%
Apparel Retail \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.60%	0.17%
Food Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 14,639	$ 5,897
Food Distributors \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.47%	0.19%
Food Distributors \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 15,484	$ 5,166
Investment owned, percent of net assets (as a percent)	1.04%	0.34%
Food Distributors \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.51%	0.18%
Health Care Supplies
Schedule of Investments [Line Items]
Investment owned, at cost	$ 14,426	$ 11,646
Health Care Supplies \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.46%	0.38%
Health Care Supplies \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 14,218	$ 11,363
Investment owned, percent of net assets (as a percent)	0.96%	0.75%
Health Care Supplies \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.47%	0.39%
Advertising
Schedule of Investments [Line Items]
Investment owned, at cost	$ 11,418	$ 25,597
Advertising \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.36%	0.84%
Advertising \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 11,515	$ 11,955
Investment owned, percent of net assets (as a percent)	0.77%	0.79%
Advertising \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.38%	0.41%
Education Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 8,205	$ 13,871
Education Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.26%	0.46%
Education Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 8,263	$ 13,618
Investment owned, percent of net assets (as a percent)	0.56%	0.90%
Education Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.27%	0.47%
Financial Exchanges & Data
Schedule of Investments [Line Items]
Investment owned, at cost	$ 8,050	$ 0
Financial Exchanges & Data \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.26%	0.00%
Financial Exchanges & Data \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 8,065	$ 0
Investment owned, percent of net assets (as a percent)	0.54%	0.00%
Financial Exchanges & Data \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.27%	0.00%
Housewares & Specialties
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,806	$ 2,908
Housewares & Specialties \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.09%	0.10%
Housewares & Specialties \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 2,546	$ 2,808
Investment owned, percent of net assets (as a percent)	0.17%	0.19%
Housewares & Specialties \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.08%	0.10%
Integrated Telecommunication Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,057	$ 18,801
Integrated Telecommunication Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.07%	0.62%
Integrated Telecommunication Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 1,657	$ 16,492
Investment owned, percent of net assets (as a percent)	0.11%	1.09%
Integrated Telecommunication Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.05%	0.57%
Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 1,733	$ 37,666
Distributors \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.06%	1.24%
Distributors \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 2,220	$ 37,311
Investment owned, percent of net assets (as a percent)	0.15%	2.46%
Distributors \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.07%	1.29%
Auto Parts & Equipment
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 48,536
Auto Parts & Equipment \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	1.59%
Auto Parts & Equipment \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 49,148
Investment owned, percent of net assets (as a percent)	0.00%	3.24%
Auto Parts & Equipment \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	1.70%
Consumer Finance
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 16,440
Consumer Finance \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.54%
Consumer Finance \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 15,087
Investment owned, percent of net assets (as a percent)	0.00%	1.00%
Consumer Finance \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.52%
Restaurants
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 12,603
Restaurants \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.41%
Restaurants \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 12,464
Investment owned, percent of net assets (as a percent)	0.00%	0.82%
Restaurants \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.43%
Air Freight & Logistics
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 4,925
Air Freight & Logistics \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.16%
Air Freight & Logistics \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 4,263
Investment owned, percent of net assets (as a percent)	0.00%	0.28%
Air Freight & Logistics \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.15%
Integrated Oil & Gas
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 4,894
Integrated Oil & Gas \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.16%
Integrated Oil & Gas \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 4,785
Investment owned, percent of net assets (as a percent)	0.00%	0.32%
Integrated Oil & Gas \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.17%
Cable & Satellite
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 4,619
Cable & Satellite \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.15%
Cable & Satellite \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 4,546
Investment owned, percent of net assets (as a percent)	0.00%	0.30%
Cable & Satellite \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.16%
Research & Consulting Services
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 4,871
Research & Consulting Services \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.16%
Research & Consulting Services \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 4,831
Investment owned, percent of net assets (as a percent)	0.00%	0.32%
Research & Consulting Services \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.17%
Other Specialized REITs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 4,379
Other Specialized REITs \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.14%
Other Specialized REITs \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 3,198
Investment owned, percent of net assets (as a percent)	0.00%	0.21%
Other Specialized REITs \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.11%
Leisure Products
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 2,055
Leisure Products \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.07%
Leisure Products \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 2,063
Investment owned, percent of net assets (as a percent)	0.00%	0.14%
Leisure Products \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.07%
Technology Distributors
Schedule of Investments [Line Items]
Investment owned, at cost	$ 0	$ 813
Technology Distributors \| Investment Owned, At Cost \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.03%
Technology Distributors \| Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 0	$ 776
Investment owned, percent of net assets (as a percent)	0.00%	0.05%
Technology Distributors \| Investment Owned, At Fair Value \| Investment Sector Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.00%	0.03%

Share Data and Net Assets (Tables)

12 Months Ended

Sep. 30, 2024

Stockholders' Equity Note [Abstract]

Schedule of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the years ended September 30, 2024, 2023 and 2022:


(Share amounts in thousands)	Year ended September 30, 2024		Year ended September 30, 2023		Year ended September 30, 2022
Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operations	$	57,905	$	117,331	$	29,223
Weighted average common shares outstanding — basic and diluted	80,418		72,119		60,727
Earnings (loss) per common share — basic and diluted	$	0.72	$	1.63	$	0.48

Schedule of Changes in Net Assets

The following table presents the changes in net assets for the years ended September 30, 2024, 2023 and 2022:


	Common Stock
(Share amounts in thousands)	Shares	Par Value		Additional paid-in-capital		Accumulated Overdistributed Earnings		Total Net Assets
Balance as of September 30, 2021	60,120	$	601	$	1,805,557	$	(493,335)	$	1,312,823
Net investment income	—	—		—		148,621		148,621
Net unrealized appreciation (depreciation)	—	—		—		(136,248)		(136,248)
Net realized gains (losses)	—	—		—		17,179		17,179
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(329)		(329)
Distributions to stockholders	—	—		—		(118,657)		(118,657)
Issuance of common stock in connection with the "at the market" offering	934	9		20,613		—		20,622
Issuance of common stock under dividend reinvestment plan	166	2		3,407		—		3,409
Repurchase of common stock under dividend reinvestment plan	(95)	(1)		(1,856)		—		(1,857)
Balance as of September 30, 2022	61,125	611		1,827,721		(582,769)		1,245,563
Net investment income	—	—		—		180,697		180,697
Net unrealized appreciation (depreciation)	—	—		—		(28,555)		(28,555)
Net realized gains (losses)	—	—		—		(33,155)		(33,155)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		(1,656)		(1,656)
Distributions to stockholders	—	—		—		(185,900)		(185,900)
Issuance of common stock in connection with the OSI2 Merger	15,860	159		333,875		—		334,034
Issuance of common stock in connection with the "at the market" offering	69	1		1,299		—		1,300
Issuance of common stock under dividend reinvestment plan	297	3		5,851		—		5,854
Repurchase of common stock under dividend reinvestment plan	(126)	(2)		(2,416)		—		(2,418)
Balance as of September 30, 2023	77,225	772		2,166,330		(651,338)		1,515,764
Net investment income	—	—		—		175,052		175,052
Net unrealized appreciation (depreciation)	—	—		—		19,101		19,101
Net realized gains (losses)	—	—		—		(136,356)		(136,356)
(Provision) benefit for taxes on realized and unrealized gains (losses)	—	—		—		108		108
Distributions to stockholders	—	—		—		(184,027)		(184,027)
Issuance of common stock in connection with the "at the market" offering	4,725	47		92,460		—		92,507
Issuance of common stock under dividend reinvestment plan	390	4		7,209		—		7,213
Repurchase of common stock under dividend reinvestment plan	(95)	(1)		(1,550)		—		(1,551)
Balance as of September 30, 2024	82,245	$	822	$	2,264,449	$	(777,460)	$	1,487,811

Schedule of Distributions


Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	November 8, 2023	December 15, 2023	December 29, 2023	$	0.55	$	41.7	million	87,472	(1)	$	1.7	million
Special	November 8, 2023	December 15, 2023	December 29, 2023	0.07		5.3		million	11,133	(1)	0.2		million
Quarterly	January 26, 2024	March 15, 2024	March 29, 2024	0.55		42.8		million	96,850	(1)	1.9		million
Quarterly	April 26, 2024	June 14, 2024	June 28, 2024	0.55		43.3		million	100,029	(1)	1.9		million
Quarterly	July 26, 2024	September 16, 2024	September 30, 2024	0.55		43.7		million	94,873	(2)	1.6		million
Total for the year ended September 30, 2024				$	2.27	$	176.8	million	390,357		$	7.2	million
Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	November 10, 2022	December 15, 2022	December 30, 2022	$	0.54	$	32.0	million	53,369	(1)	$	1.1	million
Special	November 10, 2022	December 15, 2022	December 30, 2022	0.42		24.8		million	41,510	(1)	0.8		million
Quarterly	January 27, 2023	March 15, 2023	March 31, 2023	0.55		41.1		million	68,412	(2)	1.3		million
Quarterly	April 28, 2023	June 15, 2023	June 30, 2023	0.55		41.3		million	57,279	(2)	1.1		million
Quarterly	July 28, 2023	September 15, 2023	September 29, 2023	0.55		40.9		million	76,766	(1)	1.5 million
Total for the year ended September 30, 2023				$	2.61	$	180.0	million	297,336		$	5.9	million
Distribution	Date Declared	Record Date	Payment Date	Amount per Share		Cash Distribution			DRIP Shares Issued		DRIP Shares Value (3)
Quarterly	October 13, 2021	December 15, 2021	December 31, 2021	$	0.465	$	27.2	million	35,990	(1)	$	0.8	million
Quarterly	January 28, 2022	March 15, 2022	March 31, 2022	0.48		28.5		million	34,804	(1)	0.8		million
Quarterly	April 29, 2022	June 15, 2022	June 30, 2022	0.495		29.4		million	43,676	(2)	0.9		million
Quarterly	July 29, 2022	September 15, 2022	September 30, 2022	0.51		30.2		million	51,181	(2)	1.0		million
Total for the year ended September 30, 2022				$	1.95	$	115.3	million	165,651		$	3.4	million

__________

(1) New shares were issued and distributed.

(2) Shares were purchased on the open market and distributed.

(3) Totals may not sum due to rounding.

Schedule of Common Stock Issued and Sold


	Number of Shares Issued	Gross Proceeds		Placement Agent Fees		Net Proceeds (1)		Average Sales Price per Share (2)
"At the market" offering	4,724,506	$	93,685	$	937	$	92,748	$	19.83

(1) Net proceeds excludes offering costs of $0.2 million.

(2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.


	Number of Shares Issued	Gross Proceeds		Placement Agent Fees		Net Proceeds (1)		Average Sales Price per Share (2)
"At the market" offering	68,752	$	1,384	$	14	$	1,370	$	20.13

(1) Net proceeds excludes offering costs of $0.1 million.

(2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.

Taxable/Distributable Income and Dividend Distributions - Components of Accumulated Overdistributed Earnings (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Undistributed ordinary income, net	$ 2,986
Net realized capital losses	(642,467)
Unrealized losses, net	(137,979)
Accumulated overdistributed earnings	$ (777,460)	$ (651,338)

- Definition

Amount of accumulated undistributed earnings (deficit).

+ References + Details

Derivative Instruments (Tables)

12 Months Ended

Sep. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Foreign Currency Forward Contracts and Interest Rate Swap

Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2024.


Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	84,291	€	76,394	11/7/2024	$	—	$	1,102	Derivative liability
Foreign currency forward contract	$	53,624	£	42,021	11/7/2024	—		2,739		Derivative liability
						$	—	$	3,841

Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2023.


Description	Notional Amount to be Purchased		Notional Amount to be Sold		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Foreign currency forward contract	$	42,182	€	38,026	11/9/2023	$	1,857	$	—	Derivative asset
Foreign currency forward contract	$	72,098	£	56,556	11/9/2023	3,053		—		Derivative asset
						$	4,910	$	—

Certain information related to the Company’s interest rate swaps is presented below as of September 30, 2024.


Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	20,229	Derivative liability
Interest rate swap	300,000		2/15/2029	7,227		—		Derivative liability
				$	7,227	$	20,229

Certain information related to the Company’s interest rate swap is presented below as of September 30, 2023.


Description	Notional Amount		Maturity Date	Gross Amount of Recognized Assets		Gross Amount of Recognized Liabilities		Balance Sheet Location of Net Amounts
Interest rate swap	$	350,000	1/15/2027	$	—	$	40,519	Derivative liability
Interest rate swap	300,000		2/15/2029	—		7,000		Derivative liability
				$	—	$	47,519

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References + Details

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 311,361	$ 232,740
Debt and Equity Financing
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	284,300	205,600
Amount which can be drawn immediately	247,600	154,200
JV Financing
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 27,100	$ 27,100

Portfolio Investments - Summarized Balance Sheet Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 3,021,279	$ 2,892,420
Cash and cash equivalents	63,966	136,450	$ 23,528
Restricted cash	14,577	9,089	$ 2,836
Other assets	775	1,681
Total assets	3,198,341	3,217,839
Senior credit facility payable	710,000	710,000
Secured borrowings	5,766	18,106
Other liabilities	4,088	4,310
Total liabilities	1,710,530	1,702,075
Total liabilities and net assets	3,198,341	3,217,839
Investment owned, at cost	3,144,919	3,044,119
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	329,496	322,179
Cash and cash equivalents	36,082	31,950
Restricted cash	6,994	2,987
Other assets	3,260	18,988
Total assets	375,832	376,104
Senior credit facility payable	200,000	149,000
Secured borrowings	11,311	38,845
Notes payable at fair value	128,750	128,750
Other liabilities	10,007	26,630
Total liabilities	350,068	343,225
Members' equity	25,764	32,879
Total liabilities and net assets	375,832	376,104
Investment owned, at cost	337,882	331,808
Net proceeds	128,750	128,750
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	124,887	123,343
Cash and cash equivalents	10,907	12,119
Restricted cash	1,032	184
Other assets	8,177	5,521
Total assets	145,003	141,167
Senior credit facility payable	79,000	53,000
Notes payable at fair value	55,886	57,201
Other liabilities	4,351	12,860
Total liabilities	145,003	141,167
Members' equity	0	0
Total liabilities and net assets	145,003	141,167
Investment owned, at cost	127,867	127,788
Net proceeds	$ 66,685	$ 66,685

Cover - USD ($) $ in Millions	12 Months Ended
Cover - USD ($) $ in Millions	Sep. 30, 2024	Nov. 15, 2024	Mar. 31, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Sep. 30, 2024
Current Fiscal Year End Date	--09-30
Document Transition Report	false
Securities Act File Number	1-33901
Entity Registrant Name	Oaktree Specialty Lending Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1219283
Entity Address, Address Line One	333 South Grand Avenue
Entity Address, Address Line Two	28th Floor
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90071
City Area Code	213
Local Phone Number	830-6300
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	OCSL
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 1,559.2
Entity Common Stock, Shares Outstanding		82,245,319
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant’s definitive Proxy Statement relating to the registrant’s 2025 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission, or the SEC, within 120 days following the end of the Company’s fiscal year, are incorporated by reference in Part III of this Annual Report on Form 10-K as indicated herein.
Entity Central Index Key	0001414932
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false

Related Party Transactions	12 Months Ended
Related Party Transactions	Sep. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions As of September 30, 2024 and September 30, 2023, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $15.5 million and $19.5 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree. Investment Advisory Agreement The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company. The investment advisory agreement with Oaktree was amended and restated on March 19, 2021 in connection with the closing of the OCSI Merger, on January 23, 2023 in connection with the closing of OSI2 Merger and on November 14, 2024 to reflect a reduced base management fee. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree. Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company. Base Management Fee Effective as of July 1, 2024, the base management fee is calculated at an annual rate of 1.00% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents; provided, however, that for the period from July 1, 2024 to January 23, 2025, the base management fee shall be calculated at such an annual rate as to cause (1) the base management fee less (2) previously agreed waivers of $750,000 of base management fees per quarter (with such amount appropriately prorated for any partial quarter) to equal 1.00% of the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. From May 3, 2019 through June 30, 2024, the base management fee was 1.50% of total gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, provided that the base management fee on gross assets that exceeded the product of (A) 200% and (B) the Company’s net asset value was 1.00%. The 200% was calculated in accordance with the Investment Company Act. In connection with the OCSI Merger, Oaktree waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the OCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger. Oaktree also waived additional base management fees such that the total amount of waived base management fees (including those waived in connection with the OSI2 Merger described above) was $1.5 million for each of the three months ended March 31, 2024 and June 30, 2024. For the years ended September 30, 2024, 2023 and 2022, the base management fee incurred under the Investment Advisory Agreement was $38.2 million (net of waiver), $39.4 million (net of waiver) and $36.6 million (net of waiver), respectively. Incentive Fee The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature. For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income. Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows: •No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets; •100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and •For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved. There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle. For the year ended September 30, 2024, Oaktree waived $4.4 million of Part I incentive fees. For the years ended September 30, 2024, 2023 and 2022, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $30.3 million (net of waiver), $35.8 million and $26.6 million, respectively. Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of September 30, 2024, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). For the years ended September 30, 2024, 2023 and 2022, the Company did not incur any capital gains incentive fees. GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the years ended September 30, 2024 and 2023, there were no accrued capital gains incentive fees. For the year ended September 30, 2022, $8.8 million of previously accrued capital gains incentive fees were reversed. As of September 30, 2024, the total accrued capital gains incentive fee liability was zero. Indemnification The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser. Administrative Services The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation. Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies. For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities. For the years ended September 30, 2024, 2023 and 2022, the Company accrued administrative expenses of $1.9 million, $1.5 million and $1.5 million, respectively, including $0.4 million, $0.3 million and $0.3 million of general and administrative expenses, respectively. As of September 30, 2024 and September 30, 2023, $4.1 million and $4.3 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

+ Details

Commitments and Contingencies - Schedule of Unfunded Commitments by Investment (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 311,361	$ 232,740
Investment, Identifier [Axis]: 107 Fair Street LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,507	4,227
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	11,911	26,969
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,077	2,343
Investment, Identifier [Axis]: ACESO Holding 4 S.A.R.L.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,700	0
Investment, Identifier [Axis]: ADC Therapeutics SA
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	3,020
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	166	396
Investment, Identifier [Axis]: Accession Risk Management Group, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	11,019	0
Investment, Identifier [Axis]: Accupac, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,051	4,500
Investment, Identifier [Axis]: Acquia Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,625	1,376
Investment, Identifier [Axis]: All Web Leads, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	240	0
Investment, Identifier [Axis]: Amspec Parent LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	9,372	0
Investment, Identifier [Axis]: Assembled Brands Capital LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	7,514
Investment, Identifier [Axis]: Avalara, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,047	5,047
Investment, Identifier [Axis]: Berner Food & Beverage, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,007	1,622
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	9,383	14,547
Investment, Identifier [Axis]: Centralsquare Technologies, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,436	0
Investment, Identifier [Axis]: Coupa Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,075	2,075
Investment, Identifier [Axis]: Coyote Buyer, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	400
Investment, Identifier [Axis]: Crewline Buyer, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,180	0
Investment, Identifier [Axis]: Delta Leasing SPV II LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,581	14,639
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	6,045	1,078
Investment, Identifier [Axis]: Dominion Diagnostics, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,574	3,484
Investment, Identifier [Axis]: Enverus Holdings, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,014	0
Investment, Identifier [Axis]: Establishment Labs Holdings Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,384	3,384
Investment, Identifier [Axis]: Everbridge, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,043	0
Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,626	1,626
Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	6,585	0
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	13,090
Investment, Identifier [Axis]: Finastra USA, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	654	960
Investment, Identifier [Axis]: Galileo Parent, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,163	2,061
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,762	5,286
Investment, Identifier [Axis]: Harrow, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,438	4,011
Investment, Identifier [Axis]: Icefall Parent, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	995	0
Investment, Identifier [Axis]: Impel Pharmaceuticals Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	2,458
Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	16,436	0
Investment, Identifier [Axis]: Inventus Power, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,792	3,792
Investment, Identifier [Axis]: Kings Buyer, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,277	5,189
Investment, Identifier [Axis]: LSL Holdco, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	636	2,650
Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	4,651	0
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	1,383
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,786	821
Investment, Identifier [Axis]: MND Holdings III Corp
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	9,122
Investment, Identifier [Axis]: MRI Software LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	6,972	2,261
Investment, Identifier [Axis]: Mindbody, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,238	4,762
Investment, Identifier [Axis]: Minotaur Acquisition, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,882	0
Investment, Identifier [Axis]: Monotype Imaging Holdings Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	8,005	0
Investment, Identifier [Axis]: Next Holdco, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	7,051	0
Investment, Identifier [Axis]: OCSI Glick JV LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	13,998	13,998
Investment, Identifier [Axis]: OTG Management, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	3,190
Investment, Identifier [Axis]: Oranje Holdco, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,904	1,904
Investment, Identifier [Axis]: PPW Aero Buyer, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	10,235	1,466
Investment, Identifier [Axis]: PRGX Global, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,127	3,127
Investment, Identifier [Axis]: PetVet Care Centers, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	13,732	0
Investment, Identifier [Axis]: Pluralsight, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	8,688	1,787
Investment, Identifier [Axis]: Poseidon Midco AB
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	8,181	0
Investment, Identifier [Axis]: Protein For Pets Opco, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	2,117	0
Investment, Identifier [Axis]: Quantum Bidco Limited
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	6,311	0
Investment, Identifier [Axis]: Relativity ODA LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	2,762
Investment, Identifier [Axis]: SCP Eye Care Services, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	2,356
Investment, Identifier [Axis]: SIO2 Medical Products, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,584	1,821
Investment, Identifier [Axis]: SVP-Singer Holdings Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	621	0
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,102	3,102
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	13,125	13,125
Investment, Identifier [Axis]: Seres Therapeutics, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	8,090
Investment, Identifier [Axis]: Sorenson Communications, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,409	0
Investment, Identifier [Axis]: Spanx, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,092	2,473
Investment, Identifier [Axis]: SumUp Holdings Luxembourg
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,101	0
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,552	2,199
Investment, Identifier [Axis]: Tahoe Bidco B.V.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	0	2,162
Investment, Identifier [Axis]: Telephone and Data Systems, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	6,273	0
Investment, Identifier [Axis]: Telestream Holdings Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	244	407
Investment, Identifier [Axis]: Truck-Lite Co., LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,721	0
Investment, Identifier [Axis]: USIC Holdings, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	1,938	0
Investment, Identifier [Axis]: Verona Pharma, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	14,846	0
Investment, Identifier [Axis]: WP CPP Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	3,272	0
Investment, Identifier [Axis]: iCIMs, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	5,802	7,466
Investment, Identifier [Axis]: scPharmaceuticals Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments	$ 0	$ 5,212

Borrowings

12 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Borrowings

Syndicated Facility

On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank.

As of September 30, 2024, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances.

As of September 30, 2024, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%.

The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC, or “OSI 2 SPV”) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company.

The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of September 30, 2024, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage

ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.

As of each of September 30, 2024 and September 30, 2023, the Company had $430.0 million of borrowings outstanding under the Syndicated Facility, which had a fair value of $430.0 million. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 7.443%, 6.792% and 2.876% for the years ended September 30, 2024, 2023 and 2022, respectively. For the years ended September 30, 2024, 2023 and 2022, the Company recorded interest expense (inclusive of fees) of $39.4 million, $50.0 million and $19.5 million, respectively, related to the Syndicated Facility.

Citibank Facility

On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC, the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated.

As of September 30, 2024 and September 30, 2023, the Company did not have any borrowings outstanding under the Citibank Facility. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.781% and 3.179% for the years ended September 30, 2023 and 2022, respectively. For the years ended September 30, 2023 and 2022, the Company recorded interest expense (inclusive of fees) of $8.0 million and $5.8 million, respectively, related to the Citibank Facility.

OSI2 Citibank Facility

On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 SPV, the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.

As of September 30, 2024, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of September 30, 2024, the OSI2 Citibank Facility had a reinvestment period through May 25, 2027, during which advances may be made, and matures on January 26, 2029. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to SOFR plus 2.35% per annum. After the reinvestment period, the applicable spread is 3.35% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.

As of each of September 30, 2024 and September 30, 2023, the Company had $280.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $280.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 7.756% and 7.666% for the year ended September 30, 2024 and the period from January 23, 2023 to September 30, 2023, respectively. For the year ended September 30, 2024 and the period from January 23, 2023 to September 30, 2023, the Company recorded interest expense (inclusive of fees) of $23.8 million and $14.6 million, respectively, related to the OSI2 Citibank Facility.

2025 Notes

On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes.

The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the year ended September 30, 2024, the Company did not repurchase any of the 2025 Notes in the open market.

The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.

2027 Notes

On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes.

The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2027 Notes is paid semi-annually on January 15 and July 15 at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the year ended September 30, 2024, the Company did not repurchase any of the 2027 Notes in the open market.

The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.

In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month SOFR plus

1.658% plus a SOFR adjustment of 0.26161% on a notional amount of $350.0 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.

2029 Notes

On August 15, 2023, the Company issued $300.0 million in aggregate principal amount of the 2029 Notes for net proceeds of $292.9 million after deducting OID of $3.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.6 million. The OID on the 2029 Notes is amortized based on the effective interest method over the term of the 2029 Notes.

The 2029 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the seventh supplemental indenture, dated August 15, 2023 (collectively, the "2029 Notes Indenture"), between the Company and the Trustee. The 2029 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2029 Notes. The 2029 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2029 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2029 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.

Interest on the 2029 Notes is paid semi-annually on February 15 and August 15 at a rate of 7.100% per annum. The 2029 Notes mature on February 15, 2029 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2029 Notes can require the Company to repurchase the 2029 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2029 Notes Indenture. The 2029 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the year ended September 30, 2024, the Company did not repurchase any of the 2029 Notes in the open market.

The 2029 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2029 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2029 Notes Indenture.

In connection with the 2029 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 7.100% and pays a floating interest rate of the three-month SOFR plus 3.1255% on a notional amount of $300.0 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.

The below table presents the components of the carrying value of the 2025 Notes, the 2027 Notes and the 2029 Notes as of September 30, 2024 and September 30, 2023:


	As of September 30, 2024						As of September 30, 2023
($ in millions)	2025 Notes		2027 Notes		2029 Notes		2025 Notes		2027 Notes		2029 Notes
Principal	$	300.0	$	350.0	$	300.0	$	300.0	$	350.0	$	300.0
Unamortized financing costs	(0.3)		(1.8)		(2.9)		(1.1)		(2.5)		(3.5)
Unaccreted discount	(0.2)		(0.4)		(2.7)		(0.7)		(0.6)		(3.4)
Interest rate swap fair value adjustment	—		(20.2)		7.2		—		(40.5)		(7.0)
Net carrying value	$	299.5	$	327.6	$	301.6	$	298.2	$	306.4	$	286.1
Fair Value	$	298.1	$	327.7	$	312.3	$	286.4	$	301.8	$	290.0

The below table presents the components of interest and other debt expenses related to the 2025 Notes, the 2027 Notes and the 2029 Notes for the year ended September 30, 2024:


($ in millions)	2025 Notes			2027 Notes			2029 Notes
Coupon interest	$	10.5		$	9.5		$	21.3
Amortization of financing costs and discount	1.3			0.9			1.3
Effect of interest rate swap	—			16.3			4.4
Total interest expense	$	11.8		$	26.7		$	27.0
Coupon interest rate (net of effect of interest rate swaps)	3.500		%	7.259		%	8.437		%

The below table presents the components of interest and other debt expenses related to the 2025 Notes, the 2027 Notes and the 2029 Notes for the year ended September 30, 2023:


($ in millions)	2025 Notes			2027 Notes			2029 Notes
Coupon interest	$	10.5		$	9.5		$	2.7
Amortization of financing costs and discount	1.3			0.9			0.2
Effect of interest rate swap	—			13.4			0.6
Total interest expense	$	11.8		$	23.8		$	3.5
Coupon interest rate (net of effect of interest rate swaps)	3.500		%	6.539		%	8.490		%

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the year ended September 30, 2022:


($ in millions)	2025 Notes				2027 Notes
Coupon interest		$	10.5		$	9.5
Amortization of financing costs and discount		1.3			0.9
Effect of interest rate swap		—			(0.4)
Total interest expense		$	11.8		$	10.0
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)		3.500		%	2.585		%

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

Commitments and Contingencies

12 Months Ended

Sep. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Off-Balance Sheet Arrangements

The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of September 30, 2024, the Company's only off-balance sheet arrangements consisted of $311.4 million of unfunded commitments, which was comprised of $284.3 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. Of the $284.3 million, approximately $247.6 million can be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions. As of September 30, 2023, the Company's only off-balance sheet arrangements consisted of $232.7 million of unfunded commitments, which was comprised of $205.6 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. Of the $205.6 million, approximately $154.2 million can be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities.

A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components and subordinated notes and LLC equity interests in the JVs) as of September 30, 2024 and September 30, 2023 is shown in the table below:


	September 30, 2024		September 30, 2023
Integrity Marketing Acquisition, LLC	$	16,436	$	—
Verona Pharma, Inc.	14,846		—
OCSI Glick JV LLC	13,998		13,998
PetVet Care Centers, LLC	13,732		—
Senior Loan Fund JV I, LLC	13,125		13,125
107-109 Beech OAK22 LLC	11,911		26,969
Accession Risk Management Group, Inc.	11,019		—
PPW Aero Buyer, Inc.	10,235		1,466
BioXcel Therapeutics, Inc.	9,383		14,547
Amspec Parent LLC	9,372		—
Pluralsight, LLC	8,688		1,787
Poseidon Midco AB	8,181		—
Monotype Imaging Holdings Inc.	8,005		—
Next Holdco, LLC	7,051		—
MRI Software LLC	6,972		2,261
Eyesouth Eye Care Holdco LLC	6,585		—
Quantum Bidco Limited	6,311		—
Telephone and Data Systems, Inc.	6,273		—
Digital.AI Software Holdings, Inc.	6,045		1,078
iCIMs, Inc.	5,802		7,466
Truck-Lite Co., LLC	5,721		—
Dominion Diagnostics, LLC	5,574		3,484
Sorenson Communications, LLC	5,409		—
Mindbody, Inc.	5,238		4,762
SumUp Holdings Luxembourg	5,101		—
Avalara, Inc.	5,047		5,047
Everbridge, Inc.	5,043		—
ACESO Holding 4 S.A.R.L.	4,700		—
Legends Hospitality Holding Company, LLC	4,651		—
Accupac, Inc.	4,051		4,500
Inventus Power, Inc.	3,792		3,792
Delta Leasing SPV II LLC	3,581		14,639
107 Fair Street LLC	3,507		4,227
Harrow, Inc.	3,438		4,011


	September 30, 2024		September 30, 2023
Establishment Labs Holdings Inc.	$	3,384	$	3,384
Kings Buyer, LLC	3,277		5,189
WP CPP Holdings, LLC	3,272		—
PRGX Global, Inc.	3,127		3,127
Salus Workers' Compensation, LLC	3,102		3,102
Spanx, LLC	3,092		2,473
Enverus Holdings, Inc.	3,014		—
Crewline Buyer, Inc.	2,180		—
Protein For Pets Opco, LLC	2,117		—
Coupa Holdings, LLC	2,075		2,075
USIC Holdings, Inc.	1,938		—
Oranje Holdco, Inc.	1,904		1,904
Minotaur Acquisition, Inc.	1,882		—
MHE Intermediate Holdings, LLC	1,786		821
Grove Hotel Parcel Owner, LLC	1,762		5,286
Evergreen IX Borrower 2023, LLC	1,626		1,626
Acquia Inc.	1,625		1,376
SIO2 Medical Products, Inc.	1,584		1,821
Supreme Fitness Group NY Holdings, LLC	1,552		2,199
Centralsquare Technologies, LLC	1,436		—
Galileo Parent, Inc.	1,163		2,061
112-126 Van Houten Real22 LLC	1,077		2,343
Berner Food & Beverage, LLC	1,007		1,622
Icefall Parent, Inc.	995		—
Finastra USA, Inc.	654		960
LSL Holdco, LLC	636		2,650
SVP-Singer Holdings Inc.	621		—
Telestream Holdings Corporation	244		407
All Web Leads, Inc.	240		—
ASP-R-PAC Acquisition Co LLC	166		396
Fairbridge Strategic Capital Funding LLC	—		13,090
MND Holdings III Corp	—		9,122
Seres Therapeutics, Inc.	—		8,090
Assembled Brands Capital LLC	—		7,514
scPharmaceuticals Inc.	—		5,212
OTG Management, LLC	—		3,190
ADC Therapeutics SA	—		3,020
Relativity ODA LLC	—		2,762
Impel Pharmaceuticals Inc.	—		2,458
SCP Eye Care Services, LLC	—		2,356
Tahoe Bidco B.V.	—		2,162
Liquid Environmental Solutions Corporation	—		1,383
Coyote Buyer, LLC	—		400
Total	$	311,361	$	232,740

Share Data and Net Assets - Schedule of Distributions (Details) - USD ($) $ / shares in Units, $ in Thousands													12 Months Ended
	Sep. 30, 2024	Jun. 28, 2024	Mar. 29, 2024	Dec. 29, 2023	Sep. 29, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 30, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Investment Company, Changes in Net Assets [Line Items]
Amount per share (in dollars per share)													$ 2.27	$ 2.61	$ 1.95	$ 1.52	$ 1.17
Cash Distribution													$ 176,800	$ 180,000	$ 115,300
DRIP Shares Issued (in shares)													390,357,000	297,336,000	165,651
DRIP Shares Value													$ 7,213	$ 5,854	$ 3,409
Quarterly
Investment Company, Changes in Net Assets [Line Items]
Amount per share (in dollars per share)	$ 0.55	$ 0.55	$ 0.55	$ 0.55	$ 0.55	$ 0.55	$ 0.55	$ 0.54	$ 0.51	$ 0.495	$ 0.48	$ 0.465
Cash Distribution	$ 43,700	$ 43,300	$ 42,800	$ 41,700	$ 40,900	$ 41,300	$ 41,100	$ 32,000	$ 30,200	$ 29,400	$ 28,500	$ 27,200
DRIP Shares Issued (in shares)	94,873,000	100,029,000	96,850,000	87,472,000	76,766,000	57,279,000	68,412,000	53,369,000	51,181	43,676	34,804	35,990
DRIP Shares Value	$ 1,600	$ 1,900	$ 1,900	$ 1,700	$ 1,500	$ 1,100	$ 1,300	$ 1,100	$ 1,000	$ 900	$ 800	$ 800
Special
Investment Company, Changes in Net Assets [Line Items]
Amount per share (in dollars per share)				$ 0.07				$ 0.42
Cash Distribution				$ 5,300				$ 24,800
DRIP Shares Issued (in shares)				11,133,000				41,510,000
DRIP Shares Value				$ 200				$ 800

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Related Party Transactions (Details)						7 Months Ended	12 Months Ended			62 Months Ended
Related Party Transactions (Details)	Apr. 26, 2024 USD ($)	Jan. 23, 2023 USD ($)	Mar. 19, 2021 USD ($)	May 03, 2019	May 02, 2019	Jan. 23, 2025 USD ($)	Sep. 30, 2024 USD ($) component	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2024
Related Party Transaction [Line Items]
Base management fee and incentive fee payable							$ 15,517,000	$ 19,547,000
Base management fee rate (as a percent)				1.00%	1.00%					1.50%
Base management fee, threshold (as a percent)				200.00%
Contractual fee waived, per quarter	$ 1,500,000
Base management fee							43,412,000	44,899,000	$ 39,556,000
Part I incentive fees waived							4,438,000	0	0
Part I incentive fee							34,764,000	35,831,000	26,644,000
Due to affiliate							$ 4,088,000	4,310,000
Forecast
Related Party Transaction [Line Items]
Base management fee rate (as a percent)						1.00%
Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, termination, notice period							60 days
Part I incentive fees waived							$ 4,400,000
Administrator expense							1,900,000	1,500,000	1,500,000
General and administrative expenses							400,000	300,000	300,000
Due to affiliate							$ 4,100,000	4,300,000
Oaktree Strategic Income Corporation Merger
Related Party Transaction [Line Items]
Investment company, contractual fee waived			$ 6,000,000
Contractual fee waived, period otherwise receivable (in years)			2 years
Contractual fee waived, per quarter			$ 750,000
Oaktree Strategic Income Corporation Merger \| Forecast
Related Party Transaction [Line Items]
Investment company, contractual fee waived						$ 750,000
Oaktree Strategic Income II, Inc. Merger
Related Party Transaction [Line Items]
Investment company, contractual fee waived		$ 9,000,000
Oaktree Strategic Income II, Inc Merger, Year One
Related Party Transaction [Line Items]
Investment company, contractual fee waived		6,000,000
Contractual fee waived, per quarter		1,500,000
Oaktree Strategic Income II, Inc Merger, Year Two
Related Party Transaction [Line Items]
Investment company, contractual fee waived		3,000,000
Contractual fee waived, per quarter		$ 750,000
Investment Advisory Agreement
Related Party Transaction [Line Items]
Number of components \| component							2
Related party transaction, termination, notice period							60 days
Base management fee							$ 38,200,000	39,400,000	36,600,000
Management incentive rate (as a percent)							1.50%
Investment Advisory Agreement \| Affiliated Entity
Related Party Transaction [Line Items]
Part I incentive fee							$ 30,300,000	35,800,000	26,600,000
Incentive fee expense							9,600,000		$ 8,800,000
Accrued capital gains incentive fees expensed (reversed)							$ 0	$ 0
Investment Advisory Agreement Incentive Rate Pre Incentive Fee Net Investment Income Below Catch Up
Related Party Transaction [Line Items]
Management incentive rate (as a percent)							100.00%
Investment Advisory Agreement Incentive Rate Quarterly Catch Up Threshold
Related Party Transaction [Line Items]
Management incentive rate (as a percent)							1.8182%
Investment Advisory Agreement Cumulative Pre Incentive Fee Net Investment Income
Related Party Transaction [Line Items]
Management incentive rate (as a percent)							17.50%
Investment Advisory Agreement - Incentive Rate, Realized Capital Gains \| Affiliated Entity
Related Party Transaction [Line Items]
Management incentive rate (as a percent)							17.50%

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Operating activities:
Net increase (decrease) in net assets resulting from operations	$ 57,905	$ 117,331	$ 29,223
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciation	(19,101)	28,555	136,248
Net realized (gains) losses	136,356	33,155	(17,179)
PIK interest income	(20,832)	(19,764)	(20,526)
Accretion of original issue discount on investments	(17,991)	(22,314)	(29,091)
Accretion of original issue discount on unsecured notes payable	1,304	783	679
Amortization of deferred financing costs	5,036	4,599	3,740
Deferred taxes	(5)	1,670	(973)
Purchases of investments	(1,281,419)	(742,144)	(702,063)
Proceeds from the sales and repayments of investments	1,086,222	911,975	693,745
Cash received in the OSI2 Merger	0	22,317	0
Changes in operating assets and liabilities:
(Increase) decrease in interest, dividends and fees receivable	1,641	578	(16,115)
(Increase) decrease in due from portfolio companies	(6,213)	16,283	(20,505)
(Increase) decrease in receivables from unsettled transactions	37,893	(50,742)	3,458
(Increase) decrease in due from broker	37,200	(8,730)	(43,890)
(Increase) decrease in other assets	906	14	619
Increase (decrease) in accounts payable, accrued expenses and other liabilities	(458)	(53,118)	677
Increase (decrease) in base management fee and incentive fee payable	(4,030)	(489)	(16,709)
Increase (decrease) in due to affiliate	(222)	408	(1,177)
Increase (decrease) in interest payable	224	4,379	3,339
Increase (decrease) in payables from unsettled transactions	4,660	(15,975)	18,895
Increase (decrease) in director fees payable	0	(9)	0
Net cash provided by (used in) operating activities	19,076	228,762	22,395
Financing activities:
Distributions paid in cash	(176,814)	(180,046)	(115,248)
Borrowings under credit facilities	255,000	572,000	300,000
Repayments of borrowings under credit facilities	(255,000)	(787,000)	(230,000)
Issuance of unsecured notes	0	296,511	0
Shares issued under the "at the market" offering	92,748	1,370	20,839
Repurchases of common stock under dividend reinvestment plan	(1,551)	(2,418)	(1,857)
Deferred financing costs paid	(1,039)	(10,596)	(334)
Deferred offering costs paid	(117)	(235)	(215)
Net cash provided by (used in) financing activities	(86,773)	(110,414)	(26,815)
Effect of exchange rate changes on foreign currency	701	827	(851)
Net increase (decrease) in cash and cash equivalents and restricted cash	(66,996)	119,175	(5,271)
Cash and cash equivalents and restricted cash, beginning of period	145,539	26,364	31,635
Cash and cash equivalents and restricted cash, end of period	78,543	145,539	26,364
Supplemental information:
Cash paid for interest	122,058	98,189	39,171
Non-cash financing activities:
Issuance of shares of common stock under dividend reinvestment plan	5,662	3,436	3,409
Deferred financing costs	1,000	442	0
Deferred offering costs	0	12	0
Issuance of shares in connection with the OSI2 Merger	0	334,034	0
Reconciliation to the Consolidated Statements of Assets and Liabilities
Cash and cash equivalents	63,966	136,450	23,528
Restricted cash	14,577	9,089	2,836
Total cash and cash equivalents and restricted cash	$ 78,543	$ 145,539	$ 26,364

Portfolio Investments - Portfolio Listing (Details)
€ in Thousands, £ in Thousands, $ in Thousands

12 Months Ended

Sep. 30, 2024

USD ($)

Sep. 30, 2023

USD ($)

Sep. 30, 2024

EUR (€)

Sep. 30, 2024

GBP (£)

Sep. 30, 2023

EUR (€)

Sep. 30, 2023

GBP (£)

Sep. 30, 2022

USD ($)

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, at cost

$ 3,144,919

$ 3,044,119

Investments at fair value

$ 3,021,279

$ 2,892,420

Minimum

Investment Company, Nonconsolidated Subsidiary [Line Items]

Debt instrument, floor interest rate (as a percent)

0.00%

Maximum

Investment Company, Nonconsolidated Subsidiary [Line Items]

Debt instrument, floor interest rate (as a percent)

3.00%

2.75%

3.00%

2.75%

SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 330,094

$ 332,637

Investment owned, at cost

337,882

331,808

Investments at fair value

$ 329,496

$ 322,179

SLF JV I | 30-Day SOFR

Investment Company, Nonconsolidated Subsidiary [Line Items]

Debt instrument, basis spread, variable rate (as a percent)

4.85%

5.32%

SLF JV I | 90-Day SOFR

Investment Company, Nonconsolidated Subsidiary [Line Items]

Debt instrument, basis spread, variable rate (as a percent)

4.59%

5.39%

SLF JV I | 30-Day LIBOR

Investment Company, Nonconsolidated Subsidiary [Line Items]

Debt instrument, basis spread, variable rate (as a percent)

5.43%

SLF JV I | Minimum

Investment Company, Nonconsolidated Subsidiary [Line Items]

Debt instrument, floor interest rate (as a percent)

0.00%

SLF JV I | Maximum

Investment Company, Nonconsolidated Subsidiary [Line Items]

Debt instrument, floor interest rate (as a percent)

2.00%

1.00%

2.00%

1.00%

OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 125,405

$ 130,589

Investment owned, at cost

127,867

127,788

Investments at fair value

$ 124,887

$ 123,343

OCSI Glick JV LLC | Minimum

Investment Company, Nonconsolidated Subsidiary [Line Items]

Debt instrument, floor interest rate (as a percent)

0.00%

OCSI Glick JV LLC | Maximum

Investment Company, Nonconsolidated Subsidiary [Line Items]

Debt instrument, floor interest rate (as a percent)

2.00%

1.00%

2.00%

1.00%

Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

13.00%

^{[1],[2],[3],[4]}

12.50%

^{[5],[6],[7],[8],[9]}

13.00%

^{[1],[2],[3],[4]}

13.00%

^{[1],[2],[3],[4]}

12.50%

^{[5],[6],[7],[8],[9]}

12.50%

^{[5],[6],[7],[8],[9]}

Investment, principal

$ 1,989

^{[1],[2],[3],[10]}

$ 1,269

^{[5],[6],[8],[11]}

Investment owned, at cost

1,985

^[1],[2],[3]

1,240

^[5],[6],[8]

Investments at fair value

$ 1,934

^[1],[2],[3]

$ 1,214

^[5],[6],[8]

Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

11.00%

^[1],[2],[4]

11.00%

^{[5],[7],[8],[9]}

11.00%

^[1],[2],[4]

11.00%

^[1],[2],[4]

11.00%

^{[5],[7],[8],[9]}

11.00%

^{[5],[7],[8],[9]}

Investment, principal

$ 31,231

^[1],[2],[10]

$ 18,869

^[5],[8],[11]

Investment owned, at cost

30,920

^[1],[2]

18,687

^[5],[8]

Investments at fair value

$ 31,015

^[1],[2]

$ 18,443

^[5],[8]

Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

13.00%

^{[1],[2],[3],[4]}

12.00%

^{[5],[6],[7],[8],[9]}

13.00%

^{[1],[2],[3],[4]}

13.00%

^{[1],[2],[3],[4]}

12.00%

^{[5],[6],[7],[8],[9]}

12.00%

^{[5],[6],[7],[8],[9]}

Investment, principal

$ 5,336

^{[1],[2],[3],[10]}

$ 4,070

^{[5],[6],[8],[11]}

Investment owned, at cost

5,332

^[1],[2],[3]

4,038

^[5],[6],[8]

Investments at fair value

$ 5,288

^[1],[2],[3]

$ 4,022

^[5],[6],[8]

Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

14.25%

^{[1],[4],[12],[13]}

14.25%

^{[7],[8],[9],[14],[15]}

14.25%

^{[1],[4],[12],[13]}

14.25%

^{[1],[4],[12],[13]}

14.25%

^{[7],[8],[9],[14],[15]}

14.25%

^{[7],[8],[9],[14],[15]}

Investment, principal

$ 21,870

^{[1],[10],[12],[13]}

$ 21,434

^{[8],[11],[14],[15]}

Investment owned, at cost

21,024

^{[1],[12],[13]}

21,612

^{[8],[14],[15]}

Investments at fair value

$ 21,979

^{[1],[12],[13]}

$ 21,220

^{[8],[14],[15]}

Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

22.50%

^{[1],[12],[16]}

20.00%

^[8],[14]

22.50%

^{[1],[12],[16]}

22.50%

^{[1],[12],[16]}

20.00%

^[8],[14]

20.00%

^[8],[14]

Investment, principal

$ 7,835

^{[1],[10],[12],[16]}

$ 6,021

^{[8],[11],[14]}

Investment owned, at cost

7,028

^{[1],[12],[16]}

6,013

^[8],[14]

Investments at fair value

$ 7,796

^{[1],[12],[16]}

$ 5,900

^[8],[14]

Investment, Identifier [Axis]: ACESO Holding 4 S.A.R.L., Health Care Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[12],[17]}

5.75%

Investment, principal

^{[1],[2],[10],[12],[17]}

$ 0

Investment owned, at cost

^{[1],[2],[12],[17]}

(47)

Investments at fair value

^{[1],[2],[12],[17]}

$ (47)

Investment, Identifier [Axis]: ACESO Holding 4 S.A.R.L., Health Care Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

5.75%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

8.91%

Investment, principal | €

^{[1],[10],[12],[17]}

€ 16,817

Investment owned, at cost

^{[1],[12],[17]}

$ 18,424

Investments at fair value

^{[1],[12],[17]}

$ 18,393

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[1],[17]

6.50%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[7],[8]

Investment, interest rate (as a percent)

11.37%

^[1],[4],[17]

11.90%

^[7],[8],[9]

11.37%

^[1],[4],[17]

11.37%

^[1],[4],[17]

11.90%

^[7],[8],[9]

11.90%

^[7],[8],[9]

Investment, principal

$ 3,079

^{[1],[10],[17]}

$ 3,446

^[7],[8],[11]

Investment owned, at cost

3,062

^[1],[17]

3,411

^[7],[8]

Investments at fair value

$ 2,955

^[1],[17]

$ 3,383

^[7],[8]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[1],[17]

6.50%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[7],[8]

Investment, interest rate (as a percent)

12.01%

^[1],[4],[17]

12.15%

^[7],[8],[9]

12.01%

^[1],[4],[17]

12.01%

^[1],[4],[17]

12.15%

^[7],[8],[9]

12.15%

^[7],[8],[9]

Investment, principal

$ 875

^{[1],[10],[17]}

$ 17,901

^[7],[8],[11]

Investment owned, at cost

868

^[1],[17]

17,743

^[7],[8]

Investments at fair value

$ 840

^[1],[17]

$ 17,575

^[7],[8]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[1],[17]

6.50%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[7],[8]

Investment, interest rate (as a percent)

11.37%

^[1],[4],[17]

12.13%

^[7],[8],[9]

11.37%

^[1],[4],[17]

11.37%

^[1],[4],[17]

12.13%

^[7],[8],[9]

12.13%

^[7],[8],[9]

Investment, principal

$ 16,053

^{[1],[10],[17]}

$ 963

^[7],[8],[11]

Investment owned, at cost

15,975

^[1],[17]

948

^[7],[8]

Investments at fair value

$ 15,410

^[1],[17]

$ 945

^[7],[8]

Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

Investment, interest rate (as a percent)

11.37%

11.90%

11.37%

11.90%

Investment, principal

$ 1,026

$ 1,149

Investment owned, at cost

1,019

1,135

Investments at fair value

$ 985

$ 1,128

Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

Investment, interest rate (as a percent)

11.37%

11.90%

11.37%

11.90%

Investment, principal

$ 3,359

$ 574

Investment owned, at cost

3,341

568

Investments at fair value

$ 3,225

$ 564

Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

Investment, interest rate (as a percent)

11.37%

12.15%

11.37%

12.15%

Investment, principal

$ 6,072

$ 6,771

Investment owned, at cost

6,038

6,701

Investments at fair value

$ 5,829

$ 6,648

Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

Investment, interest rate (as a percent)

11.37%

12.15%

11.37%

12.15%

Investment, principal

$ 513

$ 3,746

Investment owned, at cost

510

3,709

Investments at fair value

$ 493

$ 3,678

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[12]

1,674,030

Investment owned, at cost

^[12]

$ 0

Investments at fair value

^[12]

$ 0

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

7.50%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

12.25%

Investment, principal

^{[1],[10],[12],[17]}

$ 6,589

Investment owned, at cost

^{[1],[12],[17]}

6,353

Investments at fair value

^{[1],[12],[17]}

$ 6,424

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

7.50%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

13.04%

Investment, principal

^{[7],[8],[11],[14]}

$ 6,589

Investment owned, at cost

^[7],[8],[14]

6,305

Investments at fair value

^[7],[8],[14]

$ 6,276

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[5],[7],[8],[14]}

7.50%

Investment, principal

^{[5],[7],[8],[11],[14]}

$ 0

Investment owned, at cost

^{[5],[7],[8],[14]}

(38)

Investments at fair value

^{[5],[7],[8],[14]}

$ (38)

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

28,948

^[1],[12]

28,948

^[8],[14]

28,948

^[1],[12]

28,948

^[1],[12]

28,948

^[8],[14]

28,948

^[8],[14]

Investment owned, at cost

$ 174

^[1],[12]

$ 174

^[8],[14]

Investments at fair value

$ 33

^[1],[12]

$ 6

^[8],[14]

Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[14]

5.00%

Investment, interest rate (as a percent)

^[7],[9],[14]

8.86%

Investment, principal | €

^{[7],[11],[14]}

€ 5,500

Investment owned, at cost

^[7],[14]

$ 6,024

Investments at fair value

^[7],[14]

$ 5,825

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

17,870

^[1]

17,870

^[8]

17,870

^[1]

17,870

^[1]

17,870

^[8]

17,870

^[8]

Investment owned, at cost

$ 1,733

^[1]

$ 1,733

^[8]

Investments at fair value

$ 2,220

^[1]

$ 2,826

^[8]

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.75%

Investment, interest rate (as a percent)

^[7],[8],[9]

13.17%

Investment, principal

^[7],[8],[11]

$ 17,873

Investment owned, at cost

^[7],[8]

17,655

Investments at fair value

^[7],[8]

$ 17,687

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

11.29%

Investment, principal

$ 290

$ 0

Investment owned, at cost

284

(7)

Investments at fair value

$ 266

$ (29)

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

11.29%

Investment, principal

$ 120

$ 0

Investment owned, at cost

118

(3)

Investments at fair value

$ 110

$ (12)

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

11.52%

11.63%

11.52%

11.63%

Investment, principal

$ 4,092

$ 4,134

Investment owned, at cost

4,048

4,076

Investments at fair value

$ 3,896

$ 3,892

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

11.52%

11.63%

11.52%

11.63%

Investment, principal

$ 1,699

$ 1,716

Investment owned, at cost

1,681

1,692

Investments at fair value

$ 1,617

$ 1,616

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[1],[2],[12],[17]}

6.00%

^{[5],[7],[8],[14]}

6.00%

^{[1],[2],[12],[17]}

6.00%

^{[1],[2],[12],[17]}

6.00%

^{[5],[7],[8],[14]}

6.00%

^{[5],[7],[8],[14]}

Investment, interest rate (as a percent)

^{[1],[2],[4],[12],[17]}

11.29%

Investment, principal

$ 230

^{[1],[2],[10],[12],[17]}

$ 0

^{[5],[7],[8],[11],[14]}

Investment owned, at cost

220

^{[1],[2],[12],[17]}

(13)

^{[5],[7],[8],[14]}

Investments at fair value

$ 211

^{[1],[2],[12],[17]}

$ (23)

^{[5],[7],[8],[14]}

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[1],[12],[17]}

6.00%

^[7],[8],[14]

6.00%

^{[1],[12],[17]}

6.00%

^{[1],[12],[17]}

6.00%

^[7],[8],[14]

6.00%

^[7],[8],[14]

Investment, interest rate (as a percent)

10.66%

^{[1],[4],[12],[17]}

11.63%

^{[7],[8],[9],[14]}

10.66%

^{[1],[4],[12],[17]}

10.66%

^{[1],[4],[12],[17]}

11.63%

^{[7],[8],[9],[14]}

11.63%

^{[7],[8],[9],[14]}

Investment, principal

$ 3,243

^{[1],[10],[12],[17]}

$ 3,276

^{[7],[8],[11],[14]}

Investment owned, at cost

3,234

^{[1],[12],[17]}

3,267

^[7],[8],[14]

Investments at fair value

$ 3,087

^{[1],[12],[17]}

3,084

^[7],[8],[14]

Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^{[1],[12],[13]}

15.89%

Investment, principal

$ 12,989

^{[1],[10],[12],[13]}

12,222

^{[8],[11],[14],[15]}

Investment owned, at cost

13,013

^{[1],[12],[13]}

12,260

^{[8],[14],[15]}

Investments at fair value

$ 12,892

^{[1],[12],[13]}

$ 11,795

^{[8],[14],[15]}

Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[17]

5.00%

Investment, interest rate (as a percent)

^[4],[17]

10.25%

Investment, principal

^[10],[17]

$ 1,985

Investment owned, at cost

^[17]

1,975

Investments at fair value

^[17]

$ 1,996

Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.25%

10.32%

10.25%

10.32%

Investment, principal

$ 10,495

$ 8,596

Investment owned, at cost

10,404

8,503

Investments at fair value

$ 10,553

$ 8,499

Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.25%

10.32%

10.25%

10.32%

Investment, principal

$ 1,980

$ 2,000

Investment owned, at cost

1,948

1,960

Investments at fair value

$ 1,991

$ 1,978

Investment, Identifier [Axis]: Accession Risk Management Group, Inc., Insurance Brokers, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

4.75%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(5)

Investments at fair value

^[1],[2],[17]

$ (5)

Investment, Identifier [Axis]: Accession Risk Management Group, Inc., Insurance Brokers, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

4.75%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(48)

Investments at fair value

^[1],[2],[17]

$ (45)

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[2],[17]

6.00%

^[5],[7],[8]

6.00%

^[1],[2],[17]

6.00%

^[1],[2],[17]

6.00%

^[5],[7],[8]

6.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

10.90%

^{[1],[2],[4],[17]}

11.55%

^{[5],[7],[8],[9]}

10.90%

^{[1],[2],[4],[17]}

10.90%

^{[1],[2],[4],[17]}

11.55%

^{[5],[7],[8],[9]}

11.55%

^{[5],[7],[8],[9]}

Investment, principal

$ 2,482

^{[1],[2],[10],[17]}

$ 2,033

^{[5],[7],[8],[11]}

Investment owned, at cost

2,471

^[1],[2],[17]

2,013

^[5],[7],[8]

Investments at fair value

$ 2,443

^[1],[2],[17]

$ 2,027

^[5],[7],[8]

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[2],[17]

6.00%

^[7],[8]

6.00%

^[1],[2],[17]

6.00%

^[1],[2],[17]

6.00%

^[7],[8]

6.00%

^[7],[8]

Investment, interest rate (as a percent)

^[7],[8],[9]

11.55%

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 20,234

^[7],[8],[11]

Investment owned, at cost

(2)

^[1],[2],[17]

20,150

^[7],[8]

Investments at fair value

$ (59)

^[1],[2],[17]

$ 20,194

^[7],[8]

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[17]

6.00%

^[5],[7],[8]

6.00%

^[1],[17]

6.00%

^[1],[17]

6.00%

^[5],[7],[8]

6.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

^[1],[4],[17]

10.90%

Investment, principal

$ 20,024

^{[1],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

19,978

^[1],[17]

(2)

^[5],[7],[8]

Investments at fair value

$ 19,724

^[1],[17]

$ (8)

^[5],[7],[8]

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[1],[2],[17]

7.00%

^[5],[7],[8]

7.00%

^[1],[2],[17]

7.00%

^[1],[2],[17]

7.00%

^[5],[7],[8]

7.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

12.47%

^{[1],[2],[4],[17]}

12.72%

^{[5],[7],[8],[9]}

12.47%

^{[1],[2],[4],[17]}

12.47%

^{[1],[2],[4],[17]}

12.72%

^{[5],[7],[8],[9]}

12.72%

^{[5],[7],[8],[9]}

Investment, principal

$ 1,084

^{[1],[2],[10],[17]}

$ 1,333

^{[5],[7],[8],[11]}

Investment owned, at cost

1,078

^[1],[2],[17]

1,322

^[5],[7],[8]

Investments at fair value

$ 1,084

^[1],[2],[17]

$ 1,324

^[5],[7],[8]

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[1],[17]

7.00%

^[7],[8]

7.00%

^[1],[17]

7.00%

^[1],[17]

7.00%

^[7],[8]

7.00%

^[7],[8]

Investment, interest rate (as a percent)

12.46%

^[1],[4],[17]

12.34%

^[7],[8],[9]

12.46%

^[1],[4],[17]

12.46%

^[1],[4],[17]

12.34%

^[7],[8],[9]

12.34%

^[7],[8],[9]

Investment, principal

$ 6,400

^{[1],[10],[17]}

$ 6,400

^[7],[8],[11]

Investment owned, at cost

6,366

^[1],[17]

6,335

^[7],[8]

Investments at fair value

$ 6,400

^[1],[17]

$ 6,380

^[7],[8]

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[1],[17]

7.00%

^[7],[8]

7.00%

^[1],[17]

7.00%

^[1],[17]

7.00%

^[7],[8]

7.00%

^[7],[8]

Investment, interest rate (as a percent)

12.46%

^[1],[4],[17]

12.34%

^[7],[8],[9]

12.46%

^[1],[4],[17]

12.46%

^[1],[4],[17]

12.34%

^[7],[8],[9]

12.34%

^[7],[8],[9]

Investment, principal

$ 25,332

^{[1],[10],[17]}

$ 25,332

^[7],[8],[11]

Investment owned, at cost

25,309

^[1],[17]

25,288

^[7],[8]

Investments at fair value

$ 25,332

^[1],[17]

$ 25,253

^[7],[8]

Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

5,715

^[1]

5,715

^[8]

5,715

^[1]

5,715

^[1]

5,715

^[8]

5,715

^[8]

Investment owned, at cost

$ 90

^[1]

$ 90

^[8]

Investments at fair value

$ 0

^[1]

^[8]

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1]

11,499

Investment, principal

$ 0

Investment owned, at cost

^[1]

1,622

Investments at fair value

$ 1,622

^[1]

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

4.00%

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

8.70%

Investment, principal

^{[1],[2],[10],[17]}

$ 1,560

Investment owned, at cost

^[1],[2],[17]

1,520

Investments at fair value

$ 1,506

^[1],[2],[17]

$ 0

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[18]

8.50%

Investment, principal

^{[7],[8],[11],[18]}

$ 23,562

Investment owned, at cost

^[7],[8],[18]

22,795

Investments at fair value

^[7],[8],[18]

9,797

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

4.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

6.70%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

2.00%

Investment, principal

^{[1],[10],[17]}

$ 1,819

Investment owned, at cost

^[1],[17]

1,757

Investments at fair value

$ 1,741

^[1],[17]

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

7.70%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

2.00%

Investment, principal

^{[1],[10],[17]}

$ 3,637

Investment owned, at cost

^[1],[17]

3,493

Investments at fair value

$ 3,463

^[1],[17]

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1],[16]

10.00%

Investment, principal

^{[1],[10],[16]}

$ 3,541

Investment owned, at cost

^[1],[16]

3,026

Investments at fair value

$ 3,183

^[1],[16]

$ 0

Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

9.63%

Investment, principal

$ 2,969

Investment owned, at cost

2,853

Investments at fair value

$ 2,810

Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[9],[14]

5.50%

Investment, principal

^[11],[14]

$ 4,050

Investment owned, at cost

^[14]

3,577

Investments at fair value

^[14]

$ 2,918

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

11.50%

^[1],[17]

11.50%

^[7],[8]

11.50%

^[1],[17]

11.50%

^[1],[17]

11.50%

^[7],[8]

11.50%

^[7],[8]

Investment, interest rate (as a percent)

8.00%

^[1],[4],[17]

5.00%

^[7],[8],[9]

8.00%

^[1],[4],[17]

8.00%

^[1],[4],[17]

5.00%

^[7],[8],[9]

5.00%

^[7],[8],[9]

Investment, interest rate, paid in kind (as a percent)

8.93%

^[1],[17]

11.99%

^[7],[8]

8.93%

^[1],[17]

8.93%

^[1],[17]

11.99%

^[7],[8]

11.99%

^[7],[8]

Investment, principal

$ 10,134

^{[1],[10],[17]}

$ 9,057

^[7],[8],[11]

Investment owned, at cost

9,666

^[1],[17]

8,434

^[7],[8]

Investments at fair value

$ 9,120

^[1],[17]

$ 8,332

^[7],[8]

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

598,283

^[1]

598,283

^[8]

598,283

^[1]

598,283

^[1]

598,283

^[8]

598,283

^[8]

Investment owned, at cost

$ 642

^[1]

$ 642

^[8]

Investments at fair value

$ 802

^[1]

$ 1,915

^[8]

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

Investment, interest rate (as a percent)

12.45%

13.04%

12.45%

13.04%

Investment, principal

$ 8,329

$ 8,798

Investment owned, at cost

8,304

8,737

Investments at fair value

$ 7,663

$ 8,218

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

Investment, interest rate (as a percent)

12.45%

13.04%

12.45%

13.04%

Investment, principal

$ 5,897

$ 6,230

Investment owned, at cost

5,880

6,185

Investments at fair value

$ 5,426

$ 5,819

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[1],[17]

7.50%

^[7],[8]

7.50%

^[1],[17]

7.50%

^[1],[17]

7.50%

^[7],[8]

7.50%

^[7],[8]

Investment, interest rate (as a percent)

12.45%

^[1],[4],[17]

13.04%

^[7],[8],[9]

12.45%

^[1],[4],[17]

12.45%

^[1],[4],[17]

13.04%

^[7],[8],[9]

13.04%

^[7],[8],[9]

Investment, principal

$ 16,143

^{[1],[10],[17]}

$ 17,053

^[7],[8],[11]

Investment owned, at cost

16,115

^[1],[17]

16,982

^[7],[8]

Investments at fair value

$ 14,852

^[1],[17]

$ 15,929

^[7],[8]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

118,744

^[12]

471,253

^[14]

118,744

^[12]

118,744

^[12]

471,253

^[14]

471,253

^[14]

Investment owned, at cost

$ 206

^[12]

$ 849

^[14]

Investments at fair value

$ 1,413

^[12]

$ 4,298

^[14]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

70,820

^{[1],[12],[19]}

141,640

^{[8],[14],[20]}

70,820

^{[1],[12],[19]}

70,820

^{[1],[12],[19]}

141,640

^{[8],[14],[20]}

141,640

^{[8],[14],[20]}

Investment owned, at cost

$ 283

^{[1],[12],[19]}

$ 566

^{[8],[14],[20]}

Investments at fair value

$ 315

^{[1],[12],[19]}

$ 368

^{[8],[14],[20]}

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[8],[14]

3.50%

Investment, principal

^{[8],[11],[14]}

$ 28,464

Investment owned, at cost

^[8],[14]

28,329

Investments at fair value

^[8],[14]

$ 27,687

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[8],[14]

3.50%

Investment, principal

^{[8],[11],[14]}

$ 2,121

Investment owned, at cost

^[8],[14]

1,945

Investments at fair value

^[8],[14]

$ 2,063

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[8],[14]

3.50%

Investment, principal

^{[8],[11],[14]}

$ 27,692

Investment owned, at cost

^[8],[14]

27,582

Investments at fair value

^[8],[14]

$ 26,936

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[8],[14]

3.50%

Investment, principal

^{[8],[11],[14]}

$ 2,064

Investment owned, at cost

^[8],[14]

1,891

Investments at fair value

^[8],[14]

$ 2,007

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

8.75%

Investment, interest rate (as a percent)

^[7],[8],[9]

14.14%

Investment, principal

^[7],[8],[11]

$ 17,048

Investment owned, at cost

^[7],[8]

16,440

Investments at fair value

^[7],[8]

$ 15,087

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[17]

5.00%

Investment, interest rate (as a percent)

^[4],[17]

9.75%

Investment, principal

^[10],[17]

$ 2,487

Investment owned, at cost

^[17]

2,469

Investments at fair value

^[17]

$ 2,501

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

8.75%

Investment, interest rate (as a percent)

^[1],[4],[17]

13.50%

Investment, principal

^{[1],[10],[17]}

$ 17,048

Investment owned, at cost

^[1],[17]

16,556

Investments at fair value

^[1],[17]

$ 16,494

Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

9.43%

Investment, principal

$ 4,957

Investment owned, at cost

4,734

Investments at fair value

$ 4,614

Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

9.43%

Investment, principal

$ 2,478

Investment owned, at cost

2,367

Investments at fair value

$ 2,307

Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

6.25%

Investment, interest rate (as a percent)

^[7],[9]

11.81%

Investment, principal

^[7],[11]

$ 19,115

Investment owned, at cost

^[7]

18,278

Investments at fair value

^[7]

$ 16,798

Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

Investment, interest rate (as a percent)

11.81%

Investment, principal

$ 4,824

Investment owned, at cost

4,763

Investments at fair value

$ 4,239

Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

Investment, interest rate (as a percent)

11.81%

Investment, principal

$ 2,860

Investment owned, at cost

2,825

Investments at fair value

$ 2,514

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.15%

Investment, interest rate (as a percent)

9.54%

Investment, principal

$ 7,720

Investment owned, at cost

7,643

Investments at fair value

$ 7,720

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.15%

Investment, interest rate (as a percent)

9.54%

Investment, principal

$ 2,895

Investment owned, at cost

2,866

Investments at fair value

$ 2,895

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

8.00%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

13.54%

Investment, principal

^{[7],[8],[11],[14]}

$ 12,500

Investment owned, at cost

^[7],[8],[14]

12,188

Investments at fair value

^[7],[8],[14]

$ 11,865

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.50%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(98)

Investments at fair value

^[1],[2],[17]

$ 0

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.10%

Investment, principal

^{[1],[10],[17]}

$ 33,390

Investment owned, at cost

^[1],[17]

32,654

Investments at fair value

^[1],[17]

$ 33,390

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.50%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(60)

Investments at fair value

^[1],[2],[17]

$ 0

Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.42%

Investment, principal

$ 2,993

Investment owned, at cost

2,913

Investments at fair value

$ 2,997

Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

9.40%

Investment, principal

$ 1,523

Investment owned, at cost

1,191

Investments at fair value

$ 1,099

Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

9.40%

Investment, principal

$ 907

Investment owned, at cost

705

Investments at fair value

$ 654

Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

3.75%

Investment, interest rate (as a percent)

^[7],[9]

9.40%

Investment, principal

^[7],[11]

$ 3,700

Investment owned, at cost

^[7]

3,067

Investments at fair value

^[7]

$ 2,669

Investment, Identifier [Axis]: Anchorage Capital CLO 20, LTD., Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[17]

7.61%

Investment, interest rate (as a percent)

^{[4],[12],[17]}

12.89%

Investment, principal

^{[10],[12],[17]}

$ 750

Investment owned, at cost

^[12],[17]

715

Investments at fair value

^[12],[17]

$ 736

Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.35%

Investment, principal

^{[1],[10],[17]}

$ 47,451

Investment owned, at cost

^[1],[17]

46,877

Investments at fair value

^[1],[17]

$ 47,428

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

7.00%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

10.95%

Investment, principal | €

^{[7],[8],[11],[14]}

€ 3,017

Investment owned, at cost

^[7],[8],[14]

$ 3,331

Investments at fair value

^[7],[8],[14]

$ 3,226

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

5.75%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

11.57%

Investment, principal

^{[7],[8],[11],[14]}

$ 10,519

Investment owned, at cost

^[7],[8],[14]

10,400

Investments at fair value

^[7],[8],[14]

$ 10,624

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

7.00%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

12.46%

Investment, principal | £

^{[7],[8],[11],[14]}

£ 4,949

Investment owned, at cost

^[7],[8],[14]

$ 6,318

Investments at fair value

^[7],[8],[14]

$ 6,101

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

7.00%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

12.46%

Investment, principal | £

^{[7],[8],[11],[14]}

£ 23,675

Investment owned, at cost

^[7],[8],[14]

$ 28,713

Investments at fair value

^[7],[8],[14]

$ 29,185

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

5.75%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

9.70%

Investment, principal | £

^{[7],[8],[11],[14]}

£ 3,649

Investment owned, at cost

^[7],[8],[14]

$ 4,094

Investments at fair value

^[7],[8],[14]

$ 3,914

Investment, Identifier [Axis]: Ares XLIV CLO, Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[17]

7.13%

Investment, interest rate (as a percent)

^{[4],[12],[17]}

12.43%

Investment, principal

^{[10],[12],[17]}

$ 3,500

Investment owned, at cost

^[12],[17]

3,399

Investments at fair value

^[12],[17]

$ 3,509

Investment, Identifier [Axis]: Artera Services LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

Investment, interest rate (as a percent)

9.10%

Investment, principal

$ 7,961

Investment owned, at cost

7,902

Investments at fair value

$ 7,781

Investment, Identifier [Axis]: Artera Services LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

Investment, interest rate (as a percent)

9.10%

Investment, principal

$ 3,485

Investment owned, at cost

3,459

Investments at fair value

$ 3,406

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Advertising, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.75%

Investment, interest rate (as a percent)

12.14%

Investment, principal

$ 21,852

Investments at fair value

$ 21,823

$ 24,225

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

12,463,242

^[1]

1,783,332

^[8]

12,463,242

^[1]

12,463,242

^[1]

1,783,332

^[8]

1,783,332

^[8]

Investment, principal

Investment owned, at cost

$ 1,963

^[1]

804

^[8]

Investments at fair value

1,246

^[1]

$ 89

^[8]

370

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[5],[7],[8]

6.75%

Investment, interest rate (as a percent)

^{[5],[7],[8],[9]}

12.14%

Investment, principal

^{[5],[7],[8],[11]}

$ 21,852

Investment owned, at cost

^[5],[7],[8]

21,855

Investments at fair value

$ 21,823

^[5],[7],[8]

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8]

1,129,453

Investment, principal

Investment owned, at cost

^[8]

1,159

Investments at fair value

$ 0

$ 1,005

^[8]

1,223

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

78,045

^[1]

78,045

^[8]

78,045

^[1]

78,045

^[1]

78,045

^[8]

78,045

^[8]

Investment, principal

Investment owned, at cost

$ 0

^[1]

^[8]

Investments at fair value

$ 0

^[1]

$ 0

^[8]

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

5.25%

Investment, interest rate (as a percent)

^[7],[9]

10.90%

Investment, principal

^[7],[11]

$ 8,490

Investment owned, at cost

^[7]

8,168

Investments at fair value

^[7]

$ 6,414

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[17]

6.75%

Investment, interest rate (as a percent)

^[4],[17]

11.35%

Investment, principal

^[10],[17]

$ 7,907

Investment owned, at cost

^[17]

7,816

Investments at fair value

^[17]

$ 6,555

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[16],[17]}

5.25%

Investment, principal

^{[1],[10],[16],[17]}

$ 12,537

Investment owned, at cost

^{[1],[16],[17]}

10,187

Investments at fair value

^{[1],[16],[17]}

$ 3,605

Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

10.90%

Investment, principal

$ 5,052

Investment owned, at cost

4,888

Investments at fair value

$ 3,817

Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

10.90%

Investment, principal

$ 2,078

Investment owned, at cost

2,039

Investments at fair value

$ 1,570

Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan 1 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.75%

Investment, interest rate (as a percent)

11.35%

Investment, principal

$ 2,546

Investment owned, at cost

2,517

Investments at fair value

$ 2,111

Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan 1 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.75%

Investment, interest rate (as a percent)

11.35%

Investment, principal

$ 1,047

Investment owned, at cost

1,035

Investments at fair value

$ 868

Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan 2 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

Investment, principal

$ 4,037

Investment owned, at cost

3,877

Investments at fair value

$ 1,161

Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan 2 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, principal

$ 1,661

Investment owned, at cost

1,619

Investments at fair value

$ 477

Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

8.95%

9.42%

8.95%

9.42%

Investment, principal

$ 7,775

$ 4,950

Investment owned, at cost

7,589

4,747

Investments at fair value

$ 7,660

$ 4,809

Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

8.95%

9.42%

8.95%

9.42%

Investment, principal

$ 3,149

$ 1,980

Investment owned, at cost

3,073

1,899

Investments at fair value

$ 3,102

$ 1,924

Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.25%

Investment, interest rate (as a percent)

9.20%

9.67%

9.20%

9.67%

Investment, principal

$ 1,970

$ 1,990

Investment owned, at cost

1,886

1,884

Investments at fair value

$ 1,944

$ 1,937

Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.25%

Investment, interest rate (as a percent)

9.20%

9.67%

9.20%

9.67%

Investment, principal

$ 985

$ 995

Investment owned, at cost

943

942

Investments at fair value

$ 972

$ 968

Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

10.68%

Investment, principal

$ 4,346

Investment owned, at cost

4,036

Investments at fair value

$ 3,871

Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

10.68%

Investment, principal

$ 2,423

Investment owned, at cost

2,244

Investments at fair value

$ 2,158

Investment, Identifier [Axis]: Aurelia Netherlands Midco 2 B.V., Interactive Media & Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

5.75%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

9.55%

Investment, principal | €

^{[1],[10],[12],[17]}

€ 28,022

Investment owned, at cost

^{[1],[12],[17]}

$ 29,727

Investments at fair value

^{[1],[12],[17]}

$ 30,698

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^{[1],[12],[17]}

6.00%

^[7],[8],[14]

7.00%

^{[1],[12],[17]}

7.00%

^{[1],[12],[17]}

6.00%

^[7],[8],[14]

6.00%

^[7],[8],[14]

Investment, interest rate (as a percent)

7.70%

^{[1],[4],[12],[17]}

11.49%

^{[7],[8],[9],[14]}

7.70%

^{[1],[4],[12],[17]}

7.70%

^{[1],[4],[12],[17]}

11.49%

^{[7],[8],[9],[14]}

11.49%

^{[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

^{[1],[12],[17]}

4.00%

Investment, principal

$ 30,724

^{[1],[10],[12],[17]}

$ 29,509

^{[7],[8],[11],[14]}

Investment owned, at cost

30,169

^{[1],[12],[17]}

29,164

^[7],[8],[14]

Investments at fair value

$ 29,802

^{[1],[12],[17]}

$ 28,284

^[7],[8],[14]

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

6.00%

7.00%

6.00%

Investment, interest rate (as a percent)

7.70%

11.49%

7.70%

11.49%

Investment, interest rate, paid in kind (as a percent)

4.00%

Investment, principal

$ 6,548

$ 6,289

Investment owned, at cost

6,430

6,216

Investments at fair value

$ 6,351

$ 6,028

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

6.00%

7.00%

6.00%

Investment, interest rate (as a percent)

7.70%

11.49%

7.70%

11.49%

Investment, interest rate, paid in kind (as a percent)

4.00%

Investment, principal

$ 3,778

$ 3,628

Investment owned, at cost

3,710

3,586

Investments at fair value

$ 3,664

$ 3,478

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^[1],[2],[17]

7.25%

^[5],[7],[8]

6.25%

^[1],[2],[17]

6.25%

^[1],[2],[17]

7.25%

^[5],[7],[8]

7.25%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

(86)

^[1],[2],[17]

(108)

^[5],[7],[8]

Investments at fair value

$ 0

^[1],[2],[17]

$ (78)

^[5],[7],[8]

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^[1],[17]

7.25%

^[7],[8]

6.25%

^[1],[17]

6.25%

^[1],[17]

7.25%

^[7],[8]

7.25%

^[7],[8]

Investment, interest rate (as a percent)

10.85%

^[1],[4],[17]

12.64%

^[7],[8],[9]

10.85%

^[1],[4],[17]

10.85%

^[1],[4],[17]

12.64%

^[7],[8],[9]

12.64%

^[7],[8],[9]

Investment, principal

$ 50,470

^{[1],[10],[17]}

$ 50,470

^[7],[8],[11]

Investment owned, at cost

49,836

^[1],[17]

49,679

^[7],[8]

Investments at fair value

$ 50,470

^[1],[17]

$ 49,688

^[7],[8]

Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

9.87%

10.65%

9.87%

10.65%

Investment, principal

$ 1,735

$ 1,753

Investment owned, at cost

1,724

1,742

Investments at fair value

$ 1,633

$ 1,711

Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

9.87%

10.65%

9.87%

10.65%

Investment, principal

$ 3,328

$ 3,363

Investment owned, at cost

3,298

3,332

Investments at fair value

$ 3,133

$ 3,282

Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

9.87%

10.65%

9.87%

10.65%

Investment, principal

$ 6,242

$ 6,306

Investment owned, at cost

6,183

6,247

Investments at fair value

$ 5,875

$ 6,155

Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

9.87%

10.65%

9.87%

10.65%

Investment, principal

$ 792

$ 800

Investment owned, at cost

787

795

Investments at fair value

$ 745

$ 780

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[1],[17]

5.00%

^[7],[8]

5.00%

^[1],[17]

5.00%

^[1],[17]

5.00%

^[7],[8]

5.00%

^[7],[8]

Investment, interest rate (as a percent)

9.87%

^[1],[4],[17]

10.65%

^[7],[8],[9]

9.87%

^[1],[4],[17]

9.87%

^[1],[4],[17]

10.65%

^[7],[8],[9]

10.65%

^[7],[8],[9]

Investment, principal

$ 3,214

^{[1],[10],[17]}

$ 3,247

^[7],[8],[11]

Investment owned, at cost

3,183

^[1],[17]

3,216

^[7],[8]

Investments at fair value

$ 3,025

^[1],[17]

$ 3,169

^[7],[8]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[1],[17]

5.00%

^[7],[8]

5.00%

^[1],[17]

5.00%

^[1],[17]

5.00%

^[7],[8]

5.00%

^[7],[8]

Investment, interest rate (as a percent)

9.87%

^[1],[4],[17]

10.65%

^[7],[8],[9]

9.87%

^[1],[4],[17]

9.87%

^[1],[4],[17]

10.65%

^[7],[8],[9]

10.65%

^[7],[8],[9]

Investment, principal

$ 1,248

^{[1],[10],[17]}

$ 1,261

^[7],[8],[11]

Investment owned, at cost

1,254

^[1],[17]

1,269

^[7],[8]

Investments at fair value

$ 1,175

^[1],[17]

$ 1,231

^[7],[8]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[1],[17]

8.50%

^[7],[8]

8.50%

^[1],[17]

8.50%

^[1],[17]

8.50%

^[7],[8]

8.50%

^[7],[8]

Investment, interest rate (as a percent)

13.35%

^[1],[4],[17]

14.15%

^[7],[8],[9]

13.35%

^[1],[4],[17]

13.35%

^[1],[4],[17]

14.15%

^[7],[8],[9]

14.15%

^[7],[8],[9]

Investment, principal

$ 6,452

^{[1],[10],[17]}

$ 8,920

^[7],[8],[11]

Investment owned, at cost

6,386

^[1],[17]

8,819

^[7],[8]

Investments at fair value

$ 5,550

^[1],[17]

$ 8,492

^[7],[8]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[1],[17]

8.50%

^[7],[8]

8.50%

^[1],[17]

8.50%

^[1],[17]

8.50%

^[7],[8]

8.50%

^[7],[8]

Investment, interest rate (as a percent)

13.37%

^[1],[4],[17]

14.15%

^[7],[8],[9]

13.37%

^[1],[4],[17]

13.37%

^[1],[4],[17]

14.15%

^[7],[8],[9]

14.15%

^[7],[8],[9]

Investment, principal

$ 8,920

^{[1],[10],[17]}

$ 2,091

^[7],[8],[11]

Investment owned, at cost

8,817

^[1],[17]

2,068

^[7],[8]

Investments at fair value

$ 7,673

^[1],[17]

$ 1,991

^[7],[8]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

8.50%

Investment, interest rate (as a percent)

^[7],[8],[9]

14.15%

Investment, principal

^[7],[8],[11]

$ 4,361

Investment owned, at cost

^[7],[8]

4,297

Investments at fair value

^[7],[8]

$ 4,152

Investment, Identifier [Axis]: Bausch + Lomb Corporation, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.25%

Investment, interest rate (as a percent)

8.27%

Investment, principal

$ 9,173

Investment owned, at cost

9,017

Investments at fair value

$ 9,151

Investment, Identifier [Axis]: Bausch + Lomb Corporation, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.25%

Investment, interest rate (as a percent)

8.27%

Investment, principal

$ 3,718

Investment owned, at cost

3,657

Investments at fair value

$ 3,710

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[1],[2],[17]

4.50%

^[5],[7],[8]

5.50%

^[1],[2],[17]

5.50%

^[1],[2],[17]

4.50%

^[5],[7],[8]

4.50%

^[5],[7],[8]

Investment, interest rate (as a percent)

10.52%

^{[1],[2],[4],[17]}

13.00%

^{[5],[7],[8],[9]}

10.52%

^{[1],[2],[4],[17]}

10.52%

^{[1],[2],[4],[17]}

13.00%

^{[5],[7],[8],[9]}

13.00%

^{[5],[7],[8],[9]}

Investment, principal

$ 2,835

^{[1],[2],[10],[17]}

$ 2,221

^{[5],[7],[8],[11]}

Investment owned, at cost

2,813

^[1],[2],[17]

2,188

^[5],[7],[8]

Investments at fair value

$ 2,811

^[1],[2],[17]

$ 2,178

^[5],[7],[8]

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[1],[17]

5.50%

^[7],[8]

5.50%

^[1],[17]

5.50%

^[1],[17]

5.50%

^[7],[8]

5.50%

^[7],[8]

Investment, interest rate (as a percent)

10.90%

^[1],[4],[17]

11.02%

^[7],[8],[9]

10.90%

^[1],[4],[17]

10.90%

^[1],[4],[17]

11.02%

^[7],[8],[9]

11.02%

^[7],[8],[9]

Investment, principal

$ 40,246

^{[1],[10],[17]}

$ 40,660

^[7],[8],[11]

Investment owned, at cost

40,085

^[1],[17]

40,440

^[7],[8]

Investments at fair value

$ 39,863

^[1],[17]

$ 40,213

^[7],[8]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[12],[17]}

7.50%

Investment, interest rate (as a percent)

^{[1],[2],[4],[12],[17]}

8.00%

^{[7],[8],[9],[14]}

^{[1],[2],[4],[12],[17]}

8.00%

^{[7],[8],[9],[14]}

8.00%

^{[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

^[8],[14]

2.25%

Investment, principal

$ 0

^{[1],[2],[10],[12],[17]}

$ 6,757

^{[8],[11],[14]}

Investment owned, at cost

^{[1],[2],[12],[17]}

6,560

^[8],[14]

Investments at fair value

$ 0

^{[1],[2],[12],[17]}

6,225

^[8],[14]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

7.50%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

8.00%

Investment, interest rate, paid in kind (as a percent)

^{[1],[12],[17]}

4.10%

Investment, principal

$ 2,930

^{[1],[10],[12],[17]}

3,316

^{[5],[8],[11],[14],[15]}

Investment owned, at cost

2,928

^{[1],[12],[17]}

3,335

^{[5],[8],[14],[15]}

Investments at fair value

$ 2,600

^{[1],[12],[17]}

$ 3,169

^{[5],[8],[14],[15]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

7.50%

Investment, interest rate (as a percent)

8.00%

^{[1],[4],[12],[17]}

8.00%

^{[5],[7],[8],[9],[14]}

8.00%

^{[1],[4],[12],[17]}

8.00%

^{[1],[4],[12],[17]}

8.00%

^{[5],[7],[8],[9],[14]}

8.00%

^{[5],[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

4.10%

^{[1],[12],[17]}

2.25%

^[5],[8],[14]

4.10%

^{[1],[12],[17]}

4.10%

^{[1],[12],[17]}

2.25%

^[5],[8],[14]

2.25%

^[5],[8],[14]

Investment, principal

$ 7,062

^{[1],[10],[12],[17]}

$ 0

^{[5],[8],[11],[14]}

Investment owned, at cost

6,921

^{[1],[12],[17]}

^[5],[8],[14]

Investments at fair value

$ 6,268

^{[1],[12],[17]}

$ 0

^[5],[8],[14]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[12],[17]}

7.50%

Investment, interest rate (as a percent)

^{[5],[7],[8],[9],[14]}

8.00%

Investment, interest rate, paid in kind (as a percent)

^[5],[8],[14]

2.25%

Investment, principal

$ 0

^{[1],[2],[10],[12],[17]}

$ 0

^{[5],[8],[11],[14]}

Investment owned, at cost

^{[1],[2],[12],[17]}

^[5],[8],[14]

Investments at fair value

$ 0

^{[1],[2],[12],[17]}

^[5],[8],[14]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[12],[17]}

7.50%

Investment, principal

$ 0

^{[1],[2],[10],[12],[17]}

^{[5],[8],[11],[14],[15]}

Investment owned, at cost

^{[1],[2],[12],[17]}

^{[5],[8],[14],[15]}

Investments at fair value

$ 0

^{[1],[2],[12],[17]}

^{[5],[8],[14],[15]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[5],[8],[11],[14],[15]}

Investment owned, at cost

^{[5],[8],[14],[15]}

Investments at fair value

^{[5],[8],[14],[15]}

$ 0

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8],[14]

26,131

Investment owned, at cost

^[8],[14]

$ 225

Investments at fair value

^[8],[14]

$ 3

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1],[12]

32,664

Investment owned, at cost

^[1],[12]

$ 225

Investments at fair value

^[1],[12]

$ 10

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1],[12]

9,382

Investment owned, at cost

^[1],[12]

$ 0

Investments at fair value

^[1],[12]

$ 3

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[17]

5.00%

Investment, interest rate (as a percent)

^[4],[17]

9.85%

Investment, principal

^[10],[17]

$ 19,336

Investment owned, at cost

^[17]

18,991

Investments at fair value

^[17]

$ 19,444

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

7.00%

Investment, interest rate (as a percent)

^[7],[9]

12.43%

Investment, principal

^[7],[11]

$ 30,625

Investment owned, at cost

^[7]

30,370

Investments at fair value

^[7]

$ 29,989

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

394,297

^[1]

394,297

^[8]

394,297

^[1]

394,297

^[1]

394,297

^[8]

394,297

^[8]

Investment owned, at cost

$ 424

^[1]

$ 424

^[8]

Investments at fair value

$ 79

^[1]

$ 158

^[8]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[8],[9]

9.00%

Investment, principal

^[8],[11]

$ 5,257

Investment owned, at cost

^[8]

5,258

Investments at fair value

^[8]

$ 5,251

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

1,708,618

^[1]

1,708,618

^[8]

1,708,618

^[1]

1,708,618

^[1]

1,708,618

^[8]

1,708,618

^[8]

Investment owned, at cost

$ 1,711

^[1]

$ 1,711

^[8]

Investments at fair value

$ 2,136

^[1]

$ 1,999

^[8]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

394,297

^[1]

394,297

^[8]

394,297

^[1]

394,297

^[1]

394,297

^[8]

394,297

^[8]

Investment owned, at cost

$ 395

^[1]

$ 395

^[8]

Investments at fair value

$ 477

^[1]

$ 442

^[8]

Investment, Identifier [Axis]: Boxer Parent Company Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

9.01%

Investment, principal

$ 8,000

Investment owned, at cost

7,983

Investments at fair value

$ 7,994

Investment, Identifier [Axis]: Boxer Parent Company Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

9.01%

Investment, principal

$ 3,000

Investment owned, at cost

2,993

Investments at fair value

$ 2,998

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

171,000

171

171,000

171

Investment owned, at cost

$ 0

Investments at fair value

$ 0

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

829

^[1]

829

^[8]

829

^[1]

829

^[1]

829

^[8]

829

^[8]

Investment owned, at cost

$ 0

^[1]

$ 0

^[8]

Investments at fair value

$ 0

^[1]

$ 0

^[8]

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

34,984,460

^[1]

34,984,460

^[8]

34,984,460

^[1]

34,984,460

^[1]

34,984,460

^[8]

34,984,460

^[8]

Investment owned, at cost

$ 34,984

^[1]

$ 34,984

^[8]

Investments at fair value

$ 27,638

^[1]

$ 27,638

^[8]

27,638

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

7,193,540,000

7,193,540

7,193,540,000

7,193,540

Investment owned, at cost

$ 7,194

Investments at fair value

$ 5,683

Investment, Identifier [Axis]: CBAM 2017-2, LTD., Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[17]

7.36%

Investment, interest rate (as a percent)

^{[4],[12],[17]}

12.65%

Investment, principal

^{[10],[12],[17]}

$ 489

Investment owned, at cost

^[12],[17]

458

Investments at fair value

^[12],[17]

$ 462

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[17]

5.75%

Investment, interest rate (as a percent)

^{[4],[12],[17]}

10.95%

Investment, principal | £

^{[10],[12],[17]}

£ 14,807

Investment owned, at cost

^[12],[17]

$ 18,480

Investments at fair value

^[12],[17]

$ 19,878

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[17]

5.50%

Investment, interest rate (as a percent)

^{[4],[12],[17]}

10.45%

Investment, principal

^{[10],[12],[17]}

$ 14,725

Investment owned, at cost

^[12],[17]

18,330

Investments at fair value

^[12],[17]

$ 19,782

Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[18]

7.75%

Investment, principal

^{[7],[8],[11],[18]}

$ 727

Investment owned, at cost

^[7],[8],[18]

462

Investments at fair value

^[7],[8],[18]

$ 396

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

6.50%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.07%

Investment, principal

^[7],[8],[11]

$ 37

Investment owned, at cost

^[7],[8]

Investments at fair value

^[7],[8]

$ 37

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

6.50%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.07%

Investment, principal

^[7],[8],[11]

$ 3,031

Investment owned, at cost

^[7],[8]

2,899

Investments at fair value

^[7],[8]

$ 3,031

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

6.50%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.07%

Investment, principal

^[7],[8],[11]

$ 1,557

Investment owned, at cost

^[7],[8]

1,489

Investments at fair value

^[7],[8]

$ 1,557

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

6.50%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.07%

Investment, principal

^[7],[8],[11]

$ 1,024

Investment owned, at cost

^[7],[8]

994

Investments at fair value

^[7],[8]

$ 1,024

Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

1,080,398

^[1]

1,080,399

^[8]

1,080,398

^[1]

1,080,398

^[1]

1,080,399

^[8]

1,080,399

^[8]

Investment, principal

Investment owned, at cost

$ 875

^[1]

1,080

^[8]

Investments at fair value

$ 594

^[1]

$ 432

^[8]

378

Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

11.57%

Investment, principal

$ 600

Investment owned, at cost

592

Investments at fair value

$ 581

Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver 1 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

11.50%

Investment, principal

$ 600

Investment owned, at cost

594

Investments at fair value

$ 447

Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver 2 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

12.02%

Investment, principal

$ 2

Investment owned, at cost

Investments at fair value

$ 1

Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

11.16%

11.55%

11.16%

11.55%

Investment, principal

$ 2,348

$ 2,354

Investment owned, at cost

2,325

2,322

Investments at fair value

$ 1,751

$ 2,281

Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

12.27%

11.55%

12.27%

11.55%

Investment, principal

$ 1,976

$ 1,983

Investment owned, at cost

1,955

1,954

Investments at fair value

$ 1,474

$ 1,921

Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 3 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

11.16%

11.55%

11.16%

11.55%

Investment, principal

$ 1,955

$ 1,960

Investment owned, at cost

1,936

1,935

Investments at fair value

$ 1,458

$ 1,899

Investment, Identifier [Axis]: Centralsquare Technologies, LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

6.00%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(33)

Investments at fair value

^[1],[2],[17]

$ (15)

Investment, Identifier [Axis]: Centralsquare Technologies, LLC, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

6.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

8.10%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

3.50%

Investment, principal

^{[1],[10],[17]}

$ 12,830

Investment owned, at cost

^[1],[17]

12,539

Investments at fair value

^[1],[17]

$ 12,694

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[9],[14]

7.50%

Investment, principal

^[11],[14]

$ 2,632

Investment owned, at cost

^[14]

2,632

Investments at fair value

^[14]

$ 2,017

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[9],[14]

7.75%

Investment, principal

^[11],[14]

$ 176

Investment owned, at cost

^[14]

170

Investments at fair value

^[14]

$ 141

Investment, Identifier [Axis]: Cloud Software Group, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

8.60%

Investment, principal

$ 8,153

Investment owned, at cost

7,621

Investments at fair value

$ 8,129

Investment, Identifier [Axis]: Cloud Software Group, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

8.60%

Investment, principal

$ 2,621

Investment owned, at cost

2,456

Investments at fair value

$ 2,613

Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[9]

7.38%

Investment, principal

^[11]

$ 8,420

Investment owned, at cost

8,261

Investments at fair value

7,059

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1]

22,267,661

Investment owned, at cost

^[1]

$ 16,172

Investments at fair value

$ 12,247

^[1]

$ 0

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[18]

8.50%

Investment, principal

^{[7],[8],[11],[18]}

$ 22,084

Investment owned, at cost

^[7],[8],[18]

21,336

Investments at fair value

^[7],[8],[18]

16,040

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1]

3,137,476

Investment owned, at cost

^[1]

$ 3,137

Investments at fair value

$ 3,357

^[1]

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, at cost

^[8]

706

Investments at fair value

^[8]

$ 0

Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

417,851

^[1]

417,851

^[8]

417,851

^[1]

417,851

^[1]

417,851

^[8]

417,851

^[8]

Investment owned, at cost

$ 605

^[1]

$ 605

^[8]

Investments at fair value

$ 894

^[1]

$ 894

^[8]

Investment, Identifier [Axis]: CoreRx, Inc., Pharmaceuticals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

7.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

12.10%

Investment, principal

^{[1],[10],[17]}

$ 6,494

Investment owned, at cost

^[1],[17]

6,347

Investments at fair value

^[1],[17]

$ 6,348

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[1],[2],[17]

7.50%

^[5],[7],[8]

5.50%

^[1],[2],[17]

5.50%

^[1],[2],[17]

7.50%

^[5],[7],[8]

7.50%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

(17)

^[1],[2],[17]

(20)

^[5],[7],[8]

Investments at fair value

$ 0

^[1],[2],[17]

$ (20)

^[5],[7],[8]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[1],[2],[17]

7.50%

^[7],[8]

5.50%

^[1],[2],[17]

5.50%

^[1],[2],[17]

7.50%

^[7],[8]

7.50%

^[7],[8]

Investment, interest rate (as a percent)

^[7],[8],[9]

12.82%

Investment, principal

^[7],[8],[11]

$ 13,157

Investment owned, at cost

$ (15)

^[1],[2],[17]

12,855

^[7],[8]

Investments at fair value

$ 0

^[1],[2],[17]

$ 12,858

^[7],[8]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[1],[17]

7.50%

^[5],[7],[8]

5.50%

^[1],[17]

5.50%

^[1],[17]

7.50%

^[5],[7],[8]

7.50%

^[5],[7],[8]

Investment, interest rate (as a percent)

^[1],[4],[17]

10.75%

Investment, principal

$ 13,124

^{[1],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

12,870

^[1],[17]

(15)

^[5],[7],[8]

Investments at fair value

$ 13,124

^[1],[17]

$ (13)

^[5],[7],[8]

Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

9.60%

10.39%

9.60%

10.39%

Investment, principal

$ 7,765

$ 6,343

Investment owned, at cost

7,428

5,983

Investments at fair value

$ 7,381

$ 6,285

Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

9.60%

10.39%

9.60%

10.39%

Investment, principal

$ 2,570

$ 2,766

Investment owned, at cost

2,446

2,607

Investments at fair value

$ 2,443

$ 2,741

Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[17]

5.00%

^[7]

5.00%

^[17]

5.00%

^[17]

5.00%

^[7]

5.00%

^[7]

Investment, interest rate (as a percent)

9.60%

^[4],[17]

10.39%

^[7],[9]

9.60%

^[4],[17]

9.60%

^[4],[17]

10.39%

^[7],[9]

10.39%

^[7],[9]

Investment, principal

$ 10,878

^[10],[17]

$ 14,750

^[7],[11]

Investment owned, at cost

10,518

^[17]

14,173

^[7]

Investments at fair value

$ 10,341

^[17]

$ 14,616

^[7]

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[5],[7],[8]

6.00%

Investment, interest rate (as a percent)

^{[5],[7],[8],[9]}

11.47%

Investment, principal

^{[5],[7],[8],[11]}

$ 933

Investment owned, at cost

^[5],[7],[8]

920

Investments at fair value

^[5],[7],[8]

$ 918

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

6.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

11.52%

Investment, principal

^[7],[8],[11]

$ 18,013

Investment owned, at cost

^[7],[8]

17,690

Investments at fair value

^[7],[8]

$ 17,812

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

6.75%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(48)

Investments at fair value

^[1],[2],[17]

$ (31)

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

6.75%

Investment, interest rate (as a percent)

^[1],[4],[17]

11.35%

Investment, principal

^{[1],[10],[17]}

$ 20,924

Investment owned, at cost

^[1],[17]

20,468

Investments at fair value

^[1],[17]

$ 20,627

Investment, Identifier [Axis]: Crown Subsea Communications Holding, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

9.25%

Investment, principal

$ 7,980

Investment owned, at cost

7,900

Investments at fair value

$ 8,039

Investment, Identifier [Axis]: Crown Subsea Communications Holding, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

9.25%

Investment, principal

$ 2,993

Investment owned, at cost

2,963

Investments at fair value

$ 3,015

Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

4.50%

4.00%

4.50%

Investment, interest rate (as a percent)

8.60%

9.89%

8.60%

9.89%

Investment, principal

$ 8,643

$ 8,730

Investment owned, at cost

8,559

8,642

Investments at fair value

$ 8,684

$ 8,730

Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

4.50%

4.00%

4.50%

Investment, interest rate (as a percent)

8.60%

9.89%

8.60%

9.89%

Investment, principal

$ 2,813

$ 2,841

Investment owned, at cost

2,792

2,820

Investments at fair value

$ 2,826

$ 2,841

Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

Investment, interest rate (as a percent)

9.60%

10.12%

9.60%

10.12%

Investment, principal

$ 9,029

$ 7,920

Investment owned, at cost

8,913

7,792

Investments at fair value

$ 9,076

$ 7,729

Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

Investment, interest rate (as a percent)

9.60%

10.12%

9.60%

10.12%

Investment, principal

$ 3,534

$ 2,970

Investment owned, at cost

3,488

2,922

Investments at fair value

$ 3,553

$ 2,899

Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

4.75%

Investment, interest rate (as a percent)

^[7],[9]

10.12%

Investment, principal

^[7],[11]

$ 4,950

Investment owned, at cost

^[7]

4,871

Investments at fair value

^[7]

$ 4,831

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1],[12]

^[8],[14]

^[1],[12]

^[8],[14]

Investment owned, at cost

$ 2

^[1],[12]

$ 2

^[8],[14]

Investments at fair value

$ 2

^[1],[12]

$ 2

^[8],[14]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

419

^[1],[12]

419

^[8],[14]

419

^[1],[12]

419

^[1],[12]

419

^[8],[14]

419

^[8],[14]

Investment owned, at cost

$ 419

^[1],[12]

$ 419

^[8],[14]

Investments at fair value

$ 531

^[1],[12]

$ 419

^[8],[14]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^{[5],[7],[8],[9],[14]}

3.00%

Investment, interest rate, paid in kind (as a percent)

^[5],[8],[14]

7.00%

Investment, principal

^{[5],[8],[11],[14]}

$ 17,465

Investment owned, at cost

^[5],[8],[14]

17,465

Investments at fair value

^[5],[8],[14]

$ 17,465

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^{[1],[2],[4],[12]}

8.00%

Investment, interest rate, paid in kind (as a percent)

^[1],[2],[12]

3.00%

Investment, principal

^{[1],[2],[10],[12]}

$ 8,456

Investment owned, at cost

^[1],[2],[12]

8,456

Investments at fair value

^[1],[2],[12]

$ 8,456

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[1],[4],[12]

3.00%

Investment, interest rate, paid in kind (as a percent)

^[1],[12]

7.00%

Investment, principal

^{[1],[10],[12]}

$ 34,316

Investment owned, at cost

^[1],[12]

34,316

Investments at fair value

^[1],[12]

$ 34,316

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1],[12]

^[8],[14]

^[1],[12]

^[8],[14]

Investment owned, at cost

$ 0

^[1],[12]

$ 0

^[8],[14]

Investments at fair value

$ 0

^[1],[12]

$ 0

^[8],[14]

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

9.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

14.54%

Investment, principal

^[7],[8],[11]

$ 20,757

Investment owned, at cost

^[7],[8]

20,146

Investments at fair value

^[7],[8]

$ 20,653

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

15.75%

Investment, principal

^{[1],[10],[17]}

$ 23,660

Investment owned, at cost

^[1],[17]

23,264

Investments at fair value

^[1],[17]

$ 21,175

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

15.75%

Investment, principal

^{[1],[10],[17]}

$ 655

Investment owned, at cost

^[1],[17]

655

Investments at fair value

^[1],[17]

$ 586

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

15.75%

Investment, principal

^{[1],[10],[17]}

$ 647

Investment owned, at cost

^[1],[17]

647

Investments at fair value

^[1],[17]

$ 579

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

15.75%

Investment, principal

^{[1],[10],[17]}

$ 1,039

Investment owned, at cost

^[1],[17]

1,039

Investments at fair value

^[1],[17]

$ 929

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 5

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

15.75%

Investment, principal

^{[1],[10],[17]}

$ 852

Investment owned, at cost

^[1],[17]

852

Investments at fair value

^[1],[17]

$ 762

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[8]

8.00%

Investment, principal

^[8],[11]

$ 654

Investment owned, at cost

^[8]

653

Investments at fair value

^[8]

$ 631

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1],[16]

10.00%

Investment, principal

^{[1],[10],[16]}

$ 725

Investment owned, at cost

^[1],[16]

724

Investments at fair value

^[1],[16]

$ 375

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1],[16]

10.00%

Investment, principal

^{[1],[10],[16]}

$ 959

Investment owned, at cost

^[1],[16]

Investments at fair value

^[1],[16]

$ 496

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1],[16]

10.00%

Investment, principal

^{[1],[10],[16]}

$ 952

Investment owned, at cost

^[1],[16]

Investments at fair value

^[1],[16]

$ 493

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1],[16]

10.00%

Investment, principal

^{[1],[10],[16]}

$ 1,679

Investment owned, at cost

^[1],[16]

Investments at fair value

^[1],[16]

$ 869

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1]

Investment owned, balance (in shares) | shares

6,397,254

^[1]

6,397,254

^[8]

6,397,254

^[1]

6,397,254

^[1]

6,397,254

^[8]

6,397,254

^[8]

Investment owned, at cost

$ 1,642

^[1]

$ 1,642

^[8]

Investments at fair value

$ 0

^[1]

$ 1,152

^[8]

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[2],[17]

7.00%

^[5],[7],[8]

6.00%

^[1],[2],[17]

6.00%

^[1],[2],[17]

7.00%

^[5],[7],[8]

7.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

^{[5],[7],[8],[9]}

12.49%

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 284

^{[5],[7],[8],[11]}

Investment owned, at cost

^[1],[2],[17]

265

^[5],[7],[8]

Investments at fair value

$ (36)

^[1],[2],[17]

$ 252

^[5],[7],[8]

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.49%

Investment, principal

^[7],[8],[11]

$ 12,386

Investment owned, at cost

^[7],[8]

12,208

Investments at fair value

^[7],[8]

$ 12,101

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

6.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.60%

Investment, principal

^{[1],[10],[17]}

$ 54,454

Investment owned, at cost

^[1],[17]

54,449

Investments at fair value

^[1],[17]

$ 54,127

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

6.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.60%

Investment, principal

^{[1],[10],[17]}

$ 2,939

Investment owned, at cost

^[1],[17]

2,913

Investments at fair value

^[1],[17]

$ 2,921

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

5.00%

Investment, interest rate (as a percent)

^[7],[9]

10.43%

Investment, principal

^[7],[11]

$ 4,641

Investment owned, at cost

^[7]

4,619

Investments at fair value

^[7]

$ 4,546

Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

5.00%

5.25%

5.00%

Investment, interest rate (as a percent)

10.21%

10.43%

10.21%

10.43%

Investment, principal

$ 6,711

$ 5,799

Investment owned, at cost

6,635

5,715

Investments at fair value

$ 6,618

$ 5,681

Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

5.00%

5.25%

5.00%

Investment, interest rate (as a percent)

10.21%

10.43%

10.21%

10.43%

Investment, principal

$ 2,957

$ 2,460

Investment owned, at cost

2,932

2,435

Investments at fair value

$ 2,916

$ 2,410

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

30,031

^[1]

30,031

^[8]

30,031

^[1]

30,031

^[1]

30,031

^[8]

30,031

^[8]

Investment owned, at cost

$ 15,222

^[1]

$ 15,222

^[8]

Investments at fair value

$ 0

^[1]

$ 2,711

^[8]

4,946

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[1],[17]

5.00%

^[7],[8]

5.00%

^[1],[17]

5.00%

^[1],[17]

5.00%

^[7],[8]

5.00%

^[7],[8]

Investment, interest rate (as a percent)

9.75%

^[1],[4],[17]

10.54%

^[7],[8],[9]

9.75%

^[1],[4],[17]

9.75%

^[1],[4],[17]

10.54%

^[7],[8],[9]

10.54%

^[7],[8],[9]

Investment, principal

$ 5,574

^{[1],[10],[17]}

$ 5,574

^[7],[8],[11]

Investment owned, at cost

5,574

^[1],[17]

5,574

^[7],[8]

Investments at fair value

$ 4,546

^[1],[17]

$ 5,574

^[7],[8]

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[1],[17]

5.00%

^[7],[8]

5.00%

^[1],[17]

5.00%

^[1],[17]

5.00%

^[7],[8]

5.00%

^[7],[8]

Investment, interest rate (as a percent)

9.74%

^[1],[4],[17]

10.54%

^[7],[8],[9]

9.74%

^[1],[4],[17]

9.74%

^[1],[4],[17]

10.54%

^[7],[8],[9]

10.54%

^[7],[8],[9]

Investment, principal

$ 13,928

^{[1],[10],[17]}

$ 14,068

^[7],[8],[11]

Investment owned, at cost

13,928

^[1],[17]

14,068

^[7],[8]

Investments at fair value

$ 11,360

^[1],[17]

$ 14,068

^[7],[8]

14,333

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[1],[2],[17]

5.00%

^[5],[7],[8]

5.00%

^[1],[2],[17]

5.00%

^[1],[2],[17]

5.00%

^[5],[7],[8]

5.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

10.42%

^{[5],[7],[8],[9]}

^{[1],[2],[4],[17]}

10.42%

^{[5],[7],[8],[9]}

10.42%

^{[5],[7],[8],[9]}

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 2,090

^{[5],[7],[8],[11]}

Investment owned, at cost

^[1],[2],[17]

2,090

^[5],[7],[8]

Investments at fair value

$ (1,028)

^[1],[2],[17]

$ 2,090

^[5],[7],[8]

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

12,500

^[1]

12,500

^[8]

12,500

^[1]

12,500

^[1]

12,500

^[8]

12,500

^[8]

Investment owned, at cost

$ 0

^[1]

$ 0

^[8]

Investments at fair value

$ 0

^[1]

$ 0

^[8]

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

488

^[1]

488

^[8]

488

^[1]

488

^[1]

488

^[8]

488

^[8]

Investment owned, at cost

$ 488

^[1]

$ 488

^[8]

Investments at fair value

$ 1,345

^[1]

$ 1,345

^[8]

Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.25%

Investment, interest rate (as a percent)

9.55%

Investment, principal

$ 1,179

Investment owned, at cost

1,177

Investments at fair value

$ 1,121

Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.25%

Investment, interest rate (as a percent)

8.85%

Investment, principal

$ 392

Investment owned, at cost

387

Investments at fair value

$ 373

Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[1],[17]

7.50%

^[7],[8]

7.50%

^[1],[17]

7.50%

^[1],[17]

7.50%

^[7],[8]

7.50%

^[7],[8]

Investment, interest rate (as a percent)

12.25%

^[1],[4],[17]

13.04%

^[7],[8],[9]

12.25%

^[1],[4],[17]

12.25%

^[1],[4],[17]

13.04%

^[7],[8],[9]

13.04%

^[7],[8],[9]

Investment, principal

$ 8,974

^{[1],[10],[17]}

$ 8,974

^[7],[8],[11]

Investment owned, at cost

8,884

^[1],[17]

8,884

^[7],[8]

Investments at fair value

$ 8,121

^[1],[17]

$ 7,987

^[7],[8]

Investment, Identifier [Axis]: Engineering Research and Consulting LLC, Construction & Engineering, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.06%

Investment, principal

^{[1],[10],[17]}

$ 11,933

Investment owned, at cost

^[1],[17]

11,697

Investments at fair value

^[1],[17]

$ 11,858

Investment, Identifier [Axis]: Engineering Research and Consulting LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.06%

Investment, principal

$ 4,208

Investment owned, at cost

4,149

Investments at fair value

$ 4,182

Investment, Identifier [Axis]: Engineering Research and Consulting LLC., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.06%

Investment, principal

$ 1,025

Investment owned, at cost

1,011

Investments at fair value

$ 1,019

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.50%

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

10.35%

Investment, principal

^{[1],[2],[10],[17]}

$ 121

Investment owned, at cost

^[1],[2],[17]

Investments at fair value

^[1],[2],[17]

$ 121

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.35%

Investment, principal

^{[1],[10],[17]}

$ 24,741

Investment owned, at cost

^[1],[17]

24,369

Investments at fair value

^[1],[17]

$ 24,741

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.50%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(16)

Investments at fair value

^[1],[2],[17]

$ 0

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

9.00%

^[1],[4],[12]

3.00%

^{[7],[8],[9],[14]}

9.00%

^[1],[4],[12]

9.00%

^[1],[4],[12]

3.00%

^{[7],[8],[9],[14]}

3.00%

^{[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

^[8],[14]

6.00%

Investment, principal

$ 1,834

^{[1],[10],[12]}

$ 11,065

^{[8],[11],[14]}

Investment owned, at cost

1,817

^[1],[12]

10,953

^[8],[14]

Investments at fair value

$ 1,834

^[1],[12]

$ 10,677

^[8],[14]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

9.00%

^{[1],[2],[4],[12]}

3.00%

^{[7],[8],[9],[14]}

9.00%

^{[1],[2],[4],[12]}

9.00%

^{[1],[2],[4],[12]}

3.00%

^{[7],[8],[9],[14]}

3.00%

^{[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

^[8],[14]

6.00%

Investment, principal

$ 0

^{[1],[2],[10],[12]}

$ 1,772

^{[8],[11],[14]}

Investment owned, at cost

^[1],[2],[12]

1,748

^[8],[14]

Investments at fair value

$ 0

^[1],[2],[12]

$ 1,710

^[8],[14]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

9.00%

^{[1],[2],[4],[12]}

3.00%

^{[5],[7],[8],[9],[14]}

9.00%

^{[1],[2],[4],[12]}

9.00%

^{[1],[2],[4],[12]}

3.00%

^{[5],[7],[8],[9],[14]}

3.00%

^{[5],[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

^[5],[8],[14]

6.00%

Investment, principal

$ 0

^{[1],[2],[10],[12]}

$ 0

^{[5],[8],[11],[14]}

Investment owned, at cost

^[1],[2],[12]

^[5],[8],[14]

Investments at fair value

$ 0

^[1],[2],[12]

$ 0

^[5],[8],[14]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

9.00%

^[1],[4],[12]

3.00%

^{[5],[7],[8],[9],[14]}

9.00%

^[1],[4],[12]

9.00%

^[1],[4],[12]

3.00%

^{[5],[7],[8],[9],[14]}

3.00%

^{[5],[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

^[5],[8],[14]

6.00%

Investment, principal

$ 11,454

^{[1],[10],[12]}

$ 0

^{[5],[8],[11],[14]}

Investment owned, at cost

11,374

^[1],[12]

^[5],[8],[14]

Investments at fair value

$ 11,454

^[1],[12]

$ 0

^[5],[8],[14]

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.00%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(10)

Investments at fair value

^[1],[2],[17]

$ (9)

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.33%

Investment, principal

^{[1],[10],[17]}

$ 20,014

Investment owned, at cost

^[1],[17]

19,914

Investments at fair value

^[1],[17]

$ 19,922

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.00%

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

10.30%

Investment, principal

^{[1],[2],[10],[17]}

$ 1,961

Investment owned, at cost

^[1],[2],[17]

1,944

Investments at fair value

^[1],[2],[17]

$ 1,950

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^[1],[2],[17]

6.00%

^[5],[7],[8]

4.75%

^[1],[2],[17]

4.75%

^[1],[2],[17]

6.00%

^[5],[7],[8]

6.00%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

(34)

^[1],[2],[17]

(41)

^[5],[7],[8]

Investments at fair value

$ (14)

^[1],[2],[17]

$ (41)

^[5],[7],[8]

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

6.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

11.32%

Investment, principal

^[7],[8],[11]

$ 14,736

Investment owned, at cost

^[7],[8]

14,368

Investments at fair value

^[7],[8]

$ 14,368

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

4.75%

Investment, interest rate (as a percent)

^[1],[4],[17]

9.35%

Investment, principal

^{[1],[10],[17]}

$ 14,625

Investment owned, at cost

^[1],[17]

14,312

Investments at fair value

^[1],[17]

$ 14,501

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

4.75%

Investment, interest rate (as a percent)

^[1],[4],[17]

9.35%

Investment, principal

^{[1],[10],[17]}

$ 3,692

Investment owned, at cost

^[1],[17]

3,656

Investments at fair value

^[1],[17]

$ 3,661

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1],[21]

1,206

Investment owned, at cost

^[1],[21]

$ 1,206

Investments at fair value

^[1],[21]

$ 1,131

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.80%

Investment, principal

^{[1],[10],[17]}

$ 4,368

Investment owned, at cost

^[1],[17]

4,289

Investments at fair value

^[1],[17]

$ 4,285

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.50%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(66)

Investments at fair value

^[1],[2],[17]

$ (125)

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

6.75%

Investment, interest rate (as a percent)

^[7],[9]

12.18%

Investment, principal

^[7],[11]

$ 31,074

Investment owned, at cost

^[7]

29,127

Investments at fair value

^[7]

$ 19,917

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

9.00%

^[1],[4]

9.00%

^{[5],[7],[8],[9]}

9.00%

^[1],[4]

9.00%

^[1],[4]

9.00%

^{[5],[7],[8],[9]}

9.00%

^{[5],[7],[8],[9]}

Investment, principal

$ 48,920

^[1],[10]

$ 59,950

^[5],[8],[11]

Investment owned, at cost

48,920

^[1]

59,950

^[5],[8]

Investments at fair value

$ 48,920

^[1]

$ 59,950

^[5],[8]

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

3,750

^{[1],[12],[22]}

3,750

^[8],[14]

3,750

^{[1],[12],[22]}

3,750

^{[1],[12],[22]}

3,750

^[8],[14]

3,750

^[8],[14]

Investment owned, at cost

$ 0

^{[1],[12],[22]}

$ 0

^[8],[14]

Investments at fair value

$ 4

^{[1],[12],[22]}

$ 3

^[8],[14]

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^{[1],[2],[12],[17]}

7.25%

^{[5],[7],[8],[14]}

7.25%

^{[1],[2],[12],[17]}

7.25%

^{[1],[2],[12],[17]}

7.25%

^{[5],[7],[8],[14]}

7.25%

^{[5],[7],[8],[14]}

Investment, interest rate (as a percent)

12.18%

^{[1],[2],[4],[12],[17]}

12.55%

^{[5],[7],[8],[9],[14]}

12.18%

^{[1],[2],[4],[12],[17]}

12.18%

^{[1],[2],[4],[12],[17]}

12.55%

^{[5],[7],[8],[9],[14]}

12.55%

^{[5],[7],[8],[9],[14]}

Investment, principal

$ 564

^{[1],[2],[10],[12],[17]}

$ 258

^{[5],[7],[8],[11],[14]}

Investment owned, at cost

544

^{[1],[2],[12],[17]}

234

^{[5],[7],[8],[14]}

Investments at fair value

$ 547

^{[1],[2],[12],[17]}

$ 234

^{[5],[7],[8],[14]}

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^{[1],[12],[17]}

7.25%

^[7],[8],[14]

7.25%

^{[1],[12],[17]}

7.25%

^{[1],[12],[17]}

7.25%

^[7],[8],[14]

7.25%

^[7],[8],[14]

Investment, interest rate (as a percent)

12.18%

^{[1],[4],[12],[17]}

12.55%

^{[7],[8],[9],[14]}

12.18%

^{[1],[4],[12],[17]}

12.18%

^{[1],[4],[12],[17]}

12.55%

^{[7],[8],[9],[14]}

12.55%

^{[7],[8],[9],[14]}

Investment, principal

$ 11,683

^{[1],[10],[12],[17]}

$ 11,742

^{[7],[8],[11],[14]}

Investment owned, at cost

11,491

^{[1],[12],[17]}

11,509

^[7],[8],[14]

Investments at fair value

$ 11,521

^{[1],[12],[17]}

11,511

^[7],[8],[14]

Investment, Identifier [Axis]: Finthrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

4.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

8.96%

Investment, principal

^{[1],[10],[17]}

$ 4,291

Investment owned, at cost

^[1],[17]

3,594

Investments at fair value

^[1],[17]

$ 3,862

Investment, Identifier [Axis]: Finthrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[16],[17]}

6.75%

Investment, principal

^{[1],[10],[16],[17]}

$ 31,074

Investment owned, at cost

^{[1],[16],[17]}

28,328

Investments at fair value

^{[1],[16],[17]}

23,616

Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investments at fair value

Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

49,413

54,051

Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 22,152

$ 28,396

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

11.00%

Investment, principal

^{[8],[11],[14]}

$ 11,918

Investment owned, at cost

^[8],[14]

11,612

Investments at fair value

^[8],[14]

$ 11,144

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

27,801

^[1],[12]

417,011

^[8],[14]

27,801

^[1],[12]

27,801

^[1],[12]

417,011

^[8],[14]

417,011

^[8],[14]

Investment owned, at cost

$ 427

^[1],[12]

$ 427

^[8],[14]

Investments at fair value

$ 13

^[1],[12]

$ 42

^[8],[14]

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.50%

Investment, interest rate (as a percent)

8.76%

Investment, principal

$ 7,000

Investment owned, at cost

6,965

Investments at fair value

$ 7,061

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.50%

Investment, interest rate (as a percent)

8.76%

Investment, principal

$ 3,000

Investment owned, at cost

2,985

Investments at fair value

$ 3,026

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[9],[14]

6.00%

Investment, principal

^[11],[14]

$ 4,881

Investment owned, at cost

^[14]

4,469

Investments at fair value

^[14]

$ 3,577

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^[1],[2],[17]

7.25%

^[5],[7],[8]

7.25%

^[1],[2],[17]

7.25%

^[1],[2],[17]

7.25%

^[5],[7],[8]

7.25%

^[5],[7],[8]

Investment, interest rate (as a percent)

11.85%

^{[1],[2],[4],[17]}

12.64%

^{[5],[7],[8],[9]}

11.85%

^{[1],[2],[4],[17]}

11.85%

^{[1],[2],[4],[17]}

12.64%

^{[5],[7],[8],[9]}

12.64%

^{[5],[7],[8],[9]}

Investment, principal

$ 2,536

^{[1],[2],[10],[17]}

$ 1,638

^{[5],[7],[8],[11]}

Investment owned, at cost

2,452

^[1],[2],[17]

1,535

^[5],[7],[8]

Investments at fair value

$ 2,536

^[1],[2],[17]

$ 1,535

^[5],[7],[8]

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^[1],[17]

7.25%

^[7],[8]

7.25%

^[1],[17]

7.25%

^[1],[17]

7.25%

^[7],[8]

7.25%

^[7],[8]

Investment, interest rate (as a percent)

11.85%

^[1],[4],[17]

12.64%

^[7],[8],[9]

11.85%

^[1],[4],[17]

11.85%

^[1],[4],[17]

12.64%

^[7],[8],[9]

12.64%

^[7],[8],[9]

Investment, principal

$ 23,536

^{[1],[10],[17]}

$ 23,774

^[7],[8],[11]

Investment owned, at cost

22,996

^[1],[17]

23,110

^[7],[8]

Investments at fair value

$ 23,536

^[1],[17]

$ 23,110

^[7],[8]

Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.57%

Investment, principal

$ 7,369

Investment owned, at cost

7,295

Investments at fair value

$ 6,190

Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.57%

Investment, principal

$ 3,930

Investment owned, at cost

3,891

Investments at fair value

$ 3,301

Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

5.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

10.57%

Investment, principal

^[7],[8],[11]

$ 2,456

Investment owned, at cost

^[7],[8]

2,055

Investments at fair value

^[7],[8]

$ 2,063

Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[14]

2.85%

Investment, interest rate (as a percent)

^[7],[9],[14]

6.56%

Investment, principal | €

^{[7],[11],[14]}

€ 1,000

Investment owned, at cost

^[7],[14]

$ 876

Investments at fair value

^[7],[14]

$ 963

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[1],[2],[17]

8.00%

^[5],[7],[8]

8.00%

^[1],[2],[17]

8.00%

^[1],[2],[17]

8.00%

^[5],[7],[8]

8.00%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

(20)

^[1],[2],[17]

(27)

^[5],[7],[8]

Investments at fair value

$ (35)

^[1],[2],[17]

$ (35)

^[5],[7],[8]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[1],[17]

8.00%

^[7],[8]

8.00%

^[1],[17]

8.00%

^[1],[17]

8.00%

^[7],[8]

8.00%

^[7],[8]

Investment, interest rate (as a percent)

12.95%

^[1],[4],[17]

13.42%

^[7],[8],[9]

12.95%

^[1],[4],[17]

12.95%

^[1],[4],[17]

13.42%

^[7],[8],[9]

13.42%

^[7],[8],[9]

Investment, principal

$ 3,524

^{[1],[10],[17]}

$ 17,444

^[7],[8],[11]

Investment owned, at cost

3,485

^[1],[17]

17,276

^[7],[8]

Investments at fair value

$ 3,454

^[1],[17]

$ 17,096

^[7],[8]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[1],[17]

8.00%

^[5],[7],[8]

8.00%

^[1],[17]

8.00%

^[1],[17]

8.00%

^[5],[7],[8]

8.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

^[1],[4],[17]

12.95%

Investment, principal

$ 17,268

^{[1],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

17,147

^[1],[17]

(54)

^[5],[7],[8]

Investments at fair value

$ 16,923

^[1],[17]

$ (70)

^[5],[7],[8]

Investment, Identifier [Axis]: HPS Loan Management 10-2016, Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[17]

6.67%

Investment, interest rate (as a percent)

^{[4],[12],[17]}

11.95%

Investment, principal

^{[10],[12],[17]}

$ 2,250

Investment owned, at cost

^[12],[17]

2,136

Investments at fair value

^[12],[17]

$ 2,264

Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

^[17]

5.25%

^[7]

5.25%

^[17]

5.25%

^[17]

5.25%

^[7]

5.25%

^[7]

Investment, interest rate (as a percent)

10.20%

^[4],[17]

10.67%

^[7],[9]

10.20%

^[4],[17]

10.20%

^[4],[17]

10.67%

^[7],[9]

10.67%

^[7],[9]

Investment, principal

$ 8,473

^[10],[17]

$ 14,347

^[7],[11]

Investment owned, at cost

8,205

^[17]

13,871

^[7]

Investments at fair value

$ 8,263

^[17]

$ 13,618

^[7]

Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

10.20%

10.67%

10.20%

10.67%

Investment, principal

$ 7,840

$ 7,920

Investment owned, at cost

7,687

7,731

Investments at fair value

$ 7,646

$ 7,517

Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

10.20%

10.67%

10.20%

10.67%

Investment, principal

$ 3,920

$ 3,960

Investment owned, at cost

3,843

3,865

Investments at fair value

$ 3,823

$ 3,759

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^{[1],[2],[12],[17]}

6.50%

^[7],[8],[14]

6.50%

^{[1],[2],[12],[17]}

6.50%

^{[1],[2],[12],[17]}

6.50%

^[7],[8],[14]

6.50%

^[7],[8],[14]

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

11.89%

Investment, principal

$ 0

^{[1],[2],[10],[12],[17]}

$ 7,448

^{[7],[8],[11],[14]}

Investment owned, at cost

(40)

^{[1],[2],[12],[17]}

7,296

^[7],[8],[14]

Investments at fair value

$ 52

^{[1],[2],[12],[17]}

$ 7,301

^[7],[8],[14]

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^{[1],[12],[17]}

6.50%

^{[5],[7],[8],[14]}

6.50%

^{[1],[12],[17]}

6.50%

^{[1],[12],[17]}

6.50%

^{[5],[7],[8],[14]}

6.50%

^{[5],[7],[8],[14]}

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

11.25%

Investment, principal

$ 1,432

^{[1],[10],[12],[17]}

$ 0

^{[5],[7],[8],[11],[14]}

Investment owned, at cost

1,413

^{[1],[12],[17]}

(82)

^{[5],[7],[8],[14]}

Investments at fair value

$ 1,454

^{[1],[12],[17]}

$ (79)

^{[5],[7],[8],[14]}

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^{[1],[12],[17]}

6.50%

^[7],[8],[14]

6.50%

^{[1],[12],[17]}

6.50%

^{[1],[12],[17]}

6.50%

^[7],[8],[14]

6.50%

^[7],[8],[14]

Investment, interest rate (as a percent)

11.25%

^{[1],[4],[12],[17]}

12.04%

^{[7],[8],[9],[14]}

11.25%

^{[1],[4],[12],[17]}

11.25%

^{[1],[4],[12],[17]}

12.04%

^{[7],[8],[9],[14]}

12.04%

^{[7],[8],[9],[14]}

Investment, principal

$ 7,448

^{[1],[10],[12],[17]}

$ 1,432

^{[7],[8],[11],[14]}

Investment owned, at cost

7,362

^{[1],[12],[17]}

1,399

^[7],[8],[14]

Investments at fair value

$ 7,560

^{[1],[12],[17]}

$ 1,404

^[7],[8],[14]

Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[9],[14]

4.46%

Investment, principal

^[11],[14]

$ 6,808

Investment owned, at cost

^[14]

5,490

Investments at fair value

^[14]

$ 5,873

Investment, Identifier [Axis]: Husky Injection Molding Systems Ltd., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.33%

Investment, principal

$ 5,089

Investment owned, at cost

5,028

Investments at fair value

$ 5,071

Investment, Identifier [Axis]: Husky Injection Molding Systems Ltd., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.33%

Investment, principal

$ 3,125

Investment owned, at cost

3,088

Investments at fair value

$ 3,114

Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^{[1],[12],[17]}

8.25%

^[7],[8],[14]

8.25%

^{[1],[12],[17]}

8.25%

^{[1],[12],[17]}

8.25%

^[7],[8],[14]

8.25%

^[7],[8],[14]

Investment, interest rate (as a percent)

13.37%

^{[1],[4],[12],[17]}

13.62%

^{[7],[8],[9],[14]}

13.37%

^{[1],[4],[12],[17]}

13.37%

^{[1],[4],[12],[17]}

13.62%

^{[7],[8],[9],[14]}

13.62%

^{[7],[8],[9],[14]}

Investment, principal

$ 23,975

^{[1],[10],[12],[17]}

$ 23,975

^{[7],[8],[11],[14]}

Investment owned, at cost

23,454

^{[1],[12],[17]}

23,310

^[7],[8],[14]

Investments at fair value

$ 25,054

^{[1],[12],[17]}

$ 23,328

^[7],[8],[14]

Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

Investment, interest rate (as a percent)

10.62%

11.40%

10.62%

11.40%

Investment, principal

$ 8,500

$ 9,000

Investment owned, at cost

8,392

8,839

Investments at fair value

$ 7,140

$ 7,080

Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

Investment, interest rate (as a percent)

10.62%

11.40%

10.62%

11.40%

Investment, principal

$ 2,125

$ 2,250

Investment owned, at cost

2,098

2,210

Investments at fair value

$ 1,785

$ 1,770

Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[17]

5.75%

^[7],[8]

5.75%

^[17]

5.75%

^[17]

5.75%

^[7],[8]

5.75%

^[7],[8]

Investment, interest rate (as a percent)

10.62%

^[4],[17]

11.40%

^[7],[8],[9]

10.62%

^[4],[17]

10.62%

^[4],[17]

11.40%

^[7],[8],[9]

11.40%

^[7],[8],[9]

Investment, principal

$ 42,075

^[10],[17]

$ 44,550

^[7],[8],[11]

Investment owned, at cost

40,978

^[17]

42,918

^[7],[8]

Investments at fair value

$ 35,343

^[17]

$ 35,046

^[7],[8]

Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[1],[17]

6.50%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[7],[8]

Investment, interest rate (as a percent)

11.97%

^[1],[4],[17]

11.92%

^[7],[8],[9]

11.97%

^[1],[4],[17]

11.97%

^[1],[4],[17]

11.92%

^[7],[8],[9]

11.92%

^[7],[8],[9]

Investment, principal

$ 36,029

^{[1],[10],[17]}

$ 40,587

^[7],[8],[11]

Investment owned, at cost

35,643

^[1],[17]

39,935

^[7],[8]

Investments at fair value

$ 35,668

^[1],[17]

$ 38,963

^[7],[8]

Investment, Identifier [Axis]: Icefall Parent, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

6.50%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(18)

Investments at fair value

^[1],[2],[17]

$ (7)

Investment, Identifier [Axis]: Icefall Parent, Inc., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

6.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

11.35%

Investment, principal

^{[1],[10],[17]}

$ 10,446

Investment owned, at cost

^[1],[17]

10,261

Investments at fair value

^[1],[17]

$ 10,372

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

10.75%

Investment, interest rate, paid in kind (as a percent)

^[7],[8]

16.06%

Investment, principal

^[7],[8],[11]

$ 26,613

Investment owned, at cost

^[7],[8]

26,492

Investments at fair value

^[7],[8]

$ 24,484

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

10.75%

Investment, interest rate, paid in kind (as a percent)

^[7],[8]

16.05%

Investment, principal

^[7],[8],[11]

$ 787

Investment owned, at cost

^[7],[8]

771

Investments at fair value

^[7],[8]

$ 787

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[5],[7],[8]

10.75%

Investment, interest rate, paid in kind (as a percent)

^[5],[7],[8]

16.06%

Investment, principal

^{[5],[7],[8],[11]}

$ 688

Investment owned, at cost

^[5],[7],[8]

688

Investments at fair value

^[5],[7],[8]

$ 688

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

350,241

Investment owned, at cost

$ 0

Investments at fair value

$ 147

Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

10.21%

10.90%

10.21%

10.90%

Investment, principal

$ 7,256

$ 7,331

Investment owned, at cost

7,205

7,249

Investments at fair value

$ 7,247

$ 7,340

Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

10.21%

10.90%

10.21%

10.90%

Investment, principal

$ 3,870

$ 3,910

Investment owned, at cost

3,842

3,866

Investments at fair value

$ 3,865

$ 3,915

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

5.75%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

11.14%

Investment, interest rate, paid in kind (as a percent)

^[7],[8],[14]

2.75%

Investment, principal

^{[7],[8],[11],[14]}

$ 7,179

Investment owned, at cost

^[7],[8],[14]

6,969

Investments at fair value

^[7],[8],[14]

$ 6,568

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

112,990

^[1],[12]

112,990

^[8],[14]

112,990

^[1],[12]

112,990

^[1],[12]

112,990

^[8],[14]

112,990

^[8],[14]

Investment owned, at cost

$ 300

^[1],[12]

$ 300

^[8],[14]

Investments at fair value

$ 0

^[1],[12]

$ 105

^[8],[14]

Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8]

1,078,284

Investment owned, at cost

^[8]

$ 113

Investments at fair value

^[8]

$ 0

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.00%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(25)

Investments at fair value

^[1],[2],[17]

$ (26)

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.08%

Investment, principal

^{[1],[10],[17]}

$ 19,559

Investment owned, at cost

^[1],[17]

19,368

Investments at fair value

^[1],[17]

$ 19,363

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.00%

Investment owned, at cost

^[1],[2],[17]

$ (68)

Investments at fair value

^[1],[2],[17]

$ (66)

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[1],[2],[17]

7.50%

^[5],[7],[8]

7.50%

^[1],[2],[17]

7.50%

^[1],[2],[17]

7.50%

^[5],[7],[8]

7.50%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

(42)

^[1],[2],[17]

(99)

^[5],[7],[8]

Investments at fair value

$ (86)

^[1],[2],[17]

$ (86)

^[5],[7],[8]

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[1],[17]

7.50%

^[7],[8]

7.50%

^[1],[17]

7.50%

^[1],[17]

7.50%

^[7],[8]

7.50%

^[7],[8]

Investment, interest rate (as a percent)

12.46%

^[1],[4],[17]

12.93%

^[7],[8],[9]

12.46%

^[1],[4],[17]

12.46%

^[1],[4],[17]

12.93%

^[7],[8],[9]

12.93%

^[7],[8],[9]

Investment, principal

$ 33,079

^{[1],[10],[17]}

$ 33,414

^[7],[8],[11]

Investment owned, at cost

32,876

^[1],[17]

32,539

^[7],[8]

Investments at fair value

32,332

^[1],[17]

$ 32,659

^[7],[8]

Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

7.25%

Investment, interest rate (as a percent)

^[7],[9]

12.78%

Investment, principal

^[7],[11]

$ 13,939

Investment owned, at cost

^[7]

12,661

Investments at fair value

^[7]

10,094

Investment, Identifier [Axis]: JN Bidco LLC, Health Care Technology, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, at cost

^[1]

9,886

Investments at fair value

^[1]

9,886

Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, at cost

34,597

83,262

Investments at fair value

$ 34,597

$ 83,262

Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

5.00%

4.50%

5.00%

Investment, interest rate (as a percent)

9.36%

10.32%

9.36%

10.32%

Investment, principal

$ 8,890

$ 10,000

Investment owned, at cost

8,675

9,666

Investments at fair value

$ 8,908

$ 9,665

Investment, Identifier [Axis]: KDC/ONE Development Corp Inc, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

5.00%

4.50%

5.00%

Investment, interest rate (as a percent)

9.36%

10.32%

9.36%

10.32%

Investment, principal

$ 3,551

$ 4,500

Investment owned, at cost

3,454

4,350

Investments at fair value

$ 3,558

$ 4,349

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

^[1],[2],[17]

6.50%

^[5],[7],[8]

4.00%

^[1],[2],[17]

4.00%

^[1],[2],[17]

6.50%

^[5],[7],[8]

6.50%

^[5],[7],[8]

Investment, interest rate (as a percent)

12.50%

^{[1],[2],[4],[17]}

11.84%

^{[5],[7],[8],[9]}

12.50%

^{[1],[2],[4],[17]}

12.50%

^{[1],[2],[4],[17]}

11.84%

^{[5],[7],[8],[9]}

11.84%

^{[5],[7],[8],[9]}

Investment, principal

$ 1,259

^{[1],[2],[10],[17]}

$ 272

^{[5],[7],[8],[11]}

Investment owned, at cost

1,223

^[1],[2],[17]

246

^[5],[7],[8]

Investments at fair value

$ 1,216

^[1],[2],[17]

$ 238

^[5],[7],[8]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

^[1],[2],[17]

6.50%

^[5],[7],[8]

4.00%

^[1],[2],[17]

4.00%

^[1],[2],[17]

6.50%

^[5],[7],[8]

6.50%

^[5],[7],[8]

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

12.00%

Investment, principal

$ 926

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

901

^[1],[2],[17]

(47)

^[5],[7],[8]

Investments at fair value

$ 894

^[1],[2],[17]

$ (47)

^[5],[7],[8]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[1],[17]

6.50%

^[7],[8]

5.00%

^[1],[17]

5.00%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[7],[8]

Investment, interest rate (as a percent)

9.95%

^[1],[4],[17]

11.84%

^[7],[8],[9]

9.95%

^[1],[4],[17]

9.95%

^[1],[4],[17]

11.84%

^[7],[8],[9]

11.84%

^[7],[8],[9]

Investment, principal

$ 37,635

^{[1],[10],[17]}

$ 16,752

^[7],[8],[11]

Investment owned, at cost

37,211

^[1],[17]

16,623

^[7],[8]

Investments at fair value

$ 37,123

^[1],[17]

$ 16,500

^[7],[8]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[1],[17]

6.50%

^[7],[8]

5.00%

^[1],[17]

5.00%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[7],[8]

Investment, interest rate (as a percent)

10.68%

^[1],[4],[17]

11.80%

^[7],[8],[9]

10.68%

^[1],[4],[17]

10.68%

^[1],[4],[17]

11.80%

^[7],[8],[9]

11.80%

^[7],[8],[9]

Investment, principal

$ 16,552

^{[1],[10],[17]}

$ 38,015

^[7],[8],[11]

Investment owned, at cost

16,423

^[1],[17]

37,447

^[7],[8]

Investments at fair value

$ 16,327

^[1],[17]

$ 37,445

^[7],[8]

Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

9.95%

10.42%

9.95%

10.42%

Investment, principal

$ 7,896

$ 3,962

Investment owned, at cost

7,682

3,815

Investments at fair value

$ 7,734

$ 3,955

Investment, Identifier [Axis]: LABL, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

9.95%

Investment, principal

$ 2,987

Investment owned, at cost

2,899

Investments at fair value

$ 2,926

Investment, Identifier [Axis]: LABL, Inc., Office Services & Supplies, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[17]

5.00%

Investment, interest rate (as a percent)

^[4],[17]

9.95%

Investment, principal

^[10],[17]

$ 19,351

Investment owned, at cost

^[17]

18,861

Investments at fair value

^[17]

$ 18,953

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[2],[17]

6.00%

^[5],[7],[8]

6.00%

^[1],[2],[17]

6.00%

^[1],[2],[17]

6.00%

^[5],[7],[8]

6.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

10.95%

Investment, principal

$ 2,014

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

1,982

^[1],[2],[17]

(41)

^[5],[7],[8]

Investments at fair value

$ 1,849

^[1],[2],[17]

$ (172)

^[5],[7],[8]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[1],[17]

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[7],[8]

Investment, interest rate (as a percent)

10.95%

^[1],[4],[17]

11.42%

^[7],[8],[9]

10.95%

^[1],[4],[17]

10.95%

^[1],[4],[17]

11.42%

^[7],[8],[9]

11.42%

^[7],[8],[9]

Investment, principal

$ 2,708

^{[1],[10],[17]}

$ 2,736

^[7],[8],[11]

Investment owned, at cost

2,601

^[1],[17]

2,595

^[7],[8]

Investments at fair value

$ 2,539

^[1],[17]

$ 2,558

^[7],[8]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[1],[17]

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[7],[8]

Investment, interest rate (as a percent)

10.95%

^[1],[4],[17]

11.42%

^[7],[8],[9]

10.95%

^[1],[4],[17]

10.95%

^[1],[4],[17]

11.42%

^[7],[8],[9]

11.42%

^[7],[8],[9]

Investment, principal

$ 23,256

^{[1],[10],[17]}

$ 23,494

^[7],[8],[11]

Investment owned, at cost

22,977

^[1],[17]

23,128

^[7],[8]

Investments at fair value

$ 21,802

^[1],[17]

21,967

^[7],[8]

Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

Investment, interest rate (as a percent)

9.60%

Investment, principal

$ 10,000

Investment owned, at cost

9,876

Investments at fair value

9,848

Investment, Identifier [Axis]: Largest Exposure To A Single Borrower | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

10,495

11,286

Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

$ 5,898

$ 6,230

Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

Investment, interest rate (as a percent)

11.32%

Investment, principal

$ 7,369

Investment owned, at cost

7,269

Investments at fair value

$ 7,267

Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

5.75%

4.75%

5.75%

Investment, interest rate (as a percent)

9.60%

11.32%

9.60%

11.32%

Investment, principal

$ 4,000

$ 3,930

Investment owned, at cost

3,950

3,877

Investments at fair value

$ 3,939

$ 3,876

Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

9.50%

^[12],[17]

9.50%

^[7],[14]

9.50%

^[12],[17]

9.50%

^[12],[17]

9.50%

^[7],[14]

9.50%

^[7],[14]

Investment, interest rate (as a percent)

14.95%

^{[4],[12],[17]}

14.95%

^[7],[9],[14]

14.95%

^{[4],[12],[17]}

14.95%

^{[4],[12],[17]}

14.95%

^[7],[9],[14]

14.95%

^[7],[9],[14]

Investment, principal

$ 26,156

^{[10],[12],[17]}

$ 26,422

^{[7],[11],[14]}

Investment owned, at cost

25,039

^[12],[17]

24,920

^[7],[14]

Investments at fair value

$ 26,556

^[12],[17]

$ 27,512

^[7],[14]

Investment, Identifier [Axis]: Learfield Communications, LLC, Movies & Entertainment, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[17]

5.50%

Investment, interest rate (as a percent)

^[4],[17]

10.35%

Investment, principal

^[10],[17]

$ 30,856

Investment owned, at cost

^[17]

30,779

Investments at fair value

^[17]

$ 30,863

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.00%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(61)

Investments at fair value

^[1],[2],[17]

$ (60)

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.13%

Investment, principal

^{[1],[10],[17]}

$ 26,358

Investment owned, at cost

^[1],[17]

25,839

Investments at fair value

^[1],[17]

$ 25,847

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.00%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(15)

Investments at fair value

^[1],[2],[17]

$ (15)

Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8]

2,000,000

Investment owned, at cost

^[8]

$ 1,399

Investments at fair value

^[8]

$ 0

Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

9.96%

10.65%

9.96%

10.65%

Investment, principal

$ 29

$ 11,249

Investment owned, at cost

11,106

Investments at fair value

$ 28

$ 10,912

Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[1],[17]

5.00%

^[7],[8]

5.00%

^[1],[17]

5.00%

^[1],[17]

5.00%

^[7],[8]

5.00%

^[7],[8]

Investment, interest rate (as a percent)

9.96%

^[1],[4],[17]

10.65%

^[7],[8],[9]

9.96%

^[1],[4],[17]

9.96%

^[1],[4],[17]

10.65%

^[7],[8],[9]

10.65%

^[7],[8],[9]

Investment, principal

$ 55,873

^{[1],[10],[17]}

$ 45,243

^[7],[8],[11]

Investment owned, at cost

55,220

^[1],[17]

44,717

^[7],[8]

Investments at fair value

$ 54,197

^[1],[17]

$ 43,886

^[7],[8]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

559

^[1]

559

^[8]

559

^[1]

559

^[1]

559

^[8]

559

^[8]

Investment, principal

^[8],[11]

Investment owned, at cost

$ 563

^[1]

563

^[8]

Investments at fair value

$ 64

^[1]

$ 372

^[8]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[1],[17]

8.50%

^[7],[8]

8.50%

^[1],[17]

8.50%

^[1],[17]

8.50%

^[7],[8]

8.50%

^[7],[8]

Investment, interest rate (as a percent)

13.20%

^[1],[4],[17]

13.99%

^[7],[8],[9]

13.20%

^[1],[4],[17]

13.20%

^[1],[4],[17]

13.99%

^[7],[8],[9]

13.99%

^[7],[8],[9]

Investment, principal

$ 3,167

^{[1],[10],[17]}

$ 5,403

^[7],[8],[11]

Investment owned, at cost

3,123

^[1],[17]

5,348

^[7],[8]

Investments at fair value

$ 2,993

^[1],[17]

$ 5,160

^[7],[8]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[1],[17]

8.50%

^[5],[7],[8]

8.50%

^[1],[17]

8.50%

^[1],[17]

8.50%

^[5],[7],[8]

8.50%

^[5],[7],[8]

Investment, interest rate (as a percent)

13.20%

^[1],[4],[17]

13.99%

^{[5],[7],[8],[9]}

13.20%

^[1],[4],[17]

13.20%

^[1],[4],[17]

13.99%

^{[5],[7],[8],[9]}

13.99%

^{[5],[7],[8],[9]}

Investment, principal

$ 5,822

^{[1],[10],[17]}

$ 2,939

^{[5],[7],[8],[11]}

Investment owned, at cost

5,785

^[1],[17]

2,884

^[5],[7],[8]

Investments at fair value

$ 5,502

^[1],[17]

$ 2,745

^[5],[7],[8]

Investment, Identifier [Axis]: M2S Group Intermediate Holdings Inc, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

Investment, interest rate (as a percent)

9.85%

Investment, principal

$ 10,000

Investment owned, at cost

9,652

Investments at fair value

$ 9,625

Investment, Identifier [Axis]: M2S Group Intermediate Holdings Inc, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

Investment, interest rate (as a percent)

9.85%

Investment, principal

$ 4,000

Investment owned, at cost

3,861

Investments at fair value

$ 3,850

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[2],[17]

6.00%

^[5],[7],[8]

6.00%

^[1],[2],[17]

6.00%

^[1],[2],[17]

6.00%

^[5],[7],[8]

6.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

^{[5],[7],[8],[9]}

11.42%

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 964

^{[5],[7],[8],[11]}

Investment owned, at cost

(21)

^[1],[2],[17]

936

^[5],[7],[8]

Investments at fair value

$ (24)

^[1],[2],[17]

$ 938

^[5],[7],[8]

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[1],[17]

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[7],[8]

Investment, interest rate (as a percent)

11.40%

^[1],[4],[17]

11.52%

^[7],[8],[9]

11.40%

^[1],[4],[17]

11.40%

^[1],[4],[17]

11.52%

^[7],[8],[9]

11.52%

^[7],[8],[9]

Investment, principal

$ 2,604

^{[1],[10],[17]}

$ 20,125

^[7],[8],[11]

Investment owned, at cost

2,561

^[1],[17]

19,912

^[7],[8]

Investments at fair value

$ 2,568

^[1],[17]

$ 19,823

^[7],[8]

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[1],[17]

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[7],[8]

Investment, interest rate (as a percent)

11.40%

^[1],[4],[17]

11.52%

^[7],[8],[9]

11.40%

^[1],[4],[17]

11.40%

^[1],[4],[17]

11.52%

^[7],[8],[9]

11.52%

^[7],[8],[9]

Investment, principal

$ 7,224

^{[1],[10],[17]}

$ 2,631

^[7],[8],[11]

Investment owned, at cost

7,167

^[1],[17]

2,587

^[7],[8]

Investments at fair value

$ 7,125

^[1],[17]

$ 2,591

^[7],[8]

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[5],[7],[8]

7.50%

Investment, interest rate (as a percent)

^{[5],[7],[8],[9]}

12.83%

Investment, principal

^{[5],[7],[8],[11]}

$ 1,466

Investment owned, at cost

^[5],[7],[8]

1,215

Investments at fair value

^[5],[7],[8]

$ 1,282

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.50%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.89%

Investment, principal

^[7],[8],[11]

$ 40,538

Investment owned, at cost

^[7],[8]

39,873

Investments at fair value

^[7],[8]

$ 39,833

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^[1],[2],[17]

5.50%

^[5],[7],[8]

4.75%

^[1],[2],[17]

4.75%

^[1],[2],[17]

5.50%

^[5],[7],[8]

5.50%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

(69)

^[1],[2],[17]

(28)

^[5],[7],[8]

Investments at fair value

$ (44)

^[1],[2],[17]

$ (47)

^[5],[7],[8]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^[1],[17]

5.50%

^[7],[8]

4.75%

^[1],[17]

4.75%

^[1],[17]

5.50%

^[7],[8]

5.50%

^[7],[8]

Investment, interest rate (as a percent)

9.35%

^[1],[4],[17]

10.99%

^[7],[8],[9]

9.35%

^[1],[4],[17]

9.35%

^[1],[4],[17]

10.99%

^[7],[8],[9]

10.99%

^[7],[8],[9]

Investment, principal

$ 33,831

^{[1],[10],[17]}

$ 13,973

^[7],[8],[11]

Investment owned, at cost

33,438

^[1],[17]

13,936

^[7],[8]

Investments at fair value

$ 33,503

^[1],[17]

$ 13,685

^[7],[8]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^[1],[17]

5.50%

^[7],[8]

4.75%

^[1],[17]

4.75%

^[1],[17]

5.50%

^[7],[8]

5.50%

^[7],[8]

Investment, interest rate (as a percent)

9.35%

^[1],[4],[17]

10.99%

^[7],[8],[9]

9.35%

^[1],[4],[17]

9.35%

^[1],[4],[17]

10.99%

^[7],[8],[9]

10.99%

^[7],[8],[9]

Investment, principal

$ 13,829

^{[1],[10],[17]}

$ 21,328

^[7],[8],[11]

Investment owned, at cost

13,797

^[1],[17]

21,021

^[7],[8]

Investments at fair value

$ 13,695

^[1],[17]

$ 20,888

^[7],[8]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

4.75%

Investment, interest rate (as a percent)

^[1],[4],[17]

9.35%

Investment, principal

^{[1],[10],[17]}

$ 6,652

Investment owned, at cost

^[1],[17]

6,609

Investments at fair value

^[1],[17]

$ 6,588

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

4.75%

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

9.35%

Investment, principal

^{[1],[2],[10],[17]}

$ 792

Investment owned, at cost

^[1],[2],[17]

776

Investments at fair value

^[1],[2],[17]

$ 760

Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

Investment, principal

$ 0

Investment owned, at cost

(3)

Investments at fair value

$ (7)

Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

Investment, principal

$ 0

Investment owned, at cost

(1)

Investments at fair value

$ (3)

Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

Investment, interest rate (as a percent)

10.99%

Investment, principal

$ 1,630

Investment owned, at cost

1,616

Investments at fair value

$ 1,596

Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

Investment, interest rate (as a percent)

10.99%

Investment, principal

$ 8,319

Investment owned, at cost

8,164

Investments at fair value

$ 8,147

Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

Investment, interest rate (as a percent)

10.99%

Investment, principal

$ 2,211

Investment owned, at cost

2,210

Investments at fair value

$ 2,165

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

11.50%

^[1],[4],[12]

11.50%

^{[7],[8],[9],[14]}

11.50%

^[1],[4],[12]

11.50%

^[1],[4],[12]

11.50%

^{[7],[8],[9],[14]}

11.50%

^{[7],[8],[9],[14]}

Investment, principal

$ 8,139

^{[1],[10],[12]}

$ 8,568

^{[8],[11],[14]}

Investment owned, at cost

8,096

^[1],[12]

8,495

^[8],[14]

Investments at fair value

$ 7,773

^[1],[12]

$ 8,132

^[8],[14]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

11.50%

^[1],[4],[12]

11.50%

^{[7],[8],[9],[14]}

11.50%

^[1],[4],[12]

11.50%

^[1],[4],[12]

11.50%

^{[7],[8],[9],[14]}

11.50%

^{[7],[8],[9],[14]}

Investment, principal

$ 3,855

^{[1],[10],[12]}

$ 4,284

^{[8],[11],[14]}

Investment owned, at cost

3,835

^[1],[12]

4,247

^[8],[14]

Investments at fair value

$ 3,682

^[1],[12]

$ 4,066

^[8],[14]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

11.50%

^[1],[4],[12]

11.50%

^{[7],[8],[9],[14]}

11.50%

^[1],[4],[12]

11.50%

^[1],[4],[12]

11.50%

^{[7],[8],[9],[14]}

11.50%

^{[7],[8],[9],[14]}

Investment, principal

$ 4,070

^{[1],[10],[12]}

$ 8,568

^{[8],[11],[14]}

Investment owned, at cost

4,048

^[1],[12]

8,495

^[8],[14]

Investments at fair value

$ 3,886

^[1],[12]

$ 8,132

^[8],[14]

Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.25%

3.75%

3.25%

3.75%

Investment, interest rate (as a percent)

8.45%

9.18%

8.45%

9.18%

Investment, principal

$ 7,890

$ 5,940

Investment owned, at cost

7,656

5,654

Investments at fair value

$ 7,872

$ 5,812

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

9.75%

^[1],[4],[12]

8.00%

^{[7],[8],[9],[14]}

9.75%

^[1],[4],[12]

9.75%

^[1],[4],[12]

8.00%

^{[7],[8],[9],[14]}

8.00%

^{[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

^[8],[14]

1.75%

Investment, principal

$ 7,660

^{[1],[10],[12]}

$ 9,106

^{[8],[11],[14]}

Investment owned, at cost

7,359

^[1],[12]

8,580

^[8],[14]

Investments at fair value

$ 7,373

^[1],[12]

$ 8,013

^[8],[14]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

33,409

^[1],[12]

259,877

^[8],[14]

33,409

^[1],[12]

33,409

^[1],[12]

259,877

^[8],[14]

259,877

^[8],[14]

Investment, principal

^{[8],[11],[14]}

Investment owned, at cost

$ 23

^[1],[12]

545

^[8],[14]

Investments at fair value

$ 154

^[1],[12]

$ 78

^[8],[14]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

129,939

^[1],[12]

66,817

^[8],[14]

129,939

^[1],[12]

129,939

^[1],[12]

66,817

^[8],[14]

66,817

^[8],[14]

Investment, principal

^{[8],[11],[14]}

Investment owned, at cost

$ 545

^[1],[12]

^[8],[14]

Investments at fair value

$ 416

^[1],[12]

$ 33

^[8],[14]

Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

Investment, principal

$ 0

Investment owned, at cost

(2)

Investments at fair value

$ (8)

Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

Investment, interest rate (as a percent)

12.52%

Investment, principal

$ 4,669

Investment owned, at cost

4,648

Investments at fair value

$ 4,594

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[1],[2],[17]

7.00%

^[5],[7],[8]

7.00%

^[1],[2],[17]

7.00%

^[1],[2],[17]

7.00%

^[5],[7],[8]

7.00%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

(21)

^[1],[2],[17]

(43)

^[5],[7],[8]

Investments at fair value

$ (56)

^[1],[2],[17]

$ (76)

^[5],[7],[8]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[1],[17]

7.00%

^[7],[8]

7.00%

^[1],[17]

7.00%

^[1],[17]

7.00%

^[7],[8]

7.00%

^[7],[8]

Investment, interest rate (as a percent)

12.40%

^[1],[4],[17]

12.52%

^[7],[8],[9]

12.40%

^[1],[4],[17]

12.40%

^[1],[4],[17]

12.52%

^[7],[8],[9]

12.52%

^[7],[8],[9]

Investment, principal

$ 51,356

^{[1],[10],[17]}

$ 5,248

^[7],[8],[11]

Investment owned, at cost

51,142

^[1],[17]

5,220

^[7],[8]

Investments at fair value

$ 50,806

^[1],[17]

$ 5,164

^[7],[8]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[1],[17]

7.00%

^[7],[8]

7.00%

^[1],[17]

7.00%

^[1],[17]

7.00%

^[7],[8]

7.00%

^[7],[8]

Investment, interest rate (as a percent)

12.40%

^[1],[4],[17]

12.52%

^[7],[8],[9]

12.40%

^[1],[4],[17]

12.40%

^[1],[4],[17]

12.52%

^[7],[8],[9]

12.52%

^[7],[8],[9]

Investment, principal

$ 2,294

^{[1],[10],[17]}

$ 46,687

^[7],[8],[11]

Investment owned, at cost

2,255

^[1],[17]

46,239

^[7],[8]

Investments at fair value

$ 2,269

^[1],[17]

$ 45,940

^[7],[8]

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[12],[17]}

5.00%

Investment, principal

^{[1],[2],[10],[12],[17]}

$ 0

Investment owned, at cost

^{[1],[2],[12],[17]}

(13)

Investments at fair value

^{[1],[2],[12],[17]}

$ (12)

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

5.00%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

9.85%

Investment, principal

^{[1],[10],[12],[17]}

$ 7,056

Investment owned, at cost

^{[1],[12],[17]}

6,923

Investments at fair value

^{[1],[12],[17]}

$ 6,932

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[12],[17]}

5.00%

Investment, principal

^{[1],[2],[10],[12],[17]}

$ 0

Investment owned, at cost

^{[1],[2],[12],[17]}

(12)

Investments at fair value

^{[1],[2],[12],[17]}

$ (11)

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

5.00%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

9.85%

Investment, principal

^{[1],[10],[12],[17]}

$ 1,176

Investment owned, at cost

^{[1],[12],[17]}

1,152

Investments at fair value

^{[1],[12],[17]}

$ 1,156

Investment, Identifier [Axis]: Mitchell International, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.25%

3.75%

3.25%

3.75%

Investment, interest rate (as a percent)

8.10%

9.18%

8.10%

9.18%

Investment, principal

$ 8,000

$ 2,985

Investment owned, at cost

7,953

2,845

Investments at fair value

$ 7,892

$ 2,941

Investment, Identifier [Axis]: Modena Buyer LLC, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[17]

4.50%

Investment, interest rate (as a percent)

^[4],[17]

9.10%

Investment, principal

^[10],[17]

$ 27,705

Investment owned, at cost

^[17]

27,169

Investments at fair value

^[17]

$ 26,588

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.50%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(65)

Investments at fair value

^[1],[2],[17]

$ 0

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.56%

Investment, principal

^{[1],[10],[17]}

$ 38,326

Investment owned, at cost

^[1],[17]

37,751

Investments at fair value

^[1],[17]

$ 38,326

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.50%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(24)

Investments at fair value

^[1],[2],[17]

$ 0

Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^[1],[17]

6.75%

^[7],[8]

8.25%

^[1],[17]

8.25%

^[1],[17]

6.75%

^[7],[8]

6.75%

^[7],[8]

Investment, interest rate (as a percent)

10.58%

^[1],[4],[17]

12.51%

^[7],[8],[9]

10.58%

^[1],[4],[17]

10.58%

^[1],[4],[17]

12.51%

^[7],[8],[9]

12.51%

^[7],[8],[9]

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

3.25%

Investment, principal

$ 50,077

^{[1],[10],[17]}

$ 54,559

^[7],[8],[11]

Investment owned, at cost

49,891

^[1],[17]

54,236

^[7],[8]

Investments at fair value

$ 48,775

^[1],[17]

$ 53,168

^[7],[8]

Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[9]

6.88%

Investment, principal

^[11]

$ 10,191

Investment owned, at cost

9,831

Investments at fair value

$ 8,743

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.88%

^{[1],[12],[17]}

6.88%

^[7],[8],[14]

8.88%

^{[1],[12],[17]}

8.88%

^{[1],[12],[17]}

6.88%

^[7],[8],[14]

6.88%

^[7],[8],[14]

Investment, interest rate (as a percent)

11.82%

^{[1],[4],[12],[17]}

12.29%

^{[7],[8],[9],[14]}

11.82%

^{[1],[4],[12],[17]}

11.82%

^{[1],[4],[12],[17]}

12.29%

^{[7],[8],[9],[14]}

12.29%

^{[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

2.00%

^{[1],[12],[17]}

2.00%

^[7],[8],[14]

2.00%

^{[1],[12],[17]}

2.00%

^{[1],[12],[17]}

2.00%

^[7],[8],[14]

2.00%

^[7],[8],[14]

Investment, principal

$ 56,701

^{[1],[10],[12],[17]}

$ 73,362

^{[7],[8],[11],[14]}

Investment owned, at cost

56,248

^{[1],[12],[17]}

72,459

^[7],[8],[14]

Investments at fair value

$ 55,737

^{[1],[12],[17]}

$ 69,694

^[7],[8],[14]

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

487,870

^[12]

487,870

^[14]

487,870

^[12]

487,870

^[12]

487,870

^[14]

487,870

^[14]

Investment owned, at cost

$ 0

^[12]

$ 0

^[14]

Investments at fair value

$ 1,898

^[12]

$ 903

^[14]

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

239,590

^[12]

487,870

^[14]

239,590

^[12]

239,590

^[12]

487,870

^[14]

487,870

^[14]

Investment owned, at cost

$ 0

^[12]

$ 0

^[14]

Investments at fair value

$ 932

^[12]

$ 903

^[14]

Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

8.50%

Investment, interest rate (as a percent)

^[7],[8],[9]

13.99%

Investment, principal

^[7],[8],[11]

$ 30,339

Investment owned, at cost

^[7],[8]

30,021

Investments at fair value

^[7],[8]

$ 29,007

Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

2.25%

^[1],[17]

9.50%

^[7],[8]

2.25%

^[1],[17]

2.25%

^[1],[17]

9.50%

^[7],[8]

9.50%

^[7],[8]

Investment, interest rate (as a percent)

6.85%

^[1],[4],[17]

14.89%

^[7],[8],[9]

6.85%

^[1],[4],[17]

6.85%

^[1],[4],[17]

14.89%

^[7],[8],[9]

14.89%

^[7],[8],[9]

Investment, principal

$ 55,783

^{[1],[10],[17]}

$ 64,606

^[7],[8],[11]

Investment owned, at cost

54,677

^[1],[17]

64,720

^[7],[8]

Investments at fair value

$ 54,668

^[1],[17]

$ 63,185

^[7],[8]

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

6.00%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(25)

Investments at fair value

^[1],[2],[17]

$ 0

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

6.00%

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

6.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

11.06%

Investment, principal

^{[1],[10],[17]}

$ 19,895

Investment owned, at cost

^[1],[17]

19,597

Investments at fair value

^[1],[17]

19,895

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[10],[17]}

Investment owned, at cost

^[1],[2],[17]

(38)

Investments at fair value

^[1],[2],[17]

$ 0

Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.76%

Investment, interest rate (as a percent)

10.15%

Investment, principal

$ 6,615

Investment owned, at cost

6,608

Investments at fair value

$ 6,565

Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.76%

Investment, interest rate (as a percent)

10.15%

Investment, principal

$ 5,198

Investment owned, at cost

5,192

Investments at fair value

5,159

Investment, Identifier [Axis]: Northwoods Capital 25 Ltd, Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[17]

7.40%

Investment, interest rate (as a percent)

^{[4],[12],[17]}

12.68%

Investment, principal

^{[10],[12],[17]}

$ 700

Investment owned, at cost

^[12],[17]

682

Investments at fair value

^[12],[17]

681

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, at cost

^{[2],[12],[23],[24]}

^{[5],[14],[25],[26]}

Investments at fair value

$ 0

^{[2],[12],[23],[24]}

$ 0

^{[5],[14],[25],[26]}

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

^{[1],[2],[12],[17],[23]}

4.50%

^{[5],[7],[8],[14],[25]}

4.50%

^{[1],[2],[12],[17],[23]}

4.50%

^{[1],[2],[12],[17],[23]}

4.50%

^{[5],[7],[8],[14],[25]}

4.50%

^{[5],[7],[8],[14],[25]}

Investment, interest rate (as a percent)

9.95%

^{[1],[2],[4],[12],[17],[23]}

9.76%

^{[5],[7],[8],[9],[14],[25]}

9.95%

^{[1],[2],[4],[12],[17],[23]}

9.95%

^{[1],[2],[4],[12],[17],[23]}

9.76%

^{[5],[7],[8],[9],[14],[25]}

9.76%

^{[5],[7],[8],[9],[14],[25]}

Investment, principal

$ 58,349

^{[1],[2],[10],[12],[17],[23]}

$ 58,349

^{[5],[7],[8],[11],[14],[25]}

Investment owned, at cost

51,668

^{[1],[2],[12],[17],[23]}

50,330

^{[5],[7],[8],[14],[25]}

Investments at fair value

$ 48,896

^{[1],[2],[12],[17],[23]}

$ 50,017

^{[5],[7],[8],[14],[25]}

50,283

Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.49%

Investment, principal

^[7],[8],[11]

$ 9,323

Investment owned, at cost

^[7],[8]

9,210

Investments at fair value

^[7],[8]

$ 9,183

Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

9.43%

Investment, principal

$ 10,987

Investment owned, at cost

10,827

Investments at fair value

$ 10,971

Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.25%

4.00%

3.25%

4.00%

Investment, interest rate (as a percent)

8.10%

9.43%

8.10%

9.43%

Investment, principal

$ 3,500

$ 3,849

Investment owned, at cost

3,480

3,830

Investments at fair value

$ 3,453

$ 3,843

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1]

2,613,034

Investment owned, at cost

^[1]

$ 22,330

Investments at fair value

^[1]

$ 13,562

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

9.50%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

14.62%

Investment, principal

^{[1],[10],[17]}

$ 12,070

Investment owned, at cost

^[1],[17]

10,611

Investments at fair value

^[1],[17]

$ 12,070

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

10.00%

Investment, interest rate, paid in kind (as a percent)

^[7],[8]

15.67%

Investment, principal

^[7],[8],[11]

$ 25,712

Investment owned, at cost

^[7],[8]

25,615

Investments at fair value

^[7],[8]

$ 25,069

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[5],[7],[8]

10.00%

Investment, principal

^{[5],[7],[8],[11]}

$ 0

Investment owned, at cost

^[5],[7],[8]

(11)

Investments at fair value

^[5],[7],[8]

$ (69)

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[5],[7],[8]

10.00%

Investment, interest rate, paid in kind (as a percent)

^[5],[7],[8]

15.64%

Investment, principal

^{[5],[7],[8],[11]}

$ 1,210

Investment owned, at cost

^[5],[7],[8]

1,193

Investments at fair value

^[5],[7],[8]

$ 1,169

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[1],[2],[17]

7.75%

^[5],[7],[8]

7.50%

^[1],[2],[17]

7.50%

^[1],[2],[17]

7.75%

^[5],[7],[8]

7.75%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

(34)

^[1],[2],[17]

(42)

^[5],[7],[8]

Investments at fair value

$ 0

^[1],[2],[17]

$ (36)

^[5],[7],[8]

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.75%

Investment, interest rate (as a percent)

^[7],[8],[9]

13.12%

Investment, principal

^[7],[8],[11]

$ 15,231

Investment owned, at cost

^[7],[8]

14,892

Investments at fair value

^[7],[8]

14,945

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

7.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

12.75%

Investment, principal

^{[1],[10],[17]}

$ 15,231

Investment owned, at cost

^[1],[17]

14,956

Investments at fair value

^[1],[17]

$ 15,231

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

7.25%

Investment, interest rate (as a percent)

^[1],[4],[17]

12.50%

Investment, principal

^{[1],[10],[17]}

$ 4,047

Investment owned, at cost

^[1],[17]

3,974

Investments at fair value

^[1],[17]

3,986

Investment, Identifier [Axis]: Other cash accounts

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, at cost

43,946

62,277

Investments at fair value

$ 43,946

$ 62,277

Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[9]

7.75%

Investment, principal

^[11]

$ 4,519

Investment owned, at cost

4,550

Investments at fair value

$ 3,305

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[1],[2],[17]

7.00%

^[5],[7],[8]

5.50%

^[1],[2],[17]

5.50%

^[1],[2],[17]

7.00%

^[5],[7],[8]

7.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

11.35%

Investment, principal

$ 753

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

710

^[1],[2],[17]

(53)

^[5],[7],[8]

Investments at fair value

$ 753

^[1],[2],[17]

$ (54)

^[5],[7],[8]

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.32%

Investment, principal

^[7],[8],[11]

$ 10,895

Investment owned, at cost

^[7],[8]

10,505

Investments at fair value

^[7],[8]

$ 10,495

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

6.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

11.35%

Investment, principal

^{[1],[10],[17]}

$ 10,786

Investment owned, at cost

^[1],[17]

10,471

Investments at fair value

^[1],[17]

$ 10,786

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.10%

Investment, principal

^{[1],[10],[17]}

$ 5,088

Investment owned, at cost

^[1],[17]

5,057

Investments at fair value

^[1],[17]

$ 5,019

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.50%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(71)

Investments at fair value

^[1],[2],[17]

$ (128)

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

100,000

^[1]

100,000

^[8]

100,000

^[1]

100,000

^[1]

100,000

^[8]

100,000

^[8]

Investment owned, at cost

$ 109

^[1]

$ 109

^[8]

Investments at fair value

$ 415

^[1]

$ 248

^[8]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[1],[2],[17]

6.50%

^[5],[7],[8]

6.50%

^[1],[2],[17]

6.50%

^[1],[2],[17]

6.50%

^[5],[7],[8]

6.50%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

(20)

^[1],[2],[17]

(34)

^[5],[7],[8]

Investments at fair value

$ 0

^[1],[2],[17]

$ (3)

^[5],[7],[8]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[1],[17]

6.50%

^[1],[17]

6.50%

^[7],[8]

6.50%

^[7],[8]

Investment, interest rate (as a percent)

11.90%

^[1],[4],[17]

12.01%

^[7],[8],[9]

11.90%

^[1],[4],[17]

11.90%

^[1],[4],[17]

12.01%

^[7],[8],[9]

12.01%

^[7],[8],[9]

Investment, principal

$ 26,176

^{[1],[10],[17]}

$ 38,414

^[7],[8],[11]

Investment owned, at cost

25,994

^[1],[17]

37,960

^[7],[8]

Investments at fair value

$ 26,176

^[1],[17]

$ 38,380

^[7],[8]

Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.42%

Investment, principal

$ 9,825

Investment owned, at cost

9,492

Investments at fair value

$ 9,698

Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

5.00%

Investment, interest rate (as a percent)

^[7],[9]

10.42%

Investment, principal

^[7],[11]

$ 9,676

Investment owned, at cost

^[7]

9,518

Investments at fair value

^[7]

$ 9,551

Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

8.70%

Investment, principal

$ 1,978

Investment owned, at cost

1,977

Investments at fair value

$ 1,909

Investment, Identifier [Axis]: Peraton Corp., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

8.70%

Investment, principal

$ 990

Investment owned, at cost

989

Investments at fair value

$ 954

Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[1],[17]

6.00%

^[7],[8]

5.75%

^[1],[17]

5.75%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[7],[8]

Investment, interest rate (as a percent)

11.11%

^[1],[4],[17]

11.57%

^[7],[8],[9]

11.11%

^[1],[4],[17]

11.11%

^[1],[4],[17]

11.57%

^[7],[8],[9]

11.57%

^[7],[8],[9]

Investment, principal

$ 22,375

^{[1],[10],[17]}

$ 22,375

^[7],[8],[11]

Investment owned, at cost

22,238

^[1],[17]

22,189

^[7],[8]

Investments at fair value

$ 22,375

^[1],[17]

$ 21,896

^[7],[8]

Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

8.70%

Investment, principal

$ 7,948

Investment owned, at cost

7,871

Investments at fair value

$ 7,893

Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

8.70%

Investment, principal

$ 2,980

Investment owned, at cost

2,944

Investments at fair value

$ 2,959

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

6.00%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(117)

Investments at fair value

^[1],[2],[17]

$ (175)

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

6.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.85%

Investment, principal

^{[1],[10],[17]}

$ 52,244

Investment owned, at cost

^[1],[17]

51,330

Investments at fair value

^[1],[17]

$ 50,912

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

6.00%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(69)

Investments at fair value

^[1],[2],[17]

$ (106)

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1]

4,531

Investment owned, at cost

^[1]

$ 4,440

Investments at fair value

^[1]

$ 5,022

Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.25%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.74%

Investment, principal

^[7],[8],[11]

$ 36,499

Investment owned, at cost

^[7],[8]

35,458

Investments at fair value

^[7],[8]

$ 33,214

Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

9.65%

Investment, principal

$ 2,416

Investment owned, at cost

2,298

Investments at fair value

$ 2,390

Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

9.65%

Investment, principal

$ 683

Investment owned, at cost

650

Investments at fair value

$ 676

Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

Investment, interest rate (as a percent)

12.74%

Investment, principal

$ 4,503

Investment owned, at cost

4,435

Investments at fair value

$ 4,098

Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

Investment, interest rate (as a percent)

12.74%

Investment, principal

$ 2,842

Investment owned, at cost

2,799

Investments at fair value

$ 2,586

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1]

4,300,526

Investment, principal

^[1],[10]

Investment owned, at cost

^[1]

14,364

Investments at fair value

^[1]

$ 14,364

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

^[1],[2],[17]

8.00%

^[5],[7],[8]

4.50%

^[1],[2],[17]

4.50%

^[1],[2],[17]

8.00%

^[5],[7],[8]

8.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

^{[5],[7],[8],[9]}

13.45%

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 3,003

^{[5],[7],[8],[11]}

Investment owned, at cost

^[1],[2],[17]

2,926

^[5],[7],[8]

Investments at fair value

$ 0

^[1],[2],[17]

$ 2,801

^[5],[7],[8]

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

8.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

13.45%

Investment, principal

^[7],[8],[11]

$ 67,244

Investment owned, at cost

^[7],[8]

66,353

Investments at fair value

^[7],[8]

$ 64,406

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

4.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

8.12%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

1.50%

Investment, principal

^{[1],[10],[17]}

$ 4,965

Investment owned, at cost

^[1],[17]

4,965

Investments at fair value

^[1],[17]

$ 4,965

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

4.50%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

Investments at fair value

^[1],[2],[17]

$ 0

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

4.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

8.12%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

1.50%

Investment, principal

^{[1],[10],[17]}

$ 8,601

Investment owned, at cost

^[1],[17]

8,601

Investments at fair value

^[1],[17]

$ 8,601

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

7.50%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

12.62%

Investment, principal

^{[1],[10],[17]}

$ 12,902

Investment owned, at cost

^[1],[17]

12,902

Investments at fair value

^[1],[17]

12,902

Investment, Identifier [Axis]: Pluralsight, LLC, Common Equity & Warrants | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, at cost

1,105

Investments at fair value

$ 1,105

Investment, Identifier [Axis]: Pluralsight, LLC, Common Stock | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

514,789,000

Investment owned, at cost

$ 1,719

Investments at fair value

$ 1,719

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

Investment, interest rate (as a percent)

13.45%

Investment, principal

$ 318

Investment owned, at cost

301

Investments at fair value

$ 297

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

Investment, interest rate (as a percent)

13.45%

Investment, principal

$ 226

Investment owned, at cost

216

Investments at fair value

$ 211

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

Investment, interest rate (as a percent)

13.45%

Investment, principal

$ 8,116

Investment owned, at cost

7,850

Investments at fair value

$ 7,773

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

Investment, interest rate (as a percent)

13.45%

Investment, principal

$ 5,182

Investment owned, at cost

5,029

Investments at fair value

$ 4,964

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan 1 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

Investment, interest rate, paid in kind (as a percent)

12.62%

Investment, principal

$ 1,544

Investment owned, at cost

1,544

Investments at fair value

$ 1,544

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

Investment, interest rate (as a percent)

8.12%

Investment, interest rate, paid in kind (as a percent)

1.50%

Investment, principal

$ 662

Investment owned, at cost

662

Investments at fair value

$ 662

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan 2 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

Investment, interest rate (as a percent)

8.12%

Investment, interest rate, paid in kind (as a percent)

1.50%

Investment, principal

$ 1,030

Investment owned, at cost

1,030

Investments at fair value

$ 1,030

Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

Investment, interest rate, paid in kind (as a percent)

12.62%

Investment, principal

$ 993

Investment owned, at cost

993

Investments at fair value

$ 993

Investment, Identifier [Axis]: Poseidon Midco AB, Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

5.50%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

8.97%

Investment, principal | €

^{[1],[10],[12],[17]}

€ 12,868

Investment owned, at cost

^{[1],[12],[17]}

$ 13,949

Investments at fair value

^{[1],[12],[17]}

$ 13,994

Investment, Identifier [Axis]: Poseidon Midco AB, Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[12],[17]}

5.50%

Investment, principal

^{[1],[2],[10],[12],[17]}

$ 0

Investment owned, at cost

^{[1],[2],[12],[17]}

Investments at fair value

^{[1],[2],[12],[17]}

$ 0

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

7.25%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

11.84%

Investment, principal

^{[1],[10],[12],[17]}

$ 26,642

Investment owned, at cost

^{[1],[12],[17]}

26,376

Investments at fair value

^{[1],[12],[17]}

$ 26,410

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.25%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.78%

Investment, principal

^[7],[8],[11]

$ 24,503

Investment owned, at cost

^[7],[8]

24,255

Investments at fair value

^[7],[8]

$ 24,081

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.25%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.78%

Investment, principal

^[7],[8],[11]

$ 2,819

Investment owned, at cost

^[7],[8]

2,797

Investments at fair value

^[7],[8]

$ 2,771

Investment, Identifier [Axis]: Protein For Pets Opco, LLC, Packaged Foods & Meats, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.25%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(39)

Investments at fair value

^[1],[2],[17]

$ (41)

Investment, Identifier [Axis]: Protein For Pets Opco, LLC, Packaged Foods & Meats, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.25%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.10%

Investment, principal

^{[1],[10],[17]}

$ 20,274

Investment owned, at cost

^[1],[17]

19,902

Investments at fair value

^[1],[17]

$ 19,887

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

5.75%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

11.21%

Investment, principal | £

^{[7],[8],[11],[14]}

£ 4,626

Investment owned, at cost

^[7],[8],[14]

$ 5,897

Investments at fair value

^[7],[8],[14]

$ 5,166

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

5.50%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

10.73%

Investment, principal | £

^{[1],[10],[12],[17]}

£ 9,739

Investment owned, at cost

^{[1],[12],[17]}

$ 12,092

Investments at fair value

^{[1],[12],[17]}

$ 12,769

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[12],[17]}

5.50%

Investment, interest rate (as a percent)

^{[1],[2],[4],[12],[17]}

10.70%

Investment, principal

^{[1],[2],[10],[12],[17]}

$ 2,123

Investment owned, at cost

^{[1],[2],[12],[17]}

2,547

Investments at fair value

^{[1],[2],[12],[17]}

$ 2,715

Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

64,887,669

^[1]

64,887,669

^[8]

64,887,669

^[1]

64,887,669

^[1]

64,887,669

^[8]

64,887,669

^[8]

Investment owned, at cost

$ 375

^[1]

$ 375

^[8]

Investments at fair value

$ 0

^[1]

$ 0

^[8]

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[5],[7],[8]

6.50%

Investment, principal

^{[5],[7],[8],[11]}

$ 0

Investment owned, at cost

^[5],[7],[8]

(43)

Investments at fair value

^[5],[7],[8]

$ (47)

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

6.50%

Investment, interest rate (as a percent)

^[7],[8],[9]

11.92%

Investment, principal

^[7],[8],[11]

$ 32,329

Investment owned, at cost

^[7],[8]

32,070

Investments at fair value

^[7],[8]

$ 31,779

Investment, Identifier [Axis]: Renaissance Holding Corp, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.25%

Investment, interest rate (as a percent)

9.10%

Investment, principal

$ 1,985

Investment owned, at cost

1,980

Investments at fair value

$ 1,986

Investment, Identifier [Axis]: Renaissance Holding Corp., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.25%

4.75%

4.25%

4.75%

Investment, interest rate (as a percent)

9.10%

9.99%

9.10%

9.99%

Investment, principal

$ 8,920

$ 5,000

Investment owned, at cost

8,793

4,860

Investments at fair value

$ 8,927

$ 4,969

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^{[1],[12],[17]}

8.25%

^[7],[8],[14]

8.25%

^{[1],[12],[17]}

8.25%

^{[1],[12],[17]}

8.25%

^[7],[8],[14]

8.25%

^[7],[8],[14]

Investment, interest rate (as a percent)

12.77%

^{[1],[4],[12],[17]}

13.90%

^{[7],[8],[9],[14]}

12.77%

^{[1],[4],[12],[17]}

12.77%

^{[1],[4],[12],[17]}

13.90%

^{[7],[8],[9],[14]}

13.90%

^{[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

1.00%

^{[1],[12],[17]}

0.50%

^[7],[8],[14]

1.00%

^{[1],[12],[17]}

1.00%

^{[1],[12],[17]}

0.50%

^[7],[8],[14]

0.50%

^[7],[8],[14]

Investment, principal

$ 8,819

^{[1],[10],[12],[17]}

$ 36,707

^{[7],[8],[11],[14]}

Investment owned, at cost

8,629

^{[1],[12],[17]}

35,548

^[7],[8],[14]

Investments at fair value

$ 8,334

^{[1],[12],[17]}

$ 34,505

^[7],[8],[14]

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^{[1],[12],[17]}

8.25%

^[7],[8],[14]

8.25%

^{[1],[12],[17]}

8.25%

^{[1],[12],[17]}

8.25%

^[7],[8],[14]

8.25%

^[7],[8],[14]

Investment, interest rate (as a percent)

12.77%

^{[1],[4],[12],[17]}

13.90%

^{[7],[8],[9],[14]}

12.77%

^{[1],[4],[12],[17]}

12.77%

^{[1],[4],[12],[17]}

13.90%

^{[7],[8],[9],[14]}

13.90%

^{[7],[8],[9],[14]}

Investment, interest rate, paid in kind (as a percent)

1.00%

^{[1],[12],[17]}

0.50%

^[7],[8],[14]

1.00%

^{[1],[12],[17]}

1.00%

^{[1],[12],[17]}

0.50%

^[7],[8],[14]

0.50%

^[7],[8],[14]

Investment, principal

$ 29,223

^{[1],[10],[12],[17]}

$ 13,504

^{[7],[8],[11],[14]}

Investment owned, at cost

28,603

^{[1],[12],[17]}

13,058

^[7],[8],[14]

Investments at fair value

$ 27,615

^{[1],[12],[17]}

$ 12,694

^[7],[8],[14]

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

204,454

^[1],[12]

204,454

^[8],[14]

204,454

^[1],[12]

204,454

^[1],[12]

204,454

^[8],[14]

204,454

^[8],[14]

Investment owned, at cost

$ 1,202

^[1],[12]

$ 1,202

^[8],[14]

Investments at fair value

$ 470

^[1],[12]

$ 756

^[8],[14]

Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.50%

Investment, interest rate (as a percent)

8.76%

Investment, principal

$ 2,963

Investment owned, at cost

2,963

Investments at fair value

$ 2,966

Investment, Identifier [Axis]: SCIH Salt Holdings Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.50%

Investment, interest rate (as a percent)

8.76%

Investment, principal

$ 1,480

Investment owned, at cost

1,481

Investments at fair value

1,483

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8]

1,037

Investment owned, at cost

^[8]

$ 1,037

Investments at fair value

^[8]

$ 951

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

8.75%

Investment, interest rate (as a percent)

^[7],[8],[9]

14.18%

Investment, principal

^[7],[8],[11]

$ 8,010

Investment owned, at cost

^[7],[8]

7,799

Investments at fair value

^[7],[8]

$ 7,778

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[5],[7],[8]

8.75%

Investment, principal

^{[5],[7],[8],[11]}

$ 0

Investment owned, at cost

^[5],[7],[8]

(35)

Investments at fair value

^[5],[7],[8]

$ (68)

Investment, Identifier [Axis]: SHO Holding I Corporation, Common Equity & Warrants | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, at cost

3,194

Investments at fair value

$ 2,337

Investment, Identifier [Axis]: SHO Holding I Corporation, Common Stock | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

2,746,000

Investment owned, at cost

$ 4,295

Investments at fair value

$ 3,145

Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

5.23%

6.50%

5.23%

Investment, interest rate (as a percent)

11.82%

10.86%

11.82%

10.86%

Investment, principal

$ 938

$ 138

Investment owned, at cost

893

138

Investments at fair value

$ 919

$ 94

Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

5.25%

6.50%

5.25%

Investment, interest rate (as a percent)

11.82%

10.88%

11.82%

10.88%

Investment, principal

$ 697

$ 6,029

Investment owned, at cost

664

6,025

Investments at fair value

$ 683

$ 4,110

Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

5.25%

6.50%

5.25%

Investment, interest rate (as a percent)

11.82%

10.88%

11.82%

10.88%

Investment, principal

$ 2,634

$ 8,113

Investment owned, at cost

2,634

8,111

Investments at fair value

$ 2,529

$ 5,531

Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

5.23%

6.50%

5.23%

Investment, interest rate (as a percent)

11.82%

10.86%

11.82%

10.86%

Investment, principal

$ 1,957

$ 103

Investment owned, at cost

1,957

102

Investments at fair value

$ 1,879

$ 70

Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 3 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

Investment, interest rate (as a percent)

12.32%

Investment, principal

$ 1,451

Investment owned, at cost

1,451

Investments at fair value

$ 1,306

Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 3 | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

Investment, interest rate (as a percent)

12.32%

Investment, principal

$ 1,078

Investment owned, at cost

1,078

Investments at fair value

$ 970

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

1,184,630

^[1]

1,184,630

^[8]

1,184,630

^[1]

1,184,630

^[1]

1,184,630

^[8]

1,184,630

^[8]

Investment owned, at cost

$ 40,093

^[1]

$ 40,093

^[8]

Investments at fair value

$ 20,802

^[1]

$ 36,226

^[8]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

12.00%

^[1]

12.00%

^[8]

12.00%

^[1]

12.00%

^[1]

12.00%

^[8]

12.00%

^[8]

Investment, principal

$ 17,907

^[1],[10]

$ 15,874

^[8],[11]

Investment owned, at cost

16,339

^[1]

14,100

^[8]

Investments at fair value

$ 17,907

^[1]

$ 15,874

^[8]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

12.00%

^[1]

12.00%

^[5],[8]

12.00%

^[1]

12.00%

^[1]

12.00%

^[5],[8]

12.00%

^[5],[8]

Investment, principal

$ 3,550

^[1],[10]

$ 1,359

^[5],[8],[11]

Investment owned, at cost

3,500

^[1]

1,337

^[5],[8]

Investments at fair value

$ 3,550

^[1]

1,359

^[5],[8]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1]

12.00%

Investment, principal

^[1],[10]

$ 3,332

Investment owned, at cost

^[1]

3,243

Investments at fair value

$ 3,332

^[1]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1]

12.00%

Investment, principal

^[1],[10]

$ 1,600

Investment owned, at cost

^[1]

1,594

Investments at fair value

$ 1,600

^[1]

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 5

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1],[2]

12.00%

Investment, principal

^[1],[2],[10]

$ 0

Investment owned, at cost

^[1],[2]

Investments at fair value

$ 0

^[1],[2]

$ 0

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

66,686

^[1]

66,686

^[8]

66,686

^[1]

66,686

^[1]

66,686

^[8]

66,686

^[8]

Investment owned, at cost

$ 0

^[1]

$ 0

^[8]

Investments at fair value

$ 0

^[1]

$ 0

^[8]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

4.75%

4.50%

4.75%

Investment, interest rate (as a percent)

10.01%

10.38%

10.01%

10.38%

Investment, principal

$ 2,947

$ 2,977

Investment owned, at cost

2,640

2,580

Investments at fair value

$ 2,888

$ 2,799

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

^[1],[17]

4.75%

^[7],[8]

4.50%

^[1],[17]

4.50%

^[1],[17]

4.75%

^[7],[8]

4.75%

^[7],[8]

Investment, interest rate (as a percent)

10.01%

^[1],[4],[17]

10.38%

^[7],[8],[9]

10.01%

^[1],[4],[17]

10.01%

^[1],[4],[17]

10.38%

^[7],[8],[9]

10.38%

^[7],[8],[9]

Investment, principal

$ 4,406

^{[1],[10],[17]}

$ 4,452

^[7],[8],[11]

Investment owned, at cost

3,908

^[1],[17]

3,806

^[7],[8]

Investments at fair value

$ 4,318

^[1],[17]

$ 4,184

^[7],[8]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[1],[17]

8.00%

^[7],[8]

8.00%

^[1],[17]

8.00%

^[1],[17]

8.00%

^[7],[8]

8.00%

^[7],[8]

Investment, interest rate (as a percent)

13.51%

^[1],[4],[17]

13.63%

^[7],[8],[9]

13.51%

^[1],[4],[17]

13.51%

^[1],[4],[17]

13.63%

^[7],[8],[9]

13.63%

^[7],[8],[9]

Investment, principal

$ 12,034

^{[1],[10],[17]}

$ 12,034

^[7],[8],[11]

Investment owned, at cost

11,367

^[1],[17]

11,250

^[7],[8]

Investments at fair value

$ 11,432

^[1],[17]

$ 9,928

^[7],[8]

Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

Investment, interest rate (as a percent)

9.92%

Investment, principal

$ 8,801

Investment owned, at cost

8,442

Investments at fair value

$ 8,794

Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

Investment, interest rate (as a percent)

9.92%

Investment, principal

$ 5,227

Investment owned, at cost

5,032

Investments at fair value

$ 5,224

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

6.75%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.40%

Investment, principal

^[7],[8],[11]

$ 25,527

Investment owned, at cost

^[7],[8]

23,859

Investments at fair value

^[7],[8]

$ 19,954

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[16],[17]}

8.25%

Investment, principal

^{[1],[10],[16],[17]}

$ 28,146

Investment owned, at cost

^{[1],[16],[17]}

23,170

Investments at fair value

^{[1],[16],[17]}

$ 8,444

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[16],[17]}

9.75%

Investment, principal

^{[1],[2],[10],[16],[17]}

$ 932

Investment owned, at cost

^{[1],[2],[16],[17]}

932

Investments at fair value

^{[1],[2],[16],[17]}

$ 932

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

10.00%

^[1],[2],[17]

10.00%

^[5],[7],[8]

10.00%

^[1],[2],[17]

10.00%

^[1],[2],[17]

10.00%

^[5],[7],[8]

10.00%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

(63)

^[1],[2],[17]

(95)

^[5],[7],[8]

Investments at fair value

$ (140)

^[1],[2],[17]

$ (93)

^[5],[7],[8]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

10.00%

^[1],[17]

10.00%

^[7],[8]

10.00%

^[1],[17]

10.00%

^[1],[17]

10.00%

^[7],[8]

10.00%

^[7],[8]

Investment, interest rate (as a percent)

14.85%

^[1],[4],[17]

15.24%

^[7],[8],[9]

14.85%

^[1],[4],[17]

14.85%

^[1],[4],[17]

15.24%

^[7],[8],[9]

15.24%

^[7],[8],[9]

Investment, principal

$ 22,107

^{[1],[10],[17]}

$ 25,558

^[7],[8],[11]

Investment owned, at cost

21,656

^[1],[17]

24,777

^[7],[8]

Investments at fair value

$ 21,112

^[1],[17]

$ 24,791

^[7],[8]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

991,019

^[1]

991,019

^[8]

991,019

^[1]

991,019

^[1]

991,019

^[8]

991,019

^[8]

Investment owned, at cost

$ 327

^[1]

$ 327

^[8]

Investments at fair value

$ 89

^[1]

$ 1,625

^[8]

Investment, Identifier [Axis]: Saratoga, Diversified Financial Services, Credit Linked Note

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17],[27]}

5.33%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17],[27]}

10.18%

Investment, principal

^{[1],[10],[12],[17],[27]}

$ 24,500

Investment owned, at cost

^{[1],[12],[17],[27]}

24,478

Investments at fair value

^{[1],[12],[17],[27]}

$ 24,478

Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

9,307

^[12]

9,307

^[14]

9,307

^[12]

9,307

^[12]

9,307

^[14]

9,307

^[14]

Investment owned, at cost

$ 78

^[12]

$ 78

^[14]

Investments at fair value

$ 9

^[12]

^[14]

Investment, Identifier [Axis]: Secure Acquisition Inc., Paper & Plastic Packaging Products & Materials, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[17]

4.25%

Investment, interest rate (as a percent)

^[4],[17]

8.85%

Investment, principal

^[10],[17]

$ 14,963

Investment owned, at cost

^[17]

14,925

Investments at fair value

^[17]

15,009

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, at cost

54,791

^{[1],[2],[12],[22],[23],[24]}

54,791

^{[5],[14],[25],[26],[28]}

Investments at fair value

$ 22,541

^{[1],[2],[12],[22],[23],[24]}

$ 28,878

^{[5],[14],[25],[26],[28]}

20,715

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^{[1],[2],[12],[17],[23]}

7.00%

^{[5],[7],[8],[14],[25]}

7.00%

^{[1],[2],[12],[17],[23]}

7.00%

^{[1],[2],[12],[17],[23]}

7.00%

^{[5],[7],[8],[14],[25]}

7.00%

^{[5],[7],[8],[14],[25]}

Investment, interest rate (as a percent)

12.45%

^{[1],[2],[4],[12],[17],[23]}

12.26%

^{[5],[7],[8],[9],[14],[25]}

12.45%

^{[1],[2],[4],[12],[17],[23]}

12.45%

^{[1],[2],[4],[12],[17],[23]}

12.26%

^{[5],[7],[8],[9],[14],[25]}

12.26%

^{[5],[7],[8],[9],[14],[25]}

Investment, principal

$ 112,656

^{[1],[2],[10],[12],[17],[23]}

$ 112,656

^{[5],[7],[8],[11],[14],[25]}

Investment owned, at cost

112,656

^{[1],[2],[12],[17],[23]}

112,656

^{[5],[7],[8],[14],[25]}

Investments at fair value

$ 112,656

^{[1],[2],[12],[17],[23]}

$ 112,656

^{[5],[7],[8],[14],[25]}

$ 96,250

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

7.88%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

12.88%

Investment, principal

^{[7],[8],[11],[14]}

$ 7,191

Investment owned, at cost

^[7],[8],[14]

6,934

Investments at fair value

^[7],[8],[14]

$ 6,937

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

7.88%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

12.88%

Investment, principal

^{[7],[8],[11],[14]}

$ 2,697

Investment owned, at cost

^[7],[8],[14]

2,601

Investments at fair value

^[7],[8],[14]

$ 2,602

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[5],[7],[8],[14]}

7.88%

Investment, principal

^{[5],[7],[8],[11],[14]}

$ 0

Investment owned, at cost

^{[5],[7],[8],[14]}

Investments at fair value

^{[5],[7],[8],[14]}

$ 0

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[5],[7],[8],[14]}

7.88%

Investment, principal

^{[5],[7],[8],[11],[14]}

$ 0

Investment owned, at cost

^{[5],[7],[8],[14]}

Investments at fair value

^{[5],[7],[8],[14]}

$ 0

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

58,210

^[1],[12]

58,210

^[8],[14]

58,210

^[1],[12]

58,210

^[1],[12]

58,210

^[8],[14]

58,210

^[8],[14]

Investment owned, at cost

$ 182

^[1],[12]

$ 182

^[8],[14]

Investments at fair value

$ 29

^[1],[12]

$ 87

^[8],[14]

Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8]

345,452

Investment owned, at cost

^[8]

$ 367

Investments at fair value

^[8]

$ 0

Investment, Identifier [Axis]: Shearer's Foods LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

8.85%

Investment, principal

$ 6,983

Investment owned, at cost

6,913

Investments at fair value

$ 6,996

Investment, Identifier [Axis]: Shearer's Foods LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

8.85%

Investment, principal

$ 2,993

Investment owned, at cost

2,963

Investments at fair value

$ 2,998

Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.50%

Investment, interest rate (as a percent)

^[7],[8],[9]

13.04%

Investment, principal

^[7],[8],[11]

$ 821

Investment owned, at cost

^[7],[8]

813

Investments at fair value

^[7],[8]

$ 776

Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.75%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(98)

Investments at fair value

^[1],[2],[17]

$ (89)

Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.75%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.60%

Investment, principal

^{[1],[10],[17]}

$ 47,730

Investment owned, at cost

^[1],[17]

46,862

Investments at fair value

^[1],[17]

$ 46,947

Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

66,000

^[12]

66,000

^[14]

66,000

^[12]

66,000

^[12]

66,000

^[14]

66,000

^[14]

Investment owned, at cost

$ 139

^[12]

$ 139

^[14]

Investments at fair value

$ 0

^[12]

$ 6

^[14]

Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

9.43%

Investment, principal

$ 7,680

Investment owned, at cost

7,642

Investments at fair value

$ 7,643

Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

4.00%

3.75%

4.00%

Investment, interest rate (as a percent)

8.00%

9.43%

8.00%

9.43%

Investment, principal

$ 3,266

$ 3,292

Investment owned, at cost

3,250

3,275

Investments at fair value

$ 3,277

$ 3,276

Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan 1 | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

8.00%

Investment, principal

$ 8,601

Investment owned, at cost

8,563

Investments at fair value

$ 8,628

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[1],[2],[17]

5.00%

^[5],[7],[8]

5.00%

^[1],[2],[17]

5.00%

^[1],[2],[17]

5.00%

^[5],[7],[8]

5.00%

^[5],[7],[8]

Investment, interest rate (as a percent)

^{[5],[7],[8],[9]}

10.42%

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 618

^{[5],[7],[8],[11]}

Investment owned, at cost

(32)

^[1],[2],[17]

576

^[5],[7],[8]

Investments at fair value

$ (15)

^[1],[2],[17]

$ 577

^[5],[7],[8]

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

^[1],[17]

5.25%

^[7],[8]

5.25%

^[1],[17]

5.25%

^[1],[17]

5.25%

^[7],[8]

5.25%

^[7],[8]

Investment, interest rate (as a percent)

10.20%

^[1],[4],[17]

10.67%

^[7],[8],[9]

10.20%

^[1],[4],[17]

10.20%

^[1],[4],[17]

10.67%

^[7],[8],[9]

10.67%

^[7],[8],[9]

Investment, principal

$ 18,058

^{[1],[10],[17]}

$ 4,488

^[7],[8],[11]

Investment owned, at cost

17,887

^[1],[17]

4,423

^[7],[8]

Investments at fair value

$ 18,032

^[1],[17]

$ 4,425

^[7],[8]

Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

10.67%

Investment, principal

$ 8,843

Investment owned, at cost

8,713

Investments at fair value

$ 8,717

Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

Investment, interest rate (as a percent)

10.67%

Investment, principal

$ 4,913

Investment owned, at cost

4,840

Investments at fair value

$ 4,843

Investment, Identifier [Axis]: Staples, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

Investment, interest rate (as a percent)

10.69%

Investment, principal

$ 5,349

Investment owned, at cost

5,147

Investments at fair value

$ 4,873

Investment, Identifier [Axis]: Staples, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

Investment, interest rate (as a percent)

10.69%

Investment, principal

$ 1,918

Investment owned, at cost

1,846

Investments at fair value

$ 1,748

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[17]

5.75%

Investment, interest rate (as a percent)

^[4],[17]

10.69%

Investment, principal

^[10],[17]

$ 13,780

Investment owned, at cost

^[17]

13,259

Investments at fair value

^[17]

$ 12,555

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[4]

10.75%

Investment, principal

^[10]

$ 6,835

Investment owned, at cost

6,771

Investments at fair value

$ 6,641

Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

4.00%

3.75%

4.00%

Investment, interest rate (as a percent)

8.35%

9.33%

8.35%

9.33%

Investment, principal

$ 7,960

$ 8,000

Investment owned, at cost

7,841

7,880

Investments at fair value

$ 7,757

$ 7,834

Investment, Identifier [Axis]: Star Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

4.00%

3.75%

4.00%

Investment, interest rate (as a percent)

8.35%

9.33%

8.35%

9.33%

Investment, principal

$ 3,980

$ 4,000

Investment owned, at cost

3,920

3,939

Investments at fair value

$ 3,878

$ 3,916

Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

8.50%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

12.32%

Investment, principal | €

^{[7],[8],[11],[14]}

€ 23,731

Investment owned, at cost

^[7],[8],[14]

$ 26,772

Investments at fair value

^[7],[8],[14]

$ 24,937

Investment, Identifier [Axis]: SumUp Holdings Luxembourg, Diversified Financial Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[12],[17]}

6.50%

Investment, interest rate (as a percent)

^{[1],[2],[4],[12],[17]}

10.04%

Investment, principal

^{[1],[2],[10],[12],[17]}

$ 18,846

Investment owned, at cost

^{[1],[2],[12],[17]}

20,199

Investments at fair value

^{[1],[2],[12],[17]}

$ 20,785

Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

8.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

13.32%

Investment, principal

^[7],[8],[11]

$ 49,520

Investment owned, at cost

^[7],[8]

48,536

Investments at fair value

^[7],[8]

$ 49,148

Investment, Identifier [Axis]: SupplyOne Inc, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.25%

Investment, interest rate (as a percent)

9.10%

Investment, principal

$ 4,478

Investment owned, at cost

4,433

Investments at fair value

$ 4,496

Investment, Identifier [Axis]: SupplyOne Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.25%

Investment, interest rate (as a percent)

9.10%

Investment, principal

$ 1,493

Investment owned, at cost

1,478

Investments at fair value

$ 1,499

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[1],[2],[17]

7.00%

^[7],[8],[29]

7.00%

^[1],[2],[17]

7.00%

^[1],[2],[17]

7.00%

^[7],[8],[29]

7.00%

^[7],[8],[29]

Investment, interest rate (as a percent)

^{[7],[8],[9],[29]}

12.44%

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 1,552

^{[7],[8],[11],[29]}

Investment owned, at cost

(8)

^[1],[2],[17]

1,540

^[7],[8],[29]

Investments at fair value

$ (62)

^[1],[2],[17]

$ 1,478

^[7],[8],[29]

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[5],[7],[8],[29]}

7.00%

Investment, interest rate (as a percent)

^{[5],[7],[8],[9],[29]}

12.51%

Investment, principal

^{[5],[7],[8],[11],[29]}

$ 1,099

Investment owned, at cost

^{[5],[7],[8],[29]}

1,062

Investments at fair value

^{[5],[7],[8],[29]}

$ 943

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[1],[17]

7.00%

^[7],[8],[29]

7.00%

^[1],[17]

7.00%

^[1],[17]

7.00%

^[7],[8],[29]

7.00%

^[7],[8],[29]

Investment, interest rate (as a percent)

12.58%

^[1],[4],[17]

12.51%

^{[7],[8],[9],[29]}

12.58%

^[1],[4],[17]

12.58%

^[1],[4],[17]

12.51%

^{[7],[8],[9],[29]}

12.51%

^{[7],[8],[9],[29]}

Investment, principal

$ 2,721

^{[1],[10],[17]}

$ 32,104

^{[7],[8],[11],[29]}

Investment owned, at cost

2,706

^[1],[17]

31,861

^[7],[8],[29]

Investments at fair value

$ 2,612

^[1],[17]

$ 30,579

^[7],[8],[29]

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[1],[17]

7.00%

^[7],[8],[29]

7.00%

^[1],[17]

7.00%

^[1],[17]

7.00%

^[7],[8],[29]

7.00%

^[7],[8],[29]

Investment, interest rate (as a percent)

12.58%

^[1],[4],[17]

12.51%

^{[7],[8],[9],[29]}

12.58%

^[1],[4],[17]

12.58%

^[1],[4],[17]

12.51%

^{[7],[8],[9],[29]}

12.51%

^{[7],[8],[9],[29]}

Investment, principal

$ 2,749

^{[7],[8],[11],[29]}

€ 3,273

^{[1],[10],[17]}

Investment owned, at cost

$ 3,160

^[1],[17]

2,726

^[7],[8],[29]

Investments at fair value

$ 3,142

^[1],[17]

$ 2,618

^[7],[8],[29]

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

7.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

12.58%

Investment, principal

^{[1],[10],[17]}

$ 31,778

Investment owned, at cost

^[1],[17]

31,612

Investments at fair value

^[1],[17]

$ 30,507

Investment, Identifier [Axis]: Swissport Stratosphere USA LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.25%

Investment, interest rate (as a percent)

9.57%

Investment, principal

$ 5,486

Investment owned, at cost

5,459

Investments at fair value

$ 5,512

Investment, Identifier [Axis]: Swissport Stratosphere Usa LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.25%

Investment, interest rate (as a percent)

9.57%

Investment, principal

$ 1,995

Investment owned, at cost

1,985

Investments at fair value

$ 2,004

Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^{[6],[7],[8],[9],[14]}

11.50%

Investment, principal

^{[6],[8],[11],[14]}

$ 4,984

Investment owned, at cost

^[6],[8],[14]

4,894

Investments at fair value

^[6],[8],[14]

$ 4,785

Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

13.00%

^[1],[4],[12]

13.00%

^{[7],[8],[9],[14]}

13.00%

^[1],[4],[12]

13.00%

^[1],[4],[12]

13.00%

^{[7],[8],[9],[14]}

13.00%

^{[7],[8],[9],[14]}

Investment, principal

$ 50,419

^{[1],[10],[12]}

$ 50,419

^{[8],[11],[14]}

Investment owned, at cost

50,061

^[1],[12]

49,842

^[8],[14]

Investments at fair value

$ 50,419

^[1],[12]

$ 49,869

^[8],[14]

Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

Investment, interest rate (as a percent)

9.99%

Investment, principal

$ 8,215

Investment owned, at cost

7,559

Investments at fair value

$ 7,913

Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

Investment, interest rate (as a percent)

9.99%

Investment, principal

$ 2,641

Investment owned, at cost

2,439

Investments at fair value

$ 2,544

Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

8.00%

Investment, interest rate (as a percent)

^[7],[9]

13.43%

Investment, principal

^[7],[11]

$ 12,843

Investment owned, at cost

^[7]

12,603

Investments at fair value

^[7]

$ 12,464

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[5],[7],[8],[14]}

6.00%

Investment, principal

^{[5],[7],[8],[11],[14]}

$ 0

Investment owned, at cost

^{[5],[7],[8],[14]}

(29)

Investments at fair value

^{[5],[7],[8],[14]}

$ (22)

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

6.00%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

11.42%

Investment, principal

^{[7],[8],[11],[14]}

$ 28,826

Investment owned, at cost

^[7],[8],[14]

28,595

Investments at fair value

^[7],[8],[14]

$ 28,537

Investment, Identifier [Axis]: Telephone and Data Systems, Inc., Wireless Telecommunication Services, Subordinated Debt Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[12],[17]}

7.00%

Investment, interest rate (as a percent)

^{[1],[4],[12],[17]}

12.25%

Investment, principal

^{[1],[10],[12],[17]}

$ 25,031

Investment owned, at cost

^{[1],[12],[17]}

24,343

Investments at fair value

^{[1],[12],[17]}

$ 24,405

Investment, Identifier [Axis]: Telephone and Data Systems, Inc., Wireless Telecommunication Services, Subordinated Debt Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[2],[12],[17]}

7.00%

Investment, principal

^{[1],[2],[10],[12],[17]}

$ 0

Investment owned, at cost

^{[1],[2],[12],[17]}

(86)

Investments at fair value

^{[1],[2],[12],[17]}

$ (94)

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

9.75%

^{[1],[2],[16],[17]}

9.75%

^[5],[7],[8]

9.75%

^{[1],[2],[16],[17]}

9.75%

^{[1],[2],[16],[17]}

9.75%

^[5],[7],[8]

9.75%

^[5],[7],[8]

Investment, interest rate (as a percent)

^{[5],[7],[8],[9]}

15.17%

Investment, principal

$ 1,946

^{[1],[2],[10],[16],[17]}

$ 1,861

^{[5],[7],[8],[11]}

Investment owned, at cost

1,918

^{[1],[2],[16],[17]}

1,845

^[5],[7],[8]

Investments at fair value

$ 1,727

^{[1],[2],[16],[17]}

$ 1,802

^[5],[7],[8]

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

9.75%

^{[1],[16],[17]}

9.75%

^[7],[8]

9.75%

^{[1],[16],[17]}

9.75%

^{[1],[16],[17]}

9.75%

^[7],[8]

9.75%

^[7],[8]

Investment, interest rate (as a percent)

^[7],[8],[9]

15.26%

Investment, principal

$ 26,553

^{[1],[10],[16],[17]}

$ 23,423

^[7],[8],[11]

Investment owned, at cost

25,237

^{[1],[16],[17]}

23,207

^[7],[8]

Investments at fair value

$ 23,898

^{[1],[16],[17]}

$ 22,814

^[7],[8]

Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[1],[17]

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[7],[8]

Investment, interest rate (as a percent)

10.74%

^[1],[4],[17]

11.32%

^[7],[8],[9]

10.74%

^[1],[4],[17]

10.74%

^[1],[4],[17]

11.32%

^[7],[8],[9]

11.32%

^[7],[8],[9]

Investment, principal

$ 19,683

^{[1],[10],[17]}

$ 19,947

^[7],[8],[11]

Investment owned, at cost

18,960

^[1],[17]

19,013

^[7],[8]

Investments at fair value

$ 18,837

^[1],[17]

$ 19,199

^[7],[8]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[18]

7.30%

Investment, principal

^{[7],[8],[11],[18]}

$ 19,163

Investment owned, at cost

^[7],[8],[18]

19,163

Investments at fair value

^[7],[8],[18]

18,340

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1],[16]

10.00%

Investment, principal

^{[1],[10],[16]}

$ 5,065

Investment owned, at cost

^[1],[16]

4,657

Investments at fair value

$ 4,087

^[1],[16]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[1],[16]

10.00%

Investment, principal

^{[1],[10],[16]}

$ 20,917

Investment owned, at cost

^[1],[16]

19,262

Investments at fair value

18,235

^[1],[16]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

Investment owned, at cost

^[1]

Investments at fair value

$ 0

^[1]

$ 0

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[18]

12.50%

Investment, principal

^{[7],[8],[11],[18]}

$ 4,641

Investment owned, at cost

^[7],[8],[18]

4,641

Investments at fair value

^[7],[8],[18]

$ 4,170

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1]

321,058

Investment, principal

^[1],[10]

$ 0

Investment owned, at cost

^[1]

Investments at fair value

^[1]

$ 0

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.00%

Investment, interest rate, paid in kind (as a percent)

^[7],[8]

12.65%

Investment, principal

^[7],[8],[11]

$ 46,832

Investment owned, at cost

^[7],[8]

45,698

Investments at fair value

^[7],[8]

$ 37,231

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

10.00%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

15.54%

Investment, principal

^{[1],[10],[17]}

$ 6,141

Investment owned, at cost

^[1],[17]

5,952

Investments at fair value

^[1],[17]

$ 6,018

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[1],[16],[17]}

10.00%

Investment, principal

^{[1],[10],[16],[17]}

$ 18,844

Investment owned, at cost

^{[1],[16],[17]}

16,279

Investments at fair value

^{[1],[16],[17]}

$ 16,536

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8]

10,616

Investment owned, at cost

^[8]

$ 120

Investments at fair value

^[8]

$ 0

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8]

358,299

Investment owned, at cost

^[8]

$ 2,912

Investments at fair value

^[8]

$ 0

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8]

60,862

Investment owned, at cost

^[8]

$ 1,207

Investments at fair value

^[8]

$ 108

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8]

32,447

Investment owned, at cost

^[8]

$ 33,353

Investments at fair value

^[8]

31,701

Investment, Identifier [Axis]: Total Portfolio Investments, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

332,637

Investment owned, at cost

331,808

Investments at fair value

$ 322,179

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

10.95%

11.42%

10.95%

11.42%

Investment, principal

$ 7,139

$ 7,212

Investment owned, at cost

7,052

7,103

Investments at fair value

$ 6,996

$ 7,022

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

Investment, interest rate (as a percent)

10.95%

11.42%

10.95%

11.42%

Investment, principal

$ 8

$ 2,993

Investment owned, at cost

2,948

Investments at fair value

$ 7

$ 2,914

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[1],[17]

6.00%

^[1],[17]

6.00%

^[7],[8]

6.00%

^[7],[8]

Investment, interest rate (as a percent)

10.95%

^[1],[4],[17]

11.42%

^[7],[8],[9]

10.95%

^[1],[4],[17]

10.95%

^[1],[4],[17]

11.42%

^[7],[8],[9]

11.42%

^[7],[8],[9]

Investment, principal

$ 14,508

^{[1],[10],[17]}

$ 11,671

^[7],[8],[11]

Investment owned, at cost

14,426

^[1],[17]

11,646

^[7],[8]

Investments at fair value

$ 14,218

^[1],[17]

$ 11,363

^[7],[8]

Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

8.60%

Investment, principal

$ 7,481

Investment owned, at cost

7,481

Investments at fair value

$ 7,502

Investment, Identifier [Axis]: Trident TPI Holdings, Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

Investment, interest rate (as a percent)

8.60%

Investment, principal

$ 2,494

Investment owned, at cost

2,494

Investments at fair value

$ 2,502

Investment, Identifier [Axis]: Trinitas CLO VI Ltd., Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[17]

7.08%

Investment, interest rate (as a percent)

^{[4],[12],[17]}

12.36%

Investment, principal

^{[10],[12],[17]}

$ 905

Investment owned, at cost

^[12],[17]

852

Investments at fair value

^[12],[17]

$ 856

Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

7.71%

^[12],[17]

7.71%

^[7],[14]

7.71%

^[12],[17]

7.71%

^[12],[17]

7.71%

^[7],[14]

7.71%

^[7],[14]

Investment, interest rate (as a percent)

12.99%

^{[4],[12],[17]}

13.06%

^[7],[9],[14]

12.99%

^{[4],[12],[17]}

12.99%

^{[4],[12],[17]}

13.06%

^[7],[9],[14]

13.06%

^[7],[9],[14]

Investment, principal

$ 1,000

^{[10],[12],[17]}

$ 1,000

^{[7],[11],[14]}

Investment owned, at cost

824

^[12],[17]

816

^[7],[14]

Investments at fair value

$ 978

^[12],[17]

$ 917

^[7],[14]

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.75%

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

10.85%

Investment, principal

^{[1],[2],[10],[17]}

$ 29

Investment owned, at cost

^[1],[2],[17]

(23)

Investments at fair value

^[1],[2],[17]

$ 29

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.75%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.86%

Investment, principal

^{[1],[10],[17]}

$ 26,457

Investment owned, at cost

^[1],[17]

25,976

Investments at fair value

^[1],[17]

$ 26,457

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.75%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(52)

Investments at fair value

^[1],[2],[17]

$ 0

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.25%

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

10.10%

Investment, principal

^{[1],[2],[10],[17]}

$ 975

Investment owned, at cost

^[1],[2],[17]

955

Investments at fair value

^[1],[2],[17]

$ 955

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

5.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

10.35%

Investment, principal

^{[1],[10],[17]}

$ 15,773

Investment owned, at cost

^[1],[17]

15,617

Investments at fair value

^[1],[17]

$ 15,618

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

5.50%

Investment, interest rate (as a percent)

^{[1],[2],[4],[17]}

10.35%

Investment, principal

^{[1],[2],[10],[17]}

$ 24

Investment owned, at cost

^[1],[2],[17]

Investments at fair value

^[1],[2],[17]

$ 15

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[9],[14]

6.50%

Investment, principal

^[11],[14]

$ 4,500

Investment owned, at cost

^[14]

4,115

Investments at fair value

^[14]

$ 2,953

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[7],[9],[14]

4.75%

Investment, principal

^[11],[14]

$ 300

Investment owned, at cost

^[14]

264

Investments at fair value

^[14]

$ 245

Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

Investment, interest rate (as a percent)

10.43%

Investment, principal

$ 6,305

Investment owned, at cost

6,257

Investments at fair value

$ 5,500

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[1],[4],[12]

11.00%

Investment, principal

^{[1],[10],[12]}

$ 2,512

Investment owned, at cost

^[1],[12]

2,466

Investments at fair value

^[1],[12]

$ 2,468

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, interest rate (as a percent)

^[1],[4],[12]

11.00%

Investment, principal

^{[1],[10],[12]}

$ 3,198

Investment owned, at cost

^[1],[12]

3,134

Investments at fair value

^[1],[12]

3,142

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[10],[12]}

Investment owned, at cost

^[1],[2],[12]

Investments at fair value

^[1],[2],[12]

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 4

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[10],[12]}

Investment owned, at cost

^[1],[2],[12]

Investments at fair value

^[1],[2],[12]

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 5

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[10],[12],[13]}

4,652

Investment owned, at cost

^{[1],[12],[13]}

4,652

Investments at fair value

^{[1],[12],[13]}

4,699

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 6

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, principal

^{[1],[2],[10],[12],[13]}

Investment owned, at cost

^{[1],[2],[12],[13]}

Investments at fair value

^{[1],[2],[12],[13]}

$ 0

Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.25%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.68%

Investment, principal

^[7],[8],[11]

$ 1,140

Investment owned, at cost

^[7],[8]

927

Investments at fair value

^[7],[8]

$ 1,139

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[2],[17]

6.75%

Investment, principal

^{[1],[2],[10],[17]}

$ 0

Investment owned, at cost

^[1],[2],[17]

(70)

Investments at fair value

^[1],[2],[17]

$ (19)

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

3.75%

Investment, interest rate (as a percent)

^[7],[9]

9.27%

Investment, principal

^[7],[11]

$ 11,792

Investment owned, at cost

^[7]

11,281

Investments at fair value

^[7]

$ 11,127

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

7.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

8.39%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

4.13%

Investment, principal

^{[1],[10],[17]}

$ 30,570

Investment owned, at cost

^[1],[17]

29,933

Investments at fair value

^[1],[17]

$ 30,396

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

7.50%

Investment, interest rate (as a percent)

^[1],[4],[17]

8.39%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

4.13%

Investment, principal

^{[1],[10],[17]}

$ 1,449

Investment owned, at cost

^[1],[17]

1,449

Investments at fair value

^[1],[17]

$ 1,448

Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

9.27%

Investment, principal

$ 1,965

Investment owned, at cost

1,920

Investments at fair value

$ 1,855

Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.75%

Investment, interest rate (as a percent)

9.27%

Investment, principal

$ 983

Investment owned, at cost

960

Investments at fair value

$ 927

Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

7.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

12.65%

Investment, principal

^[7],[8],[11]

$ 5,000

Investment owned, at cost

^[7],[8]

4,925

Investments at fair value

^[7],[8]

$ 4,263

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[1],[17]

14.00%

Investment, interest rate (as a percent)

^[1],[4],[17]

12.85%

Investment, interest rate, paid in kind (as a percent)

^[1],[17]

6.00%

Investment, principal

^{[1],[10],[17]}

$ 2,782

Investment owned, at cost

^[1],[17]

2,760

Investments at fair value

^[1],[17]

$ 2,546

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

15.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

21.68%

Investment, principal

^[7],[8],[11]

$ 1,565

Investment owned, at cost

^[7],[8]

1,551

Investments at fair value

^[7],[8]

$ 1,464

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

15.00%

Investment, interest rate (as a percent)

^[7],[8],[9]

21.68%

Investment, principal

^[7],[8],[11]

$ 1,323

Investment owned, at cost

^[7],[8]

1,311

Investments at fair value

^[7],[8]

$ 1,237

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

4,871

^[1]

4,871

^[8]

4,871

^[1]

4,871

^[1]

4,871

^[8]

4,871

^[8]

Investment owned, at cost

$ 46

^[1]

$ 46

^[8]

Investments at fair value

$ 0

^[1]

$ 107

^[8]

Investment, Identifier [Axis]: Win Brands Group LLC, Integrated Telecommunication Services, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[1]

127,452

Investment owned, at cost

^[1]

$ 2,057

Investments at fair value

^[1]

$ 1,657

Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

Investment, interest rate (as a percent)

11.67%

Investment, principal

$ 6,148

Investment owned, at cost

6,008

Investments at fair value

$ 5,939

Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

Investment, interest rate (as a percent)

11.67%

Investment, principal

$ 3,843

Investment owned, at cost

3,756

Investments at fair value

$ 3,712

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

^[8]

127,452

Investment owned, at cost

^[8]

$ 2,057

Investments at fair value

^[8]

$ 1,319

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7]

6.25%

Investment, interest rate (as a percent)

^[7],[9]

11.67%

Investment, principal

^[7],[11]

$ 8,983

Investment owned, at cost

^[7]

8,698

Investments at fair value

^[7]

$ 8,678

Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

^[1],[17]

4.00%

^[7],[8]

4.00%

^[1],[17]

4.00%

^[1],[17]

4.00%

^[7],[8]

4.00%

^[7],[8]

Investment, interest rate (as a percent)

8.25%

^[1],[4],[17]

9.32%

^[7],[8],[9]

8.25%

^[1],[4],[17]

8.25%

^[1],[4],[17]

9.32%

^[7],[8],[9]

9.32%

^[7],[8],[9]

Investment, principal

$ 19,431

^{[1],[10],[17]}

$ 19,578

^[7],[8],[11]

Investment owned, at cost

19,407

^[1],[17]

19,568

^[7],[8]

Investments at fair value

$ 19,431

^[1],[17]

$ 19,489

^[7],[8]

Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[14]

7.50%

Investment, interest rate (as a percent)

^{[7],[8],[9],[14]}

12.72%

Investment, principal | £

^{[7],[8],[11],[14]}

£ 20,000

Investment owned, at cost

^[7],[8],[14]

$ 25,841

Investments at fair value

^[7],[8],[14]

$ 22,914

Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | SLF JV I

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.25%

Investment, interest rate (as a percent)

8.10%

8.57%

8.10%

8.57%

Investment, principal

$ 9,034

$ 4,320

Investment owned, at cost

8,790

4,080

Investments at fair value

$ 8,992

$ 4,251

Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan | OCSI Glick JV LLC

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

3.25%

Investment, interest rate (as a percent)

8.10%

8.57%

8.10%

8.57%

Investment, principal

$ 2,942

$ 1,772

Investment owned, at cost

2,850

1,674

Investments at fair value

$ 2,929

$ 1,744

Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

21,523

^[1]

21,523

^[8]

21,523

^[1]

21,523

^[1]

21,523

^[8]

21,523

^[8]

Investment owned, at cost

$ 20,789

^[1]

$ 20,789

^[8]

Investments at fair value

$ 24,326

^[1]

$ 20,074

^[8]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[1],[2],[17]

6.75%

^[5],[7],[8]

5.75%

^[1],[2],[17]

5.75%

^[1],[2],[17]

6.75%

^[5],[7],[8]

6.75%

^[5],[7],[8]

Investment, interest rate (as a percent)

10.67%

^{[1],[2],[4],[17]}

12.14%

^{[5],[7],[8],[9]}

10.67%

^{[1],[2],[4],[17]}

10.67%

^{[1],[2],[4],[17]}

12.14%

^{[5],[7],[8],[9]}

12.14%

^{[5],[7],[8],[9]}

Investment, principal

$ 678

^{[1],[2],[10],[17]}

$ 377

^{[5],[7],[8],[11]}

Investment owned, at cost

643

^[1],[2],[17]

334

^[5],[7],[8]

Investments at fair value

$ 607

^[1],[2],[17]

$ 296

^[5],[7],[8]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[1],[17]

7.25%

^[7],[8]

5.75%

^[1],[17]

5.75%

^[1],[17]

7.25%

^[7],[8]

7.25%

^[7],[8]

Investment, interest rate (as a percent)

10.67%

^[1],[4],[17]

12.63%

^[7],[8],[9]

10.67%

^[1],[4],[17]

10.67%

^[1],[4],[17]

12.63%

^[7],[8],[9]

12.63%

^[7],[8],[9]

Investment, interest rate, paid in kind (as a percent)

^[7],[8]

Investment, principal

$ 25,491

^{[1],[10],[17]}

$ 24,427

^[7],[8],[11]

Investment owned, at cost

25,261

^[1],[17]

24,135

^[7],[8]

Investments at fair value

$ 24,696

^[1],[17]

$ 23,548

^[7],[8]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^[1],[17]

7.25%

^[7],[8]

6.25%

^[1],[17]

6.25%

^[1],[17]

7.25%

^[7],[8]

7.25%

^[7],[8]

Investment, interest rate (as a percent)

11.17%

^[1],[4],[17]

12.63%

^[7],[8],[9]

11.17%

^[1],[4],[17]

11.17%

^[1],[4],[17]

12.63%

^[7],[8],[9]

12.63%

^[7],[8],[9]

Investment, principal

$ 3,636

^{[1],[10],[17]}

$ 3,636

^[7],[8],[11]

Investment owned, at cost

3,609

^[1],[17]

3,602

^[7],[8]

Investments at fair value

$ 3,581

^[1],[17]

$ 3,574

^[7],[8]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^[1],[2],[17]

7.25%

^[5],[7],[8]

6.25%

^[1],[2],[17]

6.25%

^[1],[2],[17]

7.25%

^[5],[7],[8]

7.25%

^[5],[7],[8]

Investment, principal

$ 0

^{[1],[2],[10],[17]}

$ 0

^{[5],[7],[8],[11]}

Investment owned, at cost

^[1],[2],[17]

^[5],[7],[8]

Investments at fair value

$ 0

^[1],[2],[17]

$ 0

^[5],[7],[8]

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8]

8.75%

Investment, interest rate (as a percent)

^[7],[8],[9]

11.75%

Investment, principal

^[7],[8],[11]

$ 5,212

Investment owned, at cost

^[7],[8]

4,987

Investments at fair value

^[7],[8]

$ 4,990

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[5],[7],[8]

8.75%

Investment, principal

^{[5],[7],[8],[11]}

$ 0

Investment owned, at cost

^[5],[7],[8]

Investments at fair value

^[5],[7],[8]

$ 0

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment, basis spread, variable rate (as a percent)

^[5],[7],[8]

8.75%

Investment, principal

^{[5],[7],[8],[11]}

$ 0

Investment owned, at cost

^[5],[7],[8]

Investments at fair value

^[5],[7],[8]

$ 0

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants

Investment Company, Nonconsolidated Subsidiary [Line Items]

Investment owned, balance (in shares) | shares

53,700

^[1]

53,700

^[8]

53,700

^[1]

53,700

^[1]

53,700

^[8]

53,700

^[8]

Investment owned, at cost

$ 175

^[1]

$ 175

^[8]

Investments at fair value

$ 121

^[1]

$ 258

^[8]

[1]	As of September 30, 2024, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").
[2]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[3]	This investment represents a participation interest in the underlying securities shown.
[4]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[5]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[6]	This investment represents a participation interest in the underlying securities shown.
[7]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[8]	As of September 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by ASC 820.
[9]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[10]	Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[11]	Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[12]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2024, qualifying assets represented 74.4% of the Company's total assets and non-qualifying assets represented 25.6% of the Company's total assets.
[13]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[14]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 73.6% of the Company's total assets and non-qualifying assets represented 26.4% of the Company's total assets.
[15]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[16]	This investment was on non-accrual status as of September 30, 2024.
[17]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2024, the reference rates for the Company's variable rate loans were the 30-day SOFR at 4.85%, the 90-day SOFR at 4.59%, the 180-day SOFR at 4.25%, the PRIME at 8.00%, the SONIA at 5.50%, the 90-day EURIBOR at 3.54% and the 180-day EURIBOR at 3.11%. Most loans include an interest floor, which generally ranges from 0% to 3.00%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[18]	This investment was on non-accrual status as of September 30, 2023.
[19]	This investment represents Seller Earn Out Shares in Alvotech Holdings S.A. The Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech Holdings S.A. common share price is at or above a volume weighted average price ("VWAP") of $20.00 per share for any ten trading days within any twenty trading day period.
[20]	This investment represents Seller Earn Out Shares in Alvotech Holdings S.A. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech Holdings S.A. common share price is at or above a VWAP of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
[21]	This investment was renamed during the three months ended June 30, 2024. For the periods prior to June 30, 2024, this investment was referenced as SCP Eye Care Services, LLC.
[22]	Income producing through payment of dividends or distributions.
[23]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition of the Company's joint ventures.
[24]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[25]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[26]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[27]	This investment represents a credit default swap that functions, in substance, like a credit linked note and represents a credit risk transfer for a pool of reference assets owned by a bank. The Company fully funded margin up front and in return the Company receives periodic interest payments. The Company’s risk of loss is limited to the principal amount disclosed herein. The reference assets are primarily composed of investment grade corporate debt. The Company may be exposed to counterparty risk, which could make it difficult for the Company to collect on obligations, thereby resulting in potentially significant losses. In addition, the Company only has a contractual relationship with the counterparty bank, and not with the reference obligors of the reference assets. Accordingly, the Company generally may have no right to directly enforce compliance by the reference obligors with the terms of the reference assets. The Company will not directly benefit from the reference assets and will not have the benefit of the remedies that would normally be available to a holder of such reference assets. In addition, in the event of the insolvency of the counterparty bank, the Company may be treated as a general creditor of such counterparty bank, and will not have any claim with respect to the reference assets.
[28]	Income producing through payment of dividends or distributions.
[29]	This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Share Data and Net Assets - Schedule of Common Stock Issued and Sold (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Investment Company, Changes in Net Assets [Line Items]
Gross Proceeds	$ 92,748	$ 1,370	$ 20,839
Placement Agent Fees	$ 117	$ 235	$ 215
At the Market
Investment Company, Changes in Net Assets [Line Items]
Number of Shares Issued (in shares)	4,724,506	68,752
Net offering costs	$ 92,500	$ 1,300
Gross Proceeds	93,685	1,384
Placement Agent Fees	937	14
Net Proceeds	$ 92,748	$ 1,370
Average Sales Price per Share (in dollars per share)	$ 19.83	$ 20.13
Net proceeds excluding offering costs	$ 200	$ 100

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Portfolio Investments - Schedule of Financial Instruments Disclosed, but Carried at Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Schedule of Investments [Line Items]
Carrying Value	$ 1,638,693	$ 1,600,731
Fair Value	1,648,133	1,588,201
Syndicated Facility payable
Schedule of Investments [Line Items]
Carrying Value	430,000	430,000
Fair Value	430,000	430,000
OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Carrying Value	280,000	280,000
Fair Value	280,000	280,000
2025 Notes
Schedule of Investments [Line Items]
Carrying Value	299,492	298,241
Fair Value	298,146	286,437
2027 Notes
Schedule of Investments [Line Items]
Carrying Value	327,612	306,412
Fair Value	327,723	301,784
2029 Notes
Schedule of Investments [Line Items]
Carrying Value	301,589	286,078
Fair Value	312,264	289,980
Level 1
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 \| Syndicated Facility payable
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 \| OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 \| 2025 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 \| 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 1 \| 2029 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2
Schedule of Investments [Line Items]
Fair Value	938,133	878,201
Level 2 \| Syndicated Facility payable
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2 \| OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Fair Value	0	0
Level 2 \| 2025 Notes
Schedule of Investments [Line Items]
Fair Value	298,146	286,437
Level 2 \| 2027 Notes
Schedule of Investments [Line Items]
Fair Value	327,723	301,784
Level 2 \| 2029 Notes
Schedule of Investments [Line Items]
Fair Value	312,264	289,980
Level 3
Schedule of Investments [Line Items]
Fair Value	710,000	710,000
Level 3 \| Syndicated Facility payable
Schedule of Investments [Line Items]
Fair Value	430,000	430,000
Level 3 \| OSI2 Citibank Facility payable
Schedule of Investments [Line Items]
Fair Value	280,000	280,000
Level 3 \| 2025 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 3 \| 2027 Notes
Schedule of Investments [Line Items]
Fair Value	0	0
Level 3 \| 2029 Notes
Schedule of Investments [Line Items]
Fair Value	$ 0	$ 0

Financial Highlights (Tables)

12 Months Ended

Sep. 30, 2024

Investment Company [Abstract]

Schedule of Financial Highlights


	September 30, 2024				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Senior secured debt	$	2,615,066	83.14	%	$	2,594,640	85.24	%
Debt investments in the JVs	164,324		5.23	%	162,986		5.35	%
Common equity and warrants	134,452		4.28	%	72,261		2.37	%
Subordinated debt	108,068		3.44	%	59,844		1.97	%
Preferred equity	68,218		2.17	%	99,597		3.27	%
LLC equity interests of the JVs	54,791		1.74	%	54,791		1.80	%
Total	$	3,144,919	100.00	%	$	3,044,119	100.00	%


	September 30, 2024						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Senior secured debt	$	2,574,937	85.21	%	173.06	%	$	2,501,385	86.47	%	165.01	%
Debt investments in the JVs	161,552		5.35	%	10.86	%	162,673		5.62	%	10.73	%
Subordinated debt	109,921		3.64	%	7.39	%	55,717		1.93	%	3.68	%
Common equity and warrants	86,008		2.85	%	5.78	%	57,710		2.00	%	3.81	%
Preferred equity	66,320		2.20	%	4.46	%	86,057		2.98	%	5.68	%
LLC equity interests of the JVs	22,541		0.75	%	1.52	%	28,878		1.00	%	1.91	%
Total	$	3,021,279	100.00	%	203.07	%	$	2,892,420	100.00	%	190.82	%


	September 30, 2024				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Northeast	$	1,033,467	32.86	%	$	1,012,955	33.27	%
Southeast	464,992		14.79	%	375,247		12.33	%
Midwest	397,640		12.64	%	360,506		11.84	%
International	343,033		10.91	%	418,595		13.75	%
West	320,407		10.19	%	393,390		12.92	%
Southwest	285,648		9.08	%	153,318		5.04	%
South	241,098		7.67	%	202,374		6.65	%
Northwest	58,634		1.86	%	127,734		4.20	%
Total	$	3,144,919	100.00	%	$	3,044,119	100.00	%


	September 30, 2024						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Northeast	$	965,469	31.94	%	64.89	%	$	945,422	32.69	%	62.37	%
Southeast	419,669		13.89	%	28.21	%	354,444		12.25	%	23.38	%
Midwest	390,607		12.93	%	26.25	%	350,620		12.12	%	23.13	%
International	354,662		11.74	%	23.84	%	414,079		14.32	%	27.32	%
West	314,994		10.43	%	21.17	%	384,055		13.28	%	25.34	%
Southwest	279,653		9.26	%	18.80	%	130,455		4.51	%	8.61	%
South	237,634		7.87	%	15.97	%	188,541		6.52	%	12.44	%
Northwest	58,591		1.94	%	3.94	%	124,804		4.31	%	8.23	%
Total	$	3,021,279	100.00	%	203.07	%	$	2,892,420	100.00	%	190.82	%

Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of September 30, 2024 and September 30, 2023:


	September 30, 2024	September 30, 2023
Senior secured loans (1)	$330,094	$332,637
Weighted average interest rate on senior secured loans (2)	9.56%	10.62%
Number of borrowers in SLF JV I	48	48
Largest exposure to a single borrower (1)	$10,495	$11,286
Total of five largest loan exposures to borrowers (1)	$49,413	$54,051

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of September 30, 2024 and September 30, 2023:


	September 30, 2024	September 30, 2023
Senior secured loans (1)	$125,405	$130,589
Weighted average current interest rate on senior secured loans (2)	9.65%	10.77%
Number of borrowers in the Glick JV	44	38
Largest loan exposure to a single borrower (1)	$5,898	$6,230
Total of five largest loan exposures to borrowers (1)	$22,152	$28,396

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.


(Share amounts in thousands)	Year ended September 30, 2024	Year ended September 30, 2023(6)	Year ended September 30, 2022(6)	Year ended September 30, 2021(6)	Year ended September 30, 2020(6)
Net asset value per share at beginning of period	$19.63	$20.38	$21.84	$19.47	$19.81
Net investment income (1)	2.18	2.51	2.45	1.80	1.53
Net unrealized appreciation (depreciation) (1)(7)	0.25	(0.17)	(2.23)	2.19	(0.44)
Net realized gains (losses) (1)	(1.70)	(0.46)	0.28	0.49	(0.30)
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)	—	(0.02)	(0.01)	(0.02)	0.04
Distributions of net investment income to stockholders	(2.27)	(2.61)	(1.95)	(1.52)	(1.17)
Issuance of common stock	—	—	—	(0.57)	—
Net asset value per share at end of period	$18.09	$19.63	$20.38	$21.84	$19.47
Per share market value at beginning of period	$20.12	$18.00	$21.18	$14.52	$15.54
Per share market value at end of period	$16.31	$20.12	$18.00	$21.18	$14.52
Total return (2)	(8.47)%	27.30%	(6.71)%	57.61%	2.10%
Common shares outstanding at beginning of period	77,225	61,125	60,120	46,987	46,987
Common shares outstanding at end of period	82,245	77,225	61,125	60,120	46,987
Net assets at beginning of period	$1,515,764	$1,245,563	$1,312,823	$914,879	$930,630
Net assets at end of period	$1,487,811	$1,515,764	$1,245,563	$1,312,823	$914,879
Average net assets (3)	$1,520,016	$1,437,728	$1,308,518	$1,150,662	$871,305
Ratio of net investment income to average net assets (3)	11.52%	12.57%	11.36%	8.44%	8.26%
Ratio of total expenses to average net assets (3)	14.23%	14.19%	8.68%	9.65%	7.57%
Ratio of net expenses to average net assets (3)	13.59%	13.81%	8.45%	9.51%	8.16%
Ratio of portfolio turnover to average investments at fair value	35.96%	26.12%	26.99%	39.66%	38.99%
Weighted average outstanding debt (4)	$1,683,757	$1,659,701	$1,361,151	$964,390	$647,080
Average debt per share (1)	$20.94	$23.01	$22.41	$17.85	$13.77
Asset coverage ratio at end of period (5)	188.14%	187.74%	188.64%	201.68%	227.22%

__________


(1)			Calculated based upon weighted average shares outstanding for the period.
(2)			Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)			Calculated based upon the weighted average net assets for the period.
(4)			Calculated based upon the weighted average of principal debt outstanding for the period.
(5)			Based on outstanding senior securities of $1,663.8 million, $1,660.0 million, $1,350.0 million, $1,280.0 million and $714.8 million as of September 30, 2024, 2023, 2022, 2021 and 2020, respectively.
(6)			The share and per share information disclosed in this table has been retroactively adjusted as necessary to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(7)			For the year ended September 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger. For the year ended September 30, 2021, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OCSI Merger.

Senior Securities

Information about our senior securities (including debt securities and other indebtedness) is shown in the following table as of the fiscal years ended September 30 for the years indicated below.


Class and Year(1)	Total Amount Outstanding Exclusive of Treasury Securities (2)		Asset Coverage Per Unit(3)	Involuntary Liquidating Preference Per Unit(4)	Average Market Value Per Unit(5)
Syndicated Facility and Prior ING Facility
Fiscal 2015	$	383,495	2,389	—	N/A
Fiscal 2016	472,495		2,208	—	N/A
Fiscal 2017	226,495		2,274	—	N/A
Fiscal 2018	241,000		2,330	—	N/A
Fiscal 2019	314,825		2,949	—	N/A
Fiscal 2020	414,825		2,272	—	N/A
Fiscal 2021	495,000		2,017	—	N/A
Fiscal 2022	540,000		1,886	—	N/A
Fiscal 2023	430,000		1,877	—	N/A
Fiscal 2024	430,000		1,881	—	N/A

Citibank Facility
Fiscal 2021	$	135,000	2,017	—	N/A
Fiscal 2022	160,000		1,886	—	N/A

OSI2 Citibank Facility
Fiscal 2023	$	280,000	1,877	—	N/A
Fiscal 2024	280,000		1,881	—	N/A

Sumitomo Facility
Fiscal 2015	$	43,800	2,389	—	N/A
Fiscal 2016	43,800		2,208	—	N/A
Fiscal 2017	29,500		2,274	—	N/A

Convertible Notes
Fiscal 2015	$	115,000	2,389	—	N/A

Secured Borrowings
Fiscal 2015	$	21,787	2,389	—	N/A
Fiscal 2016	18,929		2,208	—	N/A
Fiscal 2017	13,489		2,274	—	N/A
Fiscal 2018	12,314		2,330	—	N/A

2019 Notes
Fiscal 2015	$	250,000	2,389	—	N/A
Fiscal 2016	250,000		2,208	—	N/A
Fiscal 2017	250,000		2,274	—	N/A
Fiscal 2018	228,825		2,330	—	N/A


Class and Year(1)	Total Amount Outstanding Exclusive of Treasury Securities (2)		Asset Coverage Per Unit(3)	Involuntary Liquidating Preference Per Unit(4)	Average Market Value Per Unit(5)
2024 Notes
Fiscal 2015	$	75,000	2,389	—	991.94
Fiscal 2016	75,000		2,208	—	993.70
Fiscal 2017	75,000		2,274	—	1,006.74
Fiscal 2018	75,000		2,330	—	1,010.72
Fiscal 2019	75,000		2,949	—	1,012.76

2025 Notes
Fiscal 2020	$	300,000	2,272	—	N/A
Fiscal 2021	300,000		2,017	—	N/A
Fiscal 2022	300,000		1,886	—	N/A
Fiscal 2023	300,000		1,877	—	N/A
Fiscal 2024	300,000		1,881	—	N/A

2027 Notes
Fiscal 2021	$	350,000	2,017	—	N/A
Fiscal 2022	350,000		1,886	—	N/A
Fiscal 2023	350,000		1,877	—	N/A
Fiscal 2024	350,000		1,881	—	N/A

2028 Notes
Fiscal 2015	$	86,250	2,389	—	988.06
Fiscal 2016	86,250		2,208	—	999.29
Fiscal 2017	86,250		2,274	—	1,007.51
Fiscal 2018	86,250		2,330	—	994.82
Fiscal 2019	86,250		2,949	—	993.33

2029 Notes
Fiscal 2023	$	300,000	1,877	—	N/A
Fiscal 2024	300,000		1,881	—	N/A

Total Senior Securities
Fiscal 2015	$	975,332	2,389	—
Fiscal 2016	946,474		2,208	—
Fiscal 2017	680,734		2,274	—
Fiscal 2018	643,389		2,330	—
Fiscal 2019	476,075		2,949	—
Fiscal 2020	714,825		2,272	—
Fiscal 2021	1,280,000		2,017	—
Fiscal 2022	1,350,000		1,886	—
Fiscal 2023	1,660,000		1,877	—
Fiscal 2024	1,660,000		1,881	—

______________

(2)Total amount of each class of senior securities outstanding at the end of the period, presented in thousands.

(5)Calculated on a daily average basis.

Schedule of Senior Securities

Information about our senior securities (including debt securities and other indebtedness) is shown in the following table as of the fiscal years ended September 30 for the years indicated below.


Class and Year(1)	Total Amount Outstanding Exclusive of Treasury Securities (2)		Asset Coverage Per Unit(3)	Involuntary Liquidating Preference Per Unit(4)	Average Market Value Per Unit(5)
Syndicated Facility and Prior ING Facility
Fiscal 2015	$	383,495	2,389	—	N/A
Fiscal 2016	472,495		2,208	—	N/A
Fiscal 2017	226,495		2,274	—	N/A
Fiscal 2018	241,000		2,330	—	N/A
Fiscal 2019	314,825		2,949	—	N/A
Fiscal 2020	414,825		2,272	—	N/A
Fiscal 2021	495,000		2,017	—	N/A
Fiscal 2022	540,000		1,886	—	N/A
Fiscal 2023	430,000		1,877	—	N/A
Fiscal 2024	430,000		1,881	—	N/A

Citibank Facility
Fiscal 2021	$	135,000	2,017	—	N/A
Fiscal 2022	160,000		1,886	—	N/A

OSI2 Citibank Facility
Fiscal 2023	$	280,000	1,877	—	N/A
Fiscal 2024	280,000		1,881	—	N/A

Sumitomo Facility
Fiscal 2015	$	43,800	2,389	—	N/A
Fiscal 2016	43,800		2,208	—	N/A
Fiscal 2017	29,500		2,274	—	N/A

Convertible Notes
Fiscal 2015	$	115,000	2,389	—	N/A

Secured Borrowings
Fiscal 2015	$	21,787	2,389	—	N/A
Fiscal 2016	18,929		2,208	—	N/A
Fiscal 2017	13,489		2,274	—	N/A
Fiscal 2018	12,314		2,330	—	N/A

2019 Notes
Fiscal 2015	$	250,000	2,389	—	N/A
Fiscal 2016	250,000		2,208	—	N/A
Fiscal 2017	250,000		2,274	—	N/A
Fiscal 2018	228,825		2,330	—	N/A


Class and Year(1)	Total Amount Outstanding Exclusive of Treasury Securities (2)		Asset Coverage Per Unit(3)	Involuntary Liquidating Preference Per Unit(4)	Average Market Value Per Unit(5)
2024 Notes
Fiscal 2015	$	75,000	2,389	—	991.94
Fiscal 2016	75,000		2,208	—	993.70
Fiscal 2017	75,000		2,274	—	1,006.74
Fiscal 2018	75,000		2,330	—	1,010.72
Fiscal 2019	75,000		2,949	—	1,012.76

2025 Notes
Fiscal 2020	$	300,000	2,272	—	N/A
Fiscal 2021	300,000		2,017	—	N/A
Fiscal 2022	300,000		1,886	—	N/A
Fiscal 2023	300,000		1,877	—	N/A
Fiscal 2024	300,000		1,881	—	N/A

2027 Notes
Fiscal 2021	$	350,000	2,017	—	N/A
Fiscal 2022	350,000		1,886	—	N/A
Fiscal 2023	350,000		1,877	—	N/A
Fiscal 2024	350,000		1,881	—	N/A

2028 Notes
Fiscal 2015	$	86,250	2,389	—	988.06
Fiscal 2016	86,250		2,208	—	999.29
Fiscal 2017	86,250		2,274	—	1,007.51
Fiscal 2018	86,250		2,330	—	994.82
Fiscal 2019	86,250		2,949	—	993.33

2029 Notes
Fiscal 2023	$	300,000	1,877	—	N/A
Fiscal 2024	300,000		1,881	—	N/A

Total Senior Securities
Fiscal 2015	$	975,332	2,389	—
Fiscal 2016	946,474		2,208	—
Fiscal 2017	680,734		2,274	—
Fiscal 2018	643,389		2,330	—
Fiscal 2019	476,075		2,949	—
Fiscal 2020	714,825		2,272	—
Fiscal 2021	1,280,000		2,017	—
Fiscal 2022	1,350,000		1,886	—
Fiscal 2023	1,660,000		1,877	—
Fiscal 2024	1,660,000		1,881	—

______________

(2)Total amount of each class of senior securities outstanding at the end of the period, presented in thousands.

(5)Calculated on a daily average basis.

Borrowings (Tables)

12 Months Ended

Sep. 30, 2024

Debt Disclosure [Abstract]

Schedule of Components of Debt

The below table presents the components of the carrying value of the 2025 Notes, the 2027 Notes and the 2029 Notes as of September 30, 2024 and September 30, 2023:


	As of September 30, 2024						As of September 30, 2023
($ in millions)	2025 Notes		2027 Notes		2029 Notes		2025 Notes		2027 Notes		2029 Notes
Principal	$	300.0	$	350.0	$	300.0	$	300.0	$	350.0	$	300.0
Unamortized financing costs	(0.3)		(1.8)		(2.9)		(1.1)		(2.5)		(3.5)
Unaccreted discount	(0.2)		(0.4)		(2.7)		(0.7)		(0.6)		(3.4)
Interest rate swap fair value adjustment	—		(20.2)		7.2		—		(40.5)		(7.0)
Net carrying value	$	299.5	$	327.6	$	301.6	$	298.2	$	306.4	$	286.1
Fair Value	$	298.1	$	327.7	$	312.3	$	286.4	$	301.8	$	290.0

The below table presents the components of interest and other debt expenses related to the 2025 Notes, the 2027 Notes and the 2029 Notes for the year ended September 30, 2024:


($ in millions)	2025 Notes			2027 Notes			2029 Notes
Coupon interest	$	10.5		$	9.5		$	21.3
Amortization of financing costs and discount	1.3			0.9			1.3
Effect of interest rate swap	—			16.3			4.4
Total interest expense	$	11.8		$	26.7		$	27.0
Coupon interest rate (net of effect of interest rate swaps)	3.500		%	7.259		%	8.437		%

The below table presents the components of interest and other debt expenses related to the 2025 Notes, the 2027 Notes and the 2029 Notes for the year ended September 30, 2023:


($ in millions)	2025 Notes			2027 Notes			2029 Notes
Coupon interest	$	10.5		$	9.5		$	2.7
Amortization of financing costs and discount	1.3			0.9			0.2
Effect of interest rate swap	—			13.4			0.6
Total interest expense	$	11.8		$	23.8		$	3.5
Coupon interest rate (net of effect of interest rate swaps)	3.500		%	6.539		%	8.490		%

The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the year ended September 30, 2022:


($ in millions)	2025 Notes				2027 Notes
Coupon interest		$	10.5		$	9.5
Amortization of financing costs and discount		1.3			0.9
Effect of interest rate swap		—			(0.4)
Total interest expense		$	11.8		$	10.0
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)		3.500		%	2.585		%

Audit Information	12 Months Ended
Audit Information	Sep. 30, 2024
Audit Information [Abstract]
Auditor Name	Ernst & Young LLP
Auditor Location	Los Angeles, California
Auditor Firm ID	42

Portfolio Investments - Roll-Forward in the Changes in Fair Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	$ 2,619,912	$ 2,169,475
Purchases	919,472	1,131,251
Sales and repayments	(738,823)	(665,727)
Transfers in	107,403	59,168
Transfers out	(103,939)	(40,093)
Capitalized PIK interest income	24,963	15,644
Accretion of OID	14,174	17,771
Fair value, ending balance	2,723,732	2,619,912
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	$ (36,459)	$ (63,990)
Unrealized gain (loss), location	Gain (Loss), Investment and Derivative, Operating, and Foreign Currency Transaction, after Tax	Gain (Loss), Investment and Derivative, Operating, and Foreign Currency Transaction, after Tax
Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	$ 21,937	$ (48,971)
Gain (loss), location	Net unrealized appreciation (depreciation)	Net unrealized appreciation (depreciation)
Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	$ (141,367)	$ (18,606)
Gain (loss), location	Realized gain (loss)	Realized gain (loss)
Senior secured debt
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	$ 2,292,691	$ 1,910,606
Purchases	838,357	1,080,654
Sales and repayments	(732,739)	(650,437)
Transfers in	43,451	19,075
Transfers out	(97,840)	(40,093)
Capitalized PIK interest income	22,624	15,016
Accretion of OID	12,756	16,322
Fair value, ending balance	2,320,310	2,292,691
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	(5,669)	(48,680)
Investment exchanged, cost	62,800
Senior secured debt \| Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	43,104	(37,253)
Senior secured debt \| Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(102,094)	(21,199)
Subordinated Debt
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	189,724	159,388
Purchases	71,788	30,690
Sales and repayments	(5,019)	(1,396)
Transfers in	0	0
Transfers out	(4,657)	0
Capitalized PIK interest income	2,339	628
Accretion of OID	1,418	1,449
Fair value, ending balance	255,346	189,724
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	(873)	(1,035)
Investment exchanged, cost	4,700
Subordinated Debt \| Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(293)	(1,035)
Subordinated Debt \| Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	46	0
Preferred equity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	86,057	79,523
Purchases	7,578	14,296
Sales and repayments	(205)	0
Transfers in	0	0
Transfers out	(1,159)	0
Capitalized PIK interest income	0	0
Accretion of OID	0	0
Fair value, ending balance	66,320	86,057
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	5,704	(7,762)
Investment exchanged, cost	1,200
Preferred equity \| Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	11,642	(7,762)
Preferred equity \| Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(37,593)	0
Common equity and warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value, beginning balance	51,440	19,958
Purchases	1,749	5,611
Sales and repayments	(860)	(13,894)
Transfers in	63,952	40,093
Transfers out	(283)	0
Capitalized PIK interest income	0	0
Accretion of OID	0	0
Fair value, ending balance	81,756	51,440
Net unrealized appreciation (depreciation) relating to Level 3 investments still held and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations	(35,621)	(6,513)
Common equity and warrants \| Net unrealized appreciation (depreciation)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(32,516)	(2,921)
Common equity and warrants \| Net realized gains (losses)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	(1,726)	$ 2,593
Equity Securities, Common Stock Converted
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Transfers out	(300)
Investment, Change in Market Quotes or Liquidity
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Transfers in	38,800
Transfers out	$ (35,000)

Commitments and Contingencies (Tables)

12 Months Ended

Sep. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Schedule of Unfunded Commitments


	September 30, 2024		September 30, 2023
Integrity Marketing Acquisition, LLC	$	16,436	$	—
Verona Pharma, Inc.	14,846		—
OCSI Glick JV LLC	13,998		13,998
PetVet Care Centers, LLC	13,732		—
Senior Loan Fund JV I, LLC	13,125		13,125
107-109 Beech OAK22 LLC	11,911		26,969
Accession Risk Management Group, Inc.	11,019		—
PPW Aero Buyer, Inc.	10,235		1,466
BioXcel Therapeutics, Inc.	9,383		14,547
Amspec Parent LLC	9,372		—
Pluralsight, LLC	8,688		1,787
Poseidon Midco AB	8,181		—
Monotype Imaging Holdings Inc.	8,005		—
Next Holdco, LLC	7,051		—
MRI Software LLC	6,972		2,261
Eyesouth Eye Care Holdco LLC	6,585		—
Quantum Bidco Limited	6,311		—
Telephone and Data Systems, Inc.	6,273		—
Digital.AI Software Holdings, Inc.	6,045		1,078
iCIMs, Inc.	5,802		7,466
Truck-Lite Co., LLC	5,721		—
Dominion Diagnostics, LLC	5,574		3,484
Sorenson Communications, LLC	5,409		—
Mindbody, Inc.	5,238		4,762
SumUp Holdings Luxembourg	5,101		—
Avalara, Inc.	5,047		5,047
Everbridge, Inc.	5,043		—
ACESO Holding 4 S.A.R.L.	4,700		—
Legends Hospitality Holding Company, LLC	4,651		—
Accupac, Inc.	4,051		4,500
Inventus Power, Inc.	3,792		3,792
Delta Leasing SPV II LLC	3,581		14,639
107 Fair Street LLC	3,507		4,227
Harrow, Inc.	3,438		4,011


	September 30, 2024		September 30, 2023
Establishment Labs Holdings Inc.	$	3,384	$	3,384
Kings Buyer, LLC	3,277		5,189
WP CPP Holdings, LLC	3,272		—
PRGX Global, Inc.	3,127		3,127
Salus Workers' Compensation, LLC	3,102		3,102
Spanx, LLC	3,092		2,473
Enverus Holdings, Inc.	3,014		—
Crewline Buyer, Inc.	2,180		—
Protein For Pets Opco, LLC	2,117		—
Coupa Holdings, LLC	2,075		2,075
USIC Holdings, Inc.	1,938		—
Oranje Holdco, Inc.	1,904		1,904
Minotaur Acquisition, Inc.	1,882		—
MHE Intermediate Holdings, LLC	1,786		821
Grove Hotel Parcel Owner, LLC	1,762		5,286
Evergreen IX Borrower 2023, LLC	1,626		1,626
Acquia Inc.	1,625		1,376
SIO2 Medical Products, Inc.	1,584		1,821
Supreme Fitness Group NY Holdings, LLC	1,552		2,199
Centralsquare Technologies, LLC	1,436		—
Galileo Parent, Inc.	1,163		2,061
112-126 Van Houten Real22 LLC	1,077		2,343
Berner Food & Beverage, LLC	1,007		1,622
Icefall Parent, Inc.	995		—
Finastra USA, Inc.	654		960
LSL Holdco, LLC	636		2,650
SVP-Singer Holdings Inc.	621		—
Telestream Holdings Corporation	244		407
All Web Leads, Inc.	240		—
ASP-R-PAC Acquisition Co LLC	166		396
Fairbridge Strategic Capital Funding LLC	—		13,090
MND Holdings III Corp	—		9,122
Seres Therapeutics, Inc.	—		8,090
Assembled Brands Capital LLC	—		7,514
scPharmaceuticals Inc.	—		5,212
OTG Management, LLC	—		3,190
ADC Therapeutics SA	—		3,020
Relativity ODA LLC	—		2,762
Impel Pharmaceuticals Inc.	—		2,458
SCP Eye Care Services, LLC	—		2,356
Tahoe Bidco B.V.	—		2,162
Liquid Environmental Solutions Corporation	—		1,383
Coyote Buyer, LLC	—		400
Total	$	311,361	$	232,740

Financial Highlights (Details)
$ / shares in Units, shares in Thousands, $ in Thousands

12 Months Ended

Jun. 30, 2023

$ / shares

Mar. 31, 2023

$ / shares

Jan. 20, 2023

Sep. 30, 2024

USD ($)

$ / shares

Sep. 30, 2023

USD ($)

$ / shares

Sep. 30, 2022

USD ($)

$ / shares

Sep. 30, 2021

USD ($)

$ / shares

Sep. 30, 2020

USD ($)

$ / shares

Sep. 30, 2019

USD ($)

Sep. 30, 2018

USD ($)

Sep. 30, 2017

USD ($)

Sep. 30, 2016

USD ($)

Sep. 30, 2015

USD ($)

Investment Company, Financial Highlights [Roll Forward]

Net asset value per share at beginning of period (in dollars per share)

$ 19.63

^[1]

$ 20.38

^[1]

$ 21.84

$ 19.47

$ 19.81

Net investment income (in dollars per share)

2.18

^[2]

2.51

^[2]

2.45

^[2]

1.80

1.53

Net unrealized appreciation (depreciation) (in dollars per share)

0.25

(0.17)

(2.23)

2.19

(0.44)

Net realized gains (losses) (in dollars per share)

(1.70)

(0.46)

0.28

0.49

(0.30)

(Provision) benefit for taxes on realized and unrealized gains (losses) (in dollars per share)

(0.02)

(0.01)

(0.02)

0.04

Distributions of net investment income to stockholders (dollars per share)

(2.27)

(2.61)

(1.95)

(1.52)

(1.17)

Issuance of common stock (in dollars per share)

(0.57)

Net asset value per share at end of period (in dollars per share)

$ 19.58

$ 19.66

18.09

^[1]

19.63

^[1]

20.38

^[1]

21.84

19.47

Per share market value at beginning of period (in dollars per share)

20.12

18.00

21.18

14.52

15.54

Per share market value at end of period (in dollars per share)

$ 16.31

$ 20.12

$ 18.00

$ 21.18

$ 14.52

Total return

(8.47%)

27.30%

(6.71%)

57.61%

2.10%

Common shares outstanding at beginning of period (in shares) | shares

77,225

^[1]

61,125

^[1]

60,120

46,987

Common shares outstanding at end of period (in shares) | shares

82,245

^[1]

77,225

^[1]

61,125

^[1]

60,120

46,987

Net assets at beginning of period | $

$ 1,515,764

$ 1,245,563

$ 1,312,823

$ 914,879

$ 930,630

Net assets at end of period | $

1,487,811

1,515,764

1,245,563

1,312,823

914,879

Average net assets | $

$ 1,520,016

$ 1,437,728

$ 1,308,518

$ 1,150,662

$ 871,305

Ratio of net investment income to average net assets

11.52%

12.57%

11.36%

8.44%

8.26%

Ratio of total expenses to average net assets

14.23%

14.19%

8.68%

9.65%

7.57%

Ratio of net expenses to average net assets

13.59%

13.81%

8.45%

9.51%

8.16%

Ratio of portfolio turnover to average investments at fair value

35.96%

26.12%

26.99%

39.66%

38.99%

Weighted average outstanding debt | $

$ 1,683,757

$ 1,659,701

$ 1,361,151

$ 964,390

$ 647,080

Average debt per share (dollars per share)

$ 20.94

$ 23.01

$ 22.41

$ 17.85

$ 13.77

Asset coverage ratio

188.14%

187.74%

188.64%

201.68%

227.22%

Outstanding senior securities | $

$ 1,660,000

$ 1,350,000

$ 1,280,000

$ 714,825

$ 476,075

$ 643,389

$ 680,734

$ 946,474

$ 975,332

Stock split, conversion ratio

0.3333

[1]	As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis as necessary.
[2]	As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis as necessary.

Portfolio Investments - Portfolio Composition (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Schedule of Investments [Line Items]
Investment owned, at cost	$ 3,144,919	$ 3,044,119
Investments at fair value	$ 3,021,279	$ 2,892,420
Investment owned, percent of net assets (as a percent)	203.07%	190.82%
Northeast
Schedule of Investments [Line Items]
Investment owned, at cost	$ 1,033,467	$ 1,012,955
Investments at fair value	$ 965,469	$ 945,422
Investment owned, percent of net assets (as a percent)	64.89%	62.37%
Southeast
Schedule of Investments [Line Items]
Investment owned, at cost	$ 464,992	$ 375,247
Investments at fair value	$ 419,669	$ 354,444
Investment owned, percent of net assets (as a percent)	28.21%	23.38%
Midwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 397,640	$ 360,506
Investments at fair value	$ 390,607	$ 350,620
Investment owned, percent of net assets (as a percent)	26.25%	23.13%
International
Schedule of Investments [Line Items]
Investment owned, at cost	$ 343,033	$ 418,595
Investments at fair value	$ 354,662	$ 414,079
Investment owned, percent of net assets (as a percent)	23.84%	27.32%
West
Schedule of Investments [Line Items]
Investment owned, at cost	$ 320,407	$ 393,390
Investments at fair value	$ 314,994	$ 384,055
Investment owned, percent of net assets (as a percent)	21.17%	25.34%
Southwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 285,648	$ 153,318
Investments at fair value	$ 279,653	$ 130,455
Investment owned, percent of net assets (as a percent)	18.80%	8.61%
South
Schedule of Investments [Line Items]
Investment owned, at cost	$ 241,098	$ 202,374
Investments at fair value	$ 237,634	$ 188,541
Investment owned, percent of net assets (as a percent)	15.97%	12.44%
Northwest
Schedule of Investments [Line Items]
Investment owned, at cost	$ 58,634	$ 127,734
Investments at fair value	$ 58,591	$ 124,804
Investment owned, percent of net assets (as a percent)	3.94%	8.23%
Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	100.00%	100.00%
Investment Owned, At Cost \| Geographic Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	100.00%	100.00%
Investment Owned, At Cost \| Geographic Concentration Risk \| Northeast
Schedule of Investments [Line Items]
Concentration risk (as a percent)	32.86%	33.27%
Investment Owned, At Cost \| Geographic Concentration Risk \| Southeast
Schedule of Investments [Line Items]
Concentration risk (as a percent)	14.79%	12.33%
Investment Owned, At Cost \| Geographic Concentration Risk \| Midwest
Schedule of Investments [Line Items]
Concentration risk (as a percent)	12.64%	11.84%
Investment Owned, At Cost \| Geographic Concentration Risk \| International
Schedule of Investments [Line Items]
Concentration risk (as a percent)	10.91%	13.75%
Investment Owned, At Cost \| Geographic Concentration Risk \| West
Schedule of Investments [Line Items]
Concentration risk (as a percent)	10.19%	12.92%
Investment Owned, At Cost \| Geographic Concentration Risk \| Southwest
Schedule of Investments [Line Items]
Concentration risk (as a percent)	9.08%	5.04%
Investment Owned, At Cost \| Geographic Concentration Risk \| South
Schedule of Investments [Line Items]
Concentration risk (as a percent)	7.67%	6.65%
Investment Owned, At Cost \| Geographic Concentration Risk \| Northwest
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.86%	4.20%
Investment Owned, At Fair Value
Schedule of Investments [Line Items]
Investments at fair value	$ 3,021,279	$ 2,892,420
Investment owned, percent of net assets (as a percent)	203.07%	190.82%
Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	100.00%	100.00%
Investment Owned, At Fair Value \| Geographic Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	100.00%	100.00%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| Northeast
Schedule of Investments [Line Items]
Concentration risk (as a percent)	31.94%	32.69%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| Southeast
Schedule of Investments [Line Items]
Concentration risk (as a percent)	13.89%	12.25%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| Midwest
Schedule of Investments [Line Items]
Concentration risk (as a percent)	12.93%	12.12%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| International
Schedule of Investments [Line Items]
Concentration risk (as a percent)	11.74%	14.32%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| West
Schedule of Investments [Line Items]
Concentration risk (as a percent)	10.43%	13.28%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| Southwest
Schedule of Investments [Line Items]
Concentration risk (as a percent)	9.26%	4.51%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| South
Schedule of Investments [Line Items]
Concentration risk (as a percent)	7.87%	6.52%
Investment Owned, At Fair Value \| Geographic Concentration Risk \| Northwest
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.94%	4.31%
Senior secured debt
Schedule of Investments [Line Items]
Investment owned, at cost	$ 2,615,066	$ 2,594,640
Investments at fair value	$ 2,574,937	$ 2,501,385
Investment owned, percent of net assets (as a percent)	173.06%	165.01%
Senior secured debt \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	83.14%	85.24%
Senior secured debt \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	85.21%	86.47%
Debt investments in the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 164,324	$ 162,986
Investments at fair value	$ 161,552	$ 162,673
Investment owned, percent of net assets (as a percent)	10.86%	10.73%
Debt investments in the JVs \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	5.23%	5.35%
Debt investments in the JVs \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	5.35%	5.62%
Common equity and warrants
Schedule of Investments [Line Items]
Investment owned, at cost	$ 134,452	$ 72,261
Investments at fair value	$ 86,008	$ 57,710
Investment owned, percent of net assets (as a percent)	5.78%	3.81%
Common equity and warrants \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	4.28%	2.37%
Common equity and warrants \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.85%	2.00%
Subordinated Debt
Schedule of Investments [Line Items]
Investment owned, at cost	$ 108,068	$ 59,844
Investments at fair value	$ 109,921	$ 55,717
Investment owned, percent of net assets (as a percent)	7.39%	3.68%
Subordinated Debt \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	3.44%	1.97%
Subordinated Debt \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	3.64%	1.93%
Preferred equity
Schedule of Investments [Line Items]
Investment owned, at cost	$ 68,218	$ 99,597
Investments at fair value	$ 66,320	$ 86,057
Investment owned, percent of net assets (as a percent)	4.46%	5.68%
Preferred equity \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.17%	3.27%
Preferred equity \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	2.20%	2.98%
LLC equity interests of the JVs
Schedule of Investments [Line Items]
Investment owned, at cost	$ 54,791	$ 54,791
Investments at fair value	$ 22,541	$ 28,878
Investment owned, percent of net assets (as a percent)	1.52%	1.91%
LLC equity interests of the JVs \| Investment Owned, At Cost \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	1.74%	1.80%
LLC equity interests of the JVs \| Investment Owned, At Fair Value \| Investment Type Concentration Risk
Schedule of Investments [Line Items]
Concentration risk (as a percent)	0.75%	1.00%

Portfolio Investments

12 Months Ended

Sep. 30, 2024

Schedule of Investments [Abstract]

Portfolio Investments

As of September 30, 2024, 203.1% of net assets at fair value, or $3.0 billion, was invested in 144 portfolio companies, including (i) $135.2 million in subordinated notes and limited liability company ("LLC") equity interests of Senior Loan Fund JV I, LLC ("SLF JV I"), a joint venture through which the Company and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation ("Kemper"), co-invest in senior secured loans of middle-market companies and other corporate debt securities and (ii) $48.9 million in subordinated notes and LLC equity interests of OCSI Glick JV LLC ("Glick JV" and, together with SLF JV I, the "JVs"), a joint venture through which the Company and GF Equity Funding 2014 LLC ("GF Equity Funding") co-invest primarily in senior secured loans of middle-market companies. As of September 30, 2024, 5.3% of net assets at fair value, or $78.5 million, was invested in cash and cash equivalents (including $14.6 million of restricted cash). In comparison, as of September 30, 2023, 190.8% of net assets at fair value, or $2.9 billion, was invested in 143 portfolio investments, including (i) $141.5 million in subordinated notes and LLC equity interests of SLF JV I and (ii) $50.0 million in subordinated notes and LLC equity interests of Glick JV. As of September 30, 2023, 9.6% of net assets at fair value, or $145.5 million, was invested in cash and cash equivalents (including $9.1 million of restricted cash). As of September 30, 2024, 85.2% of the Company's portfolio at fair value consisted of senior secured debt investments and 9.0% consisted of subordinated debt investments, including the debt investments in the JVs. As of September 30, 2023, 86.5% of the Company's portfolio at fair value consisted of senior secured debt investments and 7.5% consisted of subordinated debt investments, including the debt investments in the JVs.

The Company also held equity investments in certain of its portfolio companies consisting of common stock, preferred stock, warrants or LLC equity interests. These instruments generally do not produce a current return but are held for potential investment appreciation and capital gain.

During the years ended September 30, 2024, 2023 and 2022, the Company recorded net realized gains (losses) of $(136.4) million, $(33.2) million and $17.2 million, respectively. During the years ended September 30, 2024, 2023 and 2022, the Company recorded net unrealized appreciation (depreciation) of $19.1 million, $(28.6) million and $(136.2) million, respectively.

The composition of the Company's investments as of September 30, 2024 and September 30, 2023 at cost and fair value was as follows:


	September 30, 2024				September 30, 2023
	Cost		Fair Value		Cost		Fair Value
Investments in debt securities	$	2,723,134	$	2,684,858	$	2,654,484	$	2,557,102
Investments in equity securities	202,670		152,328		171,858		143,767
Debt investments in the JVs	164,324		161,552		162,986		162,673
Equity investments in the JVs	54,791		22,541		54,791		28,878
Total	$	3,144,919	$	3,021,279	$	3,044,119	$	2,892,420

The following table presents the composition of the Company's debt investments as of September 30, 2024 and September 30, 2023 at floating rates and fixed rates:


	September 30, 2024				September 30, 2023
	Fair Value		% of Debt Portfolio		Fair Value		% of Debt Portfolio
Floating rate debt securities, including the debt investments in the JVs	$	2,516,316	88.40	%	$	2,345,205	86.23	%
Fixed rate debt securities	330,094		11.60		374,570		13.77
Total	$	2,846,410	100.00	%	$	2,719,775	100.00	%


	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	254,627	$	2,320,310	$	—	$	2,574,937
Investments in debt securities (subordinated, including the debt investments in the JVs, CLO Notes and Credit Linked Notes)	—		16,127		255,346		—		271,473
Investments in equity securities (preferred)	—		—		66,320		—		66,320
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	1,422		2,830		81,756		22,541		108,549
Total investments at fair value	1,422		273,584		2,723,732		22,541		3,021,279
Cash equivalents	34,597		—		—		—		34,597
Total assets at fair value	$	36,019	$	273,584	$	2,723,732	$	22,541	$	3,055,876
Derivative liabilities	$	—	$	16,843	$	—	$	—	$	16,843
Total liabilities at fair value	$	—	$	16,843	$	—	$	—	$	16,843

__________


	Level 1		Level 2		Level 3		Measured at Net Asset Value (a)		Total
Investments in debt securities (senior secured)	$	—	$	208,694	$	2,292,691	$	—	$	2,501,385
Investments in debt securities (subordinated, including the debt investments in the JVs and CLO Notes)	—		28,666		189,724		—		218,390
Investments in equity securities (preferred)	—		—		86,057		—		86,057
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)	4,317		1,953		51,440		28,878		86,588
Total investments at fair value	4,317		239,313		2,619,912		28,878		2,892,420
Cash equivalents	83,262		—		—		—		83,262
Derivative assets	—		4,910		—		—		4,910
Total assets at fair value	$	87,579	$	244,223	$	2,619,912	$	28,878	$	2,980,592
Derivative liabilities	$	—	$	47,519	$	—	$	—	$	47,519
Total liabilities at fair value	$	—	$	47,519	$	—	$	—	$	47,519

__________

When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology. Transfers between levels are recognized at the beginning of the reporting period.


	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs and credit linked notes)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2023	$	2,292,691	$	189,724	$	86,057	$	51,440	$	2,619,912
Purchases	838,357		71,788		7,578		1,749		919,472
Sales and repayments	(732,739)		(5,019)		(205)		(860)		(738,823)
Transfers in (a)(c)	43,451		—		—		63,952		107,403
Transfers out (b)(c)	(97,840)		(4,657)		(1,159)		(283)		(103,939)
Capitalized PIK interest income	22,624		2,339		—		—		24,963
Accretion of OID	12,756		1,418		—		—		14,174
Net unrealized appreciation (depreciation)	43,104		(293)		11,642		(32,516)		21,937
Net realized gains (losses)	(102,094)		46		(37,593)		(1,726)		(141,367)
Fair value as of September 30, 2024	$	2,320,310	$	255,346	$	66,320	$	81,756	$	2,723,732
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of September 30, 2024 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the year ended September 30, 2024	$	(5,669)	$	(873)	$	5,704	$	(35,621)	$	(36,459)

__________

(b) There were $35.0 million of transfers out of Level 3 to Level 2 for investments during the year ended September 30, 2024

as a result of a change in the number of market quotes available and/or a change in market liquidity.


	Investments
	Senior Secured Debt		Subordinated Debt (including debt investments in the JVs)		Preferred Equity		Common Equity and Warrants		Total
Fair value as of September 30, 2022	$	1,910,606	$	159,388	$	79,523	$	19,958	$	2,169,475
Purchases (a)	1,080,654		30,690		14,296		5,611		1,131,251
Sales and repayments	(650,437)		(1,396)		—		(13,894)		(665,727)
Transfers in (b)(c)	19,075		—		—		40,093		59,168
Transfers out (c)	(40,093)		—		—		—		(40,093)
Capitalized PIK interest income	15,016		628		—		—		15,644
Accretion of OID	16,322		1,449		—		—		17,771
Net unrealized appreciation (depreciation)	(37,253)		(1,035)		(7,762)		(2,921)		(48,971)
Net realized gains (losses)	(21,199)		—		—		2,593		(18,606)
Fair value as of September 30, 2023	$	2,292,691	$	189,724	$	86,057	$	51,440	$	2,619,912
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of September 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the year ended September 30, 2023	$	(48,680)	$	(1,035)	$	(7,762)	$	(6,513)	$	(63,990)

__________

(a) Includes Level 3 investments acquired in connection with the OSI2 Merger during the year ended September 30, 2023.

(c) There was one investment restructuring in which Level 3 senior secured debt was exchanged for Level 3 common equity during the year ended September 30, 2023.

Significant Unobservable Inputs for Level 3 Investments

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2024:

Asset

Fair Value

Valuation Technique

Unobservable Input

Range

Weighted
Average (a)

Senior Secured Debt

2,044,221

Market Yield

(b)

5.7%

31.0%

12.0%

52,857

Enterprise Value

Revenue Multiple

(c)

2.0x

5.5x

3.7x

26,927

Enterprise Value

EBITDA Multiple

(c)

4.5x

7.5x

5.7x

33,272

Transaction Precedent

Transaction Price

(d)

N/A

163,033

Broker Quotations

Broker Quoted Price

(e)

N/A

Subordinated Debt

93,794

Market Yield

(b)

5.0%

45.0%

10.1%

Debt Investments in the JVs

161,552

Enterprise Value

N/A

(f)

N/A

Preferred & Common Equity

80,720

Enterprise Value

Revenue Multiple

(c)

0.3x

7.2x

2.0x

66,106

Enterprise Value

EBITDA Multiple

(c)

2.9x

15.0x

10.2x

1,250

Enterprise Value

Asset Multiple

(c)

1.0x

1.4x

Total

2,723,732

__________

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2023:

Asset

Fair Value

Valuation Technique

Unobservable Input

Range

Weighted
Average (a)

Senior Secured Debt

1,904,140

Market Yield

(b)

9.0%

32.0%

14.7%

64,802

Enterprise Value

EBITDA Multiple

(c)

3.0x

6.0x

4.6x

33,816

Transaction Precedent

Transaction Price

(d)

N/A

289,933

Broker quotations

Broker Quoted Price

(e)

N/A

Subordinated Debt

22,881

Market Yield

(b)

10.0%

22.0%

11.2%

4,170

Broker Quotations

Broker Quoted Price

(e)

N/A

Debt Investments in the JVs

162,673

Enterprise Value

N/A

(f)

N/A

Preferred & Common Equity

32,318

Enterprise Value

Revenue Multiple

(c)

0.4x

3.2x

0.5x

103,661

Enterprise Value

EBITDA Multiple

(c)

1.7x

15.1x

8.8x

1,097

Enterprise Value

Asset Multiple

(c)

1.0x

1.4x

421

Transaction Precedent

Transaction Price

(d)

N/A

Total

2,619,912

__________

(a)Weighted averages are calculated based on fair value of investments.

(b)Used when market participants would take into account market yield when pricing the investment.

(c)Used when market participants would use such multiples when pricing the investment.

(d)Used when there is an observable transaction or pending event for the investment.

Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.

Under the EV technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt or equity securities is the earnings before interest, taxes, depreciation and amortization ("EBITDA"), revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively.

Financial Instruments Disclosed, But Not Carried, At Fair Value


	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	430,000	$	430,000	$	—	$	—	$	430,000
OSI2 Citibank Facility payable	280,000		280,000		—		—		280,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	299,492		298,146		—		298,146		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	327,612		327,723		—		327,723		—
2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	301,589		312,264		—		312,264		—
Total	$	1,638,693	$	1,648,133	$	—	$	938,133	$	710,000


	Carrying Value		Fair Value		Level 1		Level 2		Level 3
Syndicated Facility payable	$	430,000	$	430,000	$	—	$	—	$	430,000
OSI2 Citibank Facility payable	280,000		280,000		—		—		280,000
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)	298,241		286,437		—		286,437		—
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	306,412		301,784		—		301,784		—
2029 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)	286,078		289,980		—		289,980		—
Total	$	1,600,731	$	1,588,201	$	—	$	878,201	$	710,000

The principal values of the credit facilities payable approximate fair value due to their variable interest rates and are included in Level 3 of the hierarchy. Oaktree used market quotes as of the valuation date to estimate the fair value of the Company's 3.500% notes due 2025 (the "2025 Notes"), 2.700% notes due 2027 (the "2027 Notes") and 7.100% notes due 2029 (the "2029 Notes"), which are included in Level 2 of the hierarchy.

Portfolio Composition


	September 30, 2024				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Senior secured debt	$	2,615,066	83.14	%	$	2,594,640	85.24	%
Debt investments in the JVs	164,324		5.23	%	162,986		5.35	%
Common equity and warrants	134,452		4.28	%	72,261		2.37	%
Subordinated debt	108,068		3.44	%	59,844		1.97	%
Preferred equity	68,218		2.17	%	99,597		3.27	%
LLC equity interests of the JVs	54,791		1.74	%	54,791		1.80	%
Total	$	3,144,919	100.00	%	$	3,044,119	100.00	%


	September 30, 2024						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Senior secured debt	$	2,574,937	85.21	%	173.06	%	$	2,501,385	86.47	%	165.01	%
Debt investments in the JVs	161,552		5.35	%	10.86	%	162,673		5.62	%	10.73	%
Subordinated debt	109,921		3.64	%	7.39	%	55,717		1.93	%	3.68	%
Common equity and warrants	86,008		2.85	%	5.78	%	57,710		2.00	%	3.81	%
Preferred equity	66,320		2.20	%	4.46	%	86,057		2.98	%	5.68	%
LLC equity interests of the JVs	22,541		0.75	%	1.52	%	28,878		1.00	%	1.91	%
Total	$	3,021,279	100.00	%	203.07	%	$	2,892,420	100.00	%	190.82	%


	September 30, 2024				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Northeast	$	1,033,467	32.86	%	$	1,012,955	33.27	%
Southeast	464,992		14.79	%	375,247		12.33	%
Midwest	397,640		12.64	%	360,506		11.84	%
International	343,033		10.91	%	418,595		13.75	%
West	320,407		10.19	%	393,390		12.92	%
Southwest	285,648		9.08	%	153,318		5.04	%
South	241,098		7.67	%	202,374		6.65	%
Northwest	58,634		1.86	%	127,734		4.20	%
Total	$	3,144,919	100.00	%	$	3,044,119	100.00	%


	September 30, 2024						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Northeast	$	965,469	31.94	%	64.89	%	$	945,422	32.69	%	62.37	%
Southeast	419,669		13.89	%	28.21	%	354,444		12.25	%	23.38	%
Midwest	390,607		12.93	%	26.25	%	350,620		12.12	%	23.13	%
International	354,662		11.74	%	23.84	%	414,079		14.32	%	27.32	%
West	314,994		10.43	%	21.17	%	384,055		13.28	%	25.34	%
Southwest	279,653		9.26	%	18.80	%	130,455		4.51	%	8.61	%
South	237,634		7.87	%	15.97	%	188,541		6.52	%	12.44	%
Northwest	58,591		1.94	%	3.94	%	124,804		4.31	%	8.23	%
Total	$	3,021,279	100.00	%	203.07	%	$	2,892,420	100.00	%	190.82	%


	September 30, 2024				September 30, 2023
Cost:			% of Total Investments				% of Total Investments
Application Software	$	532,200	16.85	%	$	468,483	15.39	%
Multi-Sector Holdings (1)	228,181		7.26		219,469		7.21
Health Care Services	149,904		4.77		81,560		2.68
Health Care Technology	105,932		3.37		106,915		3.51
Interactive Media & Services	95,564		3.04		19,013		0.62
Pharmaceuticals	94,639		3.01		84,948		2.79
Industrial Machinery & Supplies & Components	82,624		2.63		99,511		3.27
Data Processing & Outsourced Services	80,058		2.55		133,410		4.38
Diversified Support Services	79,799		2.54		23,435		0.77
Aerospace & Defense	72,927		2.32		51,797		1.70
Real Estate Operating Companies	72,839		2.32		83,754		2.75
Diversified Financial Services	66,597		2.12		61,725		2.03
Environmental & Facilities Services	65,229		2.07		63,064		2.07
Metal, Glass & Plastic Containers	64,769		2.06		55,530		1.82
Personal Care Products	63,425		2.02		68,146		2.24
Airport Services	63,110		2.01		55,961		1.84
Health Care Distributors	60,316		1.92		62,044		2.04
Real Estate Services	55,220		1.76		44,717		1.47
Fertilizers & Agricultural Chemicals	54,677		1.74		64,720		2.13
Internet Services & Infrastructure	53,376		1.70		60,934		2.00
Diversified Metals & Mining	50,061		1.59		49,842		1.64
Home Improvement Retail	49,891		1.59		54,236		1.78
Communications Equipment	46,764		1.49		—		—
Specialized Finance	45,156		1.44		73,035		2.40
Biotechnology	43,821		1.39		126,349		4.15
Soft Drinks & Non-alcoholic Beverages	42,898		1.36		42,628		1.40
Automotive Retail	40,964		1.30		57,596		1.89
Systems Software	39,316		1.25		23,111		0.76
Office Services & Supplies	38,891		1.24		—		—
Real Estate Development	38,237		1.22		23,965		0.79
Leisure Facilities	37,958		1.21		39,076		1.28
Other Specialty Retail	36,810		1.17		41,088		1.35
Electrical Components & Equipment	32,834		1.04		32,440		1.07
Construction & Engineering	31,602		1.00		22,102		0.73
Movies & Entertainment	30,779		0.98		12,188		0.40
Health Care Equipment	28,823		0.92		22,441		0.74
Construction Machinery & Heavy Transportation Equipment	25,901		0.82		—		—
Specialized Consumer Services	25,763		0.82		—		—
Passenger Airlines	25,039		0.80		24,920		0.82
Wireless Telecommunication Services	24,257		0.77		—		—
Home Furnishings	24,102		0.77		23,859		0.78
Gold	23,454		0.75		23,310		0.77
Broadline Retail	22,231		0.71		83,290		2.74
Hotels, Resorts & Cruise Lines	20,612		0.66		17,195		0.56
Packaged Foods & Meats	19,863		0.63		—		—
Specialty Chemicals	19,407		0.62		38,640		1.27
Oil & Gas Storage & Transportation	19,309		0.61		22,042		0.72
Insurance Brokers	19,222		0.61		52,856		1.74
Paper & Plastic Packaging Products & Materials	18,379		0.58		3,254		0.11
Apparel Retail	17,855		0.57		4,999		0.16
Food Distributors	14,639		0.47		5,897		0.19
Health Care Supplies	14,426		0.46		11,646		0.38
Advertising	11,418		0.36		25,597		0.84
Education Services	8,205		0.26		13,871		0.46
Financial Exchanges & Data	8,050		0.26		—		—
Housewares & Specialties	2,806		0.09		2,908		0.10
Integrated Telecommunication Services	2,057		0.07		18,801		0.62
Distributors	1,733		0.06		37,666		1.24
Auto Parts & Equipment	—		—		48,536		1.59
Consumer Finance	—		—		16,440		0.54
Restaurants	—		—		12,603		0.41
Air Freight & Logistics	—		—		4,925		0.16
Integrated Oil & Gas	—		—		4,894		0.16
Research & Consulting Services	—		—		4,871		0.16
Cable & Satellite	—		—		4,619		0.15
Other Specialized REITs	—		—		4,379		0.14
Leisure Products	—		—		2,055		0.07
Technology Distributors	—		—		813		0.03
	$	3,144,919	100.00	%	$	3,044,119	100.00	%


	September 30, 2024						September 30, 2023
Fair Value:			% of Total Investments		% of Net Assets				% of Total Investments		% of Net Assets
Application Software	$	523,007	17.34	%	35.16	%	$	455,719	15.73	%	30.03	%
Multi-Sector Holdings (1)	193,579		6.41		13.01		193,431		6.69		12.76
Health Care Services	127,935		4.23		8.60		66,683		2.31		4.40
Health Care Technology	104,795		3.47		7.04		95,404		3.30		6.29
Interactive Media & Services	96,963		3.21		6.52		19,199		0.66		1.27
Pharmaceuticals	91,804		3.04		6.17		80,455		2.78		5.31
Industrial Machinery & Supplies & Components	84,977		2.81		5.71		98,352		3.40		6.49
Diversified Support Services	80,638		2.67		5.42		23,352		0.81		1.54
Aerospace & Defense	74,327		2.46		5.00		51,862		1.79		3.42
Data Processing & Outsourced Services	73,673		2.44		4.95		125,259		4.33		8.26
Real Estate Operating Companies	71,246		2.36		4.79		82,463		2.85		5.44
Diversified Financial Services	66,324		2.20		4.46		60,003		2.07		3.96
Environmental & Facilities Services	64,119		2.12		4.31		62,413		2.16		4.12
Health Care Distributors	58,906		1.95		3.96		60,865		2.10		4.02
Personal Care Products	57,451		1.90		3.86		59,928		2.07		3.95
Airport Services	55,434		1.83		3.73		54,453		1.88		3.59
Fertilizers & Agricultural Chemicals	54,668		1.81		3.67		63,185		2.18		4.17
Real Estate Services	54,197		1.79		3.64		43,886		1.52		2.90
Internet Services & Infrastructure	53,019		1.75		3.56		60,579		2.09		4.00
Diversified Metals & Mining	50,419		1.67		3.39		49,869		1.72		3.29
Home Improvement Retail	48,775		1.61		3.28		53,168		1.84		3.51
Metal, Glass & Plastic Containers	47,191		1.56		3.17		53,459		1.85		3.53
Communications Equipment	46,858		1.55		3.15		—		—		—
Biotechnology	45,954		1.52		3.09		125,678		4.35		8.29
Specialized Finance	44,551		1.47		2.99		69,590		2.41		4.59
Soft Drinks & Non-alcoholic Beverages	42,674		1.41		2.87		42,391		1.47		2.80
Systems Software	39,813		1.32		2.68		21,968		0.76		1.45
Other Specialty Retail	39,660		1.31		2.67		41,115		1.42		2.71
Automotive Retail	39,111		1.29		2.63		55,805		1.93		3.68
Real Estate Development	38,237		1.27		2.57		23,679		0.82		1.56
Office Services & Supplies	38,149		1.26		2.56		—		—		—
Leisure Facilities	37,544		1.24		2.52		36,963		1.28		2.44
Electrical Components & Equipment	32,246		1.07		2.17		32,573		1.13		2.15
Construction & Engineering	31,063		1.03		2.09		21,903		0.76		1.45
Movies & Entertainment	30,863		1.02		2.07		11,865		0.41		0.78
Passenger Airlines	26,556		0.88		1.78		27,512		0.95		1.82
Construction Machinery & Heavy Transportation Equipment	26,486		0.88		1.78		—		—		—
Health Care Equipment	26,264		0.87		1.77		22,436		0.78		1.48
Specialized Consumer Services	25,772		0.85		1.73		—		—		—
Gold	25,054		0.83		1.68		23,328		0.81		1.54
Wireless Telecommunication Services	24,311		0.80		1.63		—		—		—
Broadline Retail	22,554		0.75		1.52		69,040		2.39		4.55
Hotels, Resorts & Cruise Lines	20,342		0.67		1.37		16,991		0.59		1.12
Packaged Foods & Meats	19,846		0.66		1.33		—		—		—
Specialty Chemicals	19,431		0.64		1.31		38,615		1.34		2.55
Insurance Brokers	19,221		0.64		1.29		53,050		1.83		3.50
Paper & Plastic Packaging Products & Materials	18,307		0.61		1.23		3,061		0.11		0.20
Apparel Retail	18,017		0.60		1.21		5,002		0.17		0.33
Oil & Gas Storage & Transportation	15,604		0.52		1.05		16,040		0.55		1.06
Food Distributors	15,484		0.51		1.04		5,166		0.18		0.34
Health Care Supplies	14,218		0.47		0.96		11,363		0.39		0.75
Advertising	11,515		0.38		0.77		11,955		0.41		0.79
Home Furnishings	9,376		0.31		0.63		19,954		0.69		1.32
Education Services	8,263		0.27		0.56		13,618		0.47		0.90
Financial Exchanges & Data	8,065		0.27		0.54		—		—		—
Housewares & Specialties	2,546		0.08		0.17		2,808		0.10		0.19
Distributors	2,220		0.07		0.15		37,311		1.29		2.46
Integrated Telecommunication Services	1,657		0.05		0.11		16,492		0.57		1.09
Auto Parts & Equipment	—		—		—		49,148		1.70		3.24
Consumer Finance	—		—		—		15,087		0.52		1.00
Restaurants	—		—		—		12,464		0.43		0.82
Research & Consulting Services	—		—		—		4,831		0.17		0.32
Integrated Oil & Gas	—		—		—		4,785		0.17		0.32
Cable & Satellite	—		—		—		4,546		0.16		0.30
Air Freight & Logistics	—		—		—		4,263		0.15		0.28
Other Specialized REITs	—		—		—		3,198		0.11		0.21
Leisure Products	—		—		—		2,063		0.07		0.14
Technology Distributors	—		—		—		776		0.03		0.05
Total	$	3,021,279	100.00	%	203.07	%	$	2,892,420	100.00	%	190.82	%

___________________

(1)This industry includes the Company's investments in the JVs and CLOs.

As of September 30, 2024 and September 30, 2023, the Company had no single investment that represented greater than 10% of the total investment portfolio at fair value. Income, consisting of interest, dividends, fees, other investment income and realization of gains or losses, may fluctuate and in any given period can be highly concentrated among several investments.

Senior Loan Fund JV I, LLC

In May 2014, the Company entered into an LLC agreement with Kemper to form SLF JV I. The Company co-invests in senior secured loans of middle-market companies and other corporate debt securities with Kemper through its investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by the Company and one representative selected by Kemper (with approval from a representative of each required). Since the Company does not have a controlling financial interest in SLF JV I, the Company does not consolidate SLF JV I.

SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to the Company and Kemper by SLF JV I. The subordinated notes issued by SLF JV I (the "SLF JV I Notes") are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt. As of September 30, 2024 and September 30, 2023, the Company and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act.

SLF JV I has a revolving credit facility with Bank of America, N.A. (as amended and/or restated from time to

time, the "SLF JV I Facility"), which permitted up to $270.0 million of borrowings (subject to borrowing base and other limitations) as of September 30, 2024. Borrowings under the SLF JV I Facility are secured by all of the assets of SLF JV I Funding II LLC, a special purpose financing subsidiary of SLF JV I. As of September 30, 2024, the revolving period of the SLF JV I Facility was scheduled to expire April 17, 2027 and the maturity date was April 22, 2027. As of September 30, 2024, borrowings under the SLF JV I Facility accrued interest at a rate equal to daily SOFR plus 1.70% per annum. As of September 30, 2024 and September 30, 2023, $200.0 million and $149.0 million of borrowings were outstanding under the SLF JV I Facility, respectively.

As of September 30, 2024 and September 30, 2023, SLF JV I had total assets of $375.8 million and $376.1 million, respectively. SLF JV I's portfolio primarily consisted of senior secured loans to 48 portfolio companies as of each of September 30, 2024 and September 30, 2023. The portfolio companies in SLF JV I are in industries similar to those in which the Company may invest directly. As of September 30, 2024, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $135.2 million in aggregate, at fair value. As of September 30, 2023, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $141.5 million in aggregate, at fair value.

As of each of September 30, 2024 and September 30, 2023, the Company and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from the Company. As of each of September 30, 2024 and September 30, 2023, the Company had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I.

Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of September 30, 2024 and September 30, 2023:


	September 30, 2024	September 30, 2023
Senior secured loans (1)	$330,094	$332,637
Weighted average interest rate on senior secured loans (2)	9.56%	10.62%
Number of borrowers in SLF JV I	48	48
Largest exposure to a single borrower (1)	$10,495	$11,286
Total of five largest loan exposures to borrowers (1)	$49,413	$54,051

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

SLF JV I Portfolio as of September 30, 2024


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.25%		8/18/2028		$	10,495	$	10,404	$	10,553	(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.37%		12/18/2025		1,026		1,019		985		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.37%		12/18/2025		6,072		6,038		5,829		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.45%		6/30/2025		8,329		8,304		7,663		(4)
Artera Services LLC	Construction & Engineering	First Lien Term Loan	SOFR+	4.50%	9.10%		2/15/2031		7,961		7,902		7,781
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.52%		12/29/2027		4,092		4,048		3,896		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%	11.29%		12/29/2027		290		284		266		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	6.75%	11.35%		2/25/2028		2,546		2,517		2,111		(4)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%			10/25/2028		4,037		3,877		1,161		(4)(6)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	8.95%		8/19/2028		7,775		7,589		7,660
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.20%		8/19/2028		1,970		1,886		1,944
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.10%		2/15/2029		9,034		8,790		8,992
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	7.00%	7.70%	4.00%	12/24/2026		6,548		6,430		6,351		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	9.87%		6/11/2027		1,735		1,724		1,633		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	9.87%		6/11/2027		6,242		6,183		5,875		(4)
Bausch + Lomb Corporation	Health Care Supplies	First Lien Term Loan	SOFR+	3.25%	8.27%		5/10/2027		9,173		9,017		9,151
Boxer Parent Company Inc.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.01%		7/30/2031		8,000		7,983		7,994
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.16%		8/10/2027		2,348		2,325		1,751
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	12.27%		8/10/2027		1,976		1,955		1,474
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.16%		8/10/2027		1,955		1,936		1,458
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	11.50%		8/10/2027		600		594		447		(5)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	12.02%		8/10/2027		2		2		1
Cloud Software Group, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	8.60%		3/30/2029		8,153		7,621		8,129
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	9.60%		10/13/2029		7,765		7,428		7,381		(4)
Crown Subsea Communications Holding, Inc.	Alternative Carriers	First Lien Term Loan	SOFR+	4.00%	9.25%		1/30/2031		7,980		7,900		8,039
Curium Bidco S.à.r.l.	Pharmaceuticals	First Lien Term Loan	SOFR+	4.00%	8.60%		7/31/2029		8,643		8,559		8,684
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.25%	10.21%		8/2/2029		6,711		6,635		6,618
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.60%		4/26/2029		9,029		8,913		9,076
Eagle Parent Corp.	Diversified Support Services	First Lien Term Loan	SOFR+	4.25%	9.55%		4/2/2029		1,179		1,177		1,121
Engineering Research and Consulting LLC	Construction & Engineering	First Lien Term Loan	SOFR+	5.00%	10.06%		8/29/2031		4,208		4,149		4,182		(4)
Frontier Communications Holdings, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	3.50%	8.76%		7/1/2031		7,000		6,965		7,061
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.20%		4/9/2029		7,840		7,687		7,646		(4)


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Husky Injection Molding Systems Ltd.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	5.00%	10.33%		2/15/2029		$	5,089	$	5,028	$	5,071
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.21%		6/30/2026		7,256		7,205		7,247
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	10.62%		3/25/2027		8,500		8,392		7,140		(4)
KDC/ONE Development Corp Inc	Personal Care Products	First Lien Term Loan	SOFR+	4.50%	9.36%		8/15/2028		8,890		8,675		8,908
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	9.95%		10/29/2028		7,896		7,682		7,734		(4)
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	SOFR+	5.00%	9.96%		5/9/2026		29		29		28		(4)
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	SOFR+	4.75%	9.60%		7/29/2029		10,000		9,876		9,848
M2S Group Intermediate Holdings Inc	Multi-Sector Holdings	First Lien Term Loan	SOFR+	4.75%	9.85%		8/25/2031		10,000		9,652		9,625
McAfee Corp.	Systems Software	First Lien Term Loan	SOFR+	3.25%	8.45%		3/1/2029		7,890		7,656		7,872
Mitchell International, Inc.	Application Software	First Lien Term Loan	SOFR+	3.25%	8.10%		6/17/2031		8,000		7,953		7,892
Peraton Corp.	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	8.70%		2/1/2028		1,978		1,977		1,909
PetSmart LLC	Other Specialty Retail	First Lien Term Loan	SOFR+	3.75%	8.70%		2/11/2028		7,948		7,871		7,893
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	7.50%		12.62%	8/22/2029		1,544		1,544		1,544		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	4.50%	8.12%	1.50%	8/22/2029		1,030		1,030		1,030		(4)
Pluralsight, LLC	Application Software	Common Stock						514,789			1,719		1,719		(4)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.25%	9.10%		4/5/2030		8,920		8,793		8,927
SCIH Salt Holdings Inc.	Diversified Chemicals	First Lien Term Loan	SOFR+	3.50%	8.76%		3/16/2027		2,963		2,963		2,966
Shearer's Foods LLC	Packaged Foods & Meats	First Lien Term Loan	SOFR+	4.00%	8.85%		2/12/2031		6,983		6,913		6,996
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	6.50%	11.82%		6/30/2029		938		893		919
SHO Holding I Corporation	Footwear	First Lien Term Loan		6.50%	11.82%		6/30/2029		2,634		2,634		2,529
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	7.00%	12.32%		6/30/2029		1,451		1,451		1,306
SHO Holding I Corporation	Footwear	Common Stock						2,746			4,295		3,145
SM Wellness Holdings, Inc.	Health Care Services	First Lien Term Loan	SOFR+	4.50%	10.01%		4/17/2028		2,947		2,640		2,888		(4)
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	3.75%	8.00%		10/5/2027		8,601		8,563		8,628
Staples, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.75%	10.69%		9/4/2029		5,349		5,147		4,873		(4)
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	3.75%	8.35%		9/27/2030		7,960		7,841		7,757
SupplyOne, Inc.	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	4.25%	9.10%		4/19/2031		4,478		4,433		4,496
Swissport Stratosphere USA LLC	Air Freight & Logistics	First Lien Term Loan	SOFR+	4.25%	9.57%		4/4/2031		5,486		5,459		5,512
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	10.95%		12/29/2028		7,139		7,052		6,996		(4)
Trident TPI Holdings, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.00%	8.60%		9/15/2028		7,481		7,481		7,502
Total Portfolio Investments									$	330,094	$	337,882	$	329,496

_______

(1) Represents the interest rate as of September 30, 2024. All interest rates are payable in cash, unless otherwise noted.

(4) This investment was held by both the Company and SLF JV I as of September 30, 2024.

(6) This investment was on non-accrual status as of September 30, 2024.

SLF JV I Portfolio as of September 30, 2023


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.32%		8/18/2028		$	8,596	$	8,503	$	8,499
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.90%		12/18/2025		1,149		1,135		1,128		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.15%		12/18/2025		6,771		6,701		6,648		(4)
Altice France S.A.	Integrated Telecommunication Services	First Lien Term Loan	L+	4.00%	9.63%		8/14/2026		2,969		2,853		2,810
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	13.04%		6/30/2025		8,798		8,737		8,218		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.43%		6/9/2028		4,957		4,734		4,614
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.81%		10/20/2028		4,824		4,763		4,239		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.15%	9.54%		11/26/2026		7,720		7,643		7,720
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.40%		8/11/2025		1,523		1,191		1,099		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027		—		(7)		(29)		(4)(5)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.63%		12/29/2027		4,134		4,076		3,892		(4)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%	10.90%		10/25/2028		5,052		4,888		3,817		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.42%		8/19/2028		4,950		4,747		4,809
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.67%		8/19/2028		1,990		1,884		1,937
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.68%		1/20/2029		4,346		4,036		3,871
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.57%		2/15/2029		4,320		4,080		4,251
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	6.00%	11.49%		12/24/2026		6,289		6,216		6,028		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027		1,753		1,742		1,711		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027		6,306		6,247		6,155		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock						171			—		—		(4)
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity						7,193,540			7,194		5,683		(4)
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.55%		8/10/2027		2,354		2,322		2,281
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.55%		8/10/2027		1,983		1,954		1,921
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Revolver	SOFR+	6.00%	11.57%		8/10/2027		600		592		581
Centerline Communications, LLC	Wireless Telecommunication Services	First Lien Term Loan	SOFR+	6.00%	11.55%		8/10/2027		1,960		1,935		1,899
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.39%		10/13/2029		6,343		5,983		6,285		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	SOFR+	4.50%	9.89%		7/31/2029		8,730		8,642		8,730
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.43%		8/2/2027		5,799		5,715		5,681		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	10.12%		4/26/2029		7,920		7,792		7,729		(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.57%		8/11/2028		7,369		7,295		6,190		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.67%		4/9/2029		7,920		7,731		7,517		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.90%		6/30/2026		7,331		7,249		7,340


Portfolio Company	Industry	Type of Investment	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Shares	Principal		Cost		Fair Value (3)		Notes
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	11.40%		3/25/2027		$	9,000	$	8,839	$	7,080	(4)
KDC/ONE Development Corp Inc	Personal Care Products	First Lien Term Loan	SOFR+	5.00%	10.32%		8/15/2028		10,000		9,666		9,665
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	10.42%		10/29/2028		3,962		3,815		3,955
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.32%		10/14/2027		7,369		7,269		7,267
Lightbox Intermediate, L.P.	Real Estate Services	First Lien Term Loan	SOFR+	5.00%	10.65%		5/9/2026		11,249		11,106		10,912		(4)
McAfee Corp.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.18%		3/1/2029		5,940		5,654		5,812
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Revolver	SOFR+	7.00%			2/14/2025		—		(2)		(8)		(4)(5)
Mindbody, Inc.	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	7.00%	12.52%		2/14/2025		4,669		4,648		4,594		(4)
Mitchell International, Inc.	Application Software	First Lien Term Loan	SOFR+	3.75%	9.18%		10/15/2028		2,985		2,845		2,941
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026		—		(3)		(7)		(4)(5)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.99%		2/10/2026		8,319		8,164		8,147		(4)
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.99%		2/10/2026		2,211		2,210		2,165		(4)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.76%	10.15%		3/31/2025		6,615		6,608		6,565
OEConnection LLC	Application Software	First Lien Term Loan	SOFR+	4.00%	9.43%		9/25/2026		10,987		10,827		10,971
Park Place Technologies, LLC	Internet Services & Infrastructure	First Lien Term Loan	SOFR+	5.00%	10.42%		11/10/2027		9,825		9,492		9,698		(4)
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.65%		12/17/2027		2,416		2,298		2,390
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.74%		12/18/2028		4,503		4,435		4,098		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.45%		4/6/2027		318		301		297		(4)(5)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.45%		4/6/2027		8,116		7,850		7,773		(4)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.75%	9.99%		4/5/2030		5,000		4,860		4,969
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.23%	10.86%		4/27/2024		138		138		94
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.25%	10.88%		4/27/2024		8,113		8,111		5,531
SM Wellness Holdings, Inc.	Health Care Services	First Lien Term Loan	SOFR+	4.75%	10.38%		4/17/2028		2,977		2,580		2,799		(4)
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	4.00%	9.43%		10/5/2027		7,680		7,642		7,643
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.25%	10.67%		11/20/2028		8,843		8,713		8,717		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.92%		4/5/2029		8,801		8,442		8,794
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	4.00%	9.33%		9/19/2030		8,000		7,880		7,834
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.99%		3/30/2029		8,215		7,559		7,913
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.42%		12/29/2028		7,212		7,103		7,022		(4)
Veritas US Inc.	Application Software	First Lien Term Loan	SOFR+	5.00%	10.43%		9/1/2025		6,305		6,257		5,500
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.67%		9/21/2027		6,148		6,008		5,939		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	9.27%		4/30/2025		1,965		1,920		1,855		(4)
Total Portfolio Investments									$	332,637	$	331,808	$	322,179

_________

(1) Represents the interest rate as of September 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(4) This investment was held by both the Company and SLF JV I as of September 30, 2023.

Both the cost and fair value of the Company's SLF JV I Notes were $112.7 million as of each of September 30, 2024 and September 30, 2023. The Company earned interest income of $14.3 million, $12.7 million and $8.0 million on the SLF JV I Notes for the years ended September 30, 2024, 2023 and 2022, respectively. As of September 30, 2024, the SLF JV I Notes bore interest at a rate of one-month SOFR plus 7.00% per annum with a SOFR floor of 1.00% and will mature on December 29, 2028.

The cost and fair value of the LLC equity interests in SLF JV I held by the Company were $54.8 million and $22.5 million, respectively, as of September 30, 2024, and $54.8 million and $28.9 million, respectively, as of September 30, 2023. The Company earned $5.3 million, $4.2 million and $2.9 million in dividend income for the years ended September 30, 2024, 2023 and 2022, respectively, with respect to its investment in the LLC equity interests of SLF JV I. The LLC equity interests of SLF JV I are generally dividend producing to the extent SLF JV I has residual cash to be distributed on a quarterly basis.

Below is certain summarized financial information for SLF JV I as of September 30, 2024 and September 30, 2023 and for the years ended September 30, 2024, 2023 and 2022:


	September 30, 2024		September 30, 2023
Selected Balance Sheet Information:
Investments at fair value (cost September 30, 2024: $337,882; cost September 30, 2023: $331,808)	$	329,496	$	322,179
Cash and cash equivalents	36,082		31,950
Restricted cash	6,994		2,987
Other assets	3,260		18,988
Total assets	$	375,832	$	376,104

Senior credit facility payable	$	200,000	$	149,000
Secured borrowings	11,311		38,845
SLF JV I Notes payable at fair value (proceeds September 30, 2024: $128,750; proceeds September 30, 2023: $128,750)	128,750		128,750
Other liabilities	10,007		26,630
Total liabilities	$	350,068	$	343,225
Members' equity	25,764		32,879
Total liabilities and members' equity	$	375,832	$	376,104


	Year ended September 30, 2024		Year ended September 30, 2023		Year ended September 30, 2022
Selected Statements of Operations Information:
Interest income	$	37,250	$	38,984	$	24,014
Other income	153		290		198
Total investment income	37,403		39,274		24,212
Senior credit facility and secured borrowing interest expense	15,904		19,002		7,713
SLF JV I Notes interest expense	16,292		14,544		9,146
Other expenses	315		442		253
Total expenses (1)	32,511		33,988		17,112
Net investment income	4,892		5,286		7,100
Net unrealized appreciation (depreciation)	1,245		13,416		(23,661)
Net realized gains (losses)	(7,251)		(10,962)		534
Net income (loss)	$	(1,114)	$	7,740	$	(16,027)

__________

(1) There are no management fees or incentive fees charged at SLF JV I.

SLF JV I has elected to fair value the SLF JV I Notes issued to the Company and Kemper under FASB ASC Topic 825, Financial Instruments - Fair Value Option ("ASC 825"). The SLF JV I Notes are valued based on the total assets less the total liabilities senior to the SLF JV I Notes in an amount not exceeding par under the EV technique.

During the year ended September 30, 2024, the Company purchased $25.1 million of senior secured debt investments from SLF JV I for $24.1 million cash consideration, which represented the fair value at the time of purchase. During the year ended September 30, 2023, the Company sold $31.8 million of senior secured debt investments to SLF JV I for $30.6 million cash consideration, which represented the fair value at the time of sale. A loss of $0.2 million was recognized by the Company on these transactions. During the year ended September 30, 2022, the Company sold $9.7 million of senior secured debt investments to SLF JV I for $9.7 million cash consideration, which represented the fair value at the time of sale. A gain of $0.5 million was recognized by the Company on these transactions.

OCSI Glick JV LLC

On March 19, 2021, the Company became party to the LLC agreement of Glick JV. The Company co-invests primarily in senior secured loans of middle-market companies with GF Equity Funding through the Glick JV. The Glick JV is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by GF Equity Funding. The Glick JV is capitalized as transactions are completed, and portfolio decisions and investment decisions in respect of the Glick JV must be approved by the Glick JV investment committee, which consists of one representative selected by the Company and one representative selected by GF Equity Funding (with approval from a representative of each required). Since the Company does not have a controlling financial interest in the Glick JV, the Company does not consolidate the Glick JV.

The members provide capital to the Glick JV in exchange for LLC equity interests, and the Company and GF Debt Funding 2014 LLC ("GF Debt Funding"), an entity advised by affiliates of GF Equity Funding, provide capital to the Glick JV in exchange for subordinated notes issued by the Glick JV (the "Glick JV Notes"). As of September 30, 2024 and September 30, 2023, the Company and GF Equity Funding owned 87.5% and 12.5%, respectively, of the outstanding LLC equity interests, and the Company and GF Debt Funding owned 87.5% and 12.5%, respectively, of the Glick JV Notes. The Glick JV is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act.

The Glick JV has a revolving credit facility with Bank of America, N.A. (as amended and/or restated from time to

time, the "Glick JV Facility"), which, as of September 30, 2024, had a revolving period end date and maturity date of April 17, 2027 and April 22, 2027, respectively, and permitted borrowings of up to $100.0 million (subject to borrowing base and other limitations). Borrowings under the Glick JV Facility are secured by all of the assets of OCSL Glick JV Funding II LLC, a special purpose financing subsidiary of the Glick JV. As of September 30, 2024, borrowings under the Glick JV Facility bore interest at a rate equal to daily SOFR plus 1.70% per annum. $79.0 million and $53.0 million of borrowings were outstanding under the Glick JV Facility as of September 30, 2024 and September 30, 2023, respectively.

As of September 30, 2024 and September 30, 2023, the Glick JV had total assets of $145.0 million and $141.2 million, respectively. The Glick JV's portfolio consisted of middle-market and other corporate debt securities of 44 and 38 portfolio companies as of September 30, 2024 and September 30, 2023, respectively. The portfolio companies in the Glick JV are in industries similar to those in which the Company may invest directly. The Company's investment in the Glick JV consisted of LLC equity interests and Glick JV Notes of $48.9 million and $50.0 million in the aggregate at fair value as of September 30, 2024 and September 30, 2023, respectively. The Glick JV Notes are junior in right of payment to the repayment of temporary contributions made by the Company to fund investments of the Glick JV that are repaid when GF Equity Funding and GF Debt Funding make their capital contributions and fund their Glick JV Notes, respectively.

As of each of September 30, 2024 and September 30, 2023, the Glick JV had total capital commitments of $100.0 million, $87.5 million of which was from the Company and the remaining $12.5 million of which was from GF Equity Funding and GF Debt Funding. Approximately $84.0 million in aggregate commitments were funded as of each of September 30, 2024 and September 30, 2023, of which $73.5 million was from the Company. As of each of September 30, 2024 and September 30, 2023, the Company had commitments to fund Glick JV Notes of $78.8 million, of which $12.4 million were unfunded. As of each of September 30, 2024 and September 30, 2023, the Company had commitments to fund LLC equity interests in the Glick JV of $8.7 million, of which $1.6 million were unfunded.

Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of September 30, 2024 and September 30, 2023:


	September 30, 2024	September 30, 2023
Senior secured loans (1)	$125,405	$130,589
Weighted average current interest rate on senior secured loans (2)	9.65%	10.77%
Number of borrowers in the Glick JV	44	38
Largest loan exposure to a single borrower (1)	$5,898	$6,230
Total of five largest loan exposures to borrowers (1)	$22,152	$28,396

__________

(1) At principal amount.

(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

Glick JV Portfolio as of September 30, 2024


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.25%		8/18/2028	$	1,980	$	1,948	$	1,991	(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.37%		12/18/2025	3,359		3,341		3,225		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.37%		12/18/2025	513		510		493		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	12.45%		6/30/2025	5,897		5,880		5,426		(4)
Artera Services LLC	Construction & Engineering	First Lien Term Loan	SOFR+	4.50%	9.10%		2/15/2031	3,485		3,459		3,406
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.52%		12/29/2027	1,699		1,681		1,617		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%	11.29%		12/29/2027	120		118		110		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	6.75%	11.35%		2/25/2028	1,047		1,035		868		(4)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%			10/25/2028	1,661		1,619		477		(4)(6)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	8.95%		8/19/2028	3,149		3,073		3,102
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.20%		8/19/2028	985		943		972
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.10%		2/15/2029	2,942		2,850		2,929
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	7.00%	7.70%	4.00%	12/24/2026	3,778		3,710		3,664		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	9.87%		6/11/2027	3,328		3,298		3,133		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	9.87%		6/11/2027	792		787		745		(4)
Bausch + Lomb Corporation	Health Care Supplies	First Lien Term Loan	SOFR+	3.25%	8.27%		5/10/2027	3,718		3,657		3,710
Boxer Parent Company Inc.	Systems Software	First Lien Term Loan	SOFR+	3.75%	9.01%		7/30/2031	3,000		2,993		2,998
Cloud Software Group, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	8.60%		3/30/2029	2,621		2,456		2,613
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	9.60%		10/13/2029	2,570		2,446		2,443		(4)
Crown Subsea Communications Holding, Inc.	Alternative Carriers	First Lien Term Loan	SOFR+	4.00%	9.25%		1/30/2031	2,993		2,963		3,015
Curium Bidco S.à.r.l.	Pharmaceuticals	First Lien Term Loan	SOFR+	4.00%	8.60%		7/31/2029	2,813		2,792		2,826
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.25%	10.21%		8/2/2029	2,957		2,932		2,916
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	9.60%		4/26/2029	3,534		3,488		3,553
Eagle Parent Corp.	Diversified Support Services	First Lien Term Loan	SOFR+	4.25%	8.85%		4/2/2029	392		387		373
Engineering Research and Consulting LLC	Construction & Engineering	First Lien Term Loan	SOFR+	5.00%	10.06%		8/29/2031	1,025		1,011		1,019		(4)
Frontier Communications Holdings, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	3.50%	8.76%		7/1/2031	3,000		2,985		3,026


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.20%		4/9/2029	$	3,920	$	3,843	$	3,823	(4)
Husky Injection Molding Systems Ltd.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	5.00%	10.33%		2/15/2029	3,125		3,088		3,114
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.21%		6/30/2026	3,870		3,842		3,865
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	10.62%		3/25/2027	2,125		2,098		1,785		(4)
KDC US Holdings, Inc.	Personal Care Products	First Lien Term Loan	SOFR+	4.50%	9.36%		8/15/2028	3,551		3,454		3,558
LABL, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.00%	9.95%		10/29/2028	2,987		2,899		2,926		(4)
LTI Holdings, Inc.	Electronic Components	First Lien Term Loan	SOFR+	4.75%	9.60%		7/29/2029	4,000		3,950		3,939
M2S Group Intermediate Holdings Inc	Multi-Sector Holdings	First Lien Term Loan	SOFR+	4.75%	9.85%		8/25/2031	4,000		3,861		3,850
Mitchell International, Inc.	Application Software	First Lien Term Loan	SOFR+	3.25%	8.10%		6/17/2031	3,500		3,480		3,453
Peraton Corp.	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	8.70%		2/1/2028	990		989		954
PetSmart LLC	Other Specialty Retail	First Lien Term Loan	SOFR+	3.75%	8.70%		2/11/2028	2,980		2,944		2,959
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	4.50%	8.12%	1.50%	8/22/2029	662		662		662		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	7.50%		12.62%	8/22/2029	993		993		993		(4)
Pluralsight, LLC	Application Software	Common Equity & Warrants								1,105		1,105		(4)
Renaissance Holding Corp.	Education Services	First Lien Term Loan	SOFR+	4.25%	9.10%		4/5/2030	1,985		1,980		1,986
SCIH Salt Holdings Inc.	Diversified Chemicals	First Lien Term Loan	SOFR+	3.50%	8.76%		3/16/2027	1,480		1,481		1,483
Shearer's Foods LLC	Packaged Foods & Meats	First Lien Term Loan	SOFR+	4.00%	8.85%		2/12/2031	2,993		2,963		2,998
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	6.50%	11.82%		6/30/2029	697		664		683
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	6.50%	11.82%		6/30/2029	1,957		1,957		1,879
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	7.00%	12.32%		6/30/2029	1,078		1,078		970
SHO Holding I Corporation	Footwear	Common Equity & Warrants								3,194		2,337
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	3.75%	8.00%		10/5/2027	3,266		3,250		3,277
Staples, Inc.	Office Services & Supplies	First Lien Term Loan	SOFR+	5.75%	10.69%		9/4/2029	1,918		1,846		1,748		(4)
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	3.75%	8.35%		9/27/2030	3,980		3,920		3,878
SupplyOne, Inc.	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	4.25%	9.10%		4/19/2031	1,493		1,478		1,499
Swissport Stratosphere USA LLC	Air Freight & Logistics	First Lien Term Loan	SOFR+	4.25%	9.57%		4/4/2031	1,995		1,985		2,004
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	10.95%		12/29/2028	8		7		7		(4)
Trident TPI Holdings, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan	SOFR+	4.00%	8.60%		9/15/2028	2,494		2,494		2,502
Total Portfolio Investments								$	125,405	$	127,867	$	124,887

__________

(1) Represents the interest rate as of September 30, 2024. All interest rates are payable in cash, unless otherwise noted.

(4) This investment was held by both the Company and the Glick JV as of September 30, 2024.

(6) This investment was on non-accrual status as of September 30, 2024.

Glick JV Portfolio as of September 30, 2023


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
Access CIG, LLC	Diversified Support Services	First Lien Term Loan	SOFR+	5.00%	10.32%		8/18/2028	$	2,000	$	1,960	$	1,978
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	11.90%		12/18/2025	574		568		564		(4)
ADB Companies, LLC	Construction & Engineering	First Lien Term Loan	SOFR+	6.50%	12.15%		12/18/2025	3,746		3,709		3,678		(4)
Alvogen Pharma US, Inc.	Pharmaceuticals	First Lien Term Loan	SOFR+	7.50%	13.04%		6/30/2025	6,230		6,185		5,819		(4)
American Rock Salt Company LLC	Diversified Metals & Mining	First Lien Term Loan	SOFR+	4.00%	9.43%		6/9/2028	2,478		2,367		2,307
American Tire Distributors, Inc.	Distributors	First Lien Term Loan	SOFR+	6.25%	11.81%		10/20/2028	2,860		2,825		2,514		(4)
Amplify Finco Pty Ltd.	Movies & Entertainment	First Lien Term Loan	SOFR+	4.15%	9.54%		11/26/2026	2,895		2,866		2,895
Amynta Agency Borrower Inc.	Property & Casualty Insurance	First Lien Term Loan	SOFR+	5.00%	10.42%		2/28/2028	2,993		2,913		2,997
Anastasia Parent, LLC	Personal Care Products	First Lien Term Loan	SOFR+	3.75%	9.40%		8/11/2025	907		705		654		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Term Loan	SOFR+	6.00%	11.63%		12/29/2027	1,716		1,692		1,616		(4)
ASP-R-PAC Acquisition Co LLC	Paper & Plastic Packaging Products & Materials	First Lien Revolver	SOFR+	6.00%			12/29/2027	—		(3)		(12)		(4)(5)
Astra Acquisition Corp.	Application Software	First Lien Term Loan	SOFR+	5.25%	10.90%		10/25/2028	2,078		2,039		1,570		(4)
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.00%	9.42%		8/19/2028	1,980		1,899		1,924
Asurion, LLC	Property & Casualty Insurance	First Lien Term Loan	SOFR+	4.25%	9.67%		8/19/2028	995		942		968
Asurion, LLC	Property & Casualty Insurance	Second Lien Term Loan	SOFR+	5.25%	10.68%		1/20/2029	2,423		2,244		2,158
athenahealth Group Inc.	Health Care Technology	First Lien Term Loan	SOFR+	3.25%	8.57%		2/15/2029	1,772		1,674		1,744
Aurora Lux Finco S.À.R.L.	Airport Services	First Lien Term Loan	SOFR+	6.00%	11.49%		12/24/2026	3,628		3,586		3,478		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027	3,363		3,332		3,282		(4)
BAART Programs, Inc.	Health Care Services	First Lien Term Loan	SOFR+	5.00%	10.65%		6/11/2027	800		795		780		(4)
Covetrus, Inc.	Health Care Distributors	First Lien Term Loan	SOFR+	5.00%	10.39%		10/13/2029	2,766		2,607		2,741		(4)
Curium Bidco S.à.r.l.	Biotechnology	First Lien Term Loan	SOFR+	4.50%	9.89%		7/31/2029	2,841		2,820		2,841
DirecTV Financing, LLC	Cable & Satellite	First Lien Term Loan	SOFR+	5.00%	10.43%		8/2/2027	2,460		2,435		2,410		(4)
DTI Holdco, Inc.	Research & Consulting Services	First Lien Term Loan	SOFR+	4.75%	10.12%		4/26/2029	2,970		2,922		2,899		(4)
Gibson Brands, Inc.	Leisure Products	First Lien Term Loan	SOFR+	5.00%	10.57%		8/11/2028	3,930		3,891		3,301		(4)
Harbor Purchaser Inc.	Education Services	First Lien Term Loan	SOFR+	5.25%	10.67%		4/9/2029	3,960		3,865		3,759		(4)
Indivior Finance S.À.R.L.	Pharmaceuticals	First Lien Term Loan	SOFR+	5.25%	10.90%		6/30/2026	3,910		3,866		3,915
INW Manufacturing, LLC	Personal Care Products	First Lien Term Loan	SOFR+	5.75%	11.40%		3/25/2027	2,250		2,210		1,770		(4)
KDC/ONE Development Corp Inc	Personal Care Products	First Lien Term Loan	SOFR+	5.00%	10.32%		8/15/2028	4,500		4,350		4,349


Portfolio Company	Industry	Investment Type	Index	Spread	Cash Interest Rate (1)(2)	PIK	Maturity Date	Principal		Cost		Fair Value (3)		Notes
LaserAway Intermediate Holdings II, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.75%	11.32%		10/14/2027	$	3,930	$	3,877	$	3,876
MRI Software LLC	Application Software	First Lien Term Loan	SOFR+	5.50%	10.99%		2/10/2026	1,630		1,616		1,596		(4)
MRI Software LLC	Application Software	First Lien Revolver	SOFR+	5.50%			2/10/2026	—		(1)		(3)		(4)(5)
Northern Star Industries Inc.	Electrical Components & Equipment	First Lien Term Loan	SOFR+	4.76%	10.15%		3/31/2025	5,198		5,192		5,159
OEConnection LLC	Application Software	First Lien Term Loan	SOFR+	4.00%	9.43%		9/25/2026	3,849		3,830		3,843
Planview Parent, Inc.	Application Software	First Lien Term Loan	SOFR+	4.00%	9.65%		12/17/2027	683		650		676
Planview Parent, Inc.	Application Software	Second Lien Term Loan	SOFR+	7.25%	12.74%		12/18/2028	2,842		2,799		2,586		(4)
Pluralsight, LLC	Application Software	First Lien Term Loan	SOFR+	8.00%	13.45%		4/6/2027	5,182		5,029		4,964		(4)
Pluralsight, LLC	Application Software	First Lien Revolver	SOFR+	8.00%	13.45%		4/6/2027	226		216		211		(4)(5)
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.25%	10.88%		4/27/2024	6,029		6,025		4,110
SHO Holding I Corporation	Footwear	First Lien Term Loan	SOFR+	5.23%	10.86%		4/27/2024	103		102		70
Southern Veterinary Partners, LLC	Health Care Facilities	First Lien Term Loan	SOFR+	4.00%	9.43%		10/5/2027	3,292		3,275		3,276
Spanx, LLC	Apparel Retail	First Lien Term Loan	SOFR+	5.25%	10.67%		11/20/2028	4,913		4,840		4,843		(4)
SPX Flow, Inc.	Industrial Machinery & Supplies & Components	First Lien Term Loan	SOFR+	4.50%	9.92%		4/5/2029	5,227		5,032		5,224
Star Parent, Inc.	Life Sciences Tools & Services	First Lien Term Loan	SOFR+	4.00%	9.33%		9/27/2030	4,000		3,939		3,916
TIBCO Software Inc.	Application Software	First Lien Term Loan	SOFR+	4.50%	9.99%		3/30/2029	2,641		2,439		2,544
Touchstone Acquisition, Inc.	Health Care Supplies	First Lien Term Loan	SOFR+	6.00%	11.42%		12/29/2028	2,993		2,948		2,914		(4)
Windstream Services II, LLC	Integrated Telecommunication Services	First Lien Term Loan	SOFR+	6.25%	11.67%		9/21/2027	3,843		3,756		3,712		(4)
WP CPP Holdings, LLC	Aerospace & Defense	First Lien Term Loan	SOFR+	3.75%	9.27%		4/30/2025	983		960		927		(4)
Total Portfolio Investments								$	130,589	$	127,788	$	123,343

__________

(1) Represents the interest rate as of September 30, 2023. All interest rates are payable in cash, unless otherwise noted.

(2) The interest rate on the principal balance outstanding for all of the floating rate loans is indexed to SOFR, which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2023, the reference rates for the Glick JV's variable rate loans were the 30-day SOFR at 5.32% and the 90-day SOFR at 5.39%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.

(4) This investment was held by both the Company and the Glick JV as of September 30, 2023.

The cost and fair value of the Company's aggregate investment in the Glick JV was $51.7 million and $48.9 million, respectively, as of September 30, 2024. The cost and fair value of the Company's aggregate investment in the Glick JV was $50.3 million and $50.0 million, respectively, as of September 30, 2023. For the years ended September 30, 2024, 2023 and 2022, the Company's investment in the Glick JV Notes earned interest income of $7.2 million, $6.7 million and $4.7 million, respectively. The Company did not earn dividend income for the years ended September 30, 2024, 2023 and 2022 with respect to its investment in the LLC equity interest of the Glick JV. As of September 30, 2024, the Glick JV Notes bore interest at a rate of one-month SOFR plus 4.50% per annum and will mature on October 20, 2028.

Below is certain summarized financial information for the Glick JV as of September 30, 2024 and September 30, 2023 and for the years ended September 30, 2024, 2023 and 2022:


	September 30, 2024		September 30, 2023
Selected Balance Sheet Information:
Investments at fair value (cost September 30, 2024: $127,867; cost September 30, 2023: $127,788)	$	124,887	$	123,343
Cash and cash equivalents	10,907		12,119
Restricted cash	1,032		184
Other assets	8,177		5,521
Total assets	$	145,003	$	141,167

Senior credit facility payable	$	79,000	$	53,000
Glick JV Notes payable at fair value (proceeds September 30, 2024: $66,685; proceeds September 30, 2023: $66,685)	55,886		57,201
Secured borrowings	5,766		18,106
Other liabilities	4,351		12,860
Total liabilities	$	145,003	$	141,167
Members' equity	—		—
Total liabilities and members' equity	$	145,003	$	141,167


	For the year ended September 30, 2024		For the year ended September 30, 2023		For the year ended September 30, 2022
Selected Statements of Operations Information:
Interest income	$	14,111	$	14,043	$	9,703
Fee income	70		63		149
Total investment income	14,181		14,106		9,852
Senior credit facility and secured borrowing interest expense	6,228		6,560		2,747
Glick JV Notes interest expense	6,743		6,056		3,576
Other expenses	143		182		168
Total expenses (1)	13,114		12,798		6,491
Net investment income	1,067		1,308		3,361
Net unrealized appreciation (depreciation)	2,781		1,254		(3,216)
Realized gain (loss)	(3,848)		(2,562)		(145)
Net income (loss)	$	—	$	—	$	—

__________

(1) There are no management fees or incentive fees charged at the Glick JV.

The Glick JV has elected to fair value the Glick JV Notes issued to the Company and GF Debt Funding under ASC 825. The Glick JV Notes are valued based on the total assets less the liabilities senior to the Glick JV Notes in an amount not exceeding par under the EV technique.

During the year ended September 30, 2024, the Company purchased $7.9 million of senior secured debt investments from Glick JV for $7.8 million cash consideration, which represented the fair value at the time of purchase. During the year ended September 30, 2023, the Company sold $6.5 million of senior secured debt investments to Glick JV for $6.3 million cash consideration, which represented the fair value at the time of sale. During the year ended September 30, 2022, the Company did not sell any debt investments to the Glick JV.

- Definition

The entire disclosure for investments owned by investment company.

+ References + Details

Fee Income (Details) - USD ($) $ in Thousands	12 Months Ended
Fee Income (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Fee income	$ 9,210	$ 6,546	$ 6,631
Recurring fee income	$ 300	$ 900	$ 900

Borrowings - Narrative (Details) - USD ($)				8 Months Ended	12 Months Ended
Borrowings - Narrative (Details) - USD ($)	Aug. 15, 2023	May 18, 2021	Feb. 25, 2020	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Line of Credit Facility [Line Items]
Credit facilities payable				$ 710,000,000	$ 710,000,000	$ 710,000,000
Fair Value				1,588,201,000	$ 1,648,133,000	1,588,201,000
Interest rate swap \| Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Interest rate (as a percent)		2.70%
Notional amount		$ 350,000,000
Base Rate
Line of Credit Facility [Line Items]
Interest rate (as a percent)					1.00%
London Interbank Offered Rate (LIBOR) \| Interest rate swap \| Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate (as a percent)		1.658%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Interest rate swap \| Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate (as a percent)		0.26161%
Secured Overnight Financing Rate (SOFR)
Line of Credit Facility [Line Items]
Interest rate (as a percent)					2.00%
Secured Overnight Financing Rate (SOFR) \| Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate (as a percent)					0.11448%
Secured Overnight Financing Rate (SOFR) \| Maximum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate (as a percent)					0.26161%
2025 Notes
Line of Credit Facility [Line Items]
Principal amount			$ 300,000,000	300,000,000.0	$ 300,000,000.0	300,000,000.0
Net proceeds			293,800,000
Unaccreted discount			2,500,000	700,000	$ 200,000	700,000
Underwriting commissions			3,000,000
Offering costs			$ 700,000
Coupon interest rate (net of effect of interest rate swaps)			3.50%		3.50%
Redemption price (as a percent)			100.00%
2027 Notes
Line of Credit Facility [Line Items]
Principal amount		$ 350,000,000		350,000,000.0	$ 350,000,000.0	350,000,000.0
Net proceeds		344,800,000
Unaccreted discount		1,000,000		600,000	$ 400,000	600,000
Underwriting commissions		3,500,000
Offering costs		$ 700,000
Coupon interest rate (net of effect of interest rate swaps)		2.70%			2.70%
Redemption price (as a percent)		100.00%
2029 Notes
Line of Credit Facility [Line Items]
Principal amount	$ 300,000,000			300,000,000.0	$ 300,000,000.0	300,000,000.0
Net proceeds	292,900,000
Unaccreted discount	3,500,000			3,400,000	$ 2,700,000	3,400,000
Underwriting commissions	3,000,000
Offering costs	$ 600,000
Coupon interest rate (net of effect of interest rate swaps)	7.10%				7.10%
Redemption price (as a percent)	100.00%
2029 Notes \| Interest rate swap \| Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Interest rate (as a percent)	7.10%
Notional amount	$ 300,000,000
2029 Notes \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Interest rate swap \| Designated as Hedging Instrument
Line of Credit Facility [Line Items]
Floating interest rate (as a percent)	3.1255%
Revolving Credit Facility \| Syndicated Facility payable \| Line of Credit
Line of Credit Facility [Line Items]
Borrowing capacity					$ 1,218,000,000
Accordion feature, increase limit					1,250,000,000
Borrowing capacity subject to expiration					$ 1,035,000,000.000
Debt instrument, covenant, total assets to total indebtedness, ratio, minimum threshold					1.50
Debt instrument, covenant, consolidated EBITDA to consolidated interest expense, ratio, minimum threshold					2.25
Credit facilities payable				430,000,000.0	$ 430,000,000.0	430,000,000.0
Fair value				$ 430,000,000.0	$ 430,000,000.0	$ 430,000,000.0
Weighted average interest rate (as a percent)				6.792%	7.443%	6.792%	2.876%
Interest expense inclusive of fees					$ 39,400,000	$ 50,000,000	$ 19,500,000
Revolving Credit Facility \| Citibank Facility \| Line of Credit
Line of Credit Facility [Line Items]
Weighted average interest rate (as a percent)				6.781%		6.781%	3.179%
Interest expense inclusive of fees						$ 8,000,000	$ 5,800,000
Revolving Credit Facility \| OSI2 Citibank Facility payable \| Line of Credit
Line of Credit Facility [Line Items]
Borrowing capacity					400,000,000
Credit facilities payable				$ 280,000,000.0	$ 280,000,000.0	$ 280,000,000.0
Weighted average interest rate (as a percent)				7.666%	7.756%	7.666%
Interest expense inclusive of fees				$ 14,600,000	$ 23,800,000
Unused capacity, commitment fee (as a percent)					0.50%
Commitment fee, unused capacity threshold percentage (as a percent)					30.00%
Fair Value				$ 280,000,000.0	$ 280,000,000.0	$ 280,000,000.0
Revolving Credit Facility \| OSI2 Citibank Facility payable \| Line of Credit \| Secured Overnight Financing Rate (SOFR) \| After Reinvestment Period
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate (as a percent)					3.35%
Revolving Credit Facility \| OSI2 Citibank Facility payable \| Line of Credit \| Secured Overnight Financing Rate (SOFR) \| Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread, variable rate (as a percent)					2.35%

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net increase (decrease) in net assets resulting from operations	$ 57,905	$ 117,331	$ 29,223

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Significant Accounting Policies (Details)		12 Months Ended
Significant Accounting Policies (Details)	Jan. 20, 2023	Sep. 30, 2024 USD ($) investment	Dec. 31, 2023 USD ($)	Sep. 30, 2023 USD ($) investment	Dec. 31, 2022 USD ($)	Sep. 30, 2022 USD ($)
Restricted Cash and Cash Equivalents Items [Line Items]
Stock split, conversion ratio	0.3333
Restricted cash		$ 14,577,000		$ 9,089,000		$ 2,836,000
Excise tax		0	$ 0	78,000	$ 100,000	$ 0
Deutsche Bank Trust Company Americas
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash		$ 14,600,000
Wells Fargo Bank, N.A.
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash				$ 9,100,000
Investment Owned, Fair Value \| Non-Accrual Status, Debt Securities \| Investment Type Concentration Risk
Restricted Cash and Cash Equivalents Items [Line Items]
Number of investments \| investment		9		4
Concentration risk (as a percent)		4.00%		1.80%
Investment Owned, Cost \| Non-Accrual Status, Debt Securities \| Investment Type Concentration Risk
Restricted Cash and Cash Equivalents Items [Line Items]
Concentration risk (as a percent)		4.90%		2.40%

Portfolio Investments - Narrative (Details)	12 Months Ended
Portfolio Investments - Narrative (Details)	Sep. 30, 2024 USD ($) borrower member	Sep. 30, 2023 USD ($) borrower	Sep. 30, 2022 USD ($)	Aug. 15, 2023	Sep. 30, 2021 USD ($)	May 18, 2021	Mar. 19, 2021 member	Feb. 25, 2020
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets (as a percent)	203.07%	190.82%
Investments at fair value	$ 3,021,279,000	$ 2,892,420,000
Number of borrowers \| borrower	144	143
Money market funds, percent of net assets (as a percent)	208.30%	9.60%
Cash, cash equivalents and restricted cash	$ 78,543,000	$ 145,539,000	$ 26,364,000		$ 31,635,000
Restricted cash	14,577,000	9,089,000	2,836,000
Net realized gains (losses)	(136,356,000)	(33,155,000)	17,179,000
Net unrealized appreciation (depreciation)	19,101,000	(28,555,000)	(136,248,000)
Credit facilities payable	710,000,000	710,000,000
Assets	3,198,341,000	3,217,839,000
Unfunded commitments	311,361,000	232,740,000
Investment owned, at cost	3,144,919,000	3,044,119,000
Cash consideration for purchase of investments	1,281,419,000	742,144,000	702,063,000
Cash consideration for sale of investments	1,086,222,000	911,975,000	693,745,000
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	135,200,000	141,500,000
SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	112,700,000
Investment owned, at cost		112,700,000
Interest income	$ 14,300,000	12,700,000	8,000,000
Investment, basis spread, variable rate (as a percent)	7.00%
Investment, interest rate, floor (as a percent)	1.00%
SLF JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 22,500,000	28,900,000
Investment owned, at cost	54,800,000	54,800,000
Dividend income	5,300,000	4,200,000	2,900,000
Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Interest income	$ 7,200,000	6,700,000	4,700,000
Investment, basis spread, variable rate (as a percent)	4.50%
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 48,900,000	50,000,000
Investment owned, at cost	$ 51,700,000	$ 50,300,000
2025 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Coupon interest rate (net of effect of interest rate swaps)	3.50%							3.50%
2027 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Coupon interest rate (net of effect of interest rate swaps)	2.70%					2.70%
2029 Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Coupon interest rate (net of effect of interest rate swaps)	7.10%			7.10%
Senior secured debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets (as a percent)	173.06%	165.01%
Investments at fair value	$ 2,574,937,000	$ 2,501,385,000
Investment owned, at cost	2,615,066,000	2,594,640,000
Subordinated debt securities, including JV debt instruments
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 271,473,000	$ 218,390,000
Investment Owned, At Fair Value
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, percent of net assets (as a percent)	203.07%	190.82%
Investments at fair value	$ 3,021,279,000	$ 2,892,420,000
Investment Owned, At Fair Value \| Investment Type Concentration Risk
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk (as a percent)	100.00%	100.00%
Investment Owned, At Fair Value \| Investment Type Concentration Risk \| Senior secured debt
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk (as a percent)	85.21%	86.47%
Investment Owned, At Fair Value \| Investment Type Concentration Risk \| Subordinated debt securities, including JV debt instruments
Investment Company, Nonconsolidated Subsidiary [Line Items]
Concentration risk (as a percent)	9.00%	7.50%
SLF JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 135,200,000	$ 141,500,000
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 48,900,000	50,000,000
The JVs
Investment Company, Nonconsolidated Subsidiary [Line Items]
Money market funds, percent of net assets (as a percent)	5.30%
Cash, cash equivalents and restricted cash	$ 78,500,000
Restricted cash	14,600,000
SLF JV I
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 329,496,000	$ 322,179,000
Number of borrowers \| borrower	48	48
Restricted cash	$ 6,994,000	$ 2,987,000
Number of board of directors \| member	4
Number of board of directors selected by company \| member	2
Number of board of directors selected by counterparty \| member	2
Number of investment committee members selected by company \| member	1
Number of investment committee members selected by counterparty \| member	1
Investment owned, ownership (as a percent)	87.50%	87.50%
Credit facilities payable	$ 200,000,000	$ 149,000,000
Assets	375,832,000	376,104,000
Financial support funded by company and counterparty	190,500,000	190,500,000
Financial support funded by company for investee	166,700,000	166,700,000
Unfunded commitments	13,100,000	13,100,000
Investment owned, at cost	337,882,000	331,808,000
Interest income	37,250,000	38,984,000	24,014,000
Investments purchased	25,100,000
Cash consideration for purchase of investments	24,100,000
Investments sold		31,800,000	9,700,000
Cash consideration for sale of investments		30,600,000	9,700,000
Gain (loss) on sale of investments		(200,000)	500,000
SLF JV I \| SLF JV I Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Unfunded commitments	9,800,000	9,800,000
SLF JV I \| SLF JV I, LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Unfunded commitments	$ 3,300,000	$ 3,300,000
SLF JV I \| 30-Day SOFR
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate (as a percent)	4.85%	5.32%
SLF JV I \| 90-Day SOFR
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate (as a percent)	4.59%	5.39%
SLF JV I \| 30-Day LIBOR
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate (as a percent)		5.43%
SLF JV I \| Kemper
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investment owned, ownership (as a percent)	12.50%	12.50%
SLF JV I \| SLF JV I Facility \| Revolving Credit Facility \| Line of Credit
Investment Company, Nonconsolidated Subsidiary [Line Items]
Borrowing capacity	$ 270,000,000
Credit facilities payable	$ 200,000,000	$ 149,000,000
SLF JV I \| SLF JV I Facility \| Revolving Credit Facility \| Line of Credit \| Until November 3, 2023 \| Secured Overnight Financing Rate (SOFR)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate (as a percent)	1.70%
OCSI Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 124,887,000	$ 123,343,000
Number of borrowers \| borrower	44	38
Restricted cash	$ 1,032,000	$ 184,000
Number of board of directors \| member							4
Number of board of directors selected by company \| member							2
Number of board of directors selected by counterparty \| member							2
Number of investment committee members selected by company \| member							1
Number of investment committee members selected by counterparty \| member							1
Credit facilities payable	79,000,000	53,000,000
Assets	145,003,000	141,167,000
Financial support funded by company and counterparty	84,000,000	84,000,000
Financial support funded by company for investee	73,500,000	73,500,000
Investment owned, at cost	127,867,000	127,788,000
Interest income	14,111,000	14,043,000	9,703,000
Investments purchased	7,900,000	6,500,000	$ 0
Cash consideration for purchase of investments	7,800,000	6,300,000
Financial commitment to investee by company and counterparty, aggregate amount	100,000,000	100,000,000
Financial commitment to investee, aggregate amount	87,500,000	87,500,000
Financial commitment to investee by counterparty, aggregate amount	12,500,000	$ 12,500,000
OCSI Glick JV LLC \| Glick JV LLC
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value	$ 48,900,000
Investment owned, ownership (as a percent)	87.50%	12.50%
Unfunded commitments	$ 1,600,000	$ 1,600,000
Investment owned, at cost	48,900,000
Financial commitment to investee, aggregate amount	$ 8,700,000	8,700,000
OCSI Glick JV LLC \| Glick JV Notes
Investment Company, Nonconsolidated Subsidiary [Line Items]
Investments at fair value		$ 50,000,000
Investment owned, ownership (as a percent)	87.50%	12.50%
Unfunded commitments	$ 12,400,000	$ 12,400,000
Investment owned, at cost		50,000,000
Financial commitment to investee, aggregate amount	78,800,000	78,800,000
OCSI Glick JV LLC \| Glick JV Facility \| Revolving Credit Facility \| Line of Credit
Investment Company, Nonconsolidated Subsidiary [Line Items]
Borrowing capacity	100,000,000
Credit facilities payable	$ 79,000,000	$ 53,000,000
OCSI Glick JV LLC \| Glick JV Facility \| Revolving Credit Facility \| Line of Credit \| Until November 3, 2023 \| Secured Overnight Financing Rate (SOFR)
Investment Company, Nonconsolidated Subsidiary [Line Items]
Debt instrument, basis spread, variable rate (as a percent)	1.70%

Consolidated Schedule of Investments
€ in Thousands, £ in Thousands, $ in Thousands

Sep. 30, 2024

USD ($)

Sep. 30, 2024

EUR (€)

Sep. 30, 2024

GBP (£)

Sep. 30, 2023

USD ($)

Sep. 30, 2023

EUR (€)

Sep. 30, 2023

GBP (£)

Sep. 30, 2022

USD ($)

Schedule of Investments [Line Items]

Investment, cost

$ 3,144,919

$ 3,044,119

Investments at fair value

$ 3,021,279

$ 2,892,420

Investment owned, percent of net assets (as a percent)

203.07%

190.82%

Money market funds, at carrying value

$ 78,543

$ 145,539

Money market funds, percent of net assets (as a percent)

208.30%

9.60%

Investment owned and money market funds, percent of net assets (as a percent)

200.40%

Total investment owned, at cost and money market funds, at carrying value

$ 3,223,462

$ 3,189,658

^{[1],[2],[3],[4]}

Total investment owned, at fair value and money market funds, at carrying value

3,099,822

3,037,959

^{[1],[2],[3],[4]}

Control investments

Schedule of Investments [Line Items]

Investment, principal

216,896

209,970

Investment, cost

372,901

^[5],[6]

345,245

^[7],[8]

Investments at fair value

$ 289,404

^[5],[6]

$ 297,091

^[7],[8]

$ 214,165

Investment owned, percent of net assets (as a percent)

19.50%

19.60%

Affiliate Investments

Schedule of Investments [Line Items]

Investment, principal

$ 36,539

$ 21,852

Investment, cost

38,175

^[9]

24,898

^[10]

Investments at fair value

$ 35,677

^[9]

$ 23,349

^[10]

26,196

Investment owned, percent of net assets (as a percent)

2.40%

1.50%

Non-control/Non-affiliate investments

Schedule of Investments [Line Items]

Investment, cost

$ 2,733,843

^[11]

$ 2,673,976

^[8]

Investments at fair value

$ 2,696,198

^[11]

$ 2,571,980

^[8]

Investment owned, percent of net assets (as a percent)

181.20%

169.70%

Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

13.00%

^{[12],[13],[14],[15]}

13.00%

^{[12],[13],[14],[15]}

13.00%

^{[12],[13],[14],[15]}

12.50%

^{[16],[17],[18],[19],[20]}

12.50%

^{[16],[17],[18],[19],[20]}

12.50%

^{[16],[17],[18],[19],[20]}

Investment, principal

$ 1,989

^{[12],[13],[14],[21]}

$ 1,269

^{[16],[17],[19],[22]}

Investment, cost

1,985

^{[12],[13],[14]}

1,240

^{[16],[17],[19]}

Investments at fair value

$ 1,934

^{[12],[13],[14]}

$ 1,214

^{[16],[17],[19]}

Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

11.00%

^{[12],[13],[15]}

11.00%

^{[12],[13],[15]}

11.00%

^{[12],[13],[15]}

11.00%

^{[16],[18],[19],[20]}

11.00%

^{[16],[18],[19],[20]}

11.00%

^{[16],[18],[19],[20]}

Investment, principal

$ 31,231

^{[12],[13],[21]}

$ 18,869

^{[16],[19],[22]}

Investment, cost

30,920

^[12],[13]

18,687

^[16],[19]

Investments at fair value

$ 31,015

^[12],[13]

$ 18,443

^[16],[19]

Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

13.00%

^{[12],[13],[14],[15]}

13.00%

^{[12],[13],[14],[15]}

13.00%

^{[12],[13],[14],[15]}

12.00%

^{[16],[17],[18],[19],[20]}

12.00%

^{[16],[17],[18],[19],[20]}

12.00%

^{[16],[17],[18],[19],[20]}

Investment, principal

$ 5,336

^{[12],[13],[14],[21]}

$ 4,070

^{[16],[17],[19],[22]}

Investment, cost

5,332

^{[12],[13],[14]}

4,038

^{[16],[17],[19]}

Investments at fair value

$ 5,288

^{[12],[13],[14]}

$ 4,022

^{[16],[17],[19]}

Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

14.25%

^{[12],[15],[23],[24]}

14.25%

^{[12],[15],[23],[24]}

14.25%

^{[12],[15],[23],[24]}

14.25%

^{[18],[19],[20],[25],[26]}

14.25%

^{[18],[19],[20],[25],[26]}

14.25%

^{[18],[19],[20],[25],[26]}

Investment, principal

$ 21,870

^{[12],[21],[23],[24]}

$ 21,434

^{[19],[22],[25],[26]}

Investment, cost

21,024

^{[12],[23],[24]}

21,612

^{[19],[25],[26]}

Investments at fair value

$ 21,979

^{[12],[23],[24]}

$ 21,220

^{[19],[25],[26]}

Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

22.50%

^{[12],[23],[27]}

22.50%

^{[12],[23],[27]}

22.50%

^{[12],[23],[27]}

20.00%

^[19],[25]

20.00%

^[19],[25]

20.00%

^[19],[25]

Investment, principal

$ 7,835

^{[12],[21],[23],[27]}

$ 6,021

^{[19],[22],[25]}

Investment, cost

7,028

^{[12],[23],[27]}

6,013

^[19],[25]

Investments at fair value

$ 7,796

^{[12],[23],[27]}

$ 5,900

^[19],[25]

Investment, Identifier [Axis]: ACESO Holding 4 S.A.R.L., Health Care Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[23],[28]}

5.75%

Investment, principal

^{[12],[13],[21],[23],[28]}

$ 0

Investment, cost

^{[12],[13],[23],[28]}

(47)

Investments at fair value

^{[12],[13],[23],[28]}

$ (47)

Investment, Identifier [Axis]: ACESO Holding 4 S.A.R.L., Health Care Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

5.75%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

8.91%

Investment, principal | €

^{[12],[21],[23],[28]}

€ 16,817

Investment, cost

^{[12],[23],[28]}

$ 18,424

Investments at fair value

^{[12],[23],[28]}

$ 18,393

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[12],[28]

6.50%

^[12],[28]

6.50%

^[12],[28]

6.50%

^[18],[19]

6.50%

^[18],[19]

6.50%

^[18],[19]

Investment, interest rate (as a percent)

11.37%

^{[12],[15],[28]}

11.37%

^{[12],[15],[28]}

11.37%

^{[12],[15],[28]}

11.90%

^{[18],[19],[20]}

11.90%

^{[18],[19],[20]}

11.90%

^{[18],[19],[20]}

Investment, principal

$ 3,079

^{[12],[21],[28]}

$ 3,446

^{[18],[19],[22]}

Investment, cost

3,062

^[12],[28]

3,411

^[18],[19]

Investments at fair value

$ 2,955

^[12],[28]

$ 3,383

^[18],[19]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[12],[28]

6.50%

^[12],[28]

6.50%

^[12],[28]

6.50%

^[18],[19]

6.50%

^[18],[19]

6.50%

^[18],[19]

Investment, interest rate (as a percent)

12.01%

^{[12],[15],[28]}

12.01%

^{[12],[15],[28]}

12.01%

^{[12],[15],[28]}

12.15%

^{[18],[19],[20]}

12.15%

^{[18],[19],[20]}

12.15%

^{[18],[19],[20]}

Investment, principal

$ 875

^{[12],[21],[28]}

$ 17,901

^{[18],[19],[22]}

Investment, cost

868

^[12],[28]

17,743

^[18],[19]

Investments at fair value

$ 840

^[12],[28]

$ 17,575

^[18],[19]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[12],[28]

6.50%

^[12],[28]

6.50%

^[12],[28]

6.50%

^[18],[19]

6.50%

^[18],[19]

6.50%

^[18],[19]

Investment, interest rate (as a percent)

11.37%

^{[12],[15],[28]}

11.37%

^{[12],[15],[28]}

11.37%

^{[12],[15],[28]}

12.13%

^{[18],[19],[20]}

12.13%

^{[18],[19],[20]}

12.13%

^{[18],[19],[20]}

Investment, principal

$ 16,053

^{[12],[21],[28]}

$ 963

^{[18],[19],[22]}

Investment, cost

15,975

^[12],[28]

948

^[18],[19]

Investments at fair value

$ 15,410

^[12],[28]

$ 945

^[18],[19]

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[23]

1,674,030

Investment, cost

^[23]

$ 0

Investments at fair value

^[23]

$ 0

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

7.50%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

12.25%

Investment, principal

^{[12],[21],[23],[28]}

$ 6,589

Investment, cost

^{[12],[23],[28]}

6,353

Investments at fair value

^{[12],[23],[28]}

$ 6,424

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

7.50%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

13.04%

Investment, principal

^{[18],[19],[22],[25]}

$ 6,589

Investment, cost

^{[18],[19],[25]}

6,305

Investments at fair value

^{[18],[19],[25]}

$ 6,276

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19],[25]}

7.50%

Investment, principal

^{[16],[18],[19],[22],[25]}

$ 0

Investment, cost

^{[16],[18],[19],[25]}

(38)

Investments at fair value

^{[16],[18],[19],[25]}

$ (38)

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

28,948

^[12],[23]

28,948

^[12],[23]

28,948

^[12],[23]

28,948

^[19],[25]

28,948

^[19],[25]

28,948

^[19],[25]

Investment, cost

$ 174

^[12],[23]

$ 174

^[19],[25]

Investments at fair value

$ 33

^[12],[23]

$ 6

^[19],[25]

Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[25]

5.00%

Investment, interest rate (as a percent)

^{[18],[20],[25]}

8.86%

Investment, principal | €

^{[18],[22],[25]}

€ 5,500

Investment, cost

^[18],[25]

$ 6,024

Investments at fair value

^[18],[25]

$ 5,825

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

17,870

^[12]

17,870

^[12]

17,870

^[12]

17,870

^[19]

17,870

^[19]

17,870

^[19]

Investment, cost

$ 1,733

^[12]

$ 1,733

^[19]

Investments at fair value

$ 2,220

^[12]

$ 2,826

^[19]

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.75%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

13.17%

Investment, principal

^{[18],[19],[22]}

$ 17,873

Investment, cost

^[18],[19]

17,655

Investments at fair value

^[18],[19]

$ 17,687

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[12],[13],[23],[28]}

6.00%

^{[12],[13],[23],[28]}

6.00%

^{[12],[13],[23],[28]}

6.00%

^{[16],[18],[19],[25]}

6.00%

^{[16],[18],[19],[25]}

6.00%

^{[16],[18],[19],[25]}

Investment, interest rate (as a percent)

^{[12],[13],[15],[23],[28]}

11.29%

Investment, principal

$ 230

^{[12],[13],[21],[23],[28]}

$ 0

^{[16],[18],[19],[22],[25]}

Investment, cost

220

^{[12],[13],[23],[28]}

(13)

^{[16],[18],[19],[25]}

Investments at fair value

$ 211

^{[12],[13],[23],[28]}

$ (23)

^{[16],[18],[19],[25]}

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[12],[23],[28]}

6.00%

^{[12],[23],[28]}

6.00%

^{[12],[23],[28]}

6.00%

^{[18],[19],[25]}

6.00%

^{[18],[19],[25]}

6.00%

^{[18],[19],[25]}

Investment, interest rate (as a percent)

10.66%

^{[12],[15],[23],[28]}

10.66%

^{[12],[15],[23],[28]}

10.66%

^{[12],[15],[23],[28]}

11.63%

^{[18],[19],[20],[25]}

11.63%

^{[18],[19],[20],[25]}

11.63%

^{[18],[19],[20],[25]}

Investment, principal

$ 3,243

^{[12],[21],[23],[28]}

$ 3,276

^{[18],[19],[22],[25]}

Investment, cost

3,234

^{[12],[23],[28]}

3,267

^{[18],[19],[25]}

Investments at fair value

$ 3,087

^{[12],[23],[28]}

3,084

^{[18],[19],[25]}

Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^{[12],[23],[24]}

15.89%

Investment, principal

$ 12,989

^{[12],[21],[23],[24]}

12,222

^{[19],[22],[25],[26]}

Investment, cost

13,013

^{[12],[23],[24]}

12,260

^{[19],[25],[26]}

Investments at fair value

$ 12,892

^{[12],[23],[24]}

$ 11,795

^{[19],[25],[26]}

Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[28]

5.00%

Investment, interest rate (as a percent)

^[15],[28]

10.25%

Investment, principal

^[21],[28]

$ 1,985

Investment, cost

^[28]

1,975

Investments at fair value

^[28]

$ 1,996

Investment, Identifier [Axis]: Accession Risk Management Group, Inc., Insurance Brokers, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

4.75%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(5)

Investments at fair value

^{[12],[13],[28]}

$ (5)

Investment, Identifier [Axis]: Accession Risk Management Group, Inc., Insurance Brokers, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

4.75%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(48)

Investments at fair value

^{[12],[13],[28]}

$ (45)

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[12],[13],[28]}

6.00%

^{[12],[13],[28]}

6.00%

^{[12],[13],[28]}

6.00%

^{[16],[18],[19]}

6.00%

^{[16],[18],[19]}

6.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

10.90%

^{[12],[13],[15],[28]}

10.90%

^{[12],[13],[15],[28]}

10.90%

^{[12],[13],[15],[28]}

11.55%

^{[16],[18],[19],[20]}

11.55%

^{[16],[18],[19],[20]}

11.55%

^{[16],[18],[19],[20]}

Investment, principal

$ 2,482

^{[12],[13],[21],[28]}

$ 2,033

^{[16],[18],[19],[22]}

Investment, cost

2,471

^{[12],[13],[28]}

2,013

^{[16],[18],[19]}

Investments at fair value

$ 2,443

^{[12],[13],[28]}

$ 2,027

^{[16],[18],[19]}

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[12],[13],[28]}

6.00%

^{[12],[13],[28]}

6.00%

^{[12],[13],[28]}

6.00%

^[18],[19]

6.00%

^[18],[19]

6.00%

^[18],[19]

Investment, interest rate (as a percent)

^{[18],[19],[20]}

11.55%

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 20,234

^{[18],[19],[22]}

Investment, cost

(2)

^{[12],[13],[28]}

20,150

^[18],[19]

Investments at fair value

$ (59)

^{[12],[13],[28]}

$ 20,194

^[18],[19]

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^{[16],[18],[19]}

6.00%

^{[16],[18],[19]}

6.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.90%

Investment, principal

$ 20,024

^{[12],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

19,978

^[12],[28]

(2)

^{[16],[18],[19]}

Investments at fair value

$ 19,724

^[12],[28]

$ (8)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^{[12],[13],[28]}

7.00%

^{[12],[13],[28]}

7.00%

^{[12],[13],[28]}

7.00%

^{[16],[18],[19]}

7.00%

^{[16],[18],[19]}

7.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

12.47%

^{[12],[13],[15],[28]}

12.47%

^{[12],[13],[15],[28]}

12.47%

^{[12],[13],[15],[28]}

12.72%

^{[16],[18],[19],[20]}

12.72%

^{[16],[18],[19],[20]}

12.72%

^{[16],[18],[19],[20]}

Investment, principal

$ 1,084

^{[12],[13],[21],[28]}

$ 1,333

^{[16],[18],[19],[22]}

Investment, cost

1,078

^{[12],[13],[28]}

1,322

^{[16],[18],[19]}

Investments at fair value

$ 1,084

^{[12],[13],[28]}

$ 1,324

^{[16],[18],[19]}

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^[18],[19]

7.00%

^[18],[19]

7.00%

^[18],[19]

Investment, interest rate (as a percent)

12.46%

^{[12],[15],[28]}

12.46%

^{[12],[15],[28]}

12.46%

^{[12],[15],[28]}

12.34%

^{[18],[19],[20]}

12.34%

^{[18],[19],[20]}

12.34%

^{[18],[19],[20]}

Investment, principal

$ 6,400

^{[12],[21],[28]}

$ 6,400

^{[18],[19],[22]}

Investment, cost

6,366

^[12],[28]

6,335

^[18],[19]

Investments at fair value

$ 6,400

^[12],[28]

$ 6,380

^[18],[19]

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^[18],[19]

7.00%

^[18],[19]

7.00%

^[18],[19]

Investment, interest rate (as a percent)

12.46%

^{[12],[15],[28]}

12.46%

^{[12],[15],[28]}

12.46%

^{[12],[15],[28]}

12.34%

^{[18],[19],[20]}

12.34%

^{[18],[19],[20]}

12.34%

^{[18],[19],[20]}

Investment, principal

$ 25,332

^{[12],[21],[28]}

$ 25,332

^{[18],[19],[22]}

Investment, cost

25,309

^[12],[28]

25,288

^[18],[19]

Investments at fair value

$ 25,332

^[12],[28]

$ 25,253

^[18],[19]

Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

5,715

^[12]

5,715

^[12]

5,715

^[12]

5,715

^[19]

5,715

^[19]

5,715

^[19]

Investment, cost

$ 90

^[12]

$ 90

^[19]

Investments at fair value

$ 0

^[12]

^[19]

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12]

11,499

Investment, principal

$ 0

Investment, cost

^[12]

1,622

Investments at fair value

$ 1,622

^[12]

Investment owned, percent of net assets (as a percent)

0.10%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

4.00%

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

8.70%

Investment, principal

^{[12],[13],[21],[28]}

$ 1,560

Investment, cost

^{[12],[13],[28]}

1,520

Investments at fair value

$ 1,506

^{[12],[13],[28]}

$ 0

Investment owned, percent of net assets (as a percent)

0.10%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[29]}

8.50%

Investment, principal

^{[18],[19],[22],[29]}

$ 23,562

Investment, cost

^{[18],[19],[29]}

22,795

Investments at fair value

^{[18],[19],[29]}

9,797

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

4.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

6.70%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

2.00%

Investment, principal

^{[12],[21],[28]}

$ 1,819

Investment, cost

^[12],[28]

1,757

Investments at fair value

$ 1,741

^[12],[28]

Investment owned, percent of net assets (as a percent)

0.10%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

7.70%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

2.00%

Investment, principal

^{[12],[21],[28]}

$ 3,637

Investment, cost

^[12],[28]

3,493

Investments at fair value

$ 3,463

^[12],[28]

Investment owned, percent of net assets (as a percent)

0.20%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12],[27]

10.00%

Investment, principal

^{[12],[21],[27]}

$ 3,541

Investment, cost

^[12],[27]

3,026

Investments at fair value

$ 3,183

^[12],[27]

$ 0

Investment owned, percent of net assets (as a percent)

0.20%

Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[20],[25]}

5.50%

Investment, principal

^[22],[25]

$ 4,050

Investment, cost

^[25]

3,577

Investments at fair value

^[25]

$ 2,918

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

11.50%

^[12],[28]

11.50%

^[12],[28]

11.50%

^[12],[28]

11.50%

^[18],[19]

11.50%

^[18],[19]

11.50%

^[18],[19]

Investment, interest rate (as a percent)

8.00%

^{[12],[15],[28]}

8.00%

^{[12],[15],[28]}

8.00%

^{[12],[15],[28]}

5.00%

^{[18],[19],[20]}

5.00%

^{[18],[19],[20]}

5.00%

^{[18],[19],[20]}

Investment, interest rate, paid in kind (as a percent)

8.93%

^[12],[28]

8.93%

^[12],[28]

8.93%

^[12],[28]

11.99%

^[18],[19]

11.99%

^[18],[19]

11.99%

^[18],[19]

Investment, principal

$ 10,134

^{[12],[21],[28]}

$ 9,057

^{[18],[19],[22]}

Investment, cost

9,666

^[12],[28]

8,434

^[18],[19]

Investments at fair value

$ 9,120

^[12],[28]

$ 8,332

^[18],[19]

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

598,283

^[12]

598,283

^[12]

598,283

^[12]

598,283

^[19]

598,283

^[19]

598,283

^[19]

Investment, cost

$ 642

^[12]

$ 642

^[19]

Investments at fair value

$ 802

^[12]

$ 1,915

^[19]

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[12],[28]

7.50%

^[12],[28]

7.50%

^[12],[28]

7.50%

^[18],[19]

7.50%

^[18],[19]

7.50%

^[18],[19]

Investment, interest rate (as a percent)

12.45%

^{[12],[15],[28]}

12.45%

^{[12],[15],[28]}

12.45%

^{[12],[15],[28]}

13.04%

^{[18],[19],[20]}

13.04%

^{[18],[19],[20]}

13.04%

^{[18],[19],[20]}

Investment, principal

$ 16,143

^{[12],[21],[28]}

$ 17,053

^{[18],[19],[22]}

Investment, cost

16,115

^[12],[28]

16,982

^[18],[19]

Investments at fair value

$ 14,852

^[12],[28]

$ 15,929

^[18],[19]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

118,744

^[23]

118,744

^[23]

118,744

^[23]

471,253

^[25]

471,253

^[25]

471,253

^[25]

Investment, cost

$ 206

^[23]

$ 849

^[25]

Investments at fair value

$ 1,413

^[23]

$ 4,298

^[25]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

70,820

^{[12],[23],[30]}

70,820

^{[12],[23],[30]}

70,820

^{[12],[23],[30]}

141,640

^{[19],[25],[31]}

141,640

^{[19],[25],[31]}

141,640

^{[19],[25],[31]}

Investment, cost

$ 283

^{[12],[23],[30]}

$ 566

^{[19],[25],[31]}

Investments at fair value

$ 315

^{[12],[23],[30]}

$ 368

^{[19],[25],[31]}

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[19],[25]

3.50%

Investment, principal

^{[19],[22],[25]}

$ 28,464

Investment, cost

^[19],[25]

28,329

Investments at fair value

^[19],[25]

$ 27,687

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[19],[25]

3.50%

Investment, principal

^{[19],[22],[25]}

$ 2,121

Investment, cost

^[19],[25]

1,945

Investments at fair value

^[19],[25]

$ 2,063

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[19],[25]

3.50%

Investment, principal

^{[19],[22],[25]}

$ 27,692

Investment, cost

^[19],[25]

27,582

Investments at fair value

^[19],[25]

$ 26,936

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[19],[25]

3.50%

Investment, principal

^{[19],[22],[25]}

$ 2,064

Investment, cost

^[19],[25]

1,891

Investments at fair value

^[19],[25]

$ 2,007

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

8.75%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

14.14%

Investment, principal

^{[18],[19],[22]}

$ 17,048

Investment, cost

^[18],[19]

16,440

Investments at fair value

^[18],[19]

$ 15,087

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[28]

5.00%

Investment, interest rate (as a percent)

^[15],[28]

9.75%

Investment, principal

^[21],[28]

$ 2,487

Investment, cost

^[28]

2,469

Investments at fair value

^[28]

$ 2,501

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

8.75%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

13.50%

Investment, principal

^{[12],[21],[28]}

$ 17,048

Investment, cost

^[12],[28]

16,556

Investments at fair value

^[12],[28]

$ 16,494

Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

6.25%

Investment, interest rate (as a percent)

^[18],[20]

11.81%

Investment, principal

^[18],[22]

$ 19,115

Investment, cost

^[18]

18,278

Investments at fair value

^[18]

$ 16,798

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

8.00%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

13.54%

Investment, principal

^{[18],[19],[22],[25]}

$ 12,500

Investment, cost

^{[18],[19],[25]}

12,188

Investments at fair value

^{[18],[19],[25]}

$ 11,865

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.50%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(98)

Investments at fair value

^{[12],[13],[28]}

$ 0

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.10%

Investment, principal

^{[12],[21],[28]}

$ 33,390

Investment, cost

^[12],[28]

32,654

Investments at fair value

^[12],[28]

$ 33,390

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.50%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(60)

Investments at fair value

^{[12],[13],[28]}

$ 0

Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

3.75%

Investment, interest rate (as a percent)

^[18],[20]

9.40%

Investment, principal

^[18],[22]

$ 3,700

Investment, cost

^[18]

3,067

Investments at fair value

^[18]

$ 2,669

Investment, Identifier [Axis]: Anchorage Capital CLO 20, LTD., Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23],[28]

7.61%

Investment, interest rate (as a percent)

^{[15],[23],[28]}

12.89%

Investment, principal

^{[21],[23],[28]}

$ 750

Investment, cost

^[23],[28]

715

Investments at fair value

^[23],[28]

$ 736

Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.35%

Investment, principal

^{[12],[21],[28]}

$ 47,451

Investment, cost

^[12],[28]

46,877

Investments at fair value

^[12],[28]

$ 47,428

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

7.00%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

10.95%

Investment, principal | €

^{[18],[19],[22],[25]}

€ 3,017

Investment, cost

^{[18],[19],[25]}

$ 3,331

Investments at fair value

^{[18],[19],[25]}

$ 3,226

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

5.75%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

11.57%

Investment, principal

^{[18],[19],[22],[25]}

$ 10,519

Investment, cost

^{[18],[19],[25]}

10,400

Investments at fair value

^{[18],[19],[25]}

$ 10,624

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

7.00%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

12.46%

Investment, principal | £

^{[18],[19],[22],[25]}

£ 4,949

Investment, cost

^{[18],[19],[25]}

$ 6,318

Investments at fair value

^{[18],[19],[25]}

$ 6,101

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

7.00%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

12.46%

Investment, principal | £

^{[18],[19],[22],[25]}

£ 23,675

Investment, cost

^{[18],[19],[25]}

$ 28,713

Investments at fair value

^{[18],[19],[25]}

$ 29,185

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

5.75%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

9.70%

Investment, principal | £

^{[18],[19],[22],[25]}

£ 3,649

Investment, cost

^{[18],[19],[25]}

$ 4,094

Investments at fair value

^{[18],[19],[25]}

$ 3,914

Investment, Identifier [Axis]: Ares XLIV CLO, Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23],[28]

7.13%

Investment, interest rate (as a percent)

^{[15],[23],[28]}

12.43%

Investment, principal

^{[21],[23],[28]}

$ 3,500

Investment, cost

^[23],[28]

3,399

Investments at fair value

^[23],[28]

$ 3,509

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Advertising, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.75%

Investment, interest rate (as a percent)

12.14%

Investment, principal

$ 21,852

Investments at fair value

$ 21,823

24,225

Investment owned, percent of net assets (as a percent)

1.40%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

12,463,242

^[12]

12,463,242

^[12]

12,463,242

^[12]

1,783,332

^[19]

1,783,332

^[19]

1,783,332

^[19]

Investment, principal

Investment, cost

$ 1,963

^[12]

804

^[19]

Investments at fair value

$ 1,246

^[12]

$ 89

^[19]

370

Investment owned, percent of net assets (as a percent)

0.10%

0.00%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19]}

6.75%

Investment, interest rate (as a percent)

^{[16],[18],[19],[20]}

12.14%

Investment, principal

^{[16],[18],[19],[22]}

$ 21,852

Investment, cost

^{[16],[18],[19]}

21,855

Investments at fair value

$ 0

$ 21,823

^{[16],[18],[19]}

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19]

1,129,453

Investment, principal

Investment, cost

^[19]

1,159

Investments at fair value

$ 0

$ 1,005

^[19]

1,223

Investment owned, percent of net assets (as a percent)

0.00%

0.10%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

78,045

^[12]

78,045

^[12]

78,045

^[12]

78,045

^[19]

78,045

^[19]

78,045

^[19]

Investment, principal

Investment, cost

$ 0

^[12]

^[19]

Investments at fair value

$ 0

^[12]

$ 0

^[19]

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

5.25%

Investment, interest rate (as a percent)

^[18],[20]

10.90%

Investment, principal

^[18],[22]

$ 8,490

Investment, cost

^[18]

8,168

Investments at fair value

^[18]

$ 6,414

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[28]

6.75%

Investment, interest rate (as a percent)

^[15],[28]

11.35%

Investment, principal

^[21],[28]

$ 7,907

Investment, cost

^[28]

7,816

Investments at fair value

^[28]

$ 6,555

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[27],[28]}

5.25%

Investment, principal

^{[12],[21],[27],[28]}

$ 12,537

Investment, cost

^{[12],[27],[28]}

10,187

Investments at fair value

^{[12],[27],[28]}

$ 3,605

Investment, Identifier [Axis]: Aurelia Netherlands Midco 2 B.V., Interactive Media & Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

5.75%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

9.55%

Investment, principal | €

^{[12],[21],[23],[28]}

€ 28,022

Investment, cost

^{[12],[23],[28]}

$ 29,727

Investments at fair value

^{[12],[23],[28]}

$ 30,698

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^{[12],[23],[28]}

7.00%

^{[12],[23],[28]}

7.00%

^{[12],[23],[28]}

6.00%

^{[18],[19],[25]}

6.00%

^{[18],[19],[25]}

6.00%

^{[18],[19],[25]}

Investment, interest rate (as a percent)

7.70%

^{[12],[15],[23],[28]}

7.70%

^{[12],[15],[23],[28]}

7.70%

^{[12],[15],[23],[28]}

11.49%

^{[18],[19],[20],[25]}

11.49%

^{[18],[19],[20],[25]}

11.49%

^{[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

^{[12],[23],[28]}

4.00%

Investment, principal

$ 30,724

^{[12],[21],[23],[28]}

$ 29,509

^{[18],[19],[22],[25]}

Investment, cost

30,169

^{[12],[23],[28]}

29,164

^{[18],[19],[25]}

Investments at fair value

$ 29,802

^{[12],[23],[28]}

$ 28,284

^{[18],[19],[25]}

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^{[12],[13],[28]}

6.25%

^{[12],[13],[28]}

6.25%

^{[12],[13],[28]}

7.25%

^{[16],[18],[19]}

7.25%

^{[16],[18],[19]}

7.25%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

(86)

^{[12],[13],[28]}

(108)

^{[16],[18],[19]}

Investments at fair value

$ 0

^{[12],[13],[28]}

$ (78)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^[12],[28]

6.25%

^[12],[28]

6.25%

^[12],[28]

7.25%

^[18],[19]

7.25%

^[18],[19]

7.25%

^[18],[19]

Investment, interest rate (as a percent)

10.85%

^{[12],[15],[28]}

10.85%

^{[12],[15],[28]}

10.85%

^{[12],[15],[28]}

12.64%

^{[18],[19],[20]}

12.64%

^{[18],[19],[20]}

12.64%

^{[18],[19],[20]}

Investment, principal

$ 50,470

^{[12],[21],[28]}

$ 50,470

^{[18],[19],[22]}

Investment, cost

49,836

^[12],[28]

49,679

^[18],[19]

Investments at fair value

$ 50,470

^[12],[28]

$ 49,688

^[18],[19]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[18],[19]

5.00%

^[18],[19]

5.00%

^[18],[19]

Investment, interest rate (as a percent)

9.87%

^{[12],[15],[28]}

9.87%

^{[12],[15],[28]}

9.87%

^{[12],[15],[28]}

10.65%

^{[18],[19],[20]}

10.65%

^{[18],[19],[20]}

10.65%

^{[18],[19],[20]}

Investment, principal

$ 3,214

^{[12],[21],[28]}

$ 3,247

^{[18],[19],[22]}

Investment, cost

3,183

^[12],[28]

3,216

^[18],[19]

Investments at fair value

$ 3,025

^[12],[28]

$ 3,169

^[18],[19]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[18],[19]

5.00%

^[18],[19]

5.00%

^[18],[19]

Investment, interest rate (as a percent)

9.87%

^{[12],[15],[28]}

9.87%

^{[12],[15],[28]}

9.87%

^{[12],[15],[28]}

10.65%

^{[18],[19],[20]}

10.65%

^{[18],[19],[20]}

10.65%

^{[18],[19],[20]}

Investment, principal

$ 1,248

^{[12],[21],[28]}

$ 1,261

^{[18],[19],[22]}

Investment, cost

1,254

^[12],[28]

1,269

^[18],[19]

Investments at fair value

$ 1,175

^[12],[28]

$ 1,231

^[18],[19]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[12],[28]

8.50%

^[12],[28]

8.50%

^[12],[28]

8.50%

^[18],[19]

8.50%

^[18],[19]

8.50%

^[18],[19]

Investment, interest rate (as a percent)

13.35%

^{[12],[15],[28]}

13.35%

^{[12],[15],[28]}

13.35%

^{[12],[15],[28]}

14.15%

^{[18],[19],[20]}

14.15%

^{[18],[19],[20]}

14.15%

^{[18],[19],[20]}

Investment, principal

$ 6,452

^{[12],[21],[28]}

$ 8,920

^{[18],[19],[22]}

Investment, cost

6,386

^[12],[28]

8,819

^[18],[19]

Investments at fair value

$ 5,550

^[12],[28]

$ 8,492

^[18],[19]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[12],[28]

8.50%

^[12],[28]

8.50%

^[12],[28]

8.50%

^[18],[19]

8.50%

^[18],[19]

8.50%

^[18],[19]

Investment, interest rate (as a percent)

13.37%

^{[12],[15],[28]}

13.37%

^{[12],[15],[28]}

13.37%

^{[12],[15],[28]}

14.15%

^{[18],[19],[20]}

14.15%

^{[18],[19],[20]}

14.15%

^{[18],[19],[20]}

Investment, principal

$ 8,920

^{[12],[21],[28]}

$ 2,091

^{[18],[19],[22]}

Investment, cost

8,817

^[12],[28]

2,068

^[18],[19]

Investments at fair value

$ 7,673

^[12],[28]

$ 1,991

^[18],[19]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

8.50%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

14.15%

Investment, principal

^{[18],[19],[22]}

$ 4,361

Investment, cost

^[18],[19]

4,297

Investments at fair value

^[18],[19]

$ 4,152

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^{[12],[13],[28]}

5.50%

^{[12],[13],[28]}

5.50%

^{[12],[13],[28]}

4.50%

^{[16],[18],[19]}

4.50%

^{[16],[18],[19]}

4.50%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

10.52%

^{[12],[13],[15],[28]}

10.52%

^{[12],[13],[15],[28]}

10.52%

^{[12],[13],[15],[28]}

13.00%

^{[16],[18],[19],[20]}

13.00%

^{[16],[18],[19],[20]}

13.00%

^{[16],[18],[19],[20]}

Investment, principal

$ 2,835

^{[12],[13],[21],[28]}

$ 2,221

^{[16],[18],[19],[22]}

Investment, cost

2,813

^{[12],[13],[28]}

2,188

^{[16],[18],[19]}

Investments at fair value

$ 2,811

^{[12],[13],[28]}

$ 2,178

^{[16],[18],[19]}

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[12],[28]

5.50%

^[12],[28]

5.50%

^[12],[28]

5.50%

^[18],[19]

5.50%

^[18],[19]

5.50%

^[18],[19]

Investment, interest rate (as a percent)

10.90%

^{[12],[15],[28]}

10.90%

^{[12],[15],[28]}

10.90%

^{[12],[15],[28]}

11.02%

^{[18],[19],[20]}

11.02%

^{[18],[19],[20]}

11.02%

^{[18],[19],[20]}

Investment, principal

$ 40,246

^{[12],[21],[28]}

$ 40,660

^{[18],[19],[22]}

Investment, cost

40,085

^[12],[28]

40,440

^[18],[19]

Investments at fair value

$ 39,863

^[12],[28]

$ 40,213

^[18],[19]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[23],[28]}

7.50%

Investment, interest rate (as a percent)

^{[12],[13],[15],[23],[28]}

8.00%

^{[18],[19],[20],[25]}

8.00%

^{[18],[19],[20],[25]}

8.00%

^{[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

^[19],[25]

2.25%

Investment, principal

$ 0

^{[12],[13],[21],[23],[28]}

$ 6,757

^{[19],[22],[25]}

Investment, cost

^{[12],[13],[23],[28]}

6,560

^[19],[25]

Investments at fair value

$ 0

^{[12],[13],[23],[28]}

6,225

^[19],[25]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

7.50%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

8.00%

Investment, interest rate, paid in kind (as a percent)

^{[12],[23],[28]}

4.10%

Investment, principal

$ 2,930

^{[12],[21],[23],[28]}

3,316

^{[16],[19],[22],[25],[26]}

Investment, cost

2,928

^{[12],[23],[28]}

3,335

^{[16],[19],[25],[26]}

Investments at fair value

$ 2,600

^{[12],[23],[28]}

$ 3,169

^{[16],[19],[25],[26]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

7.50%

Investment, interest rate (as a percent)

8.00%

^{[12],[15],[23],[28]}

8.00%

^{[12],[15],[23],[28]}

8.00%

^{[12],[15],[23],[28]}

8.00%

^{[16],[18],[19],[20],[25]}

8.00%

^{[16],[18],[19],[20],[25]}

8.00%

^{[16],[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

4.10%

^{[12],[23],[28]}

4.10%

^{[12],[23],[28]}

4.10%

^{[12],[23],[28]}

2.25%

^{[16],[19],[25]}

2.25%

^{[16],[19],[25]}

2.25%

^{[16],[19],[25]}

Investment, principal

$ 7,062

^{[12],[21],[23],[28]}

$ 0

^{[16],[19],[22],[25]}

Investment, cost

6,921

^{[12],[23],[28]}

^{[16],[19],[25]}

Investments at fair value

$ 6,268

^{[12],[23],[28]}

$ 0

^{[16],[19],[25]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[23],[28]}

7.50%

Investment, interest rate (as a percent)

^{[16],[18],[19],[20],[25]}

8.00%

Investment, interest rate, paid in kind (as a percent)

^{[16],[19],[25]}

2.25%

Investment, principal

$ 0

^{[12],[13],[21],[23],[28]}

$ 0

^{[16],[19],[22],[25]}

Investment, cost

^{[12],[13],[23],[28]}

^{[16],[19],[25]}

Investments at fair value

$ 0

^{[12],[13],[23],[28]}

^{[16],[19],[25]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[23],[28]}

7.50%

Investment, principal

$ 0

^{[12],[13],[21],[23],[28]}

^{[16],[19],[22],[25],[26]}

Investment, cost

^{[12],[13],[23],[28]}

^{[16],[19],[25],[26]}

Investments at fair value

$ 0

^{[12],[13],[23],[28]}

^{[16],[19],[25],[26]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6

Schedule of Investments [Line Items]

Investment, principal

^{[16],[19],[22],[25],[26]}

Investment, cost

^{[16],[19],[25],[26]}

Investments at fair value

^{[16],[19],[25],[26]}

$ 0

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19],[25]

26,131

Investment, cost

^[19],[25]

$ 225

Investments at fair value

^[19],[25]

$ 3

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12],[23]

32,664

Investment, cost

^[12],[23]

$ 225

Investments at fair value

^[12],[23]

$ 10

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12],[23]

9,382

Investment, cost

^[12],[23]

$ 0

Investments at fair value

^[12],[23]

$ 3

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[28]

5.00%

Investment, interest rate (as a percent)

^[15],[28]

9.85%

Investment, principal

^[21],[28]

$ 19,336

Investment, cost

^[28]

18,991

Investments at fair value

^[28]

$ 19,444

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

7.00%

Investment, interest rate (as a percent)

^[18],[20]

12.43%

Investment, principal

^[18],[22]

$ 30,625

Investment, cost

^[18]

30,370

Investments at fair value

^[18]

$ 29,989

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

394,297

^[12]

394,297

^[12]

394,297

^[12]

394,297

^[19]

394,297

^[19]

394,297

^[19]

Investment, cost

$ 424

^[12]

$ 424

^[19]

Investments at fair value

$ 79

^[12]

$ 158

^[19]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[19],[20]}

9.00%

Investment, principal

^[19],[22]

$ 5,257

Investment, cost

^[19]

5,258

Investments at fair value

^[19]

$ 5,251

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

1,708,618

^[12]

1,708,618

^[12]

1,708,618

^[12]

1,708,618

^[19]

1,708,618

^[19]

1,708,618

^[19]

Investment, cost

$ 1,711

^[12]

$ 1,711

^[19]

Investments at fair value

$ 2,136

^[12]

$ 1,999

^[19]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

394,297

^[12]

394,297

^[12]

394,297

^[12]

394,297

^[19]

394,297

^[19]

394,297

^[19]

Investment, cost

$ 395

^[12]

$ 395

^[19]

Investments at fair value

$ 477

^[12]

$ 442

^[19]

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

829

^[12]

829

^[12]

829

^[12]

829

^[19]

829

^[19]

829

^[19]

Investment, cost

$ 0

^[12]

$ 0

^[19]

Investments at fair value

$ 0

^[12]

$ 0

^[19]

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

34,984,460

^[12]

34,984,460

^[12]

34,984,460

^[12]

34,984,460

^[19]

34,984,460

^[19]

34,984,460

^[19]

Investment, cost

$ 34,984

^[12]

$ 34,984

^[19]

Investments at fair value

$ 27,638

^[12]

$ 27,638

^[19]

27,638

Investment owned, percent of net assets (as a percent)

1.90%

1.80%

Investment, Identifier [Axis]: CBAM 2017-2, LTD., Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23],[28]

7.36%

Investment, interest rate (as a percent)

^{[15],[23],[28]}

12.65%

Investment, principal

^{[21],[23],[28]}

$ 489

Investment, cost

^[23],[28]

458

Investments at fair value

^[23],[28]

$ 462

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23],[28]

5.75%

Investment, interest rate (as a percent)

^{[15],[23],[28]}

10.95%

Investment, principal | £

^{[21],[23],[28]}

£ 14,807

Investment, cost

^[23],[28]

$ 18,480

Investments at fair value

^[23],[28]

$ 19,878

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23],[28]

5.50%

Investment, interest rate (as a percent)

^{[15],[23],[28]}

10.45%

Investment, principal

^{[21],[23],[28]}

$ 14,725

Investment, cost

^[23],[28]

18,330

Investments at fair value

^[23],[28]

$ 19,782

Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[29]}

7.75%

Investment, principal

^{[18],[19],[22],[29]}

$ 727

Investment, cost

^{[18],[19],[29]}

462

Investments at fair value

^{[18],[19],[29]}

$ 396

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

6.50%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.07%

Investment, principal

^{[18],[19],[22]}

$ 37

Investment, cost

^[18],[19]

Investments at fair value

^[18],[19]

$ 37

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

6.50%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.07%

Investment, principal

^{[18],[19],[22]}

$ 3,031

Investment, cost

^[18],[19]

2,899

Investments at fair value

^[18],[19]

$ 3,031

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

6.50%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.07%

Investment, principal

^{[18],[19],[22]}

$ 1,557

Investment, cost

^[18],[19]

1,489

Investments at fair value

^[18],[19]

$ 1,557

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

6.50%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.07%

Investment, principal

^{[18],[19],[22]}

$ 1,024

Investment, cost

^[18],[19]

994

Investments at fair value

^[18],[19]

$ 1,024

Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

1,080,398

^[12]

1,080,398

^[12]

1,080,398

^[12]

1,080,399

^[19]

1,080,399

^[19]

1,080,399

^[19]

Investment, principal

Investment, cost

$ 875

^[12]

1,080

^[19]

Investments at fair value

$ 594

^[12]

$ 432

^[19]

378

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: Centralsquare Technologies, LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

6.00%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(33)

Investments at fair value

^{[12],[13],[28]}

$ (15)

Investment, Identifier [Axis]: Centralsquare Technologies, LLC, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

6.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

8.10%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

3.50%

Investment, principal

^{[12],[21],[28]}

$ 12,830

Investment, cost

^[12],[28]

12,539

Investments at fair value

^[12],[28]

$ 12,694

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[20],[25]}

7.50%

Investment, principal

^[22],[25]

$ 2,632

Investment, cost

^[25]

2,632

Investments at fair value

^[25]

$ 2,017

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[20],[25]}

7.75%

Investment, principal

^[22],[25]

$ 176

Investment, cost

^[25]

170

Investments at fair value

^[25]

$ 141

Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^[18],[20]

7.38%

Investment, principal

^[22]

$ 8,420

Investment, cost

8,261

Investments at fair value

7,059

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12]

22,267,661

Investment, cost

^[12]

$ 16,172

Investments at fair value

$ 12,247

^[12]

$ 0

Investment owned, percent of net assets (as a percent)

0.80%

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[29]}

8.50%

Investment, principal

^{[18],[19],[22],[29]}

$ 22,084

Investment, cost

^{[18],[19],[29]}

21,336

Investments at fair value

^{[18],[19],[29]}

16,040

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12]

3,137,476

Investment, cost

^[12]

$ 3,137

Investments at fair value

$ 3,357

^[12]

Investment owned, percent of net assets (as a percent)

0.20%

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants

Schedule of Investments [Line Items]

Investment, cost

^[19]

706

Investments at fair value

^[19]

$ 0

Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

417,851

^[12]

417,851

^[12]

417,851

^[12]

417,851

^[19]

417,851

^[19]

417,851

^[19]

Investment, cost

$ 605

^[12]

$ 605

^[19]

Investments at fair value

$ 894

^[12]

$ 894

^[19]

Investment, Identifier [Axis]: CoreRx, Inc., Pharmaceuticals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

7.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

12.10%

Investment, principal

^{[12],[21],[28]}

$ 6,494

Investment, cost

^[12],[28]

6,347

Investments at fair value

^[12],[28]

$ 6,348

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^{[12],[13],[28]}

5.50%

^{[12],[13],[28]}

5.50%

^{[12],[13],[28]}

7.50%

^{[16],[18],[19]}

7.50%

^{[16],[18],[19]}

7.50%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

(17)

^{[12],[13],[28]}

(20)

^{[16],[18],[19]}

Investments at fair value

$ 0

^{[12],[13],[28]}

$ (20)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^{[12],[13],[28]}

5.50%

^{[12],[13],[28]}

5.50%

^{[12],[13],[28]}

7.50%

^[18],[19]

7.50%

^[18],[19]

7.50%

^[18],[19]

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.82%

Investment, principal

^{[18],[19],[22]}

$ 13,157

Investment, cost

$ (15)

^{[12],[13],[28]}

12,855

^[18],[19]

Investments at fair value

$ 0

^{[12],[13],[28]}

$ 12,858

^[18],[19]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[12],[28]

5.50%

^[12],[28]

5.50%

^[12],[28]

7.50%

^{[16],[18],[19]}

7.50%

^{[16],[18],[19]}

7.50%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.75%

Investment, principal

$ 13,124

^{[12],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

12,870

^[12],[28]

(15)

^{[16],[18],[19]}

Investments at fair value

$ 13,124

^[12],[28]

$ (13)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[28]

5.00%

^[28]

5.00%

^[28]

5.00%

^[18]

5.00%

^[18]

5.00%

^[18]

Investment, interest rate (as a percent)

9.60%

^[15],[28]

9.60%

^[15],[28]

9.60%

^[15],[28]

10.39%

^[18],[20]

10.39%

^[18],[20]

10.39%

^[18],[20]

Investment, principal

$ 10,878

^[21],[28]

$ 14,750

^[18],[22]

Investment, cost

10,518

^[28]

14,173

^[18]

Investments at fair value

$ 10,341

^[28]

$ 14,616

^[18]

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19]}

6.00%

Investment, interest rate (as a percent)

^{[16],[18],[19],[20]}

11.47%

Investment, principal

^{[16],[18],[19],[22]}

$ 933

Investment, cost

^{[16],[18],[19]}

920

Investments at fair value

^{[16],[18],[19]}

$ 918

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

6.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

11.52%

Investment, principal

^{[18],[19],[22]}

$ 18,013

Investment, cost

^[18],[19]

17,690

Investments at fair value

^[18],[19]

$ 17,812

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

6.75%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(48)

Investments at fair value

^{[12],[13],[28]}

$ (31)

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

6.75%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

11.35%

Investment, principal

^{[12],[21],[28]}

$ 20,924

Investment, cost

^[12],[28]

20,468

Investments at fair value

^[12],[28]

$ 20,627

Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

4.75%

Investment, interest rate (as a percent)

^[18],[20]

10.12%

Investment, principal

^[18],[22]

$ 4,950

Investment, cost

^[18]

4,871

Investments at fair value

^[18]

$ 4,831

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12],[23]

^[19],[25]

Investment, cost

$ 2

^[12],[23]

$ 2

^[19],[25]

Investments at fair value

$ 2

^[12],[23]

$ 2

^[19],[25]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

419

^[12],[23]

419

^[12],[23]

419

^[12],[23]

419

^[19],[25]

419

^[19],[25]

419

^[19],[25]

Investment, cost

$ 419

^[12],[23]

$ 419

^[19],[25]

Investments at fair value

$ 531

^[12],[23]

$ 419

^[19],[25]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[16],[18],[19],[20],[25]}

3.00%

Investment, interest rate, paid in kind (as a percent)

^{[16],[19],[25]}

7.00%

Investment, principal

^{[16],[19],[22],[25]}

$ 17,465

Investment, cost

^{[16],[19],[25]}

17,465

Investments at fair value

^{[16],[19],[25]}

$ 17,465

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[12],[13],[15],[23]}

8.00%

Investment, interest rate, paid in kind (as a percent)

^{[12],[13],[23]}

3.00%

Investment, principal

^{[12],[13],[21],[23]}

$ 8,456

Investment, cost

^{[12],[13],[23]}

8,456

Investments at fair value

^{[12],[13],[23]}

$ 8,456

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[12],[15],[23]}

3.00%

Investment, interest rate, paid in kind (as a percent)

^[12],[23]

7.00%

Investment, principal

^{[12],[21],[23]}

$ 34,316

Investment, cost

^[12],[23]

34,316

Investments at fair value

^[12],[23]

$ 34,316

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12],[23]

^[19],[25]

Investment, cost

$ 0

^[12],[23]

$ 0

^[19],[25]

Investments at fair value

$ 0

^[12],[23]

$ 0

^[19],[25]

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

9.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

14.54%

Investment, principal

^{[18],[19],[22]}

$ 20,757

Investment, cost

^[18],[19]

20,146

Investments at fair value

^[18],[19]

$ 20,653

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

15.75%

Investment, principal

^{[12],[21],[28]}

$ 23,660

Investment, cost

^[12],[28]

23,264

Investments at fair value

^[12],[28]

$ 21,175

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

15.75%

Investment, principal

^{[12],[21],[28]}

$ 655

Investment, cost

^[12],[28]

655

Investments at fair value

^[12],[28]

$ 586

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

15.75%

Investment, principal

^{[12],[21],[28]}

$ 647

Investment, cost

^[12],[28]

647

Investments at fair value

^[12],[28]

$ 579

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

15.75%

Investment, principal

^{[12],[21],[28]}

$ 1,039

Investment, cost

^[12],[28]

1,039

Investments at fair value

^[12],[28]

$ 929

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 5

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

15.75%

Investment, principal

^{[12],[21],[28]}

$ 852

Investment, cost

^[12],[28]

852

Investments at fair value

^[12],[28]

$ 762

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[19]

8.00%

Investment, principal

^[19],[22]

$ 654

Investment, cost

^[19]

653

Investments at fair value

^[19]

$ 631

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12],[27]

10.00%

Investment, principal

^{[12],[21],[27]}

$ 725

Investment, cost

^[12],[27]

724

Investments at fair value

^[12],[27]

$ 375

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12],[27]

10.00%

Investment, principal

^{[12],[21],[27]}

$ 959

Investment, cost

^[12],[27]

Investments at fair value

^[12],[27]

$ 496

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 3

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12],[27]

10.00%

Investment, principal

^{[12],[21],[27]}

$ 952

Investment, cost

^[12],[27]

Investments at fair value

^[12],[27]

$ 493

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 4

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12],[27]

10.00%

Investment, principal

^{[12],[21],[27]}

$ 1,679

Investment, cost

^[12],[27]

Investments at fair value

^[12],[27]

$ 869

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12]

Investment owned, balance (in shares) | shares

6,397,254

^[12]

6,397,254

^[12]

6,397,254

^[12]

6,397,254

^[19]

6,397,254

^[19]

6,397,254

^[19]

Investment, cost

$ 1,642

^[12]

$ 1,642

^[19]

Investments at fair value

$ 0

^[12]

$ 1,152

^[19]

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[12],[13],[28]}

6.00%

^{[12],[13],[28]}

6.00%

^{[12],[13],[28]}

7.00%

^{[16],[18],[19]}

7.00%

^{[16],[18],[19]}

7.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[16],[18],[19],[20]}

12.49%

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 284

^{[16],[18],[19],[22]}

Investment, cost

^{[12],[13],[28]}

265

^{[16],[18],[19]}

Investments at fair value

$ (36)

^{[12],[13],[28]}

$ 252

^{[16],[18],[19]}

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.49%

Investment, principal

^{[18],[19],[22]}

$ 12,386

Investment, cost

^[18],[19]

12,208

Investments at fair value

^[18],[19]

$ 12,101

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

6.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.60%

Investment, principal

^{[12],[21],[28]}

$ 54,454

Investment, cost

^[12],[28]

54,449

Investments at fair value

^[12],[28]

$ 54,127

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

6.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.60%

Investment, principal

^{[12],[21],[28]}

$ 2,939

Investment, cost

^[12],[28]

2,913

Investments at fair value

^[12],[28]

$ 2,921

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

5.00%

Investment, interest rate (as a percent)

^[18],[20]

10.43%

Investment, principal

^[18],[22]

$ 4,641

Investment, cost

^[18]

4,619

Investments at fair value

^[18]

$ 4,546

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

30,031

^[12]

30,031

^[12]

30,031

^[12]

30,031

^[19]

30,031

^[19]

30,031

^[19]

Investment, cost

$ 15,222

^[12]

$ 15,222

^[19]

Investments at fair value

$ 0

^[12]

$ 2,711

^[19]

4,946

Investment owned, percent of net assets (as a percent)

0.00%

0.20%

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[18],[19]

5.00%

^[18],[19]

5.00%

^[18],[19]

Investment, interest rate (as a percent)

9.75%

^{[12],[15],[28]}

9.75%

^{[12],[15],[28]}

9.75%

^{[12],[15],[28]}

10.54%

^{[18],[19],[20]}

10.54%

^{[18],[19],[20]}

10.54%

^{[18],[19],[20]}

Investment, principal

$ 5,574

^{[12],[21],[28]}

$ 5,574

^{[18],[19],[22]}

Investment, cost

5,574

^[12],[28]

5,574

^[18],[19]

Investments at fair value

$ 4,546

^[12],[28]

$ 5,574

^[18],[19]

Investment owned, percent of net assets (as a percent)

0.30%

0.40%

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[18],[19]

5.00%

^[18],[19]

5.00%

^[18],[19]

Investment, interest rate (as a percent)

9.74%

^{[12],[15],[28]}

9.74%

^{[12],[15],[28]}

9.74%

^{[12],[15],[28]}

10.54%

^{[18],[19],[20]}

10.54%

^{[18],[19],[20]}

10.54%

^{[18],[19],[20]}

Investment, principal

$ 13,928

^{[12],[21],[28]}

$ 14,068

^{[18],[19],[22]}

Investment, cost

13,928

^[12],[28]

14,068

^[18],[19]

Investments at fair value

$ 11,360

^[12],[28]

$ 14,068

^[18],[19]

14,333

Investment owned, percent of net assets (as a percent)

0.80%

0.90%

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^{[12],[13],[28]}

5.00%

^{[12],[13],[28]}

5.00%

^{[12],[13],[28]}

5.00%

^{[16],[18],[19]}

5.00%

^{[16],[18],[19]}

5.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

10.42%

^{[16],[18],[19],[20]}

10.42%

^{[16],[18],[19],[20]}

10.42%

^{[16],[18],[19],[20]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 2,090

^{[16],[18],[19],[22]}

Investment, cost

^{[12],[13],[28]}

2,090

^{[16],[18],[19]}

Investments at fair value

$ (1,028)

^{[12],[13],[28]}

$ 2,090

^{[16],[18],[19]}

Investment owned, percent of net assets (as a percent)

(0.10%)

0.10%

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

12,500

^[12]

12,500

^[12]

12,500

^[12]

12,500

^[19]

12,500

^[19]

12,500

^[19]

Investment, cost

$ 0

^[12]

$ 0

^[19]

Investments at fair value

$ 0

^[12]

$ 0

^[19]

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

488

^[12]

488

^[12]

488

^[12]

488

^[19]

488

^[19]

488

^[19]

Investment, cost

$ 488

^[12]

$ 488

^[19]

Investments at fair value

$ 1,345

^[12]

$ 1,345

^[19]

Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[12],[28]

7.50%

^[12],[28]

7.50%

^[12],[28]

7.50%

^[18],[19]

7.50%

^[18],[19]

7.50%

^[18],[19]

Investment, interest rate (as a percent)

12.25%

^{[12],[15],[28]}

12.25%

^{[12],[15],[28]}

12.25%

^{[12],[15],[28]}

13.04%

^{[18],[19],[20]}

13.04%

^{[18],[19],[20]}

13.04%

^{[18],[19],[20]}

Investment, principal

$ 8,974

^{[12],[21],[28]}

$ 8,974

^{[18],[19],[22]}

Investment, cost

8,884

^[12],[28]

8,884

^[18],[19]

Investments at fair value

$ 8,121

^[12],[28]

$ 7,987

^[18],[19]

Investment, Identifier [Axis]: Engineering Research and Consulting LLC, Construction & Engineering, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.06%

Investment, principal

^{[12],[21],[28]}

$ 11,933

Investment, cost

^[12],[28]

11,697

Investments at fair value

^[12],[28]

$ 11,858

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.50%

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

10.35%

Investment, principal

^{[12],[13],[21],[28]}

$ 121

Investment, cost

^{[12],[13],[28]}

Investments at fair value

^{[12],[13],[28]}

$ 121

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.35%

Investment, principal

^{[12],[21],[28]}

$ 24,741

Investment, cost

^[12],[28]

24,369

Investments at fair value

^[12],[28]

$ 24,741

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.50%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(16)

Investments at fair value

^{[12],[13],[28]}

$ 0

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.00%

^{[12],[15],[23]}

9.00%

^{[12],[15],[23]}

9.00%

^{[12],[15],[23]}

3.00%

^{[18],[19],[20],[25]}

3.00%

^{[18],[19],[20],[25]}

3.00%

^{[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

^[19],[25]

6.00%

Investment, principal

$ 1,834

^{[12],[21],[23]}

$ 11,065

^{[19],[22],[25]}

Investment, cost

1,817

^[12],[23]

10,953

^[19],[25]

Investments at fair value

$ 1,834

^[12],[23]

$ 10,677

^[19],[25]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.00%

^{[12],[13],[15],[23]}

9.00%

^{[12],[13],[15],[23]}

9.00%

^{[12],[13],[15],[23]}

3.00%

^{[18],[19],[20],[25]}

3.00%

^{[18],[19],[20],[25]}

3.00%

^{[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

^[19],[25]

6.00%

Investment, principal

$ 0

^{[12],[13],[21],[23]}

$ 1,772

^{[19],[22],[25]}

Investment, cost

^{[12],[13],[23]}

1,748

^[19],[25]

Investments at fair value

$ 0

^{[12],[13],[23]}

$ 1,710

^[19],[25]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.00%

^{[12],[13],[15],[23]}

9.00%

^{[12],[13],[15],[23]}

9.00%

^{[12],[13],[15],[23]}

3.00%

^{[16],[18],[19],[20],[25]}

3.00%

^{[16],[18],[19],[20],[25]}

3.00%

^{[16],[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

^{[16],[19],[25]}

6.00%

Investment, principal

$ 0

^{[12],[13],[21],[23]}

$ 0

^{[16],[19],[22],[25]}

Investment, cost

^{[12],[13],[23]}

^{[16],[19],[25]}

Investments at fair value

$ 0

^{[12],[13],[23]}

$ 0

^{[16],[19],[25]}

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.00%

^{[12],[15],[23]}

9.00%

^{[12],[15],[23]}

9.00%

^{[12],[15],[23]}

3.00%

^{[16],[18],[19],[20],[25]}

3.00%

^{[16],[18],[19],[20],[25]}

3.00%

^{[16],[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

^{[16],[19],[25]}

6.00%

Investment, principal

$ 11,454

^{[12],[21],[23]}

$ 0

^{[16],[19],[22],[25]}

Investment, cost

11,374

^[12],[23]

^{[16],[19],[25]}

Investments at fair value

$ 11,454

^[12],[23]

$ 0

^{[16],[19],[25]}

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.00%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(10)

Investments at fair value

^{[12],[13],[28]}

$ (9)

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.33%

Investment, principal

^{[12],[21],[28]}

$ 20,014

Investment, cost

^[12],[28]

19,914

Investments at fair value

^[12],[28]

$ 19,922

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.00%

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

10.30%

Investment, principal

^{[12],[13],[21],[28]}

$ 1,961

Investment, cost

^{[12],[13],[28]}

1,944

Investments at fair value

^{[12],[13],[28]}

$ 1,950

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^{[12],[13],[28]}

4.75%

^{[12],[13],[28]}

4.75%

^{[12],[13],[28]}

6.00%

^{[16],[18],[19]}

6.00%

^{[16],[18],[19]}

6.00%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

(34)

^{[12],[13],[28]}

(41)

^{[16],[18],[19]}

Investments at fair value

$ (14)

^{[12],[13],[28]}

$ (41)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

6.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

11.32%

Investment, principal

^{[18],[19],[22]}

$ 14,736

Investment, cost

^[18],[19]

14,368

Investments at fair value

^[18],[19]

$ 14,368

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

4.75%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

9.35%

Investment, principal

^{[12],[21],[28]}

$ 14,625

Investment, cost

^[12],[28]

14,312

Investments at fair value

^[12],[28]

$ 14,501

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

4.75%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

9.35%

Investment, principal

^{[12],[21],[28]}

$ 3,692

Investment, cost

^[12],[28]

3,656

Investments at fair value

^[12],[28]

$ 3,661

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12],[32]

1,206

Investment, cost

^[12],[32]

$ 1,206

Investments at fair value

^[12],[32]

$ 1,131

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.80%

Investment, principal

^{[12],[21],[28]}

$ 4,368

Investment, cost

^[12],[28]

4,289

Investments at fair value

^[12],[28]

$ 4,285

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.50%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(66)

Investments at fair value

^{[12],[13],[28]}

$ (125)

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

6.75%

Investment, interest rate (as a percent)

^[18],[20]

12.18%

Investment, principal

^[18],[22]

$ 31,074

Investment, cost

^[18]

29,127

Investments at fair value

^[18]

$ 19,917

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.00%

^[12],[15]

9.00%

^[12],[15]

9.00%

^[12],[15]

9.00%

^{[16],[18],[19],[20]}

9.00%

^{[16],[18],[19],[20]}

9.00%

^{[16],[18],[19],[20]}

Investment, principal

$ 48,920

^[12],[21]

$ 59,950

^{[16],[19],[22]}

Investment, cost

48,920

^[12]

59,950

^[16],[19]

Investments at fair value

$ 48,920

^[12]

$ 59,950

^[16],[19]

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

3,750

^{[12],[23],[33]}

3,750

^{[12],[23],[33]}

3,750

^{[12],[23],[33]}

3,750

^[19],[25]

3,750

^[19],[25]

3,750

^[19],[25]

Investment, cost

$ 0

^{[12],[23],[33]}

$ 0

^[19],[25]

Investments at fair value

$ 4

^{[12],[23],[33]}

$ 3

^[19],[25]

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^{[12],[13],[23],[28]}

7.25%

^{[12],[13],[23],[28]}

7.25%

^{[12],[13],[23],[28]}

7.25%

^{[16],[18],[19],[25]}

7.25%

^{[16],[18],[19],[25]}

7.25%

^{[16],[18],[19],[25]}

Investment, interest rate (as a percent)

12.18%

^{[12],[13],[15],[23],[28]}

12.18%

^{[12],[13],[15],[23],[28]}

12.18%

^{[12],[13],[15],[23],[28]}

12.55%

^{[16],[18],[19],[20],[25]}

12.55%

^{[16],[18],[19],[20],[25]}

12.55%

^{[16],[18],[19],[20],[25]}

Investment, principal

$ 564

^{[12],[13],[21],[23],[28]}

$ 258

^{[16],[18],[19],[22],[25]}

Investment, cost

544

^{[12],[13],[23],[28]}

234

^{[16],[18],[19],[25]}

Investments at fair value

$ 547

^{[12],[13],[23],[28]}

$ 234

^{[16],[18],[19],[25]}

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^{[12],[23],[28]}

7.25%

^{[12],[23],[28]}

7.25%

^{[12],[23],[28]}

7.25%

^{[18],[19],[25]}

7.25%

^{[18],[19],[25]}

7.25%

^{[18],[19],[25]}

Investment, interest rate (as a percent)

12.18%

^{[12],[15],[23],[28]}

12.18%

^{[12],[15],[23],[28]}

12.18%

^{[12],[15],[23],[28]}

12.55%

^{[18],[19],[20],[25]}

12.55%

^{[18],[19],[20],[25]}

12.55%

^{[18],[19],[20],[25]}

Investment, principal

$ 11,683

^{[12],[21],[23],[28]}

$ 11,742

^{[18],[19],[22],[25]}

Investment, cost

11,491

^{[12],[23],[28]}

11,509

^{[18],[19],[25]}

Investments at fair value

$ 11,521

^{[12],[23],[28]}

11,511

^{[18],[19],[25]}

Investment, Identifier [Axis]: Finthrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

4.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

8.96%

Investment, principal

^{[12],[21],[28]}

$ 4,291

Investment, cost

^[12],[28]

3,594

Investments at fair value

^[12],[28]

$ 3,862

Investment, Identifier [Axis]: Finthrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[27],[28]}

6.75%

Investment, principal

^{[12],[21],[27],[28]}

$ 31,074

Investment, cost

^{[12],[27],[28]}

28,328

Investments at fair value

^{[12],[27],[28]}

$ 23,616

Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest

Schedule of Investments [Line Items]

Investment owned, ownership (as a percent)

100.00%

Investments at fair value

$ 0

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

11.00%

Investment, principal

^{[19],[22],[25]}

$ 11,918

Investment, cost

^[19],[25]

11,612

Investments at fair value

^[19],[25]

$ 11,144

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

27,801

^[12],[23]

27,801

^[12],[23]

27,801

^[12],[23]

417,011

^[19],[25]

417,011

^[19],[25]

417,011

^[19],[25]

Investment, cost

$ 427

^[12],[23]

$ 427

^[19],[25]

Investments at fair value

$ 13

^[12],[23]

$ 42

^[19],[25]

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[20],[25]}

6.00%

Investment, principal

^[22],[25]

$ 4,881

Investment, cost

^[25]

4,469

Investments at fair value

^[25]

$ 3,577

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^{[12],[13],[28]}

7.25%

^{[12],[13],[28]}

7.25%

^{[12],[13],[28]}

7.25%

^{[16],[18],[19]}

7.25%

^{[16],[18],[19]}

7.25%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

11.85%

^{[12],[13],[15],[28]}

11.85%

^{[12],[13],[15],[28]}

11.85%

^{[12],[13],[15],[28]}

12.64%

^{[16],[18],[19],[20]}

12.64%

^{[16],[18],[19],[20]}

12.64%

^{[16],[18],[19],[20]}

Investment, principal

$ 2,536

^{[12],[13],[21],[28]}

$ 1,638

^{[16],[18],[19],[22]}

Investment, cost

2,452

^{[12],[13],[28]}

1,535

^{[16],[18],[19]}

Investments at fair value

$ 2,536

^{[12],[13],[28]}

$ 1,535

^{[16],[18],[19]}

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^[12],[28]

7.25%

^[12],[28]

7.25%

^[12],[28]

7.25%

^[18],[19]

7.25%

^[18],[19]

7.25%

^[18],[19]

Investment, interest rate (as a percent)

11.85%

^{[12],[15],[28]}

11.85%

^{[12],[15],[28]}

11.85%

^{[12],[15],[28]}

12.64%

^{[18],[19],[20]}

12.64%

^{[18],[19],[20]}

12.64%

^{[18],[19],[20]}

Investment, principal

$ 23,536

^{[12],[21],[28]}

$ 23,774

^{[18],[19],[22]}

Investment, cost

22,996

^[12],[28]

23,110

^[18],[19]

Investments at fair value

$ 23,536

^[12],[28]

$ 23,110

^[18],[19]

Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

5.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

10.57%

Investment, principal

^{[18],[19],[22]}

$ 2,456

Investment, cost

^[18],[19]

2,055

Investments at fair value

^[18],[19]

$ 2,063

Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[25]

2.85%

Investment, interest rate (as a percent)

^{[18],[20],[25]}

6.56%

Investment, principal | €

^{[18],[22],[25]}

€ 1,000

Investment, cost

^[18],[25]

$ 876

Investments at fair value

^[18],[25]

$ 963

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^{[12],[13],[28]}

8.00%

^{[12],[13],[28]}

8.00%

^{[12],[13],[28]}

8.00%

^{[16],[18],[19]}

8.00%

^{[16],[18],[19]}

8.00%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

(20)

^{[12],[13],[28]}

(27)

^{[16],[18],[19]}

Investments at fair value

$ (35)

^{[12],[13],[28]}

$ (35)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[12],[28]

8.00%

^[12],[28]

8.00%

^[12],[28]

8.00%

^[18],[19]

8.00%

^[18],[19]

8.00%

^[18],[19]

Investment, interest rate (as a percent)

12.95%

^{[12],[15],[28]}

12.95%

^{[12],[15],[28]}

12.95%

^{[12],[15],[28]}

13.42%

^{[18],[19],[20]}

13.42%

^{[18],[19],[20]}

13.42%

^{[18],[19],[20]}

Investment, principal

$ 3,524

^{[12],[21],[28]}

$ 17,444

^{[18],[19],[22]}

Investment, cost

3,485

^[12],[28]

17,276

^[18],[19]

Investments at fair value

$ 3,454

^[12],[28]

$ 17,096

^[18],[19]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[12],[28]

8.00%

^[12],[28]

8.00%

^[12],[28]

8.00%

^{[16],[18],[19]}

8.00%

^{[16],[18],[19]}

8.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[12],[15],[28]}

12.95%

Investment, principal

$ 17,268

^{[12],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

17,147

^[12],[28]

(54)

^{[16],[18],[19]}

Investments at fair value

$ 16,923

^[12],[28]

$ (70)

^{[16],[18],[19]}

Investment, Identifier [Axis]: HPS Loan Management 10-2016, Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23],[28]

6.67%

Investment, interest rate (as a percent)

^{[15],[23],[28]}

11.95%

Investment, principal

^{[21],[23],[28]}

$ 2,250

Investment, cost

^[23],[28]

2,136

Investments at fair value

^[23],[28]

$ 2,264

Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

^[28]

5.25%

^[28]

5.25%

^[28]

5.25%

^[18]

5.25%

^[18]

5.25%

^[18]

Investment, interest rate (as a percent)

10.20%

^[15],[28]

10.20%

^[15],[28]

10.20%

^[15],[28]

10.67%

^[18],[20]

10.67%

^[18],[20]

10.67%

^[18],[20]

Investment, principal

$ 8,473

^[21],[28]

$ 14,347

^[18],[22]

Investment, cost

8,205

^[28]

13,871

^[18]

Investments at fair value

$ 8,263

^[28]

$ 13,618

^[18]

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^{[12],[13],[23],[28]}

6.50%

^{[12],[13],[23],[28]}

6.50%

^{[12],[13],[23],[28]}

6.50%

^{[18],[19],[25]}

6.50%

^{[18],[19],[25]}

6.50%

^{[18],[19],[25]}

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

11.89%

Investment, principal

$ 0

^{[12],[13],[21],[23],[28]}

$ 7,448

^{[18],[19],[22],[25]}

Investment, cost

(40)

^{[12],[13],[23],[28]}

7,296

^{[18],[19],[25]}

Investments at fair value

$ 52

^{[12],[13],[23],[28]}

$ 7,301

^{[18],[19],[25]}

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^{[12],[23],[28]}

6.50%

^{[12],[23],[28]}

6.50%

^{[12],[23],[28]}

6.50%

^{[16],[18],[19],[25]}

6.50%

^{[16],[18],[19],[25]}

6.50%

^{[16],[18],[19],[25]}

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

11.25%

Investment, principal

$ 1,432

^{[12],[21],[23],[28]}

$ 0

^{[16],[18],[19],[22],[25]}

Investment, cost

1,413

^{[12],[23],[28]}

(82)

^{[16],[18],[19],[25]}

Investments at fair value

$ 1,454

^{[12],[23],[28]}

$ (79)

^{[16],[18],[19],[25]}

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^{[12],[23],[28]}

6.50%

^{[12],[23],[28]}

6.50%

^{[12],[23],[28]}

6.50%

^{[18],[19],[25]}

6.50%

^{[18],[19],[25]}

6.50%

^{[18],[19],[25]}

Investment, interest rate (as a percent)

11.25%

^{[12],[15],[23],[28]}

11.25%

^{[12],[15],[23],[28]}

11.25%

^{[12],[15],[23],[28]}

12.04%

^{[18],[19],[20],[25]}

12.04%

^{[18],[19],[20],[25]}

12.04%

^{[18],[19],[20],[25]}

Investment, principal

$ 7,448

^{[12],[21],[23],[28]}

$ 1,432

^{[18],[19],[22],[25]}

Investment, cost

7,362

^{[12],[23],[28]}

1,399

^{[18],[19],[25]}

Investments at fair value

$ 7,560

^{[12],[23],[28]}

$ 1,404

^{[18],[19],[25]}

Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[20],[25]}

4.46%

Investment, principal

^[22],[25]

$ 6,808

Investment, cost

^[25]

5,490

Investments at fair value

^[25]

$ 5,873

Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^{[12],[23],[28]}

8.25%

^{[12],[23],[28]}

8.25%

^{[12],[23],[28]}

8.25%

^{[18],[19],[25]}

8.25%

^{[18],[19],[25]}

8.25%

^{[18],[19],[25]}

Investment, interest rate (as a percent)

13.37%

^{[12],[15],[23],[28]}

13.37%

^{[12],[15],[23],[28]}

13.37%

^{[12],[15],[23],[28]}

13.62%

^{[18],[19],[20],[25]}

13.62%

^{[18],[19],[20],[25]}

13.62%

^{[18],[19],[20],[25]}

Investment, principal

$ 23,975

^{[12],[21],[23],[28]}

$ 23,975

^{[18],[19],[22],[25]}

Investment, cost

23,454

^{[12],[23],[28]}

23,310

^{[18],[19],[25]}

Investments at fair value

$ 25,054

^{[12],[23],[28]}

$ 23,328

^{[18],[19],[25]}

Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[28]

5.75%

^[28]

5.75%

^[28]

5.75%

^[18],[19]

5.75%

^[18],[19]

5.75%

^[18],[19]

Investment, interest rate (as a percent)

10.62%

^[15],[28]

10.62%

^[15],[28]

10.62%

^[15],[28]

11.40%

^{[18],[19],[20]}

11.40%

^{[18],[19],[20]}

11.40%

^{[18],[19],[20]}

Investment, principal

$ 42,075

^[21],[28]

$ 44,550

^{[18],[19],[22]}

Investment, cost

40,978

^[28]

42,918

^[18],[19]

Investments at fair value

$ 35,343

^[28]

$ 35,046

^[18],[19]

Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[12],[28]

6.50%

^[12],[28]

6.50%

^[12],[28]

6.50%

^[18],[19]

6.50%

^[18],[19]

6.50%

^[18],[19]

Investment, interest rate (as a percent)

11.97%

^{[12],[15],[28]}

11.97%

^{[12],[15],[28]}

11.97%

^{[12],[15],[28]}

11.92%

^{[18],[19],[20]}

11.92%

^{[18],[19],[20]}

11.92%

^{[18],[19],[20]}

Investment, principal

$ 36,029

^{[12],[21],[28]}

$ 40,587

^{[18],[19],[22]}

Investment, cost

35,643

^[12],[28]

39,935

^[18],[19]

Investments at fair value

$ 35,668

^[12],[28]

$ 38,963

^[18],[19]

Investment, Identifier [Axis]: Icefall Parent, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

6.50%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(18)

Investments at fair value

^{[12],[13],[28]}

$ (7)

Investment, Identifier [Axis]: Icefall Parent, Inc., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

6.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

11.35%

Investment, principal

^{[12],[21],[28]}

$ 10,446

Investment, cost

^[12],[28]

10,261

Investments at fair value

^[12],[28]

$ 10,372

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

10.75%

Investment, interest rate, paid in kind (as a percent)

^[18],[19]

16.06%

Investment, principal

^{[18],[19],[22]}

$ 26,613

Investment, cost

^[18],[19]

26,492

Investments at fair value

^[18],[19]

$ 24,484

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

10.75%

Investment, interest rate, paid in kind (as a percent)

^[18],[19]

16.05%

Investment, principal

^{[18],[19],[22]}

$ 787

Investment, cost

^[18],[19]

771

Investments at fair value

^[18],[19]

$ 787

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19]}

10.75%

Investment, interest rate, paid in kind (as a percent)

^{[16],[18],[19]}

16.06%

Investment, principal

^{[16],[18],[19],[22]}

$ 688

Investment, cost

^{[16],[18],[19]}

688

Investments at fair value

^{[16],[18],[19]}

$ 688

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

350,241

Investment, cost

$ 0

Investments at fair value

$ 147

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

5.75%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

11.14%

Investment, interest rate, paid in kind (as a percent)

^{[18],[19],[25]}

2.75%

Investment, principal

^{[18],[19],[22],[25]}

$ 7,179

Investment, cost

^{[18],[19],[25]}

6,969

Investments at fair value

^{[18],[19],[25]}

$ 6,568

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

112,990

^[12],[23]

112,990

^[12],[23]

112,990

^[12],[23]

112,990

^[19],[25]

112,990

^[19],[25]

112,990

^[19],[25]

Investment, cost

$ 300

^[12],[23]

$ 300

^[19],[25]

Investments at fair value

$ 0

^[12],[23]

$ 105

^[19],[25]

Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19]

1,078,284

Investment, cost

^[19]

$ 113

Investments at fair value

^[19]

$ 0

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.00%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(25)

Investments at fair value

^{[12],[13],[28]}

$ (26)

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.08%

Investment, principal

^{[12],[21],[28]}

$ 19,559

Investment, cost

^[12],[28]

19,368

Investments at fair value

^[12],[28]

$ 19,363

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.00%

Investment, cost

^{[12],[13],[28]}

$ (68)

Investments at fair value

^{[12],[13],[28]}

$ (66)

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^{[12],[13],[28]}

7.50%

^{[12],[13],[28]}

7.50%

^{[12],[13],[28]}

7.50%

^{[16],[18],[19]}

7.50%

^{[16],[18],[19]}

7.50%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

(42)

^{[12],[13],[28]}

(99)

^{[16],[18],[19]}

Investments at fair value

$ (86)

^{[12],[13],[28]}

$ (86)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[12],[28]

7.50%

^[12],[28]

7.50%

^[12],[28]

7.50%

^[18],[19]

7.50%

^[18],[19]

7.50%

^[18],[19]

Investment, interest rate (as a percent)

12.46%

^{[12],[15],[28]}

12.46%

^{[12],[15],[28]}

12.46%

^{[12],[15],[28]}

12.93%

^{[18],[19],[20]}

12.93%

^{[18],[19],[20]}

12.93%

^{[18],[19],[20]}

Investment, principal

$ 33,079

^{[12],[21],[28]}

$ 33,414

^{[18],[19],[22]}

Investment, cost

32,876

^[12],[28]

32,539

^[18],[19]

Investments at fair value

32,332

^[12],[28]

$ 32,659

^[18],[19]

Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

7.25%

Investment, interest rate (as a percent)

^[18],[20]

12.78%

Investment, principal

^[18],[22]

$ 13,939

Investment, cost

^[18]

12,661

Investments at fair value

^[18]

10,094

Investment, Identifier [Axis]: JN Bidco LLC, Health Care Technology, Common Stock

Schedule of Investments [Line Items]

Investment, cost

^[12]

9,886

Investments at fair value

^[12]

9,886

Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares

Schedule of Investments [Line Items]

Investment, cost

34,597

83,262

Investments at fair value

$ 34,597

$ 83,262

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

^{[12],[13],[28]}

4.00%

^{[12],[13],[28]}

4.00%

^{[12],[13],[28]}

6.50%

^{[16],[18],[19]}

6.50%

^{[16],[18],[19]}

6.50%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

12.50%

^{[12],[13],[15],[28]}

12.50%

^{[12],[13],[15],[28]}

12.50%

^{[12],[13],[15],[28]}

11.84%

^{[16],[18],[19],[20]}

11.84%

^{[16],[18],[19],[20]}

11.84%

^{[16],[18],[19],[20]}

Investment, principal

$ 1,259

^{[12],[13],[21],[28]}

$ 272

^{[16],[18],[19],[22]}

Investment, cost

1,223

^{[12],[13],[28]}

246

^{[16],[18],[19]}

Investments at fair value

$ 1,216

^{[12],[13],[28]}

$ 238

^{[16],[18],[19]}

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

^{[12],[13],[28]}

4.00%

^{[12],[13],[28]}

4.00%

^{[12],[13],[28]}

6.50%

^{[16],[18],[19]}

6.50%

^{[16],[18],[19]}

6.50%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

12.00%

Investment, principal

$ 926

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

901

^{[12],[13],[28]}

(47)

^{[16],[18],[19]}

Investments at fair value

$ 894

^{[12],[13],[28]}

$ (47)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[12],[28]

6.50%

^[18],[19]

6.50%

^[18],[19]

6.50%

^[18],[19]

Investment, interest rate (as a percent)

9.95%

^{[12],[15],[28]}

9.95%

^{[12],[15],[28]}

9.95%

^{[12],[15],[28]}

11.84%

^{[18],[19],[20]}

11.84%

^{[18],[19],[20]}

11.84%

^{[18],[19],[20]}

Investment, principal

$ 37,635

^{[12],[21],[28]}

$ 16,752

^{[18],[19],[22]}

Investment, cost

37,211

^[12],[28]

16,623

^[18],[19]

Investments at fair value

$ 37,123

^[12],[28]

$ 16,500

^[18],[19]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[12],[28]

6.50%

^[18],[19]

6.50%

^[18],[19]

6.50%

^[18],[19]

Investment, interest rate (as a percent)

10.68%

^{[12],[15],[28]}

10.68%

^{[12],[15],[28]}

10.68%

^{[12],[15],[28]}

11.80%

^{[18],[19],[20]}

11.80%

^{[18],[19],[20]}

11.80%

^{[18],[19],[20]}

Investment, principal

$ 16,552

^{[12],[21],[28]}

$ 38,015

^{[18],[19],[22]}

Investment, cost

16,423

^[12],[28]

37,447

^[18],[19]

Investments at fair value

$ 16,327

^[12],[28]

$ 37,445

^[18],[19]

Investment, Identifier [Axis]: LABL, Inc., Office Services & Supplies, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[28]

5.00%

Investment, interest rate (as a percent)

^[15],[28]

9.95%

Investment, principal

^[21],[28]

$ 19,351

Investment, cost

^[28]

18,861

Investments at fair value

^[28]

$ 18,953

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[12],[13],[28]}

6.00%

^{[12],[13],[28]}

6.00%

^{[12],[13],[28]}

6.00%

^{[16],[18],[19]}

6.00%

^{[16],[18],[19]}

6.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

10.95%

Investment, principal

$ 2,014

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

1,982

^{[12],[13],[28]}

(41)

^{[16],[18],[19]}

Investments at fair value

$ 1,849

^{[12],[13],[28]}

$ (172)

^{[16],[18],[19]}

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[18],[19]

6.00%

^[18],[19]

6.00%

^[18],[19]

Investment, interest rate (as a percent)

10.95%

^{[12],[15],[28]}

10.95%

^{[12],[15],[28]}

10.95%

^{[12],[15],[28]}

11.42%

^{[18],[19],[20]}

11.42%

^{[18],[19],[20]}

11.42%

^{[18],[19],[20]}

Investment, principal

$ 2,708

^{[12],[21],[28]}

$ 2,736

^{[18],[19],[22]}

Investment, cost

2,601

^[12],[28]

2,595

^[18],[19]

Investments at fair value

$ 2,539

^[12],[28]

$ 2,558

^[18],[19]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[18],[19]

6.00%

^[18],[19]

6.00%

^[18],[19]

Investment, interest rate (as a percent)

10.95%

^{[12],[15],[28]}

10.95%

^{[12],[15],[28]}

10.95%

^{[12],[15],[28]}

11.42%

^{[18],[19],[20]}

11.42%

^{[18],[19],[20]}

11.42%

^{[18],[19],[20]}

Investment, principal

$ 23,256

^{[12],[21],[28]}

$ 23,494

^{[18],[19],[22]}

Investment, cost

22,977

^[12],[28]

23,128

^[18],[19]

Investments at fair value

$ 21,802

^[12],[28]

$ 21,967

^[18],[19]

Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

9.50%

^[23],[28]

9.50%

^[23],[28]

9.50%

^[23],[28]

9.50%

^[18],[25]

9.50%

^[18],[25]

9.50%

^[18],[25]

Investment, interest rate (as a percent)

14.95%

^{[15],[23],[28]}

14.95%

^{[15],[23],[28]}

14.95%

^{[15],[23],[28]}

14.95%

^{[18],[20],[25]}

14.95%

^{[18],[20],[25]}

14.95%

^{[18],[20],[25]}

Investment, principal

$ 26,156

^{[21],[23],[28]}

$ 26,422

^{[18],[22],[25]}

Investment, cost

25,039

^[23],[28]

24,920

^[18],[25]

Investments at fair value

$ 26,556

^[23],[28]

$ 27,512

^[18],[25]

Investment, Identifier [Axis]: Learfield Communications, LLC, Movies & Entertainment, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[28]

5.50%

Investment, interest rate (as a percent)

^[15],[28]

10.35%

Investment, principal

^[21],[28]

$ 30,856

Investment, cost

^[28]

30,779

Investments at fair value

^[28]

$ 30,863

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.00%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(61)

Investments at fair value

^{[12],[13],[28]}

$ (60)

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.13%

Investment, principal

^{[12],[21],[28]}

$ 26,358

Investment, cost

^[12],[28]

25,839

Investments at fair value

^[12],[28]

$ 25,847

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.00%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(15)

Investments at fair value

^{[12],[13],[28]}

$ (15)

Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19]

2,000,000

Investment, cost

^[19]

$ 1,399

Investments at fair value

^[19]

$ 0

Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[12],[28]

5.00%

^[18],[19]

5.00%

^[18],[19]

5.00%

^[18],[19]

Investment, interest rate (as a percent)

9.96%

^{[12],[15],[28]}

9.96%

^{[12],[15],[28]}

9.96%

^{[12],[15],[28]}

10.65%

^{[18],[19],[20]}

10.65%

^{[18],[19],[20]}

10.65%

^{[18],[19],[20]}

Investment, principal

$ 55,873

^{[12],[21],[28]}

$ 45,243

^{[18],[19],[22]}

Investment, cost

55,220

^[12],[28]

44,717

^[18],[19]

Investments at fair value

$ 54,197

^[12],[28]

$ 43,886

^[18],[19]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

559

^[12]

559

^[12]

559

^[12]

559

^[19]

559

^[19]

559

^[19]

Investment, principal

^[19],[22]

Investment, cost

$ 563

^[12]

563

^[19]

Investments at fair value

$ 64

^[12]

$ 372

^[19]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[12],[28]

8.50%

^[12],[28]

8.50%

^[12],[28]

8.50%

^[18],[19]

8.50%

^[18],[19]

8.50%

^[18],[19]

Investment, interest rate (as a percent)

13.20%

^{[12],[15],[28]}

13.20%

^{[12],[15],[28]}

13.20%

^{[12],[15],[28]}

13.99%

^{[18],[19],[20]}

13.99%

^{[18],[19],[20]}

13.99%

^{[18],[19],[20]}

Investment, principal

$ 3,167

^{[12],[21],[28]}

$ 5,403

^{[18],[19],[22]}

Investment, cost

3,123

^[12],[28]

5,348

^[18],[19]

Investments at fair value

$ 2,993

^[12],[28]

$ 5,160

^[18],[19]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[12],[28]

8.50%

^[12],[28]

8.50%

^[12],[28]

8.50%

^{[16],[18],[19]}

8.50%

^{[16],[18],[19]}

8.50%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

13.20%

^{[12],[15],[28]}

13.20%

^{[12],[15],[28]}

13.20%

^{[12],[15],[28]}

13.99%

^{[16],[18],[19],[20]}

13.99%

^{[16],[18],[19],[20]}

13.99%

^{[16],[18],[19],[20]}

Investment, principal

$ 5,822

^{[12],[21],[28]}

$ 2,939

^{[16],[18],[19],[22]}

Investment, cost

5,785

^[12],[28]

2,884

^{[16],[18],[19]}

Investments at fair value

$ 5,502

^[12],[28]

$ 2,745

^{[16],[18],[19]}

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[12],[13],[28]}

6.00%

^{[12],[13],[28]}

6.00%

^{[12],[13],[28]}

6.00%

^{[16],[18],[19]}

6.00%

^{[16],[18],[19]}

6.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[16],[18],[19],[20]}

11.42%

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 964

^{[16],[18],[19],[22]}

Investment, cost

(21)

^{[12],[13],[28]}

936

^{[16],[18],[19]}

Investments at fair value

$ (24)

^{[12],[13],[28]}

$ 938

^{[16],[18],[19]}

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[18],[19]

6.00%

^[18],[19]

6.00%

^[18],[19]

Investment, interest rate (as a percent)

11.40%

^{[12],[15],[28]}

11.40%

^{[12],[15],[28]}

11.40%

^{[12],[15],[28]}

11.52%

^{[18],[19],[20]}

11.52%

^{[18],[19],[20]}

11.52%

^{[18],[19],[20]}

Investment, principal

$ 2,604

^{[12],[21],[28]}

$ 20,125

^{[18],[19],[22]}

Investment, cost

2,561

^[12],[28]

19,912

^[18],[19]

Investments at fair value

$ 2,568

^[12],[28]

$ 19,823

^[18],[19]

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[18],[19]

6.00%

^[18],[19]

6.00%

^[18],[19]

Investment, interest rate (as a percent)

11.40%

^{[12],[15],[28]}

11.40%

^{[12],[15],[28]}

11.40%

^{[12],[15],[28]}

11.52%

^{[18],[19],[20]}

11.52%

^{[18],[19],[20]}

11.52%

^{[18],[19],[20]}

Investment, principal

$ 7,224

^{[12],[21],[28]}

$ 2,631

^{[18],[19],[22]}

Investment, cost

7,167

^[12],[28]

2,587

^[18],[19]

Investments at fair value

$ 7,125

^[12],[28]

$ 2,591

^[18],[19]

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19]}

7.50%

Investment, interest rate (as a percent)

^{[16],[18],[19],[20]}

12.83%

Investment, principal

^{[16],[18],[19],[22]}

$ 1,466

Investment, cost

^{[16],[18],[19]}

1,215

Investments at fair value

^{[16],[18],[19]}

$ 1,282

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.50%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.89%

Investment, principal

^{[18],[19],[22]}

$ 40,538

Investment, cost

^[18],[19]

39,873

Investments at fair value

^[18],[19]

$ 39,833

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^{[12],[13],[28]}

4.75%

^{[12],[13],[28]}

4.75%

^{[12],[13],[28]}

5.50%

^{[16],[18],[19]}

5.50%

^{[16],[18],[19]}

5.50%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

(69)

^{[12],[13],[28]}

(28)

^{[16],[18],[19]}

Investments at fair value

$ (44)

^{[12],[13],[28]}

$ (47)

^{[16],[18],[19]}

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^[12],[28]

4.75%

^[12],[28]

4.75%

^[12],[28]

5.50%

^[18],[19]

5.50%

^[18],[19]

5.50%

^[18],[19]

Investment, interest rate (as a percent)

9.35%

^{[12],[15],[28]}

9.35%

^{[12],[15],[28]}

9.35%

^{[12],[15],[28]}

10.99%

^{[18],[19],[20]}

10.99%

^{[18],[19],[20]}

10.99%

^{[18],[19],[20]}

Investment, principal

$ 33,831

^{[12],[21],[28]}

$ 13,973

^{[18],[19],[22]}

Investment, cost

33,438

^[12],[28]

13,936

^[18],[19]

Investments at fair value

$ 33,503

^[12],[28]

$ 13,685

^[18],[19]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^[12],[28]

4.75%

^[12],[28]

4.75%

^[12],[28]

5.50%

^[18],[19]

5.50%

^[18],[19]

5.50%

^[18],[19]

Investment, interest rate (as a percent)

9.35%

^{[12],[15],[28]}

9.35%

^{[12],[15],[28]}

9.35%

^{[12],[15],[28]}

10.99%

^{[18],[19],[20]}

10.99%

^{[18],[19],[20]}

10.99%

^{[18],[19],[20]}

Investment, principal

$ 13,829

^{[12],[21],[28]}

$ 21,328

^{[18],[19],[22]}

Investment, cost

13,797

^[12],[28]

21,021

^[18],[19]

Investments at fair value

$ 13,695

^[12],[28]

$ 20,888

^[18],[19]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

4.75%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

9.35%

Investment, principal

^{[12],[21],[28]}

$ 6,652

Investment, cost

^[12],[28]

6,609

Investments at fair value

^[12],[28]

$ 6,588

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

4.75%

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

9.35%

Investment, principal

^{[12],[13],[21],[28]}

$ 792

Investment, cost

^{[12],[13],[28]}

776

Investments at fair value

^{[12],[13],[28]}

$ 760

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

11.50%

^{[12],[15],[23]}

11.50%

^{[12],[15],[23]}

11.50%

^{[12],[15],[23]}

11.50%

^{[18],[19],[20],[25]}

11.50%

^{[18],[19],[20],[25]}

11.50%

^{[18],[19],[20],[25]}

Investment, principal

$ 8,139

^{[12],[21],[23]}

$ 8,568

^{[19],[22],[25]}

Investment, cost

8,096

^[12],[23]

8,495

^[19],[25]

Investments at fair value

$ 7,773

^[12],[23]

$ 8,132

^[19],[25]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

11.50%

^{[12],[15],[23]}

11.50%

^{[12],[15],[23]}

11.50%

^{[12],[15],[23]}

11.50%

^{[18],[19],[20],[25]}

11.50%

^{[18],[19],[20],[25]}

11.50%

^{[18],[19],[20],[25]}

Investment, principal

$ 3,855

^{[12],[21],[23]}

$ 4,284

^{[19],[22],[25]}

Investment, cost

3,835

^[12],[23]

4,247

^[19],[25]

Investments at fair value

$ 3,682

^[12],[23]

$ 4,066

^[19],[25]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

11.50%

^{[12],[15],[23]}

11.50%

^{[12],[15],[23]}

11.50%

^{[12],[15],[23]}

11.50%

^{[18],[19],[20],[25]}

11.50%

^{[18],[19],[20],[25]}

11.50%

^{[18],[19],[20],[25]}

Investment, principal

$ 4,070

^{[12],[21],[23]}

$ 8,568

^{[19],[22],[25]}

Investment, cost

4,048

^[12],[23]

8,495

^[19],[25]

Investments at fair value

$ 3,886

^[12],[23]

$ 8,132

^[19],[25]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.75%

^{[12],[15],[23]}

9.75%

^{[12],[15],[23]}

9.75%

^{[12],[15],[23]}

8.00%

^{[18],[19],[20],[25]}

8.00%

^{[18],[19],[20],[25]}

8.00%

^{[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

^[19],[25]

1.75%

Investment, principal

$ 7,660

^{[12],[21],[23]}

$ 9,106

^{[19],[22],[25]}

Investment, cost

7,359

^[12],[23]

8,580

^[19],[25]

Investments at fair value

$ 7,373

^[12],[23]

$ 8,013

^[19],[25]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

33,409

^[12],[23]

33,409

^[12],[23]

33,409

^[12],[23]

259,877

^[19],[25]

259,877

^[19],[25]

259,877

^[19],[25]

Investment, principal

^{[19],[22],[25]}

Investment, cost

$ 23

^[12],[23]

545

^[19],[25]

Investments at fair value

$ 154

^[12],[23]

$ 78

^[19],[25]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

129,939

^[12],[23]

129,939

^[12],[23]

129,939

^[12],[23]

66,817

^[19],[25]

66,817

^[19],[25]

66,817

^[19],[25]

Investment, principal

^{[19],[22],[25]}

Investment, cost

$ 545

^[12],[23]

^[19],[25]

Investments at fair value

$ 416

^[12],[23]

$ 33

^[19],[25]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^{[12],[13],[28]}

7.00%

^{[12],[13],[28]}

7.00%

^{[12],[13],[28]}

7.00%

^{[16],[18],[19]}

7.00%

^{[16],[18],[19]}

7.00%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

(21)

^{[12],[13],[28]}

(43)

^{[16],[18],[19]}

Investments at fair value

$ (56)

^{[12],[13],[28]}

$ (76)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^[18],[19]

7.00%

^[18],[19]

7.00%

^[18],[19]

Investment, interest rate (as a percent)

12.40%

^{[12],[15],[28]}

12.40%

^{[12],[15],[28]}

12.40%

^{[12],[15],[28]}

12.52%

^{[18],[19],[20]}

12.52%

^{[18],[19],[20]}

12.52%

^{[18],[19],[20]}

Investment, principal

$ 51,356

^{[12],[21],[28]}

$ 5,248

^{[18],[19],[22]}

Investment, cost

51,142

^[12],[28]

5,220

^[18],[19]

Investments at fair value

$ 50,806

^[12],[28]

$ 5,164

^[18],[19]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^[18],[19]

7.00%

^[18],[19]

7.00%

^[18],[19]

Investment, interest rate (as a percent)

12.40%

^{[12],[15],[28]}

12.40%

^{[12],[15],[28]}

12.40%

^{[12],[15],[28]}

12.52%

^{[18],[19],[20]}

12.52%

^{[18],[19],[20]}

12.52%

^{[18],[19],[20]}

Investment, principal

$ 2,294

^{[12],[21],[28]}

$ 46,687

^{[18],[19],[22]}

Investment, cost

2,255

^[12],[28]

46,239

^[18],[19]

Investments at fair value

$ 2,269

^[12],[28]

$ 45,940

^[18],[19]

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[23],[28]}

5.00%

Investment, principal

^{[12],[13],[21],[23],[28]}

$ 0

Investment, cost

^{[12],[13],[23],[28]}

(13)

Investments at fair value

^{[12],[13],[23],[28]}

$ (12)

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

5.00%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

9.85%

Investment, principal

^{[12],[21],[23],[28]}

$ 7,056

Investment, cost

^{[12],[23],[28]}

6,923

Investments at fair value

^{[12],[23],[28]}

$ 6,932

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[23],[28]}

5.00%

Investment, principal

^{[12],[13],[21],[23],[28]}

$ 0

Investment, cost

^{[12],[13],[23],[28]}

(12)

Investments at fair value

^{[12],[13],[23],[28]}

$ (11)

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

5.00%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

9.85%

Investment, principal

^{[12],[21],[23],[28]}

$ 1,176

Investment, cost

^{[12],[23],[28]}

1,152

Investments at fair value

^{[12],[23],[28]}

$ 1,156

Investment, Identifier [Axis]: Modena Buyer LLC, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[28]

4.50%

Investment, interest rate (as a percent)

^[15],[28]

9.10%

Investment, principal

^[21],[28]

$ 27,705

Investment, cost

^[28]

27,169

Investments at fair value

^[28]

$ 26,588

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.50%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(65)

Investments at fair value

^{[12],[13],[28]}

$ 0

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.56%

Investment, principal

^{[12],[21],[28]}

$ 38,326

Investment, cost

^[12],[28]

37,751

Investments at fair value

^[12],[28]

$ 38,326

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.50%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(24)

Investments at fair value

^{[12],[13],[28]}

$ 0

Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^[12],[28]

8.25%

^[12],[28]

8.25%

^[12],[28]

6.75%

^[18],[19]

6.75%

^[18],[19]

6.75%

^[18],[19]

Investment, interest rate (as a percent)

10.58%

^{[12],[15],[28]}

10.58%

^{[12],[15],[28]}

10.58%

^{[12],[15],[28]}

12.51%

^{[18],[19],[20]}

12.51%

^{[18],[19],[20]}

12.51%

^{[18],[19],[20]}

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

3.25%

Investment, principal

$ 50,077

^{[12],[21],[28]}

$ 54,559

^{[18],[19],[22]}

Investment, cost

49,891

^[12],[28]

54,236

^[18],[19]

Investments at fair value

$ 48,775

^[12],[28]

$ 53,168

^[18],[19]

Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^[18],[20]

6.88%

Investment, principal

^[22]

$ 10,191

Investment, cost

9,831

Investments at fair value

$ 8,743

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.88%

^{[12],[23],[28]}

8.88%

^{[12],[23],[28]}

8.88%

^{[12],[23],[28]}

6.88%

^{[18],[19],[25]}

6.88%

^{[18],[19],[25]}

6.88%

^{[18],[19],[25]}

Investment, interest rate (as a percent)

11.82%

^{[12],[15],[23],[28]}

11.82%

^{[12],[15],[23],[28]}

11.82%

^{[12],[15],[23],[28]}

12.29%

^{[18],[19],[20],[25]}

12.29%

^{[18],[19],[20],[25]}

12.29%

^{[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

2.00%

^{[12],[23],[28]}

2.00%

^{[12],[23],[28]}

2.00%

^{[12],[23],[28]}

2.00%

^{[18],[19],[25]}

2.00%

^{[18],[19],[25]}

2.00%

^{[18],[19],[25]}

Investment, principal

$ 56,701

^{[12],[21],[23],[28]}

$ 73,362

^{[18],[19],[22],[25]}

Investment, cost

56,248

^{[12],[23],[28]}

72,459

^{[18],[19],[25]}

Investments at fair value

$ 55,737

^{[12],[23],[28]}

$ 69,694

^{[18],[19],[25]}

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

487,870

^[23]

487,870

^[23]

487,870

^[23]

487,870

^[25]

487,870

^[25]

487,870

^[25]

Investment, cost

$ 0

^[23]

$ 0

^[25]

Investments at fair value

$ 1,898

^[23]

$ 903

^[25]

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

239,590

^[23]

239,590

^[23]

239,590

^[23]

487,870

^[25]

487,870

^[25]

487,870

^[25]

Investment, cost

$ 0

^[23]

$ 0

^[25]

Investments at fair value

$ 932

^[23]

$ 903

^[25]

Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

8.50%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

13.99%

Investment, principal

^{[18],[19],[22]}

$ 30,339

Investment, cost

^[18],[19]

30,021

Investments at fair value

^[18],[19]

$ 29,007

Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

2.25%

^[12],[28]

2.25%

^[12],[28]

2.25%

^[12],[28]

9.50%

^[18],[19]

9.50%

^[18],[19]

9.50%

^[18],[19]

Investment, interest rate (as a percent)

6.85%

^{[12],[15],[28]}

6.85%

^{[12],[15],[28]}

6.85%

^{[12],[15],[28]}

14.89%

^{[18],[19],[20]}

14.89%

^{[18],[19],[20]}

14.89%

^{[18],[19],[20]}

Investment, principal

$ 55,783

^{[12],[21],[28]}

$ 64,606

^{[18],[19],[22]}

Investment, cost

54,677

^[12],[28]

64,720

^[18],[19]

Investments at fair value

$ 54,668

^[12],[28]

$ 63,185

^[18],[19]

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

6.00%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(25)

Investments at fair value

^{[12],[13],[28]}

$ 0

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

6.00%

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

6.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

11.06%

Investment, principal

^{[12],[21],[28]}

$ 19,895

Investment, cost

^[12],[28]

19,597

Investments at fair value

^[12],[28]

19,895

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, principal

^{[12],[13],[21],[28]}

Investment, cost

^{[12],[13],[28]}

(38)

Investments at fair value

^{[12],[13],[28]}

$ 0

Investment, Identifier [Axis]: Northwoods Capital 25 Ltd, Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23],[28]

7.40%

Investment, interest rate (as a percent)

^{[15],[23],[28]}

12.68%

Investment, principal

^{[21],[23],[28]}

$ 700

Investment, cost

^[23],[28]

682

Investments at fair value

^[23],[28]

$ 681

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest

Schedule of Investments [Line Items]

Investment owned, ownership (as a percent)

87.50%

^{[13],[23],[34],[35]}

87.50%

^{[13],[23],[34],[35]}

87.50%

^{[13],[23],[34],[35]}

87.50%

^{[16],[25],[36],[37]}

87.50%

^{[16],[25],[36],[37]}

87.50%

^{[16],[25],[36],[37]}

Investment, cost

$ 0

^{[13],[23],[34],[35]}

$ 0

^{[16],[25],[36],[37]}

Investments at fair value

$ 0

^{[13],[23],[34],[35]}

$ 0

^{[16],[25],[36],[37]}

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

^{[12],[13],[23],[28],[34]}

4.50%

^{[12],[13],[23],[28],[34]}

4.50%

^{[12],[13],[23],[28],[34]}

4.50%

^{[16],[18],[19],[25],[36]}

4.50%

^{[16],[18],[19],[25],[36]}

4.50%

^{[16],[18],[19],[25],[36]}

Investment, interest rate (as a percent)

9.95%

^{[12],[13],[15],[23],[28],[34]}

9.95%

^{[12],[13],[15],[23],[28],[34]}

9.95%

^{[12],[13],[15],[23],[28],[34]}

9.76%

^{[16],[18],[19],[20],[25],[36]}

9.76%

^{[16],[18],[19],[20],[25],[36]}

9.76%

^{[16],[18],[19],[20],[25],[36]}

Investment, principal

$ 58,349

^{[12],[13],[21],[23],[28],[34]}

$ 58,349

^{[16],[18],[19],[22],[25],[36]}

Investment, cost

51,668

^{[12],[13],[23],[28],[34]}

50,330

^{[16],[18],[19],[25],[36]}

Investments at fair value

$ 48,896

^{[12],[13],[23],[28],[34]}

$ 50,017

^{[16],[18],[19],[25],[36]}

50,283

Investment owned, percent of net assets (as a percent)

3.30%

Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.49%

Investment, principal

^{[18],[19],[22]}

$ 9,323

Investment, cost

^[18],[19]

9,210

Investments at fair value

^[18],[19]

$ 9,183

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12]

2,613,034

Investment, cost

^[12]

$ 22,330

Investments at fair value

^[12]

$ 13,562

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

9.50%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

14.62%

Investment, principal

^{[12],[21],[28]}

$ 12,070

Investment, cost

^[12],[28]

10,611

Investments at fair value

^[12],[28]

$ 12,070

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

10.00%

Investment, interest rate, paid in kind (as a percent)

^[18],[19]

15.67%

Investment, principal

^{[18],[19],[22]}

$ 25,712

Investment, cost

^[18],[19]

25,615

Investments at fair value

^[18],[19]

$ 25,069

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19]}

10.00%

Investment, principal

^{[16],[18],[19],[22]}

$ 0

Investment, cost

^{[16],[18],[19]}

(11)

Investments at fair value

^{[16],[18],[19]}

$ (69)

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19]}

10.00%

Investment, interest rate, paid in kind (as a percent)

^{[16],[18],[19]}

15.64%

Investment, principal

^{[16],[18],[19],[22]}

$ 1,210

Investment, cost

^{[16],[18],[19]}

1,193

Investments at fair value

^{[16],[18],[19]}

$ 1,169

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^{[12],[13],[28]}

7.50%

^{[12],[13],[28]}

7.50%

^{[12],[13],[28]}

7.75%

^{[16],[18],[19]}

7.75%

^{[16],[18],[19]}

7.75%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

(34)

^{[12],[13],[28]}

(42)

^{[16],[18],[19]}

Investments at fair value

$ 0

^{[12],[13],[28]}

$ (36)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.75%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

13.12%

Investment, principal

^{[18],[19],[22]}

$ 15,231

Investment, cost

^[18],[19]

14,892

Investments at fair value

^[18],[19]

14,945

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

7.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

12.75%

Investment, principal

^{[12],[21],[28]}

$ 15,231

Investment, cost

^[12],[28]

14,956

Investments at fair value

^[12],[28]

$ 15,231

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

7.25%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

12.50%

Investment, principal

^{[12],[21],[28]}

$ 4,047

Investment, cost

^[12],[28]

3,974

Investments at fair value

^[12],[28]

3,986

Investment, Identifier [Axis]: Other cash accounts

Schedule of Investments [Line Items]

Investment, cost

43,946

62,277

Investments at fair value

$ 43,946

$ 62,277

Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^[18],[20]

7.75%

Investment, principal

^[22]

$ 4,519

Investment, cost

4,550

Investments at fair value

$ 3,305

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^{[12],[13],[28]}

5.50%

^{[12],[13],[28]}

5.50%

^{[12],[13],[28]}

7.00%

^{[16],[18],[19]}

7.00%

^{[16],[18],[19]}

7.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

11.35%

Investment, principal

$ 753

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

710

^{[12],[13],[28]}

(53)

^{[16],[18],[19]}

Investments at fair value

$ 753

^{[12],[13],[28]}

$ (54)

^{[16],[18],[19]}

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.32%

Investment, principal

^{[18],[19],[22]}

$ 10,895

Investment, cost

^[18],[19]

10,505

Investments at fair value

^[18],[19]

$ 10,495

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

6.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

11.35%

Investment, principal

^{[12],[21],[28]}

$ 10,786

Investment, cost

^[12],[28]

10,471

Investments at fair value

^[12],[28]

$ 10,786

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.10%

Investment, principal

^{[12],[21],[28]}

$ 5,088

Investment, cost

^[12],[28]

5,057

Investments at fair value

^[12],[28]

$ 5,019

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.50%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(71)

Investments at fair value

^{[12],[13],[28]}

$ (128)

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

100,000

^[12]

100,000

^[12]

100,000

^[12]

100,000

^[19]

100,000

^[19]

100,000

^[19]

Investment, cost

$ 109

^[12]

$ 109

^[19]

Investments at fair value

$ 415

^[12]

$ 248

^[19]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^{[12],[13],[28]}

6.50%

^{[12],[13],[28]}

6.50%

^{[12],[13],[28]}

6.50%

^{[16],[18],[19]}

6.50%

^{[16],[18],[19]}

6.50%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

(20)

^{[12],[13],[28]}

(34)

^{[16],[18],[19]}

Investments at fair value

$ 0

^{[12],[13],[28]}

$ (3)

^{[16],[18],[19]}

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[12],[28]

6.50%

^[12],[28]

6.50%

^[12],[28]

6.50%

^[18],[19]

6.50%

^[18],[19]

6.50%

^[18],[19]

Investment, interest rate (as a percent)

11.90%

^{[12],[15],[28]}

11.90%

^{[12],[15],[28]}

11.90%

^{[12],[15],[28]}

12.01%

^{[18],[19],[20]}

12.01%

^{[18],[19],[20]}

12.01%

^{[18],[19],[20]}

Investment, principal

$ 26,176

^{[12],[21],[28]}

$ 38,414

^{[18],[19],[22]}

Investment, cost

25,994

^[12],[28]

37,960

^[18],[19]

Investments at fair value

$ 26,176

^[12],[28]

$ 38,380

^[18],[19]

Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

5.00%

Investment, interest rate (as a percent)

^[18],[20]

10.42%

Investment, principal

^[18],[22]

$ 9,676

Investment, cost

^[18]

9,518

Investments at fair value

^[18]

$ 9,551

Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[12],[28]

5.75%

^[12],[28]

5.75%

^[12],[28]

6.00%

^[18],[19]

6.00%

^[18],[19]

6.00%

^[18],[19]

Investment, interest rate (as a percent)

11.11%

^{[12],[15],[28]}

11.11%

^{[12],[15],[28]}

11.11%

^{[12],[15],[28]}

11.57%

^{[18],[19],[20]}

11.57%

^{[18],[19],[20]}

11.57%

^{[18],[19],[20]}

Investment, principal

$ 22,375

^{[12],[21],[28]}

$ 22,375

^{[18],[19],[22]}

Investment, cost

22,238

^[12],[28]

22,189

^[18],[19]

Investments at fair value

$ 22,375

^[12],[28]

$ 21,896

^[18],[19]

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

6.00%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(117)

Investments at fair value

^{[12],[13],[28]}

$ (175)

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

6.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.85%

Investment, principal

^{[12],[21],[28]}

$ 52,244

Investment, cost

^[12],[28]

51,330

Investments at fair value

^[12],[28]

$ 50,912

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

6.00%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(69)

Investments at fair value

^{[12],[13],[28]}

$ (106)

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12]

4,531

Investment, cost

^[12]

$ 4,440

Investments at fair value

^[12]

$ 5,022

Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.25%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.74%

Investment, principal

^{[18],[19],[22]}

$ 36,499

Investment, cost

^[18],[19]

35,458

Investments at fair value

^[18],[19]

$ 33,214

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12]

4,300,526

Investment, principal

^[12],[21]

Investment, cost

^[12]

14,364

Investments at fair value

^[12]

$ 14,364

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

^{[12],[13],[28]}

4.50%

^{[12],[13],[28]}

4.50%

^{[12],[13],[28]}

8.00%

^{[16],[18],[19]}

8.00%

^{[16],[18],[19]}

8.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[16],[18],[19],[20]}

13.45%

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 3,003

^{[16],[18],[19],[22]}

Investment, cost

^{[12],[13],[28]}

2,926

^{[16],[18],[19]}

Investments at fair value

$ 0

^{[12],[13],[28]}

$ 2,801

^{[16],[18],[19]}

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

8.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

13.45%

Investment, principal

^{[18],[19],[22]}

$ 67,244

Investment, cost

^[18],[19]

66,353

Investments at fair value

^[18],[19]

$ 64,406

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

4.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

8.12%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

1.50%

Investment, principal

^{[12],[21],[28]}

$ 4,965

Investment, cost

^[12],[28]

4,965

Investments at fair value

^[12],[28]

$ 4,965

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

4.50%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

Investments at fair value

^{[12],[13],[28]}

$ 0

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

4.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

8.12%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

1.50%

Investment, principal

^{[12],[21],[28]}

$ 8,601

Investment, cost

^[12],[28]

8,601

Investments at fair value

^[12],[28]

$ 8,601

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

7.50%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

12.62%

Investment, principal

^{[12],[21],[28]}

$ 12,902

Investment, cost

^[12],[28]

12,902

Investments at fair value

^[12],[28]

$ 12,902

Investment, Identifier [Axis]: Poseidon Midco AB, Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

5.50%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

8.97%

Investment, principal | €

^{[12],[21],[23],[28]}

€ 12,868

Investment, cost

^{[12],[23],[28]}

$ 13,949

Investments at fair value

^{[12],[23],[28]}

$ 13,994

Investment, Identifier [Axis]: Poseidon Midco AB, Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[23],[28]}

5.50%

Investment, principal

^{[12],[13],[21],[23],[28]}

$ 0

Investment, cost

^{[12],[13],[23],[28]}

Investments at fair value

^{[12],[13],[23],[28]}

$ 0

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

7.25%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

11.84%

Investment, principal

^{[12],[21],[23],[28]}

$ 26,642

Investment, cost

^{[12],[23],[28]}

26,376

Investments at fair value

^{[12],[23],[28]}

$ 26,410

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.25%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.78%

Investment, principal

^{[18],[19],[22]}

$ 24,503

Investment, cost

^[18],[19]

24,255

Investments at fair value

^[18],[19]

$ 24,081

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.25%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.78%

Investment, principal

^{[18],[19],[22]}

$ 2,819

Investment, cost

^[18],[19]

2,797

Investments at fair value

^[18],[19]

$ 2,771

Investment, Identifier [Axis]: Protein For Pets Opco, LLC, Packaged Foods & Meats, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.25%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(39)

Investments at fair value

^{[12],[13],[28]}

$ (41)

Investment, Identifier [Axis]: Protein For Pets Opco, LLC, Packaged Foods & Meats, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.25%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.10%

Investment, principal

^{[12],[21],[28]}

$ 20,274

Investment, cost

^[12],[28]

19,902

Investments at fair value

^[12],[28]

$ 19,887

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

5.75%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

11.21%

Investment, principal | £

^{[18],[19],[22],[25]}

£ 4,626

Investment, cost

^{[18],[19],[25]}

$ 5,897

Investments at fair value

^{[18],[19],[25]}

$ 5,166

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

5.50%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

10.73%

Investment, principal | £

^{[12],[21],[23],[28]}

£ 9,739

Investment, cost

^{[12],[23],[28]}

$ 12,092

Investments at fair value

^{[12],[23],[28]}

$ 12,769

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[23],[28]}

5.50%

Investment, interest rate (as a percent)

^{[12],[13],[15],[23],[28]}

10.70%

Investment, principal

^{[12],[13],[21],[23],[28]}

$ 2,123

Investment, cost

^{[12],[13],[23],[28]}

2,547

Investments at fair value

^{[12],[13],[23],[28]}

$ 2,715

Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

64,887,669

^[12]

64,887,669

^[12]

64,887,669

^[12]

64,887,669

^[19]

64,887,669

^[19]

64,887,669

^[19]

Investment, cost

$ 375

^[12]

$ 375

^[19]

Investments at fair value

$ 0

^[12]

$ 0

^[19]

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19]}

6.50%

Investment, principal

^{[16],[18],[19],[22]}

$ 0

Investment, cost

^{[16],[18],[19]}

(43)

Investments at fair value

^{[16],[18],[19]}

$ (47)

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

6.50%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

11.92%

Investment, principal

^{[18],[19],[22]}

$ 32,329

Investment, cost

^[18],[19]

32,070

Investments at fair value

^[18],[19]

$ 31,779

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^{[12],[23],[28]}

8.25%

^{[12],[23],[28]}

8.25%

^{[12],[23],[28]}

8.25%

^{[18],[19],[25]}

8.25%

^{[18],[19],[25]}

8.25%

^{[18],[19],[25]}

Investment, interest rate (as a percent)

12.77%

^{[12],[15],[23],[28]}

12.77%

^{[12],[15],[23],[28]}

12.77%

^{[12],[15],[23],[28]}

13.90%

^{[18],[19],[20],[25]}

13.90%

^{[18],[19],[20],[25]}

13.90%

^{[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

1.00%

^{[12],[23],[28]}

1.00%

^{[12],[23],[28]}

1.00%

^{[12],[23],[28]}

0.50%

^{[18],[19],[25]}

0.50%

^{[18],[19],[25]}

0.50%

^{[18],[19],[25]}

Investment, principal

$ 8,819

^{[12],[21],[23],[28]}

$ 36,707

^{[18],[19],[22],[25]}

Investment, cost

8,629

^{[12],[23],[28]}

35,548

^{[18],[19],[25]}

Investments at fair value

$ 8,334

^{[12],[23],[28]}

$ 34,505

^{[18],[19],[25]}

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^{[12],[23],[28]}

8.25%

^{[12],[23],[28]}

8.25%

^{[12],[23],[28]}

8.25%

^{[18],[19],[25]}

8.25%

^{[18],[19],[25]}

8.25%

^{[18],[19],[25]}

Investment, interest rate (as a percent)

12.77%

^{[12],[15],[23],[28]}

12.77%

^{[12],[15],[23],[28]}

12.77%

^{[12],[15],[23],[28]}

13.90%

^{[18],[19],[20],[25]}

13.90%

^{[18],[19],[20],[25]}

13.90%

^{[18],[19],[20],[25]}

Investment, interest rate, paid in kind (as a percent)

1.00%

^{[12],[23],[28]}

1.00%

^{[12],[23],[28]}

1.00%

^{[12],[23],[28]}

0.50%

^{[18],[19],[25]}

0.50%

^{[18],[19],[25]}

0.50%

^{[18],[19],[25]}

Investment, principal

$ 29,223

^{[12],[21],[23],[28]}

$ 13,504

^{[18],[19],[22],[25]}

Investment, cost

28,603

^{[12],[23],[28]}

13,058

^{[18],[19],[25]}

Investments at fair value

$ 27,615

^{[12],[23],[28]}

$ 12,694

^{[18],[19],[25]}

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

204,454

^[12],[23]

204,454

^[12],[23]

204,454

^[12],[23]

204,454

^[19],[25]

204,454

^[19],[25]

204,454

^[19],[25]

Investment, cost

$ 1,202

^[12],[23]

$ 1,202

^[19],[25]

Investments at fair value

$ 470

^[12],[23]

$ 756

^[19],[25]

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19]

1,037

Investment, cost

^[19]

$ 1,037

Investments at fair value

^[19]

$ 951

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

8.75%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

14.18%

Investment, principal

^{[18],[19],[22]}

$ 8,010

Investment, cost

^[18],[19]

7,799

Investments at fair value

^[18],[19]

$ 7,778

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19]}

8.75%

Investment, principal

^{[16],[18],[19],[22]}

$ 0

Investment, cost

^{[16],[18],[19]}

(35)

Investments at fair value

^{[16],[18],[19]}

$ (68)

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

1,184,630

^[12]

1,184,630

^[12]

1,184,630

^[12]

1,184,630

^[19]

1,184,630

^[19]

1,184,630

^[19]

Investment, cost

$ 40,093

^[12]

$ 40,093

^[19]

Investments at fair value

$ 20,802

^[12]

$ 36,226

^[19]

Investment owned, percent of net assets (as a percent)

1.40%

2.40%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

12.00%

^[12]

12.00%

^[12]

12.00%

^[12]

12.00%

^[19]

12.00%

^[19]

12.00%

^[19]

Investment, principal

$ 17,907

^[12],[21]

$ 15,874

^[19],[22]

Investment, cost

16,339

^[12]

14,100

^[19]

Investments at fair value

$ 17,907

^[12]

$ 15,874

^[19]

Investment owned, percent of net assets (as a percent)

1.20%

1.00%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

12.00%

^[12]

12.00%

^[12]

12.00%

^[12]

12.00%

^[16],[19]

12.00%

^[16],[19]

12.00%

^[16],[19]

Investment, principal

$ 3,550

^[12],[21]

$ 1,359

^{[16],[19],[22]}

Investment, cost

3,500

^[12]

1,337

^[16],[19]

Investments at fair value

$ 3,550

^[12]

$ 1,359

^[16],[19]

Investment owned, percent of net assets (as a percent)

0.20%

0.10%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12]

12.00%

Investment, principal

^[12],[21]

$ 3,332

Investment, cost

^[12]

3,243

Investments at fair value

$ 3,332

^[12]

$ 0

Investment owned, percent of net assets (as a percent)

0.20%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12]

12.00%

Investment, principal

^[12],[21]

$ 1,600

Investment, cost

^[12]

1,594

Investments at fair value

$ 1,600

^[12]

Investment owned, percent of net assets (as a percent)

0.10%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 5

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12],[13]

12.00%

Investment, principal

^{[12],[13],[21]}

$ 0

Investment, cost

^[12],[13]

Investments at fair value

$ 0

^[12],[13]

$ 0

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

66,686

^[12]

66,686

^[12]

66,686

^[12]

66,686

^[19]

66,686

^[19]

66,686

^[19]

Investment, cost

$ 0

^[12]

$ 0

^[19]

Investments at fair value

$ 0

^[12]

$ 0

^[19]

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

^[12],[28]

4.50%

^[12],[28]

4.50%

^[12],[28]

4.75%

^[18],[19]

4.75%

^[18],[19]

4.75%

^[18],[19]

Investment, interest rate (as a percent)

10.01%

^{[12],[15],[28]}

10.01%

^{[12],[15],[28]}

10.01%

^{[12],[15],[28]}

10.38%

^{[18],[19],[20]}

10.38%

^{[18],[19],[20]}

10.38%

^{[18],[19],[20]}

Investment, principal

$ 4,406

^{[12],[21],[28]}

$ 4,452

^{[18],[19],[22]}

Investment, cost

3,908

^[12],[28]

3,806

^[18],[19]

Investments at fair value

$ 4,318

^[12],[28]

$ 4,184

^[18],[19]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[12],[28]

8.00%

^[12],[28]

8.00%

^[12],[28]

8.00%

^[18],[19]

8.00%

^[18],[19]

8.00%

^[18],[19]

Investment, interest rate (as a percent)

13.51%

^{[12],[15],[28]}

13.51%

^{[12],[15],[28]}

13.51%

^{[12],[15],[28]}

13.63%

^{[18],[19],[20]}

13.63%

^{[18],[19],[20]}

13.63%

^{[18],[19],[20]}

Investment, principal

$ 12,034

^{[12],[21],[28]}

$ 12,034

^{[18],[19],[22]}

Investment, cost

11,367

^[12],[28]

11,250

^[18],[19]

Investments at fair value

$ 11,432

^[12],[28]

$ 9,928

^[18],[19]

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

6.75%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.40%

Investment, principal

^{[18],[19],[22]}

$ 25,527

Investment, cost

^[18],[19]

23,859

Investments at fair value

^[18],[19]

$ 19,954

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[27],[28]}

8.25%

Investment, principal

^{[12],[21],[27],[28]}

$ 28,146

Investment, cost

^{[12],[27],[28]}

23,170

Investments at fair value

^{[12],[27],[28]}

$ 8,444

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[27],[28]}

9.75%

Investment, principal

^{[12],[13],[21],[27],[28]}

$ 932

Investment, cost

^{[12],[13],[27],[28]}

932

Investments at fair value

^{[12],[13],[27],[28]}

$ 932

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

10.00%

^{[12],[13],[28]}

10.00%

^{[12],[13],[28]}

10.00%

^{[12],[13],[28]}

10.00%

^{[16],[18],[19]}

10.00%

^{[16],[18],[19]}

10.00%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

(63)

^{[12],[13],[28]}

(95)

^{[16],[18],[19]}

Investments at fair value

$ (140)

^{[12],[13],[28]}

$ (93)

^{[16],[18],[19]}

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

10.00%

^[12],[28]

10.00%

^[12],[28]

10.00%

^[12],[28]

10.00%

^[18],[19]

10.00%

^[18],[19]

10.00%

^[18],[19]

Investment, interest rate (as a percent)

14.85%

^{[12],[15],[28]}

14.85%

^{[12],[15],[28]}

14.85%

^{[12],[15],[28]}

15.24%

^{[18],[19],[20]}

15.24%

^{[18],[19],[20]}

15.24%

^{[18],[19],[20]}

Investment, principal

$ 22,107

^{[12],[21],[28]}

$ 25,558

^{[18],[19],[22]}

Investment, cost

21,656

^[12],[28]

24,777

^[18],[19]

Investments at fair value

$ 21,112

^[12],[28]

$ 24,791

^[18],[19]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

991,019

^[12]

991,019

^[12]

991,019

^[12]

991,019

^[19]

991,019

^[19]

991,019

^[19]

Investment, cost

$ 327

^[12]

$ 327

^[19]

Investments at fair value

$ 89

^[12]

$ 1,625

^[19]

Investment, Identifier [Axis]: Saratoga, Diversified Financial Services, Credit Linked Note

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28],[38]}

5.33%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28],[38]}

10.18%

Investment, principal

^{[12],[21],[23],[28],[38]}

$ 24,500

Investment, cost

^{[12],[23],[28],[38]}

24,478

Investments at fair value

^{[12],[23],[28],[38]}

$ 24,478

Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

9,307

^[23]

9,307

^[23]

9,307

^[23]

9,307

^[25]

9,307

^[25]

9,307

^[25]

Investment, cost

$ 78

^[23]

$ 78

^[25]

Investments at fair value

$ 9

^[23]

$ 13

^[25]

Investment, Identifier [Axis]: Secure Acquisition Inc., Paper & Plastic Packaging Products & Materials, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[28]

4.25%

Investment, interest rate (as a percent)

^[15],[28]

8.85%

Investment, principal

^[21],[28]

$ 14,963

Investment, cost

^[28]

14,925

Investments at fair value

^[28]

$ 15,009

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest

Schedule of Investments [Line Items]

Investment owned, ownership (as a percent)

87.50%

^{[12],[13],[23],[33],[34],[35]}

87.50%

^{[12],[13],[23],[33],[34],[35]}

87.50%

^{[12],[13],[23],[33],[34],[35]}

87.50%

^{[16],[25],[36],[37],[39]}

87.50%

^{[16],[25],[36],[37],[39]}

87.50%

^{[16],[25],[36],[37],[39]}

Investment, cost

$ 54,791

^{[12],[13],[23],[33],[34],[35]}

$ 54,791

^{[16],[25],[36],[37],[39]}

Investments at fair value

$ 22,541

^{[12],[13],[23],[33],[34],[35]}

$ 28,878

^{[16],[25],[36],[37],[39]}

20,715

Investment owned, percent of net assets (as a percent)

1.50%

1.90%

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^{[12],[13],[23],[28],[34]}

7.00%

^{[12],[13],[23],[28],[34]}

7.00%

^{[12],[13],[23],[28],[34]}

7.00%

^{[16],[18],[19],[25],[36]}

7.00%

^{[16],[18],[19],[25],[36]}

7.00%

^{[16],[18],[19],[25],[36]}

Investment, interest rate (as a percent)

12.45%

^{[12],[13],[15],[23],[28],[34]}

12.45%

^{[12],[13],[15],[23],[28],[34]}

12.45%

^{[12],[13],[15],[23],[28],[34]}

12.26%

^{[16],[18],[19],[20],[25],[36]}

12.26%

^{[16],[18],[19],[20],[25],[36]}

12.26%

^{[16],[18],[19],[20],[25],[36]}

Investment, principal

$ 112,656

^{[12],[13],[21],[23],[28],[34]}

$ 112,656

^{[16],[18],[19],[22],[25],[36]}

Investment, cost

112,656

^{[12],[13],[23],[28],[34]}

112,656

^{[16],[18],[19],[25],[36]}

Investments at fair value

$ 112,656

^{[12],[13],[23],[28],[34]}

$ 112,656

^{[16],[18],[19],[25],[36]}

$ 96,250

Investment owned, percent of net assets (as a percent)

7.60%

7.40%

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

7.88%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

12.88%

Investment, principal

^{[18],[19],[22],[25]}

$ 7,191

Investment, cost

^{[18],[19],[25]}

6,934

Investments at fair value

^{[18],[19],[25]}

$ 6,937

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

7.88%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

12.88%

Investment, principal

^{[18],[19],[22],[25]}

$ 2,697

Investment, cost

^{[18],[19],[25]}

2,601

Investments at fair value

^{[18],[19],[25]}

$ 2,602

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19],[25]}

7.88%

Investment, principal

^{[16],[18],[19],[22],[25]}

$ 0

Investment, cost

^{[16],[18],[19],[25]}

Investments at fair value

^{[16],[18],[19],[25]}

$ 0

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19],[25]}

7.88%

Investment, principal

^{[16],[18],[19],[22],[25]}

$ 0

Investment, cost

^{[16],[18],[19],[25]}

Investments at fair value

^{[16],[18],[19],[25]}

$ 0

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

58,210

^[12],[23]

58,210

^[12],[23]

58,210

^[12],[23]

58,210

^[19],[25]

58,210

^[19],[25]

58,210

^[19],[25]

Investment, cost

$ 182

^[12],[23]

$ 182

^[19],[25]

Investments at fair value

$ 29

^[12],[23]

$ 87

^[19],[25]

Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19]

345,452

Investment, cost

^[19]

$ 367

Investments at fair value

^[19]

$ 0

Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.50%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

13.04%

Investment, principal

^{[18],[19],[22]}

$ 821

Investment, cost

^[18],[19]

813

Investments at fair value

^[18],[19]

$ 776

Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.75%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(98)

Investments at fair value

^{[12],[13],[28]}

$ (89)

Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.75%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.60%

Investment, principal

^{[12],[21],[28]}

$ 47,730

Investment, cost

^[12],[28]

46,862

Investments at fair value

^[12],[28]

$ 46,947

Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

66,000

^[23]

66,000

^[23]

66,000

^[23]

66,000

^[25]

66,000

^[25]

66,000

^[25]

Investment, cost

$ 139

^[23]

$ 139

^[25]

Investments at fair value

$ 0

^[23]

$ 6

^[25]

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^{[12],[13],[28]}

5.00%

^{[12],[13],[28]}

5.00%

^{[12],[13],[28]}

5.00%

^{[16],[18],[19]}

5.00%

^{[16],[18],[19]}

5.00%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[16],[18],[19],[20]}

10.42%

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 618

^{[16],[18],[19],[22]}

Investment, cost

(32)

^{[12],[13],[28]}

576

^{[16],[18],[19]}

Investments at fair value

$ (15)

^{[12],[13],[28]}

$ 577

^{[16],[18],[19]}

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

^[12],[28]

5.25%

^[12],[28]

5.25%

^[12],[28]

5.25%

^[18],[19]

5.25%

^[18],[19]

5.25%

^[18],[19]

Investment, interest rate (as a percent)

10.20%

^{[12],[15],[28]}

10.20%

^{[12],[15],[28]}

10.20%

^{[12],[15],[28]}

10.67%

^{[18],[19],[20]}

10.67%

^{[18],[19],[20]}

10.67%

^{[18],[19],[20]}

Investment, principal

$ 18,058

^{[12],[21],[28]}

$ 4,488

^{[18],[19],[22]}

Investment, cost

17,887

^[12],[28]

4,423

^[18],[19]

Investments at fair value

$ 18,032

^[12],[28]

$ 4,425

^[18],[19]

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[28]

5.75%

Investment, interest rate (as a percent)

^[15],[28]

10.69%

Investment, principal

^[21],[28]

$ 13,780

Investment, cost

^[28]

13,259

Investments at fair value

^[28]

$ 12,555

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^[15]

10.75%

Investment, principal

^[21]

$ 6,835

Investment, cost

6,771

Investments at fair value

$ 6,641

Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

8.50%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

12.32%

Investment, principal | €

^{[18],[19],[22],[25]}

€ 23,731

Investment, cost

^{[18],[19],[25]}

$ 26,772

Investments at fair value

^{[18],[19],[25]}

$ 24,937

Investment, Identifier [Axis]: SumUp Holdings Luxembourg, Diversified Financial Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[23],[28]}

6.50%

Investment, interest rate (as a percent)

^{[12],[13],[15],[23],[28]}

10.04%

Investment, principal

^{[12],[13],[21],[23],[28]}

$ 18,846

Investment, cost

^{[12],[13],[23],[28]}

20,199

Investments at fair value

^{[12],[13],[23],[28]}

$ 20,785

Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

8.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

13.32%

Investment, principal

^{[18],[19],[22]}

$ 49,520

Investment, cost

^[18],[19]

48,536

Investments at fair value

^[18],[19]

$ 49,148

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^{[12],[13],[28]}

7.00%

^{[12],[13],[28]}

7.00%

^{[12],[13],[28]}

7.00%

^{[18],[19],[40]}

7.00%

^{[18],[19],[40]}

7.00%

^{[18],[19],[40]}

Investment, interest rate (as a percent)

^{[18],[19],[20],[40]}

12.44%

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 1,552

^{[18],[19],[22],[40]}

Investment, cost

(8)

^{[12],[13],[28]}

1,540

^{[18],[19],[40]}

Investments at fair value

$ (62)

^{[12],[13],[28]}

$ 1,478

^{[18],[19],[40]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19],[40]}

7.00%

Investment, interest rate (as a percent)

^{[16],[18],[19],[20],[40]}

12.51%

Investment, principal

^{[16],[18],[19],[22],[40]}

$ 1,099

Investment, cost

^{[16],[18],[19],[40]}

1,062

Investments at fair value

^{[16],[18],[19],[40]}

$ 943

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^{[18],[19],[40]}

7.00%

^{[18],[19],[40]}

7.00%

^{[18],[19],[40]}

Investment, interest rate (as a percent)

12.58%

^{[12],[15],[28]}

12.58%

^{[12],[15],[28]}

12.58%

^{[12],[15],[28]}

12.51%

^{[18],[19],[20],[40]}

12.51%

^{[18],[19],[20],[40]}

12.51%

^{[18],[19],[20],[40]}

Investment, principal

$ 2,721

^{[12],[21],[28]}

$ 32,104

^{[18],[19],[22],[40]}

Investment, cost

2,706

^[12],[28]

31,861

^{[18],[19],[40]}

Investments at fair value

$ 2,612

^[12],[28]

$ 30,579

^{[18],[19],[40]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^[12],[28]

7.00%

^{[18],[19],[40]}

7.00%

^{[18],[19],[40]}

7.00%

^{[18],[19],[40]}

Investment, interest rate (as a percent)

12.58%

^{[12],[15],[28]}

12.58%

^{[12],[15],[28]}

12.58%

^{[12],[15],[28]}

12.51%

^{[18],[19],[20],[40]}

12.51%

^{[18],[19],[20],[40]}

12.51%

^{[18],[19],[20],[40]}

Investment, principal

€ 3,273

^{[12],[21],[28]}

$ 2,749

^{[18],[19],[22],[40]}

Investment, cost

$ 3,160

^[12],[28]

2,726

^{[18],[19],[40]}

Investments at fair value

$ 3,142

^[12],[28]

$ 2,618

^{[18],[19],[40]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

7.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

12.58%

Investment, principal

^{[12],[21],[28]}

$ 31,778

Investment, cost

^[12],[28]

31,612

Investments at fair value

^[12],[28]

$ 30,507

Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[17],[18],[19],[20],[25]}

11.50%

Investment, principal

^{[17],[19],[22],[25]}

$ 4,984

Investment, cost

^{[17],[19],[25]}

4,894

Investments at fair value

^{[17],[19],[25]}

$ 4,785

Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

13.00%

^{[12],[15],[23]}

13.00%

^{[12],[15],[23]}

13.00%

^{[12],[15],[23]}

13.00%

^{[18],[19],[20],[25]}

13.00%

^{[18],[19],[20],[25]}

13.00%

^{[18],[19],[20],[25]}

Investment, principal

$ 50,419

^{[12],[21],[23]}

$ 50,419

^{[19],[22],[25]}

Investment, cost

50,061

^[12],[23]

49,842

^[19],[25]

Investments at fair value

$ 50,419

^[12],[23]

$ 49,869

^[19],[25]

Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

8.00%

Investment, interest rate (as a percent)

^[18],[20]

13.43%

Investment, principal

^[18],[22]

$ 12,843

Investment, cost

^[18]

12,603

Investments at fair value

^[18]

$ 12,464

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19],[25]}

6.00%

Investment, principal

^{[16],[18],[19],[22],[25]}

$ 0

Investment, cost

^{[16],[18],[19],[25]}

(29)

Investments at fair value

^{[16],[18],[19],[25]}

$ (22)

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

6.00%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

11.42%

Investment, principal

^{[18],[19],[22],[25]}

$ 28,826

Investment, cost

^{[18],[19],[25]}

28,595

Investments at fair value

^{[18],[19],[25]}

$ 28,537

Investment, Identifier [Axis]: Telephone and Data Systems, Inc., Wireless Telecommunication Services, Subordinated Debt Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[23],[28]}

7.00%

Investment, interest rate (as a percent)

^{[12],[15],[23],[28]}

12.25%

Investment, principal

^{[12],[21],[23],[28]}

$ 25,031

Investment, cost

^{[12],[23],[28]}

24,343

Investments at fair value

^{[12],[23],[28]}

$ 24,405

Investment, Identifier [Axis]: Telephone and Data Systems, Inc., Wireless Telecommunication Services, Subordinated Debt Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[23],[28]}

7.00%

Investment, principal

^{[12],[13],[21],[23],[28]}

$ 0

Investment, cost

^{[12],[13],[23],[28]}

(86)

Investments at fair value

^{[12],[13],[23],[28]}

$ (94)

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

9.75%

^{[12],[13],[27],[28]}

9.75%

^{[12],[13],[27],[28]}

9.75%

^{[12],[13],[27],[28]}

9.75%

^{[16],[18],[19]}

9.75%

^{[16],[18],[19]}

9.75%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

^{[16],[18],[19],[20]}

15.17%

Investment, principal

$ 1,946

^{[12],[13],[21],[27],[28]}

$ 1,861

^{[16],[18],[19],[22]}

Investment, cost

1,918

^{[12],[13],[27],[28]}

1,845

^{[16],[18],[19]}

Investments at fair value

$ 1,727

^{[12],[13],[27],[28]}

$ 1,802

^{[16],[18],[19]}

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

9.75%

^{[12],[27],[28]}

9.75%

^{[12],[27],[28]}

9.75%

^{[12],[27],[28]}

9.75%

^[18],[19]

9.75%

^[18],[19]

9.75%

^[18],[19]

Investment, interest rate (as a percent)

^{[18],[19],[20]}

15.26%

Investment, principal

$ 26,553

^{[12],[21],[27],[28]}

$ 23,423

^{[18],[19],[22]}

Investment, cost

25,237

^{[12],[27],[28]}

23,207

^[18],[19]

Investments at fair value

$ 23,898

^{[12],[27],[28]}

$ 22,814

^[18],[19]

Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[18],[19]

6.00%

^[18],[19]

6.00%

^[18],[19]

Investment, interest rate (as a percent)

10.74%

^{[12],[15],[28]}

10.74%

^{[12],[15],[28]}

10.74%

^{[12],[15],[28]}

11.32%

^{[18],[19],[20]}

11.32%

^{[18],[19],[20]}

11.32%

^{[18],[19],[20]}

Investment, principal

$ 19,683

^{[12],[21],[28]}

$ 19,947

^{[18],[19],[22]}

Investment, cost

18,960

^[12],[28]

19,013

^[18],[19]

Investments at fair value

$ 18,837

^[12],[28]

$ 19,199

^[18],[19]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[29]}

7.30%

Investment, principal

^{[18],[19],[22],[29]}

$ 19,163

Investment, cost

^{[18],[19],[29]}

19,163

Investments at fair value

^{[18],[19],[29]}

18,340

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12],[27]

10.00%

Investment, principal

^{[12],[21],[27]}

$ 5,065

Investment, cost

^[12],[27]

4,657

Investments at fair value

$ 4,087

^[12],[27]

Investment owned, percent of net assets (as a percent)

0.30%

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[12],[27]

10.00%

Investment, principal

^{[12],[21],[27]}

$ 20,917

Investment, cost

^[12],[27]

19,262

Investments at fair value

$ 18,235

^[12],[27]

Investment owned, percent of net assets (as a percent)

1.20%

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest

Schedule of Investments [Line Items]

Investment owned, ownership (as a percent)

^[12]

6.40%

Investment, principal

$ 0

Investment, cost

^[12]

Investments at fair value

$ 0

^[12]

$ 0

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[29]}

12.50%

Investment, principal

^{[18],[19],[22],[29]}

$ 4,641

Investment, cost

^{[18],[19],[29]}

4,641

Investments at fair value

^{[18],[19],[29]}

$ 4,170

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12]

321,058

Investment, principal

^[12],[21]

$ 0

Investment, cost

^[12]

Investments at fair value

^[12]

$ 0

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.00%

Investment, interest rate, paid in kind (as a percent)

^[18],[19]

12.65%

Investment, principal

^{[18],[19],[22]}

$ 46,832

Investment, cost

^[18],[19]

45,698

Investments at fair value

^[18],[19]

$ 37,231

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

10.00%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

15.54%

Investment, principal

^{[12],[21],[28]}

$ 6,141

Investment, cost

^[12],[28]

5,952

Investments at fair value

^[12],[28]

$ 6,018

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[27],[28]}

10.00%

Investment, principal

^{[12],[21],[27],[28]}

$ 18,844

Investment, cost

^{[12],[27],[28]}

16,279

Investments at fair value

^{[12],[27],[28]}

$ 16,536

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19]

10,616

Investment, cost

^[19]

$ 120

Investments at fair value

^[19]

$ 0

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19]

358,299

Investment, cost

^[19]

$ 2,912

Investments at fair value

^[19]

$ 0

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19]

60,862

Investment, cost

^[19]

$ 1,207

Investments at fair value

^[19]

$ 108

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19]

32,447

Investment, cost

^[19]

$ 33,353

Investments at fair value

^[19]

$ 31,701

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[12],[28]

6.00%

^[18],[19]

6.00%

^[18],[19]

6.00%

^[18],[19]

Investment, interest rate (as a percent)

10.95%

^{[12],[15],[28]}

10.95%

^{[12],[15],[28]}

10.95%

^{[12],[15],[28]}

11.42%

^{[18],[19],[20]}

11.42%

^{[18],[19],[20]}

11.42%

^{[18],[19],[20]}

Investment, principal

$ 14,508

^{[12],[21],[28]}

$ 11,671

^{[18],[19],[22]}

Investment, cost

14,426

^[12],[28]

11,646

^[18],[19]

Investments at fair value

$ 14,218

^[12],[28]

$ 11,363

^[18],[19]

Investment, Identifier [Axis]: Trinitas CLO VI Ltd., Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23],[28]

7.08%

Investment, interest rate (as a percent)

^{[15],[23],[28]}

12.36%

Investment, principal

^{[21],[23],[28]}

$ 905

Investment, cost

^[23],[28]

852

Investments at fair value

^[23],[28]

$ 856

Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.71%

^[23],[28]

7.71%

^[23],[28]

7.71%

^[23],[28]

7.71%

^[18],[25]

7.71%

^[18],[25]

7.71%

^[18],[25]

Investment, interest rate (as a percent)

12.99%

^{[15],[23],[28]}

12.99%

^{[15],[23],[28]}

12.99%

^{[15],[23],[28]}

13.06%

^{[18],[20],[25]}

13.06%

^{[18],[20],[25]}

13.06%

^{[18],[20],[25]}

Investment, principal

$ 1,000

^{[21],[23],[28]}

$ 1,000

^{[18],[22],[25]}

Investment, cost

824

^[23],[28]

816

^[18],[25]

Investments at fair value

$ 978

^[23],[28]

$ 917

^[18],[25]

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.75%

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

10.85%

Investment, principal

^{[12],[13],[21],[28]}

$ 29

Investment, cost

^{[12],[13],[28]}

(23)

Investments at fair value

^{[12],[13],[28]}

$ 29

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.75%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.86%

Investment, principal

^{[12],[21],[28]}

$ 26,457

Investment, cost

^[12],[28]

25,976

Investments at fair value

^[12],[28]

$ 26,457

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.75%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(52)

Investments at fair value

^{[12],[13],[28]}

$ 0

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.25%

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

10.10%

Investment, principal

^{[12],[13],[21],[28]}

$ 975

Investment, cost

^{[12],[13],[28]}

955

Investments at fair value

^{[12],[13],[28]}

$ 955

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

5.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

10.35%

Investment, principal

^{[12],[21],[28]}

$ 15,773

Investment, cost

^[12],[28]

15,617

Investments at fair value

^[12],[28]

$ 15,618

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

5.50%

Investment, interest rate (as a percent)

^{[12],[13],[15],[28]}

10.35%

Investment, principal

^{[12],[13],[21],[28]}

$ 24

Investment, cost

^{[12],[13],[28]}

Investments at fair value

^{[12],[13],[28]}

$ 15

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[20],[25]}

6.50%

Investment, principal

^[22],[25]

$ 4,500

Investment, cost

^[25]

4,115

Investments at fair value

^[25]

$ 2,953

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[18],[20],[25]}

4.75%

Investment, principal

^[22],[25]

$ 300

Investment, cost

^[25]

264

Investments at fair value

^[25]

$ 245

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[12],[15],[23]}

11.00%

Investment, principal

^{[12],[21],[23]}

$ 2,512

Investment, cost

^[12],[23]

2,466

Investments at fair value

^[12],[23]

$ 2,468

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[12],[15],[23]}

11.00%

Investment, principal

^{[12],[21],[23]}

$ 3,198

Investment, cost

^[12],[23]

3,134

Investments at fair value

^[12],[23]

3,142

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, principal

^{[12],[13],[21],[23]}

Investment, cost

^{[12],[13],[23]}

Investments at fair value

^{[12],[13],[23]}

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, principal

^{[12],[13],[21],[23]}

Investment, cost

^{[12],[13],[23]}

Investments at fair value

^{[12],[13],[23]}

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 5

Schedule of Investments [Line Items]

Investment, principal

^{[12],[21],[23],[24]}

4,652

Investment, cost

^{[12],[23],[24]}

4,652

Investments at fair value

^{[12],[23],[24]}

4,699

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 6

Schedule of Investments [Line Items]

Investment, principal

^{[12],[13],[21],[23],[24]}

Investment, cost

^{[12],[13],[23],[24]}

Investments at fair value

^{[12],[13],[23],[24]}

$ 0

Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.25%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.68%

Investment, principal

^{[18],[19],[22]}

$ 1,140

Investment, cost

^[18],[19]

927

Investments at fair value

^[18],[19]

$ 1,139

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[12],[13],[28]}

6.75%

Investment, principal

^{[12],[13],[21],[28]}

$ 0

Investment, cost

^{[12],[13],[28]}

(70)

Investments at fair value

^{[12],[13],[28]}

$ (19)

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

3.75%

Investment, interest rate (as a percent)

^[18],[20]

9.27%

Investment, principal

^[18],[22]

$ 11,792

Investment, cost

^[18]

11,281

Investments at fair value

^[18]

$ 11,127

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

7.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

8.39%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

4.13%

Investment, principal

^{[12],[21],[28]}

$ 30,570

Investment, cost

^[12],[28]

29,933

Investments at fair value

^[12],[28]

$ 30,396

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

7.50%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

8.39%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

4.13%

Investment, principal

^{[12],[21],[28]}

$ 1,449

Investment, cost

^[12],[28]

1,449

Investments at fair value

^[12],[28]

$ 1,448

Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

7.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

12.65%

Investment, principal

^{[18],[19],[22]}

$ 5,000

Investment, cost

^[18],[19]

4,925

Investments at fair value

^[18],[19]

$ 4,263

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[12],[28]

14.00%

Investment, interest rate (as a percent)

^{[12],[15],[28]}

12.85%

Investment, interest rate, paid in kind (as a percent)

^[12],[28]

6.00%

Investment, principal

^{[12],[21],[28]}

$ 2,782

Investment, cost

^[12],[28]

2,760

Investments at fair value

^[12],[28]

$ 2,546

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

15.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

21.68%

Investment, principal

^{[18],[19],[22]}

$ 1,565

Investment, cost

^[18],[19]

1,551

Investments at fair value

^[18],[19]

$ 1,464

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

15.00%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

21.68%

Investment, principal

^{[18],[19],[22]}

$ 1,323

Investment, cost

^[18],[19]

1,311

Investments at fair value

^[18],[19]

$ 1,237

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

4,871

^[12]

4,871

^[12]

4,871

^[12]

4,871

^[19]

4,871

^[19]

4,871

^[19]

Investment, cost

$ 46

^[12]

$ 46

^[19]

Investments at fair value

$ 0

^[12]

$ 107

^[19]

Investment, Identifier [Axis]: Win Brands Group LLC, Integrated Telecommunication Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[12]

127,452

Investment, cost

^[12]

$ 2,057

Investments at fair value

^[12]

$ 1,657

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[19]

127,452

Investment, cost

^[19]

$ 2,057

Investments at fair value

^[19]

$ 1,319

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18]

6.25%

Investment, interest rate (as a percent)

^[18],[20]

11.67%

Investment, principal

^[18],[22]

$ 8,983

Investment, cost

^[18]

8,698

Investments at fair value

^[18]

$ 8,678

Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

^[12],[28]

4.00%

^[12],[28]

4.00%

^[12],[28]

4.00%

^[18],[19]

4.00%

^[18],[19]

4.00%

^[18],[19]

Investment, interest rate (as a percent)

8.25%

^{[12],[15],[28]}

8.25%

^{[12],[15],[28]}

8.25%

^{[12],[15],[28]}

9.32%

^{[18],[19],[20]}

9.32%

^{[18],[19],[20]}

9.32%

^{[18],[19],[20]}

Investment, principal

$ 19,431

^{[12],[21],[28]}

$ 19,578

^{[18],[19],[22]}

Investment, cost

19,407

^[12],[28]

19,568

^[18],[19]

Investments at fair value

$ 19,431

^[12],[28]

$ 19,489

^[18],[19]

Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[18],[19],[25]}

7.50%

Investment, interest rate (as a percent)

^{[18],[19],[20],[25]}

12.72%

Investment, principal | £

^{[18],[19],[22],[25]}

£ 20,000

Investment, cost

^{[18],[19],[25]}

$ 25,841

Investments at fair value

^{[18],[19],[25]}

$ 22,914

Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

21,523

^[12]

21,523

^[12]

21,523

^[12]

21,523

^[19]

21,523

^[19]

21,523

^[19]

Investment, cost

$ 20,789

^[12]

$ 20,789

^[19]

Investments at fair value

$ 24,326

^[12]

$ 20,074

^[19]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^{[12],[13],[28]}

5.75%

^{[12],[13],[28]}

5.75%

^{[12],[13],[28]}

6.75%

^{[16],[18],[19]}

6.75%

^{[16],[18],[19]}

6.75%

^{[16],[18],[19]}

Investment, interest rate (as a percent)

10.67%

^{[12],[13],[15],[28]}

10.67%

^{[12],[13],[15],[28]}

10.67%

^{[12],[13],[15],[28]}

12.14%

^{[16],[18],[19],[20]}

12.14%

^{[16],[18],[19],[20]}

12.14%

^{[16],[18],[19],[20]}

Investment, principal

$ 678

^{[12],[13],[21],[28]}

$ 377

^{[16],[18],[19],[22]}

Investment, cost

643

^{[12],[13],[28]}

334

^{[16],[18],[19]}

Investments at fair value

$ 607

^{[12],[13],[28]}

$ 296

^{[16],[18],[19]}

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[12],[28]

5.75%

^[12],[28]

5.75%

^[12],[28]

7.25%

^[18],[19]

7.25%

^[18],[19]

7.25%

^[18],[19]

Investment, interest rate (as a percent)

10.67%

^{[12],[15],[28]}

10.67%

^{[12],[15],[28]}

10.67%

^{[12],[15],[28]}

12.63%

^{[18],[19],[20]}

12.63%

^{[18],[19],[20]}

12.63%

^{[18],[19],[20]}

Investment, interest rate, paid in kind (as a percent)

^[18],[19]

Investment, principal

$ 25,491

^{[12],[21],[28]}

$ 24,427

^{[18],[19],[22]}

Investment, cost

25,261

^[12],[28]

24,135

^[18],[19]

Investments at fair value

$ 24,696

^[12],[28]

$ 23,548

^[18],[19]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^[12],[28]

6.25%

^[12],[28]

6.25%

^[12],[28]

7.25%

^[18],[19]

7.25%

^[18],[19]

7.25%

^[18],[19]

Investment, interest rate (as a percent)

11.17%

^{[12],[15],[28]}

11.17%

^{[12],[15],[28]}

11.17%

^{[12],[15],[28]}

12.63%

^{[18],[19],[20]}

12.63%

^{[18],[19],[20]}

12.63%

^{[18],[19],[20]}

Investment, principal

$ 3,636

^{[12],[21],[28]}

$ 3,636

^{[18],[19],[22]}

Investment, cost

3,609

^[12],[28]

3,602

^[18],[19]

Investments at fair value

$ 3,581

^[12],[28]

$ 3,574

^[18],[19]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^{[12],[13],[28]}

6.25%

^{[12],[13],[28]}

6.25%

^{[12],[13],[28]}

7.25%

^{[16],[18],[19]}

7.25%

^{[16],[18],[19]}

7.25%

^{[16],[18],[19]}

Investment, principal

$ 0

^{[12],[13],[21],[28]}

$ 0

^{[16],[18],[19],[22]}

Investment, cost

^{[12],[13],[28]}

^{[16],[18],[19]}

Investments at fair value

$ 0

^{[12],[13],[28]}

$ 0

^{[16],[18],[19]}

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[19]

8.75%

Investment, interest rate (as a percent)

^{[18],[19],[20]}

11.75%

Investment, principal

^{[18],[19],[22]}

$ 5,212

Investment, cost

^[18],[19]

4,987

Investments at fair value

^[18],[19]

$ 4,990

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19]}

8.75%

Investment, principal

^{[16],[18],[19],[22]}

$ 0

Investment, cost

^{[16],[18],[19]}

Investments at fair value

^{[16],[18],[19]}

$ 0

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[16],[18],[19]}

8.75%

Investment, principal

^{[16],[18],[19],[22]}

$ 0

Investment, cost

^{[16],[18],[19]}

Investments at fair value

^{[16],[18],[19]}

$ 0

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

53,700

^[12]

53,700

^[12]

53,700

^[12]

53,700

^[19]

53,700

^[19]

53,700

^[19]

Investment, cost

$ 175

^[12]

$ 175

^[19]

Investments at fair value

$ 121

^[12]

$ 258

^[19]

[1]	All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.
[2]	Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.
[3]	Equity ownership may be held in shares or units of companies related to the portfolio companies.
[4]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.
[5]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2024 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[6]	Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[7]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the Company's annual report on Form 10-K for the year ended September 30, 2023 for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[8]	Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[9]	Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
[10]	Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
[11]	Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.
[12]	As of September 30, 2024, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").
[13]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[14]	This investment represents a participation interest in the underlying securities shown.
[15]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[16]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[17]	This investment represents a participation interest in the underlying securities shown.
[18]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[19]	As of September 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by ASC 820.
[20]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[21]	Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[22]	Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[23]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2024, qualifying assets represented 74.4% of the Company's total assets and non-qualifying assets represented 25.6% of the Company's total assets.
[24]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[25]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 73.6% of the Company's total assets and non-qualifying assets represented 26.4% of the Company's total assets.
[26]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[27]	This investment was on non-accrual status as of September 30, 2024.
[28]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2024, the reference rates for the Company's variable rate loans were the 30-day SOFR at 4.85%, the 90-day SOFR at 4.59%, the 180-day SOFR at 4.25%, the PRIME at 8.00%, the SONIA at 5.50%, the 90-day EURIBOR at 3.54% and the 180-day EURIBOR at 3.11%. Most loans include an interest floor, which generally ranges from 0% to 3.00%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[29]	This investment was on non-accrual status as of September 30, 2023.
[30]	This investment represents Seller Earn Out Shares in Alvotech Holdings S.A. The Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech Holdings S.A. common share price is at or above a volume weighted average price ("VWAP") of $20.00 per share for any ten trading days within any twenty trading day period.
[31]	This investment represents Seller Earn Out Shares in Alvotech Holdings S.A. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech Holdings S.A. common share price is at or above a VWAP of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
[32]	This investment was renamed during the three months ended June 30, 2024. For the periods prior to June 30, 2024, this investment was referenced as SCP Eye Care Services, LLC.
[33]	Income producing through payment of dividends or distributions.
[34]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition of the Company's joint ventures.
[35]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[36]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[37]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[38]	This investment represents a credit default swap that functions, in substance, like a credit linked note and represents a credit risk transfer for a pool of reference assets owned by a bank. The Company fully funded margin up front and in return the Company receives periodic interest payments. The Company’s risk of loss is limited to the principal amount disclosed herein. The reference assets are primarily composed of investment grade corporate debt. The Company may be exposed to counterparty risk, which could make it difficult for the Company to collect on obligations, thereby resulting in potentially significant losses. In addition, the Company only has a contractual relationship with the counterparty bank, and not with the reference obligors of the reference assets. Accordingly, the Company generally may have no right to directly enforce compliance by the reference obligors with the terms of the reference assets. The Company will not directly benefit from the reference assets and will not have the benefit of the remedies that would normally be available to a holder of such reference assets. In addition, in the event of the insolvency of the counterparty bank, the Company may be treated as a general creditor of such counterparty bank, and will not have any claim with respect to the reference assets.
[39]	Income producing through payment of dividends or distributions.
[40]	This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Subsequent Events (Details) - Quarterly	Nov. 07, 2024 $ / shares
Subsequent Event [Line Items]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.55
Subsequent Event
Subsequent Event [Line Items]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.55

Taxable/Distributable Income and Dividend Distributions - Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Net increase (decrease) in net assets resulting from operations	$ 57,905	$ 117,331	$ 29,223
Net unrealized (appreciation) depreciation	(19,101)	28,555	136,248
Book/tax difference due to organizational costs	0	0	(87)
Book/tax difference due to capital losses suspended (utilized)	137,723	34,607	(16,490)
Other book/tax differences	(24,729)	(14,691)	(6,506)
Taxable/Distributable Income	$ 151,798	$ 165,802	$ 142,388

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Due from broker	$ 17,060	$ 54,260

Schedule 12-14

12 Months Ended

Sep. 30, 2024

Investments in and Advances to Affiliates [Abstract]

Schedule 12-14

Oaktree Specialty Lending Corporation Schedule 12-14

Schedule of Investments in and Advances to Affiliates

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Year ended September 30, 2024


Portfolio Company (1)	Industry	Investment Type	Index	Spread		Cash		PIK Rate		Maturity Date	Shares		Principal		Net Realized Gain (Loss)		Amount of Interest, Fees or Dividends Credited in Income (2)		Fair Value at October 1, 2023		Gross Additions (3)		Gross Reductions (4)		Fair Value at September 30, 2024		% of Total Net Assets
Control Investments
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock									829				$	—	$	—	$	—	$	—	$	—	$	—	—	%
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity									34,984,460				—		—		27,638		—		—		27,638		1.9	%
Continental Intermodal Group LP	Oil & Gas Storage & Transportation	Preferred Equity									3,137,476				—		—		—		3,357		—		3,357		0.2	%
Continental Intermodal Group LP	Oil & Gas Storage & Transportation	Common Stock									22,267,661				—		—		—		16,171		(3,924)		12,247		0.8	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00	%	9.74	%			8/28/2025			$	13,928	—		1,545		14,068		—		(2,708)		11,360		0.8	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00	%					8/28/2025			—		—		90		2,090		—		(3,118)		(1,028)		(0.1)	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Revolver	SOFR+	5.00	%	9.75	%			8/28/2025			5,574		—		595		5,574		—		(1,028)		4,546		0.3	%
Dominion Diagnostics, LLC	Health Care Services	Common Stock									30,031				—		—		2,711		—		(2,711)		—		—	%
First Star Speir Aviation Limited	Airlines	Equity Interest									100.00	%			786		—		—		—		—		—		—	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Subordinated Debt	SOFR+	4.50	%	9.95	%			10/20/2028			58,349		—		7,239		50,017		1,338		(2,459)		48,896		3.3	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Membership Interest									87.50	%			—		—		—		—		—		—		—	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Subordinated Debt	SOFR+	7.00	%	12.45	%			12/29/2028			112,656		—		14,256		112,656		—		—		112,656		7.6	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Membership Interest									87.50	%			—		5,250		28,878		—		(6,337)		22,541		1.5	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan						12.00	%	8/3/2028			3,332		—		166		—		3,332		—		3,332		0.2	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan						12.00	%	8/3/2028			17,907		—		2,232		15,874		2,239		(206)		17,907		1.2	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan						12.00	%	8/3/2028			3,550		—		383		1,359		2,191		—		3,550		0.2	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan						12.00	%	8/3/2028			1,600		—		18		—		1,600		—		1,600		0.1	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan						12.00	%	8/3/2028			—		—		1		—		—		—		—		—	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	Common Stock									1,184,630				—		—		36,226		—		(15,424)		20,802		1.4	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	Warrants									66,686				—		—		—		—		—		—		—	%
Total Control Investments													$	216,896	$	786	$	31,775	$	297,091	$	30,228	$	(37,915)	$	289,404	19.5	%

Affiliate Investments
All Web Leads, Inc.	Advertising	First Lien Term Loan	SOFR+	4.00	%	6.70	%	2.00	%	9/29/2026			1,819		—		103		—		1,741		—		1,741		0.1	%
All Web Leads, Inc.	Advertising	First Lien Term Loan	SOFR+	5.00	%	7.70	%	2.00	%	3/29/2027			3,637		—		224		—		3,463		—		3,463		0.2	%
All Web Leads, Inc.	Advertising	First Lien Term Loan						10.00	%	3/29/2028			3,541		—		—		—		3,183		—		3,183		0.2	%
All Web Leads, Inc.	Advertising	First Lien Revolver	SOFR+	4.00	%	8.70	%			3/30/2026			1,560		—		90		—		1,506		—		1,506		0.1	%
All Web Leads, Inc.	Advertising	Common Stock									11,499		—		—		—		—		1,622		—		1,622		0.1	%
Assembled Brands Capital LLC	Specialized Finance	First Lien Revolver													—		329		21,823		33		(21,856)		—		—	%
Assembled Brands Capital LLC	Specialized Finance	Common Stock									12,463,242				—		—		89		1,159		(2)		1,246		0.1	%
Assembled Brands Capital LLC	Specialized Finance	Preferred Equity													—		—		1,005		153		(1,158)		—		—	%
Assembled Brands Capital LLC	Specialized Finance	Warrants									78,045				—		—		—		—		—		—		—	%
The Avery	Real Estate Operating Companies	First Lien Term Loan						10.00	%	2/16/2028			5,065		—		—		—		4,657		(570)		4,087		0.3	%
The Avery	Real Estate Operating Companies	First Lien Term Loan						10.00	%	2/16/2028			20,917		—		—		—		19,262		(1,027)		18,235		1.2	%
The Avery	Real Estate Operating Companies	Membership Interest									6.40	%	—		—		—		—		—		—		—		—	%
Caregiver Services, Inc.	Health Care Services	Preferred Equity									1,080,398				—		—		432		367		(205)		594		—	%
Total Affiliate Investments													$	36,539	$	—	$	746	$	23,349	$	37,146	$	(24,818)	$	35,677	2.4	%
Total Control & Affiliate Investments													$	253,435	$	786	$	32,521	$	320,440	$	67,374	$	(62,733)	$	325,081	21.8	%

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.

______________________

(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments.

(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.

(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.

(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.

(5)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).

(6)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).

Schedule 12-14

Oaktree Specialty Lending Corporation

Schedule of Investments in and Advances to Affiliates

(in thousands, except share and per share amounts, percentages and as otherwise indicated)

Year ended September 30, 2023


Portfolio Company	Industry	Investment Type	Index	Spread		Cash		PIK Rate		Maturity Date	Shares		Principal		Net Realized Gain (Loss)		Amount of Interest, Fees or Dividends Credited in Income (2)		Fair Value at October 1, 2022		Gross Additions (3)		Gross Reductions (4)		Fair Value at September 30, 2023		% of Total Net Assets
Control Investments
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Common Stock									829				$	—	$	—	$	—	$	—	$	—	$	—	—	%
C5 Technology Holdings, LLC	Data Processing & Outsourced Services	Preferred Equity									34,984,460				—		—		27,638		—		—		27,638		1.8	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00	%	10.54	%			8/28/2025			14,068		—		1,459		14,333		—		(265)		14,068		0.9	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Term Loan	SOFR+	5.00	%	10.42	%			8/28/2025			2,090		—		10		—		2,090		—		2,090		0.1	%
Dominion Diagnostics, LLC	Health Care Services	First Lien Revolver	SOFR+	5.00	%	10.54	%			8/28/2025			5,574		—		266		—		5,574		—		5,574		0.4	%
Dominion Diagnostics, LLC	Health Care Services	Common Stock									30,031				—		—		4,946		—		(2,235)		2,711		0.2	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Subordinated Debt	SOFR+	4.50	%	9.76	%			10/20/2028			58,349		—		6,748		50,283		1,448		(1,714)		50,017		3.3	%
OCSI Glick JV LLC (5)	Multi-Sector Holdings	Membership Interest									87.50	%			—		—		—		—		—		—		—	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Subordinated Debt	SOFR+	7.00	%	12.26	%			12/29/2028			112,656		—		12,726		96,250		16,406		—		112,656		7.4	%
Senior Loan Fund JV I, LLC (6)	Multi-Sector Holdings	Membership Interest									87.50	%			—		4,200		20,715		8,163		—		28,878		1.9	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan						12.00	%	8/3/2028			15,874		—		340		—		16,653		(779)		15,874		1.0	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	First Lien Term Loan						12.00	%	8/3/2028			1,359		—		14		—		1,359		—		1,359		0.1	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	Common Stock									1,184,630				—		—		—		40,093		(3,867)		36,226		2.4	%
SIO2 Medical Products, Inc.	Metal, Glass & Plastic Containers	Warrants									66,686				—		—		—		—		—		—		—	%
Total Control Investments													$	209,970	$	—	$	25,763	$	214,165	$	91,786	$	(8,860)	$	297,091	19.6	%

Affiliate Investments
Assembled Brands Capital LLC	Specialized Finance	First Lien Revolver	SOFR+	6.75	%	12.14	%			1/25/2026			21,852		—		2,640		24,225		2,467		(4,869)		21,823		1.4	%
Assembled Brands Capital LLC	Specialized Finance	Common Stock									1,783,332				—		—		370		40		(321)		89		—	%
Assembled Brands Capital LLC	Specialized Finance	Preferred Equity									1,129,453				—		—		1,223		139		(357)		1,005		0.1	%
Assembled Brands Capital LLC	Specialized Finance	Warrants									78,045				—		—		—		—		—		—		—	%
Caregiver Services, Inc.	Health Care Services	Preferred Equity									1,080,399				—		—		378		54		—		432		—	%
Total Affiliate Investments													$	21,852	$	—	$	2,640	$	26,196	$	2,700	$	(5,547)	$	23,349	1.5	%
Total Control & Affiliate Investments													$	231,822	$	—	$	28,403	$	240,361	$	94,486	$	(14,407)	$	320,440	21.1	%

______________________

(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments.

Schedule 12-14 - Schedule of Investments in and Advances to Affiliates (Details)
€ in Thousands, £ in Thousands, $ in Thousands

12 Months Ended

Sep. 30, 2024

USD ($)

Sep. 30, 2023

USD ($)

Sep. 30, 2024

EUR (€)

Sep. 30, 2024

GBP (£)

Sep. 30, 2023

EUR (€)

Sep. 30, 2023

GBP (£)

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

$ 2,892,420

Fair value, ending balance

$ 3,021,279

$ 2,892,420

Investment owned, percent of net assets (as a percent)

203.07%

190.82%

203.07%

190.82%

Affiliate investments

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

$ 23,349

Fair value, ending balance

35,677

$ 23,349

Control investments

Schedule of Investments [Line Items]

Investment owned, balance, principal amount

216,896

209,970

Net Realized Gain (Loss)

786

Amount of Interest, Fees or Dividends Credited in Income

31,775

25,763

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

297,091

^[1],[2]

214,165

Gross Additions

30,228

91,786

Gross Reductions

(37,915)

(8,860)

Fair value, ending balance

$ 289,404

^[3],[4]

$ 297,091

^[1],[2]

Investment owned, percent of net assets (as a percent)

19.50%

19.60%

19.50%

19.60%

Affiliate Investments

Schedule of Investments [Line Items]

Investment owned, balance, principal amount

$ 36,539

$ 21,852

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

746

2,640

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

23,349

^[5]

26,196

Gross Additions

37,146

2,700

Gross Reductions

(24,818)

(5,547)

Fair value, ending balance

$ 35,677

^[6]

$ 23,349

^[5]

Investment owned, percent of net assets (as a percent)

2.40%

1.50%

2.40%

1.50%

Investment, Affiliated Issuer, Control and Affiliate

Schedule of Investments [Line Items]

Investment owned, balance, principal amount

$ 253,435

$ 231,822

Net Realized Gain (Loss)

786

Amount of Interest, Fees or Dividends Credited in Income

32,521

28,403

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

320,440

240,361

Gross Additions

67,374

94,486

Gross Reductions

(62,733)

(14,407)

Fair value, ending balance

$ 325,081

$ 320,440

Investment owned, percent of net assets (as a percent)

21.80%

21.10%

21.80%

21.10%

Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

13.00%

^{[7],[8],[9],[10]}

12.50%

^{[11],[12],[13],[14],[15]}

13.00%

^{[7],[8],[9],[10]}

13.00%

^{[7],[8],[9],[10]}

12.50%

^{[11],[12],[13],[14],[15]}

12.50%

^{[11],[12],[13],[14],[15]}

Investment owned, balance, principal amount

$ 1,989

^{[7],[8],[9],[16]}

$ 1,269

^{[11],[12],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[12],[14]}

1,214

Fair value, ending balance

$ 1,934

^[7],[8],[9]

$ 1,214

^{[11],[12],[14]}

Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

11.00%

^[7],[8],[10]

11.00%

^{[11],[13],[14],[15]}

11.00%

^[7],[8],[10]

11.00%

^[7],[8],[10]

11.00%

^{[11],[13],[14],[15]}

11.00%

^{[11],[13],[14],[15]}

Investment owned, balance, principal amount

$ 31,231

^[7],[8],[16]

$ 18,869

^{[11],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[11],[14]

18,443

Fair value, ending balance

$ 31,015

^[7],[8]

$ 18,443

^[11],[14]

Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

13.00%

^{[7],[8],[9],[10]}

12.00%

^{[11],[12],[13],[14],[15]}

13.00%

^{[7],[8],[9],[10]}

13.00%

^{[7],[8],[9],[10]}

12.00%

^{[11],[12],[13],[14],[15]}

12.00%

^{[11],[12],[13],[14],[15]}

Investment owned, balance, principal amount

$ 5,336

^{[7],[8],[9],[16]}

$ 4,070

^{[11],[12],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[12],[14]}

4,022

Fair value, ending balance

$ 5,288

^[7],[8],[9]

$ 4,022

^{[11],[12],[14]}

Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

14.25%

^{[7],[10],[18],[19]}

14.25%

^{[13],[14],[15],[20],[21]}

14.25%

^{[7],[10],[18],[19]}

14.25%

^{[7],[10],[18],[19]}

14.25%

^{[13],[14],[15],[20],[21]}

14.25%

^{[13],[14],[15],[20],[21]}

Investment owned, balance, principal amount

$ 21,870

^{[7],[16],[18],[19]}

$ 21,434

^{[14],[17],[20],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[14],[20],[21]}

21,220

Fair value, ending balance

$ 21,979

^{[7],[18],[19]}

$ 21,220

^{[14],[20],[21]}

Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

22.50%

^{[7],[18],[22]}

20.00%

^[14],[20]

22.50%

^{[7],[18],[22]}

22.50%

^{[7],[18],[22]}

20.00%

^[14],[20]

20.00%

^[14],[20]

Investment owned, balance, principal amount

$ 7,835

^{[7],[16],[18],[22]}

$ 6,021

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

5,900

Fair value, ending balance

$ 7,796

^{[7],[18],[22]}

$ 5,900

^[14],[20]

Investment, Identifier [Axis]: ACESO Holding 4 S.A.R.L., Health Care Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[18],[23]}

5.75%

Investment owned, balance, principal amount

^{[7],[8],[16],[18],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[8],[18],[23]}

$ (47)

Investment, Identifier [Axis]: ACESO Holding 4 S.A.R.L., Health Care Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

5.75%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

8.91%

Investment owned, balance, principal amount | €

^{[7],[16],[18],[23]}

€ 16,817

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[23]}

$ 18,393

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[7],[23]

6.50%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[13],[14]

Investment, interest rate (as a percent)

11.37%

^{[7],[10],[23]}

11.90%

^{[13],[14],[15]}

11.37%

^{[7],[10],[23]}

11.37%

^{[7],[10],[23]}

11.90%

^{[13],[14],[15]}

11.90%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 3,079

^{[7],[16],[23]}

$ 3,446

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

3,383

Fair value, ending balance

$ 2,955

^[7],[23]

$ 3,383

^[13],[14]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[7],[23]

6.50%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[13],[14]

Investment, interest rate (as a percent)

12.01%

^{[7],[10],[23]}

12.15%

^{[13],[14],[15]}

12.01%

^{[7],[10],[23]}

12.01%

^{[7],[10],[23]}

12.15%

^{[13],[14],[15]}

12.15%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 875

^{[7],[16],[23]}

$ 17,901

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

17,575

Fair value, ending balance

$ 840

^[7],[23]

$ 17,575

^[13],[14]

Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[7],[23]

6.50%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[13],[14]

Investment, interest rate (as a percent)

11.37%

^{[7],[10],[23]}

12.13%

^{[13],[14],[15]}

11.37%

^{[7],[10],[23]}

11.37%

^{[7],[10],[23]}

12.13%

^{[13],[14],[15]}

12.13%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 16,053

^{[7],[16],[23]}

$ 963

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

945

Fair value, ending balance

$ 15,410

^[7],[23]

$ 945

^[13],[14]

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[18]

1,674,030

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[18]

$ 0

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

7.50%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

12.25%

Investment owned, balance, principal amount

^{[7],[16],[18],[23]}

$ 6,589

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[23]}

6,424

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

7.50%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

13.04%

Investment owned, balance, principal amount

^{[13],[14],[17],[20]}

$ 6,589

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

6,276

Fair value, ending balance

^{[13],[14],[20]}

$ 6,276

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14],[20]}

7.50%

Investment owned, balance, principal amount

^{[11],[13],[14],[17],[20]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14],[20]}

$ (38)

Fair value, ending balance

^{[11],[13],[14],[20]}

$ (38)

Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

28,948

^[7],[18]

28,948

^[14],[20]

28,948

^[7],[18]

28,948

^[7],[18]

28,948

^[14],[20]

28,948

^[14],[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 6

Fair value, ending balance

^[7],[18]

$ 6

^[14],[20]

Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[20]

5.00%

Investment, interest rate (as a percent)

^{[13],[15],[20]}

8.86%

Investment owned, balance, principal amount | €

^{[13],[17],[20]}

€ 5,500

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[20]

$ 5,825

Fair value, ending balance

^[13],[20]

$ 5,825

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

17,870

^[7]

17,870

^[14]

17,870

^[7]

17,870

^[7]

17,870

^[14]

17,870

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 2,826

Fair value, ending balance

2,220

^[7]

$ 2,826

^[14]

Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.75%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

13.17%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 17,873

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 17,687

Fair value, ending balance

^[13],[14]

$ 17,687

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[7],[8],[18],[23]}

6.00%

^{[11],[13],[14],[20]}

6.00%

^{[7],[8],[18],[23]}

6.00%

^{[7],[8],[18],[23]}

6.00%

^{[11],[13],[14],[20]}

6.00%

^{[11],[13],[14],[20]}

Investment, interest rate (as a percent)

^{[7],[8],[10],[18],[23]}

11.29%

Investment owned, balance, principal amount

$ 230

^{[7],[8],[16],[18],[23]}

$ 0

^{[11],[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14],[20]}

(23)

Fair value, ending balance

$ 211

^{[7],[8],[18],[23]}

$ (23)

^{[11],[13],[14],[20]}

Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^{[7],[18],[23]}

6.00%

^{[13],[14],[20]}

6.00%

^{[7],[18],[23]}

6.00%

^{[7],[18],[23]}

6.00%

^{[13],[14],[20]}

6.00%

^{[13],[14],[20]}

Investment, interest rate (as a percent)

10.66%

^{[7],[10],[18],[23]}

11.63%

^{[13],[14],[15],[20]}

10.66%

^{[7],[10],[18],[23]}

10.66%

^{[7],[10],[18],[23]}

11.63%

^{[13],[14],[15],[20]}

11.63%

^{[13],[14],[15],[20]}

Investment owned, balance, principal amount

$ 3,243

^{[7],[16],[18],[23]}

$ 3,276

^{[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

3,084

Fair value, ending balance

$ 3,087

^{[7],[18],[23]}

3,084

^{[13],[14],[20]}

Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^{[7],[18],[19]}

15.89%

Investment owned, balance, principal amount

$ 12,989

^{[7],[16],[18],[19]}

12,222

^{[14],[17],[20],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[14],[20],[21]}

11,795

Fair value, ending balance

$ 12,892

^{[7],[18],[19]}

$ 11,795

^{[14],[20],[21]}

Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23]

5.00%

Investment, interest rate (as a percent)

^[10],[23]

10.25%

Investment owned, balance, principal amount

^[16],[23]

$ 1,985

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[23]

$ 1,996

Investment, Identifier [Axis]: Accession Risk Management Group, Inc., Insurance Brokers, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

4.75%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (5)

Investment, Identifier [Axis]: Accession Risk Management Group, Inc., Insurance Brokers, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

4.75%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (45)

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[8],[23]

6.00%

^{[11],[13],[14]}

6.00%

^[7],[8],[23]

6.00%

^[7],[8],[23]

6.00%

^{[11],[13],[14]}

6.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

10.90%

^{[7],[8],[10],[23]}

11.55%

^{[11],[13],[14],[15]}

10.90%

^{[7],[8],[10],[23]}

10.90%

^{[7],[8],[10],[23]}

11.55%

^{[11],[13],[14],[15]}

11.55%

^{[11],[13],[14],[15]}

Investment owned, balance, principal amount

$ 2,482

^{[7],[8],[16],[23]}

$ 2,033

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

2,027

Fair value, ending balance

$ 2,443

^[7],[8],[23]

$ 2,027

^{[11],[13],[14]}

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[8],[23]

6.00%

^[13],[14]

6.00%

^[7],[8],[23]

6.00%

^[7],[8],[23]

6.00%

^[13],[14]

6.00%

^[13],[14]

Investment, interest rate (as a percent)

^{[13],[14],[15]}

11.55%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 20,234

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

20,194

Fair value, ending balance

$ (59)

^[7],[8],[23]

$ 20,194

^[13],[14]

Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[23]

6.00%

^{[11],[13],[14]}

6.00%

^[7],[23]

6.00%

^[7],[23]

6.00%

^{[11],[13],[14]}

6.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.90%

Investment owned, balance, principal amount

$ 20,024

^{[7],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(8)

Fair value, ending balance

$ 19,724

^[7],[23]

$ (8)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[7],[8],[23]

7.00%

^{[11],[13],[14]}

7.00%

^[7],[8],[23]

7.00%

^[7],[8],[23]

7.00%

^{[11],[13],[14]}

7.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

12.47%

^{[7],[8],[10],[23]}

12.72%

^{[11],[13],[14],[15]}

12.47%

^{[7],[8],[10],[23]}

12.47%

^{[7],[8],[10],[23]}

12.72%

^{[11],[13],[14],[15]}

12.72%

^{[11],[13],[14],[15]}

Investment owned, balance, principal amount

$ 1,084

^{[7],[8],[16],[23]}

$ 1,333

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

1,324

Fair value, ending balance

$ 1,084

^[7],[8],[23]

$ 1,324

^{[11],[13],[14]}

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[7],[23]

7.00%

^[13],[14]

7.00%

^[7],[23]

7.00%

^[7],[23]

7.00%

^[13],[14]

7.00%

^[13],[14]

Investment, interest rate (as a percent)

12.46%

^{[7],[10],[23]}

12.34%

^{[13],[14],[15]}

12.46%

^{[7],[10],[23]}

12.46%

^{[7],[10],[23]}

12.34%

^{[13],[14],[15]}

12.34%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 6,400

^{[7],[16],[23]}

$ 6,400

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

6,380

Fair value, ending balance

$ 6,400

^[7],[23]

$ 6,380

^[13],[14]

Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[7],[23]

7.00%

^[13],[14]

7.00%

^[7],[23]

7.00%

^[7],[23]

7.00%

^[13],[14]

7.00%

^[13],[14]

Investment, interest rate (as a percent)

12.46%

^{[7],[10],[23]}

12.34%

^{[13],[14],[15]}

12.46%

^{[7],[10],[23]}

12.46%

^{[7],[10],[23]}

12.34%

^{[13],[14],[15]}

12.34%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 25,332

^{[7],[16],[23]}

$ 25,332

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

25,253

Fair value, ending balance

$ 25,332

^[7],[23]

$ 25,253

^[13],[14]

Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

5,715

^[7]

5,715

^[14]

5,715

^[7]

5,715

^[7]

5,715

^[14]

5,715

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 0

Fair value, ending balance

$ 0

^[7]

$ 0

^[14]

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7]

11,499

Investment owned, balance, principal amount

$ 0

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

1,622

Gross Reductions

Fair value, ending balance

$ 1,622

^[7]

Investment owned, percent of net assets (as a percent)

0.10%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

4.00%

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

8.70%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 1,560

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

1,506

Gross Reductions

Fair value, ending balance

$ 1,506

^[7],[8],[23]

$ 0

Investment owned, percent of net assets (as a percent)

0.10%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[24]}

8.50%

Investment owned, balance, principal amount

^{[13],[14],[17],[24]}

$ 23,562

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[24]}

$ 9,797

Fair value, ending balance

^{[13],[14],[24]}

9,797

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

4.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

6.70%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

2.00%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 1,819

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

103

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

1,741

Gross Reductions

Fair value, ending balance

$ 1,741

^[7],[23]

Investment owned, percent of net assets (as a percent)

0.10%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

7.70%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

2.00%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 3,637

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

224

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

3,463

Gross Reductions

Fair value, ending balance

$ 3,463

^[7],[23]

Investment owned, percent of net assets (as a percent)

0.20%

Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7],[22]

10.00%

Investment owned, balance, principal amount

^{[7],[16],[22]}

$ 3,541

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

3,183

Gross Reductions

Fair value, ending balance

$ 3,183

^[7],[22]

$ 0

Investment owned, percent of net assets (as a percent)

0.20%

Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[15],[20]}

5.50%

Investment owned, balance, principal amount

^[17],[20]

$ 4,050

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

$ 2,918

Fair value, ending balance

^[20]

$ 2,918

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

11.50%

^[7],[23]

11.50%

^[13],[14]

11.50%

^[7],[23]

11.50%

^[7],[23]

11.50%

^[13],[14]

11.50%

^[13],[14]

Investment, interest rate (as a percent)

8.00%

^{[7],[10],[23]}

5.00%

^{[13],[14],[15]}

8.00%

^{[7],[10],[23]}

8.00%

^{[7],[10],[23]}

5.00%

^{[13],[14],[15]}

5.00%

^{[13],[14],[15]}

Investment, interest rate, paid in kind (as a percent)

8.93%

^[7],[23]

11.99%

^[13],[14]

8.93%

^[7],[23]

8.93%

^[7],[23]

11.99%

^[13],[14]

11.99%

^[13],[14]

Investment owned, balance, principal amount

$ 10,134

^{[7],[16],[23]}

$ 9,057

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

8,332

Fair value, ending balance

$ 9,120

^[7],[23]

$ 8,332

^[13],[14]

Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

598,283

^[7]

598,283

^[14]

598,283

^[7]

598,283

^[7]

598,283

^[14]

598,283

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 1,915

Fair value, ending balance

$ 802

^[7]

$ 1,915

^[14]

Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[7],[23]

7.50%

^[13],[14]

7.50%

^[7],[23]

7.50%

^[7],[23]

7.50%

^[13],[14]

7.50%

^[13],[14]

Investment, interest rate (as a percent)

12.45%

^{[7],[10],[23]}

13.04%

^{[13],[14],[15]}

12.45%

^{[7],[10],[23]}

12.45%

^{[7],[10],[23]}

13.04%

^{[13],[14],[15]}

13.04%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 16,143

^{[7],[16],[23]}

$ 17,053

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

15,929

Fair value, ending balance

$ 14,852

^[7],[23]

$ 15,929

^[13],[14]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

118,744

^[18]

471,253

^[20]

118,744

^[18]

118,744

^[18]

471,253

^[20]

471,253

^[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

$ 4,298

Fair value, ending balance

$ 1,413

^[18]

$ 4,298

^[20]

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

70,820

^{[7],[18],[25]}

141,640

^{[14],[20],[26]}

70,820

^{[7],[18],[25]}

70,820

^{[7],[18],[25]}

141,640

^{[14],[20],[26]}

141,640

^{[14],[20],[26]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[14],[20],[26]}

$ 368

Fair value, ending balance

315

^{[7],[18],[25]}

$ 368

^{[14],[20],[26]}

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[14],[20]

3.50%

Investment owned, balance, principal amount

^{[14],[17],[20]}

$ 28,464

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

27,687

Fair value, ending balance

^[14],[20]

$ 27,687

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[14],[20]

3.50%

Investment owned, balance, principal amount

^{[14],[17],[20]}

$ 2,121

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

2,063

Fair value, ending balance

^[14],[20]

$ 2,063

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 3

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[14],[20]

3.50%

Investment owned, balance, principal amount

^{[14],[17],[20]}

$ 27,692

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

26,936

Fair value, ending balance

^[14],[20]

$ 26,936

Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 4

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

8.50%

Investment, interest rate, paid in kind (as a percent)

^[14],[20]

3.50%

Investment owned, balance, principal amount

^{[14],[17],[20]}

$ 2,064

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

2,007

Fair value, ending balance

^[14],[20]

$ 2,007

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

8.75%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

14.14%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 17,048

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 15,087

Fair value, ending balance

^[13],[14]

$ 15,087

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23]

5.00%

Investment, interest rate (as a percent)

^[10],[23]

9.75%

Investment owned, balance, principal amount

^[16],[23]

$ 2,487

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[23]

$ 2,501

Investment, Identifier [Axis]: American Auto Auction Group, LLC, Diversified Support Services, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

8.75%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

13.50%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 17,048

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

16,494

Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

6.25%

Investment, interest rate (as a percent)

^[13],[15]

11.81%

Investment owned, balance, principal amount

^[13],[17]

$ 19,115

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

16,798

Fair value, ending balance

^[13]

$ 16,798

Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

8.00%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

13.54%

Investment owned, balance, principal amount

^{[13],[14],[17],[20]}

$ 12,500

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

$ 11,865

Fair value, ending balance

^{[13],[14],[20]}

$ 11,865

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.50%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 0

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.10%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 33,390

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 33,390

Investment, Identifier [Axis]: Amspec Parent LLC, Diversified Support Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.50%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

3.75%

Investment, interest rate (as a percent)

^[13],[15]

9.40%

Investment owned, balance, principal amount

^[13],[17]

$ 3,700

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

$ 2,669

Fair value, ending balance

^[13]

$ 2,669

Investment, Identifier [Axis]: Anchorage Capital CLO 20, LTD., Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[23]

7.61%

Investment, interest rate (as a percent)

^{[10],[18],[23]}

12.89%

Investment owned, balance, principal amount

^{[16],[18],[23]}

$ 750

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[18],[23]

$ 736

Investment, Identifier [Axis]: Arches Buyer Inc., Interactive Media & Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.35%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 47,451

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

47,428

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

7.00%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

10.95%

Investment owned, balance, principal amount | €

^{[13],[14],[17],[20]}

€ 3,017

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

3,226

Fair value, ending balance

^{[13],[14],[20]}

$ 3,226

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

5.75%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

11.57%

Investment owned, balance, principal amount

^{[13],[14],[17],[20]}

$ 10,519

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

10,624

Fair value, ending balance

^{[13],[14],[20]}

$ 10,624

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

7.00%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

12.46%

Investment owned, balance, principal amount | £

^{[13],[14],[17],[20]}

£ 4,949

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

6,101

Fair value, ending balance

^{[13],[14],[20]}

$ 6,101

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

7.00%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

12.46%

Investment owned, balance, principal amount | £

^{[13],[14],[17],[20]}

£ 23,675

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

29,185

Fair value, ending balance

^{[13],[14],[20]}

$ 29,185

Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

5.75%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

9.70%

Investment owned, balance, principal amount | £

^{[13],[14],[17],[20]}

£ 3,649

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

$ 3,914

Fair value, ending balance

^{[13],[14],[20]}

$ 3,914

Investment, Identifier [Axis]: Ares XLIV CLO, Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[23]

7.13%

Investment, interest rate (as a percent)

^{[10],[18],[23]}

12.43%

Investment owned, balance, principal amount

^{[16],[18],[23]}

$ 3,500

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[18],[23]

3,509

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Advertising, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.75%

Investment, interest rate (as a percent)

12.14%

Investment owned, balance, principal amount

$ 21,852

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

2,640

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

$ 21,823

24,225

Gross Additions

2,467

Gross Reductions

(4,869)

Fair value, ending balance

$ 21,823

Investment owned, percent of net assets (as a percent)

1.40%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

12,463,242

^[7]

1,783,332

^[14]

12,463,242

^[7]

12,463,242

^[7]

1,783,332

^[14]

1,783,332

^[14]

Investment owned, balance, principal amount

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

370

Gross Additions

1,159

Gross Reductions

(2)

(321)

Fair value, ending balance

$ 1,246

^[7]

$ 89

^[14]

Investment owned, percent of net assets (as a percent)

0.10%

0.00%

0.10%

0.00%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14]}

6.75%

Investment, interest rate (as a percent)

^{[11],[13],[14],[15]}

12.14%

Investment owned, balance, principal amount

^{[11],[13],[14],[17]}

$ 21,852

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

329

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

21,823

Gross Additions

Gross Reductions

(21,856)

Fair value, ending balance

$ 0

$ 21,823

^{[11],[13],[14]}

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14]

1,129,453

Investment owned, balance, principal amount

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

1,005

^[14]

1,223

Gross Additions

153

139

Gross Reductions

(1,158)

(357)

Fair value, ending balance

$ 0

$ 1,005

^[14]

Investment owned, percent of net assets (as a percent)

0.00%

0.10%

0.00%

0.10%

Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

78,045

^[7]

78,045

^[14]

78,045

^[7]

78,045

^[7]

78,045

^[14]

78,045

^[14]

Investment owned, balance, principal amount

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

Gross Additions

Gross Reductions

Fair value, ending balance

$ 0

^[7]

$ 0

^[14]

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

5.25%

Investment, interest rate (as a percent)

^[13],[15]

10.90%

Investment owned, balance, principal amount

^[13],[17]

$ 8,490

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

$ 6,414

Fair value, ending balance

^[13]

$ 6,414

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23]

6.75%

Investment, interest rate (as a percent)

^[10],[23]

11.35%

Investment owned, balance, principal amount

^[16],[23]

$ 7,907

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[23]

$ 6,555

Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[22],[23]}

5.25%

Investment owned, balance, principal amount

^{[7],[16],[22],[23]}

$ 12,537

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[22],[23]}

$ 3,605

Investment, Identifier [Axis]: Aurelia Netherlands Midco 2 B.V., Interactive Media & Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

5.75%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

9.55%

Investment owned, balance, principal amount | €

^{[7],[16],[18],[23]}

€ 28,022

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[23]}

$ 30,698

Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^{[7],[18],[23]}

6.00%

^{[13],[14],[20]}

7.00%

^{[7],[18],[23]}

7.00%

^{[7],[18],[23]}

6.00%

^{[13],[14],[20]}

6.00%

^{[13],[14],[20]}

Investment, interest rate (as a percent)

7.70%

^{[7],[10],[18],[23]}

11.49%

^{[13],[14],[15],[20]}

7.70%

^{[7],[10],[18],[23]}

7.70%

^{[7],[10],[18],[23]}

11.49%

^{[13],[14],[15],[20]}

11.49%

^{[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

^{[7],[18],[23]}

4.00%

Investment owned, balance, principal amount

$ 30,724

^{[7],[16],[18],[23]}

$ 29,509

^{[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

28,284

Fair value, ending balance

$ 29,802

^{[7],[18],[23]}

$ 28,284

^{[13],[14],[20]}

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^[7],[8],[23]

7.25%

^{[11],[13],[14]}

6.25%

^[7],[8],[23]

6.25%

^[7],[8],[23]

7.25%

^{[11],[13],[14]}

7.25%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(78)

Fair value, ending balance

$ 0

^[7],[8],[23]

$ (78)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^[7],[23]

7.25%

^[13],[14]

6.25%

^[7],[23]

6.25%

^[7],[23]

7.25%

^[13],[14]

7.25%

^[13],[14]

Investment, interest rate (as a percent)

10.85%

^{[7],[10],[23]}

12.64%

^{[13],[14],[15]}

10.85%

^{[7],[10],[23]}

10.85%

^{[7],[10],[23]}

12.64%

^{[13],[14],[15]}

12.64%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 50,470

^{[7],[16],[23]}

$ 50,470

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

49,688

Fair value, ending balance

$ 50,470

^[7],[23]

$ 49,688

^[13],[14]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[7],[23]

5.00%

^[13],[14]

5.00%

^[7],[23]

5.00%

^[7],[23]

5.00%

^[13],[14]

5.00%

^[13],[14]

Investment, interest rate (as a percent)

9.87%

^{[7],[10],[23]}

10.65%

^{[13],[14],[15]}

9.87%

^{[7],[10],[23]}

9.87%

^{[7],[10],[23]}

10.65%

^{[13],[14],[15]}

10.65%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 3,214

^{[7],[16],[23]}

$ 3,247

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

3,169

Fair value, ending balance

$ 3,025

^[7],[23]

$ 3,169

^[13],[14]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[7],[23]

5.00%

^[13],[14]

5.00%

^[7],[23]

5.00%

^[7],[23]

5.00%

^[13],[14]

5.00%

^[13],[14]

Investment, interest rate (as a percent)

9.87%

^{[7],[10],[23]}

10.65%

^{[13],[14],[15]}

9.87%

^{[7],[10],[23]}

9.87%

^{[7],[10],[23]}

10.65%

^{[13],[14],[15]}

10.65%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 1,248

^{[7],[16],[23]}

$ 1,261

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

1,231

Fair value, ending balance

$ 1,175

^[7],[23]

$ 1,231

^[13],[14]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[7],[23]

8.50%

^[13],[14]

8.50%

^[7],[23]

8.50%

^[7],[23]

8.50%

^[13],[14]

8.50%

^[13],[14]

Investment, interest rate (as a percent)

13.35%

^{[7],[10],[23]}

14.15%

^{[13],[14],[15]}

13.35%

^{[7],[10],[23]}

13.35%

^{[7],[10],[23]}

14.15%

^{[13],[14],[15]}

14.15%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 6,452

^{[7],[16],[23]}

$ 8,920

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

8,492

Fair value, ending balance

$ 5,550

^[7],[23]

$ 8,492

^[13],[14]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[7],[23]

8.50%

^[13],[14]

8.50%

^[7],[23]

8.50%

^[7],[23]

8.50%

^[13],[14]

8.50%

^[13],[14]

Investment, interest rate (as a percent)

13.37%

^{[7],[10],[23]}

14.15%

^{[13],[14],[15]}

13.37%

^{[7],[10],[23]}

13.37%

^{[7],[10],[23]}

14.15%

^{[13],[14],[15]}

14.15%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 8,920

^{[7],[16],[23]}

$ 2,091

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

1,991

Fair value, ending balance

7,673

^[7],[23]

$ 1,991

^[13],[14]

Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

8.50%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

14.15%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 4,361

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 4,152

Fair value, ending balance

^[13],[14]

$ 4,152

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[7],[8],[23]

4.50%

^{[11],[13],[14]}

5.50%

^[7],[8],[23]

5.50%

^[7],[8],[23]

4.50%

^{[11],[13],[14]}

4.50%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

10.52%

^{[7],[8],[10],[23]}

13.00%

^{[11],[13],[14],[15]}

10.52%

^{[7],[8],[10],[23]}

10.52%

^{[7],[8],[10],[23]}

13.00%

^{[11],[13],[14],[15]}

13.00%

^{[11],[13],[14],[15]}

Investment owned, balance, principal amount

$ 2,835

^{[7],[8],[16],[23]}

$ 2,221

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

2,178

Fair value, ending balance

$ 2,811

^[7],[8],[23]

$ 2,178

^{[11],[13],[14]}

Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[7],[23]

5.50%

^[13],[14]

5.50%

^[7],[23]

5.50%

^[7],[23]

5.50%

^[13],[14]

5.50%

^[13],[14]

Investment, interest rate (as a percent)

10.90%

^{[7],[10],[23]}

11.02%

^{[13],[14],[15]}

10.90%

^{[7],[10],[23]}

10.90%

^{[7],[10],[23]}

11.02%

^{[13],[14],[15]}

11.02%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 40,246

^{[7],[16],[23]}

$ 40,660

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

40,213

Fair value, ending balance

$ 39,863

^[7],[23]

$ 40,213

^[13],[14]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[18],[23]}

7.50%

Investment, interest rate (as a percent)

^{[7],[8],[10],[18],[23]}

8.00%

^{[13],[14],[15],[20]}

^{[7],[8],[10],[18],[23]}

8.00%

^{[13],[14],[15],[20]}

8.00%

^{[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

^[14],[20]

2.25%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[18],[23]}

$ 6,757

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

6,225

Fair value, ending balance

$ 0

^{[7],[8],[18],[23]}

6,225

^[14],[20]

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

7.50%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

8.00%

Investment, interest rate, paid in kind (as a percent)

^{[7],[18],[23]}

4.10%

Investment owned, balance, principal amount

$ 2,930

^{[7],[16],[18],[23]}

3,316

^{[11],[14],[17],[20],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[14],[20],[21]}

3,169

Fair value, ending balance

$ 2,600

^{[7],[18],[23]}

$ 3,169

^{[11],[14],[20],[21]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

7.50%

Investment, interest rate (as a percent)

8.00%

^{[7],[10],[18],[23]}

8.00%

^{[11],[13],[14],[15],[20]}

8.00%

^{[7],[10],[18],[23]}

8.00%

^{[7],[10],[18],[23]}

8.00%

^{[11],[13],[14],[15],[20]}

8.00%

^{[11],[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

4.10%

^{[7],[18],[23]}

2.25%

^{[11],[14],[20]}

4.10%

^{[7],[18],[23]}

4.10%

^{[7],[18],[23]}

2.25%

^{[11],[14],[20]}

2.25%

^{[11],[14],[20]}

Investment owned, balance, principal amount

$ 7,062

^{[7],[16],[18],[23]}

$ 0

^{[11],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[14],[20]}

Fair value, ending balance

$ 6,268

^{[7],[18],[23]}

$ 0

^{[11],[14],[20]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[18],[23]}

7.50%

Investment, interest rate (as a percent)

^{[11],[13],[14],[15],[20]}

8.00%

Investment, interest rate, paid in kind (as a percent)

^{[11],[14],[20]}

2.25%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[18],[23]}

$ 0

^{[11],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[14],[20]}

Fair value, ending balance

$ 0

^{[7],[8],[18],[23]}

^{[11],[14],[20]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[18],[23]}

7.50%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[18],[23]}

^{[11],[14],[17],[20],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[14],[20],[21]}

Fair value, ending balance

^{[7],[8],[18],[23]}

^{[11],[14],[20],[21]}

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6

Schedule of Investments [Line Items]

Investment owned, balance, principal amount

^{[11],[14],[17],[20],[21]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[14],[20],[21]}

Fair value, ending balance

^{[11],[14],[20],[21]}

$ 0

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14],[20]

26,131

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 3

Fair value, ending balance

^[14],[20]

$ 3

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7],[18]

32,664

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[18]

$ 10

Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7],[18]

9,382

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[18]

$ 3

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23]

5.00%

Investment, interest rate (as a percent)

^[10],[23]

9.85%

Investment owned, balance, principal amount

^[16],[23]

$ 19,336

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[23]

19,444

Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

7.00%

Investment, interest rate (as a percent)

^[13],[15]

12.43%

Investment owned, balance, principal amount

^[13],[17]

$ 30,625

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

$ 29,989

Fair value, ending balance

^[13]

$ 29,989

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

394,297

^[7]

394,297

^[14]

394,297

^[7]

394,297

^[7]

394,297

^[14]

394,297

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 158

Fair value, ending balance

^[7]

$ 158

^[14]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[14],[15]}

9.00%

Investment owned, balance, principal amount

^[14],[17]

$ 5,257

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 5,251

Fair value, ending balance

^[14]

$ 5,251

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

1,708,618

^[7]

1,708,618

^[14]

1,708,618

^[7]

1,708,618

^[7]

1,708,618

^[14]

1,708,618

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 1,999

Fair value, ending balance

$ 2,136

^[7]

$ 1,999

^[14]

Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

394,297

^[7]

394,297

^[14]

394,297

^[7]

394,297

^[7]

394,297

^[14]

394,297

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 442

Fair value, ending balance

$ 477

^[7]

$ 442

^[14]

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

829

^[7]

829

^[14]

829

^[7]

829

^[7]

829

^[14]

829

^[14]

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

Gross Additions

Gross Reductions

Fair value, ending balance

$ 0

^[7]

$ 0

^[14]

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

34,984,460

^[7]

34,984,460

^[14]

34,984,460

^[7]

34,984,460

^[7]

34,984,460

^[14]

34,984,460

^[14]

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

27,638

^[14]

27,638

Gross Additions

Gross Reductions

Fair value, ending balance

$ 27,638

^[7]

$ 27,638

^[14]

Investment owned, percent of net assets (as a percent)

1.90%

1.80%

1.90%

1.80%

Investment, Identifier [Axis]: CBAM 2017-2, LTD., Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[23]

7.36%

Investment, interest rate (as a percent)

^{[10],[18],[23]}

12.65%

Investment owned, balance, principal amount

^{[16],[18],[23]}

$ 489

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[18],[23]

$ 462

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[23]

5.75%

Investment, interest rate (as a percent)

^{[10],[18],[23]}

10.95%

Investment owned, balance, principal amount | £

^{[16],[18],[23]}

£ 14,807

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[18],[23]

$ 19,878

Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, Other Specialty Retail, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[23]

5.50%

Investment, interest rate (as a percent)

^{[10],[18],[23]}

10.45%

Investment owned, balance, principal amount

^{[16],[18],[23]}

$ 14,725

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[18],[23]

19,782

Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[24]}

7.75%

Investment owned, balance, principal amount

^{[13],[14],[17],[24]}

$ 727

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[24]}

396

Fair value, ending balance

^{[13],[14],[24]}

$ 396

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

6.50%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.07%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 37

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

Fair value, ending balance

^[13],[14]

$ 37

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

6.50%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.07%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 3,031

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

3,031

Fair value, ending balance

^[13],[14]

$ 3,031

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

6.50%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.07%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 1,557

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

1,557

Fair value, ending balance

^[13],[14]

$ 1,557

Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

6.50%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.07%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 1,024

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 1,024

Fair value, ending balance

^[13],[14]

$ 1,024

Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

1,080,398

^[7]

1,080,399

^[14]

1,080,398

^[7]

1,080,398

^[7]

1,080,399

^[14]

1,080,399

^[14]

Investment owned, balance, principal amount

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

432

^[14]

378

Gross Additions

367

Gross Reductions

(205)

Fair value, ending balance

$ 594

^[7]

$ 432

^[14]

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: Centralsquare Technologies, LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

6.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (15)

Investment, Identifier [Axis]: Centralsquare Technologies, LLC, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

6.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

8.10%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

3.50%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 12,830

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

12,694

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[15],[20]}

7.50%

Investment owned, balance, principal amount

^[17],[20]

$ 2,632

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

2,017

Fair value, ending balance

^[20]

$ 2,017

Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[15],[20]}

7.75%

Investment owned, balance, principal amount

^[17],[20]

$ 176

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

141

Fair value, ending balance

^[20]

$ 141

Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^[13],[15]

7.38%

Investment owned, balance, principal amount

^[17]

$ 8,420

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

$ 7,059

Fair value, ending balance

7,059

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7]

22,267,661

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

16,171

Gross Reductions

(3,924)

Fair value, ending balance

$ 12,247

^[7]

$ 0

Investment owned, percent of net assets (as a percent)

0.80%

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[24]}

8.50%

Investment owned, balance, principal amount

^{[13],[14],[17],[24]}

$ 22,084

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[24]}

$ 16,040

Fair value, ending balance

^{[13],[14],[24]}

16,040

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7]

3,137,476

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

3,357

Gross Reductions

Fair value, ending balance

$ 3,357

^[7]

Investment owned, percent of net assets (as a percent)

0.20%

Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 0

Fair value, ending balance

^[14]

$ 0

Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

417,851

^[7]

417,851

^[14]

417,851

^[7]

417,851

^[7]

417,851

^[14]

417,851

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 894

Fair value, ending balance

$ 894

^[7]

$ 894

^[14]

Investment, Identifier [Axis]: CoreRx, Inc., Pharmaceuticals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

7.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

12.10%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 6,494

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 6,348

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[7],[8],[23]

7.50%

^{[11],[13],[14]}

5.50%

^[7],[8],[23]

5.50%

^[7],[8],[23]

7.50%

^{[11],[13],[14]}

7.50%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(20)

Fair value, ending balance

$ 0

^[7],[8],[23]

$ (20)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[7],[8],[23]

7.50%

^[13],[14]

5.50%

^[7],[8],[23]

5.50%

^[7],[8],[23]

7.50%

^[13],[14]

7.50%

^[13],[14]

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.82%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 13,157

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 12,858

Fair value, ending balance

$ 0

^[7],[8],[23]

$ 12,858

^[13],[14]

Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[7],[23]

7.50%

^{[11],[13],[14]}

5.50%

^[7],[23]

5.50%

^[7],[23]

7.50%

^{[11],[13],[14]}

7.50%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.75%

Investment owned, balance, principal amount

$ 13,124

^{[7],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(13)

Fair value, ending balance

$ 13,124

^[7],[23]

$ (13)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[23]

5.00%

^[13]

5.00%

^[23]

5.00%

^[23]

5.00%

^[13]

5.00%

^[13]

Investment, interest rate (as a percent)

9.60%

^[10],[23]

10.39%

^[13],[15]

9.60%

^[10],[23]

9.60%

^[10],[23]

10.39%

^[13],[15]

10.39%

^[13],[15]

Investment owned, balance, principal amount

$ 10,878

^[16],[23]

$ 14,750

^[13],[17]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

14,616

Fair value, ending balance

10,341

^[23]

$ 14,616

^[13]

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14]}

6.00%

Investment, interest rate (as a percent)

^{[11],[13],[14],[15]}

11.47%

Investment owned, balance, principal amount

^{[11],[13],[14],[17]}

$ 933

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

918

Fair value, ending balance

^{[11],[13],[14]}

$ 918

Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

6.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

11.52%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 18,013

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 17,812

Fair value, ending balance

^[13],[14]

$ 17,812

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

6.75%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (31)

Investment, Identifier [Axis]: Crewline Buyer, Inc., Systems Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

6.75%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

11.35%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 20,924

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

20,627

Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

4.75%

Investment, interest rate (as a percent)

^[13],[15]

10.12%

Investment owned, balance, principal amount

^[13],[17]

$ 4,950

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

$ 4,831

Fair value, ending balance

^[13]

$ 4,831

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7],[18]

^[14],[20]

^[7],[18]

^[14],[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 2

Fair value, ending balance

$ 2

^[7],[18]

$ 2

^[14],[20]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

419

^[7],[18]

419

^[14],[20]

419

^[7],[18]

419

^[7],[18]

419

^[14],[20]

419

^[14],[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 419

Fair value, ending balance

531

^[7],[18]

$ 419

^[14],[20]

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[11],[13],[14],[15],[20]}

3.00%

Investment, interest rate, paid in kind (as a percent)

^{[11],[14],[20]}

7.00%

Investment owned, balance, principal amount

^{[11],[14],[17],[20]}

$ 17,465

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[14],[20]}

$ 17,465

Fair value, ending balance

^{[11],[14],[20]}

$ 17,465

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[7],[8],[10],[18]}

8.00%

Investment, interest rate, paid in kind (as a percent)

^[7],[8],[18]

3.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[18]}

$ 8,456

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[18]

$ 8,456

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[7],[10],[18]}

3.00%

Investment, interest rate, paid in kind (as a percent)

^[7],[18]

7.00%

Investment owned, balance, principal amount

^{[7],[16],[18]}

$ 34,316

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[18]

$ 34,316

Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7],[18]

^[14],[20]

^[7],[18]

^[14],[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 0

Fair value, ending balance

^[7],[18]

$ 0

^[14],[20]

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

9.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

14.54%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 20,757

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 20,653

Fair value, ending balance

^[13],[14]

$ 20,653

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

15.75%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 23,660

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 21,175

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

15.75%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 655

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 586

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

15.75%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 647

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 579

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

15.75%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 1,039

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 929

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 5

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

11.00%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

15.75%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 852

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

762

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[14]

8.00%

Investment owned, balance, principal amount

^[14],[17]

$ 654

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 631

Fair value, ending balance

^[14]

$ 631

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7],[22]

10.00%

Investment owned, balance, principal amount

^{[7],[16],[22]}

$ 725

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[22]

$ 375

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7],[22]

10.00%

Investment owned, balance, principal amount

^{[7],[16],[22]}

$ 959

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[22]

$ 496

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 3

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7],[22]

10.00%

Investment owned, balance, principal amount

^{[7],[16],[22]}

$ 952

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[22]

$ 493

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan 4

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7],[22]

10.00%

Investment owned, balance, principal amount

^{[7],[16],[22]}

$ 1,679

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[22]

$ 869

Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7]

Investment owned, balance (in shares) | shares

6,397,254

^[7]

6,397,254

^[14]

6,397,254

^[7]

6,397,254

^[7]

6,397,254

^[14]

6,397,254

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 1,152

Fair value, ending balance

$ 0

^[7]

$ 1,152

^[14]

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[8],[23]

7.00%

^{[11],[13],[14]}

6.00%

^[7],[8],[23]

6.00%

^[7],[8],[23]

7.00%

^{[11],[13],[14]}

7.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[11],[13],[14],[15]}

12.49%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 284

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

252

Fair value, ending balance

(36)

^[7],[8],[23]

$ 252

^{[11],[13],[14]}

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.49%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 12,386

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 12,101

Fair value, ending balance

^[13],[14]

$ 12,101

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

6.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.60%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 54,454

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 54,127

Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

6.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.60%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 2,939

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

2,921

Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

5.00%

Investment, interest rate (as a percent)

^[13],[15]

10.43%

Investment owned, balance, principal amount

^[13],[17]

$ 4,641

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

$ 4,546

Fair value, ending balance

^[13]

$ 4,546

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

30,031

^[7]

30,031

^[14]

30,031

^[7]

30,031

^[7]

30,031

^[14]

30,031

^[14]

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

2,711

^[14]

4,946

Gross Additions

Gross Reductions

(2,711)

(2,235)

Fair value, ending balance

$ 0

^[7]

$ 2,711

^[14]

Investment owned, percent of net assets (as a percent)

0.00%

0.20%

0.00%

0.20%

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[7],[23]

5.00%

^[13],[14]

5.00%

^[7],[23]

5.00%

^[7],[23]

5.00%

^[13],[14]

5.00%

^[13],[14]

Investment, interest rate (as a percent)

9.75%

^{[7],[10],[23]}

10.54%

^{[13],[14],[15]}

9.75%

^{[7],[10],[23]}

9.75%

^{[7],[10],[23]}

10.54%

^{[13],[14],[15]}

10.54%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 5,574

^{[7],[16],[23]}

$ 5,574

^{[13],[14],[17]}

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

595

266

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

5,574

^[13],[14]

Gross Additions

5,574

Gross Reductions

(1,028)

Fair value, ending balance

$ 4,546

^[7],[23]

$ 5,574

^[13],[14]

Investment owned, percent of net assets (as a percent)

0.30%

0.40%

0.30%

0.40%

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[7],[23]

5.00%

^[13],[14]

5.00%

^[7],[23]

5.00%

^[7],[23]

5.00%

^[13],[14]

5.00%

^[13],[14]

Investment, interest rate (as a percent)

9.74%

^{[7],[10],[23]}

10.54%

^{[13],[14],[15]}

9.74%

^{[7],[10],[23]}

9.74%

^{[7],[10],[23]}

10.54%

^{[13],[14],[15]}

10.54%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 13,928

^{[7],[16],[23]}

$ 14,068

^{[13],[14],[17]}

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

1,545

1,459

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

14,068

^[13],[14]

14,333

Gross Additions

Gross Reductions

(2,708)

(265)

Fair value, ending balance

$ 11,360

^[7],[23]

$ 14,068

^[13],[14]

Investment owned, percent of net assets (as a percent)

0.80%

0.90%

0.80%

0.90%

Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[7],[8],[23]

5.00%

^{[11],[13],[14]}

5.00%

^[7],[8],[23]

5.00%

^[7],[8],[23]

5.00%

^{[11],[13],[14]}

5.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

10.42%

^{[11],[13],[14],[15]}

^{[7],[8],[10],[23]}

10.42%

^{[11],[13],[14],[15]}

10.42%

^{[11],[13],[14],[15]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 2,090

^{[11],[13],[14],[17]}

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

2,090

^{[11],[13],[14]}

Gross Additions

2,090

Gross Reductions

(3,118)

Fair value, ending balance

$ (1,028)

^[7],[8],[23]

$ 2,090

^{[11],[13],[14]}

Investment owned, percent of net assets (as a percent)

(0.10%)

0.10%

(0.10%)

0.10%

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

12,500

^[7]

12,500

^[14]

12,500

^[7]

12,500

^[7]

12,500

^[14]

12,500

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 0

Fair value, ending balance

$ 0

^[7]

$ 0

^[14]

Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

488

^[7]

488

^[14]

488

^[7]

488

^[7]

488

^[14]

488

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 1,345

Fair value, ending balance

$ 1,345

^[7]

$ 1,345

^[14]

Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[7],[23]

7.50%

^[13],[14]

7.50%

^[7],[23]

7.50%

^[7],[23]

7.50%

^[13],[14]

7.50%

^[13],[14]

Investment, interest rate (as a percent)

12.25%

^{[7],[10],[23]}

13.04%

^{[13],[14],[15]}

12.25%

^{[7],[10],[23]}

12.25%

^{[7],[10],[23]}

13.04%

^{[13],[14],[15]}

13.04%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 8,974

^{[7],[16],[23]}

$ 8,974

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

7,987

Fair value, ending balance

$ 8,121

^[7],[23]

$ 7,987

^[13],[14]

Investment, Identifier [Axis]: Engineering Research and Consulting LLC, Construction & Engineering, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.06%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 11,933

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 11,858

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.50%

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

10.35%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 121

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 121

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.35%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 24,741

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 24,741

Investment, Identifier [Axis]: Enverus Holdings, Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.50%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 0

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.00%

^{[7],[10],[18]}

3.00%

^{[13],[14],[15],[20]}

9.00%

^{[7],[10],[18]}

9.00%

^{[7],[10],[18]}

3.00%

^{[13],[14],[15],[20]}

3.00%

^{[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

^[14],[20]

6.00%

Investment owned, balance, principal amount

$ 1,834

^{[7],[16],[18]}

$ 11,065

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

10,677

Fair value, ending balance

$ 1,834

^[7],[18]

$ 10,677

^[14],[20]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.00%

^{[7],[8],[10],[18]}

3.00%

^{[13],[14],[15],[20]}

9.00%

^{[7],[8],[10],[18]}

9.00%

^{[7],[8],[10],[18]}

3.00%

^{[13],[14],[15],[20]}

3.00%

^{[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

^[14],[20]

6.00%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[18]}

$ 1,772

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

1,710

Fair value, ending balance

$ 0

^[7],[8],[18]

$ 1,710

^[14],[20]

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.00%

^{[7],[8],[10],[18]}

3.00%

^{[11],[13],[14],[15],[20]}

9.00%

^{[7],[8],[10],[18]}

9.00%

^{[7],[8],[10],[18]}

3.00%

^{[11],[13],[14],[15],[20]}

3.00%

^{[11],[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

^{[11],[14],[20]}

6.00%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[18]}

$ 0

^{[11],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[14],[20]}

Fair value, ending balance

$ 0

^[7],[8],[18]

$ 0

^{[11],[14],[20]}

Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.00%

^{[7],[10],[18]}

3.00%

^{[11],[13],[14],[15],[20]}

9.00%

^{[7],[10],[18]}

9.00%

^{[7],[10],[18]}

3.00%

^{[11],[13],[14],[15],[20]}

3.00%

^{[11],[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

^{[11],[14],[20]}

6.00%

Investment owned, balance, principal amount

$ 11,454

^{[7],[16],[18]}

$ 0

^{[11],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[14],[20]}

Fair value, ending balance

$ 11,454

^[7],[18]

$ 0

^{[11],[14],[20]}

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (9)

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.33%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 20,014

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 19,922

Investment, Identifier [Axis]: Everbridge, Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.00%

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

10.30%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 1,961

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 1,950

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^[7],[8],[23]

6.00%

^{[11],[13],[14]}

4.75%

^[7],[8],[23]

4.75%

^[7],[8],[23]

6.00%

^{[11],[13],[14]}

6.00%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(41)

Fair value, ending balance

(14)

^[7],[8],[23]

$ (41)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

6.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

11.32%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 14,736

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 14,368

Fair value, ending balance

^[13],[14]

$ 14,368

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

4.75%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

9.35%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 14,625

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 14,501

Investment, Identifier [Axis]: Evergreen IX Borrower 2023, LLC, Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

4.75%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

9.35%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 3,692

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 3,661

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7],[27]

1,206

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[27]

$ 1,131

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.80%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 4,368

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 4,285

Investment, Identifier [Axis]: Eyesouth Eye Care Holdco LLC, Health Care Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.50%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

(125)

Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

6.75%

Investment, interest rate (as a percent)

^[13],[15]

12.18%

Investment owned, balance, principal amount

^[13],[17]

$ 31,074

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

$ 19,917

Fair value, ending balance

^[13]

$ 19,917

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.00%

^[7],[10]

9.00%

^{[11],[13],[14],[15]}

9.00%

^[7],[10]

9.00%

^[7],[10]

9.00%

^{[11],[13],[14],[15]}

9.00%

^{[11],[13],[14],[15]}

Investment owned, balance, principal amount

$ 48,920

^[7],[16]

$ 59,950

^{[11],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[11],[14]

59,950

Fair value, ending balance

$ 48,920

^[7]

$ 59,950

^[11],[14]

Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

3,750

^{[7],[18],[28]}

3,750

^[14],[20]

3,750

^{[7],[18],[28]}

3,750

^{[7],[18],[28]}

3,750

^[14],[20]

3,750

^[14],[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 3

Fair value, ending balance

$ 4

^{[7],[18],[28]}

$ 3

^[14],[20]

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^{[7],[8],[18],[23]}

7.25%

^{[11],[13],[14],[20]}

7.25%

^{[7],[8],[18],[23]}

7.25%

^{[7],[8],[18],[23]}

7.25%

^{[11],[13],[14],[20]}

7.25%

^{[11],[13],[14],[20]}

Investment, interest rate (as a percent)

12.18%

^{[7],[8],[10],[18],[23]}

12.55%

^{[11],[13],[14],[15],[20]}

12.18%

^{[7],[8],[10],[18],[23]}

12.18%

^{[7],[8],[10],[18],[23]}

12.55%

^{[11],[13],[14],[15],[20]}

12.55%

^{[11],[13],[14],[15],[20]}

Investment owned, balance, principal amount

$ 564

^{[7],[8],[16],[18],[23]}

$ 258

^{[11],[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14],[20]}

234

Fair value, ending balance

$ 547

^{[7],[8],[18],[23]}

$ 234

^{[11],[13],[14],[20]}

Investment, Identifier [Axis]: Finastra USA, Inc., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^{[7],[18],[23]}

7.25%

^{[13],[14],[20]}

7.25%

^{[7],[18],[23]}

7.25%

^{[7],[18],[23]}

7.25%

^{[13],[14],[20]}

7.25%

^{[13],[14],[20]}

Investment, interest rate (as a percent)

12.18%

^{[7],[10],[18],[23]}

12.55%

^{[13],[14],[15],[20]}

12.18%

^{[7],[10],[18],[23]}

12.18%

^{[7],[10],[18],[23]}

12.55%

^{[13],[14],[15],[20]}

12.55%

^{[13],[14],[15],[20]}

Investment owned, balance, principal amount

$ 11,683

^{[7],[16],[18],[23]}

$ 11,742

^{[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

11,511

Fair value, ending balance

$ 11,521

^{[7],[18],[23]}

11,511

^{[13],[14],[20]}

Investment, Identifier [Axis]: Finthrive Software Intermediate Holdings, Inc., Health Care Technology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

4.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

8.96%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 4,291

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 3,862

Investment, Identifier [Axis]: Finthrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[22],[23]}

6.75%

Investment owned, balance, principal amount

^{[7],[16],[22],[23]}

$ 31,074

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[22],[23]}

$ 23,616

Investment, Identifier [Axis]: First Star Speir Aviation Limited, Airlines, Equity Interest

Schedule of Investments [Line Items]

Investment owned, ownership (as a percent)

100.00%

Net Realized Gain (Loss)

$ 786

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

Gross Reductions

Fair value, ending balance

$ 0

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

11.00%

Investment owned, balance, principal amount

^{[14],[17],[20]}

$ 11,918

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 11,144

Fair value, ending balance

^[14],[20]

$ 11,144

Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

27,801

^[7],[18]

417,011

^[14],[20]

27,801

^[7],[18]

27,801

^[7],[18]

417,011

^[14],[20]

417,011

^[14],[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 42

Fair value, ending balance

^[7],[18]

$ 42

^[14],[20]

Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[15],[20]}

6.00%

Investment owned, balance, principal amount

^[17],[20]

$ 4,881

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

$ 3,577

Fair value, ending balance

^[20]

$ 3,577

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^[7],[8],[23]

7.25%

^{[11],[13],[14]}

7.25%

^[7],[8],[23]

7.25%

^[7],[8],[23]

7.25%

^{[11],[13],[14]}

7.25%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

11.85%

^{[7],[8],[10],[23]}

12.64%

^{[11],[13],[14],[15]}

11.85%

^{[7],[8],[10],[23]}

11.85%

^{[7],[8],[10],[23]}

12.64%

^{[11],[13],[14],[15]}

12.64%

^{[11],[13],[14],[15]}

Investment owned, balance, principal amount

$ 2,536

^{[7],[8],[16],[23]}

$ 1,638

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

1,535

Fair value, ending balance

$ 2,536

^[7],[8],[23]

$ 1,535

^{[11],[13],[14]}

Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.25%

^[7],[23]

7.25%

^[13],[14]

7.25%

^[7],[23]

7.25%

^[7],[23]

7.25%

^[13],[14]

7.25%

^[13],[14]

Investment, interest rate (as a percent)

11.85%

^{[7],[10],[23]}

12.64%

^{[13],[14],[15]}

11.85%

^{[7],[10],[23]}

11.85%

^{[7],[10],[23]}

12.64%

^{[13],[14],[15]}

12.64%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 23,536

^{[7],[16],[23]}

$ 23,774

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

23,110

Fair value, ending balance

23,536

^[7],[23]

$ 23,110

^[13],[14]

Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

5.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

10.57%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 2,456

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

2,063

Fair value, ending balance

^[13],[14]

$ 2,063

Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[20]

2.85%

Investment, interest rate (as a percent)

^{[13],[15],[20]}

6.56%

Investment owned, balance, principal amount | €

^{[13],[17],[20]}

€ 1,000

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[20]

$ 963

Fair value, ending balance

^[13],[20]

$ 963

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[7],[8],[23]

8.00%

^{[11],[13],[14]}

8.00%

^[7],[8],[23]

8.00%

^[7],[8],[23]

8.00%

^{[11],[13],[14]}

8.00%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(35)

Fair value, ending balance

$ (35)

^[7],[8],[23]

$ (35)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[7],[23]

8.00%

^[13],[14]

8.00%

^[7],[23]

8.00%

^[7],[23]

8.00%

^[13],[14]

8.00%

^[13],[14]

Investment, interest rate (as a percent)

12.95%

^{[7],[10],[23]}

13.42%

^{[13],[14],[15]}

12.95%

^{[7],[10],[23]}

12.95%

^{[7],[10],[23]}

13.42%

^{[13],[14],[15]}

13.42%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 3,524

^{[7],[16],[23]}

$ 17,444

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

17,096

Fair value, ending balance

$ 3,454

^[7],[23]

$ 17,096

^[13],[14]

Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[7],[23]

8.00%

^{[11],[13],[14]}

8.00%

^[7],[23]

8.00%

^[7],[23]

8.00%

^{[11],[13],[14]}

8.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[7],[10],[23]}

12.95%

Investment owned, balance, principal amount

$ 17,268

^{[7],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(70)

Fair value, ending balance

$ 16,923

^[7],[23]

$ (70)

^{[11],[13],[14]}

Investment, Identifier [Axis]: HPS Loan Management 10-2016, Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[23]

6.67%

Investment, interest rate (as a percent)

^{[10],[18],[23]}

11.95%

Investment owned, balance, principal amount

^{[16],[18],[23]}

$ 2,250

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[18],[23]

$ 2,264

Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

^[23]

5.25%

^[13]

5.25%

^[23]

5.25%

^[23]

5.25%

^[13]

5.25%

^[13]

Investment, interest rate (as a percent)

10.20%

^[10],[23]

10.67%

^[13],[15]

10.20%

^[10],[23]

10.20%

^[10],[23]

10.67%

^[13],[15]

10.67%

^[13],[15]

Investment owned, balance, principal amount

$ 8,473

^[16],[23]

$ 14,347

^[13],[17]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

13,618

Fair value, ending balance

$ 8,263

^[23]

$ 13,618

^[13]

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^{[7],[8],[18],[23]}

6.50%

^{[13],[14],[20]}

6.50%

^{[7],[8],[18],[23]}

6.50%

^{[7],[8],[18],[23]}

6.50%

^{[13],[14],[20]}

6.50%

^{[13],[14],[20]}

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

11.89%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[18],[23]}

$ 7,448

^{[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

7,301

Fair value, ending balance

$ 52

^{[7],[8],[18],[23]}

$ 7,301

^{[13],[14],[20]}

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^{[7],[18],[23]}

6.50%

^{[11],[13],[14],[20]}

6.50%

^{[7],[18],[23]}

6.50%

^{[7],[18],[23]}

6.50%

^{[11],[13],[14],[20]}

6.50%

^{[11],[13],[14],[20]}

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

11.25%

Investment owned, balance, principal amount

$ 1,432

^{[7],[16],[18],[23]}

$ 0

^{[11],[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14],[20]}

(79)

Fair value, ending balance

$ 1,454

^{[7],[18],[23]}

$ (79)

^{[11],[13],[14],[20]}

Investment, Identifier [Axis]: Harrow, Inc., Pharmaceuticals, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^{[7],[18],[23]}

6.50%

^{[13],[14],[20]}

6.50%

^{[7],[18],[23]}

6.50%

^{[7],[18],[23]}

6.50%

^{[13],[14],[20]}

6.50%

^{[13],[14],[20]}

Investment, interest rate (as a percent)

11.25%

^{[7],[10],[18],[23]}

12.04%

^{[13],[14],[15],[20]}

11.25%

^{[7],[10],[18],[23]}

11.25%

^{[7],[10],[18],[23]}

12.04%

^{[13],[14],[15],[20]}

12.04%

^{[13],[14],[15],[20]}

Investment owned, balance, principal amount

$ 7,448

^{[7],[16],[18],[23]}

$ 1,432

^{[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

1,404

Fair value, ending balance

7,560

^{[7],[18],[23]}

$ 1,404

^{[13],[14],[20]}

Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[15],[20]}

4.46%

Investment owned, balance, principal amount

^[17],[20]

$ 6,808

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

$ 5,873

Fair value, ending balance

^[20]

$ 5,873

Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^{[7],[18],[23]}

8.25%

^{[13],[14],[20]}

8.25%

^{[7],[18],[23]}

8.25%

^{[7],[18],[23]}

8.25%

^{[13],[14],[20]}

8.25%

^{[13],[14],[20]}

Investment, interest rate (as a percent)

13.37%

^{[7],[10],[18],[23]}

13.62%

^{[13],[14],[15],[20]}

13.37%

^{[7],[10],[18],[23]}

13.37%

^{[7],[10],[18],[23]}

13.62%

^{[13],[14],[15],[20]}

13.62%

^{[13],[14],[15],[20]}

Investment owned, balance, principal amount

$ 23,975

^{[7],[16],[18],[23]}

$ 23,975

^{[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

23,328

Fair value, ending balance

$ 25,054

^{[7],[18],[23]}

$ 23,328

^{[13],[14],[20]}

Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[23]

5.75%

^[13],[14]

5.75%

^[23]

5.75%

^[23]

5.75%

^[13],[14]

5.75%

^[13],[14]

Investment, interest rate (as a percent)

10.62%

^[10],[23]

11.40%

^{[13],[14],[15]}

10.62%

^[10],[23]

10.62%

^[10],[23]

11.40%

^{[13],[14],[15]}

11.40%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 42,075

^[16],[23]

$ 44,550

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

35,046

Fair value, ending balance

$ 35,343

^[23]

$ 35,046

^[13],[14]

Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[7],[23]

6.50%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[13],[14]

Investment, interest rate (as a percent)

11.97%

^{[7],[10],[23]}

11.92%

^{[13],[14],[15]}

11.97%

^{[7],[10],[23]}

11.97%

^{[7],[10],[23]}

11.92%

^{[13],[14],[15]}

11.92%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 36,029

^{[7],[16],[23]}

$ 40,587

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

38,963

Fair value, ending balance

$ 35,668

^[7],[23]

$ 38,963

^[13],[14]

Investment, Identifier [Axis]: Icefall Parent, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

6.50%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (7)

Investment, Identifier [Axis]: Icefall Parent, Inc., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

6.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

11.35%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 10,446

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

10,372

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

10.75%

Investment, interest rate, paid in kind (as a percent)

^[13],[14]

16.06%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 26,613

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

24,484

Fair value, ending balance

^[13],[14]

$ 24,484

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

10.75%

Investment, interest rate, paid in kind (as a percent)

^[13],[14]

16.05%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 787

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

787

Fair value, ending balance

^[13],[14]

$ 787

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14]}

10.75%

Investment, interest rate, paid in kind (as a percent)

^{[11],[13],[14]}

16.06%

Investment owned, balance, principal amount

^{[11],[13],[14],[17]}

$ 688

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

688

Fair value, ending balance

^{[11],[13],[14]}

$ 688

Investment, Identifier [Axis]: Impel Pharmaceuticals Inc., Health Care Technology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

350,241

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

147

Fair value, ending balance

$ 147

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

5.75%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

11.14%

Investment, interest rate, paid in kind (as a percent)

^{[13],[14],[20]}

2.75%

Investment owned, balance, principal amount

^{[13],[14],[17],[20]}

$ 7,179

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

$ 6,568

Fair value, ending balance

^{[13],[14],[20]}

$ 6,568

Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

112,990

^[7],[18]

112,990

^[14],[20]

112,990

^[7],[18]

112,990

^[7],[18]

112,990

^[14],[20]

112,990

^[14],[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 105

Fair value, ending balance

^[7],[18]

$ 105

^[14],[20]

Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14]

1,078,284

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 0

Fair value, ending balance

^[14]

$ 0

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (26)

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.08%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 19,559

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 19,363

Investment, Identifier [Axis]: Integrity Marketing Acquisition, LLC, Insurance Brokers, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.00%

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (66)

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[7],[8],[23]

7.50%

^{[11],[13],[14]}

7.50%

^[7],[8],[23]

7.50%

^[7],[8],[23]

7.50%

^{[11],[13],[14]}

7.50%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(86)

Fair value, ending balance

$ (86)

^[7],[8],[23]

$ (86)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[7],[23]

7.50%

^[13],[14]

7.50%

^[7],[23]

7.50%

^[7],[23]

7.50%

^[13],[14]

7.50%

^[13],[14]

Investment, interest rate (as a percent)

12.46%

^{[7],[10],[23]}

12.93%

^{[13],[14],[15]}

12.46%

^{[7],[10],[23]}

12.46%

^{[7],[10],[23]}

12.93%

^{[13],[14],[15]}

12.93%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 33,079

^{[7],[16],[23]}

$ 33,414

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

32,659

Fair value, ending balance

32,332

^[7],[23]

$ 32,659

^[13],[14]

Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

7.25%

Investment, interest rate (as a percent)

^[13],[15]

12.78%

Investment owned, balance, principal amount

^[13],[17]

$ 13,939

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

10,094

Fair value, ending balance

^[13]

10,094

Investment, Identifier [Axis]: JN Bidco LLC, Health Care Technology, Common Stock

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7]

9,886

Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

83,262

Fair value, ending balance

$ 34,597

$ 83,262

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

^[7],[8],[23]

6.50%

^{[11],[13],[14]}

4.00%

^[7],[8],[23]

4.00%

^[7],[8],[23]

6.50%

^{[11],[13],[14]}

6.50%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

12.50%

^{[7],[8],[10],[23]}

11.84%

^{[11],[13],[14],[15]}

12.50%

^{[7],[8],[10],[23]}

12.50%

^{[7],[8],[10],[23]}

11.84%

^{[11],[13],[14],[15]}

11.84%

^{[11],[13],[14],[15]}

Investment owned, balance, principal amount

$ 1,259

^{[7],[8],[16],[23]}

$ 272

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

238

Fair value, ending balance

$ 1,216

^[7],[8],[23]

$ 238

^{[11],[13],[14]}

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

^[7],[8],[23]

6.50%

^{[11],[13],[14]}

4.00%

^[7],[8],[23]

4.00%

^[7],[8],[23]

6.50%

^{[11],[13],[14]}

6.50%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

12.00%

Investment owned, balance, principal amount

$ 926

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(47)

Fair value, ending balance

$ 894

^[7],[8],[23]

$ (47)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[7],[23]

6.50%

^[13],[14]

5.00%

^[7],[23]

5.00%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[13],[14]

Investment, interest rate (as a percent)

9.95%

^{[7],[10],[23]}

11.84%

^{[13],[14],[15]}

9.95%

^{[7],[10],[23]}

9.95%

^{[7],[10],[23]}

11.84%

^{[13],[14],[15]}

11.84%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 37,635

^{[7],[16],[23]}

$ 16,752

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

16,500

Fair value, ending balance

$ 37,123

^[7],[23]

$ 16,500

^[13],[14]

Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[7],[23]

6.50%

^[13],[14]

5.00%

^[7],[23]

5.00%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[13],[14]

Investment, interest rate (as a percent)

10.68%

^{[7],[10],[23]}

11.80%

^{[13],[14],[15]}

10.68%

^{[7],[10],[23]}

10.68%

^{[7],[10],[23]}

11.80%

^{[13],[14],[15]}

11.80%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 16,552

^{[7],[16],[23]}

$ 38,015

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

37,445

Fair value, ending balance

$ 16,327

^[7],[23]

$ 37,445

^[13],[14]

Investment, Identifier [Axis]: LABL, Inc., Office Services & Supplies, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23]

5.00%

Investment, interest rate (as a percent)

^[10],[23]

9.95%

Investment owned, balance, principal amount

^[16],[23]

$ 19,351

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[23]

$ 18,953

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[8],[23]

6.00%

^{[11],[13],[14]}

6.00%

^[7],[8],[23]

6.00%

^[7],[8],[23]

6.00%

^{[11],[13],[14]}

6.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

10.95%

Investment owned, balance, principal amount

$ 2,014

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(172)

Fair value, ending balance

$ 1,849

^[7],[8],[23]

$ (172)

^{[11],[13],[14]}

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[7],[23]

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[13],[14]

Investment, interest rate (as a percent)

10.95%

^{[7],[10],[23]}

11.42%

^{[13],[14],[15]}

10.95%

^{[7],[10],[23]}

10.95%

^{[7],[10],[23]}

11.42%

^{[13],[14],[15]}

11.42%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 2,708

^{[7],[16],[23]}

$ 2,736

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

2,558

Fair value, ending balance

$ 2,539

^[7],[23]

$ 2,558

^[13],[14]

Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[7],[23]

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[13],[14]

Investment, interest rate (as a percent)

10.95%

^{[7],[10],[23]}

11.42%

^{[13],[14],[15]}

10.95%

^{[7],[10],[23]}

10.95%

^{[7],[10],[23]}

11.42%

^{[13],[14],[15]}

11.42%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 23,256

^{[7],[16],[23]}

$ 23,494

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

21,967

Fair value, ending balance

$ 21,802

^[7],[23]

$ 21,967

^[13],[14]

Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

9.50%

^[18],[23]

9.50%

^[13],[20]

9.50%

^[18],[23]

9.50%

^[18],[23]

9.50%

^[13],[20]

9.50%

^[13],[20]

Investment, interest rate (as a percent)

14.95%

^{[10],[18],[23]}

14.95%

^{[13],[15],[20]}

14.95%

^{[10],[18],[23]}

14.95%

^{[10],[18],[23]}

14.95%

^{[13],[15],[20]}

14.95%

^{[13],[15],[20]}

Investment owned, balance, principal amount

$ 26,156

^{[16],[18],[23]}

$ 26,422

^{[13],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[20]

27,512

Fair value, ending balance

$ 26,556

^[18],[23]

$ 27,512

^[13],[20]

Investment, Identifier [Axis]: Learfield Communications, LLC, Movies & Entertainment, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23]

5.50%

Investment, interest rate (as a percent)

^[10],[23]

10.35%

Investment owned, balance, principal amount

^[16],[23]

$ 30,856

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[23]

$ 30,863

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (60)

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.13%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 26,358

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 25,847

Investment, Identifier [Axis]: Legends Hospitality Holding Company, LLC, Specialized Consumer Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

(15)

Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14]

2,000,000

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 0

Fair value, ending balance

^[14]

$ 0

Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[7],[23]

5.00%

^[13],[14]

5.00%

^[7],[23]

5.00%

^[7],[23]

5.00%

^[13],[14]

5.00%

^[13],[14]

Investment, interest rate (as a percent)

9.96%

^{[7],[10],[23]}

10.65%

^{[13],[14],[15]}

9.96%

^{[7],[10],[23]}

9.96%

^{[7],[10],[23]}

10.65%

^{[13],[14],[15]}

10.65%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 55,873

^{[7],[16],[23]}

$ 45,243

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

43,886

Fair value, ending balance

$ 54,197

^[7],[23]

$ 43,886

^[13],[14]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

559

^[7]

559

^[14]

559

^[7]

559

^[7]

559

^[14]

559

^[14]

Investment owned, balance, principal amount

^[14],[17]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 372

Fair value, ending balance

$ 64

^[7]

$ 372

^[14]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[7],[23]

8.50%

^[13],[14]

8.50%

^[7],[23]

8.50%

^[7],[23]

8.50%

^[13],[14]

8.50%

^[13],[14]

Investment, interest rate (as a percent)

13.20%

^{[7],[10],[23]}

13.99%

^{[13],[14],[15]}

13.20%

^{[7],[10],[23]}

13.20%

^{[7],[10],[23]}

13.99%

^{[13],[14],[15]}

13.99%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 3,167

^{[7],[16],[23]}

$ 5,403

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

5,160

Fair value, ending balance

$ 2,993

^[7],[23]

$ 5,160

^[13],[14]

Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.50%

^[7],[23]

8.50%

^{[11],[13],[14]}

8.50%

^[7],[23]

8.50%

^[7],[23]

8.50%

^{[11],[13],[14]}

8.50%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

13.20%

^{[7],[10],[23]}

13.99%

^{[11],[13],[14],[15]}

13.20%

^{[7],[10],[23]}

13.20%

^{[7],[10],[23]}

13.99%

^{[11],[13],[14],[15]}

13.99%

^{[11],[13],[14],[15]}

Investment owned, balance, principal amount

$ 5,822

^{[7],[16],[23]}

$ 2,939

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

2,745

Fair value, ending balance

$ 5,502

^[7],[23]

$ 2,745

^{[11],[13],[14]}

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[8],[23]

6.00%

^{[11],[13],[14]}

6.00%

^[7],[8],[23]

6.00%

^[7],[8],[23]

6.00%

^{[11],[13],[14]}

6.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[11],[13],[14],[15]}

11.42%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 964

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

938

Fair value, ending balance

$ (24)

^[7],[8],[23]

$ 938

^{[11],[13],[14]}

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[7],[23]

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[13],[14]

Investment, interest rate (as a percent)

11.40%

^{[7],[10],[23]}

11.52%

^{[13],[14],[15]}

11.40%

^{[7],[10],[23]}

11.40%

^{[7],[10],[23]}

11.52%

^{[13],[14],[15]}

11.52%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 2,604

^{[7],[16],[23]}

$ 20,125

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

19,823

Fair value, ending balance

$ 2,568

^[7],[23]

$ 19,823

^[13],[14]

Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[7],[23]

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[13],[14]

Investment, interest rate (as a percent)

11.40%

^{[7],[10],[23]}

11.52%

^{[13],[14],[15]}

11.40%

^{[7],[10],[23]}

11.40%

^{[7],[10],[23]}

11.52%

^{[13],[14],[15]}

11.52%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 7,224

^{[7],[16],[23]}

$ 2,631

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

2,591

Fair value, ending balance

7,125

^[7],[23]

$ 2,591

^[13],[14]

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14]}

7.50%

Investment, interest rate (as a percent)

^{[11],[13],[14],[15]}

12.83%

Investment owned, balance, principal amount

^{[11],[13],[14],[17]}

$ 1,466

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

1,282

Fair value, ending balance

^{[11],[13],[14]}

$ 1,282

Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.50%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.89%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 40,538

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 39,833

Fair value, ending balance

^[13],[14]

$ 39,833

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^[7],[8],[23]

5.50%

^{[11],[13],[14]}

4.75%

^[7],[8],[23]

4.75%

^[7],[8],[23]

5.50%

^{[11],[13],[14]}

5.50%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(47)

Fair value, ending balance

$ (44)

^[7],[8],[23]

$ (47)

^{[11],[13],[14]}

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^[7],[23]

5.50%

^[13],[14]

4.75%

^[7],[23]

4.75%

^[7],[23]

5.50%

^[13],[14]

5.50%

^[13],[14]

Investment, interest rate (as a percent)

9.35%

^{[7],[10],[23]}

10.99%

^{[13],[14],[15]}

9.35%

^{[7],[10],[23]}

9.35%

^{[7],[10],[23]}

10.99%

^{[13],[14],[15]}

10.99%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 33,831

^{[7],[16],[23]}

$ 13,973

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

13,685

Fair value, ending balance

$ 33,503

^[7],[23]

$ 13,685

^[13],[14]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.75%

^[7],[23]

5.50%

^[13],[14]

4.75%

^[7],[23]

4.75%

^[7],[23]

5.50%

^[13],[14]

5.50%

^[13],[14]

Investment, interest rate (as a percent)

9.35%

^{[7],[10],[23]}

10.99%

^{[13],[14],[15]}

9.35%

^{[7],[10],[23]}

9.35%

^{[7],[10],[23]}

10.99%

^{[13],[14],[15]}

10.99%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 13,829

^{[7],[16],[23]}

$ 21,328

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

20,888

Fair value, ending balance

$ 13,695

^[7],[23]

$ 20,888

^[13],[14]

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

4.75%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

9.35%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 6,652

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 6,588

Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

4.75%

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

9.35%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 792

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 760

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

11.50%

^{[7],[10],[18]}

11.50%

^{[13],[14],[15],[20]}

11.50%

^{[7],[10],[18]}

11.50%

^{[7],[10],[18]}

11.50%

^{[13],[14],[15],[20]}

11.50%

^{[13],[14],[15],[20]}

Investment owned, balance, principal amount

$ 8,139

^{[7],[16],[18]}

$ 8,568

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

8,132

Fair value, ending balance

$ 7,773

^[7],[18]

$ 8,132

^[14],[20]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

11.50%

^{[7],[10],[18]}

11.50%

^{[13],[14],[15],[20]}

11.50%

^{[7],[10],[18]}

11.50%

^{[7],[10],[18]}

11.50%

^{[13],[14],[15],[20]}

11.50%

^{[13],[14],[15],[20]}

Investment owned, balance, principal amount

$ 3,855

^{[7],[16],[18]}

$ 4,284

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

4,066

Fair value, ending balance

$ 3,682

^[7],[18]

$ 4,066

^[14],[20]

Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

11.50%

^{[7],[10],[18]}

11.50%

^{[13],[14],[15],[20]}

11.50%

^{[7],[10],[18]}

11.50%

^{[7],[10],[18]}

11.50%

^{[13],[14],[15],[20]}

11.50%

^{[13],[14],[15],[20]}

Investment owned, balance, principal amount

$ 4,070

^{[7],[16],[18]}

$ 8,568

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

8,132

Fair value, ending balance

$ 3,886

^[7],[18]

$ 8,132

^[14],[20]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

9.75%

^{[7],[10],[18]}

8.00%

^{[13],[14],[15],[20]}

9.75%

^{[7],[10],[18]}

9.75%

^{[7],[10],[18]}

8.00%

^{[13],[14],[15],[20]}

8.00%

^{[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

^[14],[20]

1.75%

Investment owned, balance, principal amount

$ 7,660

^{[7],[16],[18]}

$ 9,106

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

8,013

Fair value, ending balance

$ 7,373

^[7],[18]

$ 8,013

^[14],[20]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

33,409

^[7],[18]

259,877

^[14],[20]

33,409

^[7],[18]

33,409

^[7],[18]

259,877

^[14],[20]

259,877

^[14],[20]

Investment owned, balance, principal amount

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 78

Fair value, ending balance

$ 154

^[7],[18]

$ 78

^[14],[20]

Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

129,939

^[7],[18]

66,817

^[14],[20]

129,939

^[7],[18]

129,939

^[7],[18]

66,817

^[14],[20]

66,817

^[14],[20]

Investment owned, balance, principal amount

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 33

Fair value, ending balance

$ 416

^[7],[18]

$ 33

^[14],[20]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[7],[8],[23]

7.00%

^{[11],[13],[14]}

7.00%

^[7],[8],[23]

7.00%

^[7],[8],[23]

7.00%

^{[11],[13],[14]}

7.00%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(76)

Fair value, ending balance

$ (56)

^[7],[8],[23]

$ (76)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[7],[23]

7.00%

^[13],[14]

7.00%

^[7],[23]

7.00%

^[7],[23]

7.00%

^[13],[14]

7.00%

^[13],[14]

Investment, interest rate (as a percent)

12.40%

^{[7],[10],[23]}

12.52%

^{[13],[14],[15]}

12.40%

^{[7],[10],[23]}

12.40%

^{[7],[10],[23]}

12.52%

^{[13],[14],[15]}

12.52%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 51,356

^{[7],[16],[23]}

$ 5,248

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

5,164

Fair value, ending balance

$ 50,806

^[7],[23]

$ 5,164

^[13],[14]

Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[7],[23]

7.00%

^[13],[14]

7.00%

^[7],[23]

7.00%

^[7],[23]

7.00%

^[13],[14]

7.00%

^[13],[14]

Investment, interest rate (as a percent)

12.40%

^{[7],[10],[23]}

12.52%

^{[13],[14],[15]}

12.40%

^{[7],[10],[23]}

12.40%

^{[7],[10],[23]}

12.52%

^{[13],[14],[15]}

12.52%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 2,294

^{[7],[16],[23]}

$ 46,687

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

45,940

Fair value, ending balance

$ 2,269

^[7],[23]

$ 45,940

^[13],[14]

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[18],[23]}

5.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[18],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[8],[18],[23]}

$ (12)

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

5.00%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

9.85%

Investment owned, balance, principal amount

^{[7],[16],[18],[23]}

$ 7,056

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[23]}

$ 6,932

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[18],[23]}

5.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[18],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[8],[18],[23]}

$ (11)

Investment, Identifier [Axis]: Minotaur Acquisition, Inc., Financial Exchanges & Data, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

5.00%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

9.85%

Investment owned, balance, principal amount

^{[7],[16],[18],[23]}

$ 1,176

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[23]}

$ 1,156

Investment, Identifier [Axis]: Modena Buyer LLC, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23]

4.50%

Investment, interest rate (as a percent)

^[10],[23]

9.10%

Investment owned, balance, principal amount

^[16],[23]

$ 27,705

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[23]

$ 26,588

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.50%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 0

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.56%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 38,326

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 38,326

Investment, Identifier [Axis]: Monotype Imaging Holdings Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.50%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 0

Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^[7],[23]

6.75%

^[13],[14]

8.25%

^[7],[23]

8.25%

^[7],[23]

6.75%

^[13],[14]

6.75%

^[13],[14]

Investment, interest rate (as a percent)

10.58%

^{[7],[10],[23]}

12.51%

^{[13],[14],[15]}

10.58%

^{[7],[10],[23]}

10.58%

^{[7],[10],[23]}

12.51%

^{[13],[14],[15]}

12.51%

^{[13],[14],[15]}

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

3.25%

Investment owned, balance, principal amount

$ 50,077

^{[7],[16],[23]}

$ 54,559

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

53,168

Fair value, ending balance

48,775

^[7],[23]

$ 53,168

^[13],[14]

Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^[13],[15]

6.88%

Investment owned, balance, principal amount

^[17]

$ 10,191

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

$ 8,743

Fair value, ending balance

$ 8,743

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.88%

^{[7],[18],[23]}

6.88%

^{[13],[14],[20]}

8.88%

^{[7],[18],[23]}

8.88%

^{[7],[18],[23]}

6.88%

^{[13],[14],[20]}

6.88%

^{[13],[14],[20]}

Investment, interest rate (as a percent)

11.82%

^{[7],[10],[18],[23]}

12.29%

^{[13],[14],[15],[20]}

11.82%

^{[7],[10],[18],[23]}

11.82%

^{[7],[10],[18],[23]}

12.29%

^{[13],[14],[15],[20]}

12.29%

^{[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

2.00%

^{[7],[18],[23]}

2.00%

^{[13],[14],[20]}

2.00%

^{[7],[18],[23]}

2.00%

^{[7],[18],[23]}

2.00%

^{[13],[14],[20]}

2.00%

^{[13],[14],[20]}

Investment owned, balance, principal amount

$ 56,701

^{[7],[16],[18],[23]}

$ 73,362

^{[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

69,694

Fair value, ending balance

$ 55,737

^{[7],[18],[23]}

$ 69,694

^{[13],[14],[20]}

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

487,870

^[18]

487,870

^[20]

487,870

^[18]

487,870

^[18]

487,870

^[20]

487,870

^[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

$ 903

Fair value, ending balance

$ 1,898

^[18]

$ 903

^[20]

Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

239,590

^[18]

487,870

^[20]

239,590

^[18]

239,590

^[18]

487,870

^[20]

487,870

^[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

$ 903

Fair value, ending balance

932

^[18]

$ 903

^[20]

Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

8.50%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

13.99%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 30,339

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 29,007

Fair value, ending balance

^[13],[14]

$ 29,007

Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

2.25%

^[7],[23]

9.50%

^[13],[14]

2.25%

^[7],[23]

2.25%

^[7],[23]

9.50%

^[13],[14]

9.50%

^[13],[14]

Investment, interest rate (as a percent)

6.85%

^{[7],[10],[23]}

14.89%

^{[13],[14],[15]}

6.85%

^{[7],[10],[23]}

6.85%

^{[7],[10],[23]}

14.89%

^{[13],[14],[15]}

14.89%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 55,783

^{[7],[16],[23]}

$ 64,606

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

63,185

Fair value, ending balance

$ 54,668

^[7],[23]

$ 63,185

^[13],[14]

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

6.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 0

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

6.00%

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

6.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

11.06%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 19,895

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

19,895

Investment, Identifier [Axis]: Next Holdco, LLC, Health Care Technology, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 0

Investment, Identifier [Axis]: Northwoods Capital 25 Ltd, Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[23]

7.40%

Investment, interest rate (as a percent)

^{[10],[18],[23]}

12.68%

Investment owned, balance, principal amount

^{[16],[18],[23]}

$ 700

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[18],[23]

$ 681

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest

Schedule of Investments [Line Items]

Investment owned, ownership (as a percent)

87.50%

^{[8],[18],[29],[30]}

87.50%

^{[11],[20],[31],[32]}

87.50%

^{[8],[18],[29],[30]}

87.50%

^{[8],[18],[29],[30]}

87.50%

^{[11],[20],[31],[32]}

87.50%

^{[11],[20],[31],[32]}

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[20],[31],[32]}

Gross Additions

Gross Reductions

Fair value, ending balance

$ 0

^{[8],[18],[29],[30]}

$ 0

^{[11],[20],[31],[32]}

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

^{[7],[8],[18],[23],[29]}

4.50%

^{[11],[13],[14],[20],[31]}

4.50%

^{[7],[8],[18],[23],[29]}

4.50%

^{[7],[8],[18],[23],[29]}

4.50%

^{[11],[13],[14],[20],[31]}

4.50%

^{[11],[13],[14],[20],[31]}

Investment, interest rate (as a percent)

9.95%

^{[7],[8],[10],[18],[23],[29]}

9.76%

^{[11],[13],[14],[15],[20],[31]}

9.95%

^{[7],[8],[10],[18],[23],[29]}

9.95%

^{[7],[8],[10],[18],[23],[29]}

9.76%

^{[11],[13],[14],[15],[20],[31]}

9.76%

^{[11],[13],[14],[15],[20],[31]}

Investment owned, balance, principal amount

$ 58,349

^{[7],[8],[16],[18],[23],[29]}

$ 58,349

^{[11],[13],[14],[17],[20],[31]}

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

7,239

6,748

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

50,017

^{[11],[13],[14],[20],[31]}

50,283

Gross Additions

1,338

1,448

Gross Reductions

(2,459)

(1,714)

Fair value, ending balance

$ 48,896

^{[7],[8],[18],[23],[29]}

$ 50,017

^{[11],[13],[14],[20],[31]}

Investment owned, percent of net assets (as a percent)

3.30%

Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.49%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 9,323

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 9,183

Fair value, ending balance

^[13],[14]

$ 9,183

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7]

2,613,034

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7]

$ 13,562

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

9.50%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

14.62%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 12,070

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

12,070

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

10.00%

Investment, interest rate, paid in kind (as a percent)

^[13],[14]

15.67%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 25,712

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

25,069

Fair value, ending balance

^[13],[14]

$ 25,069

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14]}

10.00%

Investment owned, balance, principal amount

^{[11],[13],[14],[17]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(69)

Fair value, ending balance

^{[11],[13],[14]}

$ (69)

Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14]}

10.00%

Investment, interest rate, paid in kind (as a percent)

^{[11],[13],[14]}

15.64%

Investment owned, balance, principal amount

^{[11],[13],[14],[17]}

$ 1,210

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

$ 1,169

Fair value, ending balance

^{[11],[13],[14]}

$ 1,169

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.50%

^[7],[8],[23]

7.75%

^{[11],[13],[14]}

7.50%

^[7],[8],[23]

7.50%

^[7],[8],[23]

7.75%

^{[11],[13],[14]}

7.75%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(36)

Fair value, ending balance

^[7],[8],[23]

$ (36)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.75%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

13.12%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 15,231

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 14,945

Fair value, ending balance

^[13],[14]

14,945

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

7.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

12.75%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 15,231

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 15,231

Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

7.25%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

12.50%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 4,047

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

3,986

Investment, Identifier [Axis]: Other cash accounts

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

62,277

Fair value, ending balance

43,946

$ 62,277

Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^[13],[15]

7.75%

Investment owned, balance, principal amount

^[17]

$ 4,519

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

$ 3,305

Fair value, ending balance

$ 3,305

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.50%

^[7],[8],[23]

7.00%

^{[11],[13],[14]}

5.50%

^[7],[8],[23]

5.50%

^[7],[8],[23]

7.00%

^{[11],[13],[14]}

7.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

11.35%

Investment owned, balance, principal amount

$ 753

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(54)

Fair value, ending balance

753

^[7],[8],[23]

$ (54)

^{[11],[13],[14]}

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.32%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 10,895

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 10,495

Fair value, ending balance

^[13],[14]

$ 10,495

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

6.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

11.35%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 10,786

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 10,786

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.10%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 5,088

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 5,019

Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.50%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (128)

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

100,000

^[7]

100,000

^[14]

100,000

^[7]

100,000

^[7]

100,000

^[14]

100,000

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 248

Fair value, ending balance

$ 415

^[7]

$ 248

^[14]

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[7],[8],[23]

6.50%

^{[11],[13],[14]}

6.50%

^[7],[8],[23]

6.50%

^[7],[8],[23]

6.50%

^{[11],[13],[14]}

6.50%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(3)

Fair value, ending balance

$ 0

^[7],[8],[23]

$ (3)

^{[11],[13],[14]}

Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.50%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[7],[23]

6.50%

^[7],[23]

6.50%

^[13],[14]

6.50%

^[13],[14]

Investment, interest rate (as a percent)

11.90%

^{[7],[10],[23]}

12.01%

^{[13],[14],[15]}

11.90%

^{[7],[10],[23]}

11.90%

^{[7],[10],[23]}

12.01%

^{[13],[14],[15]}

12.01%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 26,176

^{[7],[16],[23]}

$ 38,414

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

38,380

Fair value, ending balance

26,176

^[7],[23]

$ 38,380

^[13],[14]

Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

5.00%

Investment, interest rate (as a percent)

^[13],[15]

10.42%

Investment owned, balance, principal amount

^[13],[17]

$ 9,676

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

$ 9,551

Fair value, ending balance

^[13]

$ 9,551

Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[7],[23]

6.00%

^[13],[14]

5.75%

^[7],[23]

5.75%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[13],[14]

Investment, interest rate (as a percent)

11.11%

^{[7],[10],[23]}

11.57%

^{[13],[14],[15]}

11.11%

^{[7],[10],[23]}

11.11%

^{[7],[10],[23]}

11.57%

^{[13],[14],[15]}

11.57%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 22,375

^{[7],[16],[23]}

$ 22,375

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

21,896

Fair value, ending balance

$ 22,375

^[7],[23]

$ 21,896

^[13],[14]

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

6.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (175)

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

6.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.85%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 52,244

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 50,912

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

6.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (106)

Investment, Identifier [Axis]: PetVet Care Centers, LLC, Health Care Services, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7]

4,531

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7]

$ 5,022

Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.25%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.74%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 36,499

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 33,214

Fair value, ending balance

^[13],[14]

$ 33,214

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7]

4,300,526

Investment owned, balance, principal amount

^[7],[16]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7]

$ 14,364

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

^[7],[8],[23]

8.00%

^{[11],[13],[14]}

4.50%

^[7],[8],[23]

4.50%

^[7],[8],[23]

8.00%

^{[11],[13],[14]}

8.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[11],[13],[14],[15]}

13.45%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 3,003

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

2,801

Fair value, ending balance

^[7],[8],[23]

$ 2,801

^{[11],[13],[14]}

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

8.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

13.45%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 67,244

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 64,406

Fair value, ending balance

^[13],[14]

$ 64,406

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

4.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

8.12%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

1.50%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 4,965

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 4,965

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

4.50%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 0

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

4.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

8.12%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

1.50%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 8,601

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 8,601

Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

7.50%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

12.62%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 12,902

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 12,902

Investment, Identifier [Axis]: Poseidon Midco AB, Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

5.50%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

8.97%

Investment owned, balance, principal amount | €

^{[7],[16],[18],[23]}

€ 12,868

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[23]}

$ 13,994

Investment, Identifier [Axis]: Poseidon Midco AB, Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[18],[23]}

5.50%

Investment owned, balance, principal amount

^{[7],[8],[16],[18],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[8],[18],[23]}

$ 0

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Floating Rate Bond

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

7.25%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

11.84%

Investment owned, balance, principal amount

^{[7],[16],[18],[23]}

$ 26,642

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[23]}

26,410

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.25%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.78%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 24,503

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

24,081

Fair value, ending balance

^[13],[14]

$ 24,081

Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.25%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.78%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 2,819

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 2,771

Fair value, ending balance

^[13],[14]

$ 2,771

Investment, Identifier [Axis]: Protein For Pets Opco, LLC, Packaged Foods & Meats, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.25%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (41)

Investment, Identifier [Axis]: Protein For Pets Opco, LLC, Packaged Foods & Meats, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.25%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.10%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 20,274

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

19,887

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

5.75%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

11.21%

Investment owned, balance, principal amount | £

^{[13],[14],[17],[20]}

£ 4,626

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

$ 5,166

Fair value, ending balance

^{[13],[14],[20]}

$ 5,166

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

5.50%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

10.73%

Investment owned, balance, principal amount | £

^{[7],[16],[18],[23]}

£ 9,739

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[23]}

$ 12,769

Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[18],[23]}

5.50%

Investment, interest rate (as a percent)

^{[7],[8],[10],[18],[23]}

10.70%

Investment owned, balance, principal amount

^{[7],[8],[16],[18],[23]}

$ 2,123

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[8],[18],[23]}

$ 2,715

Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

64,887,669

^[7]

64,887,669

^[14]

64,887,669

^[7]

64,887,669

^[7]

64,887,669

^[14]

64,887,669

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 0

Fair value, ending balance

^[7]

$ 0

^[14]

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14]}

6.50%

Investment owned, balance, principal amount

^{[11],[13],[14],[17]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(47)

Fair value, ending balance

^{[11],[13],[14]}

$ (47)

Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

6.50%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

11.92%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 32,329

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 31,779

Fair value, ending balance

^[13],[14]

$ 31,779

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^{[7],[18],[23]}

8.25%

^{[13],[14],[20]}

8.25%

^{[7],[18],[23]}

8.25%

^{[7],[18],[23]}

8.25%

^{[13],[14],[20]}

8.25%

^{[13],[14],[20]}

Investment, interest rate (as a percent)

12.77%

^{[7],[10],[18],[23]}

13.90%

^{[13],[14],[15],[20]}

12.77%

^{[7],[10],[18],[23]}

12.77%

^{[7],[10],[18],[23]}

13.90%

^{[13],[14],[15],[20]}

13.90%

^{[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

1.00%

^{[7],[18],[23]}

0.50%

^{[13],[14],[20]}

1.00%

^{[7],[18],[23]}

1.00%

^{[7],[18],[23]}

0.50%

^{[13],[14],[20]}

0.50%

^{[13],[14],[20]}

Investment owned, balance, principal amount

$ 8,819

^{[7],[16],[18],[23]}

$ 36,707

^{[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

34,505

Fair value, ending balance

$ 8,334

^{[7],[18],[23]}

$ 34,505

^{[13],[14],[20]}

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.25%

^{[7],[18],[23]}

8.25%

^{[13],[14],[20]}

8.25%

^{[7],[18],[23]}

8.25%

^{[7],[18],[23]}

8.25%

^{[13],[14],[20]}

8.25%

^{[13],[14],[20]}

Investment, interest rate (as a percent)

12.77%

^{[7],[10],[18],[23]}

13.90%

^{[13],[14],[15],[20]}

12.77%

^{[7],[10],[18],[23]}

12.77%

^{[7],[10],[18],[23]}

13.90%

^{[13],[14],[15],[20]}

13.90%

^{[13],[14],[15],[20]}

Investment, interest rate, paid in kind (as a percent)

1.00%

^{[7],[18],[23]}

0.50%

^{[13],[14],[20]}

1.00%

^{[7],[18],[23]}

1.00%

^{[7],[18],[23]}

0.50%

^{[13],[14],[20]}

0.50%

^{[13],[14],[20]}

Investment owned, balance, principal amount

$ 29,223

^{[7],[16],[18],[23]}

$ 13,504

^{[13],[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

12,694

Fair value, ending balance

$ 27,615

^{[7],[18],[23]}

$ 12,694

^{[13],[14],[20]}

Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

204,454

^[7],[18]

204,454

^[14],[20]

204,454

^[7],[18]

204,454

^[7],[18]

204,454

^[14],[20]

204,454

^[14],[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 756

Fair value, ending balance

470

^[7],[18]

$ 756

^[14],[20]

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14]

1,037

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

951

Fair value, ending balance

^[14]

$ 951

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

8.75%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

14.18%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 8,010

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

7,778

Fair value, ending balance

^[13],[14]

$ 7,778

Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14]}

8.75%

Investment owned, balance, principal amount

^{[11],[13],[14],[17]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

$ (68)

Fair value, ending balance

^{[11],[13],[14]}

$ (68)

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

1,184,630

^[7]

1,184,630

^[14]

1,184,630

^[7]

1,184,630

^[7]

1,184,630

^[14]

1,184,630

^[14]

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

36,226

^[14]

Gross Additions

40,093

Gross Reductions

(15,424)

(3,867)

Fair value, ending balance

$ 20,802

^[7]

$ 36,226

^[14]

Investment owned, percent of net assets (as a percent)

1.40%

2.40%

1.40%

2.40%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

12.00%

^[7]

12.00%

^[14]

12.00%

^[7]

12.00%

^[7]

12.00%

^[14]

12.00%

^[14]

Investment owned, balance, principal amount

$ 17,907

^[7],[16]

$ 15,874

^[14],[17]

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

2,232

340

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

15,874

^[14]

Gross Additions

2,239

16,653

Gross Reductions

(206)

(779)

Fair value, ending balance

$ 17,907

^[7]

$ 15,874

^[14]

Investment owned, percent of net assets (as a percent)

1.20%

1.00%

1.20%

1.00%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

12.00%

^[7]

12.00%

^[11],[14]

12.00%

^[7]

12.00%

^[7]

12.00%

^[11],[14]

12.00%

^[11],[14]

Investment owned, balance, principal amount

$ 3,550

^[7],[16]

$ 1,359

^{[11],[14],[17]}

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

383

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

1,359

^[11],[14]

Gross Additions

2,191

1,359

Gross Reductions

Fair value, ending balance

$ 3,550

^[7]

$ 1,359

^[11],[14]

Investment owned, percent of net assets (as a percent)

0.20%

0.10%

0.20%

0.10%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7]

12.00%

Investment owned, balance, principal amount

^[7],[16]

$ 3,332

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

166

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

3,332

Gross Reductions

Fair value, ending balance

$ 3,332

^[7]

$ 0

Investment owned, percent of net assets (as a percent)

0.20%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7]

12.00%

Investment owned, balance, principal amount

^[7],[16]

$ 1,600

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

1,600

Gross Reductions

Fair value, ending balance

$ 1,600

^[7]

Investment owned, percent of net assets (as a percent)

0.10%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 5

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7],[8]

12.00%

Investment owned, balance, principal amount

^[7],[8],[16]

$ 0

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

Gross Reductions

Fair value, ending balance

$ 0

^[7],[8]

$ 0

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

66,686

^[7]

66,686

^[14]

66,686

^[7]

66,686

^[7]

66,686

^[14]

66,686

^[14]

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

Gross Additions

Gross Reductions

Fair value, ending balance

$ 0

^[7]

$ 0

^[14]

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.50%

^[7],[23]

4.75%

^[13],[14]

4.50%

^[7],[23]

4.50%

^[7],[23]

4.75%

^[13],[14]

4.75%

^[13],[14]

Investment, interest rate (as a percent)

10.01%

^{[7],[10],[23]}

10.38%

^{[13],[14],[15]}

10.01%

^{[7],[10],[23]}

10.01%

^{[7],[10],[23]}

10.38%

^{[13],[14],[15]}

10.38%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 4,406

^{[7],[16],[23]}

$ 4,452

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

4,184

Fair value, ending balance

$ 4,318

^[7],[23]

$ 4,184

^[13],[14]

Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

8.00%

^[7],[23]

8.00%

^[13],[14]

8.00%

^[7],[23]

8.00%

^[7],[23]

8.00%

^[13],[14]

8.00%

^[13],[14]

Investment, interest rate (as a percent)

13.51%

^{[7],[10],[23]}

13.63%

^{[13],[14],[15]}

13.51%

^{[7],[10],[23]}

13.51%

^{[7],[10],[23]}

13.63%

^{[13],[14],[15]}

13.63%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 12,034

^{[7],[16],[23]}

$ 12,034

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

9,928

Fair value, ending balance

11,432

^[7],[23]

$ 9,928

^[13],[14]

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

6.75%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.40%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 25,527

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 19,954

Fair value, ending balance

^[13],[14]

$ 19,954

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[22],[23]}

8.25%

Investment owned, balance, principal amount

^{[7],[16],[22],[23]}

$ 28,146

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[22],[23]}

$ 8,444

Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[22],[23]}

9.75%

Investment owned, balance, principal amount

^{[7],[8],[16],[22],[23]}

$ 932

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[8],[22],[23]}

$ 932

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

10.00%

^[7],[8],[23]

10.00%

^{[11],[13],[14]}

10.00%

^[7],[8],[23]

10.00%

^[7],[8],[23]

10.00%

^{[11],[13],[14]}

10.00%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

(93)

Fair value, ending balance

$ (140)

^[7],[8],[23]

$ (93)

^{[11],[13],[14]}

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

10.00%

^[7],[23]

10.00%

^[13],[14]

10.00%

^[7],[23]

10.00%

^[7],[23]

10.00%

^[13],[14]

10.00%

^[13],[14]

Investment, interest rate (as a percent)

14.85%

^{[7],[10],[23]}

15.24%

^{[13],[14],[15]}

14.85%

^{[7],[10],[23]}

14.85%

^{[7],[10],[23]}

15.24%

^{[13],[14],[15]}

15.24%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 22,107

^{[7],[16],[23]}

$ 25,558

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

24,791

Fair value, ending balance

$ 21,112

^[7],[23]

$ 24,791

^[13],[14]

Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

991,019

^[7]

991,019

^[14]

991,019

^[7]

991,019

^[7]

991,019

^[14]

991,019

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 1,625

Fair value, ending balance

$ 89

^[7]

$ 1,625

^[14]

Investment, Identifier [Axis]: Saratoga, Diversified Financial Services, Credit Linked Note

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23],[33]}

5.33%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23],[33]}

10.18%

Investment owned, balance, principal amount

^{[7],[16],[18],[23],[33]}

$ 24,500

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[23],[33]}

$ 24,478

Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

9,307

^[18]

9,307

^[20]

9,307

^[18]

9,307

^[18]

9,307

^[20]

9,307

^[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

$ 13

Fair value, ending balance

$ 9

^[18]

$ 13

^[20]

Investment, Identifier [Axis]: Secure Acquisition Inc., Paper & Plastic Packaging Products & Materials, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23]

4.25%

Investment, interest rate (as a percent)

^[10],[23]

8.85%

Investment owned, balance, principal amount

^[16],[23]

$ 14,963

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[23]

$ 15,009

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest

Schedule of Investments [Line Items]

Investment owned, ownership (as a percent)

87.50%

^{[7],[8],[18],[28],[29],[30]}

87.50%

^{[11],[20],[31],[32],[34]}

87.50%

^{[7],[8],[18],[28],[29],[30]}

87.50%

^{[7],[8],[18],[28],[29],[30]}

87.50%

^{[11],[20],[31],[32],[34]}

87.50%

^{[11],[20],[31],[32],[34]}

Net Realized Gain (Loss)

$ 0

Amount of Interest, Fees or Dividends Credited in Income

5,250

4,200

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

28,878

^{[11],[20],[31],[32],[34]}

20,715

Gross Additions

8,163

Gross Reductions

(6,337)

Fair value, ending balance

$ 22,541

^{[7],[8],[18],[28],[29],[30]}

$ 28,878

^{[11],[20],[31],[32],[34]}

Investment owned, percent of net assets (as a percent)

1.50%

1.90%

1.50%

1.90%

Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^{[7],[8],[18],[23],[29]}

7.00%

^{[11],[13],[14],[20],[31]}

7.00%

^{[7],[8],[18],[23],[29]}

7.00%

^{[7],[8],[18],[23],[29]}

7.00%

^{[11],[13],[14],[20],[31]}

7.00%

^{[11],[13],[14],[20],[31]}

Investment, interest rate (as a percent)

12.45%

^{[7],[8],[10],[18],[23],[29]}

12.26%

^{[11],[13],[14],[15],[20],[31]}

12.45%

^{[7],[8],[10],[18],[23],[29]}

12.45%

^{[7],[8],[10],[18],[23],[29]}

12.26%

^{[11],[13],[14],[15],[20],[31]}

12.26%

^{[11],[13],[14],[15],[20],[31]}

Investment owned, balance, principal amount

$ 112,656

^{[7],[8],[16],[18],[23],[29]}

$ 112,656

^{[11],[13],[14],[17],[20],[31]}

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

14,256

12,726

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

112,656

^{[11],[13],[14],[20],[31]}

96,250

Gross Additions

16,406

Gross Reductions

Fair value, ending balance

$ 112,656

^{[7],[8],[18],[23],[29]}

$ 112,656

^{[11],[13],[14],[20],[31]}

Investment owned, percent of net assets (as a percent)

7.60%

7.40%

7.60%

7.40%

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

7.88%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

12.88%

Investment owned, balance, principal amount

^{[13],[14],[17],[20]}

$ 7,191

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

$ 6,937

Fair value, ending balance

^{[13],[14],[20]}

$ 6,937

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

7.88%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

12.88%

Investment owned, balance, principal amount

^{[13],[14],[17],[20]}

$ 2,697

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

2,602

Fair value, ending balance

^{[13],[14],[20]}

$ 2,602

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14],[20]}

7.88%

Investment owned, balance, principal amount

^{[11],[13],[14],[17],[20]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14],[20]}

Fair value, ending balance

^{[11],[13],[14],[20]}

$ 0

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14],[20]}

7.88%

Investment owned, balance, principal amount

^{[11],[13],[14],[17],[20]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14],[20]}

$ 0

Fair value, ending balance

^{[11],[13],[14],[20]}

$ 0

Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

58,210

^[7],[18]

58,210

^[14],[20]

58,210

^[7],[18]

58,210

^[7],[18]

58,210

^[14],[20]

58,210

^[14],[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

$ 87

Fair value, ending balance

^[7],[18]

$ 87

^[14],[20]

Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14]

345,452

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

Fair value, ending balance

^[14]

$ 0

Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.50%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

13.04%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 821

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 776

Fair value, ending balance

^[13],[14]

$ 776

Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.75%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ (89)

Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.75%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.60%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 47,730

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 46,947

Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

66,000

^[18]

66,000

^[20]

66,000

^[18]

66,000

^[18]

66,000

^[20]

66,000

^[20]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

$ 6

Fair value, ending balance

$ 0

^[18]

$ 6

^[20]

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.00%

^[7],[8],[23]

5.00%

^{[11],[13],[14]}

5.00%

^[7],[8],[23]

5.00%

^[7],[8],[23]

5.00%

^{[11],[13],[14]}

5.00%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[11],[13],[14],[15]}

10.42%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 618

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

577

Fair value, ending balance

$ (15)

^[7],[8],[23]

$ 577

^{[11],[13],[14]}

Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.25%

^[7],[23]

5.25%

^[13],[14]

5.25%

^[7],[23]

5.25%

^[7],[23]

5.25%

^[13],[14]

5.25%

^[13],[14]

Investment, interest rate (as a percent)

10.20%

^{[7],[10],[23]}

10.67%

^{[13],[14],[15]}

10.20%

^{[7],[10],[23]}

10.20%

^{[7],[10],[23]}

10.67%

^{[13],[14],[15]}

10.67%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 18,058

^{[7],[16],[23]}

$ 4,488

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

4,425

Fair value, ending balance

$ 18,032

^[7],[23]

$ 4,425

^[13],[14]

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[23]

5.75%

Investment, interest rate (as a percent)

^[10],[23]

10.69%

Investment owned, balance, principal amount

^[16],[23]

$ 13,780

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[23]

$ 12,555

Investment, Identifier [Axis]: Staples, Inc., Office Services & Supplies, Fixed Rate Bond

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^[10]

10.75%

Investment owned, balance, principal amount

^[16]

$ 6,835

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

6,641

Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

8.50%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

12.32%

Investment owned, balance, principal amount | €

^{[13],[14],[17],[20]}

€ 23,731

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

$ 24,937

Fair value, ending balance

^{[13],[14],[20]}

$ 24,937

Investment, Identifier [Axis]: SumUp Holdings Luxembourg, Diversified Financial Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[18],[23]}

6.50%

Investment, interest rate (as a percent)

^{[7],[8],[10],[18],[23]}

10.04%

Investment owned, balance, principal amount

^{[7],[8],[16],[18],[23]}

$ 18,846

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[8],[18],[23]}

20,785

Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

8.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

13.32%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 49,520

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 49,148

Fair value, ending balance

^[13],[14]

$ 49,148

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[7],[8],[23]

7.00%

^{[13],[14],[35]}

7.00%

^[7],[8],[23]

7.00%

^[7],[8],[23]

7.00%

^{[13],[14],[35]}

7.00%

^{[13],[14],[35]}

Investment, interest rate (as a percent)

^{[13],[14],[15],[35]}

12.44%

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 1,552

^{[13],[14],[17],[35]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[35]}

1,478

Fair value, ending balance

(62)

^[7],[8],[23]

$ 1,478

^{[13],[14],[35]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14],[35]}

7.00%

Investment, interest rate (as a percent)

^{[11],[13],[14],[15],[35]}

12.51%

Investment owned, balance, principal amount

^{[11],[13],[14],[17],[35]}

$ 1,099

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14],[35]}

$ 943

Fair value, ending balance

^{[11],[13],[14],[35]}

$ 943

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[7],[23]

7.00%

^{[13],[14],[35]}

7.00%

^[7],[23]

7.00%

^[7],[23]

7.00%

^{[13],[14],[35]}

7.00%

^{[13],[14],[35]}

Investment, interest rate (as a percent)

12.58%

^{[7],[10],[23]}

12.51%

^{[13],[14],[15],[35]}

12.58%

^{[7],[10],[23]}

12.58%

^{[7],[10],[23]}

12.51%

^{[13],[14],[15],[35]}

12.51%

^{[13],[14],[15],[35]}

Investment owned, balance, principal amount

$ 2,721

^{[7],[16],[23]}

$ 32,104

^{[13],[14],[17],[35]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[35]}

30,579

Fair value, ending balance

$ 2,612

^[7],[23]

$ 30,579

^{[13],[14],[35]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.00%

^[7],[23]

7.00%

^{[13],[14],[35]}

7.00%

^[7],[23]

7.00%

^[7],[23]

7.00%

^{[13],[14],[35]}

7.00%

^{[13],[14],[35]}

Investment, interest rate (as a percent)

12.58%

^{[7],[10],[23]}

12.51%

^{[13],[14],[15],[35]}

12.58%

^{[7],[10],[23]}

12.58%

^{[7],[10],[23]}

12.51%

^{[13],[14],[15],[35]}

12.51%

^{[13],[14],[15],[35]}

Investment owned, balance, principal amount

$ 2,749

^{[13],[14],[17],[35]}

€ 3,273

^{[7],[16],[23]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[35]}

$ 2,618

Fair value, ending balance

$ 3,142

^[7],[23]

$ 2,618

^{[13],[14],[35]}

Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

7.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

12.58%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 31,778

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

30,507

Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[12],[13],[14],[15],[20]}

11.50%

Investment owned, balance, principal amount

^{[12],[14],[17],[20]}

$ 4,984

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[12],[14],[20]}

$ 4,785

Fair value, ending balance

^{[12],[14],[20]}

$ 4,785

Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

13.00%

^{[7],[10],[18]}

13.00%

^{[13],[14],[15],[20]}

13.00%

^{[7],[10],[18]}

13.00%

^{[7],[10],[18]}

13.00%

^{[13],[14],[15],[20]}

13.00%

^{[13],[14],[15],[20]}

Investment owned, balance, principal amount

$ 50,419

^{[7],[16],[18]}

$ 50,419

^{[14],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14],[20]

49,869

Fair value, ending balance

50,419

^[7],[18]

$ 49,869

^[14],[20]

Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

8.00%

Investment, interest rate (as a percent)

^[13],[15]

13.43%

Investment owned, balance, principal amount

^[13],[17]

$ 12,843

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

12,464

Fair value, ending balance

^[13]

$ 12,464

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14],[20]}

6.00%

Investment owned, balance, principal amount

^{[11],[13],[14],[17],[20]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14],[20]}

(22)

Fair value, ending balance

^{[11],[13],[14],[20]}

$ (22)

Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

6.00%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

11.42%

Investment owned, balance, principal amount

^{[13],[14],[17],[20]}

$ 28,826

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

$ 28,537

Fair value, ending balance

^{[13],[14],[20]}

$ 28,537

Investment, Identifier [Axis]: Telephone and Data Systems, Inc., Wireless Telecommunication Services, Subordinated Debt Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[18],[23]}

7.00%

Investment, interest rate (as a percent)

^{[7],[10],[18],[23]}

12.25%

Investment owned, balance, principal amount

^{[7],[16],[18],[23]}

$ 25,031

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[23]}

$ 24,405

Investment, Identifier [Axis]: Telephone and Data Systems, Inc., Wireless Telecommunication Services, Subordinated Debt Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[8],[18],[23]}

7.00%

Investment owned, balance, principal amount

^{[7],[8],[16],[18],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[8],[18],[23]}

$ (94)

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

9.75%

^{[7],[8],[22],[23]}

9.75%

^{[11],[13],[14]}

9.75%

^{[7],[8],[22],[23]}

9.75%

^{[7],[8],[22],[23]}

9.75%

^{[11],[13],[14]}

9.75%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

^{[11],[13],[14],[15]}

15.17%

Investment owned, balance, principal amount

$ 1,946

^{[7],[8],[16],[22],[23]}

$ 1,861

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

1,802

Fair value, ending balance

$ 1,727

^{[7],[8],[22],[23]}

$ 1,802

^{[11],[13],[14]}

Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

9.75%

^{[7],[22],[23]}

9.75%

^[13],[14]

9.75%

^{[7],[22],[23]}

9.75%

^{[7],[22],[23]}

9.75%

^[13],[14]

9.75%

^[13],[14]

Investment, interest rate (as a percent)

^{[13],[14],[15]}

15.26%

Investment owned, balance, principal amount

$ 26,553

^{[7],[16],[22],[23]}

$ 23,423

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

22,814

Fair value, ending balance

$ 23,898

^{[7],[22],[23]}

$ 22,814

^[13],[14]

Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[7],[23]

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[13],[14]

Investment, interest rate (as a percent)

10.74%

^{[7],[10],[23]}

11.32%

^{[13],[14],[15]}

10.74%

^{[7],[10],[23]}

10.74%

^{[7],[10],[23]}

11.32%

^{[13],[14],[15]}

11.32%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 19,683

^{[7],[16],[23]}

$ 19,947

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

19,199

Fair value, ending balance

18,837

^[7],[23]

$ 19,199

^[13],[14]

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[24]}

7.30%

Investment owned, balance, principal amount

^{[13],[14],[17],[24]}

$ 19,163

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[24]}

$ 18,340

Fair value, ending balance

^{[13],[14],[24]}

18,340

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7],[22]

10.00%

Investment owned, balance, principal amount

^{[7],[16],[22]}

$ 5,065

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

4,657

Gross Reductions

(570)

Fair value, ending balance

$ 4,087

^[7],[22]

Investment owned, percent of net assets (as a percent)

0.30%

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate, paid in kind (as a percent)

^[7],[22]

10.00%

Investment owned, balance, principal amount

^{[7],[16],[22]}

$ 20,917

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

19,262

Gross Reductions

(1,027)

Fair value, ending balance

$ 18,235

^[7],[22]

Investment owned, percent of net assets (as a percent)

1.20%

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Membership Interest

Schedule of Investments [Line Items]

Investment owned, ownership (as a percent)

^[7]

6.40%

Investment owned, balance, principal amount

$ 0

Net Realized Gain (Loss)

Amount of Interest, Fees or Dividends Credited in Income

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

Gross Additions

Gross Reductions

Fair value, ending balance

$ 0

^[7]

$ 0

Investment owned, percent of net assets (as a percent)

0.00%

Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[24]}

12.50%

Investment owned, balance, principal amount

^{[13],[14],[17],[24]}

$ 4,641

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[24]}

$ 4,170

Fair value, ending balance

^{[13],[14],[24]}

$ 4,170

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7]

321,058

Investment owned, balance, principal amount

^[7],[16]

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7]

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.00%

Investment, interest rate, paid in kind (as a percent)

^[13],[14]

12.65%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 46,832

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 37,231

Fair value, ending balance

^[13],[14]

$ 37,231

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

10.00%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

15.54%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 6,141

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 6,018

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[7],[22],[23]}

10.00%

Investment owned, balance, principal amount

^{[7],[16],[22],[23]}

$ 18,844

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[22],[23]}

16,536

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14]

10,616

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

Fair value, ending balance

^[14]

$ 0

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14]

358,299

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

Fair value, ending balance

^[14]

$ 0

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14]

60,862

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

108

Fair value, ending balance

^[14]

$ 108

Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14]

32,447

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 31,701

Fair value, ending balance

^[14]

$ 31,701

Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[7],[23]

6.00%

^[7],[23]

6.00%

^[13],[14]

6.00%

^[13],[14]

Investment, interest rate (as a percent)

10.95%

^{[7],[10],[23]}

11.42%

^{[13],[14],[15]}

10.95%

^{[7],[10],[23]}

10.95%

^{[7],[10],[23]}

11.42%

^{[13],[14],[15]}

11.42%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 14,508

^{[7],[16],[23]}

$ 11,671

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

11,363

Fair value, ending balance

$ 14,218

^[7],[23]

$ 11,363

^[13],[14]

Investment, Identifier [Axis]: Trinitas CLO VI Ltd., Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[18],[23]

7.08%

Investment, interest rate (as a percent)

^{[10],[18],[23]}

12.36%

Investment owned, balance, principal amount

^{[16],[18],[23]}

$ 905

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[18],[23]

$ 856

Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

7.71%

^[18],[23]

7.71%

^[13],[20]

7.71%

^[18],[23]

7.71%

^[18],[23]

7.71%

^[13],[20]

7.71%

^[13],[20]

Investment, interest rate (as a percent)

12.99%

^{[10],[18],[23]}

13.06%

^{[13],[15],[20]}

12.99%

^{[10],[18],[23]}

12.99%

^{[10],[18],[23]}

13.06%

^{[13],[15],[20]}

13.06%

^{[13],[15],[20]}

Investment owned, balance, principal amount

$ 1,000

^{[16],[18],[23]}

$ 1,000

^{[13],[17],[20]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[20]

917

Fair value, ending balance

$ 978

^[18],[23]

$ 917

^[13],[20]

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.75%

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

10.85%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 29

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 29

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.75%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.86%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 26,457

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 26,457

Investment, Identifier [Axis]: Truck-Lite Co., LLC, Construction Machinery & Heavy Transportation Equipment, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.75%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 0

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.25%

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

10.10%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 975

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

$ 955

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

5.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

10.35%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 15,773

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 15,618

Investment, Identifier [Axis]: USIC Holdings, Inc., Diversified Support Services, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

5.50%

Investment, interest rate (as a percent)

^{[7],[8],[10],[23]}

10.35%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 24

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[15],[20]}

6.50%

Investment owned, balance, principal amount

^[17],[20]

$ 4,500

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

2,953

Fair value, ending balance

^[20]

$ 2,953

Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[13],[15],[20]}

4.75%

Investment owned, balance, principal amount

^[17],[20]

$ 300

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[20]

$ 245

Fair value, ending balance

^[20]

$ 245

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[7],[10],[18]}

11.00%

Investment owned, balance, principal amount

^{[7],[16],[18]}

$ 2,512

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[18]

$ 2,468

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, interest rate (as a percent)

^{[7],[10],[18]}

11.00%

Investment owned, balance, principal amount

^{[7],[16],[18]}

$ 3,198

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[18]

3,142

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment owned, balance, principal amount

^{[7],[8],[16],[18]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[18]

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 4

Schedule of Investments [Line Items]

Investment owned, balance, principal amount

^{[7],[8],[16],[18]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[18]

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 5

Schedule of Investments [Line Items]

Investment owned, balance, principal amount

^{[7],[16],[18],[19]}

4,652

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[18],[19]}

4,699

Investment, Identifier [Axis]: Verona Pharma, Inc., Pharmaceuticals, First Lien Term Loan 6

Schedule of Investments [Line Items]

Investment owned, balance, principal amount

^{[7],[8],[16],[18],[19]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^{[7],[8],[18],[19]}

Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.25%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.68%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 1,140

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 1,139

Fair value, ending balance

^[13],[14]

$ 1,139

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[8],[23]

6.75%

Investment owned, balance, principal amount

^{[7],[8],[16],[23]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[8],[23]

(19)

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

3.75%

Investment, interest rate (as a percent)

^[13],[15]

9.27%

Investment owned, balance, principal amount

^[13],[17]

$ 11,792

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

$ 11,127

Fair value, ending balance

^[13]

$ 11,127

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

7.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

8.39%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

4.13%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 30,570

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

$ 30,396

Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

7.50%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

8.39%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

4.13%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 1,449

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

1,448

Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

7.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

12.65%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 5,000

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 4,263

Fair value, ending balance

^[13],[14]

$ 4,263

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[7],[23]

14.00%

Investment, interest rate (as a percent)

^{[7],[10],[23]}

12.85%

Investment, interest rate, paid in kind (as a percent)

^[7],[23]

6.00%

Investment owned, balance, principal amount

^{[7],[16],[23]}

$ 2,782

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7],[23]

2,546

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

15.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

21.68%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 1,565

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

1,464

Fair value, ending balance

^[13],[14]

$ 1,464

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

15.00%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

21.68%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 1,323

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

$ 1,237

Fair value, ending balance

^[13],[14]

$ 1,237

Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

4,871

^[7]

4,871

^[14]

4,871

^[7]

4,871

^[7]

4,871

^[14]

4,871

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 107

Fair value, ending balance

$ 0

^[7]

$ 107

^[14]

Investment, Identifier [Axis]: Win Brands Group LLC, Integrated Telecommunication Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[7]

127,452

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, ending balance

^[7]

$ 1,657

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

^[14]

127,452

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

1,319

Fair value, ending balance

^[14]

$ 1,319

Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13]

6.25%

Investment, interest rate (as a percent)

^[13],[15]

11.67%

Investment owned, balance, principal amount

^[13],[17]

$ 8,983

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13]

$ 8,678

Fair value, ending balance

^[13]

$ 8,678

Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, First Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

4.00%

^[7],[23]

4.00%

^[13],[14]

4.00%

^[7],[23]

4.00%

^[7],[23]

4.00%

^[13],[14]

4.00%

^[13],[14]

Investment, interest rate (as a percent)

8.25%

^{[7],[10],[23]}

9.32%

^{[13],[14],[15]}

8.25%

^{[7],[10],[23]}

8.25%

^{[7],[10],[23]}

9.32%

^{[13],[14],[15]}

9.32%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 19,431

^{[7],[16],[23]}

$ 19,578

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

19,489

Fair value, ending balance

19,431

^[7],[23]

$ 19,489

^[13],[14]

Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[13],[14],[20]}

7.50%

Investment, interest rate (as a percent)

^{[13],[14],[15],[20]}

12.72%

Investment owned, balance, principal amount | £

^{[13],[14],[17],[20]}

£ 20,000

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[13],[14],[20]}

$ 22,914

Fair value, ending balance

^{[13],[14],[20]}

$ 22,914

Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

21,523

^[7]

21,523

^[14]

21,523

^[7]

21,523

^[7]

21,523

^[14]

21,523

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 20,074

Fair value, ending balance

$ 24,326

^[7]

$ 20,074

^[14]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[7],[8],[23]

6.75%

^{[11],[13],[14]}

5.75%

^[7],[8],[23]

5.75%

^[7],[8],[23]

6.75%

^{[11],[13],[14]}

6.75%

^{[11],[13],[14]}

Investment, interest rate (as a percent)

10.67%

^{[7],[8],[10],[23]}

12.14%

^{[11],[13],[14],[15]}

10.67%

^{[7],[8],[10],[23]}

10.67%

^{[7],[8],[10],[23]}

12.14%

^{[11],[13],[14],[15]}

12.14%

^{[11],[13],[14],[15]}

Investment owned, balance, principal amount

$ 678

^{[7],[8],[16],[23]}

$ 377

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

296

Fair value, ending balance

$ 607

^[7],[8],[23]

$ 296

^{[11],[13],[14]}

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

5.75%

^[7],[23]

7.25%

^[13],[14]

5.75%

^[7],[23]

5.75%

^[7],[23]

7.25%

^[13],[14]

7.25%

^[13],[14]

Investment, interest rate (as a percent)

10.67%

^{[7],[10],[23]}

12.63%

^{[13],[14],[15]}

10.67%

^{[7],[10],[23]}

10.67%

^{[7],[10],[23]}

12.63%

^{[13],[14],[15]}

12.63%

^{[13],[14],[15]}

Investment, interest rate, paid in kind (as a percent)

^[13],[14]

Investment owned, balance, principal amount

$ 25,491

^{[7],[16],[23]}

$ 24,427

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

23,548

Fair value, ending balance

$ 24,696

^[7],[23]

$ 23,548

^[13],[14]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^[7],[23]

7.25%

^[13],[14]

6.25%

^[7],[23]

6.25%

^[7],[23]

7.25%

^[13],[14]

7.25%

^[13],[14]

Investment, interest rate (as a percent)

11.17%

^{[7],[10],[23]}

12.63%

^{[13],[14],[15]}

11.17%

^{[7],[10],[23]}

11.17%

^{[7],[10],[23]}

12.63%

^{[13],[14],[15]}

12.63%

^{[13],[14],[15]}

Investment owned, balance, principal amount

$ 3,636

^{[7],[16],[23]}

$ 3,636

^{[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

3,574

Fair value, ending balance

$ 3,581

^[7],[23]

$ 3,574

^[13],[14]

Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

6.25%

^[7],[8],[23]

7.25%

^{[11],[13],[14]}

6.25%

^[7],[8],[23]

6.25%

^[7],[8],[23]

7.25%

^{[11],[13],[14]}

7.25%

^{[11],[13],[14]}

Investment owned, balance, principal amount

$ 0

^{[7],[8],[16],[23]}

$ 0

^{[11],[13],[14],[17]}

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

Fair value, ending balance

^[7],[8],[23]

$ 0

^{[11],[13],[14]}

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^[13],[14]

8.75%

Investment, interest rate (as a percent)

^{[13],[14],[15]}

11.75%

Investment owned, balance, principal amount

^{[13],[14],[17]}

$ 5,212

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[13],[14]

4,990

Fair value, ending balance

^[13],[14]

$ 4,990

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14]}

8.75%

Investment owned, balance, principal amount

^{[11],[13],[14],[17]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

Fair value, ending balance

^{[11],[13],[14]}

$ 0

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3

Schedule of Investments [Line Items]

Investment, basis spread, variable rate (as a percent)

^{[11],[13],[14]}

8.75%

Investment owned, balance, principal amount

^{[11],[13],[14],[17]}

$ 0

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^{[11],[13],[14]}

$ 0

Fair value, ending balance

^{[11],[13],[14]}

$ 0

Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants

Schedule of Investments [Line Items]

Investment owned, balance (in shares) | shares

53,700

^[7]

53,700

^[14]

53,700

^[7]

53,700

^[7]

53,700

^[14]

53,700

^[14]

Investments in and Advances to Affiliates, at Fair Value [Roll Forward]

Fair value, beginning balance

^[14]

$ 258

Fair value, ending balance

$ 121

^[7]

$ 258

^[14]

[1]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the Company's annual report on Form 10-K for the year ended September 30, 2023 for transactions during the year ended September 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[2]	Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[3]	As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2024 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
[4]	Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
[5]	Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
[6]	Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
[7]	As of September 30, 2024, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").
[8]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[9]	This investment represents a participation interest in the underlying securities shown.
[10]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[11]	Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
[12]	This investment represents a participation interest in the underlying securities shown.
[13]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, the London Interbank Offered Rate ("LIBOR" or "L"), SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR and SOFR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2023, the reference rates for the Company's variable rate loans were the 30-day SOFR at 5.32%, the 90-day SOFR at 5.39%, the 180-day SOFR at 5.47%, the 30-day LIBOR at 5.43%, the 90-day LIBOR at 5.65%, the 180-day LIBOR at 5.90%, the PRIME at 8.50%, the SONIA at 5.19%, the 30-day EURIBOR at 3.42%, the 90-day EURIBOR at 3.82% and the 180-day EURIBOR at 3.95%. Most loans include an interest floor, which generally ranges from 0% to 2.75%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[14]	As of September 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by ASC 820.
[15]	Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
[16]	Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[17]	Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
[18]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2024, qualifying assets represented 74.4% of the Company's total assets and non-qualifying assets represented 25.6% of the Company's total assets.
[19]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[20]	Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2023, qualifying assets represented 73.6% of the Company's total assets and non-qualifying assets represented 26.4% of the Company's total assets.
[21]	This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.
[22]	This investment was on non-accrual status as of September 30, 2024.
[23]	The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the euro interbank offered rate ("EURIBOR" or "E"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. As of September 30, 2024, the reference rates for the Company's variable rate loans were the 30-day SOFR at 4.85%, the 90-day SOFR at 4.59%, the 180-day SOFR at 4.25%, the PRIME at 8.00%, the SONIA at 5.50%, the 90-day EURIBOR at 3.54% and the 180-day EURIBOR at 3.11%. Most loans include an interest floor, which generally ranges from 0% to 3.00%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
[24]	This investment was on non-accrual status as of September 30, 2023.
[25]	This investment represents Seller Earn Out Shares in Alvotech Holdings S.A. The Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech Holdings S.A. common share price is at or above a volume weighted average price ("VWAP") of $20.00 per share for any ten trading days within any twenty trading day period.
[26]	This investment represents Seller Earn Out Shares in Alvotech Holdings S.A. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech Holdings S.A. common share price is at or above a VWAP of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
[27]	This investment was renamed during the three months ended June 30, 2024. For the periods prior to June 30, 2024, this investment was referenced as SCP Eye Care Services, LLC.
[28]	Income producing through payment of dividends or distributions.
[29]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition of the Company's joint ventures.
[30]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[31]	See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
[32]	This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
[33]	This investment represents a credit default swap that functions, in substance, like a credit linked note and represents a credit risk transfer for a pool of reference assets owned by a bank. The Company fully funded margin up front and in return the Company receives periodic interest payments. The Company’s risk of loss is limited to the principal amount disclosed herein. The reference assets are primarily composed of investment grade corporate debt. The Company may be exposed to counterparty risk, which could make it difficult for the Company to collect on obligations, thereby resulting in potentially significant losses. In addition, the Company only has a contractual relationship with the counterparty bank, and not with the reference obligors of the reference assets. Accordingly, the Company generally may have no right to directly enforce compliance by the reference obligors with the terms of the reference assets. The Company will not directly benefit from the reference assets and will not have the benefit of the remedies that would normally be available to a holder of such reference assets. In addition, in the event of the insolvency of the counterparty bank, the Company may be treated as a general creditor of such counterparty bank, and will not have any claim with respect to the reference assets.
[34]	Income producing through payment of dividends or distributions.
[35]	This investment was renamed during the three months ended March 31, 2023. For periods prior to March 31, 2023, this investment was referenced as PFNY Holdings, LLC.

Concentration of Credit Risks	12 Months Ended
Concentration of Credit Risks	Sep. 30, 2024
Risks and Uncertainties [Abstract]
Concentration of Credit Risks	Concentration of Credit Risks The Company deposits its cash with financial institutions and at times such balances are in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.

N-2 - USD ($)

3 Months Ended

12 Months Ended

14 Months Ended

Sep. 30, 2024

Jun. 30, 2024

Mar. 31, 2024

Dec. 31, 2023

Sep. 30, 2023

Jun. 30, 2023

Mar. 31, 2023

Dec. 31, 2022

Sep. 30, 2024

Sep. 30, 2019

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2016

Sep. 30, 2015

Nov. 15, 2024

Sep. 30, 2022

Sep. 30, 2021

Sep. 30, 2020

Cover [Abstract]

Entity Central Index Key

0001414932

Amendment Flag

false

Securities Act File Number

1-33901

Document Type

10-K

Entity Registrant Name

Oaktree Specialty Lending Corporation

Entity Address, Address Line One

333 South Grand Avenue

Entity Address, Address Line Two

28th Floor

Entity Address, City or Town

Los Angeles

Entity Address, State or Province

Entity Address, Postal Zip Code

90071

City Area Code

213

Local Phone Number

830-6300

Entity Well-known Seasoned Issuer

Yes

Entity Emerging Growth Company

false

Fee Table [Abstract]

Shareholder Transaction Expenses [Table Text Block]


Stockholder transaction expenses:
Sales load (as a percentage of offering price)	—%	(1)
Offering expenses (as a percentage of offering price)	—%	(2)
Dividend reinvestment plan fees	Up to $15	(3)
Total stockholder transaction expenses (as a percentage of offering price)	—%	(4)
Annual expenses (as a percentage of net assets attributable to common stock):
Base management fees	2.10%	(5)
Incentive fees (17.5%)	2.40%	(6)
Interest payments on borrowed funds (including other costs of servicing and offering debt securities)	8.08%	(7)
Other expenses	0.64%	(8)
Acquired fund fees and expenses	1.63%	(9)
Total annual expenses	14.85%	(10)

__________

(1)If applicable, the prospectus or prospectus supplement relating to an offering of our common stock will disclose the applicable sales load.

(2)In the event that we conduct an offering of our securities, the related prospectus or prospectus supplement will disclose the estimated offering expenses.

(3)The expenses of administering our dividend reinvestment plan are included in “Other expenses.” The plan administrator’s fees under the plan are paid by us. If a participant elects by notice to the plan administrator in advance of termination to have the plan administrator sell part or all of the shares held by the plan administrator in the participant’s account and remit the proceeds to the participant, the plan administrator is authorized to deduct a transaction fee of up to $15 plus a $0.10 per share fee from the proceeds.

(4)Total stockholder transaction expenses may include sales load and will be disclosed in a future prospectus supplement, if any.

(5)Effective July 1, 2024, the base management fee is calculated at an annual rate of 1.00% of our total gross assets at the end of each quarter, including any investments made with borrowings, but excluding cash and cash equivalents; provided, however, that for the period from July 1, 2024 to January 23, 2025, the base management is calculated at such an annual rate as to cause (1) the base management fee less (2) previously agreed waivers of $750,000 of base management fees per quarter (with such amount appropriately prorated for any partial quarter) to equal 1.00% of our gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents. For purposes of this table, we have assumed $3.1 billion of total gross assets (excluding cash and cash equivalents), which was the actual amount of our total gross assets as of September 30, 2024. See “Item 1. Business - Investment Advisory Agreement - Management and Incentive Fee.”

(6)The incentive fee consists of two parts. Under the Investment Advisory Agreement, the incentive fee on income is calculated and payable quarterly in arrears based upon our pre-incentive fee net investment income for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of our net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income. See “Item 1. Business - Investment Advisory Agreement - Management and Incentive Fee” for additional information.

Under the Investment Advisory Agreement, the second part of the incentive fee (the “capital gains incentive fee”) is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of our realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fees under the Investment Advisory Agreement. Any realized capital gains or losses and unrealized capital depreciation with respect to our portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the

incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. See “Item 1. Business - Investment Advisory Agreement - Management and Incentive Fee” for additional information. The incentive fee referenced in the table above is based on actual amounts of the incentive fee on income incurred during the three months ended September 30, 2024 annualized for a full year and the capital gains incentive fee payable under the Investment Advisory Agreement as of September 30, 2024 and does not reflect any waiver of the incentive fee or income by the Adviser.

(7)“Interest payments on borrowed funds (including other costs of servicing and offering debt securities)” is calculated as (1) the weighted average interest rate in effect as of September 30, 2024 multiplied by the actual debt outstanding as of September 30, 2024 of $1,660.0 million plus (2) unused fees and the expected amortization of deferred financing costs and discounts based on the unamortized financing costs and discounts as of September 30, 2024. The weighted average interest rate for our borrowings as of September 30, 2024 was 6.7% (exclusive of deferred financing costs and inclusive of the impact of an interest rate swap designated as a hedging instrument). The amount of leverage that we employ at any particular time will depend on, among other things, our Board of Directors’ assessment of market and other factors at the time of any proposed borrowing.

(8)“Other expenses” are based on estimated amounts for the current fiscal year. These expenses include certain expenses allocated to us under the Investment Advisory Agreement, including travel expenses incurred by the Adviser’s personnel in connection with investigating and monitoring our investments, such as investment due diligence and payments made under the Administration Agreement for the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement.

(9)Our stockholders indirectly bear the expenses of underlying funds or other investment vehicles that would be an investment company under section 3(a) of the Investment Company Act but for the exceptions to that definition provided for in sections 3(c)(1) and 3(c)(7) of the Investment Company Act ("Acquired Funds") in which we invest. This amount includes the annual expenses of SLF JV I and the Glick JV, which we refer to collectively as the "JVs". There are no fees paid by the JVs to the Adviser. See Note 3 to our Consolidated Financial Statements in this Form 10-K for more information on the JVs. The annual expenses of the JVs include interest payments on the subordinated notes held by Kemper and GF Debt Funding 2014 LLC, or GF Debt Funding, an entity advised by affiliates of GF Equity Funding, as applicable, which represented 11.7% of such expenses, and exclude interest payments on the subordinated notes held by us.

(10) “Total annual expenses” is presented as a percentage of net assets attributable to common stockholders because our common stockholders bear all of our fees and expenses and includes all fees and expenses of our consolidated subsidiaries. “Total annual expenses” does not reflect any potential provision (benefit) for income taxes because of the uncertainties associated with determining such amounts in future periods.

Sales Load [Percent]

0.00%

Dividend Reinvestment and Cash Purchase Fees

$ 15

Other Transaction Expenses [Abstract]

Other Transaction Expense 1 [Percent]

0.00%

Annual Expenses [Table Text Block]


Stockholder transaction expenses:
Sales load (as a percentage of offering price)	—%	(1)
Offering expenses (as a percentage of offering price)	—%	(2)
Dividend reinvestment plan fees	Up to $15	(3)
Total stockholder transaction expenses (as a percentage of offering price)	—%	(4)
Annual expenses (as a percentage of net assets attributable to common stock):
Base management fees	2.10%	(5)
Incentive fees (17.5%)	2.40%	(6)
Interest payments on borrowed funds (including other costs of servicing and offering debt securities)	8.08%	(7)
Other expenses	0.64%	(8)
Acquired fund fees and expenses	1.63%	(9)
Total annual expenses	14.85%	(10)

__________

(1)If applicable, the prospectus or prospectus supplement relating to an offering of our common stock will disclose the applicable sales load.

(2)In the event that we conduct an offering of our securities, the related prospectus or prospectus supplement will disclose the estimated offering expenses.

(4)Total stockholder transaction expenses may include sales load and will be disclosed in a future prospectus supplement, if any.

Management Fees [Percent]

2.10%

Interest Expenses on Borrowings [Percent]

8.08%

Incentive Fees [Percent]

2.40%

Acquired Fund Fees and Expenses [Percent]

1.63%

Other Annual Expenses [Abstract]

Other Annual Expenses [Percent]

0.64%

Total Annual Expenses [Percent]

14.85%

Expense Example [Table Text Block]

The following example demonstrates the projected dollar amount of total cumulative expenses that would be incurred over various periods with respect to a hypothetical investment in our common stock assuming that we hold no cash or liabilities other than debt. In calculating the following expense amounts, we have assumed that our annual operating expenses remain at the levels set forth in the table above. The example does not include any sales load or offering expenses.


An investor would pay the following expenses on a $1,000 investment	1 Year		3 Years		5 Years		10 Years
Assuming a 5% annual return (assumes no return from net realized capital gains)	$	120	$	348	$	559	$	1,017
Assuming a 5% annual return (assumes return entirely from net realized capital gains)	$	128	$	369	$	589	$	1,053

The example and the expenses in the tables above should not be considered a representation of our future expenses, and actual expenses may be greater or less than those shown. While the example assumes, as required by the SEC, a 5% annual return, our performance will vary and may result in a return greater or less than 5%. The incentive fee based on pre-incentive fee net investment income under the Investment Advisory Agreement, which, assuming a 5% annual return, would either not be payable or would have an insignificant impact on the expense amounts shown above, is not included in the

example. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger a greater incentive fee, our expenses, and returns to our investors, would be higher. For purposes of this example, we have assumed that as of October 1, 2022, the sum of our realized capital losses and unrealized capital depreciation on a cumulative basis since October 1, 2018 equaled zero. In addition, while the example assumes reinvestment of all distributions at NAV, participants in our dividend reinvestment plan will receive a number of shares of our common stock, determined by dividing the total dollar amount of the cash distribution payable to a participant by either (i) the greater of (a) the current NAV per share of our common stock and (b) 95% of the market price per share of our common stock at the close of trading on the payment date fixed by our Board of Directors in the event that we use newly issued shares to satisfy the share requirements of the dividend reinvestment plan or (ii) the average purchase price, excluding any brokerage charges or other charges, of all shares of common stock purchased by the administrator of the dividend reinvestment plan in the event that shares are purchased in the open market to satisfy the share requirements of the dividend reinvestment plan, which may be at, above or below NAV.

Expense Example, Year 01

$ 120

Expense Example, Years 1 to 3

348

Expense Example, Years 1 to 5

559

Expense Example, Years 1 to 10

$ 1,017

Purpose of Fee Table , Note [Text Block]

The following table is intended to assist stockholders in understanding the costs and expenses that an investor in shares of our common stock will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this Form 10-K contains a reference to

fees or expenses paid by “you” or “us”, or that “we” will pay fees or expenses, stockholders will indirectly bear such fees or expenses as investors in us. Such expenses also include those of our consolidated subsidiaries.

Basis of Transaction Fees, Note [Text Block]

The expenses of administering our dividend reinvestment plan are included in “Other expenses.” The plan administrator’s fees under the plan are paid by us. If a participant elects by notice to the plan administrator in advance of termination to have the plan administrator sell part or all of the shares held by the plan administrator in the participant’s account and remit the proceeds to the participant, the plan administrator is authorized to deduct a transaction fee of up to $15 plus a $0.10 per share fee from the proceeds.

Other Transaction Fees, Note [Text Block]

In the event that we conduct an offering of our securities, the related prospectus or prospectus supplement will disclose the estimated offering expenses.

Other Expenses, Note [Text Block]

“Other expenses” are based on estimated amounts for the current fiscal year. These expenses include certain expenses allocated to us under the Investment Advisory Agreement, including travel expenses incurred by the Adviser’s personnel in connection with investigating and monitoring our investments, such as investment due diligence and payments made under the Administration Agreement for the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement.

Management Fee not based on Net Assets, Note [Text Block]

Effective July 1, 2024, the base management fee is calculated at an annual rate of 1.00% of our total gross assets at the end of each quarter, including any investments made with borrowings, but excluding cash and cash equivalents; provided, however, that for the period from July 1, 2024 to January 23, 2025, the base management is calculated at such an annual rate as to cause (1) the base management fee less (2) previously agreed waivers of $750,000 of base management fees per quarter (with such amount appropriately prorated for any partial quarter) to equal 1.00% of our gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents. For purposes of this table, we have assumed $3.1 billion of total gross assets (excluding cash and cash equivalents), which was the actual amount of our total gross assets as of September 30, 2024. See “Item 1. Business - Investment Advisory Agreement - Management and Incentive Fee.”

Acquired Fund Fees and Expenses, Note [Text Block]

Our stockholders indirectly bear the expenses of underlying funds or other investment vehicles that would be an investment company under section 3(a) of the Investment Company Act but for the exceptions to that definition provided for in sections 3(c)(1) and 3(c)(7) of the Investment Company Act ("Acquired Funds") in which we invest. This amount includes the annual expenses of SLF JV I and the Glick JV, which we refer to collectively as the "JVs". There are no fees paid by the JVs to the Adviser. See Note 3 to our Consolidated Financial Statements in this Form 10-K for more information on the JVs. The annual expenses of the JVs include interest payments on the subordinated notes held by Kemper and GF Debt Funding 2014 LLC, or GF Debt Funding, an entity advised by affiliates of GF Equity Funding, as applicable, which represented 11.7% of such expenses, and exclude interest payments on the subordinated notes held by us.

Financial Highlights [Abstract]

Senior Securities [Table Text Block]

Information about our senior securities (including debt securities and other indebtedness) is shown in the following table as of the fiscal years ended September 30 for the years indicated below.


Class and Year(1)	Total Amount Outstanding Exclusive of Treasury Securities (2)		Asset Coverage Per Unit(3)	Involuntary Liquidating Preference Per Unit(4)	Average Market Value Per Unit(5)
Syndicated Facility and Prior ING Facility
Fiscal 2015	$	383,495	2,389	—	N/A
Fiscal 2016	472,495		2,208	—	N/A
Fiscal 2017	226,495		2,274	—	N/A
Fiscal 2018	241,000		2,330	—	N/A
Fiscal 2019	314,825		2,949	—	N/A
Fiscal 2020	414,825		2,272	—	N/A
Fiscal 2021	495,000		2,017	—	N/A
Fiscal 2022	540,000		1,886	—	N/A
Fiscal 2023	430,000		1,877	—	N/A
Fiscal 2024	430,000		1,881	—	N/A

Citibank Facility
Fiscal 2021	$	135,000	2,017	—	N/A
Fiscal 2022	160,000		1,886	—	N/A

OSI2 Citibank Facility
Fiscal 2023	$	280,000	1,877	—	N/A
Fiscal 2024	280,000		1,881	—	N/A

Sumitomo Facility
Fiscal 2015	$	43,800	2,389	—	N/A
Fiscal 2016	43,800		2,208	—	N/A
Fiscal 2017	29,500		2,274	—	N/A

Convertible Notes
Fiscal 2015	$	115,000	2,389	—	N/A

Secured Borrowings
Fiscal 2015	$	21,787	2,389	—	N/A
Fiscal 2016	18,929		2,208	—	N/A
Fiscal 2017	13,489		2,274	—	N/A
Fiscal 2018	12,314		2,330	—	N/A

2019 Notes
Fiscal 2015	$	250,000	2,389	—	N/A
Fiscal 2016	250,000		2,208	—	N/A
Fiscal 2017	250,000		2,274	—	N/A
Fiscal 2018	228,825		2,330	—	N/A


Class and Year(1)	Total Amount Outstanding Exclusive of Treasury Securities (2)		Asset Coverage Per Unit(3)	Involuntary Liquidating Preference Per Unit(4)	Average Market Value Per Unit(5)
2024 Notes
Fiscal 2015	$	75,000	2,389	—	991.94
Fiscal 2016	75,000		2,208	—	993.70
Fiscal 2017	75,000		2,274	—	1,006.74
Fiscal 2018	75,000		2,330	—	1,010.72
Fiscal 2019	75,000		2,949	—	1,012.76

2025 Notes
Fiscal 2020	$	300,000	2,272	—	N/A
Fiscal 2021	300,000		2,017	—	N/A
Fiscal 2022	300,000		1,886	—	N/A
Fiscal 2023	300,000		1,877	—	N/A
Fiscal 2024	300,000		1,881	—	N/A

2027 Notes
Fiscal 2021	$	350,000	2,017	—	N/A
Fiscal 2022	350,000		1,886	—	N/A
Fiscal 2023	350,000		1,877	—	N/A
Fiscal 2024	350,000		1,881	—	N/A

2028 Notes
Fiscal 2015	$	86,250	2,389	—	988.06
Fiscal 2016	86,250		2,208	—	999.29
Fiscal 2017	86,250		2,274	—	1,007.51
Fiscal 2018	86,250		2,330	—	994.82
Fiscal 2019	86,250		2,949	—	993.33

2029 Notes
Fiscal 2023	$	300,000	1,877	—	N/A
Fiscal 2024	300,000		1,881	—	N/A

Total Senior Securities
Fiscal 2015	$	975,332	2,389	—
Fiscal 2016	946,474		2,208	—
Fiscal 2017	680,734		2,274	—
Fiscal 2018	643,389		2,330	—
Fiscal 2019	476,075		2,949	—
Fiscal 2020	714,825		2,272	—
Fiscal 2021	1,280,000		2,017	—
Fiscal 2022	1,350,000		1,886	—
Fiscal 2023	1,660,000		1,877	—
Fiscal 2024	1,660,000		1,881	—

______________

(2)Total amount of each class of senior securities outstanding at the end of the period, presented in thousands.

(5)Calculated on a daily average basis.

Senior Securities Amount

$ 1,660,000,000

$ 476,075,000

$ 643,389,000

$ 680,734,000

$ 946,474,000

$ 975,332,000

$ 1,350,000,000

$ 1,280,000,000

$ 714,825,000

Senior Securities Coverage per Unit

$ 1,881

$ 1,877

$ 1,881

$ 2,949

$ 2,330

$ 2,274

$ 2,208

$ 2,389

$ 1,886

$ 2,017

$ 2,272

General Description of Registrant [Abstract]

Investment Objectives and Practices [Text Block]

Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.

In the current market environment, Oaktree intends to focus on the following areas, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital and (4) public credit, where we seek discounted, high quality public debt investments particularly in times of market dislocation.

Risk Factors [Table Text Block]

Risk Factors

Investing in our securities involves a number of significant risks. In addition to the other information contained in this annual report on Form 10-K, you should consider carefully the following information before making an investment in our securities. The risks set out below are not the only risks we face. Additional risks and uncertainties not presently known to us or not presently deemed material by us might also impair our operations and performance. If any of the following events occur, our business, financial condition and results of operations could be materially and adversely affected. In such case, our net asset value and the trading price of our securities could decline, and you may lose part or all of your investment. The risk factors described below are the principal risk factors associated with an investment in us as well as those factors generally associated with an investment company with investment objectives, investment policies, capital structure or trading markets similar to ours.

An investment in our securities involves risks. The following is a summary of the principal risks that you should carefully consider before investing in our securities.

•Global economic, political and market conditions have (and in the future, could further) adversely affect our business, results of operations and financial condition and those of our portfolio companies.

•Changes in interest rates may affect our cost of capital and net investment income.

•A significant portion of our investment portfolio is and will continue to be recorded at fair value and, as a result, there is and will continue to be uncertainty as to the value of our portfolio investments.

•Our ability to achieve our investment objective depends on our Adviser’s ability to support our investment process; if our Adviser were to lose key personnel or they were to resign, our ability to achieve our investment objective could be significantly harmed.

•Because we borrow money, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us.

•There are significant potential conflicts of interest that could adversely impact our investment returns.

•Regulations governing our operation as a Business Development Company and RIC affect our ability to raise, and the way in which we raise, additional capital or borrow for investment purposes, which may have a negative effect on our growth.

•Our investments in portfolio companies may be risky, and we could lose all or parts of our investments.

•Shares of closed-end investment companies, including Business Development Companies, may trade at a discount to their net asset value.

•The market price of our common stock may fluctuate significantly.

•Economic recessions or downturns may have a material adverse effect on our business, financial condition and results of operations, and could impair the ability of our portfolio companies to repay debt or pay interest.

Risks Relating to Our Business and Structure

Global economic, political and market conditions have (and in the future, could further) adversely affect our business, results of operations and financial condition and those of our portfolio companies.

Any disruptions in the capital markets may increase the spread between the yields realized on risk-free and higher risk securities and can result in illiquidity in parts of the capital markets, significant write-offs in the financial sector and re-pricing of credit risk in the broadly syndicated market. These and any other unfavorable economic conditions could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. During the spring of 2020, the occurrence of these events during the initial onset of the COVID-19 pandemic negatively impacted the fair value of the investments that we held and, if they were to occur again in the future, could limit our investment originations (including as a result of the investment professionals of our Adviser diverting their time to the restructuring of certain investments), negatively impact our operating results and limit our ability to grow. More recently, the fair value of our investments was adversely affected by increasing market yields.

In addition, market conditions (including inflation, supply chain issues and decreased consumer demand) have adversely impacted, and could in the future further impact, the operations of certain of our portfolio companies. If the financial results of middle-market companies, like those in which we invest, experience deterioration, it could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults, and further deterioration in market conditions will further depress the outlook for those companies. Further, adverse economic conditions decreased and may in the future decrease the value of collateral securing some of our loans and the value of our equity investments. Such conditions have required and may

in the future require us to modify the payment terms of our investments, including changes in PIK interest provisions and/or cash interest rates. The performance of certain of our portfolio companies has been, and in the future may be, negatively impacted by these economic or other conditions, which can result in our receipt of reduced interest income from our portfolio companies and/or realized and unrealized losses related to our investments, and, in turn, may adversely affect distributable income and have a material adverse effect on our results of operations.

We may be adversely affected by the foregoing events or by similar or other events in the future. In the longer term, there may be significant new regulations that could limit our activities and investment opportunities or change the functioning of the capital markets, and there is the possibility of continued severe worldwide economic downturn. Consequently, we may not be capable of, or successful at, preserving the value of our assets, generating positive investment returns or effectively managing risks.

The current state of global credit markets, coupled with the threat of a double-dip recession, may affect the value of our investments. Further disruption and deterioration of the global debt markets (particularly the U.S. debt markets) or a significant rise in market perception of counterparty default risk would be likely to significantly reduce investor demand for, and liquidity of, all securities. Oaktree itself could also be affected by difficult conditions in the capital markets and any overall weakening of the financial services industry. Ongoing disruptions in the global credit markets may affect issuers’ ability to pay debts and obligations on a timely basis. If defaults occur, we could generate realized losses in, and lose anticipated profits from, any affected investments.

Recent developments in global financial markets have illustrated that the current environment is one of uncertainty for financial services companies. The existence of such events has had, and the continuation or worsening of any such events, or other events, may have or continue to have, a material adverse effect on the availability of credit to businesses generally and may lead to further overall weakening of the U.S. and global economies. Any resulting economic downturn could adversely affect the financial resources of our investments, which in turn may adversely affect or restrict our ability to sell or liquidate investments at favorable times or at favorable prices or which otherwise may have an adverse impact on our activities and operations, restrict our investment activities and/or impede our ability to effectively achieve our investment objective. In addition, new regulations may be issued in response to economic or political developments that could limit our activities and investment opportunities.

Changes in interest rates may affect our cost of capital and net investment income.

General interest rate fluctuations and changes in credit spreads on floating rate loans may have a substantial negative impact on our investments and investment opportunities and, accordingly, may have a material adverse effect on our rate of return on invested capital, our net investment income, our net asset value and the market price of our common stock. The majority of our debt investments have, and are expected to have, variable interest rates that reset periodically based on benchmarks such as the Secured Overnight Financing Rate, or SOFR, the Sterling Overnight Index Average, or SONIA, the federal funds rate, prime rate or any other offered rate benchmark or index. Increases in interest rates made it more difficult for our portfolio companies to service their obligations under the debt investments that we will hold and increased defaults even where our investment income increased. Rising interest rates also caused borrowers to shift cash from other productive uses to the payment of interest. Additionally, if interest rates were to increase and the corresponding risk of a default by borrowers increases, the liquidity of higher interest rate loans may decrease as fewer investors may be willing to purchase such loans in the secondary market in light of the increased risk of a default by the borrower and the heightened risk of a loss of an investment in such loans. All of these risks may be exacerbated if interest rates were to again rise rapidly and/or significantly. Decreases in credit spreads on debt that pays a floating rate of return would have an impact on the income generation of our floating rate assets. Trading prices for debt that pays a fixed rate of return tend to fall as interest rates rise. Trading prices tend to fluctuate more for fixed rate securities that have longer maturities.

Conversely, as interest rates decline, borrowers may refinance their loans at lower interest rates, which could shorten the average life of the loans and reduce the associated returns on the investment, as well as require our Adviser and the Investment Professionals to incur management time and expense to re-deploy such proceeds, including on terms that may not be as favorable as our existing loans.

In addition, because we borrow to fund our investments, a portion of our net investment income is dependent upon the difference between the interest rate at which we borrow funds and the interest rate at which we invest these funds. Portions of our investment portfolio and our borrowings have floating rate components. As a result, elevated interest rates increased our interest expense as may the incurrence of additional fixed rate borrowings. In future periods of rising interest rates, our cost of funds would again increase, which would tend to reduce our net investment income. We may hedge against interest rate fluctuations by using standard hedging instruments such as interest rate swap agreements, futures, options and forward contracts, subject to applicable legal requirements, including all necessary registrations (or exemptions from registration) with

the Commodity Futures Trading Commission. In addition, our interest expense may not decrease at the same rate as overall interest rates because of our fixed rate borrowings, which could lead to greater declines in our net investment income. These activities may limit our ability to participate in the benefits of lower interest rates with respect to the hedged borrowings. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations.

Elevated interest rates have the effect of increasing our net investment income, which makes it easier for our Adviser to receive incentive fees.

Elevated interest rates have the effect of increasing the interest rate that we receive on many of our debt investments. Accordingly, in an elevated interest rate environment, it is easier for our Adviser to meet the quarterly hurdle rate for payment of income incentive fees under the Investment Advisory Agreement, which has resulted in, and may in the future result in, an increase in the amount of the income-based incentive fee payable to our Adviser.

A significant portion of our investment portfolio is and will continue to be recorded at fair value and, as a result, there is and will continue to be uncertainty as to the value of our portfolio investments.

Under the Investment Company Act, we are required to carry our portfolio investments at market value or, if there is no readily available market value, at fair value as determined by our Adviser in its capacity as our valuation designee. Typically, there is not a public market for the securities of the privately held companies in which we have invested and will generally continue to invest. As a result, our Adviser values these securities quarterly at fair value under the oversight of our Board of Directors. The fair value of such securities may change, potentially materially, between the date of the fair value determination and the release of the financial results for the corresponding period or the next date at which fair value is determined.

Certain factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s earnings and its ability to make payments on its indebtedness, the markets in which the portfolio company does business, comparison to comparable publicly-traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our Adviser's determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. In addition, any investments that include OID or PIK interest may have unreliable valuations because their continuing accruals require ongoing judgments about the collectability of their deferred payments and the value of their underlying collateral. Due to these uncertainties, our Adviser's fair value determinations may cause our net asset value on a given date to materially understate or overstate the value that we may ultimately realize upon the sale of one or more of our investments. As a result, investors purchasing our common stock based on an overstated net asset value would pay a higher price than the realizable value of our investments might warrant.

In addition, the participation of the Investment Professionals in the valuation process could result in a conflict of interest as the management fee payable to our Adviser is based on our gross assets and the incentive fees earned by the Adviser are based, in part, on unrealized gains and losses.

Our ability to achieve our investment objective depends on our Adviser’s ability to support our investment process; if our Adviser were to lose key personnel or they were to resign, our ability to achieve our investment objective could be significantly harmed.

We depend on the investment expertise, skill and network of business contacts of the senior personnel of our Adviser. Our Adviser evaluates, negotiates, structures, executes, monitors and services our investments. Key personnel of our Adviser have departed in the past and current key personnel could depart at any time. Our Adviser’s capabilities in structuring the investment process, providing competent, attentive and efficient services to us, and facilitating access to financing on acceptable terms depend on the employment of investment professionals in adequate number and of adequate sophistication to match the corresponding flow of transactions. The departure of key personnel or of a significant number of the investment professionals or partners of our Adviser could have a material adverse effect on our ability to achieve our investment objective. Our Adviser may need to hire, train, supervise and manage new investment professionals to participate in our investment selection and monitoring process and may not be able to find investment professionals in a timely manner or at all.

In addition, our Adviser may resign on 60 days’ notice. If we are unable to quickly find a new investment adviser or hire internal management with similar expertise and ability to provide the same or equivalent services on acceptable terms, our operations are likely to experience a disruption and our ability to achieve our investment objective and pay distributions would likely be materially and adversely affected.

Our business model depends to a significant extent upon strong referral relationships, and the inability of the personnel associated with our Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.

We expect that personnel associated with our Adviser will maintain and develop their relationships with intermediaries, banks and other sources, and we will rely to a significant extent upon these relationships to provide us with potential investment opportunities. If these individuals fail to maintain their existing relationships or develop new relationships with other sources of investment opportunities, we may not be able to grow or maintain our investment portfolio. In addition, individuals with whom the personnel associated with our Adviser have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us. The failure of the personnel associated with our Adviser to maintain existing relationships, grow new relationships, or for those relationships to generate investment opportunities could have an adverse effect on our business, financial condition and results of operations.

We may face increasing competition for investment opportunities, which could reduce returns and result in losses.

We compete for investments with other Business Development Companies, public and private funds (including hedge funds, mezzanine funds and CLOs) and private equity funds (to the extent they provide an alternative form of financing), as well as traditional financial services companies such as commercial and investment banks, commercial financing companies and other sources of financing. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of capital and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we are able to do. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. If we are forced to match our competitors’ pricing, terms and structure, we may not be able to achieve acceptable returns on our investments or may bear substantial risk of capital loss. A significant increase in the number and/or the size of our competitors in this target market could force us to accept less attractive investment terms. Furthermore, many of our competitors are not subject to, the regulatory restrictions that the Investment Company Act imposes on us as a Business Development Company.

The incentive fee we pay to our Adviser relating to capital gains may be effectively greater than 17.5%.

The Adviser may be entitled to receive an incentive fee based on our capital gains, calculated on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each fiscal year. As a result of the operation of the cumulative method of calculating such capital gains portion of the incentive fee, the cumulative aggregate capital gains fee received by our Adviser could be effectively greater than 17.5%, depending on the timing and extent of subsequent net realized capital losses or net unrealized depreciation. This result would occur to the extent that, following receipt by the Adviser of a capital gain incentive fee, we subsequently realized capital depreciation and capital losses in excess of cumulative realized capital gains. We cannot predict whether, or to what extent, this payment calculation would affect your investment in our securities.

Our ability to enter into transactions with our affiliates is restricted.

We are prohibited under the Investment Company Act from participating in certain transactions with certain of our affiliates without the prior approval of our independent directors and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or more of our outstanding voting securities is our affiliate for purposes of the Investment Company Act, and we are generally prohibited from buying or selling any securities (other than our securities) from or to such affiliate, absent the prior approval of our independent directors. The Investment Company Act also prohibits certain “joint” transactions with certain of our affiliates, which could include investments in the same portfolio company (whether at the same or different times), without prior approval of our independent directors and, in some cases, the SEC. If a person acquires more than 25% of our voting securities, we will be prohibited from buying or selling any security (other than any security of which we are the issuer) from or to such person or certain of that person’s affiliates, or entering into prohibited joint transactions with such person, absent the prior approval of the SEC. Similar restrictions limit our ability to transact business with our officers or directors or their affiliates. As a result of these restrictions, except in situations described below, we may be prohibited from buying or selling any security (other than any security of which we are the issuer) from or to any portfolio company of a private equity fund managed by our Adviser without the prior approval of the SEC, which may limit the scope of investment opportunities that would otherwise be available to us.

We may also invest alongside funds managed by our Adviser and its affiliates in certain circumstances where doing so is consistent with applicable law and SEC staff interpretations. For example, we may invest alongside such accounts consistent with guidance promulgated by the staff of the SEC permitting us and such other accounts to purchase interests in a single class of privately placed securities so long as certain conditions are met, including that our Adviser, acting on our behalf and on behalf of other clients, negotiates no term other than price.

A failure on our part to maintain our qualification as a Business Development Company would significantly reduce our operating flexibility.

If we fail to continuously qualify as a Business Development Company, we might be subject to regulation as a registered closed-end investment company under the Investment Company Act, which would significantly decrease our operating flexibility. In addition, failure to comply with the requirements imposed on Business Development Companies by the Investment Company Act could cause the SEC to bring an enforcement action against us.

Regulations governing our operation as a Business Development Company and RIC affect our ability to raise, and the way in which we raise, additional capital or borrow for investment purposes, which may have a negative effect on our growth.

As a Business Development Company, we are required to invest at least 70% of our total assets primarily in securities of U.S. private or thinly-traded public companies, cash, cash equivalents, U.S. government securities and other high-quality debt instruments that mature in one year or less from the date of investment.

As a Business Development Company, we may issue “senior securities,” including borrowing money from banks or other financial institutions only in amounts such that our asset coverage, as defined in the Investment Company Act, equals at least 150% after such incurrence or issuance. These requirements limit the amount that we may borrow, may unfavorably limit our investment opportunities and may reduce our ability in comparison to other companies to profit from favorable spreads between the rates at which we can borrow and the rates at which we can lend. If the value of our assets declines, we may be unable to satisfy the asset coverage test, which could prohibit us from paying distributions and could prevent us from being subject to tax as a RIC. If we cannot satisfy the asset coverage test, we may be required to sell a portion of our investments and, depending on the nature of our debt financing, repay a portion of our indebtedness at a time when such sales may be disadvantageous.

Because we will continue to need capital to grow our investment portfolio, these limitations may prevent us from incurring debt and require us to raise additional equity at a time when it may be disadvantageous to do so. As a result of these requirements we need to periodically access the capital markets to raise cash to fund new investments at a more frequent pace than our privately owned competitors. We generally are not able to issue or sell our common stock at a price below net asset value per share, which may be a disadvantage as compared with other public companies or private investment funds. When our common stock trades at a discount to net asset value, this restriction could adversely affect our ability to raise capital. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the current net asset value of the common stock if our Board of Directors and independent directors determine that such sale is in our best interests and the best interests of our stockholders, and our stockholders as well as those stockholders that are not affiliated with us approve such sale in accordance with the requirements of the Investment Company Act. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board of Directors, closely approximates the market value of such securities (less any underwriting commission or discount).

We also may make rights offerings to our stockholders at prices less than net asset value, subject to applicable requirements of the Investment Company Act. If we raise additional funds by issuing more shares of our common stock or issuing senior securities convertible into, or exchangeable for, our common stock, the percentage ownership of our stockholders may decline at that time and such stockholders may experience dilution. Moreover, we can offer no assurance that we will be able to issue and sell additional equity securities in the future, on terms favorable to us or at all. If additional funds are not available to us, we could be forced to curtail or cease new investment activities.

In addition, we may in the future seek to securitize our portfolio securities to generate cash for funding new investments. To securitize loans, we would likely create a wholly-owned subsidiary and contribute a pool of loans to the subsidiary. We would then sell interests in the subsidiary on a non-recourse basis to purchasers and we would retain all or a portion of the equity in the subsidiary. An inability to successfully securitize our loan portfolio could limit our ability to grow our business or fully execute our business strategy and may decrease our earnings, if any. The securitization market is subject to changing market conditions and we may not be able to access this market when we would otherwise deem appropriate. Moreover, the successful securitization of our portfolio might expose us to losses as the residual investments in which we do not sell interests will tend to be those that are riskier and more apt to generate losses. The Investment Company Act also may impose restrictions on the structure of any securitization.

Recent developments in the banking sector could materially affect the success of our activities and investments.

Recent insolvency, closure, receivership or other financial distress or difficulty and related events experienced by certain U.S. and non-U.S. banks, each, a Distress Event, have caused uncertainty and fear of instability in the global financial system generally. In addition, eroding market sentiment and speculation of potential future Distress Events have caused other financial institutions – in particular smaller and/or regional banks – to experience volatile stock prices and significant losses in their equity value, and there is concern that depositors at these institutions have withdrawn, or may withdraw in the future, significant sums from their accounts at these institutions, potentially triggering the occurrence of additional Distress Events. Notwithstanding intervention by certain U.S. and non-U.S. governmental agencies to protect the uninsured depositors of banks that have recently experienced Distress Events, there is no guarantee that depositors (which depositors could include us and/or our portfolio companies) that have assets in excess of the amount insured by governmental agencies on deposit with a financial institution that experiences a Distress Event will be made whole or, even if made whole, that such deposits will become available for withdrawal or other usage on a timely basis.

There is a risk that other banks, other lenders, or other financial institutions (including such financial institutions in their respective capacities as brokers, hedging counterparties, custodians, loan servicers, administrators, intermediary or other service providers (the foregoing, together with banks, each, a “Financial Institution”)) may be similarly impacted, and it is uncertain what steps (if any) government or other regulators may take in such circumstances. As a consequence, for example, Oaktree, us and/or our portfolio companies may be delayed or prevented from accessing funds or other assets, making any required payments under debt or other contractual obligations, paying distributions or pursuing key strategic initiatives. In addition, such bank or other Financial Institution Distress Events and/or attendant instability could adversely affect, in certain circumstances, the ability of both affiliated and unaffiliated joint venture partners, co-lenders, syndicate lenders or other parties to undertake and/or execute transactions with us, which in turn may result in fewer investment opportunities being made available to us or being consummated by us, result in shortfalls or defaults under existing investments, or impact our ability to provide additional follow-on support to portfolio companies. Distress Events could also impact the ability of Oaktree, us and/or portfolio companies to access hedging, loan servicing, monitoring, compliance (including compliance with anti-money laundering and related laws and regulations), administration, intermediation or other services, either permanently or for an extended period of time.

In addition, in the event that a Financial Institution that provides credit facilities and/or other financing to us, any of our affiliates, and/or one or more of our portfolio companies closes or experiences any other Distress Event, there can be no assurance that such Financial Institution will honor its obligations to provide such financing or that we or such portfolio company will be able to secure replacement financing or credit accommodations at all or on similar terms, or be able to do so without suffering delays or incurring losses or significant additional expenses. Similarly, if a Distress Event leads to a loss of access to a Financial Institution’s other services (in addition to financing and other credit accommodations), it is also possible that we or our portfolio companies will incur additional expenses or delays in putting in place alternative arrangements or that such alternative arrangements will be less favorable than those formerly in place (with respect to economic terms, service levels, access to capital, or otherwise). We and our portfolio companies are subject to similar risks if a Financial Institution utilized by our investors or by suppliers, vendors, brokers, dealers, custodians, loan and portfolio servicers, hedging and other service providers or other counterparties of us or our portfolio companies becomes subject to a Distress Event, which could have a material adverse effect on us. We, our affiliates, and our portfolio companies are expected to be subject to contractual obligations to maintain all or a portion of their respective assets with a particular Financial Institutions (including, without limitation, in connection with a credit facility or other financing transaction). Accordingly, although each of Oaktree and us seeks to do business with Financial Institutions that it believes are creditworthy and capable of fulfilling their respective obligations, there can be no expectation that any of the foregoing, or any of their respective affiliates or portfolio companies will establish banking relationships or financial arrangements with multiple Financial Institutions or maintain account balances at or below the relevant insured amounts with respect to any Financial Institution.

Uncertainty caused by recent bank failures – and general concern regarding the financial health and outlook for other Financial Institutions – could have an overall negative effect on banking systems and financial markets generally. These recent developments may also have other implications for broader economic and monetary policy, including interest rate policy. For the foregoing reasons, there can be no assurances that conditions in the banking sector and in global financial markets will not worsen and/or adversely affect us, our portfolio companies or our respective financial performance.

The ongoing conflict between Russia and Ukraine could materially affect the success of our activities and investments.

In 2022, the Russian military commenced a full-scale invasion of Russia’s forces into Ukraine. In response, the United States, United Kingdom, the European Union, or EU, and other countries have imposed significant sanctions targeting the Russian financial system, petroleum sector and extractive industries, heavy manufacturing, and other sectors. These and other jurisdictions have also imposed prohibitions on most new investment in Russia, prohibitions on trade in many Russian

securities, and prohibitions on the provision of a number of services to certain sectors of the Russian economy. Since the invasion, the sanctions and export controls landscape has been and is likely to continue to be dynamic. Russia’s invasion of Ukraine, the resulting displacement of persons both within Ukraine and to neighboring countries and the increasing international sanctions could have a negative impact on the economy and business activity globally, and therefore could adversely affect the performance of our investments. Furthermore, given the ongoing and evolving nature of the conflict between the two nations and its ongoing escalation (including with respect to the use of nuclear weapons and cyberwarfare against military and civilian targets globally), it is difficult to predict the conflict’s ultimate impact on global economic and market conditions, and, as a result, the situation presents material uncertainty and risk with respect to us and the performance of its investments or operations, and our ability to achieve our investment objectives.

The ongoing conflict between Israel and Hamas could materially affect the success of our activities and investments.

On October 7, 2023, Hamas (an organization which governs Gaza and which has been designated as a terrorist organization by the United States, the United Kingdom, the EU, Australia and other nations) committed a terrorist attack within Israel, or the October 7 Attacks. As of the date hereof, Israel and Hamas remain in active armed conflict. The ongoing conflict and rapidly evolving measures in response could have a negative impact on the economy and business activity globally, and therefore could adversely affect the performance of our investments. The severity and duration of the conflict and its future impact on global economic and market conditions (including, for example, oil prices and/or the shipping industry) are impossible to predict and, as a result, present material uncertainty and risk with respect to us and the performance of our investments and operations, and our ability to achieve our investment objectives. For example, the armed conflict may expand and may ultimately more actively involve the United States, Lebanon (and/or Hezbollah), Syria, Iran, Yemen and/or other countries or terrorist organizations, any of which may exacerbate the risks described above. Similar risks exist to the extent that any portfolio companies, service providers, vendors or certain other parties have material operations or assets in the Middle East or the immediate surrounding areas. The United States has announced sanctions and other measures against Hamas-related persons and organizations in response to the October 7 Attacks, and the United States (and/or other countries) may announce further sanctions related to the ongoing conflict in the future.

Our Board of Directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval, the effects of which may be adverse.

Our Board of Directors has the authority to modify or waive our current investment objective, operating policies and strategies without prior notice and without stockholder approval. We cannot predict the effect any changes to our current investment objective, operating policies and strategies would have on our business, net asset value, operating results and value of our stock. However, the effects might be adverse, which could negatively impact our ability to pay you distributions and cause you to lose part or all of your investment.

Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy.

We and our portfolio companies are subject to regulation at the local, state and federal level. New legislation may be enacted or new interpretations, rulings or regulations could be adopted, including those governing the types of investments we are permitted to make or that impose limits on our ability to pledge a significant amount of our assets to secure loans or that restrict the operations of a portfolio company, any of which could harm us and our stockholders and the value of our investments, potentially with retroactive effect. Any amendment or repeal of legislation, or changes in regulations or regulatory interpretations thereof, could create uncertainty in the near term, which could have a material adverse impact on our business, financial condition and results of operations.

Additionally, any changes to the laws and regulations governing our operations relating to permitted investments may cause us to alter our investment strategy in order to avail ourselves of new or different opportunities. Such changes could result in material differences to the strategies and plans set forth herein and may result in our investment focus shifting from the areas of expertise of our Adviser to other types of investments in which our Adviser may have less expertise or little or no experience. Thus, any such changes, if they occur, could have a material adverse effect on our results of operations and the value of your investment.

We are subject to risks associated with respect to ESG matters.

Oaktree has established an ESG Policy, which the Adviser intends to apply to our investments as applicable, consistent with and subject to applicable fiduciary duties and any legal, regulatory or contractual requirements. Depending on the investment, ESG factors could have a material effect on the return and risk profile of the investment. The act of selecting and evaluating material ESG factors is subjective by nature, Oaktree may be subject to competing demands from different investors and other stakeholder groups with divergent views on ESG matters, including the role of ESG factors in the investment process, and there is no guarantee that the criteria utilized or judgment exercised by the Adviser or a third-party ESG advisor will reflect the beliefs or values, internal policies or preferred practices of any particular investor or other asset managers or reflect market

trends. Although Oaktree views the consideration of ESG to be an opportunity to potentially enhance or protect the performance of its investments over the long-term, Oaktree cannot guarantee that its ESG program, which depends in part on qualitative judgments, will positively impact the performance of any individual investment or us as a whole. Similarly, to the extent the Adviser or a third-party ESG advisor engages with portfolio investments on ESG-related practices and potential enhancements thereto, there is no guarantee that such engagements will improve the performance of the investment. Successful engagement efforts on the part of the Adviser or a third-party ESG advisor will depend on the Adviser’s or any relevant third-party advisor’s ability to engage with the relevant investment and skill in properly identifying and analyzing material ESG and other factors and their value, and there can be no assurance that the strategy or techniques employed will be successful.

The materiality of ESG factors on an individual asset or issuer and on a portfolio as a whole depends on many factors, including the relevant industry, location, asset class and investment strategy. ESG factors, issues, and considerations do not apply in every instance or with respect to each investment held, or proposed to be made, by us, and will vary greatly based on numerous criteria, including, but not limited to, location, industry, investment strategy, and issuer-specific and investment-specific characteristics. In evaluating a prospective investment, the Adviser often depends upon information and data provided by the entity or obtained via third-party reporting or advisors, which may be incomplete or inaccurate and could cause the Adviser to incorrectly identify, prioritize, assess or analyze the entity’s ESG practices and/or related risks and opportunities. The Adviser does not intend to independently verify certain of the ESG information reported by our investments, and may decide in its discretion not to utilize, report on, or consider certain information provided by such investments. Any ESG reporting will be provided in the Adviser’s sole discretion.

In addition, Oaktree’s ESG Policy and associated procedures and practices are expected to change over time. Oaktree is permitted to determine in its discretion that it is not feasible or practical to implement or complete certain of its ESG initiatives based on cost, timing or other considerations. It is also possible that market dynamics or other factors will make it impractical, inadvisable or impossible for the Adviser to adhere to all elements of our investment strategy, including with respect to ESG risk and opportunity management, whether with respect to one or more individual investments or to our portfolio generally. ESG-related statements, initiatives and goals as described in this annual report on Form 10-K with respect to our investment strategy, portfolio, and investments are aspirational and not guarantees or promises that all or any such initiatives and goals will be achieved other than as set out in any applicable regulatory disclosures, including those made pursuant to the Sustainable Finance Disclosure Regulation (SFDR).

Further, ESG integration and responsible investing practices as a whole are evolving rapidly and there are different principles, frameworks, methodologies and tracking tools being implemented by asset managers, and Oaktree’s adoption of and adherence to such principles, frameworks, methodologies and tools may vary over time. For example, Oaktree’s ESG Policy does not represent a universally recognized standard for assessing ESG considerations. Any ESG-related initiatives to which Oaktree is or becomes a signatory, member, or supporter may not align with the approach used by other asset managers (or preferred by prospective investors) or with future market trends. There is no guarantee that Oaktree will remain a signatory, supporter or member of or continue to report at the intended cadence or at all under or in alignment with such initiatives or other similar industry frameworks.

Moreover, in recent years anti-ESG sentiment has gained momentum across the U.S., with several states and Congress having proposed or enacted “anti-ESG” policies, legislation, or initiatives or issued related legal opinions. Additionally, asset managers have been subject to recent scrutiny related to ESG-focused industry working groups, initiatives, and associations, including organizations advancing action to address climate change or climate-related risk. Further, some conservative groups and Republican state attorneys general have asserted that the Supreme Court’s decision striking down race-based affirmative action in higher education in June 2023 should be analogized to private employment matters and private contract matters. Several new cases alleging discrimination based on similar arguments have been filed since the decision, which has escalated scrutiny of certain practices and initiatives related to diversity, equity, and inclusion, or DEI. Such anti-ESG and anti-DEI-related policies, legislation, initiatives, litigation, legal opinions, and scrutiny could result in Oaktree facing additional compliance obligations, becoming the subject of investigations or enforcement actions, or sustaining reputational harm, or require certain investors to divest or discourage certain investors from investing in us.

There is growing regulatory interest across jurisdictions, particularly in the U.S., UK and EU (which may be looked to as models in growth markets), in improving transparency around how asset managers identify and manage financially material ESG risks as well as how they define and measure ESG performance, in order to allow investors to better understand and validate sustainability-related claims. Compliance with regulations concerning asset managers’ sustainability and ESG disclosures, including those set forth below, results in management burdens and costs because of, for example, the need to obtain advice from third-party advisors; implement specific governance, risk management systems, and internal controls; and collect information from and about investments. Further, changes to existing regulations, enactment of new regulations, and changes to enforcement patterns could subject the Adviser or us to additional compliance burdens, costs, and/or enforcement risks, or impact our ability to deliver on our investment strategy. Oaktree cannot guarantee that its current approach to ESG (including the ESG Policy) will meet future regulatory requirements.

The SEC established a Climate and ESG Enforcement Task Force in March 2021. On May 25, 2022, the SEC proposed amendments to rules and reporting forms concerning ESG factors, which rules are not in final form and therefore it cannot be determined how they may affect us.

We, Oaktree and/or our portfolio companies may be subject to disclosure laws and regulations related to a range of sustainability matters, including greenhouse gas emissions; climate change risks; diversity, equity and inclusion; and human rights matters, or Sustainability Disclosure Laws. For example, in March 2024, the SEC adopted final rules intended to enhance and standardize climate-related disclosures by public companies and in public offerings; these rules are stayed pending the outcome of consolidated legal challenges in the Eighth Circuit Court of Appeals. In the Fall of 2023, California passed the Climate Corporate Data Accountability Act (SB-253) and Climate-Related Financial Risk Act (SB-261), which will impose broad climate-related disclosure obligations on U.S.-organized entities that meet certain revenue thresholds and do business in California, as well as the Voluntary Carbon Market Disclosures Act (AB-1305), which is focused on the voluntary carbon market for carbon credits but also includes disclosure requirements for companies with a required nexus to California making certain climate-related claims. In Europe, the Corporate Sustainability Reporting Directive introduces wide-ranging and detailed obligations for European and non-European undertakings to make disclosures in accordance with the European Sustainability Reporting Standards on impacts, risks and opportunities on a “double materiality” basis. In addition to assessing the financial materiality of a sustainability matter, sustainability matters that pertain to the undertaking’s actual or potential, positive or negative impacts on people or the environment over the short-, medium-, or long-term must be disclosed. Impacts may include those connected with the entity’s own operations and upstream and downstream value chain, including through its products and services, as well as through its business relationships. Other jurisdictions have also enacted or are considering enacting mandatory climate and sustainability reporting laws (in many cases based on the recommendations of the Task Force on Climate-related Financial Disclosures or the standards published by the International Sustainability Standards Board), as well as laws requiring reporting of information on other ESG topics, such as human capital. Compliance with Sustainability Disclosure Laws may require the implementation of or changes to systems and procedures for the collection and processing of relevant data and related internal and external controls, changes to management and/or operational obligations, and dedication of substantial time and financial resources. The compliance burden and related costs may increase over time. Failure to comply with applicable Sustainability Disclosure Laws may lead to investigations and audits, fines, other enforcement action or liabilities, or reputational damage.

We, Oaktree and/or our portfolio companies may be subject to laws and regulations requiring due diligence processes and internal compliance systems in relation to a range of human rights and environmental matters, or Sustainability Due Diligence Laws. For example, a number of jurisdictions have passed or proposed mandatory due diligence requirements in relation to forced labor and human rights matters across corporate groups and supply chains. Compliance with Sustainability Due Diligence Laws may require the development or update of internal compliance and enterprise risk management policies and related procedures; assigning board and/or management oversight as well as day-to-day operational responsibility for in-scope human rights and environmental matters; implementation of periodic compliance risk assessments; updates to contractual frameworks and agreements; the development of preventative and/or corrective action plans; changes to purchasing, design, and distribution practices, where relevant; and the development or update of notification mechanisms and complaints procedures. The compliance burden and related costs may increase over time. Failure to comply with applicable Sustainability Due Diligence Laws may lead to investigations and audits, fines, exclusion from public procurement, other enforcement action or liabilities, including civil liability or liability from third-party claims, and reputational damage.

There are a number of different principles, frameworks, and/or methodologies for integrating sustainability-related incentives, mandates, and/or reporting requirements into financing arrangements. Any principles, frameworks, and/or methodologies which we anticipate referencing and/or utilizing may not align with other asset managers and/or those preferred by prospective investors. In addition, unless otherwise stated in our regulatory disclosures, no assurance is given that any of our financing arrangements will align with particular market frameworks, including the Green Loan, Social Loan, and/or Sustainability-Linked Loan Principles published by the Loan Market Association, Loan Syndications and Trading Association, and the Asia Pacific Loan Market Association, or the Principles. Furthermore, to the extent any of such financing arrangement is considered to be aligned with any relevant Principles at origination by us, there is no guarantee that such financing will maintain alignment with the Principles over the relevant term. Any declassification and/or deviation with the applicable Principles may expose us and/or Oaktree to certain investigations, claims, and/or allegations, which may lead to increased costs and/or result in adverse consequences for certain investors with sustainability-aligned portfolio mandates.

We are subject to risks associated with inflation.

High rates of inflation and rapid increases in the rate of inflation generally have a negative impact on financial markets and the broader economy. In an attempt to stabilize inflation, governments may impose wage and price controls or otherwise intervene in a country’s economy. Governmental efforts to curb inflation, including by increasing interest rates or reducing fiscal or monetary stimuli, often have negative effects on the level of economic activity. Certain countries, including the United States, have recently seen increased levels of inflation, and persistently high levels of inflation could have a material and

adverse impact on our investments and our aggregated returns. For example, if a portfolio company were unable to increase its revenue while the cost of relevant inputs were increasing, the company’s profitability would likely suffer. Likewise, to the extent a portfolio company has revenue streams that are slow or unable to adjust to changes in inflation, including by contractual arrangements or otherwise, the portfolio company could increase revenue by less than its expenses increase. Conversely, as inflation declines, a portfolio company may see its competitors’ costs stabilize sooner or more rapidly than its own. Moreover, increasing inflation will also impact currencies and can lead to significant currency fluctuations. This has recently resulted in a strengthening of the U.S. dollar vis-à-vis many other currencies but there can be no assurances that such trends will continue and/or that this trend will not reverse such that the U.S. dollar is weakened vis-à-vis other currencies. Additionally, because the hurdle is not linked to the rate of inflation, as the rate of inflation increases the proportion of real returns (i.e., the nominal rate of return less the rate of inflation), it is easier for the Adviser to meet the quarterly hurdle rate for payment of income incentive fees under the Investment Advisory Agreement, which may result in an increase in the amount of the income-based incentive fee payable to our Adviser. There can be no assurance that high rates of inflation will not have a material adverse effect on our investments.

We and/or our portfolio companies may be materially and adversely impacted by global climate change.

Global climate change is widely considered to be a significant threat to the global economy. Real estate and similar assets in particular may face risks associated with climate change, including risks related to the impact of climate-related legislation and regulation (both domestically and internationally), risks related to climate-related business trends, and risks stemming from the physical impacts of climate change, such as the increasing frequency or severity of extreme weather events and rising sea levels and temperatures.

The market’s focus on climate change may not have a positive impact on our investments.

Financial resources and public and private investment into business activities seeking to address climate change, reduce emissions and promote adaptation to climate change-related impacts are increasing. While financial and non-financial benefits may flow from these types of investments, Oaktree cannot guarantee that such activities will improve the financial or environmental, social and governance-related performance of the investment, reduce emissions or promote adaptation to climate change-related impacts and Oaktree may also not find itself in a position to maximize opportunities presented by such business activities whether in respect of financial or non-financial returns.

Additionally, the Paris Agreement and other regulatory and voluntary initiatives launched by international, federal, state, and regional policymakers and regulatory authorities as well as private actors seeking to reduce greenhouse gas, or GHG, emissions may expose real estate and similar assets to so-called “transition risks” in addition to physical risks, such as: (i) political and policy risks (e.g., changing regulatory incentives and legal requirements, including with respect to GHG emissions, that could result in increased costs or changes in business operations), (ii) regulatory and litigation risks (e.g., changing legal requirements that could result in increased permitting, tax and compliance costs, changes in business operations, or the discontinuance of certain operations, and litigation seeking monetary or injunctive relief related to impacts related to climate change), (iii) technology and market risks (e.g., declining market for assets, products and services seen as GHG intensive or less effective than alternatives in reducing GHG emissions) and (iv) reputational risks (e.g., risks tied to changing investor, customer or community perceptions of an asset’s relative contribution to GHG emissions). Oaktree cannot rule out the possibility that climate risks, including changes in weather and climate patterns, could result in unanticipated delays or expenses and, under certain circumstances, could prevent completion of investment activities or the effective management of real estate and similar assets once undertaken, any of which could have a material adverse effect on an investment, or us.

We may face significant environmental liability in connection with our investments.

We may face significant environmental liability in connection with our investments. When compared to the United States, the historical lack or inadequacy of environmental regulation in certain non-U.S. countries has led to the widespread pollution of air, ground and water resources. The legislative framework for environmental liability in these countries has not been fully established or implemented. The extent of the responsibility, if any, for the costs of abating environmental hazards may be unclear when we are considering an investment. We may engage the services of qualified environmental consultants as necessary to assess the environmental condition of property which may be or is an investment. Nevertheless, we or a company in which we invest may be considered an owner or operator of properties on or in which asbestos or other hazardous or toxic substances exist and, therefore, potentially liable for removal or remediation costs, as well as certain other related costs, including governmental fines and costs of injuries to persons and property. These costs can be substantially in excess of the value of the property. The presence of environmental contamination, pollutants or other hazardous or toxic substances on or emanating from a property (whether known at the time of acquisition or not) could also result in personal injury (and associated liability) to persons on or in the vicinity of the property and persons removing such materials, future or continuing property damage (which may adversely affect property value) or claims by third parties, including as a result of exposure to or damage from such materials through the spread of contaminants.

Environmental laws, regulations and regulatory initiatives play a significant role in the energy and utility industries and can have a substantial impact on investments in this industry. For example, global initiatives to minimize pollution have played a major role in the increase in demand for gas and alternative energy sources, creating numerous new investment opportunities. Conversely, required expenditures for environmental compliance have adversely impacted investment returns in a number of segments of the industry. The energy and utility industries will continue to face considerable oversight from environmental regulatory authorities. We may invest in portfolio companies that are subject to changing and increasingly stringent environmental and health and safety laws, regulations and permit requirements. There can be no guarantee that all costs and risks regarding compliance with environmental laws and regulations can be identified. New and more stringent environmental and health and safety laws, regulations and permit requirements or stricter interpretations of current laws or regulations could impose substantial additional costs on portfolio companies or potential investments. Compliance with such current or future environmental requirements does not ensure that the operations of the portfolio companies will not cause injury to the environment or to people under all circumstances or that the portfolio companies will not be required to incur additional unforeseen environmental expenditures. Moreover, failure to comply with any such requirements could have a material adverse effect on a portfolio company, and there can be no assurance that portfolio companies will at all times comply with all applicable environmental laws, regulations and permit requirements. Past practices or future operations of portfolio companies could also result in material personal injury or property damage claims, which could have an adverse effect on our performance.

Economic and trade sanctions and anti-bribery laws could make it more difficult or costly for us to conduct our operations or achieve our business objectives.

Economic and trade sanctions laws in the United States and other jurisdictions may prohibit Oaktree, the Investment Professionals and us from transacting with or in certain countries and with certain individuals, companies and industry sectors. In the United States, the U.S. Department of the Treasury’s Office of Foreign Assets Control, or OFAC, administers and enforces laws, Executive Orders and regulations establishing U.S. sanctions. Such sanctions prohibit, among other things, transactions with, and the provision of services to, certain foreign countries, territories, entities and individuals. These entities and individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs. In addition, certain sanctions programs prohibit dealing with individuals or entities in certain countries, or certain securities and certain industry sectors regardless of whether relevant individuals or entities appear on the lists maintained by OFAC, which may make it more difficult for us to comply with applicable sanctions. These types of sanctions may significantly restrict or limit our investment activities in certain countries (in particular, certain emerging market countries). We, Oaktree and the Investment Professionals may from time to time be subject to trade sanctions laws and regulations of other jurisdictions, which may be inconsistent with or even seek to prohibit compliance with certain sanctions programs administered by OFAC. The legal uncertainties arising from those conflicts may make it more difficult or costly for us to navigate investment activities that are subject to sanctions administered by OFAC or the laws and regulations of other jurisdictions. Some jurisdictions where Oaktree or its portfolio companies do business from time to time have adopted measures prohibiting compliance with certain U.S. sanctions programs, which may make compliance with all applicable sanctions impossible.

At the same time, Oaktree may be obligated to comply with certain anti-boycott laws and regulations that prevent Oaktree and us from engaging in certain discriminatory practices that may be allowed or required in certain jurisdictions. Oaktree’s refusal to discriminate in this manner could make it more difficult for us to pursue certain investments and engage in certain business activities, and any compliance with such practices could subject Oaktree or us to fines, penalties, and adverse legal and reputational consequences.

In some countries, there is a greater acceptance than in the United States and the UK of government involvement in commercial activities and of activities constituting corruption in the United States and the UK. Certain countries, including the United States and the UK, have laws prohibiting governmental and private commercial, or commercial, bribery. We and Oaktree are committed to complying with the U.S. Foreign Corrupt Practices Act, or the FCPA, the UK Bribery Act 2010, or the UK Bribery Act, and other anti-corruption laws, anti-bribery laws and regulations, as well as anti-boycott regulations, to which we are subject. As a result, we may be adversely affected because of our unwillingness to participate in transactions that violate such laws or regulations. Such laws and regulations may make it difficult in certain circumstances for us to act successfully on investment opportunities and for portfolio companies to obtain or retain business.

In recent years, the U.S. Department of Justice and the SEC have devoted greater resources to enforcement of the FCPA and have devoted greater scrutiny to investments by private equity sponsors. In addition, the UK, with enactment of the UK Bribery Act, has expanded the reach of its anti-bribery laws significantly. While Oaktree has developed and implemented policies and procedures designed to ensure strict compliance by Oaktree and its personnel with the FCPA and the UK Bribery Act and the sanctions regimes that apply to Oaktree, such policies and procedures may not be effective in all instances to prevent violations or offenses. In addition, in spite of Oaktree’s policies and procedures, affiliates of portfolio companies, particularly in cases in which we or an Other Oaktree Fund do not control such portfolio company, may engage in activities that could result in FCPA, UK Bribery Act or other violations of law. Any determination that Oaktree has violated or committed an

offense under the FCPA, UK Bribery Act or other applicable anti-corruption laws or anti-bribery laws or sanctions requirements could subject Oaktree to, among other things, civil and criminal penalties, reputational damage, material fines, profit disgorgement, injunctions on future conduct, securities litigation, disclosure obligations and a general loss of investor confidence, any one of which could adversely affect Oaktree’s business prospects and/or financial position, as well as our ability to achieve its investment objective and/or conduct its operations.

We may face a breach of our cyber security, which could result in adverse consequences to our operations and exposure of confidential information.

Cybersecurity incidents and cyber-attacks have been occurring globally at a more frequent and severe level and are expected to continue to increase in frequency and severity in the future. The information and technology systems of Oaktree, its affiliates, portfolio companies, issuers and service providers may be vulnerable to damage or interruption from cybersecurity breaches, computer viruses or other malicious code, network failures, computer and telecommunication failures, infiltration by unauthorized persons and other security breaches, usage errors or malfeasance by their respective professionals or service providers, power, communications or other service outages, and catastrophic events such as fires, tornadoes, floods, hurricanes, earthquakes or terrorist incidents. If unauthorized parties gain access to such information and technology systems, or if personnel abuse or misuse their access privileges, they may be able to steal, publish, delete or modify private and sensitive information, including non-public personal information related to our stockholders (and their beneficial owners) and material non-public information. Although Oaktree has implemented, and portfolio companies, issuers and service providers may implement, various measures to manage risks relating to these types of events, such systems could prove to be inadequate and, if compromised, could become inoperable for extended periods of time, cease to function properly or fail to adequately secure private information. Oaktree does not control the cybersecurity plans and systems put in place by third-party service providers, and such third-party service providers may have limited indemnification obligations to Oaktree, its affiliates, us, our stockholders and/or a portfolio company or issuer, each of whom could be negatively impacted as a result. Breaches such as those involving covertly introduced malware, impersonation of authorized users and industrial or other espionage may not be identified in a timely manner or at all, even with sophisticated prevention and detection systems. This could potentially result in further harm and prevent such breaches from being addressed appropriately. The failure of these systems and/or of disaster recovery plans for any reason could cause significant interruptions in Oaktree’s, its affiliates’, our and/or a portfolio company’s or issuer’s operations and result in a failure to maintain the security, confidentiality or privacy of sensitive data, including personal information relating to stockholders (and their beneficial owners), material non-public information and the intellectual property and trade secrets and other sensitive information of Oaktree and/or portfolio companies or issuers. We, Oaktree and/or a portfolio company could be required to make a significant investment to remedy the effects of any such failures, harm to our reputations, legal claims that we or our respective affiliates may be subjected to regulatory action or enforcement arising out of applicable privacy and other laws, adverse publicity, and other events that may affect our business and financial performance.

We and our portfolio companies will be subject to regulations related to privacy, data protection and information securities, and any failure to comply with these requirements could result in fines, sanctions or other penalties, which could have a material adverse effect on our business and our reputation.

The adoption, interpretation and application of consumer protection, data protection and/or privacy laws and regulations in the United States, Europe or other jurisdictions, or Privacy Laws, could significantly impact current and planned privacy and information security related practices, the collection, use, sharing, retention and safeguarding of personal data and current and planned business activities of Oaktree and us and/or our portfolio companies, and increase compliance costs and require the dedication of additional time and resources to compliance for such entities. A failure to comply with such Privacy Laws by any such entity or their service providers could result in fines, sanctions or other penalties, which could materially and adversely affect the results of operations and overall business, as well as have a negative impact on reputation and our performance. As Privacy Laws are implemented, interpreted and applied, compliance costs are likely to increase, particularly in the context of ensuring that adequate data protection and data transfer mechanisms are in place.

For example, California has passed the California Consumer Privacy Act of 2018 and the California Privacy Rights Act of 2020, each of which broadly impacts businesses that handle various types of personal data. Such laws impose stringent legal and operational obligations on regulated businesses, as well as the potential for significant penalties. Other jurisdictions, including other U.S. states, already have, have proposed or are considering similar Privacy Laws, which impose, or could impose if enacted, similarly significant costs, potential liabilities and operational and legal obligations. Such Privacy Laws and regulations are expected to vary from jurisdiction to jurisdiction, thus increasing costs, operational and legal burdens, and the potential for significant liability for regulated entities, which could include Oaktree and us and/or our portfolio companies.

We are subject to risks associated with artificial intelligence and machine learning technology.

Recent technological advances in artificial intelligence and machine learning technology, or Machine Learning Technology, including OpenAI’s release of its ChatGPT application, pose risks to us, Oaktree and our portfolio investments. While Oaktree may utilize Machine Learning Technology in connection with its business activities, including investment

activities, Oaktree intends to periodically evaluate and/or adjust internal policies governing use of Machine Learning Technology by its personnel. Notwithstanding any such policies, Oaktree personnel, portfolio managers, senior executives, Industry Specialists and other associated persons of Oaktree or any affiliates of Oaktree could, unbeknownst to Oaktree, utilize Machine Learning Technology in contravention of such policies. We, Oaktree and our portfolio investments could be further exposed to the risks of Machine Learning Technology if third-party service providers or any counterparties, whether or not known to Oaktree, also use Machine Learning Technology in their business activities. Oaktree will not be in a position to control the use of Machine Learning Technology in third-party products or services, including those provided by Oaktree’s and its affiliates service providers.

Use of Machine Learning Technology by any of the parties described in the previous paragraph could include the input of confidential information (including material non-public information)—either by third parties in contravention of non-disclosure agreements, or by Oaktree personnel or the aforementioned Oaktree advisors and affiliates in contravention of Oaktree’s policies, contractual or other obligations or restrictions to which any of the foregoing or any of their affiliates or representatives are subject, or otherwise in violation of applicable laws or regulations relating to treatment of confidential and/or personally identifiable information (including material non-public information) —into Machine Learning Technology applications, resulting in such confidential information becoming part of a dataset that is accessible by other third-party Machine Learning Technology applications and users.

Independent of its context of use, Machine Learning Technology is generally highly reliant on the collection and analysis of large amounts of data, and it is not possible or practicable to incorporate all relevant data into the model that Machine Learning Technology utilizes to operate. Certain data in such models will inevitably contain a degree of inaccuracy and error – potentially materially so – and could otherwise be inadequate or flawed, which would be likely to degrade the effectiveness of Machine Learning Technology. To the extent that we, Oaktree or our portfolio investments are exposed to the risks of Machine Learning Technology use, any such inaccuracies or errors could have adverse impacts on us, Oaktree or our portfolio investments. Conversely, to the extent competitors of Oaktree and its portfolio companies utilize Machine Learning Technology more extensively than Oaktree and its portfolio companies, there is a possibility that such competitors will gain a competitive advantage.

Machine Learning Technology and its applications, including in the private investment and financial sectors, continue to develop rapidly, and it is impossible to predict the future risks that may arise from such developments.

We may be unable to invest a significant portion of the net proceeds from an offering of our securities on acceptable terms within an attractive timeframe.

Delays in investing the net proceeds raised in an offering of our securities may cause our performance to be worse than that of fully invested Business Development Companies or other lenders or investors pursuing comparable investment strategies. We cannot assure you that we will be able to identify any investments that meet our investment objective or that any investment that we make will produce a positive return. We may be unable to invest the net proceeds of any offering on acceptable terms within the time period that we anticipate or at all, which could harm our financial condition and operating results.

We anticipate that, depending on market conditions, it may take us a substantial period of time to invest substantially all of the net proceeds of any offering in securities meeting our investment objective. During this period, we may use the net proceeds to pay down outstanding debt or we may invest the net proceeds of an offering primarily in cash, cash equivalents, U.S. government securities, repurchase agreements and high-quality debt instruments maturing in one year or less from the time of investment, which may produce returns that are significantly lower than the returns which we expect to achieve when our portfolio is fully invested in securities meeting our investment objective. As a result, any distributions that we pay during this period may be substantially lower than the distributions that we may be able to pay when our portfolio is fully invested in securities meeting our investment objective. In addition, until such time as the net proceeds of an offering are invested in securities meeting our investment objective, the market price for our common stock may decline. Thus, the return on your investment may be lower than when, if ever, our portfolio is fully invested in securities meeting our investment objective.

We may allocate the net proceeds from an offering in ways with which you may not agree.

We have significant flexibility in investing the net proceeds of an offering, and may do so in a way with which you may not agree. Additionally, our Adviser will select our investments subsequent to the closing of an offering, and our stockholders will have no input with respect to such investment decisions. Further, other than general limitations that may be included in a future credit facility, the holders of our debt securities will generally not have veto power or a vote in approving any changes to our investment or operational policies. These factors increase the uncertainty, and thus the risk, of investing in our securities. In addition, pending such investments, we will invest the net proceeds from an offering primarily in high quality, short-term debt securities, consistent with our Business Development Company election and our election to be taxed as a RIC, at yields

significantly below the returns which we expect to achieve when our portfolio is fully invested in securities meeting our investment objective. If we are not able to identify or gain access to suitable investments, our income may be limited.

Risks Relating to Conflicts of Interest

Our base management fee may induce our Adviser to incur leverage.

Our base management fee is payable based upon our gross assets, which includes borrowings for investment purposes, which may encourage our Adviser to use leverage to make additional investments. Given the subjective nature of the investment decisions made by our Adviser on our behalf and the discretion related to incurring leverage in connection with any such investments, it will be difficult to monitor this potential conflict of interest between us and our Adviser.

Our incentive fee may induce our Adviser to make speculative investments.

The incentive fee payable by us to our Adviser may create an incentive for it to make investments on our behalf that are risky or more speculative than would be the case in the absence of such compensation arrangement, which could result in higher investment losses, particularly during cyclical economic downturns. The incentive fee payable to our Adviser includes a component based on a percentage of our net investment income (subject to a hurdle rate), which may encourage our Adviser to use leverage to increase the return on our investments or otherwise manipulate our income so as to recognize income in quarters where the hurdle rate is exceeded and may result in an obligation for us to pay an incentive fee to the Adviser even if we have incurred a loss for an applicable period.

The incentive fee payable by us to our Adviser also may create an incentive for our Adviser to invest on our behalf in instruments that have a deferred interest feature. Under these investments, we would accrue the interest over the life of the investment but would not receive the cash income from the investment until the end of the investment’s term, if at all. Our net investment income used to calculate the income portion of our incentive fee, however, includes accrued interest. Thus, a portion of the incentive fee would be based on income that we have not yet received in cash and may never receive in cash if the portfolio company is unable to satisfy such interest payment obligation to us. While we may make incentive fee payments on income accruals that we may not collect in the future and with respect to which we do not have a formal “clawback” right against our Adviser, the amount of accrued income written off in any period will reduce the income in the period in which such write-off was taken and thereby reduce such period’s incentive fee payment.

In addition, our Adviser may be entitled to receive an incentive fee based upon net capital gains realized on our investments. Unlike the portion of the incentive fee based on income, there is no performance threshold applicable to the portion of the incentive fee based on net capital gains. As a result, our Adviser may have a tendency to invest more in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns.

Given the subjective nature of the investment decisions made by our Adviser on our behalf, we will be unable to monitor these potential conflicts of interest between us and our Adviser.

There may be conflicts of interest related to obligations that Oaktree’s senior management and investment team have to Other Oaktree Funds.

Actual and potential conflicts between Oaktree and its affiliates, on one hand, and us and our portfolio companies, on the other hand, are expected to occur. Oaktree manages or sub-advises other funds and accounts, or collectively, the Other Oaktree Funds, which present the possibility of overlapping investments, and thus the potential for conflicts of interest. Many of the investments targeted by us will be appropriate for certain Other Oaktree Funds, and in retrospect or at different points in the market cycle, investments that were made by us may seem more appropriate for an Other Oaktree Fund, and vice versa. Many of the investments targeted by us may be appropriate for Other Oaktree Funds within those strategies. Our stockholders have no ability to challenge such allocation. Such procedures give Oaktree broad authority to allocate investment opportunities, notwithstanding the potential conflicts of interest that may exist. For example, management fees, carried interest or incentive fees and liquidity provisions may differ significantly between us and the Other Oaktree Funds, creating an economic incentive for Oaktree to allocate investments that may be appropriate for a lower fee or more liquid strategy to a higher fee or less liquid strategy.

In addition, there are potential conflicts of interests between the interests of us and our stockholders, on the one hand, and the business interests of Oaktree, on the other hand. Potential conflicts of interests include, but are not limited to, the fact that Oaktree serves as our investment adviser. If any matter arises that Oaktree determines in its good faith judgment constitutes

an actual conflict of interest, Oaktree may take such actions as may be necessary or appropriate to prevent or reduce the conflict.

Our executive officers and directors, and certain members of our Adviser, serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do or of investment funds managed by our affiliates. For example, Oaktree presently serves as the investment adviser to OLPG, a private Business Development Company, and OSCF, a continuously offered Business Development Company. All of our executive officers serve in substantially similar capacities for OLPG, and one of our independent directors serves as an independent director of OSCF. OLPG and OSCF invest in senior secured loans, including first lien, unitranche and second lien debt instruments that pay interest at rates which are determined periodically on the basis of a floating base lending rate, made to private middle-market companies whose debt is rated below investment grade, similar to those we target for investment. Oaktree and its affiliates also manage or sub-advise other Business Development Companies, registered investment companies and private investment funds and accounts, and may manage other such funds and accounts in the future, which have investment mandates that are similar, in whole and in part, with ours. Therefore, there may be certain investment opportunities that satisfy the investment criteria for OLPG, OSCF and us as well as other Business Development Companies and Other Oaktree Funds. In addition, Oaktree and its affiliates may have obligations to investors in other entities that they advise or sub-advise, the fulfillment of which might not be in the best interests of us or our stockholders. An investment in us is not an investment in any of these other entities.

For example, the personnel of our Adviser may face conflicts of interest in the allocation of investment opportunities to us and such other funds and accounts. Moreover, the Adviser and the Investment Professionals are engaged in other business activities which divert their time and attention. The Investment Professionals will devote as much time to us as such professionals deem appropriate to perform their duties in accordance with the Investment Advisory Agreement. However, such persons may be committed to providing investment advisory and other services for other clients, and engage in other business ventures in which we have no interest. As a result of these separate business activities, the Adviser may have conflicts of interest in allocating management time, services and functions among us, other advisory clients and other business ventures.

Oaktree has investment allocation guidelines that govern the allocation of investment opportunities among the investment funds and accounts managed or sub-advised by Oaktree and its affiliates. To the extent an investment opportunity is appropriate for OLPG, OSCF or us or any other investment fund or account managed or sub-advised by Oaktree or its affiliates, Oaktree will adhere to its investment allocation guidelines in order to determine a fair and equitable allocation.

In addition, affiliates of our Adviser have received exemptive relief from the SEC to allow certain managed funds and accounts, each of whose investment adviser is OCM or an investment adviser controlling, controlled by or under common control with OCM, such as our Adviser, as well as proprietary accounts (subject to certain conditions) to participate in negotiated co-investment transactions where doing so is consistent with the applicable registered fund’s or Business Development Company’s investment objective and strategies as well as regulatory requirements and other pertinent factors, and pursuant to the conditions of the exemptive relief. On September 11, 2024, we, the Adviser and certain of its affiliates received a further modified exemptive order that allows us to participate in follow-on investments with private funds that are not already invested in the issuer. Each potential co-investment opportunity that falls under the terms of the exemptive relief and is appropriate for us and any affiliated fund or account, and satisfies the then-current board-established criteria, will be offered to us and such other eligible funds and accounts. If there is a sufficient amount of securities to satisfy all participants, the securities will be allocated among the participants in accordance with their proposed order size and if there is an insufficient amount of securities to satisfy all participants, the securities will be allocated pro rata based on the investment proposed by the applicable investment adviser to such participant, up to the amount proposed to be invested by each, which is reviewed and approved by an independent committee of legal, compliance and accounting professionals at our Adviser. We may also invest alongside funds managed by our Adviser and its affiliates in certain circumstances where doing so is consistent with applicable law and SEC staff interpretations. For example, we may invest alongside such accounts consistent with guidance promulgated by the staff of the SEC permitting us and such other accounts to purchase interests in a single class of privately placed securities so long as certain conditions are met, including that our Adviser, acting on our behalf and on behalf of other clients, negotiates no term other than price or terms related to price.

Although Oaktree will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our Adviser. We might not participate in each individual opportunity, but will, on an overall basis, be entitled to participate equitably with other entities managed by Oaktree and its affiliates. Oaktree seeks to treat all clients fairly and equitably such that none receive preferential treatment vis-à-vis the others over time, in a manner consistent with its fiduciary duty to each of them; however, in some instances, especially in instances of limited liquidity, the factors may not result in pro rata allocations or may result in situations where certain funds or accounts receive allocations where others do not.

Pursuant to the Investment Advisory Agreement, our Adviser’s liability is limited and we are required to indemnify our Adviser against certain liabilities. This may lead our Adviser to act in a riskier manner in performing its duties and obligations under the Investment Advisory Agreement than it would if it were acting for its own account, and creates a potential conflict of interest.

In addition, we may make investments in different parts of the capital structure of companies in which Other Oaktree Funds already hold an investment. Generally speaking, Oaktree expects that we will make such investments only when, at the time of investment, Oaktree believes that (a) such investment is in our best interests and (b)(i) the possibility of actual adversity between us, on the one hand, and the Other Oaktree Fund, on the other hand, is remote, (ii) either the potential investment by us or the investment of such Other Oaktree Fund is not large enough to control any actions taken by the collective holders of securities of such company or asset or (iii) in light of the particular circumstances, Oaktree determines in its discretion and in good faith that such investment is appropriate for us, notwithstanding the potential for conflict. If any conflict were to arise, however, Oaktree will be permitted to take certain actions that, in the absence of such conflict, it would not take, such as causing us to remain passive, investing in the same class of securities to align interests, divesting investments or taking other actions to reduce adversity, which may have the effect of benefiting certain Other Oaktree Funds, and not us. Given that we generally intend to invest higher in the capital structure, it is likely we will remain passive in the event of a conflict, meaning that we must rely on other investors holding the same types of securities or obligations to advocate on behalf of our class. Oaktree has no obligation to advise these other holders of any potential claims they may have of which Oaktree may be aware or to consider their interests when advocating on behalf of the Other Oaktree Funds that hold investments in lower parts of the capital structure.

Under certain circumstances, we potentially will be offered an opportunity to make an investment in a transaction in which one or more Other Oaktree Funds is expected to make an investment, or in a company in which one or more Other Oaktree Funds already has made, or concurrently will make, an investment. The Investment Company Act and the exemptive relief also impose restrictions on our ability to participate in certain transactions with other Oaktree Funds. As a result, we and the Other Oaktree Fund potentially will have conflicting interests in negotiating the terms of such investments. In negotiating the purchase of such investments, the nature of the covenants, and other terms and conditions of such securities, the Other Oaktree Funds potentially will have interests that conflict with ours. In that regard, subject to the requirements of the Investment Company Act and the exemptive relief, actions may be taken for the Other Oaktree Funds that are adverse to us. Such conflicts also have the potential to arise in the negotiations of amendments or waivers or in a workout or bankruptcy. It is possible that in a bankruptcy proceeding, our interests would be subordinated or otherwise adversely affected by virtue of such Other Oaktree Funds’ involvement and actions relating to its investment. Oaktree will seek to manage such conflicts in good faith and in a manner it believes is consistent with its duties to us and the Other Oaktree Funds and under the Investment Company Act and the exemptive relief, if applicable.

Pursuant to the Administration Agreement, Oaktree Administrator furnishes us with the facilities, including our principal executive office, and administrative services necessary to conduct our day-to-day operations. We pay Oaktree Administrator its allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including, without limitation a portion of the rent at market rates and the compensation of our Chief Financial Officer, Chief Compliance Officer, their respective staffs and other non-investment professionals at Oaktree that perform duties for us. This arrangement creates conflicts of interest that our Board of Directors must monitor.

The Adviser may offer other investors the opportunity to participate in investments side by side with us.

The Adviser may in its sole discretion offer strategic and other investors the opportunity to participate in one or more of our investments on a side-by-side basis, subject to compliance with the applicable provisions of the Investment Company Act and the allocation procedures described in “Item 1. Business—Allocation of Investment Opportunities and Potential Conflicts of Interest”. The terms of any such investment opportunity shall be determined by the Adviser, including any management fee or incentive fee charged in connection therewith, and may vary with respect to any such investment opportunity. In addition, Oaktree and the Investment Team currently manage, and in the future are expected to manage additional assets for one or more advisory clients through a separate account or similar arrangement employing an investment strategy investing in parallel with, or similar to, our strategy. Such arrangements potentially will afford those clients different terms than us. Advisory clients that have been granted additional access to portfolio information or enhanced transparency may be able to make investment decisions based on information and at times not generally available to other investors, including unitholders. Any such investment decisions made by these advisory clients on the basis of such information, including any substantial withdrawals or redemptions, could adversely affect the market value of our portfolio and therefore the value of our common stock.

Oaktree personnel work on matters related to Other Oaktree Funds.

The Adviser will devote such time as they deem necessary to conduct our business affairs in an appropriate manner. However, Oaktree personnel will work on matters related to Other Oaktree Funds and other Oaktree managed strategies, including providing transaction-related, legal, management and other services to Other Oaktree Funds and portfolio companies. Conflicts may arise in the allocation of personnel among us and such other funds and strategies. As a result, Oaktree personnel will work on other projects, and conflicts may therefore arise in the allocation of personnel among us and such other projects. For example, certain members of the Investment Team are contractually required to, and will, devote substantial portions of their business time to the management and operation of the Other Oaktree Funds.

We may realize different investment returns than Other Oaktree Funds.

We and Other Oaktree Funds have the potential to make investments at different times and/or on different terms or exit any of such investments at different times and/or on different terms compared to such investment made on behalf of us. In addition, we likely will not invest through the same investment vehicles, have the same access to credit or employ the same hedging or investment strategies as such Other Oaktree Funds. This likely will result in differences in price, investment terms, leverage and associated costs between us and any Other Oaktree Funds. Therefore, we may realize different investment returns than such Other Oaktree Funds, with respect to any investment made alongside some or all of such entities. Oaktree shall have sole discretion in determining what investments we will be offered to pursue. As a result, there is no guarantee that we will be offered the opportunity to invest in any particular investments or type of investments alongside any Other Oaktree Funds. The terms, conditions and the time of investment and disposition of investments held by us may be materially different from those of any such Other Oaktree Funds.

Risks Relating to Our Use of Leverage

Because we borrow money, the potential for loss on amounts invested in us will be magnified and may increase the risk of investing in us.

Borrowings, also known as leverage, magnify the potential for loss on invested equity capital. We expect to continue to use leverage to partially finance our investments, through borrowings from banks and other lenders and/or issuing unsecured notes, which will increase the risks of investing in our common stock, including the likelihood of default. We borrow under our credit facilities and unsecured notes. On November 30, 2017, we entered into a Senior Secured Revolving Credit Agreement, or as amended and/or restated from time to time, the Syndicated Facility, with the lenders, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A. as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. On January 23, 2023, we became party to a revolving credit facility, or as amended and/or restated from time to time, the OSI2 Citibank Facility, with OSI 2 Senior Lending SPV, LLC, or OSI 2 SPV, our wholly-owned and consolidated subsidiary, as the borrower, us, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent. In addition, we have three series of unsecured notes outstanding: our 3.500% notes due 2025, or the 2025 Notes, our 2.700% notes due 2027, or the 2027 Notes, and our 7.100% Notes due 2029, or the 2029 Notes. We may issue other debt securities or enter into other types of borrowing arrangements in the future. If the value of our assets decreases, leveraging would cause net asset value to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. To the extent we incur additional leverage, these effects would be further magnified, increasing the risk of investing in us. Such a decline could negatively affect our ability to make common stock distributions or scheduled debt payments. Leverage is generally considered a speculative investment technique and we only intend to use leverage if expected returns will exceed the cost of borrowing.

As of September 30, 2024, we had $710.0 million of outstanding indebtedness under our credit facilities, $300.0 million of outstanding 2025 Notes, $350.0 million of outstanding 2027 Notes and $300.0 million of outstanding 2029 Notes. These debt instruments require periodic payments of interest. The weighted average interest rate charged on our borrowings as of September 30, 2024 was 6.7% (exclusive of deferred financing costs and inclusive of the impact of an interest rate swap designated as a hedging instrument). We will need to generate sufficient cash flow to make these required interest payments. In order for us to cover our annual interest payments on indebtedness, we must achieve annual returns on our September 30, 2024 total assets of at least 3.55%. If we are unable to meet the financial obligations under our credit facilities, the lenders under such credit facilities will have a superior claim to our assets over our stockholders. If we are unable to meet the financial obligations under the 2025 Notes, 2027 Notes or 2029 Notes, the holders thereof will have the right to declare the principal amount and accrued and unpaid interest on such notes to be due and payable immediately.

The Small Business Credit Availability Act, or the SBCAA, among other things, amended Section 61(a) of the Investment Company Act to add a new Section 61(a)(2) that reduces the asset coverage requirement applicable to Business Development Companies from 200% to 150% (i.e., the amount of debt may not exceed 66.67% of the value of the Business Development Company’s assets) so long as the Business Development Company meets certain disclosure requirements and obtains certain approvals. At a special meeting of stockholders held on June 28, 2019, our stockholders approved the application of the reduced asset coverage requirements in Section 61(a)(2) of the Investment Company Act to us, effective as of June 29, 2019. When we incur additional leverage, our net asset value will decline more sharply if the value of our assets declines and the effects of leverage described above will be magnified.

Illustration. The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns, net of expenses. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing below.


Assumed Return on Portfolio (Net of Expenses)	- 10%	- 5%	0%	5%	10%
Corresponding net return to common stockholder	-28.50%	-17.98%	-7.46%	3.06%	13.58%

For purposes of this table, we have assumed $3,130.3 million in total assets (less all liabilities and indebtedness not represented by senior securities), $1,660.0 million in debt outstanding, $1,487.8 million in net assets as of September 30, 2024, and a weighted average interest rate of 6.7% as of September 30, 2024 (exclusive of deferred financing costs and inclusive of the impact of an interest rate swap designated as a hedging instrument). Actual interest payments may be different.

Substantially all of our assets are subject to security interests under our credit facilities and if we default on our obligations under any such facility, we may suffer adverse consequences, including foreclosure on our assets.

As of September 30, 2024, substantially all of our assets were pledged as collateral under our credit facilities and may be pledged as collateral under future credit facilities. If we default on our obligations under these facilities, the lenders may have the right to foreclose upon and sell, or otherwise transfer, the collateral subject to their security interests or their superior claim. In such event, we may be forced to sell our investments to raise funds to repay our outstanding borrowings in order to avoid foreclosure and these forced sales may be at times and at prices we would not consider advantageous. Moreover, such deleveraging of our company could significantly impair our ability to effectively operate our business in the manner in which we have historically operated. As a result, we could be forced to curtail or cease new investment activities and lower or eliminate the distributions that we have historically paid to our stockholders.

In addition, if the lenders exercise their right to sell the assets pledged under our credit facilities or future credit facilities, such sales may be completed at distressed sale prices, thereby diminishing or potentially eliminating the amount of cash available to us after repayment of the amounts outstanding under the credit facilities.

We may enter into reverse repurchase agreements, which are another form of leverage.

We may enter into reverse repurchase agreements as part of our management of our temporary investment portfolio. Our entry into any such reverse repurchase agreements would be subject to the Investment Company Act limitations on leverage. In connection with entry into a reverse repurchase agreement, we would effectively pledge our assets as collateral to secure a short-term loan. Generally, the other party to the agreement would make a loan to us in an amount equal to a percentage of the fair value of the collateral we have pledged. At the maturity of the reverse repurchase agreement, we will be required to repay the loan and then receive back our collateral. While used as collateral, the assets continue to pay principal and interest which are for the benefit of us.

Our use of reverse repurchase agreements, if any, involves many of the same risks involved in our use of leverage. For example, the market value of the securities acquired in the reverse repurchase agreement may decline below the price of the securities that we have sold but we would remain obligated to purchase those securities, meaning that we bear the risk of loss that the proceeds at settlement are less than the fair value of the securities pledged. In addition, the market value of the securities retained by us may decline. If a buyer of securities under a reverse repurchase agreement were to file for bankruptcy or experience insolvency, we would be adversely affected. In addition, due to the interest costs associated with reverse repurchase agreements, our net asset value would decline, and, in some cases, we may be worse off than if we had not used such agreements.

Risks Related to Distributions

Because we intend to distribute at least 90% of our taxable income each taxable year to our stockholders in connection with our election to be treated as a RIC, we will continue to need additional capital to finance our growth.

In order to qualify for the tax benefits available to RICs and to minimize corporate-level U.S. federal income taxes, we intend to distribute (or be deemed to distribute) to our stockholders at least 90% of our taxable income each taxable year, except that we may retain certain net capital gains for investment, and treat such amounts as deemed distributions to our stockholders. If we elect to treat any amounts as deemed distributions, we would be subject to U.S. federal income tax at the U.S. corporate income tax rate applicable to net capital gains on such deemed distributions on behalf of our stockholders. As a result of these requirements, we will likely need to raise capital from other sources to grow our business. Because we will continue to need capital to grow our investment portfolio, these limitations together with the asset coverage requirements applicable to us may prevent us from incurring debt and require us to raise additional equity at a time when it may be disadvantageous to do so.

We may not be able to pay you distributions, our distributions may not grow over time and a portion of our distributions may be a return of capital.

We intend to pay distributions to our stockholders out of assets legally available for distribution. We cannot assure you that we will achieve investment results that will allow us to sustain a specified level of cash distributions or periodic increases in cash distributions. In addition, the inability to satisfy the asset coverage test applicable to us as a Business Development Company can limit our ability to pay distributions. All distributions will be paid at the discretion of our Board of Directors and will depend on our earnings, our financial condition, maintenance of our ability to be subject to tax as a RIC, compliance with applicable Business Development Company regulations and such other factors as our Board of Directors may deem relevant from time to time. We cannot assure you that we will continue to pay distributions to our stockholders at current levels, or at all.

When we make distributions, our distributions generally will be treated as dividends for U.S. federal income tax purposes to the extent such distributions are paid out of our current or accumulated earnings and profits. Distributions in excess of current and accumulated earnings and profits will be treated as a non-taxable return of capital to the extent of a stockholder's basis in our stock and, assuming that a stockholder holds our stock as a capital asset, thereafter as a capital gain. A return of capital generally is a return of a stockholder’s investment rather than a return of earnings or gains derived from our investment activities. Moreover, we may pay all or a substantial portion of our distributions from the proceeds of the sale of shares of our common stock or from borrowings in anticipation of future cash flow, which could constitute a return of stockholders’ capital and will lower such stockholders’ tax basis in our shares, which may result in increased tax liability to stockholders when they sell or otherwise dispose of such shares. The tax liability incurred by such stockholders upon the sale or other disposition of shares of our common stock may increase even if such shares are sold at a loss.

We will be subject to corporate-level U.S. federal income tax if we are unable to maintain our qualification as a RIC under Subchapter M of the Code or do not satisfy the Annual Distribution Requirement.

To maintain our tax status as a RIC and be relieved of U.S. federal taxes on income and gains distributed (or be deemed distributed) to our stockholders, we must meet the following annual distribution, income source and asset diversification requirements:

•The Annual Distribution Requirement will be satisfied if we distribute dividends to our stockholders each taxable year of an amount generally at least equal to 90% of the sum of our net taxable income plus realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we use debt financing, we are and may, in the future, be subject to certain financial covenants under our debt arrangements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, we could fail to qualify for RIC tax treatment and thus could become subject to corporate-level U.S. federal income tax.

•The 90% Gross Income Test will be satisfied if we earn at least 90% of our gross income for each taxable year from dividends, interest, gains from the sale of stock or securities or similar sources.

•The Diversification Tests will be satisfied if, at the end of each quarter of our taxable year, at least 50% of the value of our assets consist of cash, cash equivalents, U.S. government securities, securities of other RICs, and other acceptable securities; and no more than 25% of the value of our assets can be invested in the securities, other than U.S. government securities or securities of other RICs, of one issuer, of two or more issuers that are controlled, as determined under applicable Code rules, by us and that are engaged in the same or similar or related trades or businesses or of certain “qualified publicly traded partnerships.” Failure to meet these requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of RIC status. Because most of our

investments will be in private companies, and therefore will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could cause us to incur substantial losses.

If we fail to be subject to tax as a RIC and are subject to corporate-level U.S. federal corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions.

We may have difficulty paying our required distributions if we are required to recognize income for U.S. federal income tax purposes before or without receiving cash representing such income.

For U.S. federal income tax purposes, we generally are required to include in income certain amounts that we have not yet received in cash, such as OID or certain income accruals on contingent payment debt instruments, which may occur if we receive warrants in connection with the origination of a loan or possibly in other circumstances. Such OID is generally required to be included in income before we receive any corresponding cash payments. In addition, our loans typically contain PIK interest provisions. Any PIK interest, computed at the contractual rate specified in each loan agreement, is generally required to be added to the principal balance of the loan and recorded as interest income. We also may be required to include in income certain other amounts that we do not receive, and may never receive, in cash. To avoid the imposition of corporate-level tax on us, this non-cash source of income may need to be distributed (or deemed distributed) to our stockholders in cash or, in the event that we determine to do so, in shares of our common stock, even though we may have not yet collected and may never collect the cash relating to such income.

Since, in certain cases, we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the Annual Distribution Requirement necessary to be relieved of corporate-level U.S. federal taxes on income and gains distributed (or deemed distributed) to our stockholders. Accordingly, we may have to sell or otherwise dispose of some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may fail to satisfy the Annual Distribution Requirement and thus become subject to corporate-level U.S. federal income tax.

We may in the future choose to pay distributions partly in our own stock, in which case you may be subject to tax in excess of the cash you receive.

We may distribute taxable distributions that are payable in part in our stock. In accordance with certain applicable Treasury Regulations and other related administrative pronouncements or interpretations therefore issued by the Internal Revenue Service, or the IRS, a RIC may be eligible to treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder is permitted to elect to receive his or her entire distribution in either cash or stock of the RIC, subject to the satisfaction of certain guidelines. If too many stockholders elect to receive cash, each stockholder electing to receive cash must receive a pro rata amount of cash (with the balance of the distribution paid in stock). If these and certain other requirements are met, the amount of the distribution paid in stock for U.S. federal income tax purposes generally will be equal to the amount of cash that could have been received instead of stock. Taxable stockholders receiving such distributions will be required to include the full amount of the distribution as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain dividend) to the extent of their share of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. stockholder may be subject to tax with respect to such distributions in excess of any cash received. If a U.S. stockholder sells the stock it receives as a distribution in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the market price of our stock at the time of the sale. Furthermore, with respect to non-U.S. stockholders, we may be required to withhold U.S. tax with respect to such distribution, including in respect of all or a portion of such distribution that is payable in stock. In addition, if a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on a distribution, such sales may put downward pressure on the trading price of our stock.

Risks Relating to Our Investments

Our investments in portfolio companies may be risky, and we could lose all or parts of our investments.

The companies in which we invest are typically highly leveraged, and, in most cases, our investments in such companies are not rated by any rating agency. If such investments were rated, we believe that they would likely receive a rating from a nationally recognized statistical rating organization of below investment grade (i.e., below BBB- or Baa), which is often referred to as "high yield" and “junk.” Exposure to below investment grade securities involves certain risks, and those securities are viewed as having predominately speculative characteristics with respect to the issuer's capacity to pay interest and repay principal. Investing in small and mid-sized companies involves a number of significant risks.

Certain of our debt investments consist of debt securities for which issuers are not required to make principal payments until the maturity of such debt securities, which could result in a substantial loss to us if such issuers are unable to refinance or repay their debt at maturity. Increases in interest rates may affect the ability of our portfolio companies to repay debt or pay interest, which may in turn affect the value of our portfolio investments, and our business, financial condition and results of operations.

Among other things, our portfolio companies:

•may have limited financial resources, may be more susceptible to elevated and/or rising interest rates and inflation, may have limited or negative EBITDA and may be unable to meet their obligations under their debt instruments that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees from subsidiaries or affiliates of our portfolio companies that we may have obtained in connection with our investments, as well as a corresponding decrease in the value of the equity components of our investments;

•may have shorter operating histories, narrower product lines, smaller market shares and/or significant customer concentrations than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns;

•may operate in regulated industries and/or provide services to federal, state or local governments, or operate in industries that provide services to regulated industries or federal, state or local governments, any of which could lead to delayed payments for services or subject the company to changing payment and reimbursement rates or other terms;

•may not have collateral sufficient to pay any outstanding interest or principal due to us in the event of a default by these companies;

•are more likely to depend on the management talents and efforts of a small group of people; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us;

•may have difficulty accessing the capital markets to fund capital needs, which may limit their ability to grow or repay outstanding indebtedness at maturity;

•may not have audited financial statements or be subject to the Sarbanes-Oxley Act and other rules that govern public companies;

•generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position; and

•generally have less publicly available information about their businesses, operations and financial condition.

These factors may make certain of our portfolio companies more susceptible to the adverse events in the economy. As a result of the limitations associated with certain of our portfolio companies, we must therefore rely on the ability of our Adviser to obtain adequate information through due diligence to evaluate the creditworthiness and potential returns from investing in these companies. In addition, certain of our officers and directors may serve as directors on the boards of such companies. To the extent that litigation arises out of our investments in these companies, our officers and directors may be named as defendants in such litigation, which could result in an expenditure of funds (through our indemnification of such officers and directors) and the diversion of management time and resources.

Finally, little public information generally exists about privately owned companies, and these companies may not have third-party debt ratings or audited financial statements. We must therefore rely on the ability of our Adviser to obtain adequate information through due diligence to evaluate the creditworthiness and potential returns from investing in these companies. Additionally, these companies and their financial information will not generally be subject to the Sarbanes-Oxley Act and other rules that govern public companies.

We may be exposed to higher risks with respect to our investments that include OID or PIK interest.

Our investments may include OID and contractual PIK interest, which typically represents contractual interest added to a loan balance and due at the end of such loan’s term. To the extent OID or PIK interest constitute a portion of our income, we are exposed to typical risks associated with such income being required to be included in taxable and accounting income prior to receipt of cash, including the following:

•OID and PIK instruments may have higher yields, which reflect the payment deferral and credit risk associated with these instruments;

•OID and PIK accruals may create uncertainty about the source of our distributions to stockholders;

•OID and PIK instruments may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of the collateral; and

•OID and PIK instruments may represent a higher credit risk than coupon loans.

If we acquire the securities and obligations of distressed or bankrupt companies, such investments may be subject to significant risks, including lack of income, extraordinary expenses, uncertainty with respect to satisfaction of debt, lower-than-expected investment values or income potentials and resale restrictions.

We may acquire the securities and other obligations of distressed or bankrupt companies. At times, distressed debt obligations may not produce income and may require us to bear certain extraordinary expenses (including legal, accounting, valuation and transaction expenses) in order to protect and recover our investment. Therefore, to the extent we invest in distressed debt, our ability to achieve current income for our stockholders may be diminished, particularly where the portfolio company has negative EBITDA.

We also will be subject to significant uncertainty as to when and in what manner and for what value the distressed debt we invest in will eventually be satisfied whether through a liquidation, an exchange offer or plan of reorganization involving the distressed debt securities or a payment of some amount in satisfaction of the obligation. In addition, even if an exchange offer is made or plan of reorganization is adopted with respect to distressed debt held by us, there can be no assurance that the securities or other assets received by us in connection with such exchange offer or plan of reorganization will not have a lower value or income potential than may have been anticipated when the investment was made.

Moreover, any securities received by us upon completion of an exchange offer or plan of reorganization may be restricted as to resale. As a result of our participation in negotiations with respect to any exchange offer or plan of reorganization with respect to an issuer of distressed debt, we may be restricted from disposing of such securities.

The lack of liquidity in our investments may adversely affect our business.

We invest, and will continue to invest, in companies whose securities are not publicly traded, and whose securities are subject to legal and other restrictions on resale or are otherwise less liquid than publicly traded securities. In fact, all of our assets may be invested in illiquid securities. The illiquidity of these investments may make it difficult for us to sell these investments when desired. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded these investments and suffer losses. Our investments may be subject to contractual or legal restrictions on resale or are otherwise illiquid because there is usually no established trading market for such investments. In addition, we may also face restrictions on our ability to liquidate our investments if our Adviser or any of its affiliates have material nonpublic information regarding the portfolio company.

We may not have the funds or ability to make additional investments in our portfolio companies.

After our initial investment in a portfolio company, we may be called upon from time to time to provide additional funds to such company or have the opportunity to increase our investment through a follow-on investment. There is no assurance that we will make, or will have sufficient funds to make, follow-on investments. Any decisions not to make a follow-on investment or any inability on our part to make such an investment may have a negative impact on a portfolio company in need of such an investment, may result in a missed opportunity for us to increase our participation in a successful operation, may reduce the expected yield on the investment or impair the value of our investment in any such portfolio company.

Some of our portfolio companies are highly leveraged.

Our investments include companies with significant leverage. Such investments are inherently more sensitive to declines in revenues and to increases in expenses and interest rates. The leveraged capital structure of such investments increases the exposure of the portfolio companies to adverse economic factors, such as downturns in the economy or deterioration in the condition of the portfolio company or its industry. Additionally, the securities acquired by us may be the most junior in what will typically be a complex capital structure, and thus subject to the greatest risk of loss.

Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.

We invest primarily in first lien, second lien and subordinated debt issued by middle-market companies. Our portfolio companies may have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt in which we invest. By their terms, such debt instruments may entitle the holders to receive payments of interest or principal on or before the dates on which we are entitled to receive payments with respect to the debt instruments in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt instruments in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.

The disposition of our investments may result in contingent liabilities.

In connection with the disposition of an investment in private securities, we may be required to make representations about the business and financial affairs of the portfolio company typical of those made in connection with the sale of a business. We may also be required to indemnify the purchasers of such investment to the extent that any such representations turn out to be inaccurate or with respect to certain potential liabilities. These arrangements may result in contingent liabilities that ultimately yield funding obligations that must be satisfied through our return of certain distributions previously made to us.

There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims.

Even though we have structured some of our investments as senior loans, if one of our portfolio companies were to enter bankruptcy proceedings, a bankruptcy court might re-characterize our debt investment and subordinate all or a portion of our claim to that of other creditors, depending on the facts and circumstances, including the extent to which we actually provided managerial assistance to that portfolio company. We may also be subject to lender liability claims for actions taken by us with respect to a borrower’s business or instances where we exercise control over the borrower. It is possible that we could become subject to a lender’s liability claim, including as a result of actions taken in rendering significant managerial assistance.

Second priority liens on collateral securing loans that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us.

Certain loans that we make to portfolio companies are secured on a second priority basis by the same collateral securing senior secured debt of such companies. The first priority liens on the collateral secures the portfolio company’s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the company under the agreements governing the loans. The holders of obligations secured by the first priority liens on the collateral will generally control the liquidation of and be entitled to receive proceeds from any realization of the collateral to repay their obligations in full before us. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from the sale or sales of all of the collateral would be sufficient to satisfy the loan obligations secured by the second priority liens after payment in full of all obligations secured by the first priority liens on the collateral. If such proceeds are not sufficient to repay amounts outstanding under the loan obligations secured by the second priority liens, then we, to the extent not repaid from the proceeds of the sale of the collateral, will only have an unsecured claim against the company’s remaining assets, if any.

The rights we may have with respect to the collateral securing the loans we make to our portfolio companies with senior debt outstanding may also be limited pursuant to the terms of one or more inter-creditor agreements that we enter into with the holders of senior debt. Under such an inter-creditor agreement, at any time that obligations that have the benefit of the first priority liens are outstanding, any of the following actions may be taken with respect to the collateral and will be at the direction of the holders of the obligations secured by the first priority liens: the ability to cause the commencement of enforcement proceedings against the collateral; the ability to control the conduct of such proceedings; the approval of amendments to collateral documents; releases of liens on the collateral; and waivers of past defaults under collateral documents. We may not have the ability to control or direct such actions, even if our rights are adversely affected.

If we make unsecured debt investments, we may lack adequate protection in the event our portfolio companies become distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event such portfolio companies default on their indebtedness.

We have made, and may in the future make, unsecured debt investments in portfolio companies. Unsecured debt investments are unsecured and junior to other indebtedness of the portfolio company. As a consequence, the holder of an unsecured debt investment may lack adequate protection in the event the portfolio company becomes distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event the portfolio company defaults on its indebtedness. In addition, unsecured debt investments of small and mid-sized companies are often highly illiquid and in adverse market conditions may experience steep declines in valuation even if they are fully performing.

Our investments may include “covenant-lite” loans, which may give us fewer rights and subject us to greater risk of loss than loans with financial maintenance covenants.

Although the loans in which we expect to invest will generally have financial maintenance covenants, which are used to proactively address materially adverse changes in a portfolio company’s financial performance, we do invest to a lesser extent in “covenant-lite” loans. We use the term “covenant-lite” to refer generally to loans that do not have financial maintenance covenants. Generally, “covenant-lite” loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower’s financial condition or operating results. Accordingly, to the extent we invest in “covenant-lite” loans, we may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants.

Our portfolio companies may prepay loans, which may reduce our yields if capital returned cannot be invested in transactions with equal or greater expected yields.

The loans in our investment portfolio may be prepaid at any time, generally with little advance notice. Whether a loan is prepaid will depend both on the continued positive performance of the portfolio company and the existence of favorable financing market conditions that allow such company the ability to replace existing financing with less expensive capital. As market conditions change, we do not know when, and if, prepayment may be possible for each portfolio company. In some cases, the prepayment of a loan may reduce our achievable yield if the capital returned cannot be invested in transactions with equal or greater expected yields, which could have a material adverse effect on our business, financial condition and results of operations.

We may incur greater risk with respect to investments we acquire through assignments or participations of interests.

We may acquire loans through assignments or participations of interests in such loans. The purchaser of an assignment typically succeeds to all the rights and obligations of the assigning institution and becomes a lender under the credit agreement with respect to such debt obligation. However, the purchaser’s rights can be more restricted than those of the assigning institution, and we may not be able to unilaterally enforce all rights and remedies under an assigned debt obligation and with regard to any associated collateral. A participation typically results in a contractual relationship only with the institution participating out the interest and not directly with the borrower. Sellers of participations typically include banks, broker-dealers, other financial institutions and lending institutions. In purchasing participations, we generally will have no right to enforce compliance by the borrower with the terms of the loan agreement against the borrower, and we may not directly benefit from the collateral supporting the debt obligation in which we have purchased the participation. As a result, we will be exposed to the credit risk of both the borrower and the institution selling the participation. Further, in purchasing participations in lending syndicates, we will not be able to conduct the same level of due diligence on a borrower or the quality of the loan with respect to which we are buying a participation as we would conduct if we were investing directly in the loan. This difference may result in us being exposed to greater credit or fraud risk with respect to such loans than we expected when initially purchasing the participation.

We generally do not, and do not expect to, control our portfolio companies.

We do not, and do not expect to, control most of our portfolio companies. As a result, we are subject to the risk that a portfolio company may make business decisions with which we disagree and the management of such company, as representatives of the holders of their common equity, may take risks or otherwise act in ways that do not serve our interests as a debt investor, including actions that could decrease the value of our investment. Due to the lack of liquidity for the majority of our investments, we may not be able to dispose of our interests in our portfolio companies as readily as we would like or at an appropriate valuation.

Non-performance or defaults by our portfolio companies would harm our operating results.

Our investment program is comprised of investments in loans or other debt instruments, focused on direct lending transactions. These obligations are subject to unique risks, including (a) the possible invalidation of investment transactions as fraudulent conveyances or preferential payments under relevant creditors’ rights and bankruptcy laws or the subordination of claims under so-called “equitable subordination” common law principles, (b) so-called lender-liability claims by the issuer of the obligations and (c) environmental liabilities that may arise with respect to collateral securing the obligations. In analyzing each loan or other debt instrument, we will compare the relative significance of the risks against the expected benefits of the investment. Successful claims by third parties arising from these and other risks, absent certain conduct by the Adviser, its affiliates and certain other individuals, will be borne by us.

Loans or other debt instruments made or otherwise acquired by us may become non-performing following their origination or acquisition for a wide variety of reasons. Such non-performing loans or debt instruments may require a substantial amount of workout negotiations or restructuring, which may entail, among other things, a substantial reduction in the interest rate and a substantial write-down of principal. It is possible that we may find it necessary or desirable to foreclose on collateral securing one or more loans purchased by us. The foreclosure process varies jurisdiction by jurisdiction and can be lengthy and expensive. Borrowers often resist foreclosure actions by asserting numerous claims, counterclaims and defenses against the holder of a real estate loan, including lender liability claims and defenses, even when such assertions may have no basis in fact, in an effort to prolong the foreclosure action. In some states, foreclosure actions can take up to several years or more to conclude. At any time during the foreclosure proceedings, the borrower may file for bankruptcy, staying the foreclosure action and further delaying the foreclosure process. Foreclosure litigation tends to create a negative public image of the collateral property and may result in disrupting ongoing leasing and management of the property.

A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, termination of its loans and foreclosure on its secured assets, which could trigger cross-defaults under other agreements and jeopardize a portfolio company’s ability to meet its obligations under the debt or equity securities that we hold. We may incur expenses to the extent necessary to seek recovery upon default or to negotiate new terms, which may include the waiver of certain financial covenants, with a defaulting portfolio company. In addition, we may write-down the value of a portfolio company investment upon the worsening of the financial condition of the portfolio company or in anticipation of a default, which could also have a material adverse effect on our business, financial condition and results of operations.

Our portfolio companies may experience financial distress and our investments in such companies may be restructured.

Our portfolio companies may experience financial distress from time to time. Debt investments in such companies may cease to be income-producing, may require us to bear certain expenses to protect our investment and may subject us to uncertainty as to when, in what manner and for what value such distressed debt will eventually be satisfied, including through liquidation, reorganization or bankruptcy. Any restructuring can fundamentally alter the nature of the related investment, and restructurings may not be subject to the same underwriting standards that our Adviser employs in connection with the origination of an investment. In addition, we may write-down the value of our investment in any such company to reflect the status of financial distress and future prospects of the business. Any restructuring could alter, reduce or delay the payment of interest or principal on any investment, which could delay the timing and reduce the amount of payments made to us. For example, if an exchange offer is made or plan of reorganization is adopted with respect to the debt securities we currently hold, there can be no assurance that the securities or other assets received by us in connection with such exchange offer or plan of reorganization will have a value or income potential similar to what we anticipated when our original investment was made or even at the time of restructuring. Restructurings of investments might also result in extensions of the term thereof, which could delay the timing of payments made to us, or we may receive equity securities, which may require significantly more of our management’s time and attention or carry restrictions on their disposition. We cannot assure you that any particular restructuring strategy pursued by our Adviser will maximize the value of or recovery on any investment.

We may not realize gains from our equity investments.

Certain investments that we have made in the past and may make in the future include warrants or other equity securities. In addition, we have made in the past and may make in the future direct equity investments in companies. Our goal is ultimately to realize gains upon our disposition of such equity interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. We also may be unable to realize any value if a portfolio company does not have a liquidity event, such as a sale of the business, recapitalization or public offering, which would allow us to sell the underlying equity interests. We may seek puts or similar rights to give us the right to sell our equity securities back to the portfolio company issuer. We may be unable to exercise these put rights for the consideration provided in our investment documents if the issuer is in financial distress.

We are subject to certain risks associated with foreign investments.

We have made in the past and may make in the future investments in foreign companies. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in foreign exchange rates, exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the U.S., higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility. In addition, our foreign investments generally do not constitute "qualifying assets" under the Investment Company Act.

Our success will depend, in part, on our ability to anticipate and effectively manage these and other risks. We cannot assure you that these and other factors will not have a material adverse effect on our business as a whole.

We may have foreign currency risks related to our investments denominated in currencies other than the U.S. dollar.

As of September 30, 2024, a portion of our investments are, and may continue to be, denominated in currencies other than the U.S. dollar. Changes in the rates of exchange between the U.S. dollar and other currencies will have an effect, which could be adverse, on our performance, amounts available for withdrawal and the value of securities distributed by us. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation and political developments. Additionally, a particular foreign country may impose exchange controls, devalue its currency or take other measures relating to its currency which could adversely affect us. Finally, we could incur costs in connection with conversions between various currencies.

We may expose ourselves to risks if we engage in hedging transactions.

Subject to applicable provisions of the Investment Company Act and applicable regulations promulgated by the Commodity Futures Trading Commission, we have in the past and may in the future enter into hedging transactions, which may expose us to risks associated with such transactions. Such hedging may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions and amounts due under any credit facility from changes in currency exchange rates and market interest rates. Use of these hedging instruments may include counterparty credit risk. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions and amounts due under our credit facilities or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. Moreover, it may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price.

The success of any hedging transactions will depend on our ability to correctly predict movements in currencies and interest rates. Therefore, while we may enter into such transactions to seek to reduce currency exchange rate and interest rate risks, unanticipated changes in currency exchange rate or interest rates may result in poorer overall investment performance than if we had not engaged in any such hedging transactions. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary. Moreover, for a variety of reasons, we may not seek to (or be able to) establish a perfect correlation between such hedging instruments and the portfolio holdings or credit facilities being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities denominated in non-U.S. currencies because the value of those securities is likely to fluctuate as a result of factors not related to currency fluctuations.

We are a non-diversified investment company within the meaning of the Investment Company Act, and therefore have few restrictions with respect to the proportion of our assets that may be invested in securities of a single industry or issuer.

We are classified as a non-diversified investment company within the meaning of the Investment Company Act, which means that we are not limited by the Investment Company Act with respect to the proportion of our assets that we may invest in securities of a single industry or issuer, excluding limitations on investments in other investment companies. We cannot predict the industries or sectors in which our investment strategy may cause us to concentrate and cannot predict the level of our diversification among industries or issuers. To the extent that we assume large positions in a certain type of security or the securities of a small number of industries or issuers, our net asset value may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of the security, industry or issuer. We may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. Beyond RIC diversification requirements, we do not have fixed guidelines for diversification, and our investments could be concentrated in relatively few industries or issuers.

Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry.

Our portfolio may be concentrated in a limited number of portfolio companies and industries. As a result, the aggregate returns we realize may be significantly and adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, while we are not targeting any specific industries, our investments may be concentrated in relatively few industries. As a result, a downturn in any particular industry in which we are invested could also significantly impact the aggregate returns we realize.

We may invest in transactions on an expedited basis.

Investment analyses and decisions by Oaktree may frequently be required to be undertaken on an expedited basis to take advantage of investment opportunities. In such cases, the information available to Oaktree at the time of making an investment decision may be limited, and Oaktree may not have access to detailed information regarding the underlying asset. Therefore, no assurance can be given that Oaktree will have knowledge of all circumstances that may adversely affect an investment. In addition, Oaktree expects to rely upon certain independent consultants in connection with its evaluation of proposed investments. No assurance can be given as to the accuracy or completeness of the information provided by such independent consultants, and we may incur liability as a result of such consultants’ actions.

Risks Relating to Our Common Stock

Shares of closed-end investment companies, including Business Development Companies, may trade at a discount to their net asset value.

Shares of closed-end investment companies, including Business Development Companies, may trade at a discount from net asset value. This characteristic of closed-end investment companies and Business Development Companies is separate and distinct from the risk that our net asset value per share may decline. During the last two years, shares of our common stock have traded both above and below our net asset value. We cannot predict whether our common stock will trade at, above or below net asset value.

Investing in our common stock may involve an above average degree of risk.

The investments we make in accordance with our investment objective may result in a higher amount of risk than alternative investment options and a higher risk of volatility or loss of principal. Our investments in portfolio companies involve higher levels of risk, and therefore, an investment in our shares may not be suitable for someone with lower risk tolerance.

The market price of our common stock may fluctuate significantly.

The market price and liquidity of the market for shares of our common stock may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include:

•significant volatility in the market price and trading volume of securities of Business Development Companies or other companies in our sector, which are not necessarily related to the operating performance of these companies;

•inability to obtain any exemptive relief that may be required by us from the SEC;

•changes in regulatory policies, accounting pronouncements or tax guidelines, particularly with respect to RICs and Business Development Companies;

•loss of our Business Development Company or RIC status;

•changes in earnings or variations in operating results or distributions that exceed our net investment income;

•increases in expenses associated with defense of litigation and responding to SEC inquiries;

•changes in accounting guidelines governing valuation of our investments;

•changes in the value of our portfolio of investments and any derivative instruments, including as a result of general economic conditions, interest rate shifts and changes in the performance of our portfolio companies;

•any shortfall in investment income or net investment income or any increase in losses from levels expected by investors or securities analysts;

•departure of our Adviser’s key personnel; and

•general economic trends and other external factors.

Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock.

Sales of substantial amounts of our common stock, including by large stockholders, or the availability of such common stock for sale, could adversely affect the prevailing market prices for our common stock. If this occurs and continues for a sustained period of time, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.

Certain provisions of our restated certificate of incorporation and fourth amended and restated bylaws as well as the Delaware General Corporation Law could deter takeover attempts and have an adverse impact on the price of our common stock.

Our restated certificate of incorporation and our fourth amended and restated bylaws as well as the Delaware General Corporation Law contain provisions that may have the effect of discouraging a third party from making an acquisition proposal for us. These anti-takeover provisions may inhibit a change in control in circumstances that could give the holders of our common stock the opportunity to realize a premium over the market price for our common stock.

Stockholders may incur dilution if we issue securities to subscribe to, convert to or purchase shares of our common stock.

The Investment Company Act prohibits us from selling shares of our common stock at a price below the current net asset value per share of such stock with certain exceptions. One such exception is stockholder approval, within one year prior, of any such sales of common stock. On March 4, 2024, our stockholders approved a proposal to authorize us, with the approval of our Board of Directors, to sell or otherwise issue shares of our common stock at a price below its then current net asset value per share, provided that the number of shares issued does not exceed 25% of our then outstanding common stock. Such authorization will expire on March 3, 2025, but we expect to seek similar authorizations from our stockholders in the future. Any decision to sell common stock at a price below its then current net asset value will be subject to the determination by the Board of Directors that such issuance is in our and our stockholders’ best interests. If we were to sell shares of our common stock below net asset value per share, such sales would result in an immediate dilution to the net asset value per share. This dilution would occur as a result of the sale of shares at a price below the then current net asset value per share of our common stock and a proportionately greater decrease in a stockholder’s interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance. The greater the difference between the sales price and the net asset value per share at the time of the offering, the more significant the dilutive impact would be. Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect, if any, cannot be currently predicted. However, if, for example, we sold an additional 10% of our common stock at a 5% discount from net asset value, an existing stockholder who did not participate in that offering for its proportionate interest would suffer net asset value dilution of up to 0.5% or $5 per $1,000 of net asset value.

Another exception is prior stockholder approval of issuances of securities to subscribe to, convert to or purchase shares of our common stock even if the subscription, conversion or purchase price per share of our common stock is below the net asset value per share of our common stock at the time of any such subscription, conversion or purchase. At our 2011 annual meeting of stockholders, our stockholders approved a proposal to authorize us to issue securities to subscribe to, convert to, or purchase shares of our common stock in one or more offerings, including under such circumstance. Such authorization has no expiration. Any decision to sell securities to subscribe to, convert to, or purchase shares of our common stock will be subject to the determination by our Board of Directors that such issuance is in our and our stockholders’ best interests. If we issue securities to subscribe to, convert to or purchase shares of common stock, the exercise or conversion of such securities would increase the number of outstanding shares of our common stock. Any such exercise or conversion would be dilutive on the voting power of existing stockholders, and could be dilutive with regard to distributions and our net asset value, and other economic aspects of the common stock.

Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted; however, the table below illustrates the impact on the net asset value per common share of a Business Development Company that would be experienced upon the exercise of a subscription right to acquire shares of common stock of the Business Development Company.

Example of Impact of Exercise of Subscription Right to Acquire Common Stock on Net Asset Value Per Share

The example assumes that the Business Development Company has 1,000,000 shares of common stock outstanding, $15,000,000 in total assets and $5,000,000 in total liabilities at the time of the exercise of the subscription right. As a result, the net asset value and net asset value per common share of the Business Development Company are $10,000,000 and $10.00, respectively.

Further, the example assumes that the subscription right permits the holder thereof to acquire 250,000 common shares under the following three different scenarios: (i) with an exercise price equal to a 10% premium to the Business Development Company’s net asset value per share at the time of exercise, or $11.00 per share, (ii) with an exercise price equal to the Business Development Company’s net asset value per share at the time of exercise, or $10.00 per share, and (iii) with an exercise price equal to a 10% discount to the Business Development Company’s net asset value per share at the time of exercise, or $9.00 per share.


Subscription Rights Exercise Price	Net Asset Value Per Share Prior To Exercise		Net Asset Value Per Share After Exercise
10% premium to net asset value per common share	$	10.00	$	10.20
Net asset value per common share	$	10.00	$	10.00
10% discount to net asset value per common share	$	10.00	$	9.80

Although have we chosen to demonstrate the impact on the net asset value per common share of a Business Development Company that would be experienced by existing stockholders of the Business Development Company upon the exercise of a subscription right to acquire shares of common stock of the Business Development Company, the results noted above would be similar in connection with the exercise or conversion of other securities exercisable or convertible into shares of the Business Development Company’s common stock. In addition, the example does not take into account the impact of other securities that may be issued in connection with the issuance of exercisable or convertible securities (e.g., the issuance of shares of common stock in conjunction with the issuance of subscription rights to acquire shares of common stock).

Risks Related to Our Notes

The Notes are unsecured and therefore are effectively subordinated to any secured indebtedness we have currently incurred or may incur in the future.

The 2025 Notes, the 2027 Notes and the 2029 Notes, which we refer to collectively as the "Notes", are not secured by any of our assets or any of the assets of our subsidiaries. As a result, the Notes are effectively subordinated to any secured indebtedness we or our subsidiaries have currently incurred and may incur in the future (or any indebtedness that is initially unsecured to which we subsequently grant security) to the extent of the value of the assets securing such indebtedness. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our existing or future secured indebtedness and the secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure that indebtedness in order to receive full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of the Notes. As of September 30, 2024, we had $710 million of outstanding borrowings under our credit facilities, all of which is secured.

The Notes are structurally subordinated to the indebtedness and other liabilities of our subsidiaries

The Notes are obligations exclusively of Oaktree Specialty Lending Corporation and not of any of our subsidiaries. None of our subsidiaries is a guarantor of the Notes and the Notes are not required to be guaranteed by any subsidiaries we may acquire or create in the future. The assets of such subsidiaries are not directly available to satisfy the claims of our creditors, including holders of the Notes.

Except to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors (including trade creditors) and holders of preferred stock, if any, of our subsidiaries have priority over our equity interests in such subsidiaries (and therefore the claims of our creditors, including holders of the Notes) with respect to the assets of such subsidiaries. Even if we are recognized as a creditor of one or more of our subsidiaries, our claims are effectively subordinated to any security interests in the assets of any such subsidiary and to any indebtedness or other liabilities of any such subsidiary senior to our claims. Consequently, the Notes are structurally subordinated to all indebtedness and other liabilities (including trade payables) of any of our subsidiaries and any subsidiaries that we may in the future acquire or establish as financing vehicles or otherwise. As of September 30, 2024, our subsidiaries had $280.0 million of outstanding borrowings under the OSI2 Citibank Facility, all of which is structurally senior to the Notes.

In addition, our subsidiaries may incur substantial additional indebtedness in the future, all of which would be structurally senior to the Notes.

The indentures under which the Notes are issued contains limited protection for holders of the Notes.

The indentures under which the Notes are issued offers limited protection to holders of the Notes. The terms of the indentures and the Notes do not restrict our or any of our subsidiaries’ ability to engage in, or otherwise be a party to, a variety of corporate transactions, circumstances or events that could have a material adverse impact on investments in the Notes. In particular, the terms of the indenture and the Notes do not place any restrictions on our or our subsidiaries’ ability to:

•issue securities or otherwise incur additional indebtedness or other obligations, including (1) any indebtedness or other obligations that would be equal in right of payment to the Notes, (2) any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the Notes to the extent of the values of the assets securing such debt, (3) indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore is structurally senior to the Notes and (4) securities, indebtedness or obligations issued or incurred by our subsidiaries that would be senior to our equity interests in our subsidiaries and therefore rank structurally senior to the Notes with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section 18(a)(1)(A) of the Investment Company Act as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions, whether or not we continue to be subject to such provisions of the Investment Company Act, but giving effect, in either case, to any exemptive relief granted to us by the SEC;

•pay dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to the Notes;

•sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);

•enter into transactions with affiliates;

•create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;

•make investments; or

•create restrictions on the payment of dividends or other amounts to us from our subsidiaries.

Furthermore, the terms of the indenture and the Notes do not protect holders of the Notes in the event that we experience changes (including significant adverse changes) in our financial condition, results of operations or credit ratings, as they do not require that we or our subsidiaries adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow or liquidity.

Our ability to recapitalize, incur additional debt and take a number of other actions that are not limited by the terms of the Notes may have important consequences for holders of the Notes, including making it more difficult for us to satisfy our obligations with respect to the Notes or negatively affecting the trading value of the Notes.

Certain of our current debt instruments include more protections for their holders than the indenture and the Notes. In addition, other debt we issue or incur in the future could contain more protections for its holders than the indenture and the Notes, including additional covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the market for and trading levels and prices of the Notes.

An active trading market for the Notes may not exist, which could limit your ability to sell the Notes or affect the market price of the Notes.

We cannot provide any assurances that an active trading market for the Notes will exist in the future or that holders will be able to sell their Notes. Even if an active trading market does exist, the Notes may trade at a discount from their initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, if any, general economic conditions, our financial condition, performance and prospects and other factors. To the extent an active trading market does not exist, the liquidity and trading price for the Notes may be harmed. Accordingly, holder of the Notes may be required to bear the financial risk of an investment in the Notes for an indefinite period of time.

If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the Notes.

Any default under the agreements governing our indebtedness, including our credit facilities and our Notes or other indebtedness to which we may be a party that is not waived by the required lenders or holders, and the remedies sought by the holders of such indebtedness could make us unable to pay principal, premium, if any, and interest on the Notes and substantially decrease the market value of the Notes. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the various covenants, including financial and operating covenants, in the instruments governing our indebtedness, we could be in default under the terms of the agreements governing such indebtedness. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, the lenders under our credit facilities or other debt we may incur in the future could elect to terminate their commitments, cease making further loans and institute foreclosure proceedings against our assets, and we could be forced into bankruptcy or liquidation. If our operating performance declines, we may in the future need to seek to obtain waivers from the required lenders under our credit facilities or the required holders of our Notes or other debt that we may incur in the future to avoid being in default. If we breach our covenants under our credit facilities, our Notes or other debt and seek a waiver, we may not be able to obtain a waiver from the required lenders or holders. If this occurs, we would be in default and our lenders or debt holders could exercise their rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to repay debt, lenders having secured obligations, including the lenders under our credit facilities, could proceed against the collateral securing the debt. Because our credit facilities and our Notes have, and any future credit facilities will likely have, customary cross-default provisions, if the indebtedness thereunder or under any future credit facility is accelerated, we may be unable to repay or finance the amounts due. In the event holders of any debt securities we have outstanding exercise their rights to accelerate following a cross-default, those holders would be entitled to receive the principal amount of their investment, subject to any subordination arrangements that may be in place. We cannot assure you that we will have sufficient liquidity to be able to repay such amounts, in which case we would be in default under the accelerated debt and holders would have the ability to sue us to recover amounts then owing.

General Risk Factors

Economic recessions or downturns may have a material adverse effect on our business, financial condition and results of operations, and could impair the ability of our portfolio companies to repay debt or pay interest.

Economic recessions or downturns may result in a prolonged period of market illiquidity which could have a material adverse effect on our business, financial condition and results of operations. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events could limit our investment originations, limit our ability to grow and negatively impact our operating results. In addition, uncertainty with regard to economic recovery from recessions or downturns could also have a negative impact on our business, financial condition and results of operations.

When recessionary conditions exist, the financial results of middle-market companies, like those in which we invest, typically experience deterioration, which could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults. Additionally, there can be reduced demand for certain of our portfolio companies’ products and services and/or other economic consequences, such as decreased margins or extended payment terms. Further, adverse economic conditions may decrease the value of collateral securing some of our loans and the value of our equity investments. Such conditions may require us to modify the payment terms of our investments, including changes in PIK interest provisions and/or cash interest rates. The performance of certain of our portfolio companies has been, and in the future may be, negatively impacted by these economic or other conditions, which may result in our receipt of reduced interest income from our portfolio companies and/or realized and unrealized losses related to our investments, and, in turn, may adversely affect distributable income and have a material adverse effect on our results of operations.

Global economic, political and market conditions, including downgrades of the U.S. credit rating, may adversely affect our business, results of operations and financial condition.

The current global financial market situation, as well as various social and political tensions in the United States and around the world, may contribute to increased market volatility, may have long-term effects on the United States and worldwide financial markets and may cause economic uncertainties or deterioration in the U.S. and worldwide. The impact of downgrades by rating agencies to the U.S. government’s sovereign credit rating or its perceived creditworthiness as well as potential government shutdowns and uncertainty surrounding transfers of power could adversely affect the U.S. and global financial markets and economic conditions. Several EU countries have faced budget issues, some of which may have negative long-term effects for the economies of those countries and other EU countries. In addition, the fiscal policy of large foreign nations, may have a severe impact on the worldwide and U.S. financial markets. Additionally, trade wars and volatility in the U.S. repo market, the U.S. high yield bond markets, the global stock markets and global markets for commodities may affect other financial markets worldwide. In addition, while governments worldwide have used stimulus measures recently to reduce volatility in the financial markets, volatility has returned as such measures are phased out, and the long-term impacts of such stimulus on fiscal policy and inflation remain unknown. We cannot predict the effects of these or similar events in the future on the U.S. and global economies and securities markets or on our investments. We monitor developments in economic, political and market conditions and seek to manage our investments in a manner consistent with achieving our investment objective, but there can be no assurance that we will be successful in doing so.

We may experience fluctuations in our quarterly originations and results.

We could experience fluctuations in our quarterly originations and results due to a number of factors, including our ability or inability to make investments in companies that meet our investment criteria, the interest rate payable on the debt securities we acquire, changes in accrual status of our portfolio company investments, distributions, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our market and general economic conditions. In addition, expected originations for a given quarter may be delayed past quarter-end and into the next quarter as a result of factors outside of our control. As a result of these factors, originations or results for any period should not be relied upon as being indicative of performance in future periods.

Control deficiencies could prevent us from accurately and timely reporting our financial results.

We may identify deficiencies in our internal control over financial reporting in the future, including significant deficiencies and material weaknesses. A “significant deficiency” is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of a company’s financial reporting. A "material weakness" is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. A deficiency in internal control exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.

Our failure to identify deficiencies in our internal control over financial reporting in a timely manner or remediate any deficiencies, or the identification of material weaknesses or significant deficiencies in the future could prevent us from accurately and timely reporting our financial results.

We incur significant costs as a result of being a publicly traded company.

As a publicly-traded company, we incur legal, accounting and other expenses, including costs associated with the periodic reporting requirements applicable to a company whose securities are registered under the Exchange Act, as well as additional corporate governance requirements, including requirements under the Sarbanes-Oxley Act, and other rules implemented by the SEC and the listing standards of the Nasdaq Global Select Market.

We may be the target of litigation or similar proceedings in the future.

We could generally be subject to litigation or similar proceedings in the future, including securities litigation and derivative actions by our stockholders whether as a result of the Mergers or otherwise . Any litigation or similar proceedings could result in substantial costs, divert management’s attention and resources from our business or otherwise have a material adverse effect on our business, financial condition and results of operations.

Effects of Leverage [Text Block]

The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns, net of expenses. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing below.

Annual Interest Rate, Current [Percent]

6.70%

Annual Coverage Return Rate [Percent]

3.55%

Effects of Leverage [Table Text Block]


Assumed Return on Portfolio (Net of Expenses)	- 10%	- 5%	0%	5%	10%
Corresponding net return to common stockholder	-28.50%	-17.98%	-7.46%	3.06%	13.58%

Return at Minus Ten [Percent]

(28.50%)

Return at Minus Five [Percent]

(17.98%)

Return at Zero [Percent]

(7.46%)

Return at Plus Five [Percent]

3.06%

Return at Plus Ten [Percent]

13.58%

Share Price [Table Text Block]


			Sale Price
	NAV (1)		High		Low		Premium (Discount) of High Sales Price to NAV (2)		Premium (Discount) of Low Sales Price to NAV (2)		Cash Distribution per Share (3)
Year ended September 30, 2023
First quarter	$	19.63	$	21.69	$	17.58	10.5	%	(10.4)	%	$	0.960
Second quarter	$	19.66	$	21.48	$	17.70	9.3	%	(10.0)	%	$	0.550
Third quarter	$	19.58	$	20.05	$	17.99	2.4	%	(8.1)	%	$	0.550
Fourth quarter	$	19.63	$	20.71	$	19.24	5.5	%	(2.0)	%	$	0.550
Year ended September 30, 2024
First quarter	$	19.14	$	20.79	$	18.41	8.6	%	(3.8)	%	$	0.620
Second quarter	$	18.72	$	21.64	$	18.95	15.6	%	1.2	%	$	0.550
Third quarter	$	18.19	$	19.95	$	18.58	9.7	%	2.1	%	$	0.550
Fourth quarter	$	18.09	$	18.93	$	15.56	4.6	%	(14.0)	%	$	0.550
Year ending September 30, 2025
First quarter (through November 15, 2024)	*		$	16.66	$	15.55	*		*		$0.550 (4)

__________

* Not determinable at the time of filing.

(1)NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The NAVs shown are based on outstanding shares at the end of each period.

(2)Calculated as the respective high or low sales price less NAV, divided by NAV.

(3)Represents the distribution declared in the specified quarter. We have adopted an “opt out” dividend reinvestment plan for our common stockholders. Distributions by us are generally taxable to U.S. stockholders as ordinary income or capital gains.

(4)On November 7, 2024, our Board of Directors declared a quarterly distribution of $0.55 per share payable on December 31, 2024 to stockholders of record on December 16, 2024.

Lowest Price or Bid

15.56

$ 18.58

$ 18.95

$ 18.41

19.24

$ 17.99

$ 17.70

$ 17.58

$ 15.55

Highest Price or Bid

$ 18.93

$ 19.95

$ 21.64

$ 20.79

$ 20.71

$ 20.05

$ 21.48

$ 21.69

$ 16.66

Highest Price or Bid, Premium (Discount) to NAV [Percent]

4.60%

9.70%

15.60%

8.60%

5.50%

2.40%

9.30%

10.50%

Lowest Price or Bid, Premium (Discount) to NAV [Percent]

(14.00%)

2.10%

1.20%

(3.80%)

(2.00%)

(8.10%)

(10.00%)

(10.40%)

NAV Per Share

$ 18.09

^[1]

$ 18.09

^[1]

$ 18.19

$ 18.72

$ 19.14

$ 19.63

^[1]

$ 19.58

$ 19.66

$ 19.63

$ 18.09

^[1]

$ 19.81

$ 20.38

^[1]

$ 21.84

$ 19.47

Latest Premium (Discount) to NAV [Percent]

11.40%

Capital Stock, Long-Term Debt, and Other Securities [Abstract]

Long Term Debt [Table Text Block]

Syndicated Facility

Citibank Facility

OSI2 Citibank Facility

2025 Notes

2027 Notes

2029 Notes

Acquired Securities of Distressed Companies Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Interest Rate Fluctuation Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Changes in interest rates may affect our cost of capital and net investment income.

Increase in Interest Rates Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Elevated interest rates have the effect of increasing our net investment income, which makes it easier for our Adviser to receive incentive fees.

Uncertainty of Value of Investment Portfolio Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Adviser Support Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Referral Relationships Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Competition for Investment Opportunities Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

We may face increasing competition for investment opportunities, which could reduce returns and result in losses.

Incentive Fee Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

The incentive fee we pay to our Adviser relating to capital gains may be effectively greater than 17.5%.

Restriction on Transactions with Affiliates Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Our ability to enter into transactions with our affiliates is restricted.

Qualification as Business Development Company Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

A failure on our part to maintain our qualification as a Business Development Company would significantly reduce our operating flexibility.

Ability to Raise Capital Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Recent Developments In Banking Sector Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Recent developments in the banking sector could materially affect the success of our activities and investments.

Ongoing Conflict Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

The ongoing conflict between Russia and Ukraine could materially affect the success of our activities and investments.

The ongoing conflict between Israel and Hamas could materially affect the success of our activities and investments.

Board of Directors Decisions Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Our Board of Directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval, the effects of which may be adverse.

Changes in Laws Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Changes in laws or regulations governing our operations may adversely affect our business or cause us to alter our business strategy.

ESG Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

We are subject to risks associated with respect to ESG matters.

Inflation Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

We are subject to risks associated with inflation.

Global Climate Change and Environmental Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

We and/or our portfolio companies may be materially and adversely impacted by global climate change.

The market’s focus on climate change may not have a positive impact on our investments.

We may face significant environmental liability in connection with our investments.

Economic Trade Sanctions And Anti-Bribery Law Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Economic and trade sanctions and anti-bribery laws could make it more difficult or costly for us to conduct our operations or achieve our business objectives.

Cyber Security Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

We may face a breach of our cyber security, which could result in adverse consequences to our operations and exposure of confidential information.

Data Privacy Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

Artificial Intelligence Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

We are subject to risks associated with artificial intelligence and machine learning technology.

Inability to Invest Offering Proceeds Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

We may be unable to invest a significant portion of the net proceeds from an offering of our securities on acceptable terms within an attractive timeframe.

Allocation of Net Offering Proceeds Risk [Member]

General Description of Registrant [Abstract]

Risk [Text Block]

We may allocate the net proceeds from an offering in ways with which you may not agree.

Conflicts of Interest Risk [Member]